"","pmid","title","nodeA","edge","nodeB","context","nodeA_normalized","edge_normalized","nodeB_normalized","context_normalized"
"29","37809459","The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.","YTHDC1","bind","m6A","cholangiocarcinoma","YTHDC1","INTERACTS_WITH","m6A","CHOL(Cholangiocarcinoma)"
"30","37809459","The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.","CTBP1-AS2","mediate","m6A","cholangiocarcinoma","CTBP1-DT","AFFECTS","m6A","CHOL(Cholangiocarcinoma)"
"31","37809459","The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.","m6A","accelerate","progression","cholangiocarcinoma","m6A","STIMULATES","progression","CHOL(Cholangiocarcinoma)"
"63","37724835","METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis","METTL3","regulate","m6A","Osteoarthritis","METTL3","AFFECTS","m6A","Osteoarthritis"
"64","37724835","METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis","m6A","is on","NEK7","Osteoarthritis","m6A","LOCATES","NEK7","Osteoarthritis"
"65","37724835","METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis","NEK7","Inhibit","formation","Osteoarthritis","NEK7","INHIBITS","formation","Osteoarthritis"
"80","37588656","Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells.","Alkbh5","maintain","self-renewal","hematopoietic stem cells","ALKBH5","MAINTAINS","Self-Renewal","Hematopoietic Stem Cells"
"103","37602313","RNA N6-methyladenosine methyltransferase WTAP promotes the differentiation of endothelial progenitor cells","WTAP","promote","differentiation","endothelial progenitor cells","WTAP","STIMULATES","cell differentiation","Endothelial Progenitor Cells"
"116","37605570","METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma","METTL3","modify","lncRNA-MALAT1","Ewing's sarcoma","METTL3","AFFECTS","MALAT1","SARC(Sarcoma)"
"117","37605570","METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma","lncRNA-MALAT1","regulate the molecular axis of","miR-124-3p/CDK4","Ewing's sarcoma","MALAT1","AFFECTS","miR-124-3p/CDK4","SARC(Sarcoma)"
"146","34132367","METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression.","METTL3","mediate","m6A","non-small cell lung cancer","METTL3","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"147","34132367","METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression.","m6A","is on","Bcl-2","non-small cell lung cancer","m6A","LOCATES","BCL2","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"148","34132367","METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression.","Bcl-2","promote","progression","non-small cell lung cancer","BCL2","STIMULATES","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"150","33676554","METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.","METTL3","mediate","m6A","lung adenocarcinoma","METTL3","AFFECTS","m6A","LUAD(Lung Adenocarcinoma)"
"151","33676554","METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.","m6A","is on","FBXW7","lung adenocarcinoma","m6A","LOCATES","FBXW7","LUAD(Lung Adenocarcinoma)"
"152","33676554","METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.","FBXW7","suppress","lung adenocarcinoma","lung adenocarcinoma","FBXW7","INHIBITS","lung adenocarcinoma","LUAD(Lung Adenocarcinoma)"
"254","34458141","m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer.","METTL14","upregulate","Cytidine Deaminase","Pancreatic Cancer","METTL14","STIMULATES","Cytidine Deaminase","PAAD(Pancreatic Adenocarcinoma)"
"255","34458141","m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer.","Cytidine Deaminase","promote","Gemcitabine Resistance","Pancreatic Cancer","Cytidine Deaminase","STIMULATES","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"262","32655129","HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.","HDAC3","regulate","FOXA2","Gastric Cancer","HDAC3","AFFECTS","FOXA2","STAD(Stomach adenocarcinoma)"
"263","32655129","HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.","FOXA2","regulate","FTO/m6A/MYC signaling","Gastric Cancer","FOXA2","AFFECTS","FTO/m6A/MYC signaling pathway","STAD(Stomach adenocarcinoma)"
"264","32655129","HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.","FTO/m6A/MYC signaling","contribute","Development","Gastric Cancer","FTO/m6A/MYC signaling pathway","AFFECTS","development","STAD(Stomach adenocarcinoma)"
"287","33846348","Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis.","Low-level arsenic exposure","impair autophagy of","FTO","Null","Low-level arsenic exposure","DISRUPTS","FTO","Null"
"288","33846348","Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis.","FTO","promote","Tumorigenesis","Null","FTO","STIMULATES","Carcinogenesis","Null"
"290","33515893","Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish.","Triclosan","induce the abnormal expression of","miR-30b","zebrafish","triclosan","DISRUPTS","MIR30B","Zebrafish"
"291","33515893","Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish.","miR-30b","regulate","FTO","zebrafish","MIR30B","AFFECTS","FTO","Zebrafish"
"292","33515893","Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish.","FTO","mediate","m6A","zebrafish","FTO","AFFECTS","m6A","Zebrafish"
"293","33515893","Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish.","m6A","cause","lipid metabolism disorder","zebrafish","m6A","CAUSES","Lipid Metabolism Disorders","Zebrafish"
"319","31582403","METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.","METTL3","mediate","m6A","Gastric Cancer","METTL3","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"320","31582403","METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.","m6A","is on","HDGF","Gastric Cancer","m6A","LOCATES","HDGF","STAD(Stomach adenocarcinoma)"
"321","31582403","METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.","HDGF","promote","Progression","Gastric Cancer","HDGF","STIMULATES","progression","STAD(Stomach adenocarcinoma)"
"347","34537760","METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.","METTL3","mediate","m6A","Prostate Cancer","METTL3","AFFECTS","m6A","PRAD(Prostate Adenocarcinoma)"
"348","34537760","METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.","m6A","is on","KIF3C-mRNA","Prostate Cancer","m6A","LOCATES","KIF3C-mRNA","PRAD(Prostate Adenocarcinoma)"
"349","34537760","METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.","miR-320d","downregulate","KIF3C-mRNA","Prostate Cancer","miR-320d","INHIBITS","KIF3C-mRNA","PRAD(Prostate Adenocarcinoma)"
"350","34537760","METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.","KIF3C-mRNA","promote","Progression","Prostate Cancer","KIF3C","STIMULATES","progression","PRAD(Prostate Adenocarcinoma)"
"404","34016959","Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.","ALKBH5","suppress","m6A","KRAS mutation/LKB1 loss lung cancer","ALKBH5","INHIBITS","m6A","LUAD(Lung Adenocarcinoma)"
"405","34016959","Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.","m6A","aggravate","oncological behavior","KRAS mutation/LKB1 loss lung cancer","m6A","COMPLICATES","oncological behavior","LUAD(Lung Adenocarcinoma)"
"451","33459381","m6A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region.","PRMT1","mediate","arginine methylation","Null","PRMT1","AFFECTS","arginine methylation","Null"
"452","33459381","m6A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region.","arginine methylation","is on","METTL14","Null","arginine methylation","LOCATES","METTL14","Null"
"453","33459381","m6A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region.","METTL14","regulate","m6A","Null","METTL14","AFFECTS","m6A","Null"
"455","34505967","METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.","METTL3","mediate","m6A","Human Adipose-Derived Stem Cells","METTL3","AFFECTS","m6A","Human Adipose-Derived Stem Cells"
"456","34505967","METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.","m6A","is on","lncRNA","Human Adipose-Derived Stem Cells","m6A","LOCATES","RNA, Long Noncoding","Human Adipose-Derived Stem Cells"
"457","34505967","METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.","lncRNA","regulate","osteogenic differentiation","Human Adipose-Derived Stem Cells","RNA, Long Noncoding","AFFECTS","Osteogenic Differentiation","Human Adipose-Derived Stem Cells"
"458","34505967","METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.","NEL-Like 1 Protein","induce","osteogenic differentiation","Human Adipose-Derived Stem Cells","NELL1","CAUSES","Osteogenic Differentiation","Human Adipose-Derived Stem Cells"
"466","33596916","Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.","Dummy","target","SNHG3/miR-186-5p","Esophageal Cancer","platinium treatment","AFFECTS","m6A","ESCA(Esophageal Carcinoma)"
"467","33596916","Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.","SNHG3/miR-186-5p","inhibit","METTL3","Esophageal Cancer","SNHG3/miR-186-5p","INHIBITS","METTL3","ESCA(Esophageal Carcinoma)"
"468","33596916","Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.","METTL3","increase","m6A","Esophageal Cancer","METTL3","AUGMENTS","m6A","ESCA(Esophageal Carcinoma)"
"469","33596916","Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.","platinium treatment","increase","m6A","Esophageal Cancer","SNHG3/miR-186-5p","AUGMENTS","m6A","ESCA(Esophageal Carcinoma)"
"528","33882457","Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.","EED","methylate","microRNA-338-5p","Gastric Cancer","EED","CONVERTS_TO","microRNA-338-5p","STAD(Stomach adenocarcinoma)"
"529","33882457","Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.","microRNA-338-5p","promote","METTL3","Gastric Cancer","microRNA-338-5p","STIMULATES","METTL3","STAD(Stomach adenocarcinoma)"
"530","33882457","Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.","METTL3","mediate","translation","Gastric Cancer","METTL3","AFFECTS","translation","STAD(Stomach adenocarcinoma)"
"531","33882457","Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.","translation","process of","CDCP1","Gastric Cancer","translation","PROCESS_OF","CDCP1","STAD(Stomach adenocarcinoma)"
"604","32552762","METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.","METTL14","mediate","N6-methyladenosine","Colorectal Cancer","METTL14","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"605","32552762","METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.","N6-methyladenosine","is on","SOX4","Colorectal Cancer","m6A","LOCATES","SOX4","COAD(Colon Adenocarcinoma)"
"606","32552762","METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.","SOX4","inhibit","Tumor Metastasis","Colorectal Cancer","SOX4","INHIBITS","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"642","31767846","m6A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2.","m6A","promote","Translation","Null","m6A","STIMULATES","translation","Null"
"643","31767846","m6A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2.","YTHDC2","bind","m6A","Null","YTHDC2","INTERACTS_WITH","m6A","Null"
"645","34098071","KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy.","KAT1","trigger","YTHDF2","Diabetic Retinopathy","HAT1","CAUSES","YTHDF2","Diabetic Retinopathy"
"646","34098071","KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy.","YTHDF2","mediate the instability of","ITGB1","Diabetic Retinopathy","YTHDF2","AFFECTS","ITGB1","Diabetic Retinopathy"
"647","34098071","KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy.","ITGB1","alleviate","Progression","Diabetic Retinopathy","ITGB1","INHIBITS","progression","Diabetic Retinopathy"
"681","33590832","METTL3-mediated m6A methylation negatively modulates autophagy to support porcine blastocyst development.","METTL3","mediate","m6A","Porcine Blastocyst","METTL3","AFFECTS","m6A","Porcine Blastocyst"
"682","33590832","METTL3-mediated m6A methylation negatively modulates autophagy to support porcine blastocyst development.","m6A","negatively modulate","Autophagy","Porcine Blastocyst","m6A","INHIBITS","autophagy","Porcine Blastocyst"
"683","33590832","METTL3-mediated m6A methylation negatively modulates autophagy to support porcine blastocyst development.","Autophagy","support","Development","Porcine Blastocyst","autophagy","STIMULATES","development","Porcine Blastocyst"
"710","33910046","Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.","Tumors","exploit","FTO","Null","Neoplasms","USES","FTO","Null"
"711","33910046","Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.","FTO","regulate","Glycolytic metabolism","Tumors","FTO","AFFECTS","Glycolytic metabolism","PANCAN(Pan-Cancer)"
"712","33910046","Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.","Glycolytic metabolism","evade","Immune surveillance","Tumors","Glycolytic metabolism","PREVENTS","Immune surveillance","PANCAN(Pan-Cancer)"
"718","33648590","METTL3-mediated m6A modification regulates cell cycle progression of dental pulp stem cells.","METTL3","mediate","m6A","Dental Pulp Stem Cells","METTL3","AFFECTS","m6A","Dental Pulp Stem Cells"
"719","33648590","METTL3-mediated m6A modification regulates cell cycle progression of dental pulp stem cells.","m6A","regulate","Cell cycle progression","Dental Pulp Stem Cells","m6A","AFFECTS","cell cycle progression","Dental Pulp Stem Cells"
"809","32064749","YTHDF1-mediated translation amplifies Wnt-driven intestinal stemness.","YTHDF1","mediate","Translation","Null","YTHDF1","AFFECTS","translation","Null"
"810","32064749","YTHDF1-mediated translation amplifies Wnt-driven intestinal stemness.","Translation","amplify","Wnt-driven intestinal stemness","Null","translation","AUGMENTS","Wnt-driven intestinal stemness","Null"
"812","30875984","m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.","YTHDF2","regulate","Inflammatory Response","Null","YTHDF2","AFFECTS","inflammatory response","Null"
"813","30875984","m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.","LPS","induce","Inflammatory Response","Null","lipopolysaccharide","CAUSES","inflammatory response","Null"
"815","32267835","YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators.","YTHDF2","promote","Mitotic Entry","Null","YTHDF2","STIMULATES","Mitotic Entry","Null"
"816","32267835","YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators.","Cell Cycle Mediators","regulate","YTHDF2","Null","Cell Cycle Mediators","AFFECTS","YTHDF2","Null"
"831","31564433","Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly.","Bi-allelic Variants","is in","METTL5","Autosomal-Recessive Intellectual Disability and Microcephaly","Bi-allelic Variants","LOCATES","METTL5","Autosomal-Recessive Intellectual Disability and Microcephaly"
"832","31564433","Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly.","METTL5","cause","Autosomal-Recessive Intellectual Disability","Autosomal-Recessive Intellectual Disability and Microcephaly","METTL5","CAUSES","Intellectual Disability","Autosomal-Recessive Intellectual Disability and Microcephaly"
"833","31564433","Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly.","METTL5","cause","Microcephaly","Autosomal-Recessive Intellectual Disability and Microcephaly","METTL5","CAUSES","Microcephaly","Autosomal-Recessive Intellectual Disability and Microcephaly"
"835","34544449","RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.","FTO","up-regulate","LINC00022","Esophageal Squamous Cell Carcinoma","FTO","STIMULATES","DLEU2","ESCA(Esophageal Carcinoma)"
"836","34544449","RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.","LINC00022","promote","tumorigenesis","Esophageal Squamous Cell Carcinoma","DLEU2","STIMULATES","Carcinogenesis","ESCA(Esophageal Carcinoma)"
"845","28247949","NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.","NSUN2","mediate","m5C Methylation","Null","NSUN2","AFFECTS","m5C","Null"
"846","28247949","NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.","METTL3","mediate","m6A Methylation","Null","METTL3","AFFECTS","m6A","Null"
"847","28247949","NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.","METTL14","mediate","m6A Methylation","Null","METTL14","AFFECTS","m6A","Null"
"848","28247949","NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.","m5C Methylation","enhance","p21 Translation","Null","m5C","AUGMENTS","p21 Translation","Null"
"849","28247949","NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.","m6A Methylation","enhance","p21 Translation","Null","m6A","AUGMENTS","p21 Translation","Null"
"856","29997116","FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.","FTO","regulate","N6-Methyladenosine","Cardiac Remodeling and Repair","FTO","AFFECTS","m6A","Cardiac Remodeling and Repair"
"857","29997116","FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.","N6-Methyladenosine","regulate","Cardiac Function","Cardiac Remodeling and Repair","m6A","AFFECTS","Cardiac Function","Cardiac Remodeling and Repair"
"859","31642031","Binding to m6A RNA promotes YTHDF2-mediated phase separation.","YTHDF2","bind","m6A","Null","YTHDF2","INTERACTS_WITH","m6A","Null"
"860","31642031","Binding to m6A RNA promotes YTHDF2-mediated phase separation.","m6A","promote","Phase Separation","Null","m6A","STIMULATES","Phase Separation","Null"
"869","29982692","m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite.","FTO","regulate","Dopaminergic Neurotransmission Deficits","Dopaminergic Neurotransmission Deficits","FTO","AFFECTS","Dopaminergic Neurotransmission Deficits","Dopaminergic Neurotransmission Deficits"
"870","29982692","m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite.","Arsenite","cause","Dopaminergic Neurotransmission Deficits","Dopaminergic Neurotransmission Deficits","arsenite(3-)","CAUSES","Dopaminergic Neurotransmission Deficits","Dopaminergic Neurotransmission Deficits"
"872","33761320","RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis.","FTO","stabilize","FOXJ1","Null","FTO","MAINTAINS","FOXJ1","Null"
"873","33761320","RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis.","FOXJ1","regulate","Motile Ciliogenesis","Null","FOXJ1","AFFECTS","Motile Ciliogenesis","Null"
"875","33932138","METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukemia.","METTL3","mediate","Bone Marrow Mesenchymal Stem Cell Adipogenesis","Acute Myeloid Leukemia","METTL3","AFFECTS","Bone Marrow Mesenchymal Stem Cell Adipogenesis","LAML(Acute Myeloid Leukemia)"
"876","33932138","METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukemia.","Bone Marrow Mesenchymal Stem Cell Adipogenesis","promote","Chemoresistance","Acute Myeloid Leukemia","Bone Marrow Mesenchymal Stem Cell Adipogenesis","STIMULATES","Chemoresistance","LAML(Acute Myeloid Leukemia)"
"970","33428593","ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma.","ALKBH5","demethylate","m6A","Uveal Melanoma","ALKBH5","CONVERTS_TO","m6A","UVM(Uveal Melanoma)"
"971","33428593","ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma.","m6A","is on","FOXM1","Uveal Melanoma","m6A","LOCATES","FOXM1","UVM(Uveal Melanoma)"
"972","33428593","ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma.","FOXM1","promote","Progression","Uveal Melanoma","FOXM1","STIMULATES","progression","UVM(Uveal Melanoma)"
"994","33125861","YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis.","YTHDF3","induce","m6A-Enriched Gene Transcripts","Breast Cancer","YTHDF3","CAUSES","m6A-Enriched Gene Transcripts","BRCA(Breast Invasive Carcinoma)"
"995","33125861","YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis.","m6A-Enriched Gene Transcripts","promote","Brain Metastasis","Breast Cancer","m6A-Enriched Gene Transcripts","STIMULATES","Brain Metastasis","BRCA(Breast Invasive Carcinoma)"
"1214","33548009","FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.","FTO overexpression","inhibit","Apoptosis","Hypoxia/reoxygenation-treated myocardial cells","FTO overexpression","INHIBITS","apoptotic process","Hypoxia/reoxygenation-treated myocardial cells"
"1215","33548009","FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.","FTO","regulate","m6A","Hypoxia/reoxygenation-treated myocardial cells","FTO","AFFECTS","m6A","Hypoxia/reoxygenation-treated myocardial cells"
"1216","33548009","FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.","m6A","is on","Mhrt","Hypoxia/reoxygenation-treated myocardial cells","m6A","LOCATES","MHRT","Hypoxia/reoxygenation-treated myocardial cells"
"1217","33548009","FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.","Mhrt","inhibit","Apoptosis","Hypoxia/reoxygenation-treated myocardial cells","MHRT","INHIBITS","apoptotic process","Hypoxia/reoxygenation-treated myocardial cells"
"1247","32169943","YTHDF2 destabilizes m6A-modified neural-specific RNAs to restrain differentiation in induced pluripotent stem cells.","YTHDF2","destabilize","neural-specific RNAs","Induced pluripotent stem cells","YTHDF2","DISRUPTS","neural-specific RNAs","Induced Pluripotent Stem Cells"
"1248","32169943","YTHDF2 destabilizes m6A-modified neural-specific RNAs to restrain differentiation in induced pluripotent stem cells.","m6A","modify","neural-specific RNAs","Induced pluripotent stem cells","m6A","AFFECTS","neural-specific RNAs","Induced Pluripotent Stem Cells"
"1249","32169943","YTHDF2 destabilizes m6A-modified neural-specific RNAs to restrain differentiation in induced pluripotent stem cells.","neural-specific RNAs","restrain","Differentiation","Induced pluripotent stem cells","neural-specific RNAs","INHIBITS","cell differentiation","Induced Pluripotent Stem Cells"
"1330","37619934","Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma","Intracellular Fusobacterium nucleatum infection","increase","METTL3","esophageal squamous cell carcinoma","Intracellular Fusobacterium nucleatum infection","AUGMENTS","METTL3","ESCA(Esophageal Carcinoma)"
"1331","37619934","Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma","METTL3","mediate","m6A methylation","esophageal squamous cell carcinoma","METTL3","AFFECTS","m6A","ESCA(Esophageal Carcinoma)"
"1332","37619934","Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma","m6A methylation","promote","metastasis","esophageal squamous cell carcinoma","m6A","STIMULATES","Neoplasm Metastasis","ESCA(Esophageal Carcinoma)"
"1363","32426101","N6-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury.","Alkbh5","regulate","Cerebral Ischemia-Reperfusion Injury","cerebral ischemia-reperfusion injury","ALKBH5","AFFECTS","Cerebral Ischemia-Reperfusion Injury","cerebral ischemia-reperfusion injury"
"1364","32426101","N6-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury.","Fto","regulate","Cerebral Ischemia-Reperfusion Injury","cerebral ischemia-reperfusion injury","FTO","AFFECTS","Cerebral Ischemia-Reperfusion Injury","cerebral ischemia-reperfusion injury"
"1369","33412003","m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells.","FTO Inhibitors","impair","Self-Renewal","Glioblastoma Stem Cells","FTO Inhibitors","INHIBITS","Self-Renewal","Glioblastoma Stem Cells"
"1371","34350169","RNA Demethylase FTO Mediated RNA m6A Modification Is Involved in Maintaining Maternal-Fetal Interface in Spontaneous Abortion.","FTO","mediate","RNA m6A Modification","Spontaneous Abortion","FTO","AFFECTS","m6A","Abortion, Spontaneous"
"1372","34350169","RNA Demethylase FTO Mediated RNA m6A Modification Is Involved in Maintaining Maternal-Fetal Interface in Spontaneous Abortion.","RNA m6A Modification","maintain","Maternal-Fetal Interface","Spontaneous Abortion","m6A","MAINTAINS","Maternal-Fetal Interface","Abortion, Spontaneous"
"1391","34491904","m6A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression.","ALKBH5 suppression","contribute","Progression","Esophageal Squamous Cell Carcinoma","ALKBH5 suppression","AFFECTS","progression","ESCA(Esophageal Carcinoma)"
"1396","29484125","Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer.","Oncogene c-Myc","promote","YTHDF1","Colorectal Cancer","Oncogene c-Myc","STIMULATES","YTHDF1","COAD(Colon Adenocarcinoma)"
"1414","29855337","Ythdf2-mediated m6A mRNA clearance modulates neural development in mice.","Ythdf2","mediate","m6A mRNA clearance","Neural development in mice","YTHDF2","AFFECTS","m6A mRNA clearance","Neural development in mice"
"1415","29855337","Ythdf2-mediated m6A mRNA clearance modulates neural development in mice.","m6A mRNA clearance","modulate","Neural development","Neural development in mice","m6A mRNA clearance","AFFECTS","Neural development","Neural development in mice"
"1417","30065315","Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion.","dummy","induce suppression of","Ythdf2","hematopoietic stem cell.","dummy","INHIBITS","YTHDF2","hematopoietic stem cell."
"1418","30065315","Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion.","Ythdf2","promote","expansion","hematopoietic stem cell.","YTHDF2","STIMULATES","expansion","hematopoietic stem cell."
"1427","33692441","N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma.","YTHDF2","mediate","long noncoding RNA FENDRR degradation","Endometrioid Endometrial Carcinoma","YTHDF2","AFFECTS","FENDRR degradation","Endometrioid Endometrial Carcinoma"
"1428","33692441","N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma.","long noncoding RNA FENDRR degradation","promote","Cell Proliferation","Endometrioid Endometrial Carcinoma","long noncoding RNA FENDRR degradation","STIMULATES","cell population proliferation","Endometrioid Endometrial Carcinoma"
"1437","28106076","Cytoplasmic m6A reader YTHDF3 promotes mRNA translation.","YTHDF3","promote","mRNA translation","Null","YTHDF3","STIMULATES","translation","Null"
"1442","33886094","Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos.","YTHDC1","regulate scaffold function of","LINE1 RNA","Mouse ESCs and early embryos","YTHDC1","AFFECTS","LINE1","Mouse ESCs and early embryos"
"1454","31031138","Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia.","YTHDF2","compromise","Cancer Stem Cells","Acute Myeloid Leukemia","YTHDF2","COMPLICATES","Cancer Stem Cells","LAML(Acute Myeloid Leukemia)"
"1472","32782536","Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation.","dummy","induce knockdown of","METTL3","Gastric Cancer","dummy","INHIBITS","METTL3","STAD(Stomach adenocarcinoma)"
"1473","32782536","Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation.","METTL3","suppress","Cell Proliferation","Gastric Cancer","METTL3","INHIBITS","cell population proliferation","STAD(Stomach adenocarcinoma)"
"1475","33083017","A defined N6-methyladenosine (m6A) profile conferred by METTL3 regulates muscle stem cell/myoblast state transitions.","METTL3","confer","N6-methyladenosine (m6A)","muscle stem cell/myoblast","METTL3","PRODUCES","m6A","muscle stem cell/myoblast"
"1476","33083017","A defined N6-methyladenosine (m6A) profile conferred by METTL3 regulates muscle stem cell/myoblast state transitions.","N6-methyladenosine (m6A)","regulate","state transition","muscle stem cell/myoblast","m6A","AFFECTS","state transition","muscle stem cell/myoblast"
"1486","32783360","The 18S rRNA m6A methyltransferase METTL5 promotes mouse embryonic stem cell differentiation.","METTL5","promote","differentiation","Mouse embryonic stem cell","METTL5","STIMULATES","cell differentiation","Mouse Embryonic Stem Cells"
"1488","26218273","The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation.","FTO","required for","Preadipocyte Differentiation","Null","FTO","CAUSES","Preadipocyte Differentiation","Null"
"1493","34315853","The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.","FTO","regulate","FOS","granulosa cells","FTO","AFFECTS","FOS_family","Granulosa Cells"
"1494","34315853","The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.","FOS","retard","Ovarian Aging","granulosa cells","FOS_family","INHIBITS","Ovarian Aging","Granulosa Cells"
"1496","34288397","Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function.","dummy","induce deficiency of","Mettl14","Substantia nigra","dummy","INHIBITS","METTL14","Substantia Nigra"
"1497","34288397","Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function.","Mettl14","alter","Dopaminergic neuron function","Substantia nigra","METTL14","AFFECTS","Dopaminergic neuron function","Substantia Nigra"
"1499","34329695","EBV downregulates the m6A writer WTAP in EBV-associated gastric carcinoma.","EBV","downregulate","WTAP","EBV-associated gastric carcinoma","Herpesvirus 4, Human","INHIBITS","WTAP","STAD(Stomach adenocarcinoma)"
"1501","31799605","The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA.","ZCCHC4","catalyses","N6-methyladenosine","Null","ZCCHC4","AUGMENTS","m6A","Null"
"1502","31799605","The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA.","N6-methyladenosine","is on","28S ribosomal RNA","Null","m6A","LOCATES","RNA, Ribosomal, 28S","Null"
"1507","32449584","m6A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis.","ALKBH5","promote","Proliferation","Esophageal Squamous Cell Carcinoma associated with poor prognosis","ALKBH5","STIMULATES","cell population proliferation","ESCA(Esophageal Carcinoma)"
"1508","32449584","m6A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis.","proliferation","associate","poor prognosis","Esophageal Squamous Cell Carcinoma associated with poor prognosis","cell population proliferation","ASSOCIATED_WITH","Poor prognosis","ESCA(Esophageal Carcinoma)"
"1510","33023892","The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells.","YTHDF2","maintain","Oncogene expression","Glioblastoma stem cells","YTHDF2","MAINTAINS","Oncogenes","Glioblastoma stem cells"
"1512","33740664","METTL3 regulates skeletal muscle specific miRNAs at both transcriptional and post-transcriptional levels.","METTL3","regulate","miRNAs","skeletal muscle","METTL3","AFFECTS","MicroRNAs","Muscle, Skeletal"
"1514","31328227","The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112.","TRMT112","stabilize","METTL5","Null","TRMT112","MAINTAINS","METTL5","Null"
"1516","33204330","YTHDF1-enhanced iron metabolism depends on TFRC m6A methylation.","YTHDF1","enhance","Iron metabolism","Null","YTHDF1","AUGMENTS","Iron metabolism","Null"
"1517","33204330","YTHDF1-enhanced iron metabolism depends on TFRC m6A methylation.","Iron metabolism","depend on","TFRC m6A methylation","Null","Iron metabolism","INTERACTS_WITH","TFRC m6A methylation","Null"
"1540","32964498","m6A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy.","METTL3","regulate","immune responses to anti-PD-1 therapy","Null","METTL3","AFFECTS","immune responses to anti-PD-1 therapy","Null"
"1541","32964498","m6A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy.","METTL14","regulate","immune responses to anti-PD-1 therapy","Null","METTL14","AFFECTS","immune responses to anti-PD-1 therapy","Null"
"1553","32843065","Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.","dummy","induce upregulation of","METTL14","Pancreatic Cancer","dummy","STIMULATES","METTL14","PAAD(Pancreatic Adenocarcinoma)"
"1554","32843065","Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.","METTL14","elevate","PERP mRNA N6 adenosine methylation","Pancreatic Cancer","METTL14","STIMULATES","PERP mRNA N6 adenosine methylation","PAAD(Pancreatic Adenocarcinoma)"
"1555","32843065","Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.","PERP mRNA N6 adenosine methylation","promote","Growth","Pancreatic Cancer","PERP mRNA N6 adenosine methylation","STIMULATES","Growth","PAAD(Pancreatic Adenocarcinoma)"
"1556","32843065","Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.","elevation of PERP mRNA N6 adenosine methylation","promote","metastasis","Pancreatic Cancer","elevation of PERP mRNA N6 adenosine methylation","STIMULATES","Neoplasm Metastasis","PAAD(Pancreatic Adenocarcinoma)"
"1567","32869897","METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.","METTL3","regulate","m6A","Endometrioid Epithelial Ovarian Cancer","METTL3","AFFECTS","m6A","UCEC(Uterine Corpus Endometrial Carcinoma)"
"1574","33217317","Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation.","USP5","stabilize","ERK-Phosphorylated METTL3","Null","USP5","MAINTAINS","ERK-Phosphorylated METTL3","Null"
"1575","33217317","Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation.","ERK-Phosphorylated METTL3","increase","m6A Methylation","Null","ERK-Phosphorylated METTL3","AUGMENTS","m6A","Null"
"1577","31697949","METTL14-Dependent m6A Regulates Vascular Calcification Induced by Indoxyl Sulfate.","METTL14","regulate","m6A","Null","METTL14","AFFECTS","m6A","Null"
"1578","31697949","METTL14-Dependent m6A Regulates Vascular Calcification Induced by Indoxyl Sulfate.","m6A","regulate","Vascular Calcification","Null","m6A","AFFECTS","Vascular Calcification","Null"
"1579","31697949","METTL14-Dependent m6A Regulates Vascular Calcification Induced by Indoxyl Sulfate.","Indoxyl Sulfate","induce","Vascular Calcification","Null","indoxyl sulfate","CAUSES","Vascular Calcification","Null"
"1581","32053707","HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle.","HIV protease","cleave","YTHDF3","Viral particle","HIV Protease","DISRUPTS","YTHDF3","Virion"
"1583","32344536","Modification of Adenosine by Mettl3 Methyltransferase in the 5'-External Transcribed Spacer of 47S Pre-rRNA Affects rRNA Maturation.","Mettl3","modify","Adenosine","5'-External Transcribed Spacer of 47S Pre-rRNA","METTL3","AFFECTS","adenosine","5'-External Transcribed Spacer of 47S Pre-rRNA"
"1584","32344536","Modification of Adenosine by Mettl3 Methyltransferase in the 5'-External Transcribed Spacer of 47S Pre-rRNA Affects rRNA Maturation.","Adenosine","affect","rRNA Maturation","5'-External Transcribed Spacer of 47S Pre-rRNA","adenosine","AFFECTS","rRNA Maturation","5'-External Transcribed Spacer of 47S Pre-rRNA"
"1598","33867838","CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.","m6A","upregulate","CircMETTL3","Breast Cancer","m6A","STIMULATES","CircMETTL3","BRCA(Breast Invasive Carcinoma)"
"1599","33867838","CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.","CircMETTL3","promote","Progression","Breast Cancer","CircMETTL3","STIMULATES","progression","BRCA(Breast Invasive Carcinoma)"
"1670","33999206","The N6-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response.","YTHDF1","modulate","TRAF6","Null","YTHDF1","AFFECTS","TRAF6","Null"
"1671","33999206","The N6-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response.","TRAF6","mediate","Intestinal immune response","Null","TRAF6","AFFECTS","Intestinal immune response","Null"
"1799","34430596","METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/beta-catenin pathway.","METTL3","induce","UCK2","Melanoma Cancer","METTL3","CAUSES","UCK2","SKCM(Skin Cutaneous Melanoma)"
"1800","34430596","METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/beta-catenin pathway.","UCK2","regulate","WNT/beta-catenin pathway","Melanoma Cancer","UCK2","AFFECTS","WNT/beta-catenin pathway","SKCM(Skin Cutaneous Melanoma)"
"1801","34430596","METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/beta-catenin pathway.","WNT/beta-catenin pathway","promote","Metastasis","Melanoma Cancer","WNT/beta-catenin pathway","STIMULATES","Neoplasm Metastasis","SKCM(Skin Cutaneous Melanoma)"
"1812","29879109","METTL3-mediated m6A modification is required for cerebellar development.","METTL3","mediate","m6A","Cerebellar Development","METTL3","AFFECTS","m6A","Cerebellar Development"
"1813","29879109","METTL3-mediated m6A modification is required for cerebellar development.","m6A","is required for","cerebellar development","Cerebellar Development","m6A","CAUSES","cerebellar development","Cerebellar Development"
"1815","30364964","N6-methyladenosine modification and METTL3 modulate enterovirus 71 replication.","N6-methyladenosine","modulate","Replication","Enterovirus 71","m6A","AFFECTS","replication","Enterovirus 71"
"1816","30364964","N6-methyladenosine modification and METTL3 modulate enterovirus 71 replication.","METTL3","modulate","Replication","Enterovirus 71","METTL3","AFFECTS","replication","Enterovirus 71"
"1822","31015515","Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation.","METTL3","mediate","m6A methylation","dendritic cell","METTL3","AFFECTS","m6A","Dendritic Cells"
"1823","31015515","Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation.","m6A methylation","activate","dendritic cell","dendritic cell","m6A","STIMULATES","Dendritic Cells","Dendritic Cells"
"1829","33795874","m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype.","METTL3","drive","the senescence-associated secretory phenotype","Null","METTL3","STIMULATES","the senescence-associated secretory phenotype","Null"
"1830","33795874","m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype.","METTL14","drive","the senescence-associated secretory phenotype","Null","METTL14","STIMULATES","the senescence-associated secretory phenotype","Null"
"1832","33852874","A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease.","methionine-Mettl3-N6-methyladenosine axis","promote","Polycystic Kidney Disease","Polycystic Kidney Disease","methionine-Mettl3-N6-methyladenosine axis","STIMULATES","polycystic kidney disease","polycystic kidney disease"
"1849","34530916","METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors.","METTL3","regulate","MALAT1","Thymic Epithelial Tumors","METTL3","AFFECTS","MALAT1","THYM(Thymoma)"
"1850","34530916","METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors.","MALAT1","drive","c-Myc","Thymic Epithelial Tumors","MALAT1","STIMULATES","MYC","THYM(Thymoma)"
"1852","34535671","METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells.","METTL3","mediate","m6A methylation","natural killer cell","METTL3","AFFECTS","m6A","Killer Cells, Natural"
"1853","34535671","METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells.","m6A methylation","promote","Anti-tumour immunity","natural killer cell","m6A","STIMULATES","anti-tumor immunity","Killer Cells, Natural"
"1855","34547464","METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease.","METTL3-m6A-Rubicon axis","inhibit","Autophagy","Nonalcoholic fatty liver disease","METTL3-m6A-Rubicon axis","INHIBITS","autophagy","Non-alcoholic Fatty Liver Disease"
"1857","33658391","SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.","SEDT2","mediate","m6A methylation","pulmonary arterial hypertension in mice","SEDT2","AFFECTS","m6A","pulmonary arterial hypertension in mice"
"1858","33658391","SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.","METTL14","mediate","m6A methylation","pulmonary arterial hypertension in mice","METTL14","AFFECTS","m6A","pulmonary arterial hypertension in mice"
"1859","33658391","SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.","m6A methylation","contribute","pulmonary arterial hypertension","pulmonary arterial hypertension in mice","m6A","AFFECTS","Pulmonary Arterial Hypertension","pulmonary arterial hypertension in mice"
"1860","33658391","SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.","hypoxia","induce","pulmonary arterial hypertension","pulmonary arterial hypertension in mice","Hypoxia","CAUSES","Pulmonary Arterial Hypertension","pulmonary arterial hypertension in mice"
"1865","28525753","The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention.","METTL16","regulate","SAM Synthetase Intron Retention","Null","METTL16","AFFECTS","SAM Synthetase Intron Retention","Null"
"1870","32350990","The 18S ribosomal RNA m6A methyltransferase Mettl5 is required for normal walking behavior in Drosophila.","Mettl5","is required","Normal walking behavior","Drosophila","METTL5","CAUSES","Normal walking behavior","Drosophila"
"1875","32518161","Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish.","dummy","induce loss of","Rbm15","zebrafish","dummy","INHIBITS","RBM15","Zebrafish"
"1876","32518161","Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish.","Rbm15","disrupt","Liver maturation","zebrafish","RBM15","DISRUPTS","Liver maturation","Zebrafish"
"1878","28398475","Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis.","FTO","regulate","Adult neurogenesis","Null","FTO","AFFECTS","Adult neurogenesis","Null"
"1880","37734910","Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis.","CerS6","mediate","sphingolipid metabolism","Ulcerative Colitis","CERS6","AFFECTS","sphingolipid metabolic process","Colitis, Ulcerative"
"1881","37734910","Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis.","FTO deficiency","disrupt","CerS6","Ulcerative Colitis","FTO deficiency","DISRUPTS","CERS6","Colitis, Ulcerative"
"1882","37734910","Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis.","FTO deficiency","aggravate","ulcerative colitis","Ulcerative Colitis","FTO deficiency","COMPLICATES","Colitis, Ulcerative","Colitis, Ulcerative"
"1883","37734910","Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis.","sphingolipid metabolism","regulate","ulcerative colitis","Ulcerative Colitis","sphingolipid metabolic process","AFFECTS","Colitis, Ulcerative","Colitis, Ulcerative"
"1885","37735401","Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer.","Curdione","induce","Ferroptosis","Colorectal Cancer","Curdione","CAUSES","Ferroptosis","COAD(Colon Adenocarcinoma)"
"1886","37735401","Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer.","Curdione","regulate","METTL14","Colorectal Cancer","Curdione","AFFECTS","METTL14","COAD(Colon Adenocarcinoma)"
"1887","37735401","Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer.","Curdione","regulate","YTHDF2","Colorectal Cancer","Curdione","AFFECTS","YTHDF2","COAD(Colon Adenocarcinoma)"
"1888","37735401","Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer.","METTL14","regulate","m6A methylation","Colorectal Cancer","METTL14","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"1889","37735401","Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer.","YTHDF2","bind","m6A methylation","Colorectal Cancer","YTHDF2","INTERACTS_WITH","m6A","COAD(Colon Adenocarcinoma)"
"1890","37735401","Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer.","m6A methylation","regulate","Ferroptosis","Colorectal Cancer","m6A","AFFECTS","Ferroptosis","COAD(Colon Adenocarcinoma)"
"1892","37735874","METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression.","METTL5","mediate","18S rRNA m6A modification","Intrahepatic Cholangiocarcinoma","METTL5","AFFECTS","18S rRNA m6A modification","CHOL(Cholangiocarcinoma)"
"1893","37735874","METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression.","18S rRNA m6A modification","promote","oncogenic mRNA translation","Intrahepatic Cholangiocarcinoma","18S rRNA m6A modification","STIMULATES","oncogenic mRNA translation","CHOL(Cholangiocarcinoma)"
"1894","37735874","METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression.","oncogenic mRNA translation","promote","Intrahepatic Cholangiocarcinoma progression","Intrahepatic Cholangiocarcinoma","oncogenic mRNA translation","STIMULATES","Intrahepatic Cholangiocarcinoma Progression","CHOL(Cholangiocarcinoma)"
"1896","37737187","FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.","FTO","target","siRNA","Parkinson's disease","FTO","INTERACTS_WITH","RNA, Small Interfering","Parkinson Disease"
"1897","37737187","FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.","siRNA","delivered by","MSC-derived exosomes","Parkinson's disease","RNA, Small Interfering","delivered by","MSC-derived exosomes","Parkinson Disease"
"1898","37737187","FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.","MSC-derived exosomes","alleviate","dopaminergic neuronal death","Parkinson's disease","MSC-derived exosomes","INHIBITS","dopaminergic neuronal death","Parkinson Disease"
"1899","37737187","FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.","m6A","regulate","ATM mRNA","Parkinson's disease","m6A","AFFECTS","ATM","Parkinson Disease"
"1900","37737187","FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.","ATM mRNA","regulate","dopaminergic neuronal death","Parkinson's disease","ATM","AFFECTS","dopaminergic neuronal death","Parkinson Disease"
"1902","37741489","YTHDF1 shapes ""cold"" tumor and inhibits CD8+ T cells infiltration and function in breast cancer.","YTHDF1","shape","cold tumor","Breast Cancer","YTHDF1","shape","""cold"" tumor","BRCA(Breast Invasive Carcinoma)"
"1903","37741489","YTHDF1 shapes ""cold"" tumor and inhibits CD8+ T cells infiltration and function in breast cancer.","YTHDF1","inhibit","CD8+ T cells","Breast Cancer","YTHDF1","INHIBITS","CD8+ T cells","BRCA(Breast Invasive Carcinoma)"
"1905","37741915","METTL14-upregulated miR-6858 triggers cell apoptosis in keratinocytes of oral lichen planus through decreasing GSDMC.","METTL14","upregulate","miR-6858","Keratinocytes of Oral Lichen Planus","METTL14","STIMULATES","MIR6858","Keratinocytes of Oral Lichen Planus"
"1906","37741915","METTL14-upregulated miR-6858 triggers cell apoptosis in keratinocytes of oral lichen planus through decreasing GSDMC.","miR-6858","trigger","Cell Apoptosis","Keratinocytes of Oral Lichen Planus","MIR6858","CAUSES","Cell Apoptosis","Keratinocytes of Oral Lichen Planus"
"1907","37741915","METTL14-upregulated miR-6858 triggers cell apoptosis in keratinocytes of oral lichen planus through decreasing GSDMC.","miR-6858","decrease","GSDMC","Keratinocytes of Oral Lichen Planus","MIR6858","INHIBITS","GSDMC","Keratinocytes of Oral Lichen Planus"
"1908","37741915","METTL14-upregulated miR-6858 triggers cell apoptosis in keratinocytes of oral lichen planus through decreasing GSDMC.","GSDMC","regulate","Cell Apoptosis","Keratinocytes of Oral Lichen Planus","GSDMC","AFFECTS","Cell Apoptosis","Keratinocytes of Oral Lichen Planus"
"1910","37742030","METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.","METTL3","regulate","m6A methylation","Lung Adenocarcinoma","METTL3","AFFECTS","m6A","LUAD(Lung Adenocarcinoma)"
"1911","37742030","METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.","METTL3","regulate","histone modification","Lung Adenocarcinoma","METTL3","AFFECTS","histone modification","LUAD(Lung Adenocarcinoma)"
"1912","37742030","METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.","METTL3","regulate","VGF","Lung Adenocarcinoma","METTL3","AFFECTS","VGF","LUAD(Lung Adenocarcinoma)"
"1913","37742030","METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.","m6A methylation","regulate","VGF","Lung Adenocarcinoma","m6A","AFFECTS","VGF","LUAD(Lung Adenocarcinoma)"
"1914","37742030","METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.","histone modification","regulate","VGF","Lung Adenocarcinoma","histone modification","AFFECTS","VGF","LUAD(Lung Adenocarcinoma)"
"1916","37742376","H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP.","H3K18 lactylation","promote","Progression","Arsenite-related Idiopathic Pulmonary Fibrosis","H3K18 lactylation","STIMULATES","progression","Arsenite-related Idiopathic Pulmonary Fibrosis"
"1917","37742376","H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP.","H3K18 lactylation","regulate","YTHDF1","Arsenite-related Idiopathic Pulmonary Fibrosis","H3K18 lactylation","AFFECTS","YTHDF1","Arsenite-related Idiopathic Pulmonary Fibrosis"
"1918","37742376","H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP.","YTHDF1","bind","m6A","Arsenite-related Idiopathic Pulmonary Fibrosis","YTHDF1","INTERACTS_WITH","m6A","Arsenite-related Idiopathic Pulmonary Fibrosis"
"1919","37742376","H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP.","m6A","is on","NREP","Arsenite-related Idiopathic Pulmonary Fibrosis","m6A","LOCATES","NREP","Arsenite-related Idiopathic Pulmonary Fibrosis"
"1920","37742376","H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP.","NREP","regulate","Progression","Arsenite-related Idiopathic Pulmonary Fibrosis","NREP","AFFECTS","progression","Arsenite-related Idiopathic Pulmonary Fibrosis"
"1922","37743642","IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.","IGF2BP3","mediate","mRNA degradation of NF1","Triple-negative Breast Cancer","IGF2BP3","AFFECTS","mRNA degradation of NF1","BRCA(Breast Invasive Carcinoma)"
"1923","37743642","IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.","IGF2BP3","regulate","m6A","Triple-negative Breast Cancer","IGF2BP3","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"1924","37743642","IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.","mRNA degradation of NF1","promote","Triple-negative Breast Cancer Progression","Triple-negative Breast Cancer","mRNA degradation of NF1","STIMULATES","Triple-negative Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"1926","37744330","CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease.","CircUBXN7","promote","Macrophage Infiltration","Diabetic Kidney Disease","CircUBXN7","STIMULATES","Macrophage Infiltration","Diabetic Nephropathies"
"1927","37744330","CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease.","CircUBXN7","promote","Renal Fibrosis","Diabetic Kidney Disease","CircUBXN7","STIMULATES","Renal fibrosis","Diabetic Nephropathies"
"1928","37744330","CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease.","CircUBXN7","regulate","IGF2BP2","Diabetic Kidney Disease","CircUBXN7","AFFECTS","IGF2BP2","Diabetic Nephropathies"
"1929","37744330","CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease.","IGF2BP2","bind","SP1 mRNA","Diabetic Kidney Disease","IGF2BP2","INTERACTS_WITH","SP1","Diabetic Nephropathies"
"1930","37744330","CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease.","SP1 mRNA","regulate","Macrophage Infiltration","Diabetic Kidney Disease","SP1","AFFECTS","Macrophage Infiltration","Diabetic Nephropathies"
"1931","37744330","CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease.","SP1 mRNA","regulate","Renal Fibrosis","Diabetic Kidney Disease","SP1","AFFECTS","Renal fibrosis","Diabetic Nephropathies"
"1933","37751743","Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.","METTL3","reprogram","Tumor microenvironment","Tumor microenvironment","METTL3","CONVERTS_TO","Tumor Microenvironment","Tumor Microenvironment"
"1934","37751743","Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.","Tumor microenvironment","improve","Cancer immunotherapy","Tumor microenvironment","Tumor Microenvironment","STIMULATES","Cancer immunotherapy","Tumor Microenvironment"
"1936","37755125","METTL3-induced FGD5-AS1 contributes to the tumorigenesis and PD-1/PD-L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma.","METTL3","induce","FGD5-AS1","Endometrial Carcinoma","METTL3","CAUSES","FGD5-AS1","UCEC(Uterine Corpus Endometrial Carcinoma)"
"1937","37755125","METTL3-induced FGD5-AS1 contributes to the tumorigenesis and PD-1/PD-L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma.","FGD5-AS1","contribute","tumorigenesis","Endometrial Carcinoma","FGD5-AS1","AFFECTS","Carcinogenesis","UCEC(Uterine Corpus Endometrial Carcinoma)"
"1938","37755125","METTL3-induced FGD5-AS1 contributes to the tumorigenesis and PD-1/PD-L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma.","FGD5-AS1","contribute","PD-1/PD-L1 checkpoint","Endometrial Carcinoma","FGD5-AS1","AFFECTS","PD-1/PD-L1 checkpoint","UCEC(Uterine Corpus Endometrial Carcinoma)"
"1939","37755125","METTL3-induced FGD5-AS1 contributes to the tumorigenesis and PD-1/PD-L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma.","PD-1/PD-L1 checkpoint","enhance","resistance","Endometrial Carcinoma","PD-1/PD-L1 checkpoint","AUGMENTS","resistance","UCEC(Uterine Corpus Endometrial Carcinoma)"
"1940","37755125","METTL3-induced FGD5-AS1 contributes to the tumorigenesis and PD-1/PD-L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma.","tumorigenesis","contribute","resistance","Endometrial Carcinoma","Carcinogenesis","AFFECTS","resistance","UCEC(Uterine Corpus Endometrial Carcinoma)"
"1942","37756562","Super enhancer-regulated lncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis.","Super enhancer","regulate","LINC01089","Hepatocellular Carcinoma","Super enhancer","AFFECTS","LINC01089","LIHC(Liver Hepatocellular Carcinoma)"
"1943","37756562","Super enhancer-regulated lncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis.","LINC01089","induce","Alternative Splicing","Hepatocellular Carcinoma","LINC01089","CAUSES","Alternative Splicing","LIHC(Liver Hepatocellular Carcinoma)"
"1944","37756562","Super enhancer-regulated lncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis.","Alternative Splicing","is on","DIAPH3","Hepatocellular Carcinoma","Alternative Splicing","LOCATES","DIAPH3","LIHC(Liver Hepatocellular Carcinoma)"
"1945","37756562","Super enhancer-regulated lncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis.","DIAPH3","drive","Metastasis","Hepatocellular Carcinoma","DIAPH3","STIMULATES","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"1947","37762418","METTL3 Promotes the Differentiation of Goat Skeletal Muscle Satellite Cells by Regulating MEF2C mRNA Stability in a m6A-Dependent Manner.","METTL3","promote","Differentiation","Goat Skeletal Muscle Satellite Cells","METTL3","STIMULATES","cell differentiation","Goat Skeletal Muscle Satellite Cells"
"1948","37762418","METTL3 Promotes the Differentiation of Goat Skeletal Muscle Satellite Cells by Regulating MEF2C mRNA Stability in a m6A-Dependent Manner.","METTL3","regulate","MEF2C mRNA","Goat Skeletal Muscle Satellite Cells","METTL3","AFFECTS","MEF2C","Goat Skeletal Muscle Satellite Cells"
"1949","37762418","METTL3 Promotes the Differentiation of Goat Skeletal Muscle Satellite Cells by Regulating MEF2C mRNA Stability in a m6A-Dependent Manner.","METTL3","regulate","m6A","Goat Skeletal Muscle Satellite Cells","METTL3","AFFECTS","m6A","Goat Skeletal Muscle Satellite Cells"
"1950","37762418","METTL3 Promotes the Differentiation of Goat Skeletal Muscle Satellite Cells by Regulating MEF2C mRNA Stability in a m6A-Dependent Manner.","m6A","regulate","MEF2C mRNA","Goat Skeletal Muscle Satellite Cells","m6A","AFFECTS","MEF2C","Goat Skeletal Muscle Satellite Cells"
"1952","37772373","METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.","METTL3","promote","Proliferation","Colorectal Cancer Cells","METTL3","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"1953","37772373","METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.","METTL3","promote","Migration","Colorectal Cancer Cells","METTL3","STIMULATES","migration","COAD(Colon Adenocarcinoma)"
"1954","37772373","METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.","METTL3","increase stability of","SNHG1","Colorectal Cancer Cells","METTL3","increase stability of","SNHG1","COAD(Colon Adenocarcinoma)"
"1955","37772373","METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.","SNHG1","regulate","Proliferation","Colorectal Cancer Cells","SNHG1","AFFECTS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"1956","37772373","METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.","SNHG1","regulate","Migration","Colorectal Cancer Cells","SNHG1","AFFECTS","migration","COAD(Colon Adenocarcinoma)"
"1958","37773181","LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation.","LncRNA TIALD","contribute","Hepatocellular Carcinoma Metastasis","Hepatocellular Carcinoma","TIALD","AFFECTS","Hepatocellular Carcinoma Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"1959","37773181","LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation.","LncRNA TIALD","induce","AURKA","Hepatocellular Carcinoma","TIALD","CAUSES","AURKA","LIHC(Liver Hepatocellular Carcinoma)"
"1960","37773181","LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation.","AURKA","undergo","Lysosomal Degradation","Hepatocellular Carcinoma","AURKA","undergo","Lysosomal Degradation","LIHC(Liver Hepatocellular Carcinoma)"
"1961","37773181","LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation.","Lysosomal Degradation","contribute","Hepatocellular Carcinoma Metastasis","Hepatocellular Carcinoma","Lysosomal Degradation","AFFECTS","Hepatocellular Carcinoma Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"1963","37774794","c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.","c-MYC/METTL3/LINC01006 positive feedback loop","promote","migration","Non-small cell lung cancer","c-MYC/METTL3/LINC01006 positive feedback loop","STIMULATES","migration","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"1964","37774794","c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.","c-MYC/METTL3/LINC01006 positive feedback loop","promote","invasion","Non-small cell lung cancer","c-MYC/METTL3/LINC01006 positive feedback loop","STIMULATES","Neoplasm Invasiveness","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"1965","37774794","c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.","c-MYC/METTL3/LINC01006 positive feedback loop","promote","proliferation","Non-small cell lung cancer","c-MYC/METTL3/LINC01006 positive feedback loop","STIMULATES","cell population proliferation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"1967","37777158","Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2/ERK depending on downregulation of proteasome-related genes.","dummy","induce deficiency","Wtap","Hepatocytes","dummy","induce deficiency","WTAP","Hepatocytes"
"1968","37777158","Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2/ERK depending on downregulation of proteasome-related genes.","Wtap","promote","Hepatocellular Carcinoma","Hepatocytes","WTAP","STIMULATES","hepatocellular carcinoma","Hepatocytes"
"1969","37777158","Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2/ERK depending on downregulation of proteasome-related genes.","Wtap","activate","GRB2/ERK","Hepatocytes","WTAP","STIMULATES","GRB2/ERK","Hepatocytes"
"1970","37777158","Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2/ERK depending on downregulation of proteasome-related genes.","Wtap","downregulate","proteasome-related genes","Hepatocytes","WTAP","INHIBITS","proteasome-related genes","Hepatocytes"
"1971","37777158","Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2/ERK depending on downregulation of proteasome-related genes.","GRB2/ERK","promote","Hepatocellular Carcinoma","Hepatocytes","GRB2/ERK","STIMULATES","hepatocellular carcinoma","Hepatocytes"
"1972","37777158","Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2/ERK depending on downregulation of proteasome-related genes.","proteasome-related genes","regulate","GRB2/ERK","Hepatocytes","proteasome-related genes","AFFECTS","GRB2/ERK","Hepatocytes"
"1974","37778684","LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.","LIMK1","induce","m6A","Colorectal Cancer","LIMK1","CAUSES","m6A","COAD(Colon Adenocarcinoma)"
"1975","37778684","LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.","YTHDC2","recognize","m6A","Colorectal Cancer","YTHDC2","DIAGNOSES","m6A","COAD(Colon Adenocarcinoma)"
"1976","37778684","LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.","m6A","induce","5-FU chemoresistance","Colorectal Cancer","m6A","CAUSES","5-FU chemoresistance","COAD(Colon Adenocarcinoma)"
"1977","37778684","LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.","m6A","induce","endoplasmic reticulum stress","Colorectal Cancer","m6A","CAUSES","Endoplasmic Reticulum Stress","COAD(Colon Adenocarcinoma)"
"1978","37778684","LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.","m6A","induce","stress granule formation","Colorectal Cancer","m6A","CAUSES","stress granule formation","COAD(Colon Adenocarcinoma)"
"1979","37778684","LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.","endoplasmic reticulum stress","regulate","5-FU chemoresistance","Colorectal Cancer","Endoplasmic Reticulum Stress","AFFECTS","5-FU chemoresistance","COAD(Colon Adenocarcinoma)"
"1980","37778684","LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.","stress granule formation","regulate","5-FU chemoresistance","Colorectal Cancer","stress granule formation","AFFECTS","5-FU chemoresistance","COAD(Colon Adenocarcinoma)"
"1982","37781028","Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis.","YTHDC1","promote","Progression","Ovarian Cancer","YTHDC1","STIMULATES","progression","OV(Ovarian Serous Cystadenocarcinoma)"
"1983","37781028","Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis.","YTHDC1","regulate","PIK3R1/STAT3/GANAB axis","Ovarian Cancer","YTHDC1","AFFECTS","PIK3R1/STAT3/GANAB axis","OV(Ovarian Serous Cystadenocarcinoma)"
"1984","37781028","Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis.","PIK3R1/STAT3/GANAB axis","promote","Progression","Ovarian Cancer","PIK3R1/STAT3/GANAB axis","STIMULATES","progression","OV(Ovarian Serous Cystadenocarcinoma)"
"1986","37781923","FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1.","FTO","fuel","vascular endothelial dysfunction","Diabetes","FTO","STIMULATES","Vascular Endothelial Dysfunction","Diabetes Mellitus"
"1987","37781923","FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1.","FTO","erase","m6A","Diabetes","FTO","erase","m6A","Diabetes Mellitus"
"1988","37781923","FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1.","m6A","is on","TNIP1","Diabetes","m6A","LOCATES","TNIP1","Diabetes Mellitus"
"1989","37781923","FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1.","vascular endothelial dysfunction","associate","inflammation","Diabetes","Vascular Endothelial Dysfunction","ASSOCIATED_WITH","inflammatory response","Diabetes Mellitus"
"1990","37781923","FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1.","TNIP1","regulate","vascular endothelial dysfunction","Diabetes","TNIP1","AFFECTS","Vascular Endothelial Dysfunction","Diabetes Mellitus"
"1992","37782793","A deregulated m6A writer complex axis driven by BRD4 confers an epitranscriptomic vulnerability in combined DNA repair-targeted therapy.","BRD4","drive","m6A writer complex axis","Combined DNA repair-targeted therapy","BRD4","STIMULATES","m6A writer complex","Combined DNA repair-targeted therapy"
"1993","37782793","A deregulated m6A writer complex axis driven by BRD4 confers an epitranscriptomic vulnerability in combined DNA repair-targeted therapy.","m6A writer complex axis","confer","epitranscriptomic vulnerability","Combined DNA repair-targeted therapy","m6A writer complex","PRODUCES","epitranscriptomic vulnerability","Combined DNA repair-targeted therapy"
"1995","37783390","Gastric cancer derived exosomal THBS1 enhanced Vgamma9Vdelta2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner.","exosomal THBS1","enhance","Vgamma9Vdelta2 T-cell function","Gastric Cancer","exosomal THBS1","AUGMENTS","Vgamma9Vdelta2 T-cell function","STAD(Stomach adenocarcinoma)"
"1996","37783390","Gastric cancer derived exosomal THBS1 enhanced Vgamma9Vdelta2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner.","exosomal THBS1","activate","RIG-I-like receptor signaling pathway","Gastric Cancer","exosomal THBS1","STIMULATES","RIG-I-like receptor signaling pathway","STAD(Stomach adenocarcinoma)"
"1997","37783390","Gastric cancer derived exosomal THBS1 enhanced Vgamma9Vdelta2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner.","N6-methyladenosine methylation","regulate","exosomal THBS1","Gastric Cancer","m6A","AFFECTS","exosomal THBS1","STAD(Stomach adenocarcinoma)"
"1998","37783390","Gastric cancer derived exosomal THBS1 enhanced Vgamma9Vdelta2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner.","RIG-I-like receptor signaling pathway","enhance","Vgamma9Vdelta2 T-cell function","Gastric Cancer","RIG-I-like receptor signaling pathway","AUGMENTS","Vgamma9Vdelta2 T-cell function","STAD(Stomach adenocarcinoma)"
"2000","37783915","HIF-1alpha-induced upregulation of m6A reader IGF2BP1 facilitates peripheral nerve injury recovery by enhancing SLC7A11 mRNA stabilization.","HIF-1alpha","upregulate","IGF2BP1","Peripheral Nerve Injury Recovery","HIF1A","STIMULATES","IGF2BP1","Peripheral Nerve Injury Recovery"
"2001","37783915","HIF-1alpha-induced upregulation of m6A reader IGF2BP1 facilitates peripheral nerve injury recovery by enhancing SLC7A11 mRNA stabilization.","IGF2BP1","facilitate","Peripheral Nerve Injury Recovery","Peripheral Nerve Injury Recovery","IGF2BP1","AUGMENTS","Peripheral Nerve Injury Recovery","Peripheral Nerve Injury Recovery"
"2002","37783915","HIF-1alpha-induced upregulation of m6A reader IGF2BP1 facilitates peripheral nerve injury recovery by enhancing SLC7A11 mRNA stabilization.","IGF2BP1","enhance","SLC7A11 mRNA","Peripheral Nerve Injury Recovery","IGF2BP1","AUGMENTS","SLC7A11","Peripheral Nerve Injury Recovery"
"2003","37783915","HIF-1alpha-induced upregulation of m6A reader IGF2BP1 facilitates peripheral nerve injury recovery by enhancing SLC7A11 mRNA stabilization.","SLC7A11 mRNA","stabilize","Stabilization","Peripheral Nerve Injury Recovery","SLC7A11","MAINTAINS","stabilization","Peripheral Nerve Injury Recovery"
"2004","37783915","HIF-1alpha-induced upregulation of m6A reader IGF2BP1 facilitates peripheral nerve injury recovery by enhancing SLC7A11 mRNA stabilization.","Stabilization","facilitate","Peripheral Nerve Injury Recovery","Peripheral Nerve Injury Recovery","stabilization","AUGMENTS","Peripheral Nerve Injury Recovery","Peripheral Nerve Injury Recovery"
"2006","37788092","USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis.","USP47","inhibit","m6A","Regulatory T cells","USP47","INHIBITS","m6A","T-Lymphocytes, Regulatory"
"2007","37788092","USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis.","m6A","regulate","c-Myc translation","Regulatory T cells","m6A","AFFECTS","MYC","T-Lymphocytes, Regulatory"
"2008","37788092","USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis.","c-Myc translation","maintain","metabolic homeostasis","Regulatory T cells","MYC","MAINTAINS","metabolic homeostasis","T-Lymphocytes, Regulatory"
"2009","37788092","USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis.","c-Myc translation","maintain","functional homeostasis","Regulatory T cells","MYC","MAINTAINS","functional homeostasis","T-Lymphocytes, Regulatory"
"2010","37788092","USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis.","metabolic homeostasis","regulate","USP47","Regulatory T cells","metabolic homeostasis","AFFECTS","USP47","T-Lymphocytes, Regulatory"
"2011","37788092","USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis.","functional homeostasis","regulate","USP47","Regulatory T cells","functional homeostasis","AFFECTS","USP47","T-Lymphocytes, Regulatory"
"2013","37789010","WTAP-VIRMA counteracts dsDNA binding of the m6A writer METTL3-METTL14 complex and maintains N6-adenosine methylation activity.","WTAP-VIRMA","counteract","dsDNA","Null","WTAP-VIRMA","PREVENTS","dsdna","Null"
"2014","37789010","WTAP-VIRMA counteracts dsDNA binding of the m6A writer METTL3-METTL14 complex and maintains N6-adenosine methylation activity.","METTL3-METTL14 complex","bind","dsDNA","Null","METTL3-METTL14","INTERACTS_WITH","dsdna","Null"
"2015","37789010","WTAP-VIRMA counteracts dsDNA binding of the m6A writer METTL3-METTL14 complex and maintains N6-adenosine methylation activity.","WTAP-VIRMA","maintain","N6-adenosine methylation activity","Null","WTAP-VIRMA","MAINTAINS","m6A","Null"
"2016","37789010","WTAP-VIRMA counteracts dsDNA binding of the m6A writer METTL3-METTL14 complex and maintains N6-adenosine methylation activity.","METTL3-METTL14 complex","write","m6A","Null","METTL3-METTL14","write","m6A","Null"
"2017","37789010","WTAP-VIRMA counteracts dsDNA binding of the m6A writer METTL3-METTL14 complex and maintains N6-adenosine methylation activity.","m6A","regulate","N6-adenosine methylation activity","Null","m6A","AFFECTS","m6A","Null"
"2019","37792239","N6-methyladenosine (m6A) reader YTHDF2 accelerates endothelial cells ferroptosis in cerebrovascular atherosclerosis.","YTHDF2","accelerate","Endothelial cells ferroptosis","Cerebrovascular Atherosclerosis","YTHDF2","STIMULATES","Endothelial cells ferroptosis","Cerebrovascular Atherosclerosis"
"2020","37792239","N6-methyladenosine (m6A) reader YTHDF2 accelerates endothelial cells ferroptosis in cerebrovascular atherosclerosis.","YTHDF2","bind","m6A","Cerebrovascular Atherosclerosis","YTHDF2","INTERACTS_WITH","m6A","Cerebrovascular Atherosclerosis"
"2021","37792239","N6-methyladenosine (m6A) reader YTHDF2 accelerates endothelial cells ferroptosis in cerebrovascular atherosclerosis.","m6A","regulate","Endothelial cells ferroptosis","Cerebrovascular Atherosclerosis","m6A","AFFECTS","Endothelial cells ferroptosis","Cerebrovascular Atherosclerosis"
"2023","37803374","Retraction Note: m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.","m6A modification","mediate","CBX8","Colon Cancer","m6A","AFFECTS","CBX8","COAD(Colon Adenocarcinoma)"
"2024","37803374","Retraction Note: m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.","CBX8","regulate","stemness","Colon Cancer","CBX8","AFFECTS","Stemness","COAD(Colon Adenocarcinoma)"
"2025","37803374","Retraction Note: m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.","CBX8","regulate","chemosensitivity","Colon Cancer","CBX8","AFFECTS","chemosensitivity","COAD(Colon Adenocarcinoma)"
"2026","37803374","Retraction Note: m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.","CBX8","upregulate","LGR5","Colon Cancer","CBX8","STIMULATES","LGR5","COAD(Colon Adenocarcinoma)"
"2027","37803374","Retraction Note: m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.","LGR5","regulate","stemness","Colon Cancer","LGR5","AFFECTS","Stemness","COAD(Colon Adenocarcinoma)"
"2028","37803374","Retraction Note: m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.","LGR5","regulate","chemosensitivity","Colon Cancer","LGR5","AFFECTS","chemosensitivity","COAD(Colon Adenocarcinoma)"
"2030","37805166","Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expression.","dummy","inhibit","METTL3","Alveolar Epithelial Cells","dummy","INHIBITS","METTL3","Alveolar Epithelial Cells"
"2031","37805166","Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expression.","METTL3","alleviate","Apoptosis","Alveolar Epithelial Cells","METTL3","INHIBITS","apoptotic process","Alveolar Epithelial Cells"
"2032","37805166","Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expression.","METTL3","alleviate","Acute Lung Injury","Alveolar Epithelial Cells","METTL3","INHIBITS","Acute Lung Injury","Alveolar Epithelial Cells"
"2033","37805166","Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expression.","METTL3","restore","Neprilysin","Alveolar Epithelial Cells","METTL3","restore","MME","Alveolar Epithelial Cells"
"2034","37805166","Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expression.","Neprilysin","regulate","Apoptosis","Alveolar Epithelial Cells","MME","AFFECTS","apoptotic process","Alveolar Epithelial Cells"
"2035","37805166","Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expression.","Neprilysin","regulate","Acute Lung Injury","Alveolar Epithelial Cells","MME","AFFECTS","Acute Lung Injury","Alveolar Epithelial Cells"
"2037","37807062","N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.","KIAA1429","promote","Ovarian Cancer","Ovarian Cancer","VIRMA","STIMULATES","Ovarian Neoplasms","OV(Ovarian Serous Cystadenocarcinoma)"
"2038","37807062","N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.","KIAA1429","promote","Aerobic Glycolysis","Ovarian Cancer","VIRMA","STIMULATES","aerobic glycolysis","OV(Ovarian Serous Cystadenocarcinoma)"
"2039","37807062","N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.","KIAA1429","enhance","ENO1","Ovarian Cancer","VIRMA","AUGMENTS","ENO1","OV(Ovarian Serous Cystadenocarcinoma)"
"2040","37807062","N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.","ENO1","regulate","Ovarian Cancer","Ovarian Cancer","ENO1","AFFECTS","Ovarian Neoplasms","OV(Ovarian Serous Cystadenocarcinoma)"
"2041","37807062","N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.","ENO1","regulate","Aerobic Glycolysis","Ovarian Cancer","ENO1","AFFECTS","aerobic glycolysis","OV(Ovarian Serous Cystadenocarcinoma)"
"2043","37809663","Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53.","Remimazolam","relieve","injury","Human embryo liver cell line","remimazolam","relieve","Wounds and Injuries","Human embryo liver cell line"
"2044","37809663","Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53.","Remimazolam","target","METTL3","Human embryo liver cell line","remimazolam","INTERACTS_WITH","METTL3","Human embryo liver cell line"
"2045","37809663","Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53.","METTL3","mediate","m6A","Human embryo liver cell line","METTL3","AFFECTS","m6A","Human embryo liver cell line"
"2046","37809663","Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53.","m6A","modify","P53","Human embryo liver cell line","m6A","AFFECTS","TP53","Human embryo liver cell line"
"2047","37809663","Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53.","P53","regulate","injury","Human embryo liver cell line","TP53","AFFECTS","Wounds and Injuries","Human embryo liver cell line"
"2049","37810561","Retracted: PCBP2 Reduced Oxidative Stress-Induced Apoptosis in Glioma through cGAS/STING Pathway by METTL3-Mediated m6A Modification.","PCBP2","reduce","Oxidative Stress-Induced Apoptosis","Glioma","PCBP2","INHIBITS","Oxidative Stress-Induced Apoptosis","Glioma"
"2050","37810561","Retracted: PCBP2 Reduced Oxidative Stress-Induced Apoptosis in Glioma through cGAS/STING Pathway by METTL3-Mediated m6A Modification.","PCBP2","regulate","cGAS/STING Pathway","Glioma","PCBP2","AFFECTS","cGAS/STING Pathway","Glioma"
"2051","37810561","Retracted: PCBP2 Reduced Oxidative Stress-Induced Apoptosis in Glioma through cGAS/STING Pathway by METTL3-Mediated m6A Modification.","METTL3","mediate","m6A Modification","Glioma","METTL3","AFFECTS","m6A","Glioma"
"2052","37810561","Retracted: PCBP2 Reduced Oxidative Stress-Induced Apoptosis in Glioma through cGAS/STING Pathway by METTL3-Mediated m6A Modification.","m6A Modification","regulate","cGAS/STING Pathway","Glioma","m6A","AFFECTS","cGAS/STING Pathway","Glioma"
"2054","37811274","Retracted: Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner.","TLR4","suppress","Inflammatory Response","Inflammatory Bowel Disease (IBD)","TLR4","INHIBITS","inflammatory response","Inflammatory Bowel Disease (IBD)"
"2055","37811274","Retracted: Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner.","TLR4","modulate","PDK1-Induced Metabolism Reprogramming","Inflammatory Bowel Disease (IBD)","TLR4","AFFECTS","PDK1-Induced Metabolism Reprogramming","Inflammatory Bowel Disease (IBD)"
"2056","37811274","Retracted: Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner.","m6A","regulate","PDK1-Induced Metabolism Reprogramming","Inflammatory Bowel Disease (IBD)","m6A","AFFECTS","PDK1-Induced Metabolism Reprogramming","Inflammatory Bowel Disease (IBD)"
"2057","37811274","Retracted: Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner.","PDK1-Induced Metabolism Reprogramming","regulate","Inflammatory Response","Inflammatory Bowel Disease (IBD)","PDK1-Induced Metabolism Reprogramming","AFFECTS","inflammatory response","Inflammatory Bowel Disease (IBD)"
"2059","37812019","Neural stem cell-derived exosomal FTO protects neuron from microglial inflammatory injury by inhibiting microglia NRF2 mRNA m6A modification.","exosomal FTO","protect","Microglial Inflammatory Injury","Neural Stem Cells","exosomal FTO","PREVENTS","Microglial Inflammatory Injury","Neural Stem Cells"
"2060","37812019","Neural stem cell-derived exosomal FTO protects neuron from microglial inflammatory injury by inhibiting microglia NRF2 mRNA m6A modification.","exosomal FTO","inhibit","m6A modification","Neural Stem Cells","exosomal FTO","INHIBITS","m6A","Neural Stem Cells"
"2061","37812019","Neural stem cell-derived exosomal FTO protects neuron from microglial inflammatory injury by inhibiting microglia NRF2 mRNA m6A modification.","m6A modification","is on","NRF2 mRNA","Neural Stem Cells","m6A","LOCATES","NFE2L2","Neural Stem Cells"
"2062","37812019","Neural stem cell-derived exosomal FTO protects neuron from microglial inflammatory injury by inhibiting microglia NRF2 mRNA m6A modification.","NRF2 mRNA","regulate","Microglial Inflammatory Injury","Neural Stem Cells","NFE2L2","AFFECTS","Microglial Inflammatory Injury","Neural Stem Cells"
"2064","37655555","Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation.","Homeobox-D 1","form","FTO","Head and Neck Cancer","Homeobox-D 1","form","FTO","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2065","37655555","Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation.","FTO","form","Homeobox-D 1","Head and Neck Cancer","FTO","form","Homeobox-D 1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2066","37655555","Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation.","Homeobox-D 1","promote","proliferation","Head and Neck Cancer","Homeobox-D 1","STIMULATES","cell population proliferation","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2067","37655555","Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation.","FTO","promote","proliferation","Head and Neck Cancer","FTO","STIMULATES","cell population proliferation","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2069","37656787","Mettl3-catalyzed m6A regulates histone modifier and modification expression in self-renewing somatic tissue.","Mettl3","catalyze","m6A","Self-renewing somatic tissue","METTL3","catalyze","m6A","Self-renewing somatic tissue"
"2070","37656787","Mettl3-catalyzed m6A regulates histone modifier and modification expression in self-renewing somatic tissue.","m6A","regulate","histone modifier","Self-renewing somatic tissue","m6A","AFFECTS","histone modifier","Self-renewing somatic tissue"
"2071","37656787","Mettl3-catalyzed m6A regulates histone modifier and modification expression in self-renewing somatic tissue.","m6A","regulate","modification expression","Self-renewing somatic tissue","m6A","AFFECTS","modification expression","Self-renewing somatic tissue"
"2073","37658413","METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.","METTL3","induce","lncRNA GBAP1","Hepatocellular Carcinoma","METTL3","CAUSES","GBAP1","LIHC(Liver Hepatocellular Carcinoma)"
"2074","37658413","METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.","lncRNA GBAP1","promote","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","GBAP1","STIMULATES","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"2075","37658413","METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.","lncRNA GBAP1","activate","BMP/SMAD pathway","Hepatocellular Carcinoma","GBAP1","STIMULATES","BMP/SMAD pathway","LIHC(Liver Hepatocellular Carcinoma)"
"2076","37658413","METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.","BMP/SMAD pathway","promote","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","BMP/SMAD pathway","STIMULATES","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"2078","37658588","METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.","METTL3","stabilize","super enhancers-lncRNA SUCLG2-AS1","Nasopharyngeal Carcinoma","METTL3","MAINTAINS","super enhancers-lncRNA SUCLG2-AS1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2079","37658588","METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.","super enhancers-lncRNA SUCLG2-AS1","mediate","formation of a long-range chromatin loop","Nasopharyngeal Carcinoma","super enhancers-lncRNA SUCLG2-AS1","AFFECTS","formation of a long-range chromatin loop","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2080","37658588","METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.","formation of a long-range chromatin loop","between","enhancers","Nasopharyngeal Carcinoma","formation of a long-range chromatin loop","between","enhancers","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2081","37658588","METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.","formation of a long-range chromatin loop","between","promoters of SOX2","Nasopharyngeal Carcinoma","formation of a long-range chromatin loop","between","promoters of SOX2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2082","37658588","METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.","enhancers","in","metastasis and radiosensitivity","Nasopharyngeal Carcinoma","enhancers","in","metastasis and radiosensitivity","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2083","37658588","METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.","promoters of SOX2","in","metastasis and radiosensitivity","Nasopharyngeal Carcinoma","promoters of SOX2","in","metastasis and radiosensitivity","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2085","37659467","Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification.","Hypoxia","promote","Immune Escape","Pancreatic Cancer Cells","Hypoxia","STIMULATES","Immune Escape","PAAD(Pancreatic Adenocarcinoma)"
"2086","37659467","Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification.","Hypoxia","regulate","lncRNA NNT-AS1","Pancreatic Cancer Cells","Hypoxia","AFFECTS","NNT-AS1","PAAD(Pancreatic Adenocarcinoma)"
"2087","37659467","Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification.","lncRNA NNT-AS1","regulate","METTL3","Pancreatic Cancer Cells","NNT-AS1","AFFECTS","METTL3","PAAD(Pancreatic Adenocarcinoma)"
"2088","37659467","Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification.","METTL3","regulate","HuR","Pancreatic Cancer Cells","METTL3","AFFECTS","ELAVL1","PAAD(Pancreatic Adenocarcinoma)"
"2089","37659467","Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification.","HuR","regulate","ITGB1 m6A modification","Pancreatic Cancer Cells","ELAVL1","AFFECTS","ITGB1 m6A modification","PAAD(Pancreatic Adenocarcinoma)"
"2090","37659467","Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification.","ITGB1 m6A modification","regulate","Immune Escape","Pancreatic Cancer Cells","ITGB1 m6A modification","AFFECTS","Immune Escape","PAAD(Pancreatic Adenocarcinoma)"
"2092","37665628","IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6 A-dependent manner.","IGF2BP2","promote","Ovarian Cancer Growth","Ovarian Cancer","IGF2BP2","STIMULATES","Ovarian Cancer Growth","OV(Ovarian Serous Cystadenocarcinoma)"
"2093","37665628","IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6 A-dependent manner.","IGF2BP2","promote","Metastasis","Ovarian Cancer","IGF2BP2","STIMULATES","Neoplasm Metastasis","OV(Ovarian Serous Cystadenocarcinoma)"
"2094","37665628","IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6 A-dependent manner.","IGF2BP2","upregulate","CKAP2L protein","Ovarian Cancer","IGF2BP2","STIMULATES","CKAP2L protein","OV(Ovarian Serous Cystadenocarcinoma)"
"2095","37665628","IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6 A-dependent manner.","IGF2BP2","regulate","m6A","Ovarian Cancer","IGF2BP2","AFFECTS","m6A","OV(Ovarian Serous Cystadenocarcinoma)"
"2096","37665628","IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6 A-dependent manner.","CKAP2L protein","promote","Ovarian Cancer Growth","Ovarian Cancer","CKAP2L protein","STIMULATES","Ovarian Cancer Growth","OV(Ovarian Serous Cystadenocarcinoma)"
"2097","37665628","IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6 A-dependent manner.","CKAP2L protein","promote","Metastasis","Ovarian Cancer","CKAP2L protein","STIMULATES","Neoplasm Metastasis","OV(Ovarian Serous Cystadenocarcinoma)"
"2099","37666478","Branched-chain amino acids prevent obesity by inhibiting the cell cycle in an NADPH-FTO-m6A coordinated manner.","Branched-chain amino acids","prevent","Obesity","Obesity","branched-chain amino acid","PREVENTS","Obesity","Obesity"
"2100","37666478","Branched-chain amino acids prevent obesity by inhibiting the cell cycle in an NADPH-FTO-m6A coordinated manner.","Branched-chain amino acids","inhibit","Cell Cycle","Obesity","branched-chain amino acid","INHIBITS","cell cycle","Obesity"
"2101","37666478","Branched-chain amino acids prevent obesity by inhibiting the cell cycle in an NADPH-FTO-m6A coordinated manner.","Branched-chain amino acids","regulate","NADPH","Obesity","branched-chain amino acid","AFFECTS","NADPH","Obesity"
"2102","37666478","Branched-chain amino acids prevent obesity by inhibiting the cell cycle in an NADPH-FTO-m6A coordinated manner.","FTO","bind","m6A","Obesity","FTO","INTERACTS_WITH","m6A","Obesity"
"2103","37666478","Branched-chain amino acids prevent obesity by inhibiting the cell cycle in an NADPH-FTO-m6A coordinated manner.","m6A","regulate","Cell Cycle","Obesity","m6A","AFFECTS","cell cycle","Obesity"
"2105","37669863","Synapse-enriched m6A-modified Malat1 interacts with the novel m6A reader, DPYSL2, and is required for fear-extinction memory.","m6A","is on","Malat1","Synapse","m6A","LOCATES","MALAT1","synapse"
"2106","37669863","Synapse-enriched m6A-modified Malat1 interacts with the novel m6A reader, DPYSL2, and is required for fear-extinction memory.","Malat1","interact","DPYSL2","Synapse","MALAT1","interact","DPYSL2","synapse"
"2107","37669863","Synapse-enriched m6A-modified Malat1 interacts with the novel m6A reader, DPYSL2, and is required for fear-extinction memory.","Malat1","required for","fear-extinction memory","Synapse","MALAT1","CAUSES","fear-extinction memory","synapse"
"2109","37669906","N6 -methyladenosine-modified circFUT8 competitively interacts with YTHDF2 and miR-186-5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma.","N6 -methyladenosine-modified circFUT8","interact","YTHDF2","Lung Adenocarcinoma","m6A-modified circFUT8","interact","YTHDF2","LUAD(Lung Adenocarcinoma)"
"2110","37669906","N6 -methyladenosine-modified circFUT8 competitively interacts with YTHDF2 and miR-186-5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma.","N6 -methyladenosine-modified circFUT8","interact","miR-186-5p","Lung Adenocarcinoma","m6A-modified circFUT8","interact","miR-186-5p","LUAD(Lung Adenocarcinoma)"
"2111","37669906","N6 -methyladenosine-modified circFUT8 competitively interacts with YTHDF2 and miR-186-5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma.","N6 -methyladenosine-modified circFUT8","stabilize","FUT8 mRNA","Lung Adenocarcinoma","m6A-modified circFUT8","MAINTAINS","FUT8","LUAD(Lung Adenocarcinoma)"
"2112","37669906","N6 -methyladenosine-modified circFUT8 competitively interacts with YTHDF2 and miR-186-5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma.","FUT8 mRNA","promote","malignant progression","Lung Adenocarcinoma","FUT8","STIMULATES","Malignant Progression","LUAD(Lung Adenocarcinoma)"
"2114","37670228","N6-methyladenosine modification of PLOD2 causes spermatocyte damage in rats with varicocele.","PLOD2","cause","spermatocyte damage","Rats with varicocele","PLOD2","CAUSES","spermatocyte damage","Rats with varicocele"
"2116","37673880","METTL16 controls Kaposi's sarcoma-associated herpesvirus replication by regulating S-adenosylmethionine cycle.","METTL16","regulate","S-adenosylmethionine cycle","Kaposi's sarcoma-associated herpesvirus","METTL16","AFFECTS","S-adenosylmethionine cycle","Herpesvirus 8, Human"
"2117","37673880","METTL16 controls Kaposi's sarcoma-associated herpesvirus replication by regulating S-adenosylmethionine cycle.","S-adenosylmethionine cycle","regulate","replication","Kaposi's sarcoma-associated herpesvirus","S-adenosylmethionine cycle","AFFECTS","replication","Herpesvirus 8, Human"
"2119","37683648","eIF3d controls the persistent integrated stress response.","eIF3d","control","persistent integrated stress response","Null","EIF3D","AFFECTS","persistent integrated stress response","Null"
"2121","37688756","m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.","m6A","mediate","lncRNA NEAT1","Non-small cell lung cancer","m6A","AFFECTS","NEAT1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2122","37688756","m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.","lncRNA NEAT1","play","oncogenic role","Non-small cell lung cancer","NEAT1","play","oncogenic role","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2123","37688756","m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.","lncRNA NEAT1","upregulate","HMGA1","Non-small cell lung cancer","NEAT1","STIMULATES","HMGA1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2124","37688756","m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.","lncRNA NEAT1","bind","miR-361-3p","Non-small cell lung cancer","NEAT1","INTERACTS_WITH","miR-361-3p","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2125","37688756","m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.","HMGA1","regulate","oncogenic role","Non-small cell lung cancer","HMGA1","AFFECTS","oncogenic role","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2127","37689242","ALKBH5 Induces Fibroblast-to-Myofibroblast Transformation During Hypoxia to Protect Against Cardiac Rupture After Myocardial Infarction.","ALKBH5","induce","Fibroblast-to-Myofibroblast Transformation","Myocardial Infarction","ALKBH5","CAUSES","Fibroblast-to-Myofibroblast Transformation","Myocardial Infarction"
"2128","37689242","ALKBH5 Induces Fibroblast-to-Myofibroblast Transformation During Hypoxia to Protect Against Cardiac Rupture After Myocardial Infarction.","Hypoxia","occur during","Fibroblast-to-Myofibroblast Transformation","Myocardial Infarction","Hypoxia","occur during","Fibroblast-to-Myofibroblast Transformation","Myocardial Infarction"
"2129","37689242","ALKBH5 Induces Fibroblast-to-Myofibroblast Transformation During Hypoxia to Protect Against Cardiac Rupture After Myocardial Infarction.","Fibroblast-to-Myofibroblast Transformation","protect against","Cardiac Rupture","Myocardial Infarction","Fibroblast-to-Myofibroblast Transformation","protect against","Heart Rupture","Myocardial Infarction"
"2131","37698736","N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner.","YTHDF1","repress","CD8 + T cell-mediated antitumor immunity","Prostate Cancer","YTHDF1","INHIBITS","CD8 + T cell-mediated antitumor immunity","PRAD(Prostate Adenocarcinoma)"
"2132","37698736","N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner.","YTHDF1","repress","ferroptosis","Prostate Cancer","YTHDF1","INHIBITS","Ferroptosis","PRAD(Prostate Adenocarcinoma)"
"2133","37698736","N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner.","YTHDF1","regulate","m6A","Prostate Cancer","YTHDF1","AFFECTS","m6A","PRAD(Prostate Adenocarcinoma)"
"2134","37698736","N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner.","PD-L1","bind","m6A","Prostate Cancer","CD274","INTERACTS_WITH","m6A","PRAD(Prostate Adenocarcinoma)"
"2135","37698736","N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner.","m6A","regulate","CD8 + T cell-mediated antitumor immunity","Prostate Cancer","m6A","AFFECTS","CD8 + T cell-mediated antitumor immunity","PRAD(Prostate Adenocarcinoma)"
"2136","37698736","N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner.","m6A","regulate","ferroptosis","Prostate Cancer","m6A","AFFECTS","Ferroptosis","PRAD(Prostate Adenocarcinoma)"
"2138","37698901","The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.","FTO","required for","odontoblast differentiation","In vitro and mice","FTO","CAUSES","odontoblast differentiation","In vitro and mice"
"2139","37698901","The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.","FTO","required for","dentine formation","In vitro and mice","FTO","CAUSES","dentine formation","In vitro and mice"
"2140","37698901","The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.","FTO","promote","RUNX2 exon 5","In vitro and mice","FTO","STIMULATES","RUNX2 exon 5","In vitro and mice"
"2141","37698901","The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.","RUNX2 exon 5","through","RBM4","In vitro and mice","RUNX2 exon 5","through","RBM4","In vitro and mice"
"2142","37698901","The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.","RBM4","regulate","odontoblast differentiation","In vitro and mice","RBM4","AFFECTS","odontoblast differentiation","In vitro and mice"
"2143","37698901","The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.","RBM4","regulate","dentine formation","In vitro and mice","RBM4","AFFECTS","dentine formation","In vitro and mice"
"2145","37715457","METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury.","METTL3","mediate","N6-methyladenosine","Sepsis-induced acute lung injury","METTL3","AFFECTS","m6A","Sepsis-induced acute lung injury"
"2146","37715457","METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury.","METTL3","regulate","m6A","Sepsis-induced acute lung injury","METTL3","AFFECTS","m6A","Sepsis-induced acute lung injury"
"2147","37715457","METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury.","IGF2BP2","bind","m6A","Sepsis-induced acute lung injury","IGF2BP2","INTERACTS_WITH","m6A","Sepsis-induced acute lung injury"
"2148","37715457","METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury.","m6A","exacerbate","ferroptosis","Sepsis-induced acute lung injury","m6A","COMPLICATES","Ferroptosis","Sepsis-induced acute lung injury"
"2150","37716414","NAT10 regulates the repair of UVB-induced DNA damage and tumorigenicity.","NAT10","regulate","UVB-induced DNA damage","Null","NAT10","AFFECTS","UVB-induced DNA damage","Null"
"2151","37716414","NAT10 regulates the repair of UVB-induced DNA damage and tumorigenicity.","NAT10","regulate","tumorigenicity","Null","NAT10","AFFECTS","Tumorigenicity","Null"
"2153","37724907","YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.","ALKBH5","mediate","m6A","Cancer","ALKBH5","AFFECTS","m6A","PANCAN(Pan-Cancer)"
"2154","37724907","YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.","m6A","regulate","YY1","Cancer","m6A","AFFECTS","YY1","PANCAN(Pan-Cancer)"
"2155","37724907","YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.","YY1","promote","autophagy","Cancer","YY1","STIMULATES","autophagy","PANCAN(Pan-Cancer)"
"2156","37724907","YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.","YY1","target","ATG4B","Cancer","YY1","INTERACTS_WITH","ATG4B","PANCAN(Pan-Cancer)"
"2157","37724907","YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.","ATG4B","regulate","autophagy","Cancer","ATG4B","AFFECTS","autophagy","PANCAN(Pan-Cancer)"
"2159","37726400","LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.","BCAN-AS1","stabilize","c-Myc","Pancreatic Cancer","BCAN-AS1","MAINTAINS","MYC","PAAD(Pancreatic Adenocarcinoma)"
"2160","37726400","LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.","BCAN-AS1","regulate","N6-methyladenosine","Pancreatic Cancer","BCAN-AS1","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"2161","37726400","LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.","SNIP1","bind","N6-methyladenosine","Pancreatic Cancer","SNIP1","INTERACTS_WITH","m6A","PAAD(Pancreatic Adenocarcinoma)"
"2162","37726400","LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.","c-Myc","promote","Pancreatic Cancer","Pancreatic Cancer","MYC","STIMULATES","pancreatic cancer","PAAD(Pancreatic Adenocarcinoma)"
"2164","37729957","Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.","dummy","target","hnRNPC","Autoimmune Thyroid Disease","dummy","INTERACTS_WITH","HNRNPC","Thyroiditis, Autoimmune"
"2165","37729957","Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.","hnRNPC","suppress","Thyroid Follicular Epithelial Cell Apoptosis","Autoimmune Thyroid Disease","HNRNPC","INHIBITS","Thyroid Follicular Epithelial Cell Apoptosis","Thyroiditis, Autoimmune"
"2166","37729957","Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.","hnRNPC","suppress","Necroptosis","Autoimmune Thyroid Disease","HNRNPC","INHIBITS","necroptotic process","Thyroiditis, Autoimmune"
"2167","37729957","Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.","hnRNPC","modify","m6A","Autoimmune Thyroid Disease","HNRNPC","AFFECTS","m6A","Thyroiditis, Autoimmune"
"2168","37729957","Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.","m6A","is on","ATF4","Autoimmune Thyroid Disease","m6A","LOCATES","ATF4","Thyroiditis, Autoimmune"
"2169","37729957","Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.","ATF4","regulate","Thyroid Follicular Epithelial Cell Apoptosis","Autoimmune Thyroid Disease","ATF4","AFFECTS","Thyroid Follicular Epithelial Cell Apoptosis","Thyroiditis, Autoimmune"
"2170","37729957","Targeting hnRNPC suppresses thyroid follicular epithelial cell apoptosis and necroptosis through m6A-modified ATF4 in autoimmune thyroid disease.","ATF4","regulate","Necroptosis","Autoimmune Thyroid Disease","ATF4","AFFECTS","necroptotic process","Thyroiditis, Autoimmune"
"2172","37730054","m6A methylation-mediated PGC-1alpha contributes to ferroptosis via regulating GSTK1 in arsenic-induced hepatic insulin resistance.","PGC-1alpha","contribute","ferroptosis","Arsenic-induced hepatic insulin resistance","PPARGC1A","AFFECTS","Ferroptosis","Arsenic-induced hepatic insulin resistance"
"2173","37730054","m6A methylation-mediated PGC-1alpha contributes to ferroptosis via regulating GSTK1 in arsenic-induced hepatic insulin resistance.","PGC-1alpha","regulate","GSTK1","Arsenic-induced hepatic insulin resistance","PPARGC1A","AFFECTS","GSTK1","Arsenic-induced hepatic insulin resistance"
"2174","37730054","m6A methylation-mediated PGC-1alpha contributes to ferroptosis via regulating GSTK1 in arsenic-induced hepatic insulin resistance.","GSTK1","regulate","ferroptosis","Arsenic-induced hepatic insulin resistance","GSTK1","AFFECTS","Ferroptosis","Arsenic-induced hepatic insulin resistance"
"2175","37730054","m6A methylation-mediated PGC-1alpha contributes to ferroptosis via regulating GSTK1 in arsenic-induced hepatic insulin resistance.","ferroptosis","regulate","insulin resistance","Arsenic-induced hepatic insulin resistance","Ferroptosis","AFFECTS","Insulin Resistance","Arsenic-induced hepatic insulin resistance"
"2178","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","dummy","down-regulate","FTO","Colorectal Cancer","dummy","INHIBITS","FTO","COAD(Colon Adenocarcinoma)"
"2179","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","dummy","down-regulate","ALKBH5","Colorectal Cancer","dummy","INHIBITS","ALKBH5","COAD(Colon Adenocarcinoma)"
"2180","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","FTO","activate","FOXO signaling","Colorectal Cancer","FTO","STIMULATES","FOXM1 axis","COAD(Colon Adenocarcinoma)"
"2181","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","ALKBH5","activate","FOXO signaling","Colorectal Cancer","ALKBH5","STIMULATES","FOXM1 axis","COAD(Colon Adenocarcinoma)"
"2182","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","FTO","regulate","m6A","Colorectal Cancer","FTO","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"2183","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","ALKBH5","regulate","m6A","Colorectal Cancer","ALKBH5","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"2184","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","m6A","is in","HK2 mRNA","Colorectal Cancer","m6A","LOCATES","HK2","COAD(Colon Adenocarcinoma)"
"2185","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","IGF2BP2","mediate","m6A","Colorectal Cancer","IGF2BP2","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"2186","37580808","Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.","FOXO signaling","enhance","glycolysis","Colorectal Cancer","FOXM1 axis","AUGMENTS","glycolytic process","COAD(Colon Adenocarcinoma)"
"2188","37584416","FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p.","FTO","upregulate","LINC01559","Breast Carcinoma","FTO","STIMULATES","LINC01559","BRCA(Breast Invasive Carcinoma)"
"2189","37584416","FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p.","LINC01559","confer","Cell Resistance","Breast Carcinoma","LINC01559","PRODUCES","Cell Resistance","BRCA(Breast Invasive Carcinoma)"
"2190","37584416","FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p.","LINC01559","suppress","miR-1343-3p","Breast Carcinoma","LINC01559","INHIBITS","miR-1343-3p","BRCA(Breast Invasive Carcinoma)"
"2191","37584416","FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p.","miR-1343-3p","regulate","Cell Resistance","Breast Carcinoma","miR-1343-3p","AFFECTS","Cell Resistance","BRCA(Breast Invasive Carcinoma)"
"2198","37586322","METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy.","METTL3","drive","NAFLD-related hepatocellular carcinoma","NAFLD-related hepatocellular carcinoma","METTL3","STIMULATES","NAFLD-related hepatocellular carcinoma","LIHC(Liver Hepatocellular Carcinoma)"
"2199","37586322","METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy.","METTL3","boost","immunotherapy","NAFLD-related hepatocellular carcinoma","METTL3","boost","Immunotherapy","LIHC(Liver Hepatocellular Carcinoma)"
"2201","37594126","RBM15-mediating MDR1 mRNA m6A methylation regulated by the TGF-beta signaling pathway in paclitaxel-resistant ovarian cancer.","RBM15","mediate","m6A methylation","Paclitaxel-resistant ovarian cancer","RBM15","AFFECTS","m6A","OV(Ovarian Serous Cystadenocarcinoma)"
"2202","37594126","RBM15-mediating MDR1 mRNA m6A methylation regulated by the TGF-beta signaling pathway in paclitaxel-resistant ovarian cancer.","m6A methylation","is on","MDR1 mRNA","Paclitaxel-resistant ovarian cancer","m6A","LOCATES","TBC1D9","OV(Ovarian Serous Cystadenocarcinoma)"
"2203","37594126","RBM15-mediating MDR1 mRNA m6A methylation regulated by the TGF-beta signaling pathway in paclitaxel-resistant ovarian cancer.","TGF-beta signaling pathway","regulate","RBM15","Paclitaxel-resistant ovarian cancer","TGF-beta signaling pathway","AFFECTS","RBM15","OV(Ovarian Serous Cystadenocarcinoma)"
"2204","37594126","RBM15-mediating MDR1 mRNA m6A methylation regulated by the TGF-beta signaling pathway in paclitaxel-resistant ovarian cancer.","MDR1 mRNA","regulate","paclitaxel-resistant ovarian cancer","Paclitaxel-resistant ovarian cancer","TBC1D9","AFFECTS","paclitaxel-resistant ovarian cancer","OV(Ovarian Serous Cystadenocarcinoma)"
"2206","37599359","P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.","P300/SP1 complex","mediate","METTL1","CRPC","P300/SP1 complex","AFFECTS","METTL1","PRAD(Prostate Adenocarcinoma)"
"2207","37599359","P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.","METTL1","regulate","m7G modification","CRPC","METTL1","AFFECTS","7-methylguanosine","PRAD(Prostate Adenocarcinoma)"
"2208","37599359","P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.","m7G modification","is on","CDK14 mRNA","CRPC","7-methylguanosine","LOCATES","CDK14","PRAD(Prostate Adenocarcinoma)"
"2209","37599359","P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.","CDK14 mRNA","regulate","stability","CRPC","CDK14","AFFECTS","stability","PRAD(Prostate Adenocarcinoma)"
"2217","37605595","Role of METTL3-mediated m6A modification in osteogenic differentiation of periodontal ligament stem cells extracted from adult periodontal ligaments ex-vivo.","METTL3","mediate","m6A","Periodontal Ligament Stem Cells","METTL3","AFFECTS","m6A","Periodontal Ligament Stem Cells"
"2218","37605595","Role of METTL3-mediated m6A modification in osteogenic differentiation of periodontal ligament stem cells extracted from adult periodontal ligaments ex-vivo.","m6A","involved in","Osteogenic Differentiation","Periodontal Ligament Stem Cells","m6A","involved in","Osteogenic Differentiation","Periodontal Ligament Stem Cells"
"2226","37609256","SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.","dummy","cause","YTHDF2","EBV replication","dummy","CAUSES","YTHDF2","EBV replication"
"2227","37609256","SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.","PIAS1","cause","YTHDF2","EBV replication","PIAS1","CAUSES","YTHDF2","EBV replication"
"2228","37609256","SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.","YTHDF2","promote","viral RNA decay","EBV replication","YTHDF2","STIMULATES","viral RNA decay","EBV replication"
"2229","37609256","SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.","viral RNA decay","restrict","EBV replication","EBV replication","viral RNA decay","restrict","EBV replication","EBV replication"
"2231","37610605","METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.","dummy","induce deficiency of","METTL3","Cerebral I/R Injury","dummy","INHIBITS","METTL3","Cerebral I/R Injury"
"2232","37610605","METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.","METTL3","suppress","Neural Apoptosis","Cerebral I/R Injury","METTL3","INHIBITS","Neural Apoptosis","Cerebral I/R Injury"
"2233","37610605","METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.","Neural Apoptosis","induce","Protective Effects","Cerebral I/R Injury","Neural Apoptosis","CAUSES","Protective Effects","Cerebral I/R Injury"
"2234","37610605","METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.","METTL3","inhibit","RNA m6A Modifications","Cerebral I/R Injury","METTL3","INHIBITS","m6A","Cerebral I/R Injury"
"2235","37610605","METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.","RNA m6A Modifications","regulate","Neural Apoptosis","Cerebral I/R Injury","m6A","AFFECTS","Neural Apoptosis","Cerebral I/R Injury"
"2247","37614036","Propofol suppresses OGD/R-induced ferroptosis in neurons by inhibiting the HIF-1alpha/YTHDF1/BECN1 axis.","Propofol","suppress","Ferroptosis","Neurons","propofol","INHIBITS","Ferroptosis","Neurons"
"2248","37614036","Propofol suppresses OGD/R-induced ferroptosis in neurons by inhibiting the HIF-1alpha/YTHDF1/BECN1 axis.","Propofol","inhibit","HIF-1alpha/YTHDF1/BECN1 axis","Neurons","propofol","INHIBITS","HIF-1alpha/YTHDF1/BECN1 axis","Neurons"
"2249","37614036","Propofol suppresses OGD/R-induced ferroptosis in neurons by inhibiting the HIF-1alpha/YTHDF1/BECN1 axis.","HIF-1alpha/YTHDF1/BECN1 axis","regulate","Ferroptosis","Neurons","HIF-1alpha/YTHDF1/BECN1 axis","AFFECTS","Ferroptosis","Neurons"
"2262","37624905","DNA N6-methyladenine methylase N6AMT1 controls neuropathic pain through epigenetically modifying Kcnj16 in dorsal horn neurons.","N6AMT1","control","Neuropathic Pain","Dorsal Horn Neurons","N6AMT1","AFFECTS","Neuralgia","Posterior Horn Cells"
"2263","37624905","DNA N6-methyladenine methylase N6AMT1 controls neuropathic pain through epigenetically modifying Kcnj16 in dorsal horn neurons.","N6AMT1","modify","Kcnj16","Dorsal Horn Neurons","N6AMT1","AFFECTS","KCNJ16","Posterior Horn Cells"
"2264","37624905","DNA N6-methyladenine methylase N6AMT1 controls neuropathic pain through epigenetically modifying Kcnj16 in dorsal horn neurons.","Kcnj16","regulate","Neuropathic Pain","Dorsal Horn Neurons","KCNJ16","AFFECTS","Neuralgia","Posterior Horn Cells"
"2266","37626036","N6-methyladenosine modification of REG1alpha facilitates colorectal cancer progression via beta-catenin/MYC/LDHA axis mediated glycolytic reprogramming.","N6-methyladenosine","modify","REG1alpha","Colorectal Cancer","m6A","AFFECTS","REG1A","COAD(Colon Adenocarcinoma)"
"2267","37626036","N6-methyladenosine modification of REG1alpha facilitates colorectal cancer progression via beta-catenin/MYC/LDHA axis mediated glycolytic reprogramming.","REG1alpha","facilitate","Colorectal Cancer Progression","Colorectal Cancer","REG1A","AUGMENTS","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"2268","37626036","N6-methyladenosine modification of REG1alpha facilitates colorectal cancer progression via beta-catenin/MYC/LDHA axis mediated glycolytic reprogramming.","REG1alpha","regulate","beta-catenin/MYC/LDHA axis","Colorectal Cancer","REG1A","AFFECTS","beta-catenin/MYC/LDHA axis","COAD(Colon Adenocarcinoma)"
"2269","37626036","N6-methyladenosine modification of REG1alpha facilitates colorectal cancer progression via beta-catenin/MYC/LDHA axis mediated glycolytic reprogramming.","beta-catenin/MYC/LDHA axis","mediate","glycolytic reprogramming","Colorectal Cancer","beta-catenin/MYC/LDHA axis","AFFECTS","Glycolytic Reprogramming","COAD(Colon Adenocarcinoma)"
"2270","37626036","N6-methyladenosine modification of REG1alpha facilitates colorectal cancer progression via beta-catenin/MYC/LDHA axis mediated glycolytic reprogramming.","glycolytic reprogramming","facilitate","Colorectal Cancer Progression","Colorectal Cancer","Glycolytic Reprogramming","AUGMENTS","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"2272","37626050","The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.","m6A modification","mediate","OGDHL","ccRCC","m6A","AFFECTS","OGDHL","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2273","37626050","The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.","OGDHL","exert","tumor suppressor role","ccRCC","OGDHL","exert","tumor suppressor role","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2274","37626050","The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.","OGDHL","downregulate","FASN","ccRCC","OGDHL","INHIBITS","FASN","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2275","37626050","The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.","FASN","inhibit","lipid synthesis","ccRCC","FASN","INHIBITS","lipid biosynthetic process","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2276","37626050","The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.","FASN","inhibit","ERK signaling","ccRCC","FASN","INHIBITS","ERK signaling pathway","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2277","37626050","The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.","lipid synthesis","contribute","tumor suppressor role","ccRCC","lipid biosynthetic process","AFFECTS","tumor suppressor role","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2278","37626050","The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.","ERK signaling","contribute","tumor suppressor role","ccRCC","ERK signaling pathway","AFFECTS","tumor suppressor role","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2280","37628671","The 3' Non-Coding Sequence Negatively Regulates PD-L1 Expression, and Its Regulators Are Systematically Identified in Pan-Cancer.","3' Non-Coding Sequence","negatively regulate","PD-L1 Expression","Pan-Cancer","3' Non-Coding Sequence","INHIBITS","PD-L1 Expression","PANCAN(Pan-Cancer)"
"2281","37628671","The 3' Non-Coding Sequence Negatively Regulates PD-L1 Expression, and Its Regulators Are Systematically Identified in Pan-Cancer.","dummy","regulate","3' Non-Coding Sequence","Pan-Cancer","dummy","AFFECTS","3' Non-Coding Sequence","PANCAN(Pan-Cancer)"
"2283","37636387","YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation.","YTHDC2","inhibit","Osteogenic Differentiation","Rat Bone Mesenchymal Stem Cells","YTHDC2","INHIBITS","Osteogenic Differentiation","Rat Bone Mesenchymal Stem Cells"
"2284","37636387","YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation.","YTHDC2","accelerate degradation","RUNX2 mRNA","Rat Bone Mesenchymal Stem Cells","YTHDC2","accelerate degradation","RUNX2","Rat Bone Mesenchymal Stem Cells"
"2285","37636387","YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation.","YTHDC2","regulate","m6A Methylation","Rat Bone Mesenchymal Stem Cells","YTHDC2","AFFECTS","m6A","Rat Bone Mesenchymal Stem Cells"
"2286","37636387","YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation.","m6A Methylation","regulate","RUNX2 mRNA","Rat Bone Mesenchymal Stem Cells","m6A","AFFECTS","RUNX2","Rat Bone Mesenchymal Stem Cells"
"2288","37639444","Kar4 is required for the normal pattern of meiotic gene expression.","Kar4","required for","meiotic gene expression","Null","KAR 4","CAUSES","meiotic gene expression","Null"
"2290","37640841","RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation.","RBFOX2","recognize","N6-methyladenosine","Myeloid Leukaemia","RBFOX2","DIAGNOSES","m6A","LAML(Acute Myeloid Leukemia)"
"2291","37640841","RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation.","RBFOX2","suppress","transcription","Myeloid Leukaemia","RBFOX2","INHIBITS","transcription, DNA-templated","LAML(Acute Myeloid Leukemia)"
"2292","37640841","RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation.","RBFOX2","block","differentiation","Myeloid Leukaemia","RBFOX2","INHIBITS","cell differentiation","LAML(Acute Myeloid Leukemia)"
"2294","37643553","IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization.","IGF2BP3","drive","Cancer Progression","Gallbladder Cancer","IGF2BP3","STIMULATES","Cancer Progression","CHOL(Cholangiocarcinoma)"
"2295","37643553","IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization.","IGF2BP3","modify","m6A","Gallbladder Cancer","IGF2BP3","AFFECTS","m6A","CHOL(Cholangiocarcinoma)"
"2296","37643553","IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization.","m6A","is on","CLDN4","Gallbladder Cancer","m6A","LOCATES","CLDN4","CHOL(Cholangiocarcinoma)"
"2297","37643553","IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization.","IGF2BP3","induce","Macrophage Immunosuppressive Polarization","Gallbladder Cancer","IGF2BP3","CAUSES","Macrophage Immunosuppressive Polarization","CHOL(Cholangiocarcinoma)"
"2298","37643553","IGF2BP3 drives gallbladder cancer progression by m6A-modified CLDN4 and inducing macrophage immunosuppressive polarization.","CLDN4","regulate","Cancer Progression","Gallbladder Cancer","CLDN4","AFFECTS","Cancer Progression","CHOL(Cholangiocarcinoma)"
"2300","37644505","Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells.","IGF2BP1","enhance","mRNA stability","Esophageal Squamous Cancer Cells","IGF2BP1","AUGMENTS","mrna stability","ESCA(Esophageal Carcinoma)"
"2301","37644505","Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells.","mRNA stability","is of","INHBA","Esophageal Squamous Cancer Cells","mrna stability","is of","INHBA","ESCA(Esophageal Carcinoma)"
"2302","37644505","Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells.","INHBA","promote","Invasion and Migration","Esophageal Squamous Cancer Cells","INHBA","STIMULATES","Invasion and Migration","ESCA(Esophageal Carcinoma)"
"2303","37644505","Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells.","mRNA stability","promote","Invasion and Migration","Esophageal Squamous Cancer Cells","mrna stability","STIMULATES","Invasion and Migration","ESCA(Esophageal Carcinoma)"
"2305","37647025","m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression.","METTL16","mediate","Immune Evasion","Colorectal Cancer Cells","METTL16","AFFECTS","Immune Evasion","COAD(Colon Adenocarcinoma)"
"2306","37647025","m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression.","METTL16","regulate","PD-L1","Colorectal Cancer Cells","METTL16","AFFECTS","CD274","COAD(Colon Adenocarcinoma)"
"2307","37647025","m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression.","PD-L1","have","Expression","Colorectal Cancer Cells","CD274","have","expression","COAD(Colon Adenocarcinoma)"
"2308","37647025","m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression.","Expression","mediate","Immune Evasion","Colorectal Cancer Cells","expression","AFFECTS","Immune Evasion","COAD(Colon Adenocarcinoma)"
"2310","37647111","m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1/HuR.","m6A","mediate","circDDIT4","Prostate Cancer","m6A","AFFECTS","circDDIT4","PRAD(Prostate Adenocarcinoma)"
"2311","37647111","m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1/HuR.","circDDIT4","inhibit","Prostate Cancer Progression","Prostate Cancer","circDDIT4","INHIBITS","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"2312","37647111","m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1/HuR.","circDDIT4","sequestrate","ELAVL1/HuR","Prostate Cancer","circDDIT4","sequestrate","ELAVL1/HuR","PRAD(Prostate Adenocarcinoma)"
"2313","37647111","m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1/HuR.","ELAVL1/HuR","regulate","Prostate Cancer Progression","Prostate Cancer","ELAVL1/HuR","AFFECTS","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"2315","37648786","METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.","M2 macrophage-derived extracellular vesicles","induce inhibition","METTL3","Thyroid Cancer","M2 macrophage-derived extracellular vesicles","induce inhibition","METTL3","THCA(Thyroid Carcinoma)"
"2316","37648786","METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.","METTL3","drive","anti-PD-1 therapy resistance","Thyroid Cancer","METTL3","STIMULATES","anti-PD-1 therapy resistance","THCA(Thyroid Carcinoma)"
"2317","37648786","METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.","METTL3","regulate","m6A","Thyroid Cancer","METTL3","AFFECTS","m6A","THCA(Thyroid Carcinoma)"
"2318","37648786","METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.","m6A","mediate","CD70","Thyroid Cancer","m6A","AFFECTS","CD70","THCA(Thyroid Carcinoma)"
"2319","37648786","METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.","CD70","mediate","immune suppression","Thyroid Cancer","CD70","AFFECTS","Immune Suppression","THCA(Thyroid Carcinoma)"
"2321","37652905","CircMIB2 therapy can effectively treat pathogenic infection by encoding a novel protein.","CircMIB2 therapy","treat","pathogenic infection","Null","CircMIB2 therapy","TREATS","pathogenic infection","Null"
"2322","37652905","CircMIB2 therapy can effectively treat pathogenic infection by encoding a novel protein.","CircMIB2 therapy","encode","novel protein","Null","CircMIB2 therapy","encode","novel protein","Null"
"2323","37652905","CircMIB2 therapy can effectively treat pathogenic infection by encoding a novel protein.","novel protein","treat","pathogenic infection","Null","novel protein","TREATS","pathogenic infection","Null"
"2325","37504262","RNA Methyltransferase METTL16's Protein Domains Have Differential Functional Effects on Cell Processes.","METTL16's Protein Domains","have effects on","Cell Processes","Null","METTL16's Protein Domains","have effects on","Cell Processes","Null"
"2327","37506852","Downregulation of FTO in the hippocampus is associated with mental disorders induced by fear stress during pregnancy.","FTO","downregulate","mental disorders","Hippocampus","FTO","INHIBITS","Mental Disorders","Hippocampus"
"2328","37506852","Downregulation of FTO in the hippocampus is associated with mental disorders induced by fear stress during pregnancy.","fear stress","induce","mental disorders","Hippocampus","Fear Stress","CAUSES","Mental Disorders","Hippocampus"
"2330","37516644","WTAP-mediated m6A modification of IFNE is required for antiviral defense in condyloma acuminata.","WTAP","mediate","m6A","Condyloma Acuminata","WTAP","AFFECTS","m6A","Condyloma Acuminata"
"2331","37516644","WTAP-mediated m6A modification of IFNE is required for antiviral defense in condyloma acuminata.","m6A","modify","IFNE","Condyloma Acuminata","m6A","AFFECTS","IFNE","Condyloma Acuminata"
"2332","37516644","WTAP-mediated m6A modification of IFNE is required for antiviral defense in condyloma acuminata.","IFNE","required for","antiviral defense","Condyloma Acuminata","IFNE","CAUSES","antiviral defense","Condyloma Acuminata"
"2333","37516644","WTAP-mediated m6A modification of IFNE is required for antiviral defense in condyloma acuminata.","m6A","regulate","antiviral defense","Condyloma Acuminata","m6A","AFFECTS","antiviral defense","Condyloma Acuminata"
"2335","37517144","m6A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis.","KIAA1429","accelerate","Oral Squamous Cell Carcinoma","Oral Squamous Cell Carcinoma","VIRMA","STIMULATES","oral squamous cell carcinoma","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2336","37517144","m6A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis.","KIAA1429","regulate","Glycolysis","Oral Squamous Cell Carcinoma","VIRMA","AFFECTS","glycolytic process","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2337","37517144","m6A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis.","KIAA1429","regulate","Ferroptosis","Oral Squamous Cell Carcinoma","VIRMA","AFFECTS","Ferroptosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2338","37517144","m6A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis.","Glycolysis","regulate","Oral Squamous Cell Carcinoma","Oral Squamous Cell Carcinoma","glycolytic process","AFFECTS","oral squamous cell carcinoma","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2339","37517144","m6A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis.","Ferroptosis","regulate","Oral Squamous Cell Carcinoma","Oral Squamous Cell Carcinoma","Ferroptosis","AFFECTS","oral squamous cell carcinoma","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2341","37524872","ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.","ALKBH5","demethylate","m6A","MSC senescence and osteoarthritis progression","ALKBH5","CONVERTS_TO","m6A","MSC senescence and osteoarthritis progression"
"2342","37524872","ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.","m6A","is on","CYP1B1 mRNA","MSC senescence and osteoarthritis progression","m6A","LOCATES","CYP1B1","MSC senescence and osteoarthritis progression"
"2343","37524872","ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.","CYP1B1 mRNA","alleviate","MSC senescence","MSC senescence and osteoarthritis progression","CYP1B1","INHIBITS","MSC senescence","MSC senescence and osteoarthritis progression"
"2344","37524872","ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.","CYP1B1 mRNA","alleviate","osteoarthritis progression","MSC senescence and osteoarthritis progression","CYP1B1","INHIBITS","Osteoarthritis Progression","MSC senescence and osteoarthritis progression"
"2345","37524872","ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.","ALKBH5","regulate","CYP1B1 mRNA","MSC senescence and osteoarthritis progression","ALKBH5","AFFECTS","CYP1B1","MSC senescence and osteoarthritis progression"
"2346","37524872","ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.","ALKBH5","alleviate","MSC senescence","MSC senescence and osteoarthritis progression","ALKBH5","INHIBITS","MSC senescence","MSC senescence and osteoarthritis progression"
"2347","37524872","ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.","ALKBH5","alleviate","osteoarthritis progression","MSC senescence and osteoarthritis progression","ALKBH5","INHIBITS","Osteoarthritis Progression","MSC senescence and osteoarthritis progression"
"2349","37528369","HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.","HNRNPC","promote","Collagen Fiber Alignment","Breast Cancer","HNRNPC","STIMULATES","Collagen Fiber Alignment","BRCA(Breast Invasive Carcinoma)"
"2350","37528369","HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.","HNRNPC","promote","Immune Evasion","Breast Cancer","HNRNPC","STIMULATES","Immune Evasion","BRCA(Breast Invasive Carcinoma)"
"2351","37528369","HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.","HNRNPC","activate","VIRMA","Breast Cancer","HNRNPC","STIMULATES","VIRMA","BRCA(Breast Invasive Carcinoma)"
"2352","37528369","HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.","VIRMA","mediate","TFAP2A/DDR1 axis","Breast Cancer","VIRMA","AFFECTS","TFAP2A/DDR1 axis","BRCA(Breast Invasive Carcinoma)"
"2353","37528369","HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.","TFAP2A/DDR1 axis","regulate","Collagen Fiber Alignment","Breast Cancer","TFAP2A/DDR1 axis","AFFECTS","Collagen Fiber Alignment","BRCA(Breast Invasive Carcinoma)"
"2354","37528369","HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.","TFAP2A/DDR1 axis","regulate","Immune Evasion","Breast Cancer","TFAP2A/DDR1 axis","AFFECTS","Immune Evasion","BRCA(Breast Invasive Carcinoma)"
"2356","37529797","Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner.","FTO","inhibit","Prostate Cancer","Prostate Cancer","FTO","INHIBITS","Prostatic Neoplasms","PRAD(Prostate Adenocarcinoma)"
"2357","37529797","Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner.","FTO","upregulate","EGR2","Prostate Cancer","FTO","STIMULATES","EGR2","PRAD(Prostate Adenocarcinoma)"
"2358","37529797","Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner.","FTO","regulate","m6A","Prostate Cancer","FTO","AFFECTS","m6A","PRAD(Prostate Adenocarcinoma)"
"2359","37529797","Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner.","m6A","regulate","EGR2","Prostate Cancer","m6A","AFFECTS","EGR2","PRAD(Prostate Adenocarcinoma)"
"2361","37530646","Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4-mediated ferroptosis.","Klf6","aggravate","myocardial ischemia/reperfusion injury","Myocardial ischemia/reperfusion injury","KLF6","COMPLICATES","Myocardial Ischemia Reperfusion Injury","Myocardial ischemia/reperfusion injury"
"2362","37530646","Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4-mediated ferroptosis.","Klf6","activate","Acsl4","Myocardial ischemia/reperfusion injury","KLF6","STIMULATES","ACSL4","Myocardial ischemia/reperfusion injury"
"2363","37530646","Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4-mediated ferroptosis.","Acsl4","mediate","ferroptosis","Myocardial ischemia/reperfusion injury","ACSL4","AFFECTS","Ferroptosis","Myocardial ischemia/reperfusion injury"
"2364","37530646","Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4-mediated ferroptosis.","ferroptosis","aggravate","myocardial ischemia/reperfusion injury","Myocardial ischemia/reperfusion injury","Ferroptosis","COMPLICATES","Myocardial Ischemia Reperfusion Injury","Myocardial ischemia/reperfusion injury"
"2366","37533592","The m6A Reader YTHDF1 Accelerates the Osteogenesis of Bone Marrow Mesenchymal Stem Cells Partly via Activation of the Autophagy Signaling Pathway.","YTHDF1","accelerate","Osteogenesis","Bone Marrow Mesenchymal Stem Cells","YTHDF1","STIMULATES","ossification","Bone Marrow Mesenchymal Stem Cells"
"2367","37533592","The m6A Reader YTHDF1 Accelerates the Osteogenesis of Bone Marrow Mesenchymal Stem Cells Partly via Activation of the Autophagy Signaling Pathway.","YTHDF1","activate","Autophagy Signaling Pathway","Bone Marrow Mesenchymal Stem Cells","YTHDF1","STIMULATES","Autophagy Signaling Pathway","Bone Marrow Mesenchymal Stem Cells"
"2368","37533592","The m6A Reader YTHDF1 Accelerates the Osteogenesis of Bone Marrow Mesenchymal Stem Cells Partly via Activation of the Autophagy Signaling Pathway.","Autophagy Signaling Pathway","accelerate","Osteogenesis","Bone Marrow Mesenchymal Stem Cells","Autophagy Signaling Pathway","STIMULATES","ossification","Bone Marrow Mesenchymal Stem Cells"
"2370","37534933","METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism.","METTL14","reverse","Liver Fibrosis","Liver","METTL14","reverse","Liver Cirrhosis","Liver"
"2371","37534933","METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism.","METTL14","inhibit","NOVA2","Liver","METTL14","INHIBITS","NOVA2","Liver"
"2372","37534933","METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism.","METTL14","regulate","m6A","Liver","METTL14","AFFECTS","m6A","Liver"
"2373","37534933","METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism.","YTHDF2","bind","m6A","Liver","YTHDF2","INTERACTS_WITH","m6A","Liver"
"2374","37534933","METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism.","m6A","regulate","NOVA2","Liver","m6A","AFFECTS","NOVA2","Liver"
"2376","37536262","ZC3H13 reduced DUOX1-mediated ferroptosis in laryngeal squamous cell carcinoma cells through m6A-dependent modification.","ZC3H13","reduce","Ferroptosis","Laryngeal Squamous Cell Carcinoma Cells","ZC3H13","INHIBITS","Ferroptosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2377","37536262","ZC3H13 reduced DUOX1-mediated ferroptosis in laryngeal squamous cell carcinoma cells through m6A-dependent modification.","ZC3H13","regulate","m6A","Laryngeal Squamous Cell Carcinoma Cells","ZC3H13","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2378","37536262","ZC3H13 reduced DUOX1-mediated ferroptosis in laryngeal squamous cell carcinoma cells through m6A-dependent modification.","m6A","regulate","Ferroptosis","Laryngeal Squamous Cell Carcinoma Cells","m6A","AFFECTS","Ferroptosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2380","37537731","Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.","METTL3","inhibit","Renal Fibrosis","Renal Fibrosis","METTL3","INHIBITS","Renal fibrosis","Renal fibrosis"
"2381","37537731","Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.","METTL3","reduce","m6A","Renal Fibrosis","METTL3","INHIBITS","m6A","Renal fibrosis"
"2382","37537731","Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.","m6A","is on","EVL","Renal Fibrosis","m6A","LOCATES","EVL","Renal fibrosis"
"2383","37537731","Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.","IGF2BP2","bind","m6A","Renal Fibrosis","IGF2BP2","INTERACTS_WITH","m6A","Renal fibrosis"
"2384","37537731","Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.","m6A","regulate","Renal Fibrosis","Renal Fibrosis","m6A","AFFECTS","Renal fibrosis","Renal fibrosis"
"2386","37538000","FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.","FTO","promote","Proliferation","Bladder Cancer","FTO","STIMULATES","cell population proliferation","BLCA(Bladder Urothelial Carcinoma)"
"2387","37538000","FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.","FTO","promote","Migration","Bladder Cancer","FTO","STIMULATES","migration","BLCA(Bladder Urothelial Carcinoma)"
"2388","37538000","FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.","FTO","enhance stability of","STAT3 mRNA","Bladder Cancer","FTO","enhance stability of","STAT3","BLCA(Bladder Urothelial Carcinoma)"
"2389","37538000","FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.","FTO","erase","m6A","Bladder Cancer","FTO","erase","m6A","BLCA(Bladder Urothelial Carcinoma)"
"2390","37538000","FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.","STAT3 mRNA","regulate","Proliferation","Bladder Cancer","STAT3","AFFECTS","cell population proliferation","BLCA(Bladder Urothelial Carcinoma)"
"2391","37538000","FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.","STAT3 mRNA","regulate","Migration","Bladder Cancer","STAT3","AFFECTS","migration","BLCA(Bladder Urothelial Carcinoma)"
"2393","37541353","METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis.","METTL14","regulate","microglia/macrophage polarization","Ischemic Stroke","METTL14","AFFECTS","microglia/macrophage polarization","Ischemic Stroke"
"2394","37541353","METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis.","METTL14","regulate","NLRP3 inflammasome activation","Ischemic Stroke","METTL14","AFFECTS","NLRP3 inflammasome complex assembly","Ischemic Stroke"
"2395","37541353","METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis.","METTL14","regulate","KAT3B-STING axis","Ischemic Stroke","METTL14","AFFECTS","KAT3B-STING axis","Ischemic Stroke"
"2396","37541353","METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis.","KAT3B-STING axis","regulate","microglia/macrophage polarization","Ischemic Stroke","KAT3B-STING axis","AFFECTS","microglia/macrophage polarization","Ischemic Stroke"
"2397","37541353","METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis.","KAT3B-STING axis","regulate","NLRP3 inflammasome activation","Ischemic Stroke","KAT3B-STING axis","AFFECTS","NLRP3 inflammasome complex assembly","Ischemic Stroke"
"2399","37542992","METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis.","METTL3","mediate","N6-methyladenosine modification","Kidney Tubular Epithelial Cells following Acute Kidney Injury","METTL3","AFFECTS","m6A","Kidney Tubular Epithelial Cells following Acute Kidney Injury"
"2400","37542992","METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis.","N6-methyladenosine modification","stimulate","Mitochondrial Damage","Kidney Tubular Epithelial Cells following Acute Kidney Injury","m6A","STIMULATES","Mitochondrial Damage","Kidney Tubular Epithelial Cells following Acute Kidney Injury"
"2401","37542992","METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis.","N6-methyladenosine modification","stimulate","Ferroptosis","Kidney Tubular Epithelial Cells following Acute Kidney Injury","m6A","STIMULATES","Ferroptosis","Kidney Tubular Epithelial Cells following Acute Kidney Injury"
"2402","37542992","METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis.","N6-methyladenosine modification","modulate","Stabilization","Kidney Tubular Epithelial Cells following Acute Kidney Injury","m6A","AFFECTS","stabilization","Kidney Tubular Epithelial Cells following Acute Kidney Injury"
"2403","37542992","METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis.","Stabilization","is on","MDM2-p53-LMNB1 axis","Kidney Tubular Epithelial Cells following Acute Kidney Injury","stabilization","LOCATES","MDM2-p53-LMNB1 axis","Kidney Tubular Epithelial Cells following Acute Kidney Injury"
"2404","37542992","METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis.","MDM2-p53-LMNB1 axis","regulate","Mitochondrial Damage","Kidney Tubular Epithelial Cells following Acute Kidney Injury","MDM2-p53-LMNB1 axis","AFFECTS","Mitochondrial Damage","Kidney Tubular Epithelial Cells following Acute Kidney Injury"
"2405","37542992","METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis.","MDM2-p53-LMNB1 axis","regulate","Ferroptosis","Kidney Tubular Epithelial Cells following Acute Kidney Injury","MDM2-p53-LMNB1 axis","AFFECTS","Ferroptosis","Kidney Tubular Epithelial Cells following Acute Kidney Injury"
"2407","37543013","LncRNA THRIL, transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells.","AP-1","activate","THRIL","Alveolar Epithelial Cells","AP1","STIMULATES","THRIL","Alveolar Epithelial Cells"
"2408","37543013","LncRNA THRIL, transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells.","METTL14","mediate","m6A","Alveolar Epithelial Cells","METTL14","AFFECTS","m6A","Alveolar Epithelial Cells"
"2409","37543013","LncRNA THRIL, transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells.","m6A","stabilize","THRIL","Alveolar Epithelial Cells","m6A","MAINTAINS","THRIL","Alveolar Epithelial Cells"
"2410","37543013","LncRNA THRIL, transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells.","THRIL","accelerate","acute injury","Alveolar Epithelial Cells","THRIL","STIMULATES","acute injury","Alveolar Epithelial Cells"
"2411","37543013","LncRNA THRIL, transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells.","LPS","evoke","acute injury","Alveolar Epithelial Cells","lipopolysaccharide","evoke","acute injury","Alveolar Epithelial Cells"
"2412","37543013","LncRNA THRIL, transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells.","m6A","stabilize","THRIL","Alveolar Epithelial Cells","m6A","MAINTAINS","THRIL","Alveolar Epithelial Cells"
"2414","37543219","CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.","CircCDK1","block","IGF2BP2","Laryngeal Squamous Cell Carcinoma","CircCDK1","INHIBITS","IGF2BP2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2415","37543219","CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.","IGF2BP2","bind","m6A","Laryngeal Squamous Cell Carcinoma","IGF2BP2","INTERACTS_WITH","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2416","37543219","CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.","m6A","is on","CPPED1","Laryngeal Squamous Cell Carcinoma","m6A","LOCATES","CPPED1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2417","37543219","CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.","CPPED1","regulate","Metastasis","Laryngeal Squamous Cell Carcinoma","CPPED1","AFFECTS","Neoplasm Metastasis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2418","37543219","CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.","Metastasis","via","PI3K/AKT signal pathway","Laryngeal Squamous Cell Carcinoma","Neoplasm Metastasis","via","PI3K/AKT signaling pathway","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2420","37548590","Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity.","METTL3","inhibit","interferon response","Null","METTL3","INHIBITS","interferon response","Null"
"2421","37548590","Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity.","interferon response","enhance","anti-tumour immunity","Null","interferon response","AUGMENTS","anti-tumor immunity","Null"
"2423","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","RBM15","promote","Progression","Diabetic Nephropathy","RBM15","STIMULATES","progression","DIANPH"
"2424","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","RBM15","regulate","Cell Proliferation","Diabetic Nephropathy","RBM15","AFFECTS","cell population proliferation","DIANPH"
"2425","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","RBM15","regulate","Inflammation","Diabetic Nephropathy","RBM15","AFFECTS","inflammatory response","DIANPH"
"2426","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","RBM15","regulate","Oxidative Stress","Diabetic Nephropathy","RBM15","AFFECTS","Oxidative Stress","DIANPH"
"2427","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","RBM15","regulate","Pyroptosis","Diabetic Nephropathy","RBM15","AFFECTS","pyroptosis","DIANPH"
"2428","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","RBM15","activate","AGE-RAGE pathway","Diabetic Nephropathy","RBM15","STIMULATES","AGE-RAGE pathway","DIANPH"
"2429","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","AGE-RAGE pathway","regulate","Cell Proliferation","Diabetic Nephropathy","AGE-RAGE pathway","AFFECTS","cell population proliferation","DIANPH"
"2430","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","AGE-RAGE pathway","regulate","Inflammation","Diabetic Nephropathy","AGE-RAGE pathway","AFFECTS","inflammatory response","DIANPH"
"2431","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","AGE-RAGE pathway","regulate","Oxidative Stress","Diabetic Nephropathy","AGE-RAGE pathway","AFFECTS","Oxidative Stress","DIANPH"
"2432","37551785","N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.","AGE-RAGE pathway","regulate","Pyroptosis","Diabetic Nephropathy","AGE-RAGE pathway","AFFECTS","pyroptosis","DIANPH"
"2434","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","RNA N6-methyladenosine","is on","DHAPAT","Bombyx mori","m6A","LOCATES","GNPAT","Bombyx mori"
"2435","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","RNA N6-methyladenosine","is on","PAP","Bombyx mori","m6A","LOCATES","PAP","Bombyx mori"
"2436","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","RNA N6-methyladenosine","regulate","diapause","Bombyx mori","m6A","AFFECTS","Diapause","Bombyx mori"
"2437","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","DHAPAT","regulate","diapause","Bombyx mori","GNPAT","AFFECTS","Diapause","Bombyx mori"
"2438","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","PAP","regulate","diapause","Bombyx mori","PAP","AFFECTS","Diapause","Bombyx mori"
"2439","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","lipid metabolism pathway","regulate.","diapause","Bombyx mori","lipid metabolism pathway","regulate.","Diapause","Bombyx mori"
"2440","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","RNA N6-methyladenosine","regulate","lipid metabolism pathway","Bombyx mori","m6A","AFFECTS","lipid metabolism pathway","Bombyx mori"
"2441","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","DHAPAT","regulate","lipid metabolism pathway","Bombyx mori","GNPAT","AFFECTS","lipid metabolism pathway","Bombyx mori"
"2442","37555240","RNA N6-methyladenosine of DHAPAT and PAP involves in regulation of diapause of Bombyx mori via the lipid metabolism pathway.","PAP","regulate.","lipid metabolism pathway","Bombyx mori","PAP","regulate.","lipid metabolism pathway","Bombyx mori"
"2444","37558013","EGR1 mediates METTL3/m6A/CHI3L1 to promote osteoclastogenesis in osteoporosis.","EGR1","mediate","METTL3","Osteoporosis","EGR1","AFFECTS","METTL3","Osteoporosis"
"2445","37558013","EGR1 mediates METTL3/m6A/CHI3L1 to promote osteoclastogenesis in osteoporosis.","METTL3","regulate","m6A","Osteoporosis","METTL3","AFFECTS","m6A","Osteoporosis"
"2446","37558013","EGR1 mediates METTL3/m6A/CHI3L1 to promote osteoclastogenesis in osteoporosis.","m6A","regulate","CHI3L1","Osteoporosis","m6A","AFFECTS","CHI3L1","Osteoporosis"
"2447","37558013","EGR1 mediates METTL3/m6A/CHI3L1 to promote osteoclastogenesis in osteoporosis.","CHI3L1","promote","osteoclastogenesis","Osteoporosis","CHI3L1","STIMULATES","osteoclastogenesis","Osteoporosis"
"2449","37558663","PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.","PRMT1","methylate","WTAP","Multiple Myeloma","PRMT1","CONVERTS_TO","WTAP","Multiple Myeloma"
"2450","37558663","PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.","WTAP","promote","tumorigenesis","Multiple Myeloma","WTAP","STIMULATES","Carcinogenesis","Multiple Myeloma"
"2451","37558663","PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.","WTAP","activate","oxidative phosphorylation","Multiple Myeloma","WTAP","STIMULATES","oxidative phosphorylation","Multiple Myeloma"
"2452","37558663","PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.","WTAP","regulate","m6A","Multiple Myeloma","WTAP","AFFECTS","m6A","Multiple Myeloma"
"2453","37558663","PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.","m6A","modify","NDUFS6","Multiple Myeloma","m6A","AFFECTS","NDUFS6","Multiple Myeloma"
"2454","37558663","PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.","NDUFS6","regulate","oxidative phosphorylation","Multiple Myeloma","NDUFS6","AFFECTS","oxidative phosphorylation","Multiple Myeloma"
"2456","37559689","Decreased expression of the m6A RNA methyltransferase METTL3 is associated with residual ridge resorption.","METTL3","decrease","expression","Null","METTL3","INHIBITS","expression","Null"
"2457","37559689","Decreased expression of the m6A RNA methyltransferase METTL3 is associated with residual ridge resorption.","expression","associate","residual ridge resorption","Null","expression","ASSOCIATED_WITH","residual ridge resorption","Null"
"2459","37560007","IGF2BP2-modified UBE2D1 interacts with Smad2/3 to promote the progression of breast cancer.","IGF2BP2","modify","UBE2D1","Breast Cancer","IGF2BP2","AFFECTS","UBE2D1","BRCA(Breast Invasive Carcinoma)"
"2460","37560007","IGF2BP2-modified UBE2D1 interacts with Smad2/3 to promote the progression of breast cancer.","UBE2D1","interact","Smad2/3","Breast Cancer","UBE2D1","interact","SMAD2/3","BRCA(Breast Invasive Carcinoma)"
"2461","37560007","IGF2BP2-modified UBE2D1 interacts with Smad2/3 to promote the progression of breast cancer.","Smad2/3","promote","progression","Breast Cancer","SMAD2/3","STIMULATES","progression","BRCA(Breast Invasive Carcinoma)"
"2463","37560008","Mettl3 synergistically regulates TGF-beta/SMAD2/3 to promote proliferation and metastasis of gastric cancer.","Mettl3","regulate","TGF-beta/SMAD2/3","Gastric Cancer","METTL3","AFFECTS","TGF-beta/SMAD2/3","STAD(Stomach adenocarcinoma)"
"2464","37560008","Mettl3 synergistically regulates TGF-beta/SMAD2/3 to promote proliferation and metastasis of gastric cancer.","TGF-beta/SMAD2/3","promote","Proliferation","Gastric Cancer","TGF-beta/SMAD2/3","STIMULATES","cell population proliferation","STAD(Stomach adenocarcinoma)"
"2465","37560008","Mettl3 synergistically regulates TGF-beta/SMAD2/3 to promote proliferation and metastasis of gastric cancer.","TGF-beta/SMAD2/3","promote","Metastasis","Gastric Cancer","TGF-beta/SMAD2/3","STIMULATES","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"2467","37563361","m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.","m6A","modify","circABCC4","Prostate Cancer","m6A","AFFECTS","circABCC4","PRAD(Prostate Adenocarcinoma)"
"2468","37563361","m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.","circABCC4","promote","stemness","Prostate Cancer","circABCC4","STIMULATES","Stemness","PRAD(Prostate Adenocarcinoma)"
"2469","37563361","m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.","circABCC4","promote","metastasis","Prostate Cancer","circABCC4","STIMULATES","Neoplasm Metastasis","PRAD(Prostate Adenocarcinoma)"
"2470","37563361","m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.","circABCC4","recruit","IGF2BP2","Prostate Cancer","circABCC4","recruit","IGF2BP2","PRAD(Prostate Adenocarcinoma)"
"2471","37563361","m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.","IGF2BP2","increase stability","CCAR1","Prostate Cancer","IGF2BP2","increase stability","CCAR1","PRAD(Prostate Adenocarcinoma)"
"2472","37563361","m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.","CCAR1","regulate","stemness","Prostate Cancer","CCAR1","AFFECTS","Stemness","PRAD(Prostate Adenocarcinoma)"
"2473","37563361","m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.","CCAR1","regulate","metastasis","Prostate Cancer","CCAR1","AFFECTS","Neoplasm Metastasis","PRAD(Prostate Adenocarcinoma)"
"2475","37563688","N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression.","WTAP","mediate","miR-92b-5p","Osteoarthritis","WTAP","AFFECTS","miR-92b-5p","Osteoarthritis"
"2476","37563688","N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression.","miR-92b-5p","accelerate","Osteoarthritis Progression","Osteoarthritis","miR-92b-5p","STIMULATES","Osteoarthritis Progression","Osteoarthritis"
"2478","37564203","The m6A reader YTHDF1 attenuates fulminant hepatitis via MFG-E8 translation in an m6A dependent manner.","YTHDF1","attenuate","Fulminant Hepatitis","Fulminant Hepatitis","YTHDF1","INHIBITS","Fulminant hepatitis","Fulminant hepatitis"
"2479","37564203","The m6A reader YTHDF1 attenuates fulminant hepatitis via MFG-E8 translation in an m6A dependent manner.","YTHDF1","regulate","MFG-E8","Fulminant Hepatitis","YTHDF1","AFFECTS","MFGE8","Fulminant hepatitis"
"2480","37564203","The m6A reader YTHDF1 attenuates fulminant hepatitis via MFG-E8 translation in an m6A dependent manner.","m6A","dependent","YTHDF1","Fulminant Hepatitis","m6A","dependent","YTHDF1","Fulminant hepatitis"
"2481","37564203","The m6A reader YTHDF1 attenuates fulminant hepatitis via MFG-E8 translation in an m6A dependent manner.","MFG-E8","attenuate","Fulminant Hepatitis","Fulminant Hepatitis","MFGE8","INHIBITS","Fulminant hepatitis","Fulminant hepatitis"
"2483","37565545","Mettl14-mediated m6 A modification regulates the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.","Mettl14","mediate","m6A modification","Small Intestinal Epithelial Stem Cells in Diabetic State","METTL14","AFFECTS","m6A","Small Intestinal Epithelial Stem Cells in Diabetic State"
"2484","37565545","Mettl14-mediated m6 A modification regulates the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.","m6A modification","regulate","abnormal differentiation","Small Intestinal Epithelial Stem Cells in Diabetic State","m6A","AFFECTS","abnormal differentiation","Small Intestinal Epithelial Stem Cells in Diabetic State"
"2486","37572160","The m6A Reader YTHDF1 Improves Sevoflurane-Induced Neuronal Pyroptosis and Cognitive Dysfunction Through Augmenting CREB-BDNF Signaling.","YTHDF1","improve","Neuronal Pyroptosis","Neurons","YTHDF1","STIMULATES","Neuronal Pyroptosis","Neurons"
"2487","37572160","The m6A Reader YTHDF1 Improves Sevoflurane-Induced Neuronal Pyroptosis and Cognitive Dysfunction Through Augmenting CREB-BDNF Signaling.","YTHDF1","improve","Cognitive Dysfunction","Neurons","YTHDF1","STIMULATES","Cognitive Dysfunction","Neurons"
"2488","37572160","The m6A Reader YTHDF1 Improves Sevoflurane-Induced Neuronal Pyroptosis and Cognitive Dysfunction Through Augmenting CREB-BDNF Signaling.","YTHDF1","augment","CREB-BDNF Signaling","Neurons","YTHDF1","AUGMENTS","CREB-BDNF signaling pathway","Neurons"
"2489","37572160","The m6A Reader YTHDF1 Improves Sevoflurane-Induced Neuronal Pyroptosis and Cognitive Dysfunction Through Augmenting CREB-BDNF Signaling.","CREB-BDNF Signaling","regulate","Neuronal Pyroptosis","Neurons","CREB-BDNF signaling pathway","AFFECTS","Neuronal Pyroptosis","Neurons"
"2490","37572160","The m6A Reader YTHDF1 Improves Sevoflurane-Induced Neuronal Pyroptosis and Cognitive Dysfunction Through Augmenting CREB-BDNF Signaling.","CREB-BDNF Signaling","regulate","Cognitive Dysfunction","Neurons","CREB-BDNF signaling pathway","AFFECTS","Cognitive Dysfunction","Neurons"
"2492","37573296","Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.","N6-methyladenosine","induce","mir-143-3p","Lung Cancer","m6A","CAUSES","mir-143-3p","LUAD(Lung Adenocarcinoma)"
"2493","37573296","Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.","mir-143-3p","regulate","VASH1","Lung Cancer","mir-143-3p","AFFECTS","VASH1","LUAD(Lung Adenocarcinoma)"
"2494","37573296","Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.","VASH1","promote","Brain Metastasis","Lung Cancer","VASH1","STIMULATES","Brain Metastasis","LUAD(Lung Adenocarcinoma)"
"2495","37573296","Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.","mir-143-3p","promote","Brain Metastasis","Lung Cancer","mir-143-3p","STIMULATES","Brain Metastasis","LUAD(Lung Adenocarcinoma)"
"2497","37573961","Benzo[a]pyrene-induced up-regulation of circ_0003552 via ALKBH5-mediated m6A modification promotes DNA damage in human bronchial epithelial cells.","Benzo[a]pyrene","up-regulate","circ_0003552","Human Bronchial Epithelial Cells","benzo[a]pyrene","STIMULATES","circ_0003552","Human Bronchial Epithelial Cells"
"2498","37573961","Benzo[a]pyrene-induced up-regulation of circ_0003552 via ALKBH5-mediated m6A modification promotes DNA damage in human bronchial epithelial cells.","circ_0003552","promote","DNA damage","Human Bronchial Epithelial Cells","circ_0003552","STIMULATES","DNA Damage","Human Bronchial Epithelial Cells"
"2499","37573961","Benzo[a]pyrene-induced up-regulation of circ_0003552 via ALKBH5-mediated m6A modification promotes DNA damage in human bronchial epithelial cells.","ALKBH5","mediate","m6A","Human Bronchial Epithelial Cells","ALKBH5","AFFECTS","m6A","Human Bronchial Epithelial Cells"
"2500","37573961","Benzo[a]pyrene-induced up-regulation of circ_0003552 via ALKBH5-mediated m6A modification promotes DNA damage in human bronchial epithelial cells.","m6A","modify","circ_0003552","Human Bronchial Epithelial Cells","m6A","AFFECTS","circ_0003552","Human Bronchial Epithelial Cells"
"2501","37573961","Benzo[a]pyrene-induced up-regulation of circ_0003552 via ALKBH5-mediated m6A modification promotes DNA damage in human bronchial epithelial cells.","m6A","promote","DNA damage","Human Bronchial Epithelial Cells","m6A","STIMULATES","DNA Damage","Human Bronchial Epithelial Cells"
"2503","37575058","Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating Patched homolog 1 via N6-methyladenosine methylation.","Methyltransferase-like 3","facilitate","stem cell properties","Esophageal Cancer","METTL3","AUGMENTS","stem cell properties","ESCA(Esophageal Carcinoma)"
"2504","37575058","Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating Patched homolog 1 via N6-methyladenosine methylation.","Methyltransferase-like 3","upregulate","Patched homolog 1","Esophageal Cancer","METTL3","STIMULATES","Patched-1 Receptor","ESCA(Esophageal Carcinoma)"
"2505","37575058","Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating Patched homolog 1 via N6-methyladenosine methylation.","Methyltransferase-like 3","regulate","N6-methyladenosine methylation","Esophageal Cancer","METTL3","AFFECTS","m6A","ESCA(Esophageal Carcinoma)"
"2506","37575058","Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating Patched homolog 1 via N6-methyladenosine methylation.","Patched homolog 1","regulate","stem cell properties","Esophageal Cancer","Patched-1 Receptor","AFFECTS","stem cell properties","ESCA(Esophageal Carcinoma)"
"2508","37580442","Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma.","Focused ultrasound","combine","miR-1208-equipped exosomes","Glioma","Focused ultrasound","combine","miR-1208-equipped exosomes","Glioma"
"2509","37580442","Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma.","miR-1208-equipped exosomes","inhibit","Malignant Progression","Glioma","miR-1208-equipped exosomes","INHIBITS","Malignant Progression","Glioma"
"2511","37436654","The m6A methylation enzyme METTL14 regulates myocardial ischemia/reperfusion injury through the Akt/mTOR signaling pathway.","METTL14","regulate","myocardial ischemia/reperfusion injury","Myocardial Ischemia/Reperfusion Injury","METTL14","AFFECTS","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia/Reperfusion Injury"
"2512","37436654","The m6A methylation enzyme METTL14 regulates myocardial ischemia/reperfusion injury through the Akt/mTOR signaling pathway.","METTL14","regulate","Akt/mTOR signaling pathway","Myocardial Ischemia/Reperfusion Injury","METTL14","AFFECTS","AKT/mTOR pathway","Myocardial Ischemia/Reperfusion Injury"
"2513","37436654","The m6A methylation enzyme METTL14 regulates myocardial ischemia/reperfusion injury through the Akt/mTOR signaling pathway.","Akt/mTOR signaling pathway","regulate","myocardial ischemia/reperfusion injury","Myocardial Ischemia/Reperfusion Injury","AKT/mTOR pathway","AFFECTS","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia/Reperfusion Injury"
"2515","37436898","ALKBH5 causes retinal pigment epithelium anomalies and choroidal neovascularization in age-related macular degeneration via the AKT/mTOR pathway.","ALKBH5","cause","retinal pigment epithelium anomalies","Age-related macular degeneration","ALKBH5","CAUSES","retinal pigment epithelium anomalies","Macular Degeneration"
"2516","37436898","ALKBH5 causes retinal pigment epithelium anomalies and choroidal neovascularization in age-related macular degeneration via the AKT/mTOR pathway.","ALKBH5","cause","choroidal neovascularization","Age-related macular degeneration","ALKBH5","CAUSES","Choroidal neovascularization","Macular Degeneration"
"2517","37436898","ALKBH5 causes retinal pigment epithelium anomalies and choroidal neovascularization in age-related macular degeneration via the AKT/mTOR pathway.","ALKBH5","regulate","AKT/mTOR pathway","Age-related macular degeneration","ALKBH5","AFFECTS","AKT/mTOR pathway","Macular Degeneration"
"2518","37436898","ALKBH5 causes retinal pigment epithelium anomalies and choroidal neovascularization in age-related macular degeneration via the AKT/mTOR pathway.","AKT/mTOR pathway","regulate","retinal pigment epithelium anomalies","Age-related macular degeneration","AKT/mTOR pathway","AFFECTS","retinal pigment epithelium anomalies","Macular Degeneration"
"2519","37436898","ALKBH5 causes retinal pigment epithelium anomalies and choroidal neovascularization in age-related macular degeneration via the AKT/mTOR pathway.","AKT/mTOR pathway","regulate","choroidal neovascularization","Age-related macular degeneration","AKT/mTOR pathway","AFFECTS","Choroidal neovascularization","Macular Degeneration"
"2521","37437797","Downregulated FTO promotes microRNA-155-mediated inflammatory response in cerebral ischemia/reperfusion injury.","dummy","downregulate","FTO","Cerebral ischemia/reperfusion injury","dummy","INHIBITS","FTO","Cerebral ischemia/reperfusion injury"
"2522","37437797","Downregulated FTO promotes microRNA-155-mediated inflammatory response in cerebral ischemia/reperfusion injury.","FTO","promote","microRNA-155","Cerebral ischemia/reperfusion injury","FTO","STIMULATES","MIR155","Cerebral ischemia/reperfusion injury"
"2523","37437797","Downregulated FTO promotes microRNA-155-mediated inflammatory response in cerebral ischemia/reperfusion injury.","microRNA-155","mediate","inflammatory response","Cerebral ischemia/reperfusion injury","MIR155","AFFECTS","inflammatory response","Cerebral ischemia/reperfusion injury"
"2525","37438359","METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/beta-catenin signaling.","METTL3","mediate","m6A","Glioma Stem Cells","METTL3","AFFECTS","m6A","Glioma Stem Cells"
"2526","37438359","METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/beta-catenin signaling.","m6A","modify","LINC00839","Glioma Stem Cells","m6A","AFFECTS","LINC00839","Glioma Stem Cells"
"2527","37438359","METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/beta-catenin signaling.","LINC00839","maintain","Radiation Resistance","Glioma Stem Cells","LINC00839","MAINTAINS","Radiation Resistance","Glioma Stem Cells"
"2528","37438359","METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/beta-catenin signaling.","LINC00839","activate","Wnt/beta-catenin signaling","Glioma Stem Cells","LINC00839","STIMULATES","WNT/beta-catenin pathway","Glioma Stem Cells"
"2529","37438359","METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/beta-catenin signaling.","Wnt/beta-catenin signaling","maintain","Radiation Resistance","Glioma Stem Cells","WNT/beta-catenin pathway","MAINTAINS","Radiation Resistance","Glioma Stem Cells"
"2531","37449516","METTL14 mediates m6a modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873.","METTL14","mediate","m6A modification","Bone Marrow Mesenchymal Stem Cells","METTL14","AFFECTS","m6A","Bone Marrow Mesenchymal Stem Cells"
"2532","37449516","METTL14 mediates m6a modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873.","m6A modification","regulate","osteogenic proliferation","Bone Marrow Mesenchymal Stem Cells","m6A","AFFECTS","osteogenic proliferation","Bone Marrow Mesenchymal Stem Cells"
"2533","37449516","METTL14 mediates m6a modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873.","m6A modification","regulate","differentiation","Bone Marrow Mesenchymal Stem Cells","m6A","AFFECTS","cell differentiation","Bone Marrow Mesenchymal Stem Cells"
"2534","37449516","METTL14 mediates m6a modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873.","METTL14","regulate","pri-miR-873","Bone Marrow Mesenchymal Stem Cells","METTL14","AFFECTS","pri-miR-873","Bone Marrow Mesenchymal Stem Cells"
"2535","37449516","METTL14 mediates m6a modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873.","pri-miR-873","regulate","osteogenic proliferation","Bone Marrow Mesenchymal Stem Cells","pri-miR-873","AFFECTS","osteogenic proliferation","Bone Marrow Mesenchymal Stem Cells"
"2536","37449516","METTL14 mediates m6a modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873.","pri-miR-873","regulate","differentiation","Bone Marrow Mesenchymal Stem Cells","pri-miR-873","AFFECTS","cell differentiation","Bone Marrow Mesenchymal Stem Cells"
"2538","37449789","m6 A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m6 A-EGFR/STAT3 axis and EMT.","YTHDF3","trigger","Progression","Hepatocellular Carcinoma","YTHDF3","CAUSES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"2539","37449789","m6 A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m6 A-EGFR/STAT3 axis and EMT.","YTHDF3","bind","m6A","Hepatocellular Carcinoma","YTHDF3","INTERACTS_WITH","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"2540","37449789","m6 A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m6 A-EGFR/STAT3 axis and EMT.","m6A","is on","EGFR","Hepatocellular Carcinoma","m6A","LOCATES","EGFR","LIHC(Liver Hepatocellular Carcinoma)"
"2541","37449789","m6 A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m6 A-EGFR/STAT3 axis and EMT.","EGFR","regulate","STAT3","Hepatocellular Carcinoma","EGFR","AFFECTS","STAT3","LIHC(Liver Hepatocellular Carcinoma)"
"2542","37449789","m6 A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m6 A-EGFR/STAT3 axis and EMT.","STAT3","regulate","EMT","Hepatocellular Carcinoma","STAT3","AFFECTS","epithelial to mesenchymal transition","LIHC(Liver Hepatocellular Carcinoma)"
"2544","37453198","Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes.","Cinnamic Acid","mitigate","Left Ventricular Hypertrophy","Cardiomyocytes","cinnamic acid","INHIBITS","Hypertrophy, Left Ventricular","Myocytes, Cardiac"
"2545","37453198","Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes.","Cinnamic Acid","mitigate","Heart Failure","Cardiomyocytes","cinnamic acid","INHIBITS","Heart Failure","Myocytes, Cardiac"
"2546","37453198","Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes.","Cinnamic Acid","modulate","FTO","Cardiomyocytes","cinnamic acid","AFFECTS","FTO","Myocytes, Cardiac"
"2547","37453198","Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes.","FTO","regulate","N6-methyladenosine RNA modification","Cardiomyocytes","FTO","AFFECTS","m6A","Myocytes, Cardiac"
"2548","37453198","Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes.","N6-methyladenosine RNA modification","regulate","Left Ventricular Hypertrophy","Cardiomyocytes","m6A","AFFECTS","Hypertrophy, Left Ventricular","Myocytes, Cardiac"
"2549","37453198","Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes.","N6-methyladenosine RNA modification","regulate","Heart Failure","Cardiomyocytes","m6A","AFFECTS","Heart Failure","Myocytes, Cardiac"
"2551","37454738","Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival.","USP9X","stabilize","ALKBH5","Acute Myeloid Leukemia cells","USP9X","MAINTAINS","ALKBH5","LAML(Acute Myeloid Leukemia)"
"2552","37454738","Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival.","ALKBH5","promote","cell survival","Acute Myeloid Leukemia cells","ALKBH5","STIMULATES","Cell Survival","LAML(Acute Myeloid Leukemia)"
"2554","37456679","Downregulation of hepatic METTL3 contributes to APAP-induced liver injury in mice.","dummy","induce downregulation of","METTL3","Mice","dummy","induce downregulation of","METTL3","Mice"
"2555","37456679","Downregulation of hepatic METTL3 contributes to APAP-induced liver injury in mice.","METTL3","contribute","Liver Injury","Mice","METTL3","AFFECTS","Liver Injury","Mice"
"2556","37456679","Downregulation of hepatic METTL3 contributes to APAP-induced liver injury in mice.","APAP","induce","Liver Injury","Mice","paracetamol","CAUSES","Liver Injury","Mice"
"2558","37458420","The Drosophila Nab2 RNA binding protein inhibits m6A methylation and male-specific splicing of Sex lethal transcript in female neuronal tissue.","Nab2 RNA binding protein","inhibit","m6A methylation","Female Neuronal Tissue of Drosophila","Nab2 RNA binding protein","INHIBITS","m6A","Female Neuronal Tissue of Drosophila"
"2559","37458420","The Drosophila Nab2 RNA binding protein inhibits m6A methylation and male-specific splicing of Sex lethal transcript in female neuronal tissue.","Nab2 RNA binding protein","inhibit","male-specific splicing","Female Neuronal Tissue of Drosophila","Nab2 RNA binding protein","INHIBITS","male-specific splicing","Female Neuronal Tissue of Drosophila"
"2560","37458420","The Drosophila Nab2 RNA binding protein inhibits m6A methylation and male-specific splicing of Sex lethal transcript in female neuronal tissue.","male-specific splicing","is on","Sex lethal transcript","Female Neuronal Tissue of Drosophila","male-specific splicing","LOCATES","Sex lethal transcript","Female Neuronal Tissue of Drosophila"
"2561","37458420","The Drosophila Nab2 RNA binding protein inhibits m6A methylation and male-specific splicing of Sex lethal transcript in female neuronal tissue.","m6A methylation","regulate","male-specific splicing","Female Neuronal Tissue of Drosophila","m6A","AFFECTS","male-specific splicing","Female Neuronal Tissue of Drosophila"
"2563","37462772","A feed-forward loop based on aerobic glycolysis and TGF-beta between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escape.","aerobic glycolysis","based on","TGF-beta","Bladder Cancer","aerobic glycolysis","based on","TGFB","BLCA(Bladder Urothelial Carcinoma)"
"2564","37462772","A feed-forward loop based on aerobic glycolysis and TGF-beta between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escape.","TGF-beta","between","tumor-associated macrophages","Bladder Cancer","TGFB","between","Tumor-Associated Macrophages","BLCA(Bladder Urothelial Carcinoma)"
"2565","37462772","A feed-forward loop based on aerobic glycolysis and TGF-beta between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escape.","tumor-associated macrophages","promote","malignant progression","Bladder Cancer","Tumor-Associated Macrophages","STIMULATES","Malignant Progression","BLCA(Bladder Urothelial Carcinoma)"
"2567","37466203","Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m6 A RNA methylation in ocular melanoma.","dummy","target","Histone Deacetylase","Ocular Melanoma","dummy","INTERACTS_WITH","HDAC","UVM(Uveal Melanoma)"
"2568","37466203","Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m6 A RNA methylation in ocular melanoma.","Histone Deacetylase","suppress","Tumor Growth","Ocular Melanoma","HDAC","INHIBITS","Tumor Growth","UVM(Uveal Melanoma)"
"2569","37466203","Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m6 A RNA methylation in ocular melanoma.","Histone Deacetylase","elicit","METTL14","Ocular Melanoma","HDAC","elicit","METTL14","UVM(Uveal Melanoma)"
"2570","37466203","Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m6 A RNA methylation in ocular melanoma.","METTL14","modify","m6A RNA methylation","Ocular Melanoma","METTL14","AFFECTS","m6A","UVM(Uveal Melanoma)"
"2571","37466203","Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m6 A RNA methylation in ocular melanoma.","m6A RNA methylation","regulate","Tumor Growth","Ocular Melanoma","m6A","AFFECTS","Tumor Growth","UVM(Uveal Melanoma)"
"2573","37467831","N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation.","YTHDF2","identify","N6-methyladenosine-modified circIRF2","Liver","YTHDF2","DIAGNOSES","m6A-modified circIRF2","Liver"
"2574","37467831","N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation.","N6-methyladenosine-modified circIRF2","suppress","Liver Fibrosis","Liver","m6A-modified circIRF2","INHIBITS","Liver Cirrhosis","Liver"
"2575","37467831","N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation.","N6-methyladenosine-modified circIRF2","facilitate","FOXO3","Liver","m6A-modified circIRF2","AUGMENTS","FOXO3","Liver"
"2576","37467831","N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation.","FOXO3","undergo","Nuclear Translocation","Liver","FOXO3","undergo","Nuclear Translocation","Liver"
"2577","37467831","N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation.","Nuclear Translocation","suppress","Liver Fibrosis","Liver","Nuclear Translocation","INHIBITS","Liver Cirrhosis","Liver"
"2579","37468464","circRNF13, a novel N6-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability.","circRNF13","enhance","Radioresistance","Cervical Cancer","circRNF13","AUGMENTS","Radioresistance","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2580","37468464","circRNF13, a novel N6-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability.","circRNF13","increase stability","CXCL1 mRNA","Cervical Cancer","circRNF13","increase stability","CXCL1","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2581","37468464","circRNF13, a novel N6-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability.","CXCL1 mRNA","enhance","Radioresistance","Cervical Cancer","CXCL1","AUGMENTS","Radioresistance","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2583","37469973","N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.","dummy","regulate","N6-methyladenosine","Hepatocellular Carcinoma","dummy","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"2584","37469973","N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.","dummy","regulate","immune infiltration","Hepatocellular Carcinoma","dummy","AFFECTS","immune infiltration","LIHC(Liver Hepatocellular Carcinoma)"
"2585","37469973","N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.","dummy","regulate","PD-L1","Hepatocellular Carcinoma","dummy","AFFECTS","CD274","LIHC(Liver Hepatocellular Carcinoma)"
"2587","37474102","The disordered C terminus of ALKBH5 promotes phase separation and paraspeckles assembly.","C terminus of ALKBH5","promote","phase separation","Null","C terminus of ALKBH5","STIMULATES","Phase Separation","Null"
"2588","37474102","The disordered C terminus of ALKBH5 promotes phase separation and paraspeckles assembly.","C terminus of ALKBH5","promote","paraspeckles assembly","Null","C terminus of ALKBH5","STIMULATES","paraspeckles assembly","Null"
"2590","37478627","METTL3 promotes hyperoxia-induced pyroptosis in neonatal bronchopulmonary dysplasia by inhibiting ATG8-mediated autophagy.","METTL3","promote","hyperoxia-induced pyroptosis","Neonatal Bronchopulmonary Dysplasia","METTL3","STIMULATES","hyperoxia-induced pyroptosis","Neonatal Bronchopulmonary Dysplasia"
"2591","37478627","METTL3 promotes hyperoxia-induced pyroptosis in neonatal bronchopulmonary dysplasia by inhibiting ATG8-mediated autophagy.","METTL3","inhibit","ATG8","Neonatal Bronchopulmonary Dysplasia","METTL3","INHIBITS","GABARAPL2","Neonatal Bronchopulmonary Dysplasia"
"2592","37478627","METTL3 promotes hyperoxia-induced pyroptosis in neonatal bronchopulmonary dysplasia by inhibiting ATG8-mediated autophagy.","ATG8","mediate","autophagy","Neonatal Bronchopulmonary Dysplasia","GABARAPL2","AFFECTS","autophagy","Neonatal Bronchopulmonary Dysplasia"
"2593","37478627","METTL3 promotes hyperoxia-induced pyroptosis in neonatal bronchopulmonary dysplasia by inhibiting ATG8-mediated autophagy.","autophagy","inhibit","hyperoxia-induced pyroptosis","Neonatal Bronchopulmonary Dysplasia","autophagy","INHIBITS","hyperoxia-induced pyroptosis","Neonatal Bronchopulmonary Dysplasia"
"2595","37478845","A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.","FTO locus","produce","lncRNA","Null","FTO locus","PRODUCES","RNA, Long Noncoding","Null"
"2596","37478845","A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.","lncRNA","suppress","m6A writer complex","Null","RNA, Long Noncoding","INHIBITS","m6A writer complex","Null"
"2597","37478845","A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.","lncRNA","suppress","p53 tumor suppression signaling","Null","RNA, Long Noncoding","INHIBITS","p53 tumor suppression signaling pathway","Null"
"2599","37480971","HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.","HPV E7","drive","ALKBH5","Cervical Cancer","HPV E7","STIMULATES","ALKBH5","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2600","37480971","HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.","ALKBH5","promote","Cervical Cancer Progression","Cervical Cancer","ALKBH5","STIMULATES","Cervical Cancer Progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2601","37480971","HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.","ALKBH5","modulate","m6A","Cervical Cancer","ALKBH5","AFFECTS","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2602","37480971","HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.","m6A","is on","PAK5","Cervical Cancer","m6A","LOCATES","PAK5","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2603","37480971","HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.","PAK5","regulate","Cervical Cancer Progression","Cervical Cancer","PAK5","AFFECTS","Cervical Cancer Progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2605","37482304","N6-Methyladenosine methylase METTL3 contributes to neuropathic pain by epigenetic silencing of mu opioid receptor.","METTL3","contribute","Neuropathic Pain","Neuropathic Pain","METTL3","AFFECTS","Neuralgia","Neuralgia"
"2606","37482304","N6-Methyladenosine methylase METTL3 contributes to neuropathic pain by epigenetic silencing of mu opioid receptor.","METTL3","silence","mu opioid receptor","Neuropathic Pain","METTL3","INHIBITS","OPRM1","Neuralgia"
"2607","37482304","N6-Methyladenosine methylase METTL3 contributes to neuropathic pain by epigenetic silencing of mu opioid receptor.","mu opioid receptor","regulate","Neuropathic Pain","Neuropathic Pain","OPRM1","AFFECTS","Neuralgia","Neuralgia"
"2609","37482682","Targeting PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to enhance cancer cell radiosensitivity.","Dummy","target","PARP1","Cancer Cells","dummy","INTERACTS_WITH","PARP1","PANCAN(Pan-Cancer)"
"2610","37482682","Targeting PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to enhance cancer cell radiosensitivity.","PARP1","modulate","METTL3 promoter chromatin accessibility","Cancer Cells","PARP1","AFFECTS","METTL3 promoter chromatin accessibility","PANCAN(Pan-Cancer)"
"2611","37482682","Targeting PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to enhance cancer cell radiosensitivity.","PARP1","modulate","LPAR5 RNA m6A methylation","Cancer Cells","PARP1","AFFECTS","LPAR5 RNA m6A methylation","PANCAN(Pan-Cancer)"
"2612","37482682","Targeting PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to enhance cancer cell radiosensitivity.","LPAR5 RNA m6A methylation","enhance","Cancer cell radiosensitivity","Cancer Cells","LPAR5 RNA m6A methylation","AUGMENTS","Cancer cell radiosensitivity","PANCAN(Pan-Cancer)"
"2614","37486003","Homogeneous Electrochemiluminescence for Highly Sensitive Determination of Demethylase FTO Based on Target-Regulated DNAzyme Cleavage and Host-Guest Interaction.","Electrochemiluminescence","determine","Demethylase FTO","Null","Electrochemiluminescence","determine","FTO","Null"
"2615","37486003","Homogeneous Electrochemiluminescence for Highly Sensitive Determination of Demethylase FTO Based on Target-Regulated DNAzyme Cleavage and Host-Guest Interaction.","Demethylase FTO","regulate","DNAzyme Cleavage","Null","FTO","AFFECTS","DNAzyme Cleavage","Null"
"2616","37486003","Homogeneous Electrochemiluminescence for Highly Sensitive Determination of Demethylase FTO Based on Target-Regulated DNAzyme Cleavage and Host-Guest Interaction.","Demethylase FTO","regulate","Host-Guest Interaction","Null","FTO","AFFECTS","Host-Guest Interaction","Null"
"2618","37488356","N6-adenosine methylation controls the translation of insulin mRNA.","N6-adenosine methylation","control","translation","Null","m6A","AFFECTS","translation","Null"
"2619","37488356","N6-adenosine methylation controls the translation of insulin mRNA.","translation","of","insulin mRNA","Null","translation","of","INS","Null"
"2621","37490181","SETD2 controls m6A modification of transcriptome and regulates the molecular oncogenesis of glioma.","SETD2","control","m6A modification","Glioma","SETD2","AFFECTS","m6A","Glioma"
"2622","37490181","SETD2 controls m6A modification of transcriptome and regulates the molecular oncogenesis of glioma.","m6A modification","is on","transcriptome","Glioma","m6A","LOCATES","Transcriptome","Glioma"
"2623","37490181","SETD2 controls m6A modification of transcriptome and regulates the molecular oncogenesis of glioma.","SETD2","regulate","molecular oncogenesis","Glioma","SETD2","AFFECTS","molecular oncogenesis","Glioma"
"2624","37490181","SETD2 controls m6A modification of transcriptome and regulates the molecular oncogenesis of glioma.","transcriptome","regulate","molecular oncogenesis","Glioma","Transcriptome","AFFECTS","molecular oncogenesis","Glioma"
"2626","37491377","Circular RNA encoded MET variant promotes glioblastoma tumorigenesis.","Circular RNA","encode","MET variant","Glioblastoma","RNA, Circular","encode","MET variant","GBM(Glioblastoma Multiforme)"
"2627","37491377","Circular RNA encoded MET variant promotes glioblastoma tumorigenesis.","MET variant","promote","tumorigenesis","Glioblastoma","MET variant","STIMULATES","Carcinogenesis","GBM(Glioblastoma Multiforme)"
"2629","37492748","FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4/TLR4/NF-kappaB signaling axis.","FTO","mediate","m6A modification","Autoimmune Uveitis","FTO","AFFECTS","m6A","autoimmune uveitis"
"2630","37492748","FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4/TLR4/NF-kappaB signaling axis.","m6A modification","alleviate","Autoimmune Uveitis","Autoimmune Uveitis","m6A","INHIBITS","autoimmune uveitis","autoimmune uveitis"
"2631","37492748","FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4/TLR4/NF-kappaB signaling axis.","m6A modification","regulate","Microglia Phenotypes","Autoimmune Uveitis","m6A","AFFECTS","Microglia Phenotypes","autoimmune uveitis"
"2632","37492748","FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4/TLR4/NF-kappaB signaling axis.","Microglia Phenotypes","regulate","GPC4/TLR4/NF-kappaB signaling axis","Autoimmune Uveitis","Microglia Phenotypes","AFFECTS","GPC4/TLR4/NF-kappaB signaling axis","autoimmune uveitis"
"2633","37492748","FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4/TLR4/NF-kappaB signaling axis.","GPC4/TLR4/NF-kappaB signaling axis","regulate","Autoimmune Uveitis","Autoimmune Uveitis","GPC4/TLR4/NF-kappaB signaling axis","AFFECTS","autoimmune uveitis","autoimmune uveitis"
"2635","37493109","USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma.","USF1","mediate","ALKBH5","Prostate Adenocarcinoma","USF1","AFFECTS","ALKBH5","PRAD(Prostate Adenocarcinoma)"
"2636","37493109","USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma.","ALKBH5","stabilize","FLII mRNA","Prostate Adenocarcinoma","ALKBH5","MAINTAINS","FLII","PRAD(Prostate Adenocarcinoma)"
"2637","37493109","USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma.","ALKBH5","regulate","m6A","Prostate Adenocarcinoma","ALKBH5","AFFECTS","m6A","PRAD(Prostate Adenocarcinoma)"
"2638","37493109","USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma.","m6A","bind","YTHDF2","Prostate Adenocarcinoma","m6A","INTERACTS_WITH","YTHDF2","PRAD(Prostate Adenocarcinoma)"
"2639","37493109","USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma.","FLII mRNA","repress","glycolytic activity","Prostate Adenocarcinoma","FLII","INHIBITS","glycolytic activity","PRAD(Prostate Adenocarcinoma)"
"2640","37493109","USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma.","YTHDF2","regulate","FLII mRNA","Prostate Adenocarcinoma","YTHDF2","AFFECTS","FLII","PRAD(Prostate Adenocarcinoma)"
"2642","37495067","Decreased expression of Chrna4 by METTL3-mediated m6A modification participates in BPA-induced spatial memory deficit.","METTL3","decrease","Chrna4","BPA-induced spatial memory deficit","METTL3","INHIBITS","CHRNA4","BPA-induced spatial memory deficit"
"2643","37495067","Decreased expression of Chrna4 by METTL3-mediated m6A modification participates in BPA-induced spatial memory deficit.","METTL3","mediate","m6A modification","BPA-induced spatial memory deficit","METTL3","AFFECTS","m6A","BPA-induced spatial memory deficit"
"2644","37495067","Decreased expression of Chrna4 by METTL3-mediated m6A modification participates in BPA-induced spatial memory deficit.","Chrna4","participate in","spatial memory deficit","BPA-induced spatial memory deficit","CHRNA4","participate in","spatial memory deficit","BPA-induced spatial memory deficit"
"2645","37495067","Decreased expression of Chrna4 by METTL3-mediated m6A modification participates in BPA-induced spatial memory deficit.","m6A modification","regulate","Chrna4","BPA-induced spatial memory deficit","m6A","AFFECTS","CHRNA4","BPA-induced spatial memory deficit"
"2647","37498069","LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination.","SLC7A11-AS1","promote","Progression","Hepatocellular Carcinoma","SLC7A11-AS1","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"2648","37498069","LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination.","SLC7A11-AS1","mediate","KLF9 ubiquitination","Hepatocellular Carcinoma","SLC7A11-AS1","AFFECTS","KLF9 ubiquitination","LIHC(Liver Hepatocellular Carcinoma)"
"2649","37498069","LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination.","KLF9 ubiquitination","regulate","Progression","Hepatocellular Carcinoma","KLF9 ubiquitination","AFFECTS","progression","LIHC(Liver Hepatocellular Carcinoma)"
"2651","37498408","EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A.","EZH2","contribute","Anoikis Resistance","Epithelial Ovarian Cancer","EZH2","AFFECTS","Anoikis Resistance","OV(Ovarian Serous Cystadenocarcinoma)"
"2652","37498408","EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A.","EZH2","promote","Peritoneal Metastasis","Epithelial Ovarian Cancer","EZH2","STIMULATES","Peritoneal Metastasis","OV(Ovarian Serous Cystadenocarcinoma)"
"2653","37498408","EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A.","EZH2","regulate","m6A","Epithelial Ovarian Cancer","EZH2","AFFECTS","m6A","OV(Ovarian Serous Cystadenocarcinoma)"
"2654","37498408","EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A.","m6A","regulate","Anoikis Resistance","Epithelial Ovarian Cancer","m6A","AFFECTS","Anoikis Resistance","OV(Ovarian Serous Cystadenocarcinoma)"
"2655","37498408","EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A.","m6A","regulate","Peritoneal Metastasis","Epithelial Ovarian Cancer","m6A","AFFECTS","Peritoneal Metastasis","OV(Ovarian Serous Cystadenocarcinoma)"
"2657","37500815","RNA methylation reading protein YTHDF2 relieves myocardial ischemia-reperfusion injury by downregulating BNIP3 via m6A modification.","YTHDF2","relieve","Myocardial Ischemia-Reperfusion Injury","Myocardial Ischemia-Reperfusion Injury","YTHDF2","relieve","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia-Reperfusion Injury"
"2658","37500815","RNA methylation reading protein YTHDF2 relieves myocardial ischemia-reperfusion injury by downregulating BNIP3 via m6A modification.","YTHDF2","downregulate","BNIP3","Myocardial Ischemia-Reperfusion Injury","YTHDF2","INHIBITS","BNIP3","Myocardial Ischemia-Reperfusion Injury"
"2659","37500815","RNA methylation reading protein YTHDF2 relieves myocardial ischemia-reperfusion injury by downregulating BNIP3 via m6A modification.","YTHDF2","bind","m6A","Myocardial Ischemia-Reperfusion Injury","YTHDF2","INTERACTS_WITH","m6A","Myocardial Ischemia-Reperfusion Injury"
"2660","37500815","RNA methylation reading protein YTHDF2 relieves myocardial ischemia-reperfusion injury by downregulating BNIP3 via m6A modification.","m6A","regulate","BNIP3","Myocardial Ischemia-Reperfusion Injury","m6A","AFFECTS","BNIP3","Myocardial Ischemia-Reperfusion Injury"
"2662","37365312","Globally reduced N6-methyladenosine (m6A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration.","dummy","reduce","m6A","C9ORF72-ALS/FTD","dummy","INHIBITS","m6A","C9ORF72-ALS/FTD"
"2663","37365312","Globally reduced N6-methyladenosine (m6A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration.","m6A","dysregulate","RNA metabolism","C9ORF72-ALS/FTD","m6A","dysregulate","RNA metabolic process","C9ORF72-ALS/FTD"
"2664","37365312","Globally reduced N6-methyladenosine (m6A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration.","RNA metabolism","contribute","neurodegeneration","C9ORF72-ALS/FTD","RNA metabolic process","AFFECTS","Neurodegeneration","C9ORF72-ALS/FTD"
"2666","37366109","Aberrant DNA N6 -methyladenine incorporation via adenylate kinase 1 is suppressed by ADAL deaminase-dependent 2'-deoxynucleotide pool sanitation.","dummy","incorporate","DNA N6 -methyladenine","Null","dummy","incorporate","DNA N6 -methyladenine","Null"
"2667","37366109","Aberrant DNA N6 -methyladenine incorporation via adenylate kinase 1 is suppressed by ADAL deaminase-dependent 2'-deoxynucleotide pool sanitation.","dummy","regulate","adenylate kinase 1","Null","dummy","AFFECTS","AK1","Null"
"2668","37366109","Aberrant DNA N6 -methyladenine incorporation via adenylate kinase 1 is suppressed by ADAL deaminase-dependent 2'-deoxynucleotide pool sanitation.","adenylate kinase 1","regulate","DNA N6 -methyladenine","Null","AK1","AFFECTS","DNA N6 -methyladenine","Null"
"2669","37366109","Aberrant DNA N6 -methyladenine incorporation via adenylate kinase 1 is suppressed by ADAL deaminase-dependent 2'-deoxynucleotide pool sanitation.","ADAL deaminase","regulate","2'-deoxynucleotide pool sanitation","Null","ADAL deaminase","AFFECTS","2'-deoxynucleotide pool sanitation","Null"
"2670","37366109","Aberrant DNA N6 -methyladenine incorporation via adenylate kinase 1 is suppressed by ADAL deaminase-dependent 2'-deoxynucleotide pool sanitation.","2'-deoxynucleotide pool sanitation","suppress","DNA N6 -methyladenine","Null","2'-deoxynucleotide pool sanitation","INHIBITS","DNA N6 -methyladenine","Null"
"2672","37368192","Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.","circ_KIAA1429","accelerate","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","circ_KIAA1429","STIMULATES","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"2673","37368192","Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.","circ_KIAA1429","regulate","miR-133a-3p/HMGA2 axis","Hepatocellular Carcinoma","circ_KIAA1429","AFFECTS","miR-133a-3p/HMGA2 axis","LIHC(Liver Hepatocellular Carcinoma)"
"2674","37368192","Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.","m6A","regulate","miR-133a-3p/HMGA2 axis","Hepatocellular Carcinoma","m6A","AFFECTS","miR-133a-3p/HMGA2 axis","LIHC(Liver Hepatocellular Carcinoma)"
"2675","37368192","Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.","miR-133a-3p/HMGA2 axis","regulate","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","miR-133a-3p/HMGA2 axis","AFFECTS","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"2677","37369679","K235 acetylation couples with PSPC1 to regulate the m6A demethylation activity of ALKBH5 and tumorigenesis.","K235 acetylation","couple","PSPC1","Null","K235 acetylation","couple","PSPC1","Null"
"2678","37369679","K235 acetylation couples with PSPC1 to regulate the m6A demethylation activity of ALKBH5 and tumorigenesis.","PSPC1","regulate","m6A demethylation activity","Null","PSPC1","AFFECTS","m6A demethylation","Null"
"2679","37369679","K235 acetylation couples with PSPC1 to regulate the m6A demethylation activity of ALKBH5 and tumorigenesis.","m6A demethylation activity","is of","ALKBH5","Null","m6A demethylation","is of","ALKBH5","Null"
"2680","37369679","K235 acetylation couples with PSPC1 to regulate the m6A demethylation activity of ALKBH5 and tumorigenesis.","ALKBH5","regulate","tumorigenesis","Null","ALKBH5","AFFECTS","Carcinogenesis","Null"
"2682","37379372","Erratum for the Research Article ""Aberrant activation of m6A demethylase FTO renders HIF2alphalow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors"" by C. Zhang et al.","dummy","activate","FTO","Clear cell renal cell carcinoma","dummy","STIMULATES","FTO","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2683","37379372","Erratum for the Research Article ""Aberrant activation of m6A demethylase FTO renders HIF2alphalow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors"" by C. Zhang et al.","FTO","render low","HIF2alpha","Clear cell renal cell carcinoma","FTO","render low","EPAS1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2684","37379372","Erratum for the Research Article ""Aberrant activation of m6A demethylase FTO renders HIF2alphalow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors"" by C. Zhang et al.","HIF2alpha","is in","clear cell renal cell carcinoma","Clear cell renal cell carcinoma","EPAS1","LOCATES","Clear Cell Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2685","37379372","Erratum for the Research Article ""Aberrant activation of m6A demethylase FTO renders HIF2alphalow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors"" by C. Zhang et al.","clear cell renal cell carcinoma","sensitive to","BRD9 inhibitors","Clear cell renal cell carcinoma","Clear Cell Renal Cell Carcinoma Progression","sensitive to","BRD9 inhibitors","KIRC(Kidney Renal Clear Cell Carcinoma)"
"2687","37379961","METTL3 Boosts Mitochondrial Fission and Induces Cardiac Fibrosis by Enhancing LncRNA GAS5 Methylation.","METTL3","boost","Mitochondrial Fission","Heart","METTL3","boost","mitochondrial fission","Heart"
"2688","37379961","METTL3 Boosts Mitochondrial Fission and Induces Cardiac Fibrosis by Enhancing LncRNA GAS5 Methylation.","METTL3","induce","Cardiac Fibrosis","Heart","METTL3","CAUSES","Cardiac Fibrosis","Heart"
"2689","37379961","METTL3 Boosts Mitochondrial Fission and Induces Cardiac Fibrosis by Enhancing LncRNA GAS5 Methylation.","METTL3","enhance","Methylation","Heart","METTL3","AUGMENTS","methylation","Heart"
"2690","37379961","METTL3 Boosts Mitochondrial Fission and Induces Cardiac Fibrosis by Enhancing LncRNA GAS5 Methylation.","Methylation","is on","LncRNA GAS5","Heart","methylation","LOCATES","GAS5","Heart"
"2691","37379961","METTL3 Boosts Mitochondrial Fission and Induces Cardiac Fibrosis by Enhancing LncRNA GAS5 Methylation.","LncRNA GAS5","regulate","Cardiac Fibrosis","Heart","GAS5","AFFECTS","Cardiac Fibrosis","Heart"
"2693","37385994","High glucose induces tau hyperphosphorylation in hippocampal neurons via inhibition of ALKBH5-mediated Dgkh m6A demethylation: a potential mechanism for diabetic cognitive dysfunction.","High Glucose","induce","Tau Hyperphosphorylation","Hippocampal Neurons","High Glucose","CAUSES","Tau Hyperphosphorylation","Hippocampal Neurons"
"2694","37385994","High glucose induces tau hyperphosphorylation in hippocampal neurons via inhibition of ALKBH5-mediated Dgkh m6A demethylation: a potential mechanism for diabetic cognitive dysfunction.","High Glucose","inhibit","ALKBH5","Hippocampal Neurons","High Glucose","INHIBITS","ALKBH5","Hippocampal Neurons"
"2695","37385994","High glucose induces tau hyperphosphorylation in hippocampal neurons via inhibition of ALKBH5-mediated Dgkh m6A demethylation: a potential mechanism for diabetic cognitive dysfunction.","ALKBH5","demethylate","m6A","Hippocampal Neurons","ALKBH5","CONVERTS_TO","m6A","Hippocampal Neurons"
"2696","37385994","High glucose induces tau hyperphosphorylation in hippocampal neurons via inhibition of ALKBH5-mediated Dgkh m6A demethylation: a potential mechanism for diabetic cognitive dysfunction.","m6A","is on","Dgkh","Hippocampal Neurons","m6A","LOCATES","DGKH","Hippocampal Neurons"
"2697","37385994","High glucose induces tau hyperphosphorylation in hippocampal neurons via inhibition of ALKBH5-mediated Dgkh m6A demethylation: a potential mechanism for diabetic cognitive dysfunction.","Tau Hyperphosphorylation","cause","Cognitive Dysfunction","Hippocampal Neurons","Tau Hyperphosphorylation","CAUSES","Cognitive Dysfunction","Hippocampal Neurons"
"2699","37386028","The mRNA methyltransferase Mettl3 modulates cytokine mRNA stability and limits functional responses in mast cells.","Mettl3","modulate","cytokine mRNA stability","Mast Cells","METTL3","AFFECTS","cytokine mRNA stability","Mast Cells"
"2700","37386028","The mRNA methyltransferase Mettl3 modulates cytokine mRNA stability and limits functional responses in mast cells.","Mettl3","limit","functional responses","Mast Cells","METTL3","limit","functional responses","Mast Cells"
"2702","37389889","Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression.","deficiency","cause","Prmt5","Mouse B cells","deficiency","CAUSES","PRMT5","Mouse B cells"
"2703","37389889","Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression.","Prmt5","display","RNA processing complexity","Mouse B cells","PRMT5","display","RNA processing complexity","Mouse B cells"
"2704","37389889","Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression.","Prmt5","cause","slower colorectal tumor progression","Mouse B cells","PRMT5","CAUSES","slower colorectal tumor progression","Mouse B cells"
"2706","37391589","VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.","VIRMA","facilitate","Progression","Intrahepatic Cholangiocarcinoma","VIRMA","AUGMENTS","progression","CHOL(Cholangiocarcinoma)"
"2707","37391589","VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.","VIRMA","augment","TMED2","Intrahepatic Cholangiocarcinoma","VIRMA","AUGMENTS","TMED2","CHOL(Cholangiocarcinoma)"
"2708","37391589","VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.","VIRMA","augment","PARD3B","Intrahepatic Cholangiocarcinoma","VIRMA","AUGMENTS","PARD3B","CHOL(Cholangiocarcinoma)"
"2709","37391589","VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.","TMED2","regulate","Progression","Intrahepatic Cholangiocarcinoma","TMED2","AFFECTS","progression","CHOL(Cholangiocarcinoma)"
"2710","37391589","VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.","PARD3B","regulate","Progression","Intrahepatic Cholangiocarcinoma","PARD3B","AFFECTS","progression","CHOL(Cholangiocarcinoma)"
"2712","37392859","LINC00426, a novel m6A-regulated long non-coding RNA, induces EMT in cervical cancer by binding to ZEB1.","m6A","regulate","LINC00426","Cervical Cancer","m6A","AFFECTS","LINC00426","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2713","37392859","LINC00426, a novel m6A-regulated long non-coding RNA, induces EMT in cervical cancer by binding to ZEB1.","LINC00426","induce","EMT","Cervical Cancer","LINC00426","CAUSES","epithelial to mesenchymal transition","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2714","37392859","LINC00426, a novel m6A-regulated long non-coding RNA, induces EMT in cervical cancer by binding to ZEB1.","LINC00426","bind","ZEB1","Cervical Cancer","LINC00426","INTERACTS_WITH","ZEB1","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2716","37393819","Altered m6A modification is involved YAP-mediated apoptosis response in 4-vinylcyclohexene diepoxide induced ovotoxicity.","dummy","alter","m6A modification","4-vinylcyclohexene diepoxide induced ovotoxicity","dummy","AFFECTS","m6A","4-vinylcyclohexene diepoxide induced ovotoxicity"
"2717","37393819","Altered m6A modification is involved YAP-mediated apoptosis response in 4-vinylcyclohexene diepoxide induced ovotoxicity.","m6A modification","involve","YAP","4-vinylcyclohexene diepoxide induced ovotoxicity","m6A","ASSOCIATED_WITH","YAP1","4-vinylcyclohexene diepoxide induced ovotoxicity"
"2718","37393819","Altered m6A modification is involved YAP-mediated apoptosis response in 4-vinylcyclohexene diepoxide induced ovotoxicity.","YAP","mediate","apoptosis","4-vinylcyclohexene diepoxide induced ovotoxicity","YAP1","AFFECTS","apoptotic process","4-vinylcyclohexene diepoxide induced ovotoxicity"
"2720","37396548","Decreased expression of m6A demethylase ALKBH5 in decidua contributes to preeclampsia via m6A-CORIN-HuR pathway.","dummy","decrease expression of","ALKBH5","Decidua","dummy","decrease expression of","ALKBH5","Decidua"
"2721","37396548","Decreased expression of m6A demethylase ALKBH5 in decidua contributes to preeclampsia via m6A-CORIN-HuR pathway.","ALKBH5","demethylate","m6A","Decidua","ALKBH5","CONVERTS_TO","m6A","Decidua"
"2722","37396548","Decreased expression of m6A demethylase ALKBH5 in decidua contributes to preeclampsia via m6A-CORIN-HuR pathway.","m6A","is in","m6A-CORIN-HuR pathway","Decidua","m6A","LOCATES","'m6A-CORIN-HuR pathway'","Decidua"
"2723","37396548","Decreased expression of m6A demethylase ALKBH5 in decidua contributes to preeclampsia via m6A-CORIN-HuR pathway.","m6A-CORIN-HuR pathway","contribute to","preeclampsia","Decidua","'m6A-CORIN-HuR pathway'","CAUSES","Pre-Eclampsia","Decidua"
"2725","37408034","FTO-dependent m6A regulates muscle fiber remodeling in an NFATC1-YTHDF2 dependent manner.","FTO","regulate","m6A","Muscle fiber","FTO","AFFECTS","m6A","muscle fiber"
"2726","37408034","FTO-dependent m6A regulates muscle fiber remodeling in an NFATC1-YTHDF2 dependent manner.","m6A","regulate","muscle fiber remodeling","Muscle fiber","m6A","AFFECTS","muscle fiber remodeling","muscle fiber"
"2727","37408034","FTO-dependent m6A regulates muscle fiber remodeling in an NFATC1-YTHDF2 dependent manner.","NFATC1","regulate","YTHDF2","Muscle fiber","NFATC1","AFFECTS","YTHDF2","muscle fiber"
"2728","37408034","FTO-dependent m6A regulates muscle fiber remodeling in an NFATC1-YTHDF2 dependent manner.","YTHDF2","bind","m6A","Muscle fiber","YTHDF2","INTERACTS_WITH","m6A","muscle fiber"
"2729","37408034","FTO-dependent m6A regulates muscle fiber remodeling in an NFATC1-YTHDF2 dependent manner.","YTHDF2","regulate","muscle fiber remodeling","Muscle fiber","YTHDF2","AFFECTS","muscle fiber remodeling","muscle fiber"
"2731","37414203","m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3/ miRNA-193a/BCL2L2 pathway.","m6A","upregulate","miRNA-193a","Sepsis-induced Cardiomyopathy","m6A","STIMULATES","miRNA-193a","Sepsis-induced Cardiomyopathy"
"2732","37414203","m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3/ miRNA-193a/BCL2L2 pathway.","miRNA-193a","aggravate","Cardiomyocyte Apoptosis","Sepsis-induced Cardiomyopathy","miRNA-193a","COMPLICATES","Cardiomyocyte Apoptosis","Sepsis-induced Cardiomyopathy"
"2733","37414203","m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3/ miRNA-193a/BCL2L2 pathway.","miRNA-193a","aggravate","Inflammatory Response","Sepsis-induced Cardiomyopathy","miRNA-193a","COMPLICATES","inflammatory response","Sepsis-induced Cardiomyopathy"
"2734","37414203","m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3/ miRNA-193a/BCL2L2 pathway.","METTL3","regulate","miRNA-193a","Sepsis-induced Cardiomyopathy","METTL3","AFFECTS","miRNA-193a","Sepsis-induced Cardiomyopathy"
"2735","37414203","m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3/ miRNA-193a/BCL2L2 pathway.","miRNA-193a","regulate","BCL2L2","Sepsis-induced Cardiomyopathy","miRNA-193a","AFFECTS","BCL2L2","Sepsis-induced Cardiomyopathy"
"2736","37414203","m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3/ miRNA-193a/BCL2L2 pathway.","BCL2L2","regulate","Cardiomyocyte Apoptosis","Sepsis-induced Cardiomyopathy","BCL2L2","AFFECTS","Cardiomyocyte Apoptosis","Sepsis-induced Cardiomyopathy"
"2737","37414203","m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3/ miRNA-193a/BCL2L2 pathway.","BCL2L2","regulate","Inflammatory Response","Sepsis-induced Cardiomyopathy","BCL2L2","AFFECTS","inflammatory response","Sepsis-induced Cardiomyopathy"
"2739","37416772","FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.","FABP5","suppress","Cancer Progression","Colorectal Cancer","FABP5","INHIBITS","Cancer Progression","COAD(Colon Adenocarcinoma)"
"2740","37416772","FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.","FABP5","regulate","mTOR","Colorectal Cancer","FABP5","AFFECTS","MTOR","COAD(Colon Adenocarcinoma)"
"2741","37416772","FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.","mTOR","mediate","Autophagy","Colorectal Cancer","MTOR","AFFECTS","autophagy","COAD(Colon Adenocarcinoma)"
"2742","37416772","FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.","FABP5","decrease","FASN","Colorectal Cancer","FABP5","INHIBITS","FASN","COAD(Colon Adenocarcinoma)"
"2743","37416772","FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.","Autophagy","suppress","Cancer Progression","Colorectal Cancer","autophagy","INHIBITS","Cancer Progression","COAD(Colon Adenocarcinoma)"
"2745","37417881","UVB promotes melanogenesis by regulating METTL3.","UVB","regulate","METTL3","UVB exposure","UVB","AFFECTS","METTL3","UVB exposure"
"2746","37417881","UVB promotes melanogenesis by regulating METTL3.","METTL3","regulate","melanogenesis","UVB exposure","METTL3","AFFECTS","melanogenesis","UVB exposure"
"2748","37418592","METTL14 and FTO mediated m6A modification regulate PCV2 replication by affecting miR-30a-5p maturity.","METTL14","mediate","m6A modification","Null","METTL14","AFFECTS","m6A","Null"
"2749","37418592","METTL14 and FTO mediated m6A modification regulate PCV2 replication by affecting miR-30a-5p maturity.","FTO","mediate","m6A modification","Null","FTO","AFFECTS","m6A","Null"
"2750","37418592","METTL14 and FTO mediated m6A modification regulate PCV2 replication by affecting miR-30a-5p maturity.","m6A modification","affect","miR-30a-5p maturity","Null","m6A","AFFECTS","miR-30a-5p maturity","Null"
"2751","37418592","METTL14 and FTO mediated m6A modification regulate PCV2 replication by affecting miR-30a-5p maturity.","miR-30a-5p maturity","regulate","PCV2 replication","Null","miR-30a-5p maturity","AFFECTS","PCV2 replication","Null"
"2753","37420030","Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.","Dummy","inhibit","Methyltransferase like 3","Intrahepatic Cholangiocarcinoma","dummy","INHIBITS","METTL3","CHOL(Cholangiocarcinoma)"
"2754","37420030","Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.","Methyltransferase like 3","limit","Metabolic Reprogramming","Intrahepatic Cholangiocarcinoma","METTL3","limit","Metabolic Reprogramming","CHOL(Cholangiocarcinoma)"
"2755","37420030","Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.","Methyltransferase like 3","potentiate","Chemotherapy","Intrahepatic Cholangiocarcinoma","METTL3","AUGMENTS","Drug Therapy","CHOL(Cholangiocarcinoma)"
"2757","37421841","ALKB homolog 5 (ALKBH5)-induced circPUM1 upregulation facilitated the progression of neuroblastoma via miR-423-5p/PA2G4 axis.","ALKBH5","induce","circPUM1","Neuroblastoma","ALKBH5","CAUSES","circPUM1","Neuroblastoma"
"2758","37421841","ALKB homolog 5 (ALKBH5)-induced circPUM1 upregulation facilitated the progression of neuroblastoma via miR-423-5p/PA2G4 axis.","circPUM1","facilitate","Progression of Neuroblastoma","Neuroblastoma","circPUM1","AUGMENTS","Progression of Neuroblastoma","Neuroblastoma"
"2759","37421841","ALKB homolog 5 (ALKBH5)-induced circPUM1 upregulation facilitated the progression of neuroblastoma via miR-423-5p/PA2G4 axis.","circPUM1","regulate","miR-423-5p/PA2G4 axis","Neuroblastoma","circPUM1","AFFECTS","miR-423-5p/PA2G4 axis","Neuroblastoma"
"2760","37421841","ALKB homolog 5 (ALKBH5)-induced circPUM1 upregulation facilitated the progression of neuroblastoma via miR-423-5p/PA2G4 axis.","miR-423-5p/PA2G4 axis","facilitate","Progression of Neuroblastoma","Neuroblastoma","miR-423-5p/PA2G4 axis","AUGMENTS","Progression of Neuroblastoma","Neuroblastoma"
"2762","37422970","METTL3-mediated m6A methylation of PYGB facilitates pancreatic ductal adenocarcinoma progression through the activation of NF-kappaB signaling.","METTL3","mediate","m6A","Pancreatic Ductal Adenocarcinoma","METTL3","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"2763","37422970","METTL3-mediated m6A methylation of PYGB facilitates pancreatic ductal adenocarcinoma progression through the activation of NF-kappaB signaling.","m6A","is on","PYGB","Pancreatic Ductal Adenocarcinoma","m6A","LOCATES","PYGB","PAAD(Pancreatic Adenocarcinoma)"
"2764","37422970","METTL3-mediated m6A methylation of PYGB facilitates pancreatic ductal adenocarcinoma progression through the activation of NF-kappaB signaling.","PYGB","activate","NF-kappaB signaling","Pancreatic Ductal Adenocarcinoma","PYGB","STIMULATES","NF-kappaB signaling pathway","PAAD(Pancreatic Adenocarcinoma)"
"2765","37422970","METTL3-mediated m6A methylation of PYGB facilitates pancreatic ductal adenocarcinoma progression through the activation of NF-kappaB signaling.","PYGB","facilitate","progression","Pancreatic Ductal Adenocarcinoma","PYGB","AUGMENTS","progression","PAAD(Pancreatic Adenocarcinoma)"
"2766","37422970","METTL3-mediated m6A methylation of PYGB facilitates pancreatic ductal adenocarcinoma progression through the activation of NF-kappaB signaling.","NF-kappaB signaling","facilitate","progression","Pancreatic Ductal Adenocarcinoma","NF-kappaB signaling pathway","AUGMENTS","progression","PAAD(Pancreatic Adenocarcinoma)"
"2768","37426524","RNA m6A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO.","m6A","regulate","dummy","Doxorubicin-Induced Cardiotoxicity","m6A","AFFECTS","dummy","Doxorubicin-Induced Cardiotoxicity"
"2769","37426524","RNA m6A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO.","dummy","suppress","circ-ZNF609","Doxorubicin-Induced Cardiotoxicity","dummy","INHIBITS","circ-ZNF609","Doxorubicin-Induced Cardiotoxicity"
"2770","37426524","RNA m6A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO.","circ-ZNF609","ameliorate","Doxorubicin-Induced Cardiotoxicity","Doxorubicin-Induced Cardiotoxicity","circ-ZNF609","TREATS","Doxorubicin-Induced Cardiotoxicity","Doxorubicin-Induced Cardiotoxicity"
"2771","37426524","RNA m6A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO.","circ-ZNF609","upregulate","FTO","Doxorubicin-Induced Cardiotoxicity","circ-ZNF609","STIMULATES","FTO","Doxorubicin-Induced Cardiotoxicity"
"2772","37426524","RNA m6A-Regulated circ-ZNF609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO.","FTO","ameliorate","Doxorubicin-Induced Cardiotoxicity","Doxorubicin-Induced Cardiotoxicity","FTO","TREATS","Doxorubicin-Induced Cardiotoxicity","Doxorubicin-Induced Cardiotoxicity"
"2774","37428236","METTL14 promotes the development of diabetic kidney disease by regulating m6A modification of TUG1.","METTL14","promote","Diabetic Kidney Disease","Diabetic Kidney Disease","METTL14","STIMULATES","Diabetic Nephropathies","Diabetic Nephropathies"
"2775","37428236","METTL14 promotes the development of diabetic kidney disease by regulating m6A modification of TUG1.","METTL14","regulate","m6A","Diabetic Kidney Disease","METTL14","AFFECTS","m6A","Diabetic Nephropathies"
"2776","37428236","METTL14 promotes the development of diabetic kidney disease by regulating m6A modification of TUG1.","m6A","is on","TUG1","Diabetic Kidney Disease","m6A","LOCATES","TUG1","Diabetic Nephropathies"
"2777","37428236","METTL14 promotes the development of diabetic kidney disease by regulating m6A modification of TUG1.","TUG1","regulate","Diabetic Kidney Disease","Diabetic Kidney Disease","TUG1","AFFECTS","Diabetic Nephropathies","Diabetic Nephropathies"
"2779","37428639","WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.","WTAP","activate","MAPK signaling","Colorectal Cancer","WTAP","STIMULATES","MAPK cascade","COAD(Colon Adenocarcinoma)"
"2780","37428639","WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.","WTAP","regulate","m6A methylation","Colorectal Cancer","WTAP","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"2781","37428639","WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.","m6A methylation","is on","VEGFA mRNA","Colorectal Cancer","m6A","LOCATES","VEGFA","COAD(Colon Adenocarcinoma)"
"2782","37428639","WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.","YTHDC1","mediate","m6A methylation","Colorectal Cancer","YTHDC1","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"2783","37428639","WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.","MAPK signaling","promote","Colorectal Cancer Development","Colorectal Cancer","MAPK cascade","STIMULATES","Colorectal Cancer Development","COAD(Colon Adenocarcinoma)"
"2785","37432876","SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants.","SNORD90","induce","glutamatergic signaling","Treatment with monoaminergic antidepressants","SNORD90","CAUSES","glutamatergic signaling pathway","Treatment with monoaminergic antidepressants"
"2787","37434495","The m6 A modification of Il17a in CD4+ T cells promotes inflammation in psoriasis.","m6A","modify","Il17a","CD4+ T cells","m6A","AFFECTS","IL17A","CD4+ T cells"
"2788","37434495","The m6 A modification of Il17a in CD4+ T cells promotes inflammation in psoriasis.","Il17a","promote","inflammation","CD4+ T cells","IL17A","STIMULATES","inflammatory response","CD4+ T cells"
"2790","37277716","Increased METTL3 expression and m6A RNA methylation may contribute to the development of dry eye in primary Sjogren's syndrome.","METTL3","contribute","dry eye","Primary Sjogren's Syndrome","METTL3","AFFECTS","Dry Eye Syndromes","Primary Sjogren's Syndrome"
"2791","37277716","Increased METTL3 expression and m6A RNA methylation may contribute to the development of dry eye in primary Sjogren's syndrome.","m6A RNA methylation","contribute","dry eye","Primary Sjogren's Syndrome","m6A","AFFECTS","Dry Eye Syndromes","Primary Sjogren's Syndrome"
"2793","37279381","H19 recruited m6A reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer.","H19","recruit","YTHDF1","Gastric Cancer","H19","recruit","YTHDF1","STAD(Stomach adenocarcinoma)"
"2794","37279381","H19 recruited m6A reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer.","YTHDF1","read","m6A","Gastric Cancer","YTHDF1","read","m6A","STAD(Stomach adenocarcinoma)"
"2795","37279381","H19 recruited m6A reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer.","YTHDF1","promote","SCARB1 translation","Gastric Cancer","YTHDF1","STIMULATES","SCARB1 translation","STAD(Stomach adenocarcinoma)"
"2796","37279381","H19 recruited m6A reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer.","SCARB1 translation","facilitate","angiogenesis","Gastric Cancer","SCARB1 translation","AUGMENTS","angiogenesis","STAD(Stomach adenocarcinoma)"
"2797","37279381","H19 recruited m6A reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer.","m6A","regulate","SCARB1 translation","Gastric Cancer","m6A","AFFECTS","SCARB1 translation","STAD(Stomach adenocarcinoma)"
"2799","37280654","EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.","EIF4A3","induce","Circ_0001187","AML","EIF4A3","CAUSES","Circ_0001187","LAML(Acute Myeloid Leukemia)"
"2800","37280654","EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.","Circ_0001187","suppress","AML","AML","Circ_0001187","INHIBITS","Leukemia, Myeloid, Acute","LAML(Acute Myeloid Leukemia)"
"2801","37280654","EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.","Circ_0001187","promote","ubiquitin-proteasomal degradation","AML","Circ_0001187","STIMULATES","ubiquitin-proteasomal degradation","LAML(Acute Myeloid Leukemia)"
"2802","37280654","EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.","ubiquitin-proteasomal degradation","degrade","METTL3","AML","ubiquitin-proteasomal degradation","INHIBITS","METTL3","LAML(Acute Myeloid Leukemia)"
"2803","37280654","EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.","Circ_0001187","decrease","m6A modification level","AML","Circ_0001187","INHIBITS","m6A","LAML(Acute Myeloid Leukemia)"
"2804","37280654","EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.","m6A modification level","mediate","miR-499a-5p/RNF113A pathway","AML","m6A","AFFECTS","miR-499a-5p/RNF113A pathway","LAML(Acute Myeloid Leukemia)"
"2805","37280654","EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.","ubiquitin-proteasomal degradation","suppress","AML","AML","ubiquitin-proteasomal degradation","INHIBITS","Leukemia, Myeloid, Acute","LAML(Acute Myeloid Leukemia)"
"2806","37280654","EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.","miR-499a-5p/RNF113A pathway","suppress","AML","AML","miR-499a-5p/RNF113A pathway","INHIBITS","Leukemia, Myeloid, Acute","LAML(Acute Myeloid Leukemia)"
"2808","37293163","Linc00662 m6A promotes the progression and metastasis of pancreatic cancer by activating focal adhesion through the GTF2B-ITGA1-FAK pathway.","Linc00662","promote","m6A","Pancreatic Cancer","LINC00662","STIMULATES","m6A","PAAD(Pancreatic Adenocarcinoma)"
"2809","37293163","Linc00662 m6A promotes the progression and metastasis of pancreatic cancer by activating focal adhesion through the GTF2B-ITGA1-FAK pathway.","m6A","promote","Progression and Metastasis","Pancreatic Cancer","m6A","STIMULATES","Progression and Metastasis","PAAD(Pancreatic Adenocarcinoma)"
"2810","37293163","Linc00662 m6A promotes the progression and metastasis of pancreatic cancer by activating focal adhesion through the GTF2B-ITGA1-FAK pathway.","m6A","activate","Focal Adhesion","Pancreatic Cancer","m6A","STIMULATES","focal adhesion","PAAD(Pancreatic Adenocarcinoma)"
"2811","37293163","Linc00662 m6A promotes the progression and metastasis of pancreatic cancer by activating focal adhesion through the GTF2B-ITGA1-FAK pathway.","m6A","activate","GTF2B-ITGA1-FAK pathway","Pancreatic Cancer","m6A","STIMULATES","GTF2B-ITGA1-FAK pathway","PAAD(Pancreatic Adenocarcinoma)"
"2812","37293163","Linc00662 m6A promotes the progression and metastasis of pancreatic cancer by activating focal adhesion through the GTF2B-ITGA1-FAK pathway.","GTF2B-ITGA1-FAK pathway","regulate","Focal Adhesion","Pancreatic Cancer","GTF2B-ITGA1-FAK pathway","AFFECTS","focal adhesion","PAAD(Pancreatic Adenocarcinoma)"
"2814","37295326","Site-specific Atg13 methylation-mediated autophagy regulates epithelial inflammation in PM2.5-induced pulmonary fibrosis.","Atg13","undergo","methylation","PM2.5-induced pulmonary fibrosis","ATG13","undergo","methylation","PM2.5-induced pulmonary fibrosis"
"2815","37295326","Site-specific Atg13 methylation-mediated autophagy regulates epithelial inflammation in PM2.5-induced pulmonary fibrosis.","methylation","mediate","autophagy","PM2.5-induced pulmonary fibrosis","methylation","AFFECTS","autophagy","PM2.5-induced pulmonary fibrosis"
"2816","37295326","Site-specific Atg13 methylation-mediated autophagy regulates epithelial inflammation in PM2.5-induced pulmonary fibrosis.","autophagy","regulate","epithelial inflammation","PM2.5-induced pulmonary fibrosis","autophagy","AFFECTS","epithelial inflammation","PM2.5-induced pulmonary fibrosis"
"2817","37295326","Site-specific Atg13 methylation-mediated autophagy regulates epithelial inflammation in PM2.5-induced pulmonary fibrosis.","Atg13","regulate","autophagy","PM2.5-induced pulmonary fibrosis","ATG13","AFFECTS","autophagy","PM2.5-induced pulmonary fibrosis"
"2819","37300304","Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.","Astragaloside IV","alleviate","Neuronal Ferroptosis","Ischemic Stroke","astragaloside IV","INHIBITS","Neuronal Ferroptosis","Ischemic Stroke"
"2820","37300304","Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.","Astragaloside IV","regulate","fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis","Ischemic Stroke","astragaloside IV","AFFECTS","fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis","Ischemic Stroke"
"2821","37300304","Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.","fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis","regulate","Neuronal Ferroptosis","Ischemic Stroke","fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis","AFFECTS","Neuronal Ferroptosis","Ischemic Stroke"
"2823","37301390","As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m6A-mediated miR-142-5p maturation.","As3MT","consume","SAM","Nonalcoholic Fatty Liver Disease","AS3MT","consume","S-adenosyl-L-methionine","Non-alcoholic Fatty Liver Disease"
"2824","37301390","As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m6A-mediated miR-142-5p maturation.","As3MT","involved in","Arsenic","Nonalcoholic Fatty Liver Disease","AS3MT","involved in","arsenic atom","Non-alcoholic Fatty Liver Disease"
"2825","37301390","As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m6A-mediated miR-142-5p maturation.","As3MT","block","m6A","Nonalcoholic Fatty Liver Disease","AS3MT","INHIBITS","m6A","Non-alcoholic Fatty Liver Disease"
"2826","37301390","As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m6A-mediated miR-142-5p maturation.","m6A","mediate","miR-142-5p maturation","Nonalcoholic Fatty Liver Disease","m6A","AFFECTS","miR-142-5p maturation","Non-alcoholic Fatty Liver Disease"
"2827","37301390","As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m6A-mediated miR-142-5p maturation.","miR-142-5p maturation","regulate","Arsenic","Nonalcoholic Fatty Liver Disease","miR-142-5p maturation","AFFECTS","arsenic atom","Non-alcoholic Fatty Liver Disease"
"2829","37304234","LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells.","CACNA1G-AS1","up-regulate","FTH1","Ovarian Cancer Cells","CACNA1G-AS1","STIMULATES","FTH1","OV(Ovarian Serous Cystadenocarcinoma)"
"2830","37304234","LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells.","FTH1","inhibit","Ferroptosis","Ovarian Cancer Cells","FTH1","INHIBITS","Ferroptosis","OV(Ovarian Serous Cystadenocarcinoma)"
"2832","37306026","FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.","FTO","promote","Progression","Cervical Cancer","FTO","STIMULATES","progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2833","37306026","FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.","FTO","regulate","N6-methyladenosine","Cervical Cancer","FTO","AFFECTS","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2834","37306026","FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.","N6-methyladenosine","is on","ZEB1","Cervical Cancer","m6A","LOCATES","ZEB1","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2835","37306026","FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.","N6-methyladenosine","is on","Myc","Cervical Cancer","m6A","LOCATES","MYC","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2836","37306026","FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.","ZEB1","regulate","Progression","Cervical Cancer","ZEB1","AFFECTS","progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2837","37306026","FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.","Myc","regulate","Progression","Cervical Cancer","MYC","AFFECTS","progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2839","37308993","HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.","HNRNPA2B1","mediate","m6A","Non-small cell lung cancer","HNRNPA2B1","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2840","37308993","HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.","m6A","modify","lncRNA MEG3","Non-small cell lung cancer","m6A","AFFECTS","MEG3","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2841","37308993","HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.","lncRNA MEG3","facilitate","tumorigenesis","Non-small cell lung cancer","MEG3","AUGMENTS","Carcinogenesis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2842","37308993","HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.","lncRNA MEG3","facilitate","metastasis","Non-small cell lung cancer","MEG3","AUGMENTS","Neoplasm Metastasis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2843","37308993","HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.","lncRNA MEG3","regulate","miR-21-5p/PTEN axis","Non-small cell lung cancer","MEG3","AFFECTS","miR-21-5p/PTEN axis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2844","37308993","HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.","miR-21-5p/PTEN axis","regulate","tumorigenesis","Non-small cell lung cancer","miR-21-5p/PTEN axis","AFFECTS","Carcinogenesis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2845","37308993","HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.","miR-21-5p/PTEN axis","regulate","metastasis","Non-small cell lung cancer","miR-21-5p/PTEN axis","AFFECTS","Neoplasm Metastasis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2847","37309980","METTL14 is decreased and regulates m6 A modification of alpha-synuclein in Parkinson's disease.","dummy","decrease","METTL14","Parkinson's disease","dummy","INHIBITS","METTL14","Parkinson Disease"
"2848","37309980","METTL14 is decreased and regulates m6 A modification of alpha-synuclein in Parkinson's disease.","METTL14","regulate","m6A","Parkinson's disease","METTL14","AFFECTS","m6A","Parkinson Disease"
"2849","37309980","METTL14 is decreased and regulates m6 A modification of alpha-synuclein in Parkinson's disease.","m6A","is on","alpha-synuclein","Parkinson's disease","m6A","LOCATES","SNCA","Parkinson Disease"
"2851","37310554","Oxidative Stress Induced by Arsenite is Involved in YTHDF2 Phase Separation.","YTHDF2","involve","Phase Separation","Oxidative Stress Induced by Arsenite","YTHDF2","ASSOCIATED_WITH","Phase Separation","Oxidative Stress Induced by Arsenite"
"2853","37311754","Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer.","N6-methyladenosine","modify","LINC00641","Lung Cancer","m6A","AFFECTS","LINC00641","LUAD(Lung Adenocarcinoma)"
"2854","37311754","Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer.","LINC00641","promote","EMT","Lung Cancer","LINC00641","STIMULATES","epithelial to mesenchymal transition","LUAD(Lung Adenocarcinoma)"
"2855","37311754","Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer.","LINC00641","provide","ferroptotic vulnerability","Lung Cancer","LINC00641","provide","ferroptotic vulnerability","LUAD(Lung Adenocarcinoma)"
"2857","37313656","PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.","PD1hi CD200hi CD4+ exhausted T cell","increase","Immunotherapy Resistance","Bladder Cancer","PD1hi CD200hi CD4+ exhausted T cell","AUGMENTS","Immunotherapy Resistance","BLCA(Bladder Urothelial Carcinoma)"
"2858","37313656","PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.","PD1hi CD200hi CD4+ exhausted T cell","increase","Tumor Progression","Bladder Cancer","PD1hi CD200hi CD4+ exhausted T cell","AUGMENTS","Tumor Progression","BLCA(Bladder Urothelial Carcinoma)"
"2859","37313656","PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.","PD1hi CD200hi CD4+ exhausted T cell","promote","Epithelial-Mesenchymal Transition","Bladder Cancer","PD1hi CD200hi CD4+ exhausted T cell","STIMULATES","epithelial to mesenchymal transition","BLCA(Bladder Urothelial Carcinoma)"
"2860","37313656","PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.","Epithelial-Mesenchymal Transition","increase","Immunotherapy Resistance","Bladder Cancer","epithelial to mesenchymal transition","AUGMENTS","Immunotherapy Resistance","BLCA(Bladder Urothelial Carcinoma)"
"2861","37313656","PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.","Epithelial-Mesenchymal Transition","increase","Tumor Progression","Bladder Cancer","epithelial to mesenchymal transition","AUGMENTS","Tumor Progression","BLCA(Bladder Urothelial Carcinoma)"
"2863","37314930","METTL14 regulates chromatin bivalent domains in mouse embryonic stem cells.","METTL14","regulate","chromatin bivalent domains","Mouse embryonic stem cell","METTL14","AFFECTS","chromatin bivalent domains","Mouse Embryonic Stem Cells"
"2865","37315764","Ythdf2 regulates cardiac remodeling through its mRNA target transcripts.","Ythdf2","regulate","mRNA target transcripts","Heart","YTHDF2","AFFECTS","mRNA target transcripts","Heart"
"2866","37315764","Ythdf2 regulates cardiac remodeling through its mRNA target transcripts.","mRNA target transcripts","regulate","cardiac remodeling","Heart","mRNA target transcripts","AFFECTS","cardiac remodeling","Heart"
"2868","37320907","Mechanistic exploration on neurodevelopmental toxicity induced by upregulation of alkbh5 targeted by triclosan exposure to larval zebrafish.","dummy","upregulate","alkbh5","Larval Zebrafish","dummy","STIMULATES","ALKBH5","Larval Zebrafish"
"2869","37320907","Mechanistic exploration on neurodevelopmental toxicity induced by upregulation of alkbh5 targeted by triclosan exposure to larval zebrafish.","triclosan","target","alkbh5","Larval Zebrafish","triclosan","INTERACTS_WITH","ALKBH5","Larval Zebrafish"
"2870","37320907","Mechanistic exploration on neurodevelopmental toxicity induced by upregulation of alkbh5 targeted by triclosan exposure to larval zebrafish.","alkbh5","induce","neurodevelopmental toxicity","Larval Zebrafish","ALKBH5","CAUSES","neurodevelopmental toxicity","Larval Zebrafish"
"2871","37320907","Mechanistic exploration on neurodevelopmental toxicity induced by upregulation of alkbh5 targeted by triclosan exposure to larval zebrafish.","triclosan","induce","neurodevelopmental toxicity","Larval Zebrafish","triclosan","CAUSES","neurodevelopmental toxicity","Larval Zebrafish"
"2873","37321527","FTO alleviates cerebral ischemia/reperfusion-induced neuroinflammation by decreasing cGAS mRNA stability in an m6A-dependent manner.","FTO","alleviate","Neuroinflammation","Cerebral ischemia/reperfusion","FTO","INHIBITS","Neuroinflammation","Cerebral ischemia/reperfusion"
"2874","37321527","FTO alleviates cerebral ischemia/reperfusion-induced neuroinflammation by decreasing cGAS mRNA stability in an m6A-dependent manner.","FTO","decrease","cGAS mRNA","Cerebral ischemia/reperfusion","FTO","INHIBITS","CGAS","Cerebral ischemia/reperfusion"
"2875","37321527","FTO alleviates cerebral ischemia/reperfusion-induced neuroinflammation by decreasing cGAS mRNA stability in an m6A-dependent manner.","FTO","decrease","Stability","Cerebral ischemia/reperfusion","FTO","INHIBITS","stability","Cerebral ischemia/reperfusion"
"2876","37321527","FTO alleviates cerebral ischemia/reperfusion-induced neuroinflammation by decreasing cGAS mRNA stability in an m6A-dependent manner.","m6A","regulate","cGAS mRNA","Cerebral ischemia/reperfusion","m6A","AFFECTS","CGAS","Cerebral ischemia/reperfusion"
"2877","37321527","FTO alleviates cerebral ischemia/reperfusion-induced neuroinflammation by decreasing cGAS mRNA stability in an m6A-dependent manner.","cGAS mRNA","regulate","Neuroinflammation","Cerebral ischemia/reperfusion","CGAS","AFFECTS","Neuroinflammation","Cerebral ischemia/reperfusion"
"2879","37326469","N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer.","N6-methyladenosine","modify","FZR1 mRNA","Pancreatic Cancer","m6A","AFFECTS","FZR1","PAAD(Pancreatic Adenocarcinoma)"
"2880","37326469","N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer.","FZR1 mRNA","promote","gemcitabine resistance","Pancreatic Cancer","FZR1","STIMULATES","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"2882","37327357","METTL14-mediated m6A modification of TNFAIP3 involved in inflammation in patients with active rheumatoid arthritis.","METTL14","mediate","m6A","Active Rheumatoid Arthritis","METTL14","AFFECTS","m6A","Active Rheumatoid Arthritis"
"2883","37327357","METTL14-mediated m6A modification of TNFAIP3 involved in inflammation in patients with active rheumatoid arthritis.","m6A","is on","TNFAIP3","Active Rheumatoid Arthritis","m6A","LOCATES","TNFAIP3","Active Rheumatoid Arthritis"
"2884","37327357","METTL14-mediated m6A modification of TNFAIP3 involved in inflammation in patients with active rheumatoid arthritis.","TNFAIP3","involve","inflammation","Active Rheumatoid Arthritis","TNFAIP3","ASSOCIATED_WITH","inflammatory response","Active Rheumatoid Arthritis"
"2886","37329536","Expression of RNA-m6A-related genes correlates with the HIV latent reservoir level and the CD4+ and CD8+T cell profiles of patients with AIDS.","RNA-m6A-related genes","correlate","HIV latent reservoir level","AIDS","m6A genes","correlate","HIV latent reservoir level","Acquired Immunodeficiency Syndrome"
"2887","37329536","Expression of RNA-m6A-related genes correlates with the HIV latent reservoir level and the CD4+ and CD8+T cell profiles of patients with AIDS.","RNA-m6A-related genes","correlate","CD4+ T cell profiles","AIDS","m6A genes","correlate","CD4+ T cell profiles","Acquired Immunodeficiency Syndrome"
"2888","37329536","Expression of RNA-m6A-related genes correlates with the HIV latent reservoir level and the CD4+ and CD8+T cell profiles of patients with AIDS.","RNA-m6A-related genes","correlate","CD8+ T cell profiles","AIDS","m6A genes","correlate","CD8+ T cell profiles","Acquired Immunodeficiency Syndrome"
"2890","37330168","Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPalpha expression.","FTO","promote","gefitinib resistance","Non-small cell lung cancer","FTO","STIMULATES","Gefitinib Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2891","37330168","Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPalpha expression.","FTO","up-regulate","FLRT3","Non-small cell lung cancer","FTO","STIMULATES","FLRT3","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2892","37330168","Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPalpha expression.","FTO","up-regulate","PTGIS","Non-small cell lung cancer","FTO","STIMULATES","PTGIS","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2893","37330168","Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPalpha expression.","FTO","up-regulate","SIRPalpha","Non-small cell lung cancer","FTO","STIMULATES","SIRPA","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2894","37330168","Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPalpha expression.","FLRT3","regulate","gefitinib resistance","Non-small cell lung cancer","FLRT3","AFFECTS","Gefitinib Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2895","37330168","Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPalpha expression.","PTGIS","regulate","gefitinib resistance","Non-small cell lung cancer","PTGIS","AFFECTS","Gefitinib Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2896","37330168","Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPalpha expression.","SIRPalpha","regulate","gefitinib resistance","Non-small cell lung cancer","SIRPA","AFFECTS","Gefitinib Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2898","37332938","M6A modification promotes blood-brain barrier breakdown during cerebral ischemia/reperfusion injury through increasing matrix metalloproteinase 3 expression.","m6A modification","promote","blood-brain barrier breakdown","Cerebral ischemia/reperfusion injury","m6A","STIMULATES","blood-brain barrier breakdown","Cerebral ischemia/reperfusion injury"
"2899","37332938","M6A modification promotes blood-brain barrier breakdown during cerebral ischemia/reperfusion injury through increasing matrix metalloproteinase 3 expression.","m6A modification","increase","matrix metalloproteinase 3 expression","Cerebral ischemia/reperfusion injury","m6A","AUGMENTS","MMP3","Cerebral ischemia/reperfusion injury"
"2900","37332938","M6A modification promotes blood-brain barrier breakdown during cerebral ischemia/reperfusion injury through increasing matrix metalloproteinase 3 expression.","matrix metalloproteinase 3 expression","promote","blood-brain barrier breakdown","Cerebral ischemia/reperfusion injury","MMP3","STIMULATES","blood-brain barrier breakdown","Cerebral ischemia/reperfusion injury"
"2902","37334368","Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.","Abrine","inhibit","IDO1","Hepatocellular Carcinoma","abrine","INHIBITS","IDO1","LIHC(Liver Hepatocellular Carcinoma)"
"2903","37334368","Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.","IDO1","suppress","Immune Escape","Hepatocellular Carcinoma","IDO1","INHIBITS","Immune Escape","LIHC(Liver Hepatocellular Carcinoma)"
"2904","37334368","Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.","Abrine","enhance","Immunotherapy","Hepatocellular Carcinoma","abrine","AUGMENTS","Immunotherapy","LIHC(Liver Hepatocellular Carcinoma)"
"2905","37334368","Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.","Immunotherapy","is of","anti-PD-1 antibody","Hepatocellular Carcinoma","Immunotherapy","is of","anti-PD-1 antibody","LIHC(Liver Hepatocellular Carcinoma)"
"2907","37334762","RBM15 m6 A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT/mTOR signaling.","RBM15","mediate","m6A modification","Cervical Cancer","RBM15","AFFECTS","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2908","37334762","RBM15 m6 A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT/mTOR signaling.","m6A modification","mediate","OTUB2","Cervical Cancer","m6A","AFFECTS","OTUB2","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2909","37334762","RBM15 m6 A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT/mTOR signaling.","OTUB2","promote","Cervical Cancer Progression","Cervical Cancer","OTUB2","STIMULATES","Cervical Cancer Progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2910","37334762","RBM15 m6 A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT/mTOR signaling.","OTUB2","regulate","AKT/mTOR signaling","Cervical Cancer","OTUB2","AFFECTS","AKT/mTOR pathway","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2911","37334762","RBM15 m6 A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT/mTOR signaling.","AKT/mTOR signaling","promote","Cervical Cancer Progression","Cervical Cancer","AKT/mTOR pathway","STIMULATES","Cervical Cancer Progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2913","37335109","Mettl3-mediated m6A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression.","Mettl3","mediate","m6A modification","Mice","METTL3","AFFECTS","m6A","Mice"
"2914","37335109","Mettl3-mediated m6A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression.","m6A modification","regulate","lipid metabolism disorders","Mice","m6A","AFFECTS","Lipid Metabolism Disorders","Mice"
"2915","37335109","Mettl3-mediated m6A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression.","m6A modification","regulate","progressive liver damage","Mice","m6A","AFFECTS","progressive liver damage","Mice"
"2916","37335109","Mettl3-mediated m6A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression.","m6A modification","regulate","lipid metabolism-related gene expression","Mice","m6A","AFFECTS","lipid metabolism-related gene expression","Mice"
"2917","37335109","Mettl3-mediated m6A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression.","lipid metabolism-related gene expression","regulate","lipid metabolism disorders","Mice","lipid metabolism-related gene expression","AFFECTS","Lipid Metabolism Disorders","Mice"
"2918","37335109","Mettl3-mediated m6A modification plays a role in lipid metabolism disorders and progressive liver damage in mice by regulating lipid metabolism-related gene expression.","lipid metabolism-related gene expression","regulate","progressive liver damage","Mice","lipid metabolism-related gene expression","AFFECTS","progressive liver damage","Mice"
"2920","37336334","Qinzhu Liangxue inhibits IL-6-induced hyperproliferation and inflammation in HaCaT cells by regulating METTL14/SOCS3/STAT3 axis.","Qinzhu Liangxue","regulate","METTL14/SOCS3/STAT3 axis","HaCaT cells","qinzhu liangxue","AFFECTS","METTL14/SOCS3/STAT3 axis","HaCaT Cells"
"2921","37336334","Qinzhu Liangxue inhibits IL-6-induced hyperproliferation and inflammation in HaCaT cells by regulating METTL14/SOCS3/STAT3 axis.","IL-6","induce","hyperproliferation","HaCaT cells","IL6","CAUSES","hyperproliferation","HaCaT Cells"
"2922","37336334","Qinzhu Liangxue inhibits IL-6-induced hyperproliferation and inflammation in HaCaT cells by regulating METTL14/SOCS3/STAT3 axis.","IL-6","induce","inflammation","HaCaT cells","IL6","CAUSES","inflammatory response","HaCaT Cells"
"2923","37336334","Qinzhu Liangxue inhibits IL-6-induced hyperproliferation and inflammation in HaCaT cells by regulating METTL14/SOCS3/STAT3 axis.","METTL14/SOCS3/STAT3 axis","inhibit","hyperproliferation","HaCaT cells","METTL14/SOCS3/STAT3 axis","INHIBITS","hyperproliferation","HaCaT Cells"
"2924","37336334","Qinzhu Liangxue inhibits IL-6-induced hyperproliferation and inflammation in HaCaT cells by regulating METTL14/SOCS3/STAT3 axis.","METTL14/SOCS3/STAT3 axis","inhibit","inflammation","HaCaT cells","METTL14/SOCS3/STAT3 axis","INHIBITS","inflammatory response","HaCaT Cells"
"2926","37337726","m6A-mediated upregulation of lncRNA RMRP boosts the progression of bladder cancer via epigenetically suppressing SCARA5.","m6A","mediate","lncRNA RMRP","Bladder Cancer","m6A","AFFECTS","RMRP","BLCA(Bladder Urothelial Carcinoma)"
"2927","37337726","m6A-mediated upregulation of lncRNA RMRP boosts the progression of bladder cancer via epigenetically suppressing SCARA5.","lncRNA RMRP","boost","Progression","Bladder Cancer","RMRP","boost","progression","BLCA(Bladder Urothelial Carcinoma)"
"2928","37337726","m6A-mediated upregulation of lncRNA RMRP boosts the progression of bladder cancer via epigenetically suppressing SCARA5.","lncRNA RMRP","suppress","SCARA5","Bladder Cancer","RMRP","INHIBITS","SCARA5","BLCA(Bladder Urothelial Carcinoma)"
"2929","37337726","m6A-mediated upregulation of lncRNA RMRP boosts the progression of bladder cancer via epigenetically suppressing SCARA5.","SCARA5","regulate","Progression","Bladder Cancer","SCARA5","AFFECTS","progression","BLCA(Bladder Urothelial Carcinoma)"
"2931","37340443","METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.","METTL16","promote","glycolytic metabolism reprogramming","Colorectal Cancer","METTL16","STIMULATES","glycolytic metabolism reprogramming","COAD(Colon Adenocarcinoma)"
"2932","37340443","METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.","METTL16","promote","cancer progression","Colorectal Cancer","METTL16","STIMULATES","Cancer Progression","COAD(Colon Adenocarcinoma)"
"2934","37343655","Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA.","FTZ capsule","ameliorate","Diabetes-accelerated atherosclerosis","Diabetes-accelerated atherosclerosis","FTZ capsule","TREATS","Diabetes-accelerated atherosclerosis","Diabetes-accelerated atherosclerosis"
"2935","37343655","Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA.","FTZ capsule","suppress","YTHDF2","Diabetes-accelerated atherosclerosis","FTZ capsule","INHIBITS","YTHDF2","Diabetes-accelerated atherosclerosis"
"2936","37343655","Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA.","YTHDF2","mediate","m6A","Diabetes-accelerated atherosclerosis","YTHDF2","AFFECTS","m6A","Diabetes-accelerated atherosclerosis"
"2937","37343655","Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA.","m6A","is on","SIRT3 mRNA","Diabetes-accelerated atherosclerosis","m6A","LOCATES","SIRT3","Diabetes-accelerated atherosclerosis"
"2938","37343655","Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA.","SIRT3 mRNA","regulate","Diabetes-accelerated atherosclerosis","Diabetes-accelerated atherosclerosis","SIRT3","AFFECTS","Diabetes-accelerated atherosclerosis","Diabetes-accelerated atherosclerosis"
"2940","37344779","METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.","METTL3","regulate","N6-methyladenosine modification","Stomach Adenocarcinoma","METTL3","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"2941","37344779","METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.","N6-methyladenosine modification","is on","ANGPTL3 mRNA","Stomach Adenocarcinoma","m6A","LOCATES","ANGPTL3","STAD(Stomach adenocarcinoma)"
"2942","37344779","METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.","METTL3","potentiate","malignant progression","Stomach Adenocarcinoma","METTL3","AUGMENTS","Malignant Progression","STAD(Stomach adenocarcinoma)"
"2943","37344779","METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.","ANGPTL3 mRNA","regulate","malignant progression","Stomach Adenocarcinoma","ANGPTL3","AFFECTS","Malignant Progression","STAD(Stomach adenocarcinoma)"
"2945","37348798","N6-methyladenosine profiling reveals that Xuefu Zhuyu decoction upregulates METTL14 and BDNF in a rat model of traumatic brain injury.","Xuefu Zhuyu decoction","upregulate","METTL14","Rat model of traumatic brain injury","Xuefu Zhuyu decoction","STIMULATES","METTL14","Rat model of traumatic brain injury"
"2946","37348798","N6-methyladenosine profiling reveals that Xuefu Zhuyu decoction upregulates METTL14 and BDNF in a rat model of traumatic brain injury.","Xuefu Zhuyu decoction","upregulate","BDNF","Rat model of traumatic brain injury","Xuefu Zhuyu decoction","STIMULATES","BDNF","Rat model of traumatic brain injury"
"2948","37353784","m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma.","IGF2BP2","bind","m6A","Lung Adenocarcinoma","IGF2BP2","INTERACTS_WITH","m6A","LUAD(Lung Adenocarcinoma)"
"2949","37353784","m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma.","IGF2BP2","activate","Endothelial Cells","Lung Adenocarcinoma","IGF2BP2","STIMULATES","Endothelial Cells","LUAD(Lung Adenocarcinoma)"
"2950","37353784","m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma.","Endothelial Cells","promote","Angiogenesis","Lung Adenocarcinoma","Endothelial Cells","STIMULATES","angiogenesis","LUAD(Lung Adenocarcinoma)"
"2951","37353784","m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma.","Endothelial Cells","promote","Metastasis","Lung Adenocarcinoma","Endothelial Cells","STIMULATES","Neoplasm Metastasis","LUAD(Lung Adenocarcinoma)"
"2953","37353804","METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.","METTL3","mediate","m6A","Endometriosis","METTL3","AFFECTS","m6A","Endometriosis"
"2954","37353804","METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.","m6A","modify","SIRT1 mRNA","Endometriosis","m6A","AFFECTS","SIRT1","Endometriosis"
"2955","37353804","METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.","cellular senescence","enhance","progression of endometriosis","Endometriosis","cellular senescence","AUGMENTS","progression of endometriosis","Endometriosis"
"2956","37353804","METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.","SIRT1 mRNA","regulate","cellular senescence","Endometriosis","SIRT1","AFFECTS","cellular senescence","Endometriosis"
"2959","37354721","Sperm Rhoa m6A modification mediates intergenerational transmission of paternally acquired hippocampal neuronal senescence and cognitive deficits after combined exposure to environmental cadmium and high-fat diet in mice.","Sperm Rhoa","undergo","m6A modification","Mice","Sperm Rhoa","undergo","m6A","Mice"
"2960","37354721","Sperm Rhoa m6A modification mediates intergenerational transmission of paternally acquired hippocampal neuronal senescence and cognitive deficits after combined exposure to environmental cadmium and high-fat diet in mice.","m6A modification","mediate","Intergenerational Transmission","Mice","m6A","AFFECTS","Intergenerational Transmission","Mice"
"2961","37354721","Sperm Rhoa m6A modification mediates intergenerational transmission of paternally acquired hippocampal neuronal senescence and cognitive deficits after combined exposure to environmental cadmium and high-fat diet in mice.","Intergenerational Transmission","transmit","Paternally Acquired Hippocampal Neuronal Senescence","Mice","Intergenerational Transmission","transmit","Paternally Acquired Hippocampal Neuronal Senescence","Mice"
"2962","37354721","Sperm Rhoa m6A modification mediates intergenerational transmission of paternally acquired hippocampal neuronal senescence and cognitive deficits after combined exposure to environmental cadmium and high-fat diet in mice.","Intergenerational Transmission","transmit","Cognitive Deficits","Mice","Intergenerational Transmission","transmit","Neurocognitive Disorders","Mice"
"2963","37354721","Sperm Rhoa m6A modification mediates intergenerational transmission of paternally acquired hippocampal neuronal senescence and cognitive deficits after combined exposure to environmental cadmium and high-fat diet in mice.","Environmental Cadmium and High-Fat Diet","affect","Sperm Rhoa","Mice","Environmental Cadmium and High-Fat Diet","AFFECTS","Sperm Rhoa","Mice"
"2965","37355987","A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth.","METTL14 mutation","induce","aberrant m6A modification","Cancer","METTL14 mutation","CAUSES","aberrant m6A modification","PANCAN(Pan-Cancer)"
"2966","37355987","A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth.","aberrant m6A modification","affect","tumor growth","Cancer","aberrant m6A modification","AFFECTS","Tumor Growth","PANCAN(Pan-Cancer)"
"2968","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","METTL3","mediate","m6A methylation","gammadelta T1 and gammadelta T17 cells","METTL3","AFFECTS","m6A","gammadelta T1 and gammadelta T17 cells"
"2969","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","m6A methylation","orchestrate","mRNA stability","gammadelta T1 and gammadelta T17 cells","m6A","orchestrate","mrna stability","gammadelta T1 and gammadelta T17 cells"
"2970","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","m6A methylation","orchestrate","dsRNA contents","gammadelta T1 and gammadelta T17 cells","m6A","orchestrate","dsRNA contents","gammadelta T1 and gammadelta T17 cells"
"2971","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","m6A methylation","equilibrate","gammadelta T1 cells","gammadelta T1 and gammadelta T17 cells","m6A","equilibrate","gammadelta T1 cells","gammadelta T1 and gammadelta T17 cells"
"2972","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","m6A methylation","equilibrate","gammadelta T17 cells","gammadelta T1 and gammadelta T17 cells","m6A","equilibrate","gammadelta T17 cells","gammadelta T1 and gammadelta T17 cells"
"2973","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","mRNA stability","regulate","gammadelta T1 cells","gammadelta T1 and gammadelta T17 cells","mrna stability","AFFECTS","gammadelta T1 cells","gammadelta T1 and gammadelta T17 cells"
"2974","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","mRNA stability","regulate","gammadelta T17 cells","gammadelta T1 and gammadelta T17 cells","mrna stability","AFFECTS","gammadelta T17 cells","gammadelta T1 and gammadelta T17 cells"
"2975","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","dsRNA contents","regulate","gammadelta T1 cells","gammadelta T1 and gammadelta T17 cells","dsRNA contents","AFFECTS","gammadelta T1 cells","gammadelta T1 and gammadelta T17 cells"
"2976","37355989","METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate gammadelta T1 and gammadelta T17 cells.","dsRNA contents","regulate","gammadelta T17 cells","gammadelta T1 and gammadelta T17 cells","dsRNA contents","AFFECTS","gammadelta T17 cells","gammadelta T1 and gammadelta T17 cells"
"2978","37356601","METTL3-mediated m6A RNA modification promotes corneal neovascularization by upregulating the canonical Wnt pathway during HSV-1 infection.","METTL3","mediate","m6A RNA modification","HSV-1 infection","METTL3","AFFECTS","m6A","HSV-1 infection"
"2979","37356601","METTL3-mediated m6A RNA modification promotes corneal neovascularization by upregulating the canonical Wnt pathway during HSV-1 infection.","m6A RNA modification","promote","corneal neovascularization","HSV-1 infection","m6A","STIMULATES","Corneal Neovascularization","HSV-1 infection"
"2980","37356601","METTL3-mediated m6A RNA modification promotes corneal neovascularization by upregulating the canonical Wnt pathway during HSV-1 infection.","m6A RNA modification","upregulate","canonical Wnt pathway","HSV-1 infection","m6A","STIMULATES","canonical Wnt pathway","HSV-1 infection"
"2981","37356601","METTL3-mediated m6A RNA modification promotes corneal neovascularization by upregulating the canonical Wnt pathway during HSV-1 infection.","canonical Wnt pathway","promote","corneal neovascularization","HSV-1 infection","canonical Wnt pathway","STIMULATES","Corneal Neovascularization","HSV-1 infection"
"2983","37357252","YTHDF2 negatively correlates with tumor immune infiltration in small cell lung cancer.","YTHDF2","negatively correlate with","Tumor Immune Infiltration","Small Cell Lung Cancer","YTHDF2","negatively correlate with","Tumor Immune Infiltration","SCLC(Small Cell Lung Carcinoma)"
"2985","37357526","METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m6 A-dependent manner.","METTL16","promote","Osteosarcoma Progression","Osteosarcoma","METTL16","STIMULATES","Osteosarcoma Progression","SARC(Sarcoma)"
"2986","37357526","METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m6 A-dependent manner.","METTL16","downregulate","VPS33B","Osteosarcoma","METTL16","INHIBITS","VPS33B","SARC(Sarcoma)"
"2987","37357526","METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m6 A-dependent manner.","METTL16","regulate","m6A","Osteosarcoma","METTL16","AFFECTS","m6A","SARC(Sarcoma)"
"2988","37357526","METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m6 A-dependent manner.","m6A","regulate","VPS33B","Osteosarcoma","m6A","AFFECTS","VPS33B","SARC(Sarcoma)"
"2990","37357537","Intron retention decreases METTL3 expression by inhibiting mRNA export to the cytoplasm.","Intron retention","decrease","METTL3","Null","Intron retention","INHIBITS","METTL3","Null"
"2991","37357537","Intron retention decreases METTL3 expression by inhibiting mRNA export to the cytoplasm.","METTL3","inhibit","mRNA export","Null","METTL3","INHIBITS","mrna export","Null"
"2993","37195267","METTL14 represses osteoclast formation to ameliorate osteoporosis via enhancing GPX4 mRNA stability.","METTL14","repress","osteoclast formation","Osteoporosis","METTL14","INHIBITS","osteoclast formation","Osteoporosis"
"2994","37195267","METTL14 represses osteoclast formation to ameliorate osteoporosis via enhancing GPX4 mRNA stability.","METTL14","enhance","stability","Osteoporosis","METTL14","AUGMENTS","stability","Osteoporosis"
"2995","37195267","METTL14 represses osteoclast formation to ameliorate osteoporosis via enhancing GPX4 mRNA stability.","stability","repress","osteoclast formation","Osteoporosis","stability","INHIBITS","osteoclast formation","Osteoporosis"
"2997","37196908","METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.","METTL3","promote","Pancreatic Cancer Proliferation","Pancreatic Cancer","METTL3","STIMULATES","Pancreatic Cancer Proliferation","PAAD(Pancreatic Adenocarcinoma)"
"2998","37196908","METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.","METTL3","promote","Stemness","Pancreatic Cancer","METTL3","STIMULATES","Stemness","PAAD(Pancreatic Adenocarcinoma)"
"2999","37196908","METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.","METTL3","stabilize","ID2 mRNA","Pancreatic Cancer","METTL3","MAINTAINS","ID2","PAAD(Pancreatic Adenocarcinoma)"
"3000","37196908","METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.","METTL3","depend on","m6A","Pancreatic Cancer","METTL3","INTERACTS_WITH","m6A","PAAD(Pancreatic Adenocarcinoma)"
"3001","37196908","METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.","ID2 mRNA","regulate","Pancreatic Cancer Proliferation","Pancreatic Cancer","ID2","AFFECTS","Pancreatic Cancer Proliferation","PAAD(Pancreatic Adenocarcinoma)"
"3002","37196908","METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.","ID2 mRNA","regulate","Stemness","Pancreatic Cancer","ID2","AFFECTS","Stemness","PAAD(Pancreatic Adenocarcinoma)"
"3004","37198207","The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination.","LINC01977","promote","HCC progression","HCC","LINC01977","STIMULATES","HCC progression","HYCC1"
"3005","37198207","The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination.","LINC01977","interact","RBM39","HCC","LINC01977","interact","RBM39","HYCC1"
"3006","37198207","The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination.","RBM39","prevent ubiquitination","Notch2","HCC","RBM39","prevent ubiquitination","NOTCH2","HYCC1"
"3007","37198207","The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination.","Notch2","regulate","HCC progression","HCC","NOTCH2","AFFECTS","HCC progression","HYCC1"
"3009","37199660","FTO represses NLRP3-mediated pyroptosis and alleviates myocardial ischemia-reperfusion injury via inhibiting CBL-mediated ubiquitination and degradation of beta-catenin.","FTO","repress","NLRP3","Myocardial ischemia-reperfusion injury","FTO","INHIBITS","NLRP3","Myocardial ischemia-reperfusion injury"
"3010","37199660","FTO represses NLRP3-mediated pyroptosis and alleviates myocardial ischemia-reperfusion injury via inhibiting CBL-mediated ubiquitination and degradation of beta-catenin.","NLRP3","mediate","Pyroptosis","Myocardial ischemia-reperfusion injury","NLRP3","AFFECTS","pyroptosis","Myocardial ischemia-reperfusion injury"
"3011","37199660","FTO represses NLRP3-mediated pyroptosis and alleviates myocardial ischemia-reperfusion injury via inhibiting CBL-mediated ubiquitination and degradation of beta-catenin.","FTO","inhibit","CBL","Myocardial ischemia-reperfusion injury","FTO","INHIBITS","CBL","Myocardial ischemia-reperfusion injury"
"3012","37199660","FTO represses NLRP3-mediated pyroptosis and alleviates myocardial ischemia-reperfusion injury via inhibiting CBL-mediated ubiquitination and degradation of beta-catenin.","CBL","mediate","Ubiquitination","Myocardial ischemia-reperfusion injury","CBL","AFFECTS","Ubiquitination","Myocardial ischemia-reperfusion injury"
"3013","37199660","FTO represses NLRP3-mediated pyroptosis and alleviates myocardial ischemia-reperfusion injury via inhibiting CBL-mediated ubiquitination and degradation of beta-catenin.","CBL","mediate","Degradation","Myocardial ischemia-reperfusion injury","CBL","AFFECTS","catabolic process","Myocardial ischemia-reperfusion injury"
"3014","37199660","FTO represses NLRP3-mediated pyroptosis and alleviates myocardial ischemia-reperfusion injury via inhibiting CBL-mediated ubiquitination and degradation of beta-catenin.","Ubiquitination","is on","Beta-catenin","Myocardial ischemia-reperfusion injury","Ubiquitination","LOCATES","CTNNB1","Myocardial ischemia-reperfusion injury"
"3015","37199660","FTO represses NLRP3-mediated pyroptosis and alleviates myocardial ischemia-reperfusion injury via inhibiting CBL-mediated ubiquitination and degradation of beta-catenin.","Degradation","is on","Beta-catenin","Myocardial ischemia-reperfusion injury","catabolic process","LOCATES","CTNNB1","Myocardial ischemia-reperfusion injury"
"3016","37199660","FTO represses NLRP3-mediated pyroptosis and alleviates myocardial ischemia-reperfusion injury via inhibiting CBL-mediated ubiquitination and degradation of beta-catenin.","Beta-catenin","regulate","NLRP3","Myocardial ischemia-reperfusion injury","CTNNB1","AFFECTS","NLRP3","Myocardial ischemia-reperfusion injury"
"3018","37202791","Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.","Dummy","silence","lncRNA SNAI3-AS1","Glioma","dummy","INHIBITS","SNAI3-AS1","Glioma"
"3019","37202791","Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.","lncRNA SNAI3-AS1","promote","Ferroptosis","Glioma","SNAI3-AS1","STIMULATES","Ferroptosis","Glioma"
"3020","37202791","Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.","lncRNA SNAI3-AS1","perturb","m6A","Glioma","SNAI3-AS1","perturb","m6A","Glioma"
"3021","37202791","Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.","m6A","is on","Nrf2 mRNA","Glioma","m6A","LOCATES","NFE2L2","Glioma"
"3022","37202791","Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.","SND1","mediate","Nrf2 mRNA","Glioma","SND1","AFFECTS","NFE2L2","Glioma"
"3023","37202791","Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.","Nrf2 mRNA","regulate","Ferroptosis","Glioma","NFE2L2","AFFECTS","Ferroptosis","Glioma"
"3025","37203239","RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.","ALKBH5","promote","Colorectal Cancer Progression","Colorectal Cancer","ALKBH5","STIMULATES","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"3026","37203239","RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.","ALKBH5","activate","RAB5A","Colorectal Cancer","ALKBH5","STIMULATES","RAB5A","COAD(Colon Adenocarcinoma)"
"3027","37203239","RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.","ALKBH5","demethylate","m6A","Colorectal Cancer","ALKBH5","CONVERTS_TO","m6A","COAD(Colon Adenocarcinoma)"
"3028","37203239","RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Colorectal Cancer","YTHDF2","INTERACTS_WITH","m6A","COAD(Colon Adenocarcinoma)"
"3029","37203239","RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.","RAB5A","promote","Colorectal Cancer Progression","Colorectal Cancer","RAB5A","STIMULATES","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"3031","37208565","CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner.","CSNK1D","mediate","HNRNPA2B1","Prostate Cancer Cells","CSNK1D","AFFECTS","HNRNPA2B1","PRAD(Prostate Adenocarcinoma)"
"3032","37208565","CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner.","HNRNPA2B1","induce","miR-25-3p/miR-93-5p maturation","Prostate Cancer Cells","HNRNPA2B1","CAUSES","miR-25-3p/miR-93-5p maturation","PRAD(Prostate Adenocarcinoma)"
"3033","37208565","CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner.","HNRNPA2B1","regulate","m6A","Prostate Cancer Cells","HNRNPA2B1","AFFECTS","m6A","PRAD(Prostate Adenocarcinoma)"
"3034","37208565","CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner.","miR-25-3p/miR-93-5p maturation","promote","Prostate Cancer Cell Proliferation","Prostate Cancer Cells","miR-25-3p/miR-93-5p maturation","STIMULATES","Prostate Cancer Cell Proliferation","PRAD(Prostate Adenocarcinoma)"
"3035","37208565","CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner.","miR-25-3p/miR-93-5p maturation","promote","Prostate Cancer Cell Migration","Prostate Cancer Cells","miR-25-3p/miR-93-5p maturation","STIMULATES","Prostate Cancer Cell Migration","PRAD(Prostate Adenocarcinoma)"
"3037","37215454","METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner.","METTL14","facilitate","Metastasis","Pancreatic Carcinoma","METTL14","AUGMENTS","Neoplasm Metastasis","PAAD(Pancreatic Adenocarcinoma)"
"3038","37215454","METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner.","METTL14","stabilize","LINC00941","Pancreatic Carcinoma","METTL14","MAINTAINS","LINC00941","PAAD(Pancreatic Adenocarcinoma)"
"3039","37215454","METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner.","METTL14","regulate","m6A","Pancreatic Carcinoma","METTL14","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"3040","37215454","METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner.","IGF2BP2","bind","m6A","Pancreatic Carcinoma","IGF2BP2","INTERACTS_WITH","m6A","PAAD(Pancreatic Adenocarcinoma)"
"3041","37215454","METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner.","m6A","regulate","LINC00941","Pancreatic Carcinoma","m6A","AFFECTS","LINC00941","PAAD(Pancreatic Adenocarcinoma)"
"3043","37222774","m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.","METTL3","facilitate","Cell Growth","Multiple Myeloma Cells","METTL3","AUGMENTS","cell growth","Multiple Myeloma Cells"
"3044","37222774","m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.","METTL3","modify","BZW2","Multiple Myeloma Cells","METTL3","AFFECTS","BZW2","Multiple Myeloma Cells"
"3045","37222774","m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.","BZW2","regulate","Cell Growth","Multiple Myeloma Cells","BZW2","AFFECTS","cell growth","Multiple Myeloma Cells"
"3047","37224383","Activation of METTL3 promotes white adipose tissue beiging and combats obesity.","dummy","activate","METTL3","White Adipose Tissue","dummy","STIMULATES","METTL3","Adipose Tissue, White"
"3048","37224383","Activation of METTL3 promotes white adipose tissue beiging and combats obesity.","METTL3","promote","beiging","White Adipose Tissue","METTL3","STIMULATES","beiging","Adipose Tissue, White"
"3049","37224383","Activation of METTL3 promotes white adipose tissue beiging and combats obesity.","beiging","combat","obesity","White Adipose Tissue","beiging","combat","Obesity","Adipose Tissue, White"
"3051","37224767","RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer.","ALKBH5","suppress","tumorigenesis","Colorectal Cancer","ALKBH5","INHIBITS","Carcinogenesis","COAD(Colon Adenocarcinoma)"
"3052","37224767","RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer.","ALKBH5","inhibit","proliferation","Colorectal Cancer","ALKBH5","INHIBITS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"3053","37224767","RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer.","ALKBH5","inhibit","invasion","Colorectal Cancer","ALKBH5","INHIBITS","Neoplasm Invasiveness","COAD(Colon Adenocarcinoma)"
"3054","37224767","RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer.","ALKBH5","promote","CD8+ T cell infiltration","Colorectal Cancer","ALKBH5","STIMULATES","CD8+ T cell infiltration","COAD(Colon Adenocarcinoma)"
"3055","37224767","RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer.","proliferation","regulate","tumorigenesis","Colorectal Cancer","cell population proliferation","AFFECTS","Carcinogenesis","COAD(Colon Adenocarcinoma)"
"3056","37224767","RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer.","invasion","regulate","tumorigenesis","Colorectal Cancer","Neoplasm Invasiveness","AFFECTS","Carcinogenesis","COAD(Colon Adenocarcinoma)"
"3057","37224767","RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer.","CD8+ T cell infiltration","regulate","tumorigenesis","Colorectal Cancer","CD8+ T cell infiltration","AFFECTS","Carcinogenesis","COAD(Colon Adenocarcinoma)"
"3059","37229595","FTO Promotes the Stemness of Gastric Cancer Cells.","FTO","promote","Stemness","Gastric Cancer Cells","FTO","STIMULATES","Stemness","STAD(Stomach adenocarcinoma)"
"3061","37231451","METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.","METTL3","form loop","STAT3","Hepatocellular Carcinoma","METTL3","form loop","STAT3","LIHC(Liver Hepatocellular Carcinoma)"
"3062","37231451","METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.","STAT3","form loop","METTL3","Hepatocellular Carcinoma","STAT3","form loop","METTL3","LIHC(Liver Hepatocellular Carcinoma)"
"3063","37231451","METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.","METTL3","promote","Cell Metastasis","Hepatocellular Carcinoma","METTL3","STIMULATES","Cell Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"3064","37231451","METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.","STAT3","promote","Cell Metastasis","Hepatocellular Carcinoma","STAT3","STIMULATES","Cell Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"3066","37236586","METTL3-mediated m6A mRNA modification was involved in cadmium-induced liver injury.","METTL3","mediate","m6A mRNA modification","Liver","METTL3","AFFECTS","m6A","Liver"
"3067","37236586","METTL3-mediated m6A mRNA modification was involved in cadmium-induced liver injury.","m6A mRNA modification","involve","Liver Injury","Liver","m6A","ASSOCIATED_WITH","Liver Injury","Liver"
"3068","37236586","METTL3-mediated m6A mRNA modification was involved in cadmium-induced liver injury.","Cadmium","induce","Liver Injury","Liver","cadmium atom","CAUSES","Liver Injury","Liver"
"3070","37243702","METTL3-mediated m6A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis.","METTL3","mediate","m6A","Breast Cancer","METTL3","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"3071","37243702","METTL3-mediated m6A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis.","m6A","modify","lnc KCNQ1OT1","Breast Cancer","m6A","AFFECTS","KCNQ1OT1","BRCA(Breast Invasive Carcinoma)"
"3072","37243702","METTL3-mediated m6A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis.","lnc KCNQ1OT1","regulate","miR-103a-3p/MDR1 axis","Breast Cancer","KCNQ1OT1","AFFECTS","miR-103a-3p/MDR1 axis","BRCA(Breast Invasive Carcinoma)"
"3073","37243702","METTL3-mediated m6A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis.","miR-103a-3p/MDR1 axis","promote","Doxorubicin Resistance","Breast Cancer","miR-103a-3p/MDR1 axis","STIMULATES","Doxorubicin Resistance","BRCA(Breast Invasive Carcinoma)"
"3074","37243702","METTL3-mediated m6A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis.","lnc KCNQ1OT1","promote","Doxorubicin Resistance","Breast Cancer","KCNQ1OT1","STIMULATES","Doxorubicin Resistance","BRCA(Breast Invasive Carcinoma)"
"3076","37244037","ALKBH5-YTHDF2 m6A modification axis inhibits rheumatoid arthritis progression by suppressing NLRP3.","ALKBH5-YTHDF2 m6A modification axis","inhibit","Rheumatoid Arthritis Progression","Rheumatoid Arthritis","ALKBH5-YTHDF2 m6A modification axis","INHIBITS","Rheumatoid Arthritis Progression","Arthritis, Rheumatoid"
"3077","37244037","ALKBH5-YTHDF2 m6A modification axis inhibits rheumatoid arthritis progression by suppressing NLRP3.","ALKBH5-YTHDF2 m6A modification axis","suppress","NLRP3","Rheumatoid Arthritis","ALKBH5-YTHDF2 m6A modification axis","INHIBITS","NLRP3","Arthritis, Rheumatoid"
"3078","37244037","ALKBH5-YTHDF2 m6A modification axis inhibits rheumatoid arthritis progression by suppressing NLRP3.","NLRP3","regulate","Rheumatoid Arthritis Progression","Rheumatoid Arthritis","NLRP3","AFFECTS","Rheumatoid Arthritis Progression","Arthritis, Rheumatoid"
"3080","37244946","NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc.","NCBP1","enhance","proliferation","DLBCL cells","NCBP1","AUGMENTS","cell population proliferation","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3081","37244946","NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc.","NCBP1","regulate","METTL3","DLBCL cells","NCBP1","AFFECTS","METTL3","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3082","37244946","NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc.","METTL3","regulate","m6A","DLBCL cells","METTL3","AFFECTS","m6A","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3083","37244946","NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc.","m6A","modify","c-Myc","DLBCL cells","m6A","AFFECTS","MYC","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3084","37244946","NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc.","c-Myc","regulate","proliferation","DLBCL cells","MYC","AFFECTS","cell population proliferation","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3086","37245538","METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNA.","Lipopolysaccharide","induce","METTL3","Myocardial Injury","lipopolysaccharide","CAUSES","METTL3","Myocardial Injury"
"3087","37245538","METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNA.","METTL3","regulate","m6A","Myocardial Injury","METTL3","AFFECTS","m6A","Myocardial Injury"
"3088","37245538","METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNA.","m6A","stabilize","Myh3 mRNA","Myocardial Injury","m6A","MAINTAINS","Myh3","Myocardial Injury"
"3089","37245538","METTL3 achieves lipopolysaccharide-induced myocardial injury via m6A-dependent stabilization of Myh3 mRNA.","Myh3 mRNA","induce","METTL3","Myocardial Injury","Myh3","CAUSES","METTL3","Myocardial Injury"
"3091","37249328","METTL3-mediated ANXA2 inhibition confers neuroprotection in ischemic stroke: Evidence from in vivo and in vitro studies.","METTL3","inhibit","ANXA2","Ischemic Stroke","METTL3","INHIBITS","ANXA2","Ischemic Stroke"
"3092","37249328","METTL3-mediated ANXA2 inhibition confers neuroprotection in ischemic stroke: Evidence from in vivo and in vitro studies.","ANXA2","confer","Neuroprotection","Ischemic Stroke","ANXA2","PRODUCES","Neuroprotection","Ischemic Stroke"
"3094","37256823","N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export.","N6-methyladenosine modification","facilitate","Gastric Cancer Metastasis","Gastric Cancer","m6A","AUGMENTS","Gastric Cancer Metastasis","STAD(Stomach adenocarcinoma)"
"3095","37256823","N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export.","N6-methyladenosine modification","is on","CENPF mRNA","Gastric Cancer","m6A","LOCATES","CENPF","STAD(Stomach adenocarcinoma)"
"3096","37256823","N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export.","N6-methyladenosine modification","regulate","FAK","Gastric Cancer","m6A","AFFECTS","PTK2","STAD(Stomach adenocarcinoma)"
"3097","37256823","N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export.","FAK","is on","Nuclear Export","Gastric Cancer","PTK2","LOCATES","nuclear export","STAD(Stomach adenocarcinoma)"
"3098","37256823","N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export.","Nuclear Export","facilitate","Gastric Cancer Metastasis","Gastric Cancer","nuclear export","AUGMENTS","Gastric Cancer Metastasis","STAD(Stomach adenocarcinoma)"
"3100","37257451","RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity.","RBM33","bind","m6A","Null","RBM33","INTERACTS_WITH","m6A","Null"
"3101","37257451","RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity.","RBM33","regulate","ALKBH5","Null","RBM33","AFFECTS","ALKBH5","Null"
"3102","37257451","RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity.","RBM33","regulate","substrate selectivity","Null","RBM33","AFFECTS","substrate selectivity","Null"
"3104","37257765","IGF2BP3/HIF1A/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming.","IGF2BP3/HIF1A/YAP signaling","activate","hepatocyte reprogramming","Acute-on-chronic liver failure","IGF2BP3/HIF1A/YAP signaling pathway","STIMULATES","hepatocyte reprogramming","Acute-On-Chronic Liver Failure"
"3105","37257765","IGF2BP3/HIF1A/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming.","hepatocyte reprogramming","drive","acute-on-chronic liver failure","Acute-on-chronic liver failure","hepatocyte reprogramming","STIMULATES","Acute-On-Chronic Liver Failure","Acute-On-Chronic Liver Failure"
"3107","37257820","m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma.","LINC00839","promote","Tumor Progression","Nasopharyngeal Carcinoma","LINC00839","STIMULATES","Tumor Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3108","37257820","m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma.","LINC00839","enhance","TAF15","Nasopharyngeal Carcinoma","LINC00839","AUGMENTS","TAF15","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3109","37257820","m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma.","TAF15","mediate transcription of","AOC1","Nasopharyngeal Carcinoma","TAF15","mediate transcription of","AOC1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3110","37257820","m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma.","AOC1","regulate","Tumor Progression","Nasopharyngeal Carcinoma","AOC1","AFFECTS","Tumor Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3112","37258572","The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression.","YTHDC1/GLUT3/RNF183 axis","modulate","Glucose Metabolism","Bladder Cancer","YTHDC1/GLUT3/RNF183 axis","AFFECTS","glucose metabolic process","BLCA(Bladder Urothelial Carcinoma)"
"3113","37258572","The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression.","YTHDC1/GLUT3/RNF183 axis","modulate","Bladder Cancer Progression","Bladder Cancer","YTHDC1/GLUT3/RNF183 axis","AFFECTS","Bladder Cancer Progression","BLCA(Bladder Urothelial Carcinoma)"
"3114","37258572","The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression.","Glucose Metabolism","affect","Bladder Cancer Progression","Bladder Cancer","glucose metabolic process","AFFECTS","Bladder Cancer Progression","BLCA(Bladder Urothelial Carcinoma)"
"3116","37264021","RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m6A modification.","RPS15","interact","IGF2BP1","Esophageal Squamous Cell Carcinoma","RPS15","interact","IGF2BP1","ESCA(Esophageal Carcinoma)"
"3117","37264021","RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m6A modification.","IGF2BP1","recognize","m6A","Esophageal Squamous Cell Carcinoma","IGF2BP1","DIAGNOSES","m6A","ESCA(Esophageal Carcinoma)"
"3118","37264021","RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m6A modification.","m6A","promote","esophageal squamous cell carcinoma development","Esophageal Squamous Cell Carcinoma","m6A","STIMULATES","Esophageal Squamous Cell Carcinoma","ESCA(Esophageal Carcinoma)"
"3120","37268280","TROP2 translation mediated by dual m6A/m7G RNA modifications promotes bladder cancer development.","m6A","mediate","TROP2","Bladder Cancer","m6A","AFFECTS","TACSTD2","BLCA(Bladder Urothelial Carcinoma)"
"3121","37268280","TROP2 translation mediated by dual m6A/m7G RNA modifications promotes bladder cancer development.","m7G","mediate","TROP2","Bladder Cancer","7-methylguanosine","AFFECTS","TACSTD2","BLCA(Bladder Urothelial Carcinoma)"
"3122","37268280","TROP2 translation mediated by dual m6A/m7G RNA modifications promotes bladder cancer development.","TROP2","promote","Bladder Cancer Development","Bladder Cancer","TACSTD2","STIMULATES","Bladder Cancer Development","BLCA(Bladder Urothelial Carcinoma)"
"3123","37268280","TROP2 translation mediated by dual m6A/m7G RNA modifications promotes bladder cancer development.","m6A","promote","Bladder Cancer Development","Bladder Cancer","m6A","STIMULATES","Bladder Cancer Development","BLCA(Bladder Urothelial Carcinoma)"
"3124","37268280","TROP2 translation mediated by dual m6A/m7G RNA modifications promotes bladder cancer development.","m7G","promote","Bladder Cancer Development","Bladder Cancer","7-methylguanosine","STIMULATES","Bladder Cancer Development","BLCA(Bladder Urothelial Carcinoma)"
"3126","37269288","Mettl14-mediated m6A modification ensures the cell-cycle progression of late-born retinal progenitor cells.","Mettl14","mediate","m6A modification","Late-born retinal progenitor cells","METTL14","AFFECTS","m6A","Late-born retinal progenitor cells"
"3127","37269288","Mettl14-mediated m6A modification ensures the cell-cycle progression of late-born retinal progenitor cells.","m6A modification","ensure","cell-cycle progression","Late-born retinal progenitor cells","m6A","ensure","cell-cycle progression","Late-born retinal progenitor cells"
"3129","37269817","PRMT1 methylates METTL14 to modulate its oncogenic function.","PRMT1","methylate","METTL14","Null","PRMT1","CONVERTS_TO","METTL14","Null"
"3130","37269817","PRMT1 methylates METTL14 to modulate its oncogenic function.","METTL14","modulate","oncogenic function","Null","METTL14","AFFECTS","oncogenic function","Null"
"3132","37270527","m6A-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma.","m6A","upregulate","LINC01003","Glioma","m6A","STIMULATES","LINC01003","Glioma"
"3133","37270527","m6A-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma.","LINC01003","regulate","Cell Migration","Glioma","LINC01003","AFFECTS","cell migration","Glioma"
"3134","37270527","m6A-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma.","LINC01003","target","CAV1/FAK signaling pathway","Glioma","LINC01003","INTERACTS_WITH","CAV1/FAK signaling pathway","Glioma"
"3135","37270527","m6A-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma.","CAV1/FAK signaling pathway","regulate","Cell Migration","Glioma","CAV1/FAK signaling pathway","AFFECTS","cell migration","Glioma"
"3137","37270544","METTL3-dependent m6A methylation facilitates uterine receptivity and female fertility via balancing estrogen and progesterone signaling.","METTL3","facilitate","m6A methylation","Uterine Receptivity and Female Fertility","METTL3","AUGMENTS","m6A","Uterine Receptivity and Female Fertility"
"3138","37270544","METTL3-dependent m6A methylation facilitates uterine receptivity and female fertility via balancing estrogen and progesterone signaling.","m6A methylation","balance","Estrogen Signaling","Uterine Receptivity and Female Fertility","m6A","balance","Estrogen signaling pathway","Uterine Receptivity and Female Fertility"
"3139","37270544","METTL3-dependent m6A methylation facilitates uterine receptivity and female fertility via balancing estrogen and progesterone signaling.","m6A methylation","balance","Progesterone Signaling","Uterine Receptivity and Female Fertility","m6A","balance","Progesterone signaling pathway","Uterine Receptivity and Female Fertility"
"3140","37270544","METTL3-dependent m6A methylation facilitates uterine receptivity and female fertility via balancing estrogen and progesterone signaling.","Estrogen Signaling","regulate","Uterine Receptivity","Uterine Receptivity and Female Fertility","Estrogen signaling pathway","AFFECTS","Uterine Receptivity","Uterine Receptivity and Female Fertility"
"3141","37270544","METTL3-dependent m6A methylation facilitates uterine receptivity and female fertility via balancing estrogen and progesterone signaling.","Progesterone Signaling","regulate","Uterine Receptivity","Uterine Receptivity and Female Fertility","Progesterone signaling pathway","AFFECTS","Uterine Receptivity","Uterine Receptivity and Female Fertility"
"3143","37272931","Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.","Tumor-associated macrophages","promote","cisplatin resistance","Ovarian Cancer Cells","Tumor-Associated Macrophages","STIMULATES","Cisplatin Resistance","OV(Ovarian Serous Cystadenocarcinoma)"
"3144","37272931","Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.","WTAP","mediate","N6-methyladenosine RNA methylation","Ovarian Cancer Cells","WTAP","AFFECTS","m6A","OV(Ovarian Serous Cystadenocarcinoma)"
"3145","37272931","Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.","CXCL16/CXCR6 axis","regulate","WTAP","Ovarian Cancer Cells","CXCL16/CXCR6 axis","AFFECTS","WTAP","OV(Ovarian Serous Cystadenocarcinoma)"
"3146","37272931","Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.","N6-methyladenosine RNA methylation","regulate","cisplatin resistance","Ovarian Cancer Cells","m6A","AFFECTS","Cisplatin Resistance","OV(Ovarian Serous Cystadenocarcinoma)"
"3148","37095108","Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.","dummy","modify","METTL3","Prostate Cancer","dummy","AFFECTS","METTL3","PRAD(Prostate Adenocarcinoma)"
"3149","37095108","Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.","METTL3","regulate","ERK","Prostate Cancer","METTL3","AFFECTS","ERK","PRAD(Prostate Adenocarcinoma)"
"3150","37095108","Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.","ERK","induce","Androgen-Deprived Treatment Resistance","Prostate Cancer","ERK","CAUSES","Androgen-Deprived Treatment Resistance","PRAD(Prostate Adenocarcinoma)"
"3151","37095108","Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.","METTL3","regulate","Androgen-Deprived Treatment Resistance","Prostate Cancer","METTL3","AFFECTS","Androgen-Deprived Treatment Resistance","PRAD(Prostate Adenocarcinoma)"
"3153","37103476","N6-methyladenosine promotes translation of VEGFA to accelerate angiogenesis in lung cancer.","N6-methyladenosine","promote","VEGFA","Lung Cancer","m6A","STIMULATES","VEGFA","LUAD(Lung Adenocarcinoma)"
"3154","37103476","N6-methyladenosine promotes translation of VEGFA to accelerate angiogenesis in lung cancer.","VEGFA","accelerate","angiogenesis","Lung Cancer","VEGFA","STIMULATES","angiogenesis","LUAD(Lung Adenocarcinoma)"
"3156","37105375","METTL3 silenced inhibited the ferroptosis development via regulating the TFRC levels in the Intracerebral hemorrhage progression.","METTL3","inhibit","Ferroptosis Development","Intracerebral Hemorrhage Progression","METTL3","INHIBITS","Ferroptosis Development","Intracerebral Hemorrhage Progression"
"3157","37105375","METTL3 silenced inhibited the ferroptosis development via regulating the TFRC levels in the Intracerebral hemorrhage progression.","METTL3","regulate","TFRC","Intracerebral Hemorrhage Progression","METTL3","AFFECTS","TFRC","Intracerebral Hemorrhage Progression"
"3158","37105375","METTL3 silenced inhibited the ferroptosis development via regulating the TFRC levels in the Intracerebral hemorrhage progression.","TFRC","regulate","Ferroptosis Development","Intracerebral Hemorrhage Progression","TFRC","AFFECTS","Ferroptosis Development","Intracerebral Hemorrhage Progression"
"3160","37106069","METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2.","METTL3","promote","Malignancy","Non-Small Cell Lung Cancer","METTL3","STIMULATES","cancer","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3161","37106069","METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2.","METTL3","modify","N6-methyladenosine","Non-Small Cell Lung Cancer","METTL3","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3162","37106069","METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2.","N6-methyladenosine","is on","SFRP2","Non-Small Cell Lung Cancer","m6A","LOCATES","SFRP2","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3163","37106069","METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2.","SFRP2","regulate","Malignancy","Non-Small Cell Lung Cancer","SFRP2","AFFECTS","cancer","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3165","37106446","CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure.","CircZBTB44","promote","Renal Carcinoma Progression","Renal Carcinoma","CircZBTB44","STIMULATES","Renal Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3166","37106446","CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure.","CircZBTB44","stabilize","HK3 mRNA","Renal Carcinoma","CircZBTB44","MAINTAINS","HK3","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3167","37106446","CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure.","HK3 mRNA","regulate","Renal Carcinoma Progression","Renal Carcinoma","HK3","AFFECTS","Renal Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3169","37120495","LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.","FTO","demethylate","m6A","NSCLC","FTO","CONVERTS_TO","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3170","37120495","LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.","m6A","regulate","GAS5","NSCLC","m6A","AFFECTS","GAS5","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3171","37120495","LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.","GAS5","promote","autophagic cell death","NSCLC","GAS5","STIMULATES","autophagic cell death","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3172","37120495","LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.","GAS5","target","UPF1/BRD4 axis","NSCLC","GAS5","INTERACTS_WITH","UPF1/BRD4 axis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3173","37120495","LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.","UPF1/BRD4 axis","regulate","autophagic cell death","NSCLC","UPF1/BRD4 axis","AFFECTS","autophagic cell death","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3175","37121538","ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.","ZBTB7C","modify","m6A","Osteosarcoma","ZBTB7C","AFFECTS","m6A","SARC(Sarcoma)"
"3176","37121538","ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.","METTL3","incur","m6A","Osteosarcoma","METTL3","incur","m6A","SARC(Sarcoma)"
"3177","37121538","ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.","m6A","promote","Osteosarcoma Progression","Osteosarcoma","m6A","STIMULATES","Osteosarcoma Progression","SARC(Sarcoma)"
"3179","37121553","Mettl14 sustains FOXP3 expression to promote the differentiation and functions of induced-regulatory T cells via the mTOR signaling pathway.","Mettl14","sustain","FOXP3 expression","Induced-regulatory T cells","METTL14","MAINTAINS","FOXP3","Induced-regulatory T cells"
"3180","37121553","Mettl14 sustains FOXP3 expression to promote the differentiation and functions of induced-regulatory T cells via the mTOR signaling pathway.","FOXP3 expression","promote","differentiation","Induced-regulatory T cells","FOXP3","STIMULATES","cell differentiation","Induced-regulatory T cells"
"3181","37121553","Mettl14 sustains FOXP3 expression to promote the differentiation and functions of induced-regulatory T cells via the mTOR signaling pathway.","FOXP3 expression","promote","functions","Induced-regulatory T cells","FOXP3","STIMULATES","functions","Induced-regulatory T cells"
"3182","37121553","Mettl14 sustains FOXP3 expression to promote the differentiation and functions of induced-regulatory T cells via the mTOR signaling pathway.","FOXP3 expression","regulate","mTOR signaling pathway","Induced-regulatory T cells","FOXP3","AFFECTS","mTOR signaling pathway","Induced-regulatory T cells"
"3183","37121553","Mettl14 sustains FOXP3 expression to promote the differentiation and functions of induced-regulatory T cells via the mTOR signaling pathway.","mTOR signaling pathway","regulate","differentiation","Induced-regulatory T cells","mTOR signaling pathway","AFFECTS","cell differentiation","Induced-regulatory T cells"
"3184","37121553","Mettl14 sustains FOXP3 expression to promote the differentiation and functions of induced-regulatory T cells via the mTOR signaling pathway.","mTOR signaling pathway","regulate","functions","Induced-regulatory T cells","mTOR signaling pathway","AFFECTS","functions","Induced-regulatory T cells"
"3186","37122072","The increase of Nrf2 m6A modification induced by FTO downregulation promotes hippocampal neuron injury and aggravates the progression of epilepsy in a rat model.","dummy1","increase","m6A modification","Rat model","dummy","AUGMENTS","m6A","Rat model"
"3187","37122072","The increase of Nrf2 m6A modification induced by FTO downregulation promotes hippocampal neuron injury and aggravates the progression of epilepsy in a rat model.","Nrf2","is on","m6A modification","Rat model","NFE2L2","LOCATES","m6A","Rat model"
"3188","37122072","The increase of Nrf2 m6A modification induced by FTO downregulation promotes hippocampal neuron injury and aggravates the progression of epilepsy in a rat model.","m6A modification","promote","hippocampal neuron injury","Rat model","m6A","STIMULATES","hippocampal neuron injury","Rat model"
"3189","37122072","The increase of Nrf2 m6A modification induced by FTO downregulation promotes hippocampal neuron injury and aggravates the progression of epilepsy in a rat model.","dummy2","downregulate","FTO","Rat model","dummy","INHIBITS","FTO","Rat model"
"3190","37122072","The increase of Nrf2 m6A modification induced by FTO downregulation promotes hippocampal neuron injury and aggravates the progression of epilepsy in a rat model.","m6A modification","aggravate","progression","Rat model","m6A","COMPLICATES","progression","Rat model"
"3191","37122072","The increase of Nrf2 m6A modification induced by FTO downregulation promotes hippocampal neuron injury and aggravates the progression of epilepsy in a rat model.","progression","is in","epilepsy","Rat model","progression","LOCATES","Epilepsy","Rat model"
"3193","37129929","KRT17 promotes T-lymphocyte infiltration through the YTHDF2-CXCL10 axis in colorectal cancer.","KRT17","promote","T-lymphocyte infiltration","Colorectal Cancer","KRT17","STIMULATES","T-lymphocyte infiltration","COAD(Colon Adenocarcinoma)"
"3194","37129929","KRT17 promotes T-lymphocyte infiltration through the YTHDF2-CXCL10 axis in colorectal cancer.","KRT17","regulate","YTHDF2-CXCL10 axis","Colorectal Cancer","KRT17","AFFECTS","YTHDF2-CXCL10 axis","COAD(Colon Adenocarcinoma)"
"3195","37129929","KRT17 promotes T-lymphocyte infiltration through the YTHDF2-CXCL10 axis in colorectal cancer.","YTHDF2-CXCL10 axis","promote","T-lymphocyte infiltration","Colorectal Cancer","YTHDF2-CXCL10 axis","STIMULATES","T-lymphocyte infiltration","COAD(Colon Adenocarcinoma)"
"3197","37148414","m6A-dependent mevalonate kinase in juvenile hormone synthesis pathway regulates the diapause process of bivoltine silkworm (Bombyx mori).","m6A","regulate","mevalonate kinase","Bivoltine silkworm (Bombyx mori)","m6A","AFFECTS","MVK","Bivoltine silkworm (Bombyx mori)"
"3198","37148414","m6A-dependent mevalonate kinase in juvenile hormone synthesis pathway regulates the diapause process of bivoltine silkworm (Bombyx mori).","mevalonate kinase","in","juvenile hormone synthesis pathway","Bivoltine silkworm (Bombyx mori)","MVK","in","juvenile hormone synthesis pathway","Bivoltine silkworm (Bombyx mori)"
"3199","37148414","m6A-dependent mevalonate kinase in juvenile hormone synthesis pathway regulates the diapause process of bivoltine silkworm (Bombyx mori).","juvenile hormone synthesis pathway","regulate","diapause process","Bivoltine silkworm (Bombyx mori)","juvenile hormone synthesis pathway","AFFECTS","Diapause Process","Bivoltine silkworm (Bombyx mori)"
"3201","37149646","N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness.","N6-methyladenine","mediate","lncRNA SOX2OT-GLI1 loop","Non-small-cell lung cancer","m6A","AFFECTS","SOX2OT-GLI1 loop","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3202","37149646","N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness.","lncRNA SOX2OT-GLI1 loop","promote","stemness","Non-small-cell lung cancer","SOX2OT-GLI1 loop","STIMULATES","Stemness","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3204","37149664","m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1alpha positive feedback loop.","m6A methylation","regulate","glycolytic metabolism","Pancreatic Cancer","m6A","AFFECTS","Glycolytic metabolism","PAAD(Pancreatic Adenocarcinoma)"
"3205","37149664","m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1alpha positive feedback loop.","m6A methylation","regulate","ALKBH5-HDAC4-HIF1alpha positive feedback loop","Pancreatic Cancer","m6A","AFFECTS","ALKBH5-HDAC4-HIF1alpha positive feedback loop","PAAD(Pancreatic Adenocarcinoma)"
"3206","37149664","m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1alpha positive feedback loop.","ALKBH5-HDAC4-HIF1alpha positive feedback loop","regulate","glycolytic metabolism","Pancreatic Cancer","ALKBH5-HDAC4-HIF1alpha positive feedback loop","AFFECTS","Glycolytic metabolism","PAAD(Pancreatic Adenocarcinoma)"
"3208","37151889","Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m6A/ATG5 axis.","USP13","stabilize","METTL3/m6A/ATG5 axis","Osteosarcoma","USP13","MAINTAINS","METTL3/m6A/ATG5 axis","SARC(Sarcoma)"
"3209","37151889","Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m6A/ATG5 axis.","METTL3/m6A/ATG5 axis","regulate","Glycolytic Reprogramming","Osteosarcoma","METTL3/m6A/ATG5 axis","AFFECTS","Glycolytic Reprogramming","SARC(Sarcoma)"
"3210","37151889","Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m6A/ATG5 axis.","METTL3/m6A/ATG5 axis","regulate","Progression","Osteosarcoma","METTL3/m6A/ATG5 axis","AFFECTS","progression","SARC(Sarcoma)"
"3212","37156046","Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1alpha-METTL3-m6A/CDK2AP2 axis.","Cigarette smoking","accelerate","cell cycle","Non-small cell lung cancer","Cigarette Smoking","STIMULATES","cell cycle","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3213","37156046","Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1alpha-METTL3-m6A/CDK2AP2 axis.","cell cycle","promote","progression","Non-small cell lung cancer","cell cycle","STIMULATES","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3214","37156046","Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1alpha-METTL3-m6A/CDK2AP2 axis.","cell cycle","regulate","HIF-1alpha-METTL3-m6A/CDK2AP2 axis","Non-small cell lung cancer","cell cycle","AFFECTS","HIF-1alpha-METTL3-m6A/CDK2AP2 axis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3215","37156046","Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1alpha-METTL3-m6A/CDK2AP2 axis.","HIF-1alpha-METTL3-m6A/CDK2AP2 axis","regulate","progression","Non-small cell lung cancer","HIF-1alpha-METTL3-m6A/CDK2AP2 axis","AFFECTS","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3217","37156775","RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.","IGF2BP3","bind","m6A","Neuroblastoma cells","IGF2BP3","INTERACTS_WITH","m6A","Neuroblastoma"
"3218","37156775","RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.","IGF2BP3","interact","MYCN","Neuroblastoma cells","IGF2BP3","interact","MYCN","Neuroblastoma"
"3219","37156775","RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.","MYCN","facilitate","cell proliferation","Neuroblastoma cells","MYCN","AUGMENTS","cell population proliferation","Neuroblastoma"
"3221","37168328","METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m6A modifications and splicing factors.","METTL3","regulate","alternative splicing","Null","METTL3","AFFECTS","Alternative Splicing","Null"
"3222","37168328","METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m6A modifications and splicing factors.","METTL3","regulate","m6A modifications","Null","METTL3","AFFECTS","m6A","Null"
"3223","37168328","METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m6A modifications and splicing factors.","m6A modifications","interact","splicing factors","Null","m6A","interact","RNA Splicing Factors","Null"
"3224","37168328","METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m6A modifications and splicing factors.","splicing factors","regulate","alternative splicing","Null","RNA Splicing Factors","AFFECTS","Alternative Splicing","Null"
"3226","37169182","ALKBH5 Drives Immune Suppression via targeting AXIN2 to Promote Colorectal Cancer and is a Target for Boosting Immunotherapy.","ALKBH5","drive","Immune Suppression","Colorectal Cancer","ALKBH5","STIMULATES","Immune Suppression","COAD(Colon Adenocarcinoma)"
"3227","37169182","ALKBH5 Drives Immune Suppression via targeting AXIN2 to Promote Colorectal Cancer and is a Target for Boosting Immunotherapy.","ALKBH5","target","AXIN2","Colorectal Cancer","ALKBH5","INTERACTS_WITH","AXIN2","COAD(Colon Adenocarcinoma)"
"3228","37169182","ALKBH5 Drives Immune Suppression via targeting AXIN2 to Promote Colorectal Cancer and is a Target for Boosting Immunotherapy.","Immunotherapy","target","ALKBH5","Colorectal Cancer","Immunotherapy","INTERACTS_WITH","ALKBH5","COAD(Colon Adenocarcinoma)"
"3229","37169182","ALKBH5 Drives Immune Suppression via targeting AXIN2 to Promote Colorectal Cancer and is a Target for Boosting Immunotherapy.","AXIN2","regulate","Immune Suppression","Colorectal Cancer","AXIN2","AFFECTS","Immune Suppression","COAD(Colon Adenocarcinoma)"
"3231","37169236","linc01515 regulates PM2.5-induced oxidative stress via targeting NRF2 in airway epithelial cells.","linc01515","target","NRF2","Airway Epithelial Cells","LINC01515","INTERACTS_WITH","NFE2L2","Airway Epithelial Cells"
"3232","37169236","linc01515 regulates PM2.5-induced oxidative stress via targeting NRF2 in airway epithelial cells.","NRF2","regulate","PM2.5-induced oxidative stress","Airway Epithelial Cells","NFE2L2","AFFECTS","PM2.5-induced oxidative stress","Airway Epithelial Cells"
"3234","37170591","GPX8 deficiency-induced oxidative stress reprogrammed m6A epitranscriptome of oral cancer cells.","GPX8 deficiency","induce","Oxidative Stress","Oral Cancer Cells","GPX8 deficiency","CAUSES","Oxidative Stress","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3235","37170591","GPX8 deficiency-induced oxidative stress reprogrammed m6A epitranscriptome of oral cancer cells.","Oxidative Stress","reprogram","m6A epitranscriptome","Oral Cancer Cells","Oxidative Stress","CONVERTS_TO","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3237","37171272","Kupffer cell pyroptosis mediated by METTL3 contributes to the progression of alcoholic steatohepatitis.","METTL3","mediate","Kupffer cell pyroptosis","Alcoholic Steatohepatitis","METTL3","AFFECTS","Kupffer cell pyroptosis","Alcoholic Steatohepatitis"
"3238","37171272","Kupffer cell pyroptosis mediated by METTL3 contributes to the progression of alcoholic steatohepatitis.","Kupffer cell pyroptosis","contribute","progression of alcoholic steatohepatitis","Alcoholic Steatohepatitis","Kupffer cell pyroptosis","AFFECTS","progression of alcoholic steatohepatitis","Alcoholic Steatohepatitis"
"3240","37178367","METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.","METTL3","suppress","Pancreatic Ductal Adenocarcinoma Progression","Pancreatic Ductal Adenocarcinoma","METTL3","INHIBITS","Pancreatic Ductal Adenocarcinoma Progression","PAAD(Pancreatic Adenocarcinoma)"
"3241","37178367","METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.","METTL3","activate","dsRNA","Pancreatic Ductal Adenocarcinoma","METTL3","STIMULATES","double-stranded RNA","PAAD(Pancreatic Adenocarcinoma)"
"3242","37178367","METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.","dsRNA","induce","Anti-tumor Immunity","Pancreatic Ductal Adenocarcinoma","double-stranded RNA","CAUSES","anti-tumor immunity","PAAD(Pancreatic Adenocarcinoma)"
"3243","37178367","METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.","Anti-tumor Immunity","suppress","Pancreatic Ductal Adenocarcinoma Progression","Pancreatic Ductal Adenocarcinoma","anti-tumor immunity","INHIBITS","Pancreatic Ductal Adenocarcinoma Progression","PAAD(Pancreatic Adenocarcinoma)"
"3245","37179374","Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome.","Short-chain fatty acid-butyric acid","ameliorate","Granulosa cells inflammation","Polycystic Ovarian Syndrome","Short-chain fatty acid-butyric acid","TREATS","Granulosa cells inflammation","Polycystic Ovary Syndrome"
"3246","37179374","Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome.","Short-chain fatty acid-butyric acid","regulate","METTL3","Polycystic Ovarian Syndrome","Short-chain fatty acid-butyric acid","AFFECTS","METTL3","Polycystic Ovary Syndrome"
"3247","37179374","Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome.","METTL3","mediate","N6-methyladenosine","Polycystic Ovarian Syndrome","METTL3","AFFECTS","m6A","Polycystic Ovary Syndrome"
"3248","37179374","Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome.","N6-methyladenosine","modify","FOSL2","Polycystic Ovarian Syndrome","m6A","AFFECTS","FOSL2","Polycystic Ovary Syndrome"
"3250","37180836","Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression.","rs8400","enhance","ALKBH5","Neuroblastoma","rs8400","AUGMENTS","ALKBH5","Neuroblastoma"
"3251","37180836","Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression.","rs8400","disrupt","miR-186","Neuroblastoma","rs8400","DISRUPTS","MIR186","Neuroblastoma"
"3252","37180836","Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression.","ALKBH5","promote","Neuroblastoma Progression","Neuroblastoma","ALKBH5","STIMULATES","Neuroblastoma Progression","Neuroblastoma"
"3254","37182151","The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.","METTL16","inhibit","Proliferation","Pancreatic Adenocarcinoma Cancer Cells","METTL16","INHIBITS","cell population proliferation","PAAD(Pancreatic Adenocarcinoma)"
"3255","37182151","The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.","METTL16","regulate","p21 signaling pathway","Pancreatic Adenocarcinoma Cancer Cells","METTL16","AFFECTS","p21 signaling pathway","PAAD(Pancreatic Adenocarcinoma)"
"3256","37182151","The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.","p21 signaling pathway","inhibit","Proliferation","Pancreatic Adenocarcinoma Cancer Cells","p21 signaling pathway","INHIBITS","cell population proliferation","PAAD(Pancreatic Adenocarcinoma)"
"3258","37188676","IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification.","IGF2BP3","promote","Myocardial Regeneration","Adult Myocardium","IGF2BP3","STIMULATES","Myocardial Regeneration","Adult Myocardium"
"3259","37188676","IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification.","IGF2BP3","stabilize","MMP3 mRNA","Adult Myocardium","IGF2BP3","MAINTAINS","MMP3","Adult Myocardium"
"3260","37188676","IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification.","IGF2BP3","interact","m6A","Adult Myocardium","IGF2BP3","interact","m6A","Adult Myocardium"
"3261","37188676","IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification.","MMP3 mRNA","regulate","Myocardial Regeneration","Adult Myocardium","MMP3","AFFECTS","Myocardial Regeneration","Adult Myocardium"
"3263","37189342","Endogenous Glycoprotein GPM6a Is Involved in Neurite Outgrowth in Rat Dorsal Root Ganglion Neurons.","GPM6a","involved in","Neurite Outgrowth","Rat Dorsal Root Ganglion Neurons","GPM6A","involved in","Neuronal Outgrowth","Rat Dorsal Root Ganglion Neurons"
"3265","37191290","HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.","HPV E6","promote","Cell Proliferation","Cervical Cancer Cells","HPV E6","STIMULATES","cell population proliferation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3266","37191290","HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.","HPV E6","accelerate","RBM15","Cervical Cancer Cells","HPV E6","STIMULATES","RBM15","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3267","37191290","HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.","Autophagy","cause","Inhibition","Cervical Cancer Cells","autophagy","CAUSES","inhibition","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3268","37191290","HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.","RBM15","promote","Cell Proliferation","Cervical Cancer Cells","RBM15","STIMULATES","cell population proliferation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3270","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","FTO","promote","Proliferation","Cervical Cancer Cells","FTO","STIMULATES","cell population proliferation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3271","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","FTO","promote","Colony Formation","Cervical Cancer Cells","FTO","STIMULATES","Colony Formation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3272","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","FTO","promote","Migration","Cervical Cancer Cells","FTO","STIMULATES","migration","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3273","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","FTO","promote","Invasion","Cervical Cancer Cells","FTO","STIMULATES","Neoplasm Invasiveness","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3274","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","FTO","regulate","BMP4/Hippo/YAP1/TAZ pathway","Cervical Cancer Cells","FTO","AFFECTS","BMP4/Hippo/YAP1/TAZ pathway","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3275","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","BMP4/Hippo/YAP1/TAZ pathway","regulate","Proliferation","Cervical Cancer Cells","BMP4/Hippo/YAP1/TAZ pathway","AFFECTS","cell population proliferation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3276","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","BMP4/Hippo/YAP1/TAZ pathway","regulate","Colony Formation","Cervical Cancer Cells","BMP4/Hippo/YAP1/TAZ pathway","AFFECTS","Colony Formation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3277","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","BMP4/Hippo/YAP1/TAZ pathway","regulate","Migration","Cervical Cancer Cells","BMP4/Hippo/YAP1/TAZ pathway","AFFECTS","migration","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3278","37030332","FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.","BMP4/Hippo/YAP1/TAZ pathway","regulate","Invasion","Cervical Cancer Cells","BMP4/Hippo/YAP1/TAZ pathway","AFFECTS","Neoplasm Invasiveness","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3280","37030526","Donor graft METTL3 gene transfer ameliorates rat liver transplantation ischemia-reperfusion injury by enhancing HO-1 expression in an m6A-dependent manner.","METTL3","transfer","Donor Graft","Rat Liver Transplantation","METTL3","transfer","Donor Graft","Rat Liver Transplantation"
"3281","37030526","Donor graft METTL3 gene transfer ameliorates rat liver transplantation ischemia-reperfusion injury by enhancing HO-1 expression in an m6A-dependent manner.","Donor Graft","ameliorate","Ischemia-Reperfusion Injury","Rat Liver Transplantation","Donor Graft","TREATS","Reperfusion Injury","Rat Liver Transplantation"
"3282","37030526","Donor graft METTL3 gene transfer ameliorates rat liver transplantation ischemia-reperfusion injury by enhancing HO-1 expression in an m6A-dependent manner.","Donor Graft","enhance","HO-1","Rat Liver Transplantation","Donor Graft","AUGMENTS","HMOX1","Rat Liver Transplantation"
"3283","37030526","Donor graft METTL3 gene transfer ameliorates rat liver transplantation ischemia-reperfusion injury by enhancing HO-1 expression in an m6A-dependent manner.","Donor Graft","regulate","m6A","Rat Liver Transplantation","Donor Graft","AFFECTS","m6A","Rat Liver Transplantation"
"3284","37030526","Donor graft METTL3 gene transfer ameliorates rat liver transplantation ischemia-reperfusion injury by enhancing HO-1 expression in an m6A-dependent manner.","m6A","regulate","HO-1","Rat Liver Transplantation","m6A","AFFECTS","HMOX1","Rat Liver Transplantation"
"3286","37036576","RUNX1-IT1 favors breast cancer carcinogenesis through regulation of IGF2BP1/GPX4 axis.","RUNX1-IT1","regulate","IGF2BP1/GPX4 axis","Breast Cancer","RUNX1-IT1","AFFECTS","IGF2BP1/GPX4 axis","BRCA(Breast Invasive Carcinoma)"
"3287","37036576","RUNX1-IT1 favors breast cancer carcinogenesis through regulation of IGF2BP1/GPX4 axis.","IGF2BP1/GPX4 axis","promote","carcinogenesis","Breast Cancer","IGF2BP1/GPX4 axis","STIMULATES","Carcinogenesis","BRCA(Breast Invasive Carcinoma)"
"3289","37037089","LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification.","DGUOK-AS1","facilitate","Cancer Growth","Non-small cell lung cancer","DGUOK-AS1","AUGMENTS","Cancer Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3290","37037089","LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification.","DGUOK-AS1","facilitate","Metastasis","Non-small cell lung cancer","DGUOK-AS1","AUGMENTS","Neoplasm Metastasis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3291","37037089","LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification.","DGUOK-AS1","increase stability","TRPM7","Non-small cell lung cancer","DGUOK-AS1","increase stability","TRPM7","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3293","37037853","Vascular mimicry induced by m6A mediated IGFL2-AS1/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma.","m6A","mediate","IGFL2-AS1/AR axis","Clear Cell Renal Cell Carcinoma","m6A","AFFECTS","IGFL2-AS1/AR axis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3294","37037853","Vascular mimicry induced by m6A mediated IGFL2-AS1/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma.","IGFL2-AS1/AR axis","induce","Vascular Mimicry","Clear Cell Renal Cell Carcinoma","IGFL2-AS1/AR axis","CAUSES","Vascular Mimicry","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3295","37037853","Vascular mimicry induced by m6A mediated IGFL2-AS1/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma.","Vascular Mimicry","contribute","Pazopanib Resistance","Clear Cell Renal Cell Carcinoma","Vascular Mimicry","AFFECTS","Pazopanib Resistance","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3297","37039556","NR3C1/Glucocorticoid receptor activation promotes pancreatic beta-cell autophagy overload in response to glucolipotoxicity.","NR3C1/Glucocorticoid receptor","activate","Activation","Pancreatic Beta-Cell","NR3C1/Glucocorticoid receptor","STIMULATES","activation","Insulin-Secreting Cells"
"3298","37039556","NR3C1/Glucocorticoid receptor activation promotes pancreatic beta-cell autophagy overload in response to glucolipotoxicity.","Activation","promote","Autophagy Overload","Pancreatic Beta-Cell","activation","STIMULATES","Autophagy Overload","Insulin-Secreting Cells"
"3299","37039556","NR3C1/Glucocorticoid receptor activation promotes pancreatic beta-cell autophagy overload in response to glucolipotoxicity.","Glucolipotoxicity","induce","Activation","Pancreatic Beta-Cell","Glucolipotoxicity","CAUSES","activation","Insulin-Secreting Cells"
"3300","37039556","NR3C1/Glucocorticoid receptor activation promotes pancreatic beta-cell autophagy overload in response to glucolipotoxicity.","Glucolipotoxicity","induce","Autophagy Overload","Pancreatic Beta-Cell","Glucolipotoxicity","CAUSES","Autophagy Overload","Insulin-Secreting Cells"
"3302","37041485","METTL3 enhances dentinogenesis differentiation of dental pulp stem cells via increasing GDF6 and STC1 mRNA stability.","METTL3","enhance","Dentinogenesis Differentiation","Dental Pulp Stem Cells","METTL3","AUGMENTS","Dentinogenesis Differentiation","Dental Pulp Stem Cells"
"3303","37041485","METTL3 enhances dentinogenesis differentiation of dental pulp stem cells via increasing GDF6 and STC1 mRNA stability.","METTL3","increase stability","GDF6","Dental Pulp Stem Cells","METTL3","increase stability","GDF6","Dental Pulp Stem Cells"
"3304","37041485","METTL3 enhances dentinogenesis differentiation of dental pulp stem cells via increasing GDF6 and STC1 mRNA stability.","METTL3","increase stability","STC1","Dental Pulp Stem Cells","METTL3","increase stability","STC1","Dental Pulp Stem Cells"
"3305","37041485","METTL3 enhances dentinogenesis differentiation of dental pulp stem cells via increasing GDF6 and STC1 mRNA stability.","GDF6","regulate","Dentinogenesis Differentiation","Dental Pulp Stem Cells","GDF6","AFFECTS","Dentinogenesis Differentiation","Dental Pulp Stem Cells"
"3306","37041485","METTL3 enhances dentinogenesis differentiation of dental pulp stem cells via increasing GDF6 and STC1 mRNA stability.","STC1","regulate","Dentinogenesis Differentiation","Dental Pulp Stem Cells","STC1","AFFECTS","Dentinogenesis Differentiation","Dental Pulp Stem Cells"
"3308","37048078","Targeted Demethylation of the TGFbeta1 mRNA Promotes Myoblast Proliferation via Activating the SMAD2 Signaling Pathway.","dummy","demethylate","TGFbeta1 mRNA","Null","dummy","CONVERTS_TO","TGFbeta1","Null"
"3309","37048078","Targeted Demethylation of the TGFbeta1 mRNA Promotes Myoblast Proliferation via Activating the SMAD2 Signaling Pathway.","TGFbeta1 mRNA","activate","SMAD2","Null","TGFbeta1","STIMULATES","SMAD2","Null"
"3310","37048078","Targeted Demethylation of the TGFbeta1 mRNA Promotes Myoblast Proliferation via Activating the SMAD2 Signaling Pathway.","SMAD2","is in","Signaling Pathway","Null","SMAD2","LOCATES","signal transduction","Null"
"3311","37048078","Targeted Demethylation of the TGFbeta1 mRNA Promotes Myoblast Proliferation via Activating the SMAD2 Signaling Pathway.","Signaling Pathway","promote","Myoblast Proliferation","Null","signal transduction","STIMULATES","myoblast proliferation","Null"
"3313","37050878","FLK Is an mRNA m6A Reader that Regulates Floral Transition by Modulating the Stability and Splicing of FLC in Arabidopsis.","FLK","bind","m6A","Arabidopsis","FLK","INTERACTS_WITH","m6A","Arabidopsis"
"3314","37050878","FLK Is an mRNA m6A Reader that Regulates Floral Transition by Modulating the Stability and Splicing of FLC in Arabidopsis.","FLK","regulate","Floral Transition","Arabidopsis","FLK","AFFECTS","floral transition","Arabidopsis"
"3315","37050878","FLK Is an mRNA m6A Reader that Regulates Floral Transition by Modulating the Stability and Splicing of FLC in Arabidopsis.","FLK","modulate","FLC","Arabidopsis","FLK","AFFECTS","Fibrolamellar Carcinoma","Arabidopsis"
"3316","37050878","FLK Is an mRNA m6A Reader that Regulates Floral Transition by Modulating the Stability and Splicing of FLC in Arabidopsis.","FLC","regulate","Floral Transition","Arabidopsis","Fibrolamellar Carcinoma","AFFECTS","floral transition","Arabidopsis"
"3318","37053288","N6-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication.","YTHDC1","regulate","NS segment","Influenza A virus","YTHDC1","AFFECTS","NS segment","Influenza A virus"
"3319","37053288","N6-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication.","YTHDC1","regulate","splicing","Influenza A virus","YTHDC1","AFFECTS","splicing","Influenza A virus"
"3320","37053288","N6-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication.","YTHDC1","regulate","replication","Influenza A virus","YTHDC1","AFFECTS","replication","Influenza A virus"
"3322","37054644","Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m6A-YTHDF2-dependent manner.","Cobalt","induce","FTO","Neurons","Cobalt","CAUSES","FTO","Neurons"
"3323","37054644","Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m6A-YTHDF2-dependent manner.","FTO","trigger","Autophagy Impairment","Neurons","FTO","CAUSES","Autophagy Impairment","Neurons"
"3324","37054644","Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m6A-YTHDF2-dependent manner.","FTO","target","TSC1","Neurons","FTO","INTERACTS_WITH","TSC1","Neurons"
"3325","37054644","Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Neurons","YTHDF2","INTERACTS_WITH","m6A","Neurons"
"3326","37054644","Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m6A-YTHDF2-dependent manner.","TSC1","regulate","Autophagy Impairment","Neurons","TSC1","AFFECTS","Autophagy Impairment","Neurons"
"3328","37056835","Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.","dummy","induce depletion of","FTO","Clear Cell Renal Cell Carcinoma","dummy","induce depletion of","FTO","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3329","37056835","Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.","dummy","induce depletion of","ALKBH5","Clear Cell Renal Cell Carcinoma","dummy","induce depletion of","ALKBH5","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3330","37056835","Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.","FTO","impair","growth and metastatic capacity","Clear Cell Renal Cell Carcinoma","FTO","INHIBITS","growth and metastatic capacity","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3331","37056835","Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.","ALKBH5","impair","growth and metastatic capacity","Clear Cell Renal Cell Carcinoma","ALKBH5","INHIBITS","growth and metastatic capacity","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3332","37056835","Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.","growth and metastatic capacity","through","EMT phenotype change","Clear Cell Renal Cell Carcinoma","growth and metastatic capacity","through","EMT phenotype change","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3334","37056926","M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.","m6A","modify","circRBM33","Prostate Cancer","m6A","AFFECTS","circRBM33","PRAD(Prostate Adenocarcinoma)"
"3335","37056926","M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.","circRBM33","promote","Prostate Cancer Progression","Prostate Cancer","circRBM33","STIMULATES","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"3336","37056926","M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.","circRBM33","regulate","PDHA1","Prostate Cancer","circRBM33","AFFECTS","PDHA1","PRAD(Prostate Adenocarcinoma)"
"3337","37056926","M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.","PDHA1","regulate","Mitochondrial Respiration Regulation","Prostate Cancer","PDHA1","AFFECTS","Mitochondrial Respiration Regulation","PRAD(Prostate Adenocarcinoma)"
"3338","37056926","M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.","circRBM33","target","ARSI therapy","Prostate Cancer","circRBM33","INTERACTS_WITH","ARSI therapy","PRAD(Prostate Adenocarcinoma)"
"3339","37056926","M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.","Mitochondrial Respiration Regulation","regulate","Prostate Cancer Progression","Prostate Cancer","Mitochondrial Respiration Regulation","AFFECTS","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"3341","37056932","IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation.","IGF2BP3","regulate","TMA7","Laryngeal Cancer","IGF2BP3","AFFECTS","TMA7","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3342","37056932","IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation.","IGF2BP3","regulate","m6A RNA Methylation","Laryngeal Cancer","IGF2BP3","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3343","37056932","IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation.","m6A RNA Methylation","regulate","TMA7","Laryngeal Cancer","m6A","AFFECTS","TMA7","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3344","37056932","IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation.","TMA7","mediate","Autophagy","Laryngeal Cancer","TMA7","AFFECTS","autophagy","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3345","37056932","IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation.","TMA7","mediate","Cisplatin Resistance","Laryngeal Cancer","TMA7","AFFECTS","Cisplatin Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3346","37056932","IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation.","Autophagy","regulate","Cisplatin Resistance","Laryngeal Cancer","autophagy","AFFECTS","Cisplatin Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3348","37056933","Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification.","Cancer-associated fibroblasts","promote","migration","Non-small cell lung cancer cells","Cancer-Associated Fibroblasts","STIMULATES","migration","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3349","37056933","Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification.","Cancer-associated fibroblasts","promote","invasion","Non-small cell lung cancer cells","Cancer-Associated Fibroblasts","STIMULATES","Neoplasm Invasiveness","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3350","37056933","Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification.","METTL3","mediate","RAC3","Non-small cell lung cancer cells","METTL3","AFFECTS","RAC3","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3351","37056933","Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification.","RAC3","is on","m6A","Non-small cell lung cancer cells","RAC3","LOCATES","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3352","37056933","Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification.","m6A","regulate","migration","Non-small cell lung cancer cells","m6A","AFFECTS","migration","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3353","37056933","Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification.","m6A","regulate","invasion","Non-small cell lung cancer cells","m6A","AFFECTS","Neoplasm Invasiveness","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3355","37060505","IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia.","IGF2BP2","promote","lncRNA DANCR","FLT3-ITD + acute myeloid leukemia","IGF2BP2","STIMULATES","DANCR","LAML(Acute Myeloid Leukemia)"
"3356","37060505","IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia.","lncRNA DANCR","stabilize","Stability","FLT3-ITD + acute myeloid leukemia","DANCR","MAINTAINS","stability","LAML(Acute Myeloid Leukemia)"
"3357","37060505","IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia.","Stability","mediate","Glycolysis","FLT3-ITD + acute myeloid leukemia","stability","AFFECTS","glycolytic process","LAML(Acute Myeloid Leukemia)"
"3358","37060505","IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia.","Glycolysis","affect","Progression","FLT3-ITD + acute myeloid leukemia","glycolytic process","AFFECTS","progression","LAML(Acute Myeloid Leukemia)"
"3360","37060562","YTHDF1 phase separation triggers the fate transition of spermatogonial stem cells by activating the IkappaB-NF-kappaB-CCND1 axis.","YTHDF1","induce phase separation","dummy","Spermatogonial Stem Cells","YTHDF1","induce phase separation","dummy","Spermatogonial Stem Cells"
"3361","37060562","YTHDF1 phase separation triggers the fate transition of spermatogonial stem cells by activating the IkappaB-NF-kappaB-CCND1 axis.","dummy","trigger","fate transition","Spermatogonial Stem Cells","dummy","CAUSES","fate transition","Spermatogonial Stem Cells"
"3362","37060562","YTHDF1 phase separation triggers the fate transition of spermatogonial stem cells by activating the IkappaB-NF-kappaB-CCND1 axis.","dummy","activate","IkappaB-NF-kappaB-CCND1 axis","Spermatogonial Stem Cells","dummy","STIMULATES","IkappaB-NF-kappaB-CCND1 axis","Spermatogonial Stem Cells"
"3363","37060562","YTHDF1 phase separation triggers the fate transition of spermatogonial stem cells by activating the IkappaB-NF-kappaB-CCND1 axis.","IkappaB-NF-kappaB-CCND1 axis","regulate","fate transition","Spermatogonial Stem Cells","IkappaB-NF-kappaB-CCND1 axis","AFFECTS","fate transition","Spermatogonial Stem Cells"
"3365","37061119","m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition.","m6A","modify","cyclin D1","Glioblastoma","m6A","AFFECTS","CCND1","GBM(Glioblastoma Multiforme)"
"3366","37061119","m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition.","m6A","modify","c-myc IRESs","Glioblastoma","m6A","AFFECTS","c-myc IRESs","GBM(Glioblastoma Multiforme)"
"3367","37061119","m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition.","cyclin D1","control","ITAF activity","Glioblastoma","CCND1","AFFECTS","ITAF activity","GBM(Glioblastoma Multiforme)"
"3368","37061119","m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition.","cyclin D1","control","mTOR inhibition","Glioblastoma","CCND1","AFFECTS","mTOR inhibition","GBM(Glioblastoma Multiforme)"
"3369","37061119","m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition.","c-myc IRESs","control","ITAF activity","Glioblastoma","c-myc IRESs","AFFECTS","ITAF activity","GBM(Glioblastoma Multiforme)"
"3370","37061119","m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition.","c-myc IRESs","control","mTOR inhibition","Glioblastoma","c-myc IRESs","AFFECTS","mTOR inhibition","GBM(Glioblastoma Multiforme)"
"3372","37061993","Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer.","IGF2BP3","drive","Metabolic Reprogramming","Non-small cell lung cancer","IGF2BP3","STIMULATES","Metabolic Reprogramming","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3373","37061993","Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer.","Metabolic Reprogramming","promote","Acquired Resistance","Non-small cell lung cancer","Metabolic Reprogramming","STIMULATES","acquired resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3374","37061993","Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer.","Acquired Resistance","is on","EGFR inhibitors","Non-small cell lung cancer","acquired resistance","LOCATES","EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3376","37063837","LRPPRC facilitates tumor progression and immune evasion through upregulation of m6A modification of PD-L1 mRNA in hepatocellular carcinoma.","LRPPRC","facilitate","Tumor Progression","Hepatocellular Carcinoma","LRPPRC","AUGMENTS","Tumor Progression","LIHC(Liver Hepatocellular Carcinoma)"
"3377","37063837","LRPPRC facilitates tumor progression and immune evasion through upregulation of m6A modification of PD-L1 mRNA in hepatocellular carcinoma.","LRPPRC","upregulate","m6A","Hepatocellular Carcinoma","LRPPRC","STIMULATES","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"3378","37063837","LRPPRC facilitates tumor progression and immune evasion through upregulation of m6A modification of PD-L1 mRNA in hepatocellular carcinoma.","m6A","is on","PD-L1 mRNA","Hepatocellular Carcinoma","m6A","LOCATES","PD-L1","LIHC(Liver Hepatocellular Carcinoma)"
"3379","37063837","LRPPRC facilitates tumor progression and immune evasion through upregulation of m6A modification of PD-L1 mRNA in hepatocellular carcinoma.","PD-L1 mRNA","facilitate","Tumor Progression","Hepatocellular Carcinoma","PD-L1","AUGMENTS","Tumor Progression","LIHC(Liver Hepatocellular Carcinoma)"
"3380","37063837","LRPPRC facilitates tumor progression and immune evasion through upregulation of m6A modification of PD-L1 mRNA in hepatocellular carcinoma.","PD-L1 mRNA","facilitate","Immune Evasion","Hepatocellular Carcinoma","PD-L1","AUGMENTS","Immune Evasion","LIHC(Liver Hepatocellular Carcinoma)"
"3382","37065597","YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer.","YTHDC2","mediate","m6A","Non-small cell lung cancer","YTHDC2","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3383","37065597","YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer.","m6A","modify","Id3","Non-small cell lung cancer","m6A","AFFECTS","ID3","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3384","37065597","YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer.","Id3","suppress","cisplatin resistance","Non-small cell lung cancer","ID3","INHIBITS","Cisplatin Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3386","37072102","The deficiency of N6-methyladenosine demethylase ALKBH5 enhances the neurodegenerative damage induced by cobalt.","ALKBH5","enhance","neurodegenerative damage","Neurodegenerative Damage","ALKBH5","AUGMENTS","neurodegenerative damage","Neurodegenerative Damage"
"3387","37072102","The deficiency of N6-methyladenosine demethylase ALKBH5 enhances the neurodegenerative damage induced by cobalt.","cobalt","induce","neurodegenerative damage","Neurodegenerative Damage","Cobalt","CAUSES","neurodegenerative damage","Neurodegenerative Damage"
"3389","37074506","FTO overexpression expedites wound healing and alleviates depression in burn rats through facilitating keratinocyte migration and angiogenesis via mediating TFPI-2 demethylation.","FTO","expedite","Wound Healing","Burn Rats","FTO","expedite","wound healing","Burn Rats"
"3390","37074506","FTO overexpression expedites wound healing and alleviates depression in burn rats through facilitating keratinocyte migration and angiogenesis via mediating TFPI-2 demethylation.","FTO","alleviate","Depression","Burn Rats","FTO","INHIBITS","Depression","Burn Rats"
"3391","37074506","FTO overexpression expedites wound healing and alleviates depression in burn rats through facilitating keratinocyte migration and angiogenesis via mediating TFPI-2 demethylation.","FTO","facilitate","Keratinocyte Migration","Burn Rats","FTO","AUGMENTS","keratinocyte migration","Burn Rats"
"3392","37074506","FTO overexpression expedites wound healing and alleviates depression in burn rats through facilitating keratinocyte migration and angiogenesis via mediating TFPI-2 demethylation.","FTO","facilitate","Angiogenesis","Burn Rats","FTO","AUGMENTS","angiogenesis","Burn Rats"
"3393","37074506","FTO overexpression expedites wound healing and alleviates depression in burn rats through facilitating keratinocyte migration and angiogenesis via mediating TFPI-2 demethylation.","FTO","mediate","TFPI-2","Burn Rats","FTO","AFFECTS","TFPI2","Burn Rats"
"3394","37074506","FTO overexpression expedites wound healing and alleviates depression in burn rats through facilitating keratinocyte migration and angiogenesis via mediating TFPI-2 demethylation.","TFPI-2","regulate","Keratinocyte Migration","Burn Rats","TFPI2","AFFECTS","keratinocyte migration","Burn Rats"
"3395","37074506","FTO overexpression expedites wound healing and alleviates depression in burn rats through facilitating keratinocyte migration and angiogenesis via mediating TFPI-2 demethylation.","TFPI-2","regulate","Angiogenesis","Burn Rats","TFPI2","AFFECTS","angiogenesis","Burn Rats"
"3397","37076497","LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1alpha/NF-kappaB axis in psoriasis.","UCA1","promote","Keratinocyte-driven inflammation","Psoriasis","UCA1","STIMULATES","Keratinocyte-driven inflammation","Psoriasis"
"3398","37076497","LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1alpha/NF-kappaB axis in psoriasis.","UCA1","suppress","METTL14","Psoriasis","UCA1","INHIBITS","METTL14","Psoriasis"
"3399","37076497","LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1alpha/NF-kappaB axis in psoriasis.","UCA1","activate","HIF-1alpha/NF-kappaB axis","Psoriasis","UCA1","STIMULATES","HIF-1alpha/NF-kappaB axis","Psoriasis"
"3400","37076497","LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1alpha/NF-kappaB axis in psoriasis.","METTL14","regulate","Keratinocyte-driven inflammation","Psoriasis","METTL14","AFFECTS","Keratinocyte-driven inflammation","Psoriasis"
"3401","37076497","LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1alpha/NF-kappaB axis in psoriasis.","HIF-1alpha/NF-kappaB axis","regulate","Keratinocyte-driven inflammation","Psoriasis","HIF-1alpha/NF-kappaB axis","AFFECTS","Keratinocyte-driven inflammation","Psoriasis"
"3403","37076815","KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.","KIAA1429","modify","m6A","Diffuse Large B-cell Lymphoma","VIRMA","AFFECTS","m6A","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3404","37076815","KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.","m6A","is on","CHST11","Diffuse Large B-cell Lymphoma","m6A","LOCATES","CHST11","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3405","37076815","KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.","CHST11","promote","Progression","Diffuse Large B-cell Lymphoma","CHST11","STIMULATES","progression","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3406","37076815","KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.","CHST11","regulate","Hippo-YAP pathway","Diffuse Large B-cell Lymphoma","CHST11","AFFECTS","Hippo-YAP pathway","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3407","37076815","KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.","Hippo-YAP pathway","regulate","Progression","Diffuse Large B-cell Lymphoma","Hippo-YAP pathway","AFFECTS","progression","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3409","37080415","FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.","FTO","stabilize","miR-139-5p","Prostate Cancer Cells","FTO","MAINTAINS","miR-139-5p","PRAD(Prostate Adenocarcinoma)"
"3410","37080415","FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.","miR-139-5p","target","ZNF217","Prostate Cancer Cells","miR-139-5p","INTERACTS_WITH","ZNF217","PRAD(Prostate Adenocarcinoma)"
"3411","37080415","FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.","miR-139-5p","inactivate","PI3K/Akt/mTOR signal pathway","Prostate Cancer Cells","miR-139-5p","inactivate","PI3K/AKT/mTOR pathway","PRAD(Prostate Adenocarcinoma)"
"3412","37080415","FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.","PI3K/Akt/mTOR signal pathway","lead to","Inactivation","Prostate Cancer Cells","PI3K/AKT/mTOR pathway","CAUSES","inactivation","PRAD(Prostate Adenocarcinoma)"
"3413","37080415","FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.","Inactivation","suppress","Prostate Cancer Cell Malignancies","Prostate Cancer Cells","inactivation","INHIBITS","Prostate Cancer Cell Malignancies","PRAD(Prostate Adenocarcinoma)"
"3415","37085864","METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.","METTL3","facilitate","Immunosurveillance","Endometrial Cancer","METTL3","AUGMENTS","Monitoring, Immunologic","Dientamoebiasis"
"3416","37085864","METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.","METTL3","inhibit","YTHDF2","Endometrial Cancer","METTL3","INHIBITS","YTHDF2","Dientamoebiasis"
"3417","37085864","METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.","YTHDF2","mediate degradation of","NLRC5 mRNA","Endometrial Cancer","YTHDF2","mediate degradation of","NLRC5","Dientamoebiasis"
"3418","37085864","METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.","NLRC5 mRNA","regulate","Immunosurveillance","Endometrial Cancer","NLRC5","AFFECTS","Monitoring, Immunologic","Dientamoebiasis"
"3420","37086786","O-GlcNAcylation promotes the cytosolic localization of the m6A reader YTHDF1 and colorectal cancer tumorigenesis.","O-GlcNAcylation","promote","cytosolic localization","Colorectal Cancer","o-glcnacylation","STIMULATES","cytosolic localization","COAD(Colon Adenocarcinoma)"
"3421","37086786","O-GlcNAcylation promotes the cytosolic localization of the m6A reader YTHDF1 and colorectal cancer tumorigenesis.","cytosolic localization","is of","YTHDF1","Colorectal Cancer","cytosolic localization","is of","YTHDF1","COAD(Colon Adenocarcinoma)"
"3422","37086786","O-GlcNAcylation promotes the cytosolic localization of the m6A reader YTHDF1 and colorectal cancer tumorigenesis.","cytosolic localization","promote","colorectal cancer tumorigenesis","Colorectal Cancer","cytosolic localization","STIMULATES","colorectal cancer tumorigenesis","COAD(Colon Adenocarcinoma)"
"3423","37086786","O-GlcNAcylation promotes the cytosolic localization of the m6A reader YTHDF1 and colorectal cancer tumorigenesis.","YTHDF1","promote","colorectal cancer tumorigenesis","Colorectal Cancer","YTHDF1","STIMULATES","colorectal cancer tumorigenesis","COAD(Colon Adenocarcinoma)"
"3425","37088992","METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability.","METTL3","mediate","Autophagy","FLT3-ITD+ acute myeloid leukemia","METTL3","AFFECTS","autophagy","LAML(Acute Myeloid Leukemia)"
"3426","37088992","METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability.","METTL3","regulate","PSMA3-AS1","FLT3-ITD+ acute myeloid leukemia","METTL3","AFFECTS","PSMA3-AS1","LAML(Acute Myeloid Leukemia)"
"3427","37088992","METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability.","PSMA3-AS1","has","Stability","FLT3-ITD+ acute myeloid leukemia","PSMA3-AS1","has","stability","LAML(Acute Myeloid Leukemia)"
"3428","37088992","METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability.","Stability","regulate","Autophagy","FLT3-ITD+ acute myeloid leukemia","stability","AFFECTS","autophagy","LAML(Acute Myeloid Leukemia)"
"3430","37092305","m6A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression.","m6A-modification","regulate","circ-CCT3","Hepatocellular Carcinoma","m6A","AFFECTS","circ-CCT3","LIHC(Liver Hepatocellular Carcinoma)"
"3431","37092305","m6A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression.","circ-CCT3","sponge","miR-378a-3p","Hepatocellular Carcinoma","circ-CCT3","sponge","miR-378a-3p","LIHC(Liver Hepatocellular Carcinoma)"
"3432","37092305","m6A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression.","miR-378a-3p","promote","progression","Hepatocellular Carcinoma","miR-378a-3p","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"3434","36939388","The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response.","YTHDF2","promote","Bladder Cancer Progression","Bladder Cancer","YTHDF2","STIMULATES","Bladder Cancer Progression","BLCA(Bladder Urothelial Carcinoma)"
"3435","36939388","The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response.","YTHDF2","suppress","RIG-I","Bladder Cancer","YTHDF2","INHIBITS","DDX58","BLCA(Bladder Urothelial Carcinoma)"
"3436","36939388","The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response.","RIG-I","mediate","Immune Response","Bladder Cancer","DDX58","AFFECTS","immune response","BLCA(Bladder Urothelial Carcinoma)"
"3437","36939388","The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response.","Immune Response","regulate","Bladder Cancer Progression","Bladder Cancer","immune response","AFFECTS","Bladder Cancer Progression","BLCA(Bladder Urothelial Carcinoma)"
"3439","36943192","Role of miR-124-3p in regulatory mechanisms of Gpm6a expression in the hippocampus of chronically stressed rats.","miR-124-3p","regulate","Gpm6a expression","Hippocampus of chronically stressed rats","miR-124-3p","AFFECTS","GPM6A","Hippocampus of chronically stressed rats"
"3441","36944332","m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis.","m6A","drive","SF3B1","Genome integrity and leukemogenesis","m6A","STIMULATES","SF3B1","Genome integrity and leukemogenesis"
"3442","36944332","m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis.","SF3B1","steer","splicing","Genome integrity and leukemogenesis","SF3B1","steer","splicing","Genome integrity and leukemogenesis"
"3444","36945110","METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition.","METTL3","mediate","m6A","Null","METTL3","AFFECTS","m6A","Null"
"3445","36945110","METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition.","m6A","modify","HMGA2 mRNA","Null","m6A","AFFECTS","HMGA2","Null"
"3446","36945110","METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition.","HMGA2 mRNA","promote","subretinal fibrosis","Null","HMGA2","STIMULATES","subretinal fibrosis","Null"
"3447","36945110","METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition.","HMGA2 mRNA","promote","epithelial-mesenchymal transition","Null","HMGA2","STIMULATES","epithelial to mesenchymal transition","Null"
"3449","36949231","A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m6A -dependent activation of multiple oncogenes.","MYCN","regulate","YTHDF1","Retinoblastoma","MYCN","AFFECTS","YTHDF1","Retinoblastoma"
"3450","36949231","A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m6A -dependent activation of multiple oncogenes.","YTHDF1","elicit","m6A","Retinoblastoma","YTHDF1","elicit","m6A","Retinoblastoma"
"3451","36949231","A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m6A -dependent activation of multiple oncogenes.","m6A","activate","Oncogenes","Retinoblastoma","m6A","STIMULATES","Oncogenes","Retinoblastoma"
"3452","36949231","A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m6A -dependent activation of multiple oncogenes.","Oncogenes","contribute","Tumor Growth","Retinoblastoma","Oncogenes","AFFECTS","Tumor Growth","Retinoblastoma"
"3454","36950992","Exosomal circCLIP1 regulates PM2.5-induced airway obstruction via targeting SEPT10 in vitro.","Exosomal circCLIP1","regulate","PM2.5-induced airway obstruction","In vitro","Exosomal circCLIP1","AFFECTS","PM2.5-induced airway obstruction","In vitro"
"3455","36950992","Exosomal circCLIP1 regulates PM2.5-induced airway obstruction via targeting SEPT10 in vitro.","Exosomal circCLIP1","target","10-Sep","In vitro","Exosomal circCLIP1","INTERACTS_WITH","10-Sep","In vitro"
"3456","36950992","Exosomal circCLIP1 regulates PM2.5-induced airway obstruction via targeting SEPT10 in vitro.","10-Sep","regulate","PM2.5-induced airway obstruction","In vitro","10-Sep","AFFECTS","PM2.5-induced airway obstruction","In vitro"
"3458","36958694","m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/beta-catenin signaling pathway.","m6A","upregulate","HLF","Intrahepatic Cholangiocarcinoma","m6A","STIMULATES","HLF","CHOL(Cholangiocarcinoma)"
"3459","36958694","m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/beta-catenin signaling pathway.","HLF","promote","Intrahepatic Cholangiocarcinoma Progression","Intrahepatic Cholangiocarcinoma","HLF","STIMULATES","Intrahepatic Cholangiocarcinoma Progression","CHOL(Cholangiocarcinoma)"
"3460","36958694","m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/beta-catenin signaling pathway.","HLF","regulate","FZD4/beta-catenin signaling pathway","Intrahepatic Cholangiocarcinoma","HLF","AFFECTS","FZD4/beta-catenin signaling pathway","CHOL(Cholangiocarcinoma)"
"3461","36958694","m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/beta-catenin signaling pathway.","FZD4/beta-catenin signaling pathway","regulate","Intrahepatic Cholangiocarcinoma Progression","Intrahepatic Cholangiocarcinoma","FZD4/beta-catenin signaling pathway","AFFECTS","Intrahepatic Cholangiocarcinoma Progression","CHOL(Cholangiocarcinoma)"
"3463","36959603","Suxiao Jiuxin Pill alleviates myocardial ischemia-reperfusion injury through the ALKBH5/GSK3beta/mTOR pathway.","Suxiao Jiuxin Pill","alleviate","myocardial ischemia-reperfusion injury","Myocardial ischemia-reperfusion injury","Suxiao Jiuxin Pill","INHIBITS","Myocardial Ischemia Reperfusion Injury","Myocardial ischemia-reperfusion injury"
"3464","36959603","Suxiao Jiuxin Pill alleviates myocardial ischemia-reperfusion injury through the ALKBH5/GSK3beta/mTOR pathway.","Suxiao Jiuxin Pill","regulate","ALKBH5/GSK3beta/mTOR pathway","Myocardial ischemia-reperfusion injury","Suxiao Jiuxin Pill","AFFECTS","ALKBH5/GSK3beta/mTOR pathway","Myocardial ischemia-reperfusion injury"
"3465","36959603","Suxiao Jiuxin Pill alleviates myocardial ischemia-reperfusion injury through the ALKBH5/GSK3beta/mTOR pathway.","ALKBH5/GSK3beta/mTOR pathway","regulate","myocardial ischemia-reperfusion injury","Myocardial ischemia-reperfusion injury","ALKBH5/GSK3beta/mTOR pathway","AFFECTS","Myocardial Ischemia Reperfusion Injury","Myocardial ischemia-reperfusion injury"
"3467","36960869","METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.","METTL3/YTHDF2 m6A axis","promote","Malignant Progression","Bladder Cancer","METTL3/YTHDF2 m6A axis","STIMULATES","Malignant Progression","BLCA(Bladder Urothelial Carcinoma)"
"3468","36960869","METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.","METTL3/YTHDF2 m6A axis","suppress","RRAS","Bladder Cancer","METTL3/YTHDF2 m6A axis","INHIBITS","RRAS","BLCA(Bladder Urothelial Carcinoma)"
"3469","36960869","METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.","RRAS","regulate","Malignant Progression","Bladder Cancer","RRAS","AFFECTS","Malignant Progression","BLCA(Bladder Urothelial Carcinoma)"
"3471","36973285","Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation.","m6A epitranscriptomic networks","link","mutant p53","Neoplastic Transformation","m6A","link","mutant p53","Neoplastic Transformation"
"3472","36973285","Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation.","mutant p53","link","neoplastic transformation","Neoplastic Transformation","mutant p53","link","neoplastic transformation","Neoplastic Transformation"
"3474","36977205","METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2.","METTL3","relieve","Injury","SH-SY5Y cells","METTL3","relieve","Wounds and Injuries","SH-SY5Y cells"
"3475","36977205","METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2.","METTL3","regulate","m6A","SH-SY5Y cells","METTL3","AFFECTS","m6A","SH-SY5Y cells"
"3476","36977205","METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2.","m6A","is on","Sox2","SH-SY5Y cells","m6A","LOCATES","SOX2","SH-SY5Y cells"
"3477","36977205","METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2.","Sox2","regulate","Injury","SH-SY5Y cells","SOX2","AFFECTS","Wounds and Injuries","SH-SY5Y cells"
"3479","36977668","METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.","METTL3","enhance","Pancreatic Ductal Adenocarcinoma Progression","Pancreatic Ductal Adenocarcinoma","METTL3","AUGMENTS","Pancreatic Ductal Adenocarcinoma Progression","PAAD(Pancreatic Adenocarcinoma)"
"3480","36977668","METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.","METTL3","enhance","Gemcitabine Resistance","Pancreatic Ductal Adenocarcinoma","METTL3","AUGMENTS","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"3481","36977668","METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.","METTL3","modify","N6 Adenosine Methylation","Pancreatic Ductal Adenocarcinoma","METTL3","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"3482","36977668","METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.","N6 Adenosine Methylation","is on","DDX23 mRNA","Pancreatic Ductal Adenocarcinoma","m6A","LOCATES","DDX23","PAAD(Pancreatic Adenocarcinoma)"
"3483","36977668","METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.","DDX23 mRNA","regulate","Pancreatic Ductal Adenocarcinoma Progression","Pancreatic Ductal Adenocarcinoma","DDX23","AFFECTS","Pancreatic Ductal Adenocarcinoma Progression","PAAD(Pancreatic Adenocarcinoma)"
"3484","36977668","METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.","DDX23 mRNA","regulate","Gemcitabine Resistance","Pancreatic Ductal Adenocarcinoma","DDX23","AFFECTS","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"3486","36980863","TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner.","TNC","accelerate","Cardiac Injury","Cardiac Injury","TNC","STIMULATES","Cardiac Injury","Cardiac Injury"
"3487","36980863","TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner.","Hypoxia","induce","Cardiac Injury","Cardiac Injury","Hypoxia","CAUSES","Cardiac Injury","Cardiac Injury"
"3488","36980863","TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner.","TNC","regulate","METTL3","Cardiac Injury","TNC","AFFECTS","METTL3","Cardiac Injury"
"3489","36980863","TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner.","METTL3","regulate","Cardiac Injury","Cardiac Injury","METTL3","AFFECTS","Cardiac Injury","Cardiac Injury"
"3496","36992945","N6-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m6A/cyclin D1 in asthma.","YTHDF1","regulate","Proliferation","Asthma","YTHDF1","AFFECTS","cell population proliferation","Asthma"
"3497","36992945","N6-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m6A/cyclin D1 in asthma.","YTHDF1","regulate","Migration","Asthma","YTHDF1","AFFECTS","migration","Asthma"
"3498","36992945","N6-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m6A/cyclin D1 in asthma.","YTHDF1","bind","m6A","Asthma","YTHDF1","INTERACTS_WITH","m6A","Asthma"
"3499","36992945","N6-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m6A/cyclin D1 in asthma.","m6A","regulate","Cyclin D1","Asthma","m6A","AFFECTS","CCND1","Asthma"
"3500","36992945","N6-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m6A/cyclin D1 in asthma.","Cyclin D1","regulate","Proliferation","Asthma","CCND1","AFFECTS","cell population proliferation","Asthma"
"3501","36992945","N6-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m6A/cyclin D1 in asthma.","Cyclin D1","regulate","Migration","Asthma","CCND1","AFFECTS","migration","Asthma"
"3503","36999803","PLAGL2 promotes Snail expression and gastric cancer progression via UCA1/miR-145-5p/YTHDF1 axis.","PLAGL2","promote","Snail","Gastric Cancer","PLAGL2","STIMULATES","SNAI1","STAD(Stomach adenocarcinoma)"
"3504","36999803","PLAGL2 promotes Snail expression and gastric cancer progression via UCA1/miR-145-5p/YTHDF1 axis.","PLAGL2","regulate","UCA1/miR-145-5p/YTHDF1 axis","Gastric Cancer","PLAGL2","AFFECTS","UCA1/miR-145-5p/YTHDF1 axis","STAD(Stomach adenocarcinoma)"
"3505","36999803","PLAGL2 promotes Snail expression and gastric cancer progression via UCA1/miR-145-5p/YTHDF1 axis.","UCA1/miR-145-5p/YTHDF1 axis","regulate","Snail","Gastric Cancer","UCA1/miR-145-5p/YTHDF1 axis","AFFECTS","SNAI1","STAD(Stomach adenocarcinoma)"
"3507","37003532","Targeted m6A demethylation of ITGA6 mRNA by a multisite dCasRx-m6A editor inhibits bladder cancer development.","dCasRx-m6A editor","demethylate","m6A","Bladder Cancer","dCasRx-m6A editor","CONVERTS_TO","m6A","BLCA(Bladder Urothelial Carcinoma)"
"3508","37003532","Targeted m6A demethylation of ITGA6 mRNA by a multisite dCasRx-m6A editor inhibits bladder cancer development.","m6A","is on","ITGA6 mRNA","Bladder Cancer","m6A","LOCATES","ITGA6","BLCA(Bladder Urothelial Carcinoma)"
"3509","37003532","Targeted m6A demethylation of ITGA6 mRNA by a multisite dCasRx-m6A editor inhibits bladder cancer development.","dCasRx-m6A editor","inhibit","Bladder Cancer Development","Bladder Cancer","dCasRx-m6A editor","INHIBITS","Bladder Cancer Development","BLCA(Bladder Urothelial Carcinoma)"
"3510","37003532","Targeted m6A demethylation of ITGA6 mRNA by a multisite dCasRx-m6A editor inhibits bladder cancer development.","ITGA6 mRNA","regulate","Bladder Cancer Development","Bladder Cancer","ITGA6","AFFECTS","Bladder Cancer Development","BLCA(Bladder Urothelial Carcinoma)"
"3512","37003652","FTO regulates the DNA damage response via effects on cell-cycle progression.","FTO","regulate","DNA damage response","Null","FTO","AFFECTS","cellular response to DNA damage stimulus","Null"
"3513","37003652","FTO regulates the DNA damage response via effects on cell-cycle progression.","FTO","affect","cell-cycle progression","Null","FTO","AFFECTS","cell-cycle progression","Null"
"3514","37003652","FTO regulates the DNA damage response via effects on cell-cycle progression.","cell-cycle progression","regulate","DNA damage response","Null","cell-cycle progression","AFFECTS","cellular response to DNA damage stimulus","Null"
"3516","37009154","m6A reader IGF2BP1 accelerates apoptosis of high glucose-induced vascular endothelial cells in a m6A-HMGB1 dependent manner.","IGF2BP1","accelerate","apoptosis","High glucose-induced vascular endothelial cells","IGF2BP1","STIMULATES","apoptotic process","High glucose-induced vascular endothelial cells"
"3517","37009154","m6A reader IGF2BP1 accelerates apoptosis of high glucose-induced vascular endothelial cells in a m6A-HMGB1 dependent manner.","IGF2BP1","bind","m6A","High glucose-induced vascular endothelial cells","IGF2BP1","INTERACTS_WITH","m6A","High glucose-induced vascular endothelial cells"
"3518","37009154","m6A reader IGF2BP1 accelerates apoptosis of high glucose-induced vascular endothelial cells in a m6A-HMGB1 dependent manner.","HMGB1","bind","m6A","High glucose-induced vascular endothelial cells","HMGB1","INTERACTS_WITH","m6A","High glucose-induced vascular endothelial cells"
"3519","37009154","m6A reader IGF2BP1 accelerates apoptosis of high glucose-induced vascular endothelial cells in a m6A-HMGB1 dependent manner.","m6A","regulate","apoptosis","High glucose-induced vascular endothelial cells","m6A","AFFECTS","apoptotic process","High glucose-induced vascular endothelial cells"
"3521","37010483","WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.","WTAP","mediate","m6A RNA Methylation","Bone Marrow Mesenchymal Stem Cells","WTAP","AFFECTS","m6A","Bone Marrow Mesenchymal Stem Cells"
"3522","37010483","WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.","m6A RNA Methylation","regulate","Differentiation","Bone Marrow Mesenchymal Stem Cells","m6A","AFFECTS","cell differentiation","Bone Marrow Mesenchymal Stem Cells"
"3523","37010483","WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.","m6A RNA Methylation","via","miR-29b-3p/HDAC4 Axis","Bone Marrow Mesenchymal Stem Cells","m6A","via","miR-29b-3p/HDAC4 Axis","Bone Marrow Mesenchymal Stem Cells"
"3524","37010483","WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.","miR-29b-3p/HDAC4 Axis","regulate","Differentiation","Bone Marrow Mesenchymal Stem Cells","miR-29b-3p/HDAC4 Axis","AFFECTS","cell differentiation","Bone Marrow Mesenchymal Stem Cells"
"3526","37012388","N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition.","YTHDF2","promote","Cell Proliferation","Multiple Myeloma Cells","YTHDF2","STIMULATES","cell population proliferation","Multiple Myeloma Cells"
"3527","37012388","N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition.","YTHDF2","promote","EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis","Multiple Myeloma Cells","YTHDF2","STIMULATES","EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis","Multiple Myeloma Cells"
"3528","37012388","N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition.","EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis","regulate","Cell Proliferation","Multiple Myeloma Cells","EGR1/p21cip1/waf1/CDK2-Cyclin E1 axis","AFFECTS","cell population proliferation","Multiple Myeloma Cells"
"3530","37013774","METTL3-mediated downregulation of splicing factor SRSF11 is associated with carcinogenesis and poor survival of cancer patients.","METTL3","downregulate","SRSF11","Cancer patients","METTL3","INHIBITS","SRSF11","Cancer patients"
"3531","37013774","METTL3-mediated downregulation of splicing factor SRSF11 is associated with carcinogenesis and poor survival of cancer patients.","SRSF11","associate with","carcinogenesis","Cancer patients","SRSF11","associate with","Carcinogenesis","Cancer patients"
"3533","37019244","WTAP promotes macrophage recruitment and increases VEGF secretion via N6-methyladenosine modification in corneal neovascularization.","WTAP","promote","Macrophage Recruitment","Corneal Neovascularization","WTAP","STIMULATES","Macrophage Recruitment","Corneal Neovascularization"
"3534","37019244","WTAP promotes macrophage recruitment and increases VEGF secretion via N6-methyladenosine modification in corneal neovascularization.","WTAP","regulate","N6-methyladenosine modification","Corneal Neovascularization","WTAP","AFFECTS","m6A","Corneal Neovascularization"
"3535","37019244","WTAP promotes macrophage recruitment and increases VEGF secretion via N6-methyladenosine modification in corneal neovascularization.","N6-methyladenosine modification","induce","VEGF Secretion","Corneal Neovascularization","m6A","CAUSES","VEGF Secretion","Corneal Neovascularization"
"3536","37019244","WTAP promotes macrophage recruitment and increases VEGF secretion via N6-methyladenosine modification in corneal neovascularization.","VEGF Secretion","promote","Macrophage Recruitment","Corneal Neovascularization","VEGF Secretion","STIMULATES","Macrophage Recruitment","Corneal Neovascularization"
"3539","36855062","Lactoferrin suppresses the progression of colon cancer under hyperglycemia by targeting WTAP/m6A/NT5DC3/HKDC1 axis.","Lactoferrin","suppress","Progression","Colon Cancer under hyperglycemia","LTF","INHIBITS","progression","COAD(Colon Adenocarcinoma)"
"3540","36855062","Lactoferrin suppresses the progression of colon cancer under hyperglycemia by targeting WTAP/m6A/NT5DC3/HKDC1 axis.","Lactoferrin","target","WTAP/m6A/NT5DC3/HKDC1 axis","Colon Cancer under hyperglycemia","LTF","INTERACTS_WITH","WTAP/m6A/NT5DC3/HKDC1 axis","COAD(Colon Adenocarcinoma)"
"3541","36855062","Lactoferrin suppresses the progression of colon cancer under hyperglycemia by targeting WTAP/m6A/NT5DC3/HKDC1 axis.","WTAP","regulate","m6A","Colon Cancer under hyperglycemia","WTAP","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"3542","36855062","Lactoferrin suppresses the progression of colon cancer under hyperglycemia by targeting WTAP/m6A/NT5DC3/HKDC1 axis.","m6A","regulate","NT5DC3","Colon Cancer under hyperglycemia","m6A","AFFECTS","NT5DC3","COAD(Colon Adenocarcinoma)"
"3543","36855062","Lactoferrin suppresses the progression of colon cancer under hyperglycemia by targeting WTAP/m6A/NT5DC3/HKDC1 axis.","NT5DC3","regulate","HKDC1","Colon Cancer under hyperglycemia","NT5DC3","AFFECTS","HKDC1","COAD(Colon Adenocarcinoma)"
"3544","36855062","Lactoferrin suppresses the progression of colon cancer under hyperglycemia by targeting WTAP/m6A/NT5DC3/HKDC1 axis.","WTAP/m6A/NT5DC3/HKDC1 axis","regulate","Progression","Colon Cancer under hyperglycemia","WTAP/m6A/NT5DC3/HKDC1 axis","AFFECTS","progression","COAD(Colon Adenocarcinoma)"
"3546","36857977","METTL3-mediated m6A methylation regulates granulosa cells autophagy during follicular atresia in pig ovaries.","METTL3","mediate","m6A methylation","Pig Ovaries","METTL3","AFFECTS","m6A","Pig Ovaries"
"3547","36857977","METTL3-mediated m6A methylation regulates granulosa cells autophagy during follicular atresia in pig ovaries.","m6A methylation","regulate","granulosa cells autophagy","Pig Ovaries","m6A","AFFECTS","granulosa cells autophagy","Pig Ovaries"
"3548","36857977","METTL3-mediated m6A methylation regulates granulosa cells autophagy during follicular atresia in pig ovaries.","follicular atresia","context","granulosa cells autophagy","Pig Ovaries","Follicular Atresia","context","granulosa cells autophagy","Pig Ovaries"
"3550","36859428","Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.","Dummy","inhibit","ALKBH5","Male Mice","dummy","INHIBITS","ALKBH5","Male Mice"
"3551","36859428","Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.","ALKBH5","attenuate","I/R-induced renal injury","Male Mice","ALKBH5","INHIBITS","I/R-induced renal injury","Male Mice"
"3552","36859428","Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.","ALKBH5","promote","Ccl28 m6A modification","Male Mice","ALKBH5","STIMULATES","Ccl28 m6A modification","Male Mice"
"3553","36859428","Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.","Ccl28 m6A modification","increase","Treg recruitment","Male Mice","Ccl28 m6A modification","AUGMENTS","Treg recruitment","Male Mice"
"3554","36859428","Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.","Treg recruitment","attenuate","I/R-induced renal injury","Male Mice","Treg recruitment","INHIBITS","I/R-induced renal injury","Male Mice"
"3556","36860124","N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.","N6-methyladenosine","modify","DBT","Clear Cell Renal Cell Carcinoma","m6A","AFFECTS","DBT","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3557","36860124","N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.","DBT","alleviate","Lipid Accumulation","Clear Cell Renal Cell Carcinoma","DBT","INHIBITS","Lipid Accumulation","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3558","36860124","N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.","DBT","inhibit","Tumor Progression","Clear Cell Renal Cell Carcinoma","DBT","INHIBITS","Tumor Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3559","36860124","N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.","DBT","regulate","ANXA2/YAP axis","Clear Cell Renal Cell Carcinoma","DBT","AFFECTS","ANXA2/YAP axis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3560","36860124","N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.","ANXA2/YAP axis","regulate","Hippo pathway","Clear Cell Renal Cell Carcinoma","ANXA2/YAP axis","AFFECTS","Hippo Signaling Pathway","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3561","36860124","N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.","Hippo pathway","regulate","Lipid Accumulation","Clear Cell Renal Cell Carcinoma","Hippo Signaling Pathway","AFFECTS","Lipid Accumulation","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3562","36860124","N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.","Hippo pathway","regulate","Tumor Progression","Clear Cell Renal Cell Carcinoma","Hippo Signaling Pathway","AFFECTS","Tumor Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3564","36860916","Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification.","Erianin","induce","Ferroptosis","Renal Cancer Stem Cells","Erianin","CAUSES","Ferroptosis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3565","36860916","Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification.","Erianin","promote","ALOX12","Renal Cancer Stem Cells","Erianin","STIMULATES","ALOX12","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3566","36860916","Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification.","Erianin","promote","P53 mRNA","Renal Cancer Stem Cells","Erianin","STIMULATES","P53","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3567","36860916","Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification.","Erianin","promote","N6-methyladenosine Modification","Renal Cancer Stem Cells","Erianin","STIMULATES","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3568","36860916","Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification.","ALOX12","regulate","Ferroptosis","Renal Cancer Stem Cells","ALOX12","AFFECTS","Ferroptosis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3569","36860916","Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification.","P53 mRNA","regulate","Ferroptosis","Renal Cancer Stem Cells","P53","AFFECTS","Ferroptosis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3570","36860916","Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification.","N6-methyladenosine Modification","regulate","Ferroptosis","Renal Cancer Stem Cells","m6A","AFFECTS","Ferroptosis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3572","36864027","N6-methyladenosine of Spi2a attenuates inflammation and sepsis-associated myocardial dysfunction in mice.","N6-methyladenosine","is on","Spi2a","Mice","m6A","LOCATES","Spi2a","Mice"
"3573","36864027","N6-methyladenosine of Spi2a attenuates inflammation and sepsis-associated myocardial dysfunction in mice.","Spi2a","attenuate","inflammation","Mice","Spi2a","INHIBITS","inflammatory response","Mice"
"3574","36864027","N6-methyladenosine of Spi2a attenuates inflammation and sepsis-associated myocardial dysfunction in mice.","Spi2a","attenuate","sepsis-associated myocardial dysfunction","Mice","Spi2a","INHIBITS","sepsis-associated myocardial dysfunction","Mice"
"3576","36864711","LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6 A-YTHDF2-dependent manner.","LINC00659","cooperate","ALKBH5","Gastric Cancer","LINC00659","INTERACTS_WITH","ALKBH5","STAD(Stomach adenocarcinoma)"
"3577","36864711","LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6 A-YTHDF2-dependent manner.","LINC00659","accelerate","Gastric Cancer Progression","Gastric Cancer","LINC00659","STIMULATES","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"3578","36864711","LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6 A-YTHDF2-dependent manner.","ALKBH5","accelerate","Gastric Cancer Progression","Gastric Cancer","ALKBH5","STIMULATES","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"3579","36864711","LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6 A-YTHDF2-dependent manner.","LINC00659","stabilize","JAK1 mRNA","Gastric Cancer","LINC00659","MAINTAINS","JAK1","STAD(Stomach adenocarcinoma)"
"3580","36864711","LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6 A-YTHDF2-dependent manner.","ALKBH5","stabilize","JAK1 mRNA","Gastric Cancer","ALKBH5","MAINTAINS","JAK1","STAD(Stomach adenocarcinoma)"
"3581","36864711","LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6 A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Gastric Cancer","YTHDF2","INTERACTS_WITH","m6A","STAD(Stomach adenocarcinoma)"
"3582","36864711","LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6 A-YTHDF2-dependent manner.","JAK1 mRNA","regulate","Gastric Cancer Progression","Gastric Cancer","JAK1","AFFECTS","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"3584","36865750","METTL3 Promotes Endothelium-Mesenchymal Transition of Pulmonary Artery Endothelial Cells by Regulating TRPC6/Calcineurin/NFAT Signaling Pathways.","METTL3","promote","Endothelium-Mesenchymal Transition","Pulmonary Artery Endothelial Cells","METTL3","STIMULATES","Endothelium-Mesenchymal Transition","Pulmonary Artery Endothelial Cells"
"3585","36865750","METTL3 Promotes Endothelium-Mesenchymal Transition of Pulmonary Artery Endothelial Cells by Regulating TRPC6/Calcineurin/NFAT Signaling Pathways.","METTL3","regulate","TRPC6/Calcineurin/NFAT Signaling Pathways","Pulmonary Artery Endothelial Cells","METTL3","AFFECTS","TRPC6/Calcineurin/NFAT Signaling Pathways","Pulmonary Artery Endothelial Cells"
"3586","36865750","METTL3 Promotes Endothelium-Mesenchymal Transition of Pulmonary Artery Endothelial Cells by Regulating TRPC6/Calcineurin/NFAT Signaling Pathways.","TRPC6/Calcineurin/NFAT Signaling Pathways","regulate","Endothelium-Mesenchymal Transition","Pulmonary Artery Endothelial Cells","TRPC6/Calcineurin/NFAT Signaling Pathways","AFFECTS","Endothelium-Mesenchymal Transition","Pulmonary Artery Endothelial Cells"
"3588","36873555","N6-methyladenosine (m6A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose.","METTL3","accelerate","apoptosis","Vascular Endothelial Cells in high glucose","METTL3","STIMULATES","apoptotic process","Vascular Endothelial Cells in high glucose"
"3590","36873735","METTL14 Regulates PLAGL2/beta-Catenin Signaling Axis to Promote the Development of Nonsmall Cell Lung Cancer.","METTL14","regulate","PLAGL2/beta-Catenin Signaling Axis","Nonsmall Cell Lung Cancer","METTL14","AFFECTS","PLAGL2/beta-Catenin Signaling Axis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3591","36873735","METTL14 Regulates PLAGL2/beta-Catenin Signaling Axis to Promote the Development of Nonsmall Cell Lung Cancer.","PLAGL2/beta-Catenin Signaling Axis","promote","Development of Nonsmall Cell Lung Cancer","Nonsmall Cell Lung Cancer","PLAGL2/beta-Catenin Signaling Axis","STIMULATES","Development of Nonsmall Cell Lung Cancer","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3593","36874096","Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model.","fat mass and obesity-associated protein","mitigate","human colorectal cancer growth","Human colorectal cancer and murine model","FTO","INHIBITS","human colorectal cancer growth","COAD(Colon Adenocarcinoma)"
"3594","36874096","Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model.","fat mass and obesity-associated protein","mitigate","murine model","Human colorectal cancer and murine model","FTO","INHIBITS","murine model","COAD(Colon Adenocarcinoma)"
"3596","36876119","m6A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3.","ALKBH5","attenuate","cardiotoxicity","Doxorubicin-induced cardiotoxicity","ALKBH5","INHIBITS","Cardiotoxicity","Doxorubicin-induced cardiotoxicity"
"3597","36876119","m6A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3.","ALKBH5","stabilize","Rasal3","Doxorubicin-induced cardiotoxicity","ALKBH5","MAINTAINS","RASAL3","Doxorubicin-induced cardiotoxicity"
"3598","36876119","m6A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3.","Rasal3","regulate","cardiotoxicity","Doxorubicin-induced cardiotoxicity","RASAL3","AFFECTS","Cardiotoxicity","Doxorubicin-induced cardiotoxicity"
"3600","36877222","Silencing m6A Reader YTHDC1 reduces inflammatory response in sepsis-induced cardiomyopathy by inhibiting SERPINA3N expression.","dummy","induce silencing of","YTHDC1","Sepsis-induced Cardiomyopathy","dummy","induce silencing of","YTHDC1","Sepsis-induced Cardiomyopathy"
"3601","36877222","Silencing m6A Reader YTHDC1 reduces inflammatory response in sepsis-induced cardiomyopathy by inhibiting SERPINA3N expression.","YTHDC1","reduce","inflammatory response","Sepsis-induced Cardiomyopathy","YTHDC1","INHIBITS","inflammatory response","Sepsis-induced Cardiomyopathy"
"3602","36877222","Silencing m6A Reader YTHDC1 reduces inflammatory response in sepsis-induced cardiomyopathy by inhibiting SERPINA3N expression.","YTHDC1","inhibit","SERPINA3N expression","Sepsis-induced Cardiomyopathy","YTHDC1","INHIBITS","SERPINA3N expression","Sepsis-induced Cardiomyopathy"
"3603","36877222","Silencing m6A Reader YTHDC1 reduces inflammatory response in sepsis-induced cardiomyopathy by inhibiting SERPINA3N expression.","SERPINA3N expression","regulate","inflammatory response","Sepsis-induced Cardiomyopathy","SERPINA3N expression","AFFECTS","inflammatory response","Sepsis-induced Cardiomyopathy"
"3605","36878272","FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.","FTO-Nrf2 axis","regulate","m6A","Leydig cells","FTO-Nrf2 axis","AFFECTS","m6A","Leydig Cells"
"3606","36878272","FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.","bisphenol F","induce","Leydig cell toxicity","Leydig cells","bisphenol F","CAUSES","Leydig cell toxicity","Leydig Cells"
"3607","36878272","FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Leydig cells","YTHDF2","INTERACTS_WITH","m6A","Leydig Cells"
"3608","36878272","FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.","m6A","regulate","Leydig cell toxicity","Leydig cells","m6A","AFFECTS","Leydig cell toxicity","Leydig Cells"
"3610","36878846","METTL14 promotes fibroblast-like synoviocytes activation via the LASP1/SRC/AKT axis in RA.","METTL14","promote","fibroblast-like synoviocytes activation","RA","METTL14","STIMULATES","fibroblast-like synoviocytes activation","retinoic acid"
"3611","36878846","METTL14 promotes fibroblast-like synoviocytes activation via the LASP1/SRC/AKT axis in RA.","METTL14","regulate","LASP1/SRC/AKT axis","RA","METTL14","AFFECTS","LASP1/SRC/AKT axis","retinoic acid"
"3612","36878846","METTL14 promotes fibroblast-like synoviocytes activation via the LASP1/SRC/AKT axis in RA.","LASP1/SRC/AKT axis","promote","fibroblast-like synoviocytes activation","RA","LASP1/SRC/AKT axis","STIMULATES","fibroblast-like synoviocytes activation","retinoic acid"
"3614","36881554","Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer's disease pathology in mice.","dummy","induce loss of","METTL3","Monocyte-derived Macrophages","dummy","INHIBITS","METTL3","Macrophages"
"3615","36881554","Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer's disease pathology in mice.","METTL3","ameliorate","Alzheimer's disease pathology","Monocyte-derived Macrophages","METTL3","TREATS","Alzheimer's disease pathology","Macrophages"
"3617","36892464","Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export.","YTHDC1","promote","Activation/Proliferation","Muscle Stem Cells","YTHDC1","STIMULATES","Activation/Proliferation","Muscle Stem Cells"
"3618","36892464","Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export.","YTHDC1","regulate","mRNA splicing","Muscle Stem Cells","YTHDC1","AFFECTS","Group I intron splicing","Muscle Stem Cells"
"3619","36892464","Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export.","YTHDC1","regulate","Nuclear Export","Muscle Stem Cells","YTHDC1","AFFECTS","nuclear export","Muscle Stem Cells"
"3620","36892464","Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export.","mRNA splicing","regulate","Activation/Proliferation","Muscle Stem Cells","Group I intron splicing","AFFECTS","Activation/Proliferation","Muscle Stem Cells"
"3621","36892464","Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export.","Nuclear Export","regulate","Activation/Proliferation","Muscle Stem Cells","nuclear export","AFFECTS","Activation/Proliferation","Muscle Stem Cells"
"3623","36894806","m6A methyltransferase WTAP regulates myocardial ischemia reperfusion injury through YTHDF1/FOXO3a signaling.","WTAP","regulate","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia Reperfusion Injury","WTAP","AFFECTS","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia Reperfusion Injury"
"3624","36894806","m6A methyltransferase WTAP regulates myocardial ischemia reperfusion injury through YTHDF1/FOXO3a signaling.","WTAP","regulate","YTHDF1/FOXO3a signaling","Myocardial Ischemia Reperfusion Injury","WTAP","AFFECTS","YTHDF1/FOXO3a signaling pathway","Myocardial Ischemia Reperfusion Injury"
"3625","36894806","m6A methyltransferase WTAP regulates myocardial ischemia reperfusion injury through YTHDF1/FOXO3a signaling.","YTHDF1/FOXO3a signaling","regulate","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia Reperfusion Injury","YTHDF1/FOXO3a signaling pathway","AFFECTS","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia Reperfusion Injury"
"3627","36899424","RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification.","ALKBH5","promote","tumorigenesis","t (8;21) acute myeloid leukemia","ALKBH5","STIMULATES","Carcinogenesis","LAML(Acute Myeloid Leukemia)"
"3628","36899424","RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification.","ALKBH5","regulate","ITPA","t (8;21) acute myeloid leukemia","ALKBH5","AFFECTS","ITPA","LAML(Acute Myeloid Leukemia)"
"3629","36899424","RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification.","m6A","is on","ITPA","t (8;21) acute myeloid leukemia","m6A","LOCATES","ITPA","LAML(Acute Myeloid Leukemia)"
"3630","36899424","RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification.","ITPA","regulate","tumorigenesis","t (8;21) acute myeloid leukemia","ITPA","AFFECTS","Carcinogenesis","LAML(Acute Myeloid Leukemia)"
"3632","36915895","The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma.","m6A methyltransferase KIAA1429","regulate","JAK2/STAT3 signaling pathway","Osteosarcoma","VIRMA","AFFECTS","JAK2/STAT3 signaling pathway","SARC(Sarcoma)"
"3634","36916936","YTHDF2 Is Downregulated in Response to Host Shutoff Induced by DNA Virus Infection and Regulates Interferon-Stimulated Gene Expression.","DNA Virus Infection","downregulate","YTHDF2","DNA Virus Infection","DNA Virus Infections","INHIBITS","YTHDF2","DNA Virus Infections"
"3635","36916936","YTHDF2 Is Downregulated in Response to Host Shutoff Induced by DNA Virus Infection and Regulates Interferon-Stimulated Gene Expression.","YTHDF2","regulate","Interferon-Stimulated Gene Expression","DNA Virus Infection","YTHDF2","AFFECTS","Interferon-Stimulated Gene Expression","DNA Virus Infections"
"3636","36916936","YTHDF2 Is Downregulated in Response to Host Shutoff Induced by DNA Virus Infection and Regulates Interferon-Stimulated Gene Expression.","DNA Virus Infection","induce","Host Shutoff","DNA Virus Infection","DNA Virus Infections","CAUSES","Host Shutoff","DNA Virus Infections"
"3637","36916936","YTHDF2 Is Downregulated in Response to Host Shutoff Induced by DNA Virus Infection and Regulates Interferon-Stimulated Gene Expression.","Host Shutoff","downregulate","YTHDF2","DNA Virus Infection","Host Shutoff","INHIBITS","YTHDF2","DNA Virus Infections"
"3639","36917263","METTL3 promotes proliferation of goat endometrial epithelial cells by regulating CTGF in an m6A-dependent manner.","METTL3","promote","Proliferation","Goat Endometrial Epithelial Cells","METTL3","STIMULATES","cell population proliferation","Goat Endometrial Epithelial Cells"
"3640","36917263","METTL3 promotes proliferation of goat endometrial epithelial cells by regulating CTGF in an m6A-dependent manner.","METTL3","regulate","CTGF","Goat Endometrial Epithelial Cells","METTL3","AFFECTS","CCN2","Goat Endometrial Epithelial Cells"
"3641","36917263","METTL3 promotes proliferation of goat endometrial epithelial cells by regulating CTGF in an m6A-dependent manner.","METTL3","regulate","m6A","Goat Endometrial Epithelial Cells","METTL3","AFFECTS","m6A","Goat Endometrial Epithelial Cells"
"3642","36917263","METTL3 promotes proliferation of goat endometrial epithelial cells by regulating CTGF in an m6A-dependent manner.","m6A","regulate","CTGF","Goat Endometrial Epithelial Cells","m6A","AFFECTS","CCN2","Goat Endometrial Epithelial Cells"
"3644","36917877","N6-methyladenosine mediates Nrf2 protein expression involved in PM2.5-induced pulmonary fibrosis.","N6-methyladenosine","mediate","Nrf2 protein expression","PM2.5-induced pulmonary fibrosis","m6A","AFFECTS","NFE2L2","PM2.5-induced pulmonary fibrosis"
"3645","36917877","N6-methyladenosine mediates Nrf2 protein expression involved in PM2.5-induced pulmonary fibrosis.","Nrf2 protein expression","involved in","pulmonary fibrosis","PM2.5-induced pulmonary fibrosis","NFE2L2","involved in","Pulmonary Fibrosis","PM2.5-induced pulmonary fibrosis"
"3647","36918410","FTO-mediated m6A modification promotes malignant transformation of gastric mucosal epithelial cells in chronic Cag A+ Helicobacter pylori infection.","FTO","mediate","m6A modification","Chronic Cag A+ Helicobacter pylori infection","FTO","AFFECTS","m6A","Chronic Cag A+ Helicobacter pylori infection"
"3648","36918410","FTO-mediated m6A modification promotes malignant transformation of gastric mucosal epithelial cells in chronic Cag A+ Helicobacter pylori infection.","m6A modification","promote","Malignant Transformation","Chronic Cag A+ Helicobacter pylori infection","m6A","STIMULATES","Malignant Transformation","Chronic Cag A+ Helicobacter pylori infection"
"3649","36918410","FTO-mediated m6A modification promotes malignant transformation of gastric mucosal epithelial cells in chronic Cag A+ Helicobacter pylori infection.","Gastric mucosal epithelial cells","undergo","Malignant Transformation","Chronic Cag A+ Helicobacter pylori infection","Gastric mucosal epithelial cells","undergo","Malignant Transformation","Chronic Cag A+ Helicobacter pylori infection"
"3651","36918845","Attenuation of IFN signaling due to m6A modification of the host epitranscriptome promotes EBV lytic reactivation.","m6A modification","attenuate","IFN signaling","Host Epitranscriptome","m6A","INHIBITS","IFN signaling pathway","Host Epitranscriptome"
"3652","36918845","Attenuation of IFN signaling due to m6A modification of the host epitranscriptome promotes EBV lytic reactivation.","m6A modification","is on","host epitranscriptome","Host Epitranscriptome","m6A","LOCATES","host epitranscriptome","Host Epitranscriptome"
"3653","36918845","Attenuation of IFN signaling due to m6A modification of the host epitranscriptome promotes EBV lytic reactivation.","IFN signaling","promote","EBV lytic reactivation","Host Epitranscriptome","IFN signaling pathway","STIMULATES","EBV lytic reactivation","Host Epitranscriptome"
"3655","36920907","METTL3-mediated m6A mRNA methylation regulates neutrophil activation through targeting TLR4 signaling.","METTL3","mediate","m6A mRNA methylation","Neutrophils","METTL3","AFFECTS","m6A","Segmented Neutrophils to Neutrophils Ratio Measurement"
"3656","36920907","METTL3-mediated m6A mRNA methylation regulates neutrophil activation through targeting TLR4 signaling.","m6A mRNA methylation","regulate","Neutrophil Activation","Neutrophils","m6A","AFFECTS","neutrophil activation","Segmented Neutrophils to Neutrophils Ratio Measurement"
"3657","36920907","METTL3-mediated m6A mRNA methylation regulates neutrophil activation through targeting TLR4 signaling.","m6A mRNA methylation","target","TLR4 signaling","Neutrophils","m6A","INTERACTS_WITH","TLR4 signaling pathway","Segmented Neutrophils to Neutrophils Ratio Measurement"
"3658","36920907","METTL3-mediated m6A mRNA methylation regulates neutrophil activation through targeting TLR4 signaling.","TLR4 signaling","regulate","Neutrophil Activation","Neutrophils","TLR4 signaling pathway","AFFECTS","neutrophil activation","Segmented Neutrophils to Neutrophils Ratio Measurement"
"3659","36920907","METTL3-mediated m6A mRNA methylation regulates neutrophil activation through targeting TLR4 signaling.","METTL3","regulate","TLR4 signaling","Neutrophils","METTL3","AFFECTS","TLR4 signaling pathway","Segmented Neutrophils to Neutrophils Ratio Measurement"
"3661","36924977","Mettl3-mediated transcriptome-wide m6A methylation induced by cigarette smoking in human bronchial epithelial cells.","Mettl3","mediate","m6A methylation","Human Bronchial Epithelial Cells","METTL3","AFFECTS","m6A","Human Bronchial Epithelial Cells"
"3662","36924977","Mettl3-mediated transcriptome-wide m6A methylation induced by cigarette smoking in human bronchial epithelial cells.","m6A methylation","is in","transcriptome","Human Bronchial Epithelial Cells","m6A","LOCATES","Transcriptome","Human Bronchial Epithelial Cells"
"3664","36932115","Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.","Hypoxia","respond","PPARGC1A/BAMBI/ACSL5 axis","Hepatocellular Carcinoma","Hypoxia","respond","PPARGC1A/BAMBI/ACSL5 axis","LIHC(Liver Hepatocellular Carcinoma)"
"3665","36932115","Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.","PPARGC1A/BAMBI/ACSL5 axis","promote","Progression","Hepatocellular Carcinoma","PPARGC1A/BAMBI/ACSL5 axis","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"3666","36932115","Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.","PPARGC1A/BAMBI/ACSL5 axis","promote","Resistance","Hepatocellular Carcinoma","PPARGC1A/BAMBI/ACSL5 axis","STIMULATES","resistance","LIHC(Liver Hepatocellular Carcinoma)"
"3667","36932115","Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.","Resistance","resist","Lenvatinib","Hepatocellular Carcinoma","resistance","resist","lenvatinib","LIHC(Liver Hepatocellular Carcinoma)"
"3669","36932387","Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.","Exosome-derived circCCAR1","promote","CD8 + T-cell dysfunction","Hepatocellular Carcinoma","Exosome-derived circCCAR1","STIMULATES","CD8 + T-cell dysfunction","LIHC(Liver Hepatocellular Carcinoma)"
"3670","36932387","Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.","Exosome-derived circCCAR1","promote","anti-PD1 resistance","Hepatocellular Carcinoma","Exosome-derived circCCAR1","STIMULATES","anti-PD1 resistance","LIHC(Liver Hepatocellular Carcinoma)"
"3672","36932427","METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.","METTL3","promote","Chemoresistance","Small Cell Lung Cancer","METTL3","STIMULATES","Chemoresistance","SCLC(Small Cell Lung Carcinoma)"
"3673","36932427","METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.","METTL3","induce","Mitophagy","Small Cell Lung Cancer","METTL3","CAUSES","mitophagy","SCLC(Small Cell Lung Carcinoma)"
"3674","36932427","METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.","Mitophagy","promote","Chemoresistance","Small Cell Lung Cancer","mitophagy","STIMULATES","Chemoresistance","SCLC(Small Cell Lung Carcinoma)"
"3676","36933158","lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.","lncRNA miR4458HG","modulate","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","MIR155HG","AFFECTS","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"3677","36933158","lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.","lncRNA miR4458HG","activate","m6A","Hepatocellular Carcinoma","MIR155HG","STIMULATES","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"3678","36933158","lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.","m6A","regulate","Glycolysis","Hepatocellular Carcinoma","m6A","AFFECTS","glycolytic process","LIHC(Liver Hepatocellular Carcinoma)"
"3679","36933158","lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.","lncRNA miR4458HG","promote","Polarization","Hepatocellular Carcinoma","MIR155HG","STIMULATES","polarization","LIHC(Liver Hepatocellular Carcinoma)"
"3680","36933158","lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.","Polarization","is on","Tumor-associated Macrophages","Hepatocellular Carcinoma","polarization","LOCATES","Tumor-Associated Macrophages","LIHC(Liver Hepatocellular Carcinoma)"
"3681","36933158","lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.","Glycolysis","regulate","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","glycolytic process","AFFECTS","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"3682","36933158","lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.","Tumor-associated Macrophages","regulate","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","Tumor-Associated Macrophages","AFFECTS","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"3684","36779260","Analyzing the mechanism by which oyster peptides target IL-2 in melanoma cell apoptosis based on RNA-seq and m6A-seq.","Oyster peptides","target","IL-2","Melanoma cells","Oyster peptides","INTERACTS_WITH","IL2","SKCM(Skin Cutaneous Melanoma)"
"3685","36779260","Analyzing the mechanism by which oyster peptides target IL-2 in melanoma cell apoptosis based on RNA-seq and m6A-seq.","IL-2","involved in","apoptosis","Melanoma cells","IL2","involved in","apoptotic process","SKCM(Skin Cutaneous Melanoma)"
"3687","36780989","YTHDC1 maintains trophoblasts function by promoting degradation of mA6-modified circMPP1.","YTHDC1","promote degradation of","mA6-modified circMPP1","Trophoblasts","YTHDC1","promote degradation of","m6A-modified circMPP1","Trophoblasts"
"3688","36780989","YTHDC1 maintains trophoblasts function by promoting degradation of mA6-modified circMPP1.","mA6-modified circMPP1","maintain","Trophoblasts function","Trophoblasts","m6A-modified circMPP1","MAINTAINS","Trophoblasts function","Trophoblasts"
"3690","36781839","m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner.","m6A","modify","circRNA MYO1C","Pancreatic Ductal Adenocarcinoma","m6A","AFFECTS","circRNA MYO1C","PAAD(Pancreatic Adenocarcinoma)"
"3691","36781839","m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner.","circRNA MYO1C","participate","Tumor Immune Surveillance","Pancreatic Ductal Adenocarcinoma","circRNA MYO1C","participate","Tumor Immune Surveillance","PAAD(Pancreatic Adenocarcinoma)"
"3692","36781839","m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner.","circRNA MYO1C","regulate","m6A","Pancreatic Ductal Adenocarcinoma","circRNA MYO1C","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"3693","36781839","m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner.","PD-L1","bind","m6A","Pancreatic Ductal Adenocarcinoma","CD274","INTERACTS_WITH","m6A","PAAD(Pancreatic Adenocarcinoma)"
"3694","36781839","m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner.","m6A","regulate","Tumor Immune Surveillance","Pancreatic Ductal Adenocarcinoma","m6A","AFFECTS","Tumor Immune Surveillance","PAAD(Pancreatic Adenocarcinoma)"
"3696","36788604","Decreased ubiquitin modifying enzyme A20 associated with hyper-responsiveness to ovalbumin challenge following intrauterine growth restriction.","dummy","decrease","A20","Intrauterine growth restriction","dummy","INHIBITS","TNFAIP3","Infant, Small for Gestational Age"
"3697","36788604","Decreased ubiquitin modifying enzyme A20 associated with hyper-responsiveness to ovalbumin challenge following intrauterine growth restriction.","A20","associate","hyper-responsiveness","Intrauterine growth restriction","TNFAIP3","ASSOCIATED_WITH","hyper-responsiveness","Infant, Small for Gestational Age"
"3698","36788604","Decreased ubiquitin modifying enzyme A20 associated with hyper-responsiveness to ovalbumin challenge following intrauterine growth restriction.","hyper-responsiveness","to","ovalbumin challenge","Intrauterine growth restriction","hyper-responsiveness","to","ovalbumin challenge","Infant, Small for Gestational Age"
"3700","36790471","The m6A methyltransferase METTL3 affects cell proliferation and migration by regulating YAP expression in Hirschsprung disease.","METTL3","affect","cell proliferation","Hirschsprung disease","METTL3","AFFECTS","cell population proliferation","Hirschsprung Disease"
"3701","36790471","The m6A methyltransferase METTL3 affects cell proliferation and migration by regulating YAP expression in Hirschsprung disease.","METTL3","affect","migration","Hirschsprung disease","METTL3","AFFECTS","migration","Hirschsprung Disease"
"3702","36790471","The m6A methyltransferase METTL3 affects cell proliferation and migration by regulating YAP expression in Hirschsprung disease.","METTL3","regulate","YAP","Hirschsprung disease","METTL3","AFFECTS","YAP1","Hirschsprung Disease"
"3703","36790471","The m6A methyltransferase METTL3 affects cell proliferation and migration by regulating YAP expression in Hirschsprung disease.","YAP","regulate","cell proliferation","Hirschsprung disease","YAP1","AFFECTS","cell population proliferation","Hirschsprung Disease"
"3704","36790471","The m6A methyltransferase METTL3 affects cell proliferation and migration by regulating YAP expression in Hirschsprung disease.","YAP","regulate","migration","Hirschsprung disease","YAP1","AFFECTS","migration","Hirschsprung Disease"
"3706","36792603","Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B.","ENST00000436340","promote","Podocyte Injury","Diabetic Kidney Disease","ENST00000436340","STIMULATES","Podocyte Injury","Diabetic Nephropathies"
"3707","36792603","Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B.","ENST00000436340","facilitate","Association","Diabetic Kidney Disease","ENST00000436340","AUGMENTS","Association","Diabetic Nephropathies"
"3708","36792603","Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B.","Association","is on","PTBP1","Diabetic Kidney Disease","Association","LOCATES","PTBP1","Diabetic Nephropathies"
"3709","36792603","Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B.","Association","is on","RAB3B","Diabetic Kidney Disease","Association","LOCATES","RAB3B","Diabetic Nephropathies"
"3710","36792603","Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B.","PTBP1","regulate","Podocyte Injury","Diabetic Kidney Disease","PTBP1","AFFECTS","Podocyte Injury","Diabetic Nephropathies"
"3711","36792603","Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B.","RAB3B","regulate","Podocyte Injury","Diabetic Kidney Disease","RAB3B","AFFECTS","Podocyte Injury","Diabetic Nephropathies"
"3713","36793308","METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3.","METTL3","promote","chondrogenic differentiation","SMSCs","METTL3","STIMULATES","chondrogenic differentiation","SMSCs"
"3714","36793308","METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3.","METTL3","target","MMP3","SMSCs","METTL3","INTERACTS_WITH","MMP3","SMSCs"
"3715","36793308","METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3.","METTL3","target","MMP13","SMSCs","METTL3","INTERACTS_WITH","MMP13","SMSCs"
"3716","36793308","METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3.","METTL3","target","GATA3","SMSCs","METTL3","INTERACTS_WITH","GATA3","SMSCs"
"3717","36793308","METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3.","MMP3","regulate","chondrogenic differentiation","SMSCs","MMP3","AFFECTS","chondrogenic differentiation","SMSCs"
"3718","36793308","METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3.","MMP13","regulate","chondrogenic differentiation","SMSCs","MMP13","AFFECTS","chondrogenic differentiation","SMSCs"
"3719","36793308","METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3.","GATA3","regulate","chondrogenic differentiation","SMSCs","GATA3","AFFECTS","chondrogenic differentiation","SMSCs"
"3721","36794723","Structure of the Caenorhabditis elegans m6A methyltransferase METT10 that regulates SAM homeostasis.","METT10","regulate","SAM homeostasis","Caenorhabditis elegans","METT10","AFFECTS","SAM homeostasis","Caenorhabditis elegans"
"3723","36795489","The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment.","METTL16","negatively regulate","MCP1 expression","Mesenchymal Stem Cells during monocyte recruitment","METTL16","INHIBITS","MCP1 expression","Mesenchymal Stem Cells during monocyte recruitment"
"3725","36801705","Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages.","Ythdf2","promote","Pulmonary Hypertension","Alveolar Macrophages","YTHDF2","STIMULATES","Hypertension, Pulmonary","Macrophages, Alveolar"
"3726","36801705","Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages.","Ythdf2","suppress","Hmox1","Alveolar Macrophages","YTHDF2","INHIBITS","HMOX1","Macrophages, Alveolar"
"3727","36801705","Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages.","Hmox1","promote","anti-inflammatory and antioxidant function","Alveolar Macrophages","HMOX1","STIMULATES","anti-inflammatory and antioxidant function","Macrophages, Alveolar"
"3728","36801705","Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages.","anti-inflammatory and antioxidant function","suppress","Pulmonary Hypertension","Alveolar Macrophages","anti-inflammatory and antioxidant function","INHIBITS","Hypertension, Pulmonary","Macrophages, Alveolar"
"3730","36801892","Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization.","dummy","target","FTO","Choroidal Neovascularization","dummy","INTERACTS_WITH","FTO","Choroidal Neovascularization"
"3731","36801892","Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization.","FTO","suppress","Vascular Endothelial Growth Factor (VEGF) release","Choroidal Neovascularization","FTO","INHIBITS","Vascular Endothelial Growth Factor (VEGF) release","Choroidal Neovascularization"
"3732","36801892","Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization.","Vascular Endothelial Growth Factor (VEGF) release","promote","Choroidal Neovascularization","Choroidal Neovascularization","Vascular Endothelial Growth Factor (VEGF) release","STIMULATES","Choroidal Neovascularization","Choroidal Neovascularization"
"3734","36803098","RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.","RBM15","suppress","hepatic insulin sensitivity","Offspring of gestational diabetes mellitus mice","RBM15","INHIBITS","hepatic insulin sensitivity","Offspring of gestational diabetes mellitus mice"
"3735","36803098","RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.","RBM15","regulate","m6A","Offspring of gestational diabetes mellitus mice","RBM15","AFFECTS","m6A","Offspring of gestational diabetes mellitus mice"
"3736","36803098","RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.","m6A","regulate","CLDN4","Offspring of gestational diabetes mellitus mice","m6A","AFFECTS","CLDN4","Offspring of gestational diabetes mellitus mice"
"3737","36803098","RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.","CLDN4","regulate","hepatic insulin sensitivity","Offspring of gestational diabetes mellitus mice","CLDN4","AFFECTS","hepatic insulin sensitivity","Offspring of gestational diabetes mellitus mice"
"3739","36806557","N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.","N6-methyadenosine modified SUV39H2","regulate","Homologous Recombination","Gastric Cancer","m6A-modified SUV39H2","AFFECTS","homologous recombination","STAD(Stomach adenocarcinoma)"
"3740","36806557","N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.","N6-methyadenosine modified SUV39H2","induce","Epigenetic Repression","Gastric Cancer","m6A-modified SUV39H2","CAUSES","Epigenetic Repression","STAD(Stomach adenocarcinoma)"
"3741","36806557","N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.","Epigenetic Repression","is on","DUSP6","Gastric Cancer","Epigenetic Repression","LOCATES","DUSP6","STAD(Stomach adenocarcinoma)"
"3742","36806557","N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.","DUSP6","regulate","Homologous Recombination","Gastric Cancer","DUSP6","AFFECTS","homologous recombination","STAD(Stomach adenocarcinoma)"
"3744","36811004","Splice site m6A methylation prevents binding of DGCR8 to suppress KRT4 pre-mRNA splicing in oral squamous cell carcinoma.","m6A methylation","is on","Splice site","Oral Squamous Cell Carcinoma","m6A","LOCATES","splice site","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3745","36811004","Splice site m6A methylation prevents binding of DGCR8 to suppress KRT4 pre-mRNA splicing in oral squamous cell carcinoma.","m6A methylation","prevent binding","DGCR8","Oral Squamous Cell Carcinoma","m6A","prevent binding","DGCR8","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3746","36811004","Splice site m6A methylation prevents binding of DGCR8 to suppress KRT4 pre-mRNA splicing in oral squamous cell carcinoma.","DGCR8","suppress","KRT4 pre-mRNA splicing","Oral Squamous Cell Carcinoma","DGCR8","INHIBITS","KRT4 pre-mRNA splicing","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3747","36811004","Splice site m6A methylation prevents binding of DGCR8 to suppress KRT4 pre-mRNA splicing in oral squamous cell carcinoma.","m6A methylation","regulate","KRT4 pre-mRNA splicing","Oral Squamous Cell Carcinoma","m6A","AFFECTS","KRT4 pre-mRNA splicing","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3749","36812496","MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1.","MALAT-1","regulate","AML progression","AML","MALAT1","AFFECTS","AML progression","LAML(Acute Myeloid Leukemia)"
"3750","36812496","MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1.","MALAT-1","promote","m6A modification","AML","MALAT1","STIMULATES","m6A","LAML(Acute Myeloid Leukemia)"
"3751","36812496","MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1.","m6A modification","is on","ZEB1","AML","m6A","LOCATES","ZEB1","LAML(Acute Myeloid Leukemia)"
"3752","36812496","MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1.","ZEB1","regulate","AML progression","AML","ZEB1","AFFECTS","AML progression","LAML(Acute Myeloid Leukemia)"
"3754","36813093","m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis.","m6A methylation","induce","NR1D1","Hepatic Stellate Cells","m6A","CAUSES","NR1D1","Hepatic Stellate Cells"
"3755","36813093","m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis.","NR1D1","disrupt","HSC circadian clock","Hepatic Stellate Cells","NR1D1","DISRUPTS","HSC circadian clock","Hepatic Stellate Cells"
"3756","36813093","m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis.","HSC circadian clock","promote","hepatic fibrosis","Hepatic Stellate Cells","HSC circadian clock","STIMULATES","hepatic fibrosis","Hepatic Stellate Cells"
"3758","36814156","MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6.","MiR-141-3p","promote","Malignant Progression","Prostate Cancer","MiR-141-3p","STIMULATES","Malignant Progression","PRAD(Prostate Adenocarcinoma)"
"3759","36814156","MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6.","MiR-141-3p","regulate","AlkB homolog 5","Prostate Cancer","MiR-141-3p","AFFECTS","ALKBH5","PRAD(Prostate Adenocarcinoma)"
"3760","36814156","MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6.","AlkB homolog 5","mediate","m6A","Prostate Cancer","ALKBH5","AFFECTS","m6A","PRAD(Prostate Adenocarcinoma)"
"3761","36814156","MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6.","m6A","modify","protein arginine methyltransferase 6","Prostate Cancer","m6A","AFFECTS","PRMT6","PRAD(Prostate Adenocarcinoma)"
"3762","36814156","MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6.","protein arginine methyltransferase 6","regulate","Malignant Progression","Prostate Cancer","PRMT6","AFFECTS","Malignant Progression","PRAD(Prostate Adenocarcinoma)"
"3764","36814345","Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","METTL3","initiate","m6A","NSCLC","METTL3","CAUSES","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3765","36814345","Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","m6A","promote","YAP translation","NSCLC","m6A","STIMULATES","YAP translation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3766","36814345","Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","YAP translation","increase","YAP activity","NSCLC","YAP translation","AUGMENTS","YAP activity","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3767","36814345","Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","YAP activity","regulate","MALAT1-miR-1914-3p-YAP axis","NSCLC","YAP activity","AFFECTS","MALAT1-miR-1914-3p-YAP axis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3768","36814345","Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","MALAT1-miR-1914-3p-YAP axis","induce","drug resistance","NSCLC","MALAT1-miR-1914-3p-YAP axis","CAUSES","Drug Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3769","36814345","Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","MALAT1-miR-1914-3p-YAP axis","induce.","metastasis","NSCLC","MALAT1-miR-1914-3p-YAP axis","induce.","Neoplasm Metastasis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3771","36815224","N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.","FTO","promote","Oxidative Stress","Ovarian Cancer","FTO","STIMULATES","Oxidative Stress","OV(Ovarian Serous Cystadenocarcinoma)"
"3772","36815224","N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.","FTO","induce","Cell Apoptosis","Ovarian Cancer","FTO","CAUSES","Cell Apoptosis","OV(Ovarian Serous Cystadenocarcinoma)"
"3774","36819785","The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.","N6-Methyladenosine Regulators","regulate","YTHDC1","Human Aortic Dissection","m6A","AFFECTS","YTHDC1","Human Aortic Dissection"
"3775","36819785","The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.","YTHDC1","mediate","N6-Methyladenosine Modification","Human Aortic Dissection","YTHDC1","AFFECTS","m6A","Human Aortic Dissection"
"3776","36819785","The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.","N6-Methyladenosine Modification","involve","Oxidative Stress","Human Aortic Dissection","m6A","ASSOCIATED_WITH","Oxidative Stress","Human Aortic Dissection"
"3778","36820954","ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.","ALKBH5","decrease","SLC7A11","Colorectal Cancer Cells","ALKBH5","INHIBITS","SLC7A11","COAD(Colon Adenocarcinoma)"
"3779","36820954","ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.","ALKBH5","erase","m6A","Colorectal Cancer Cells","ALKBH5","erase","m6A","COAD(Colon Adenocarcinoma)"
"3780","36820954","ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.","m6A","modify","SLC7A11","Colorectal Cancer Cells","m6A","AFFECTS","SLC7A11","COAD(Colon Adenocarcinoma)"
"3781","36820954","ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.","ALKBH5","promote","ferroptosis","Colorectal Cancer Cells","ALKBH5","STIMULATES","Ferroptosis","COAD(Colon Adenocarcinoma)"
"3783","36822223","The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/beta-catenin pathway.","CangFu Daotan Decoction","ameliorate","Polycystic Ovary Syndrome","Rodent Model of Polycystic Ovary Syndrome","CangFu Daotan Decoction","TREATS","Polycystic Ovary Syndrome","Rodent Model of Polycystic Ovary Syndrome"
"3784","36822223","The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/beta-catenin pathway.","CangFu Daotan Decoction","associate","m6A methylation","Rodent Model of Polycystic Ovary Syndrome","CangFu Daotan Decoction","ASSOCIATED_WITH","m6A","Rodent Model of Polycystic Ovary Syndrome"
"3785","36822223","The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/beta-catenin pathway.","CangFu Daotan Decoction","associate","Wnt/beta-catenin pathway","Rodent Model of Polycystic Ovary Syndrome","CangFu Daotan Decoction","ASSOCIATED_WITH","WNT/beta-catenin pathway","Rodent Model of Polycystic Ovary Syndrome"
"3786","36822223","The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/beta-catenin pathway.","m6A methylation","regulate","Polycystic Ovary Syndrome","Rodent Model of Polycystic Ovary Syndrome","m6A","AFFECTS","Polycystic Ovary Syndrome","Rodent Model of Polycystic Ovary Syndrome"
"3787","36822223","The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/beta-catenin pathway.","Wnt/beta-catenin pathway","regulate","Polycystic Ovary Syndrome","Rodent Model of Polycystic Ovary Syndrome","WNT/beta-catenin pathway","AFFECTS","Polycystic Ovary Syndrome","Rodent Model of Polycystic Ovary Syndrome"
"3789","36828914","N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2.","N6-Methyladenosine-modified circSAV1","trigger","ferroptosis","COPD","m6A-modified circSAV1","CAUSES","Ferroptosis","Pulmonary Disease, Chronic Obstructive"
"3790","36828914","N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2.","N6-Methyladenosine-modified circSAV1","recruit","YTHDF1","COPD","m6A-modified circSAV1","recruit","YTHDF1","Pulmonary Disease, Chronic Obstructive"
"3791","36828914","N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2.","YTHDF1","facilitate","translation","COPD","YTHDF1","AUGMENTS","translation","Pulmonary Disease, Chronic Obstructive"
"3792","36828914","N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2.","translation","of","IREB2","COPD","translation","of","IREB2","Pulmonary Disease, Chronic Obstructive"
"3793","36828914","N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2.","IREB2","regulate","ferroptosis","COPD","IREB2","AFFECTS","Ferroptosis","Pulmonary Disease, Chronic Obstructive"
"3795","36831430","RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines.","RBM15","promote","Proliferation","Pancreatic Cancer Cell Lines","RBM15","STIMULATES","cell population proliferation","PAAD(Pancreatic Adenocarcinoma)"
"3796","36831430","RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines.","RBM15","promote","Migration","Pancreatic Cancer Cell Lines","RBM15","STIMULATES","migration","PAAD(Pancreatic Adenocarcinoma)"
"3797","36831430","RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines.","RBM15","promote","Invasion","Pancreatic Cancer Cell Lines","RBM15","STIMULATES","Neoplasm Invasiveness","PAAD(Pancreatic Adenocarcinoma)"
"3799","36840486","METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.","METTL3","modify","m6A","Diffuse Large B-cell Lymphoma Cells","METTL3","AFFECTS","m6A","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3800","36840486","METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.","m6A","is on","NEDD1 mRNA","Diffuse Large B-cell Lymphoma Cells","m6A","LOCATES","NEDD1","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3801","36840486","METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.","YTHDF1","bind","NEDD1 mRNA","Diffuse Large B-cell Lymphoma Cells","YTHDF1","INTERACTS_WITH","NEDD1","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3802","36840486","METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.","NEDD1 mRNA","regulate","stability","Diffuse Large B-cell Lymphoma Cells","NEDD1","AFFECTS","stability","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3804","36840945","METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2.","METTL16","promote","Translation","Lung Tumorigenesis","METTL16","STIMULATES","translation","LUSC(Lung Squamous Cell Carcinoma)"
"3805","36840945","METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2.","METTL16","sequester","eIF4E2","Lung Tumorigenesis","METTL16","sequester","EIF4E2","LUSC(Lung Squamous Cell Carcinoma)"
"3807","36845072","Osthole regulates N6-methyladenosine-modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease.","Osthole","regulate","N6-methyladenosine","Rheumatoid Arthritis and associated Interstitial Lung Disease","osthole","AFFECTS","m6A","Rheumatoid Arthritis and associated Interstitial Lung Disease"
"3808","36845072","Osthole regulates N6-methyladenosine-modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease.","N6-methyladenosine","modify","TGM2","Rheumatoid Arthritis and associated Interstitial Lung Disease","m6A","AFFECTS","TGM2","Rheumatoid Arthritis and associated Interstitial Lung Disease"
"3809","36845072","Osthole regulates N6-methyladenosine-modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease.","TGM2","inhibit","Progression","Rheumatoid Arthritis and associated Interstitial Lung Disease","TGM2","INHIBITS","progression","Rheumatoid Arthritis and associated Interstitial Lung Disease"
"3810","36845072","Osthole regulates N6-methyladenosine-modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease.","Osthole","inhibit","Progression","Rheumatoid Arthritis and associated Interstitial Lung Disease","osthole","INHIBITS","progression","Rheumatoid Arthritis and associated Interstitial Lung Disease"
"3812","36849408","WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine.","WTAP","regulate","Autophagy","Colon Cancer Cells","WTAP","AFFECTS","autophagy","COAD(Colon Adenocarcinoma)"
"3813","36849408","WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine.","WTAP","inhibit","FLNA","Colon Cancer Cells","WTAP","INHIBITS","FLNA","COAD(Colon Adenocarcinoma)"
"3814","36849408","WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine.","WTAP","regulate","N6-methyladenosine","Colon Cancer Cells","WTAP","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"3815","36849408","WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine.","N6-methyladenosine","regulate","FLNA","Colon Cancer Cells","m6A","AFFECTS","FLNA","COAD(Colon Adenocarcinoma)"
"3817","36851875","ALKBH5-induced circRNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2.","ALKBH5","induce","circRNA NRIP1","Thyroid Cancer Cells","ALKBH5","CAUSES","circRNA NRIP1","THCA(Thyroid Carcinoma)"
"3818","36851875","ALKBH5-induced circRNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2.","circRNA NRIP1","promote","Glycolysis","Thyroid Cancer Cells","circRNA NRIP1","STIMULATES","glycolytic process","THCA(Thyroid Carcinoma)"
"3819","36851875","ALKBH5-induced circRNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2.","circRNA NRIP1","target","PKM2","Thyroid Cancer Cells","circRNA NRIP1","INTERACTS_WITH","PKM","THCA(Thyroid Carcinoma)"
"3820","36851875","ALKBH5-induced circRNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2.","PKM2","regulate","Glycolysis","Thyroid Cancer Cells","PKM","AFFECTS","glycolytic process","THCA(Thyroid Carcinoma)"
"3823","36690262","WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.","WTAP","contribute","Tumorigenesis","Osteosarcoma","WTAP","AFFECTS","Carcinogenesis","SARC(Sarcoma)"
"3824","36690262","WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.","WTAP","modulate","ALB","Osteosarcoma","WTAP","AFFECTS","ALB","SARC(Sarcoma)"
"3825","36690262","WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.","WTAP","regulate","m6A","Osteosarcoma","WTAP","AFFECTS","m6A","SARC(Sarcoma)"
"3826","36690262","WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.","ALB","contribute","Tumorigenesis","Osteosarcoma","ALB","AFFECTS","Carcinogenesis","SARC(Sarcoma)"
"3828","36691046","CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification.","CCL3","promote","Metastasis","Hepatocytes","CCL3","STIMULATES","Neoplasm Metastasis","Hepatocytes"
"3829","36691046","CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification.","VIRMA","mediate","m6A modification","Hepatocytes","VIRMA","AFFECTS","m6A","Hepatocytes"
"3830","36691046","CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification.","m6A modification","promote","Metastasis","Hepatocytes","m6A","STIMULATES","Neoplasm Metastasis","Hepatocytes"
"3832","36691477","N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis.","IGF2BP1","bind","m6A","Clear-cell Renal Cell Carcinoma","IGF2BP1","INTERACTS_WITH","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3833","36691477","N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis.","IGF2BP1","facilitate","Aerobic Glycolysis","Clear-cell Renal Cell Carcinoma","IGF2BP1","AUGMENTS","aerobic glycolysis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3834","36691477","N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis.","m6A","regulate","Aerobic Glycolysis","Clear-cell Renal Cell Carcinoma","m6A","AFFECTS","aerobic glycolysis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"3836","36693099","METTL3 is essential for normal progesterone signaling during embryo implantation via m6A-mediated translation control of progesterone receptor.","METTL3","is essential for","progesterone signaling","Embryo Implantation","METTL3","PREDISPOSES","Progesterone signaling pathway","embryo implantation"
"3837","36693099","METTL3 is essential for normal progesterone signaling during embryo implantation via m6A-mediated translation control of progesterone receptor.","METTL3","control","m6A","Embryo Implantation","METTL3","AFFECTS","m6A","embryo implantation"
"3838","36693099","METTL3 is essential for normal progesterone signaling during embryo implantation via m6A-mediated translation control of progesterone receptor.","m6A","is on","progesterone receptor","Embryo Implantation","m6A","LOCATES","PGR","embryo implantation"
"3839","36693099","METTL3 is essential for normal progesterone signaling during embryo implantation via m6A-mediated translation control of progesterone receptor.","progesterone receptor","regulate","progesterone signaling","Embryo Implantation","PGR","AFFECTS","Progesterone signaling pathway","embryo implantation"
"3841","36693492","m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer.","HNRNPA2B1","destabilize","ATG4B","Breast Cancer","HNRNPA2B1","DISRUPTS","ATG4B","BRCA(Breast Invasive Carcinoma)"
"3842","36693492","m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer.","ATG4B","regulate","autophagic activity","Breast Cancer","ATG4B","AFFECTS","autophagic activity","BRCA(Breast Invasive Carcinoma)"
"3843","36693492","m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer.","ATG4B","regulate","proliferation","Breast Cancer","ATG4B","AFFECTS","cell population proliferation","BRCA(Breast Invasive Carcinoma)"
"3844","36693492","m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer.","ATG4B","regulate","olaparib sensitivity","Breast Cancer","ATG4B","AFFECTS","olaparib sensitivity","BRCA(Breast Invasive Carcinoma)"
"3845","36693492","m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer.","HNRNPA2B1","regulate","autophagic activity","Breast Cancer","HNRNPA2B1","AFFECTS","autophagic activity","BRCA(Breast Invasive Carcinoma)"
"3846","36693492","m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer.","HNRNPA2B1","regulate","proliferation","Breast Cancer","HNRNPA2B1","AFFECTS","cell population proliferation","BRCA(Breast Invasive Carcinoma)"
"3847","36693492","m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer.","HNRNPA2B1","regulate","olaparib sensitivity","Breast Cancer","HNRNPA2B1","AFFECTS","olaparib sensitivity","BRCA(Breast Invasive Carcinoma)"
"3849","36700472","N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.","N6-methyladenine","induce","LINC00667","Breast Cancer","m6A","CAUSES","LINC00667","BRCA(Breast Invasive Carcinoma)"
"3850","36700472","N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.","LINC00667","regulate","m6A","Breast Cancer","LINC00667","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"3851","36700472","N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.","KIAA1429","bind","m6A","Breast Cancer","VIRMA","INTERACTS_WITH","m6A","BRCA(Breast Invasive Carcinoma)"
"3852","36700472","N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.","m6A","promote","Breast Cancer Progression","Breast Cancer","m6A","STIMULATES","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"3854","36705046","ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via a m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.","ALKBH5","inhibit","SIRT3/ACC1 axis","Cervical Squamous Cell Carcinoma","ALKBH5","INHIBITS","SIRT3/ACC1 axis","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3855","36705046","ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via a m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.","ALKBH5","regulate","m6A","Cervical Squamous Cell Carcinoma","ALKBH5","AFFECTS","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3856","36705046","ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via a m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.","IGF2BP1","bind","m6A","Cervical Squamous Cell Carcinoma","IGF2BP1","INTERACTS_WITH","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3857","36705046","ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via a m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.","m6A","regulate","fatty acid metabolism","Cervical Squamous Cell Carcinoma","m6A","AFFECTS","fatty acid metabolic process","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3859","36705430","METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2.","METTL3","potentiate","osteogenic differentiation","Bone Marrow Mesenchymal Stem Cells","METTL3","AUGMENTS","Osteogenic Differentiation","Bone Marrow Mesenchymal Stem Cells"
"3860","36705430","METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2.","METTL3","regulate","IGF2BP1","Bone Marrow Mesenchymal Stem Cells","METTL3","AFFECTS","IGF2BP1","Bone Marrow Mesenchymal Stem Cells"
"3861","36705430","METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2.","IGF2BP1","bind","m6A","Bone Marrow Mesenchymal Stem Cells","IGF2BP1","INTERACTS_WITH","m6A","Bone Marrow Mesenchymal Stem Cells"
"3862","36705430","METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2.","m6A","regulate","RUNX2","Bone Marrow Mesenchymal Stem Cells","m6A","AFFECTS","RUNX2","Bone Marrow Mesenchymal Stem Cells"
"3863","36705430","METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2.","RUNX2","regulate","osteogenic differentiation","Bone Marrow Mesenchymal Stem Cells","RUNX2","AFFECTS","Osteogenic Differentiation","Bone Marrow Mesenchymal Stem Cells"
"3865","36709989","m6 A mRNA methylation in human brain is disrupted in Lewy body disorders.","m6A mRNA methylation","disrupt","Lewy body disorders","Human Brain","m6A","DISRUPTS","Lewy body disorders","Human Brain"
"3867","36711243","MAEL gene contributes to bovine testicular development through the m5C-mediated splicing.","MAEL gene","contribute","splicing","Bovine Testicular Development","MAEL gene","AFFECTS","splicing","Bovine Testicular Development"
"3868","36711243","MAEL gene contributes to bovine testicular development through the m5C-mediated splicing.","MAEL gene","regulate","m5C","Bovine Testicular Development","MAEL gene","AFFECTS","m5C","Bovine Testicular Development"
"3869","36711243","MAEL gene contributes to bovine testicular development through the m5C-mediated splicing.","m5C","regulate","splicing","Bovine Testicular Development","m5C","AFFECTS","splicing","Bovine Testicular Development"
"3871","36711495","Light and temperature regulate m 6 A-RNA modification to regulate growth in plants.","Light","regulate","m6A-RNA modification","Plants","Light","AFFECTS","m6A","Plants"
"3872","36711495","Light and temperature regulate m 6 A-RNA modification to regulate growth in plants.","Temperature","regulate","m6A-RNA modification","Plants","Temperature","AFFECTS","m6A","Plants"
"3873","36711495","Light and temperature regulate m 6 A-RNA modification to regulate growth in plants.","m6A-RNA modification","regulate","Growth","Plants","m6A","AFFECTS","Growth","Plants"
"3875","36717220","Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer.","YTHDF1","augment","antitumour immunity","Colorectal Cancer","YTHDF1","AUGMENTS","anti-tumor immunity","COAD(Colon Adenocarcinoma)"
"3876","36717220","Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer.","YTHDF1","boost","anti-PD-1 efficacy","Colorectal Cancer","YTHDF1","boost","anti-PD-1 efficacy","COAD(Colon Adenocarcinoma)"
"3878","36718950","HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer.","HNRNPC","suppress","Tumor Immune Microenvironment","Prostate Cancer","HNRNPC","INHIBITS","Tumor Immune Microenvironment","PRAD(Prostate Adenocarcinoma)"
"3879","36718950","HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer.","HNRNPC","activate","Treg cells","Prostate Cancer","HNRNPC","STIMULATES","T-Lymphocytes, Regulatory","PRAD(Prostate Adenocarcinoma)"
"3880","36718950","HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer.","Treg cells","promote","Progression","Prostate Cancer","T-Lymphocytes, Regulatory","STIMULATES","progression","PRAD(Prostate Adenocarcinoma)"
"3881","36718950","HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer.","Tumor Immune Microenvironment","regulate","Progression","Prostate Cancer","Tumor Immune Microenvironment","AFFECTS","progression","PRAD(Prostate Adenocarcinoma)"
"3883","36719469","m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.","WTAP","target","NRF2","Bladder Cancer","WTAP","INTERACTS_WITH","NFE2L2","BLCA(Bladder Urothelial Carcinoma)"
"3884","36719469","m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.","WTAP","regulate","m6A","Bladder Cancer","WTAP","AFFECTS","m6A","BLCA(Bladder Urothelial Carcinoma)"
"3885","36719469","m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.","m6A","regulate","Ferroptosis Regulation","Bladder Cancer","m6A","AFFECTS","Ferroptosis Regulation","BLCA(Bladder Urothelial Carcinoma)"
"3886","36719469","m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.","Ferroptosis Regulation","accelerate","Bladder Cancer Malignancy","Bladder Cancer","Ferroptosis Regulation","STIMULATES","Bladder Cancer Malignancy","BLCA(Bladder Urothelial Carcinoma)"
"3888","36722312","The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K-Akt-mTOR signalling.","YTHDC1","regulate","Muscle Stem Cell Proliferation","Muscle Stem Cells","YTHDC1","AFFECTS","Muscle Stem Cell Proliferation","Muscle Stem Cells"
"3889","36722312","The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K-Akt-mTOR signalling.","YTHDC1","regulate","PI4K-Akt-mTOR signaling","Muscle Stem Cells","YTHDC1","AFFECTS","PI3K/AKT/mTOR pathway","Muscle Stem Cells"
"3890","36722312","The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K-Akt-mTOR signalling.","PI4K-Akt-mTOR signaling","regulate","Muscle Stem Cell Proliferation","Muscle Stem Cells","PI3K/AKT/mTOR pathway","AFFECTS","Muscle Stem Cell Proliferation","Muscle Stem Cells"
"3892","36725888","METTL3 regulates breast cancer-associated alternative splicing switches.","METTL3","regulate","Alternative Splicing","Breast Cancer","METTL3","AFFECTS","Alternative Splicing","BRCA(Breast Invasive Carcinoma)"
"3893","36725888","METTL3 regulates breast cancer-associated alternative splicing switches.","Alternative Splicing","regulate","Switches","Breast Cancer","Alternative Splicing","AFFECTS","Switches","BRCA(Breast Invasive Carcinoma)"
"3895","36736530","IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression.","IGF2BP1","mediate","N6-methyladenosine modification","Intrahepatic Cholangiocarcinoma","IGF2BP1","AFFECTS","m6A","CHOL(Cholangiocarcinoma)"
"3896","36736530","IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression.","N6-methyladenosine modification","promote","progression","Intrahepatic Cholangiocarcinoma","m6A","STIMULATES","progression","CHOL(Cholangiocarcinoma)"
"3898","36739042","YTHDF2 controls hexavalent chromium-induced mitophagy through modulating Hif1alpha and Bnip3 decay via the m6A/mRNA pathway in spermatogonial stem cells/progenitors.","YTHDF2","control","Hexavalent Chromium-induced Mitophagy","Spermatogonial Stem Cells/Progenitors","YTHDF2","AFFECTS","Hexavalent Chromium-induced Mitophagy","Spermatogonial Stem Cells/Progenitors"
"3899","36739042","YTHDF2 controls hexavalent chromium-induced mitophagy through modulating Hif1alpha and Bnip3 decay via the m6A/mRNA pathway in spermatogonial stem cells/progenitors.","YTHDF2","modulate","Hif1alpha","Spermatogonial Stem Cells/Progenitors","YTHDF2","AFFECTS","HIF1A","Spermatogonial Stem Cells/Progenitors"
"3900","36739042","YTHDF2 controls hexavalent chromium-induced mitophagy through modulating Hif1alpha and Bnip3 decay via the m6A/mRNA pathway in spermatogonial stem cells/progenitors.","YTHDF2","modulate","Bnip3","Spermatogonial Stem Cells/Progenitors","YTHDF2","AFFECTS","BNIP3","Spermatogonial Stem Cells/Progenitors"
"3901","36739042","YTHDF2 controls hexavalent chromium-induced mitophagy through modulating Hif1alpha and Bnip3 decay via the m6A/mRNA pathway in spermatogonial stem cells/progenitors.","YTHDF2","modulate","m6A/mRNA pathway","Spermatogonial Stem Cells/Progenitors","YTHDF2","AFFECTS","m6A/mRNA pathway","Spermatogonial Stem Cells/Progenitors"
"3902","36739042","YTHDF2 controls hexavalent chromium-induced mitophagy through modulating Hif1alpha and Bnip3 decay via the m6A/mRNA pathway in spermatogonial stem cells/progenitors.","Hif1alpha","regulate","Hexavalent Chromium-induced Mitophagy","Spermatogonial Stem Cells/Progenitors","HIF1A","AFFECTS","Hexavalent Chromium-induced Mitophagy","Spermatogonial Stem Cells/Progenitors"
"3903","36739042","YTHDF2 controls hexavalent chromium-induced mitophagy through modulating Hif1alpha and Bnip3 decay via the m6A/mRNA pathway in spermatogonial stem cells/progenitors.","Bnip3","regulate","Hexavalent Chromium-induced Mitophagy","Spermatogonial Stem Cells/Progenitors","BNIP3","AFFECTS","Hexavalent Chromium-induced Mitophagy","Spermatogonial Stem Cells/Progenitors"
"3905","36739231","Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.","ZC3H13","suppress","Papillary Thyroid Carcinoma Growth","Papillary Thyroid Carcinoma","ZC3H13","INHIBITS","Papillary Thyroid Carcinoma Growth","THCA(Thyroid Carcinoma)"
"3906","36739231","Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.","ZC3H13","regulate","m6A modification","Papillary Thyroid Carcinoma","ZC3H13","AFFECTS","m6A","THCA(Thyroid Carcinoma)"
"3907","36739231","Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.","m6A modification","mediate","IQGAP1","Papillary Thyroid Carcinoma","m6A","AFFECTS","IQGAP1","THCA(Thyroid Carcinoma)"
"3908","36739231","Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.","IQGAP1","regulate","Papillary Thyroid Carcinoma Growth","Papillary Thyroid Carcinoma","IQGAP1","AFFECTS","Papillary Thyroid Carcinoma Growth","THCA(Thyroid Carcinoma)"
"3910","36750551","RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA.","RBM3","suppress","stemness remodeling","Bone Microenvironment","RBM3","INHIBITS","stemness remodeling","Bone Microenvironment"
"3911","36750551","RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA.","RBM3","modulate","m6A","Bone Microenvironment","RBM3","AFFECTS","m6A","Bone Microenvironment"
"3912","36750551","RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA.","m6A","is on","CTNNB1 mRNA","Bone Microenvironment","m6A","LOCATES","CTNNB1","Bone Microenvironment"
"3913","36750551","RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA.","CTNNB1 mRNA","regulate","stemness remodeling","Bone Microenvironment","CTNNB1","AFFECTS","stemness remodeling","Bone Microenvironment"
"3915","36752613","Heterogeneous Nuclear Protein U Degraded the m6A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.","Heterogeneous Nuclear Protein U","degrade","m6A","Porcine Epidemic Diarrhea Virus Replication","Heterogeneous Nuclear Protein U","INHIBITS","m6A","Porcine Epidemic Diarrhea Virus Replication"
"3916","36752613","Heterogeneous Nuclear Protein U Degraded the m6A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.","m6A","is on","TRAF3 Transcript","Porcine Epidemic Diarrhea Virus Replication","m6A","LOCATES","TRAF3 Transcript","Porcine Epidemic Diarrhea Virus Replication"
"3917","36752613","Heterogeneous Nuclear Protein U Degraded the m6A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.","TRAF3 Transcript","promote","Virus Replication","Porcine Epidemic Diarrhea Virus Replication","TRAF3 Transcript","STIMULATES","Virus Replication","Porcine Epidemic Diarrhea Virus Replication"
"3918","36752613","Heterogeneous Nuclear Protein U Degraded the m6A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.","YTHDF2","bind","m6A","Porcine Epidemic Diarrhea Virus Replication","YTHDF2","INTERACTS_WITH","m6A","Porcine Epidemic Diarrhea Virus Replication"
"3919","36752613","Heterogeneous Nuclear Protein U Degraded the m6A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.","m6A","regulate","Virus Replication","Porcine Epidemic Diarrhea Virus Replication","m6A","AFFECTS","Virus Replication","Porcine Epidemic Diarrhea Virus Replication"
"3921","36754578","The catalytic-dead Pcif1 regulates gene expression and fertility in Drosophila.","catalytic-dead Pcif1","regulate","gene expression","Drosophila","catalytic-dead Pcif1","AFFECTS","gene expression","Drosophila"
"3922","36754578","The catalytic-dead Pcif1 regulates gene expression and fertility in Drosophila.","catalytic-dead Pcif1","regulate","fertility","Drosophila","catalytic-dead Pcif1","AFFECTS","Fertility","Drosophila"
"3924","36755057","METTL3 stabilization by PIN1 promotes breast tumorigenesis via enhanced m6A-dependent translation.","PIN1","stabilize","METTL3","Breast Tumorigenesis","PIN1","MAINTAINS","METTL3","BRCA(Breast Invasive Carcinoma)"
"3925","36755057","METTL3 stabilization by PIN1 promotes breast tumorigenesis via enhanced m6A-dependent translation.","METTL3","enhance","translation","Breast Tumorigenesis","METTL3","AUGMENTS","translation","BRCA(Breast Invasive Carcinoma)"
"3926","36755057","METTL3 stabilization by PIN1 promotes breast tumorigenesis via enhanced m6A-dependent translation.","METTL3","regulate","m6A","Breast Tumorigenesis","METTL3","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"3927","36755057","METTL3 stabilization by PIN1 promotes breast tumorigenesis via enhanced m6A-dependent translation.","m6A","regulate","translation","Breast Tumorigenesis","m6A","AFFECTS","translation","BRCA(Breast Invasive Carcinoma)"
"3929","36760238","The m6A demethylase FTO promotes keloid formation by up-regulating COL1A1.","FTO","up-regulate","COL1A1","Keloid formation","FTO","STIMULATES","COL1A1","Keloid formation"
"3930","36760238","The m6A demethylase FTO promotes keloid formation by up-regulating COL1A1.","COL1A1","promote","Keloid formation","Keloid formation","COL1A1","STIMULATES","Keloid formation","Keloid formation"
"3932","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","Metformin","attenuate","Cell Proliferation","Multiple Myeloma Cells","metformin","INHIBITS","cell population proliferation","Multiple Myeloma Cells"
"3933","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","Metformin","encourage","Apoptosis","Multiple Myeloma Cells","metformin","encourage","apoptotic process","Multiple Myeloma Cells"
"3934","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","Metformin","suppress","METTL3","Multiple Myeloma Cells","metformin","INHIBITS","METTL3","Multiple Myeloma Cells"
"3935","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","METTL3","mediate","m6A methylation","Multiple Myeloma Cells","METTL3","AFFECTS","m6A","Multiple Myeloma Cells"
"3936","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","m6A methylation","is on","THRAP3","Multiple Myeloma Cells","m6A","LOCATES","THRAP3","Multiple Myeloma Cells"
"3937","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","m6A methylation","is on","RBM25","Multiple Myeloma Cells","m6A","LOCATES","RBM25","Multiple Myeloma Cells"
"3938","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","m6A methylation","is on","USP4","Multiple Myeloma Cells","m6A","LOCATES","USP4","Multiple Myeloma Cells"
"3939","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","THRAP3","regulate","Cell Proliferation","Multiple Myeloma Cells","THRAP3","AFFECTS","cell population proliferation","Multiple Myeloma Cells"
"3940","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","THRAP3","regulate","Apoptosis","Multiple Myeloma Cells","THRAP3","AFFECTS","apoptotic process","Multiple Myeloma Cells"
"3941","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","RBM25","regulate","Cell Proliferation","Multiple Myeloma Cells","RBM25","AFFECTS","cell population proliferation","Multiple Myeloma Cells"
"3942","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","RBM25","regulate","Apoptosis","Multiple Myeloma Cells","RBM25","AFFECTS","apoptotic process","Multiple Myeloma Cells"
"3943","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","USP4","regulate","Cell Proliferation","Multiple Myeloma Cells","USP4","AFFECTS","cell population proliferation","Multiple Myeloma Cells"
"3944","36762777","Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.","USP4","regulate","Apoptosis","Multiple Myeloma Cells","USP4","AFFECTS","apoptotic process","Multiple Myeloma Cells"
"3946","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","m6A","mediate","FZD10","Liver Cancer Stem Cells","m6A","AFFECTS","FZD10","LIHC(Liver Hepatocellular Carcinoma)"
"3947","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","FZD10","regulate","Liver Cancer Stem Cells properties","Liver Cancer Stem Cells","FZD10","AFFECTS","Liver Cancer Stem Cells properties","LIHC(Liver Hepatocellular Carcinoma)"
"3948","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","FZD10","regulate","Lenvatinib resistance","Liver Cancer Stem Cells","FZD10","AFFECTS","Lenvatinib resistance","LIHC(Liver Hepatocellular Carcinoma)"
"3949","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","FZD10","regulate","WNT/beta-catenin signaling pathway","Liver Cancer Stem Cells","FZD10","AFFECTS","WNT/beta-catenin pathway","LIHC(Liver Hepatocellular Carcinoma)"
"3950","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","FZD10","regulate","Hippo signaling pathway","Liver Cancer Stem Cells","FZD10","AFFECTS","Hippo Signaling Pathway","LIHC(Liver Hepatocellular Carcinoma)"
"3951","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","WNT/beta-catenin signaling pathway","regulate","Liver Cancer Stem Cells properties","Liver Cancer Stem Cells","WNT/beta-catenin pathway","AFFECTS","Liver Cancer Stem Cells properties","LIHC(Liver Hepatocellular Carcinoma)"
"3952","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","WNT/beta-catenin signaling pathway","regulate","Lenvatinib resistance","Liver Cancer Stem Cells","WNT/beta-catenin pathway","AFFECTS","Lenvatinib resistance","LIHC(Liver Hepatocellular Carcinoma)"
"3953","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","Hippo signaling pathway","regulate","Liver Cancer Stem Cells properties","Liver Cancer Stem Cells","Hippo Signaling Pathway","AFFECTS","Liver Cancer Stem Cells properties","LIHC(Liver Hepatocellular Carcinoma)"
"3954","36764493","M6A-mediated upregulation of FZD10 regulates liver cancer stem cells properties and lenvatinib resistance through WNT/beta-catenin and Hippo signaling pathways.","Hippo signaling pathway","regulate","Lenvatinib resistance","Liver Cancer Stem Cells","Hippo Signaling Pathway","AFFECTS","Lenvatinib resistance","LIHC(Liver Hepatocellular Carcinoma)"
"3956","36765030","O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner.","O-GlcNAcylation","modify","YTHDF2","HBV-related hepatocellular carcinoma","o-glcnacylation","AFFECTS","YTHDF2","LIHC(Liver Hepatocellular Carcinoma)"
"3957","36765030","O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner.","YTHDF2","promote","HBV-related hepatocellular carcinoma progression","HBV-related hepatocellular carcinoma","YTHDF2","STIMULATES","HBV-related hepatocellular carcinoma progression","LIHC(Liver Hepatocellular Carcinoma)"
"3958","36765030","O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner.","YTHDF2","bind","N6-methyladenosine","HBV-related hepatocellular carcinoma","YTHDF2","INTERACTS_WITH","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"3959","36765030","O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner.","N6-methyladenosine","regulate","HBV-related hepatocellular carcinoma progression","HBV-related hepatocellular carcinoma","m6A","AFFECTS","HBV-related hepatocellular carcinoma progression","LIHC(Liver Hepatocellular Carcinoma)"
"3961","36765397","METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.","METTL3","contribute","Tumor Progression","HR+HER2- Breast Cancer","METTL3","AFFECTS","Tumor Progression","BRCA(Breast Invasive Carcinoma)"
"3962","36765397","METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.","METTL3","contribute","Drug Resistance","HR+HER2- Breast Cancer","METTL3","AFFECTS","Drug Resistance","BRCA(Breast Invasive Carcinoma)"
"3963","36765397","METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.","METTL3","regulate","N6 methyladenosine","HR+HER2- Breast Cancer","METTL3","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"3964","36765397","METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.","N6 methyladenosine","regulate","Tumor Progression","HR+HER2- Breast Cancer","m6A","AFFECTS","Tumor Progression","BRCA(Breast Invasive Carcinoma)"
"3965","36765397","METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.","N6 methyladenosine","regulate","Drug Resistance","HR+HER2- Breast Cancer","m6A","AFFECTS","Drug Resistance","BRCA(Breast Invasive Carcinoma)"
"3967","36765911","F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.","N6-Methyladenosine Methylation","stabilize","F-Box Protein 43","Hepatocellular Carcinoma","m6A","MAINTAINS","FBXO43","LIHC(Liver Hepatocellular Carcinoma)"
"3968","36765911","F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.","F-Box Protein 43","enhance","Hepatocellular Carcinoma Cell Growth","Hepatocellular Carcinoma","FBXO43","AUGMENTS","Hepatocellular Carcinoma Cell Growth","LIHC(Liver Hepatocellular Carcinoma)"
"3969","36765911","F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.","F-Box Protein 43","enhance","Invasion","Hepatocellular Carcinoma","FBXO43","AUGMENTS","Neoplasm Invasiveness","LIHC(Liver Hepatocellular Carcinoma)"
"3970","36765911","F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.","F-Box Protein 43","promote degradation","p53","Hepatocellular Carcinoma","FBXO43","promote degradation","TP53","LIHC(Liver Hepatocellular Carcinoma)"
"3971","36765911","F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.","F-Box Protein 43","regulate","Ubiquitin Conjugating Enzyme E2 C","Hepatocellular Carcinoma","FBXO43","AFFECTS","UBE2C","LIHC(Liver Hepatocellular Carcinoma)"
"3972","36765911","F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.","p53","regulate","Hepatocellular Carcinoma Cell Growth","Hepatocellular Carcinoma","TP53","AFFECTS","Hepatocellular Carcinoma Cell Growth","LIHC(Liver Hepatocellular Carcinoma)"
"3973","36765911","F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner.","p53","regulate","Invasion","Hepatocellular Carcinoma","TP53","AFFECTS","Neoplasm Invasiveness","LIHC(Liver Hepatocellular Carcinoma)"
"3975","36608679","METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.","METTL16","drive","leukemogenesis","Leukemia","METTL16","STIMULATES","Leukemogenesis","LAML(Acute Myeloid Leukemia)"
"3976","36608679","METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.","METTL16","drive","leukemia stem cell self-renewal","Leukemia","METTL16","STIMULATES","leukemia stem cell self-renewal","LAML(Acute Myeloid Leukemia)"
"3977","36608679","METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.","METTL16","reprogram","BCAA metabolism","Leukemia","METTL16","CONVERTS_TO","BCAA metabolism","LAML(Acute Myeloid Leukemia)"
"3978","36608679","METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.","BCAA metabolism","regulate","leukemogenesis","Leukemia","BCAA metabolism","AFFECTS","Leukemogenesis","LAML(Acute Myeloid Leukemia)"
"3979","36608679","METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.","BCAA metabolism","regulate","leukemia stem cell self-renewal","Leukemia","BCAA metabolism","AFFECTS","leukemia stem cell self-renewal","LAML(Acute Myeloid Leukemia)"
"3981","36608773","METTL3 alleviates D-gal-induced renal tubular epithelial cellular senescence via promoting miR-181a maturation.","D-gal","induce","Cellular Senescence","Renal Tubular Epithelial Cells","D-galactose","CAUSES","cellular senescence","Renal Tubular Epithelial Cells"
"3982","36608773","METTL3 alleviates D-gal-induced renal tubular epithelial cellular senescence via promoting miR-181a maturation.","METTL3","alleviate","Cellular Senescence","Renal Tubular Epithelial Cells","METTL3","INHIBITS","cellular senescence","Renal Tubular Epithelial Cells"
"3983","36608773","METTL3 alleviates D-gal-induced renal tubular epithelial cellular senescence via promoting miR-181a maturation.","METTL3","promote","miR-181a","Renal Tubular Epithelial Cells","METTL3","STIMULATES","miR-181a","Renal Tubular Epithelial Cells"
"3984","36608773","METTL3 alleviates D-gal-induced renal tubular epithelial cellular senescence via promoting miR-181a maturation.","miR-181a","undergo","Maturation","Renal Tubular Epithelial Cells","miR-181a","undergo","maturation","Renal Tubular Epithelial Cells"
"3985","36608773","METTL3 alleviates D-gal-induced renal tubular epithelial cellular senescence via promoting miR-181a maturation.","Maturation","alleviate","Cellular Senescence","Renal Tubular Epithelial Cells","maturation","INHIBITS","cellular senescence","Renal Tubular Epithelial Cells"
"3987","36608868","RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.","RBM10","recruit","METTL3","NSCLC","RBM10","recruit","METTL3","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3988","36608868","RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.","METTL3","induce","N6-methyladenosine","NSCLC","METTL3","CAUSES","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3989","36608868","RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.","MALAT1","bind","N6-methyladenosine","NSCLC","MALAT1","INTERACTS_WITH","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3990","36608868","RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.","N6-methyladenosine","inhibit","invasion and migration","NSCLC","m6A","INHIBITS","Invasion and Migration","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3992","36609396","The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.","METTL3","regulate","tumorigenesis","Breast Cancer","METTL3","AFFECTS","Carcinogenesis","BRCA(Breast Invasive Carcinoma)"
"3993","36609396","The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.","METTL3","regulate","glycolysis","Breast Cancer","METTL3","AFFECTS","glycolytic process","BRCA(Breast Invasive Carcinoma)"
"3994","36609396","The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.","METTL3","mediate","m6A methylation","Breast Cancer","METTL3","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"3995","36609396","The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.","m6A methylation","is on","LATS1","Breast Cancer","m6A","LOCATES","LATS1","BRCA(Breast Invasive Carcinoma)"
"3996","36609396","The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.","LATS1","regulate","tumorigenesis","Breast Cancer","LATS1","AFFECTS","Carcinogenesis","BRCA(Breast Invasive Carcinoma)"
"3997","36609396","The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.","LATS1","regulate","glycolysis","Breast Cancer","LATS1","AFFECTS","glycolytic process","BRCA(Breast Invasive Carcinoma)"
"3999","36609444","A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1.","potassium-chloride co-transporter","promote","tumor progression","Prostate Cancer","potassium-chloride co-transporter","STIMULATES","Tumor Progression","PRAD(Prostate Adenocarcinoma)"
"4000","36609444","A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1.","potassium-chloride co-transporter","promote","castration resistance","Prostate Cancer","potassium-chloride co-transporter","STIMULATES","castration resistance","PRAD(Prostate Adenocarcinoma)"
"4001","36609444","A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1.","potassium-chloride co-transporter","regulate","YTHDC1","Prostate Cancer","potassium-chloride co-transporter","AFFECTS","YTHDC1","PRAD(Prostate Adenocarcinoma)"
"4002","36609444","A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1.","YTHDC1","bind","m6A","Prostate Cancer","YTHDC1","INTERACTS_WITH","m6A","PRAD(Prostate Adenocarcinoma)"
"4003","36609444","A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1.","m6A","regulate","tumor progression","Prostate Cancer","m6A","AFFECTS","Tumor Progression","PRAD(Prostate Adenocarcinoma)"
"4004","36609444","A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1.","m6A","regulate","castration resistance","Prostate Cancer","m6A","AFFECTS","castration resistance","PRAD(Prostate Adenocarcinoma)"
"4006","36609501","ALKBH5 alleviates hypoxia postconditioning injury in D-galactose-induced senescent cardiomyocytes by regulating STAT3.","ALKBH5","alleviate","hypoxia postconditioning injury","D-galactose-induced senescent cardiomyocytes","ALKBH5","INHIBITS","hypoxia postconditioning injury","D-galactose-induced senescent cardiomyocytes"
"4007","36609501","ALKBH5 alleviates hypoxia postconditioning injury in D-galactose-induced senescent cardiomyocytes by regulating STAT3.","ALKBH5","regulate","STAT3","D-galactose-induced senescent cardiomyocytes","ALKBH5","AFFECTS","STAT3","D-galactose-induced senescent cardiomyocytes"
"4008","36609501","ALKBH5 alleviates hypoxia postconditioning injury in D-galactose-induced senescent cardiomyocytes by regulating STAT3.","STAT3","regulate","hypoxia postconditioning injury","D-galactose-induced senescent cardiomyocytes","STAT3","AFFECTS","hypoxia postconditioning injury","D-galactose-induced senescent cardiomyocytes"
"4010","36628934","FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.","FTO","demethylate","m6A","Gastric Cancer","FTO","CONVERTS_TO","m6A","STAD(Stomach adenocarcinoma)"
"4011","36628934","FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.","m6A","is in","CDKAL1 mRNA","Gastric Cancer","m6A","LOCATES","CDKAL1","STAD(Stomach adenocarcinoma)"
"4012","36628934","FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.","FTO","promote","chemoresistance","Gastric Cancer","FTO","STIMULATES","chemoresistance","STAD(Stomach adenocarcinoma)"
"4013","36628934","FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.","FTO","alter","mitochondrial dynamics","Gastric Cancer","FTO","AFFECTS","Mitochondrial Dynamics","STAD(Stomach adenocarcinoma)"
"4014","36628934","FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.","mitochondrial dynamics","regulate","chemoresistance","Gastric Cancer","Mitochondrial Dynamics","AFFECTS","chemoresistance","STAD(Stomach adenocarcinoma)"
"4016","36632222","ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer.","ALKBH5","activate","FAK signaling","Ovarian Cancer","ALKBH5","STIMULATES","FAK signaling pathway","OV(Ovarian Serous Cystadenocarcinoma)"
"4017","36632222","ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer.","ALKBH5","demethylate","m6A","Ovarian Cancer","ALKBH5","CONVERTS_TO","m6A","OV(Ovarian Serous Cystadenocarcinoma)"
"4018","36632222","ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer.","m6A","is on","ITGB1 mRNA","Ovarian Cancer","m6A","LOCATES","ITGB1","OV(Ovarian Serous Cystadenocarcinoma)"
"4019","36632222","ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer.","FAK signaling","enhance","tumor-associated lymphangiogenesis","Ovarian Cancer","FAK signaling pathway","AUGMENTS","tumor-associated lymphangiogenesis","OV(Ovarian Serous Cystadenocarcinoma)"
"4020","36632222","ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer.","FAK signaling","enhance","lymph node metastasis","Ovarian Cancer","FAK signaling pathway","AUGMENTS","lymph node metastatic carcinoma","OV(Ovarian Serous Cystadenocarcinoma)"
"4022","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","Dummy","inhibit","IGF2BP1","Kidney","dummy","INHIBITS","IGF2BP1","Kidney"
"4023","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","IGF2BP1","attenuate","Renal Injury","Kidney","IGF2BP1","INHIBITS","Renal Injury","Kidney"
"4024","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","IGF2BP1","attenuate","Inflammation","Kidney","IGF2BP1","INHIBITS","inflammatory response","Kidney"
"4025","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","IGF2BP1","alleviate","m6A modifications","Kidney","IGF2BP1","INHIBITS","m6A","Kidney"
"4026","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","IGF2BP1","alleviate","E2F1/MIF pathway","Kidney","IGF2BP1","INHIBITS","E2F1/MIF pathway","Kidney"
"4027","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","m6A modifications","regulate","Renal Injury","Kidney","m6A","AFFECTS","Renal Injury","Kidney"
"4028","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","m6A modifications","regulate","Inflammation","Kidney","m6A","AFFECTS","inflammatory response","Kidney"
"4029","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","E2F1/MIF pathway","regulate","Renal Injury","Kidney","E2F1/MIF pathway","AFFECTS","Renal Injury","Kidney"
"4030","36632449","Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway.","E2F1/MIF pathway","regulate","Inflammation","Kidney","E2F1/MIF pathway","AFFECTS","inflammatory response","Kidney"
"4032","36632454","Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner.","USP10","stabilize","IGF2BP1","Breast Cancer","USP10","MAINTAINS","IGF2BP1","BRCA(Breast Invasive Carcinoma)"
"4033","36632454","Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner.","IGF2BP1","promote","Breast Cancer Metastasis","Breast Cancer","IGF2BP1","STIMULATES","Breast Cancer Metastasis","BRCA(Breast Invasive Carcinoma)"
"4034","36632454","Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner.","IGF2BP1","regulate","CPT1A","Breast Cancer","IGF2BP1","AFFECTS","CPT1A","BRCA(Breast Invasive Carcinoma)"
"4035","36632454","Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner.","IGF2BP1","bind","m6A","Breast Cancer","IGF2BP1","INTERACTS_WITH","m6A","BRCA(Breast Invasive Carcinoma)"
"4036","36632454","Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner.","m6A","promote","Breast Cancer Metastasis","Breast Cancer","m6A","STIMULATES","Breast Cancer Metastasis","BRCA(Breast Invasive Carcinoma)"
"4038","36634204","The RNA m6A reader YTHDF1 is required for acute myeloid leukemia progression.","YTHDF1","required for","leukemia progression","Acute Myeloid Leukemia","YTHDF1","CAUSES","leukemia progression","LAML(Acute Myeloid Leukemia)"
"4040","36639675","STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.","STRIP2","motivate","Non-small cell lung cancer progression","Non-small cell lung cancer","STRIP2","motivate","Non-small cell lung cancer progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4041","36639675","STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.","STRIP2","modulate","dummy","Non-small cell lung cancer","STRIP2","AFFECTS","dummy","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4042","36639675","STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.","IGF2BP3","bind","dummy","Non-small cell lung cancer","IGF2BP3","INTERACTS_WITH","dummy","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4043","36639675","STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.","dummy","regulate","Non-small cell lung cancer progression","Non-small cell lung cancer","dummy","AFFECTS","Non-small cell lung cancer progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4045","36639869","ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH.","ABRO1","arrest","cardiomyocyte proliferation","Postnatal cardiomyocytes","ABRAXAS2","arrest","cardiac muscle cell proliferation","Postnatal cardiomyocytes"
"4046","36639869","ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH.","ABRO1","arrest","myocardial repair","Postnatal cardiomyocytes","ABRAXAS2","arrest","myocardial repair","Postnatal cardiomyocytes"
"4047","36639869","ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH.","ABRO1","block","N6-methyladenosine methylation","Postnatal cardiomyocytes","ABRAXAS2","INHIBITS","m6A","Postnatal cardiomyocytes"
"4048","36639869","ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH.","ABRO1","block","PSPH","Postnatal cardiomyocytes","ABRAXAS2","INHIBITS","PSPH","Postnatal cardiomyocytes"
"4049","36639869","ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH.","N6-methyladenosine methylation","regulate","cardiomyocyte proliferation","Postnatal cardiomyocytes","m6A","AFFECTS","cardiac muscle cell proliferation","Postnatal cardiomyocytes"
"4050","36639869","ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH.","N6-methyladenosine methylation","regulate","myocardial repair","Postnatal cardiomyocytes","m6A","AFFECTS","myocardial repair","Postnatal cardiomyocytes"
"4051","36639869","ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH.","PSPH","regulate","cardiomyocyte proliferation","Postnatal cardiomyocytes","PSPH","AFFECTS","cardiac muscle cell proliferation","Postnatal cardiomyocytes"
"4052","36639869","ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH.","PSPH","regulate","myocardial repair","Postnatal cardiomyocytes","PSPH","AFFECTS","myocardial repair","Postnatal cardiomyocytes"
"4054","36642058","Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.","YTHDF2","attenuate","Autoimmune Hepatitis","Autoimmune Hepatitis","YTHDF2","INHIBITS","Hepatitis, Autoimmune","Hepatitis, Autoimmune"
"4055","36642058","Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.","YTHDF2","expand","Myeloid-derived suppressor cells","Autoimmune Hepatitis","YTHDF2","expand","Myeloid-Derived Suppressor Cells","Hepatitis, Autoimmune"
"4056","36642058","Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.","Myeloid-derived suppressor cells","attenuate","Autoimmune Hepatitis","Autoimmune Hepatitis","Myeloid-Derived Suppressor Cells","INHIBITS","Hepatitis, Autoimmune","Hepatitis, Autoimmune"
"4058","36642844","Non-SMC condensin I complex subunit H participates in anti-programmed cell death-1 resistance of clear cell renal cell carcinomas.","Non-SMC condensin I complex subunit H","participate","anti-programmed cell death-1 resistance","Clear Cell Renal Cell Carcinomas","NCAPH","participate","anti-programmed cell death-1 resistance","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4060","36645573","N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis.","METTL3","accelerate","Sepsis-induced myocardial injury","Sepsis-induced myocardial injury","METTL3","STIMULATES","Sepsis-induced myocardial injury","Sepsis-induced myocardial injury"
"4061","36645573","N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis.","METTL3","regulate","m6A","Sepsis-induced myocardial injury","METTL3","AFFECTS","m6A","Sepsis-induced myocardial injury"
"4062","36645573","N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis.","m6A","regulate","Ferroptosis","Sepsis-induced myocardial injury","m6A","AFFECTS","Ferroptosis","Sepsis-induced myocardial injury"
"4063","36645573","N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis.","Ferroptosis","accelerate","Sepsis-induced myocardial injury","Sepsis-induced myocardial injury","Ferroptosis","STIMULATES","Sepsis-induced myocardial injury","Sepsis-induced myocardial injury"
"4065","36647682","YTHDF1 enhances chondrogenic differentiation by activating the Wnt/beta-catenin signaling pathway.","YTHDF1","enhance","chondrogenic differentiation","Null","YTHDF1","AUGMENTS","chondrogenic differentiation","Null"
"4066","36647682","YTHDF1 enhances chondrogenic differentiation by activating the Wnt/beta-catenin signaling pathway.","YTHDF1","activate","Wnt/beta-catenin signaling pathway","Null","YTHDF1","STIMULATES","WNT/beta-catenin pathway","Null"
"4067","36647682","YTHDF1 enhances chondrogenic differentiation by activating the Wnt/beta-catenin signaling pathway.","Wnt/beta-catenin signaling pathway","regulate","chondrogenic differentiation","Null","WNT/beta-catenin pathway","AFFECTS","chondrogenic differentiation","Null"
"4069","36648699","LncRNA CRNDE binds hnRNPA1 to facilitate carbon monoxide poisoning-induced delayed encephalopathy via inhibiting UCHL5-mediated SMO deubiquitination.","CRNDE","bind","hnRNPA1","Carbon monoxide poisoning-induced delayed encephalopathy","CRNDE","INTERACTS_WITH","HNRNPA1","Carbon monoxide poisoning-induced delayed encephalopathy"
"4070","36648699","LncRNA CRNDE binds hnRNPA1 to facilitate carbon monoxide poisoning-induced delayed encephalopathy via inhibiting UCHL5-mediated SMO deubiquitination.","CRNDE","inhibit","UCHL5","Carbon monoxide poisoning-induced delayed encephalopathy","CRNDE","INHIBITS","UCHL5","Carbon monoxide poisoning-induced delayed encephalopathy"
"4071","36648699","LncRNA CRNDE binds hnRNPA1 to facilitate carbon monoxide poisoning-induced delayed encephalopathy via inhibiting UCHL5-mediated SMO deubiquitination.","UCHL5","mediate","SMO","Carbon monoxide poisoning-induced delayed encephalopathy","UCHL5","AFFECTS","SMO","Carbon monoxide poisoning-induced delayed encephalopathy"
"4072","36648699","LncRNA CRNDE binds hnRNPA1 to facilitate carbon monoxide poisoning-induced delayed encephalopathy via inhibiting UCHL5-mediated SMO deubiquitination.","SMO","regulate","deubiquitination","Carbon monoxide poisoning-induced delayed encephalopathy","SMO","AFFECTS","protein deubiquitination","Carbon monoxide poisoning-induced delayed encephalopathy"
"4074","36650131","WTAP-mediated m6A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis.","WTAP","mediate","m6A modification","Bone Marrow Mesenchymal Stem Cells","WTAP","AFFECTS","m6A","Bone Marrow Mesenchymal Stem Cells"
"4075","36650131","WTAP-mediated m6A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis.","m6A modification","modulate","differentiation potential","Bone Marrow Mesenchymal Stem Cells","m6A","AFFECTS","differentiation potential","Bone Marrow Mesenchymal Stem Cells"
"4076","36650131","WTAP-mediated m6A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis.","m6A modification","modulate","osteoporosis","Bone Marrow Mesenchymal Stem Cells","m6A","AFFECTS","Osteoporosis","Bone Marrow Mesenchymal Stem Cells"
"4078","36650153","Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation.","YTHDF1","drive","immune evasion","Tumor","YTHDF1","STIMULATES","Immune Evasion","PANCAN(Pan-Cancer)"
"4079","36650153","Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation.","YTHDF1","promote","MHC-I degradation","Tumor","YTHDF1","STIMULATES","MHC-I degradation","PANCAN(Pan-Cancer)"
"4080","36650153","Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation.","immune evasion","resist","immune checkpoint inhibitors","Tumor","Immune Evasion","resist","Immune Checkpoint Inhibitors","PANCAN(Pan-Cancer)"
"4081","36650153","Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation.","MHC-I degradation","induce","immune evasion","Tumor","MHC-I degradation","CAUSES","Immune Evasion","PANCAN(Pan-Cancer)"
"4083","36653190","USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA.","USP1/UAF1","stabilize","METTL3","Spinal Cord Injury","USP1/UAF1","MAINTAINS","METTL3","Spinal Cord Injuries"
"4084","36653190","USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA.","METTL3","promote","reactive astrogliosis","Spinal Cord Injury","METTL3","STIMULATES","reactive astrogliosis","Spinal Cord Injuries"
"4085","36653190","USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA.","METTL3","improve","functional recovery","Spinal Cord Injury","METTL3","STIMULATES","functional recovery","Spinal Cord Injuries"
"4086","36653190","USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA.","METTL3","modify","m6A","Spinal Cord Injury","METTL3","AFFECTS","m6A","Spinal Cord Injuries"
"4087","36653190","USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA.","m6A","is on","YAP1 mRNA","Spinal Cord Injury","m6A","LOCATES","YAP1","Spinal Cord Injuries"
"4088","36653190","USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA.","YAP1 mRNA","regulate","reactive astrogliosis","Spinal Cord Injury","YAP1","AFFECTS","reactive astrogliosis","Spinal Cord Injuries"
"4089","36653190","USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA.","YAP1 mRNA","regulate","functional recovery","Spinal Cord Injury","YAP1","AFFECTS","functional recovery","Spinal Cord Injuries"
"4091","36656457","METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.","METTL3","mediate","N6-Methyladenosine Modification","Schwann Cells after Sciatic Nerve Injury","METTL3","AFFECTS","m6A","Schwann Cells after Sciatic Nerve Injury"
"4092","36656457","METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.","N6-Methyladenosine Modification","is on","lncRNA D26496","Schwann Cells after Sciatic Nerve Injury","m6A","LOCATES","D26496","Schwann Cells after Sciatic Nerve Injury"
"4093","36656457","METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.","lncRNA D26496","suppress","Proliferation","Schwann Cells after Sciatic Nerve Injury","D26496","INHIBITS","cell population proliferation","Schwann Cells after Sciatic Nerve Injury"
"4094","36656457","METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.","lncRNA D26496","suppress","Migration","Schwann Cells after Sciatic Nerve Injury","D26496","INHIBITS","migration","Schwann Cells after Sciatic Nerve Injury"
"4096","36657656","IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis.","METTL3","promote","IGFBP3","Cardiac Fibroblast","METTL3","STIMULATES","IGFBP3","cardiac fibroblast"
"4097","36657656","IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis.","IGFBP3","boost","Cardiac Fibroblast Activation","Cardiac Fibroblast","IGFBP3","boost","Cardiac Fibroblast Activation","cardiac fibroblast"
"4098","36657656","IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis.","IGFBP3","boost","Fibrosis","Cardiac Fibroblast","IGFBP3","boost","Fibrosis","cardiac fibroblast"
"4100","36658237","YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.","YTHDF2","orchestrate","macrophage reprogramming","Tumor-associated macrophages","YTHDF2","orchestrate","macrophage reprogramming","Tumor-Associated Macrophages"
"4101","36658237","YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.","YTHDF2","control","CD8+ T cells","Tumor-associated macrophages","YTHDF2","AFFECTS","CD8+ T cells","Tumor-Associated Macrophages"
"4102","36658237","YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.","CD8+ T cells","control","antitumor immunity","Tumor-associated macrophages","CD8+ T cells","AFFECTS","antitumor immunity","Tumor-Associated Macrophages"
"4103","36658237","YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.","macrophage reprogramming","regulate","antitumor immunity","Tumor-associated macrophages","macrophage reprogramming","AFFECTS","antitumor immunity","Tumor-Associated Macrophages"
"4105","36662856","Lnc956 regulates mouse embryonic stem cell differentiation in response to DNA damage in a p53-independent pathway.","Lnc956","regulate","differentiation","Mouse embryonic stem cell","Lnc956","AFFECTS","cell differentiation","Mouse Embryonic Stem Cells"
"4106","36662856","Lnc956 regulates mouse embryonic stem cell differentiation in response to DNA damage in a p53-independent pathway.","DNA damage","respond","Lnc956","Mouse embryonic stem cell","DNA Damage","respond","Lnc956","Mouse Embryonic Stem Cells"
"4107","36662856","Lnc956 regulates mouse embryonic stem cell differentiation in response to DNA damage in a p53-independent pathway.","Lnc956","through","p53-independent pathway","Mouse embryonic stem cell","Lnc956","through","p53-independent pathway","Mouse Embryonic Stem Cells"
"4109","36670199","YTHDF2 in dentate gyrus is the m6A reader mediating m6A modification in hippocampus-dependent learning and memory.","YTHDF2","mediate","m6A modification","Dentate Gyrus","YTHDF2","AFFECTS","m6A","Dentate Gyrus"
"4110","36670199","YTHDF2 in dentate gyrus is the m6A reader mediating m6A modification in hippocampus-dependent learning and memory.","m6A modification","is in","hippocampus-dependent learning and memory","Dentate Gyrus","m6A","LOCATES","hippocampus-dependent learning and memory","Dentate Gyrus"
"4112","36681189","YTH domain family 2 (YTHDF2) regulates cell growth and cycle by facilitating KDM1A mRNA stability.","YTHDF2","regulate","cell growth","Cells","YTHDF2","AFFECTS","cell growth","Cells"
"4113","36681189","YTH domain family 2 (YTHDF2) regulates cell growth and cycle by facilitating KDM1A mRNA stability.","YTHDF2","regulate","cell cycle","Cells","YTHDF2","AFFECTS","cell cycle","Cells"
"4114","36681189","YTH domain family 2 (YTHDF2) regulates cell growth and cycle by facilitating KDM1A mRNA stability.","YTHDF2","facilitate","KDM1A mRNA","Cells","YTHDF2","AUGMENTS","KDM1A","Cells"
"4115","36681189","YTH domain family 2 (YTHDF2) regulates cell growth and cycle by facilitating KDM1A mRNA stability.","KDM1A mRNA","regulate","cell growth","Cells","KDM1A","AFFECTS","cell growth","Cells"
"4116","36681189","YTH domain family 2 (YTHDF2) regulates cell growth and cycle by facilitating KDM1A mRNA stability.","KDM1A mRNA","regulate","cell cycle","Cells","KDM1A","AFFECTS","cell cycle","Cells"
"4118","36681355","N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.","HNRNPC","promote","Vascular Endothelial Dysfunction","Type 2 Diabetes Mellitus","HNRNPC","STIMULATES","Vascular Endothelial Dysfunction","Diabetes Mellitus, Type 2"
"4119","36681355","N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.","HNRNPC","activate","PSEN1","Type 2 Diabetes Mellitus","HNRNPC","STIMULATES","PSEN1","Diabetes Mellitus, Type 2"
"4120","36681355","N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.","PSEN1","mediate","Notch Pathway","Type 2 Diabetes Mellitus","PSEN1","AFFECTS","Notch signaling pathway","Diabetes Mellitus, Type 2"
"4121","36681355","N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.","Notch Pathway","regulate","Vascular Endothelial Dysfunction","Type 2 Diabetes Mellitus","Notch signaling pathway","AFFECTS","Vascular Endothelial Dysfunction","Diabetes Mellitus, Type 2"
"4123","36683086","METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability.","dummy","induce knockdown of","METTL3","Glioma Stem Cells","dummy","INHIBITS","METTL3","Glioma Stem Cells"
"4124","36683086","METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability.","METTL3","promote","temozolomide sensitivity","Glioma Stem Cells","METTL3","STIMULATES","temozolomide sensitivity","Glioma Stem Cells"
"4125","36683086","METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability.","METTL3","decrease","MGMT","Glioma Stem Cells","METTL3","INHIBITS","MGMT","Glioma Stem Cells"
"4126","36683086","METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability.","METTL3","decrease","APNG","Glioma Stem Cells","METTL3","INHIBITS","APNG","Glioma Stem Cells"
"4127","36683086","METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability.","MGMT","regulate","mRNA stability","Glioma Stem Cells","MGMT","AFFECTS","mrna stability","Glioma Stem Cells"
"4128","36683086","METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability.","APNG","regulate","mRNA stability","Glioma Stem Cells","APNG","AFFECTS","mrna stability","Glioma Stem Cells"
"4130","36685533","m6A eraser FTO modulates autophagy by targeting SQSTM1/P62 in the prevention of canagliflozin against renal fibrosis.","FTO","modulate","Autophagy","Renal Fibrosis","FTO","AFFECTS","autophagy","Renal fibrosis"
"4131","36685533","m6A eraser FTO modulates autophagy by targeting SQSTM1/P62 in the prevention of canagliflozin against renal fibrosis.","FTO","target","SQSTM1/P62","Renal Fibrosis","FTO","INTERACTS_WITH","SQSTM1/P62","Renal fibrosis"
"4133","36536495","Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2 mRNA in fibroblast-like synoviocytes.","Artemisitene","suppress","Rheumatoid Arthritis Progression","Fibroblast-like Synoviocytes","artemisitene","INHIBITS","Rheumatoid Arthritis Progression","Fibroblast-like Synoviocytes"
"4134","36536495","Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2 mRNA in fibroblast-like synoviocytes.","Artemisitene","modulate","METTL3","Fibroblast-like Synoviocytes","artemisitene","AFFECTS","METTL3","Fibroblast-like Synoviocytes"
"4135","36536495","Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2 mRNA in fibroblast-like synoviocytes.","METTL3","mediate","N6-methyladenosine","Fibroblast-like Synoviocytes","METTL3","AFFECTS","m6A","Fibroblast-like Synoviocytes"
"4136","36536495","Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2 mRNA in fibroblast-like synoviocytes.","N6-methyladenosine","is on","ICAM2 mRNA","Fibroblast-like Synoviocytes","m6A","LOCATES","ICAM2","Fibroblast-like Synoviocytes"
"4137","36536495","Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2 mRNA in fibroblast-like synoviocytes.","ICAM2 mRNA","regulate","Rheumatoid Arthritis Progression","Fibroblast-like Synoviocytes","ICAM2","AFFECTS","Rheumatoid Arthritis Progression","Fibroblast-like Synoviocytes"
"4139","36538851","Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4/MyD88/NF-kappaB axis.","dummy","induce overexpression of","FTO","Osteoarthritis","dummy","induce overexpression of","FTO","Osteoarthritis"
"4140","36538851","Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4/MyD88/NF-kappaB axis.","FTO","regulate","miR-515-5p","Osteoarthritis","FTO","AFFECTS","miR-515-5p","Osteoarthritis"
"4141","36538851","Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4/MyD88/NF-kappaB axis.","FTO","regulate","TLR4/MyD88/NF-kappaB axis","Osteoarthritis","FTO","AFFECTS","TLR4/MyD88/NF-kappaB axis","Osteoarthritis"
"4142","36538851","Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4/MyD88/NF-kappaB axis.","miR-515-5p","regulate","TLR4/MyD88/NF-kappaB axis","Osteoarthritis","miR-515-5p","AFFECTS","TLR4/MyD88/NF-kappaB axis","Osteoarthritis"
"4143","36538851","Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4/MyD88/NF-kappaB axis.","TLR4/MyD88/NF-kappaB axis","alleviate","dummy","Osteoarthritis","TLR4/MyD88/NF-kappaB axis","INHIBITS","dummy","Osteoarthritis"
"4145","36542845","HDAC1 overexpression promoted by METTL3-IGF2BP2 inhibits FGF21 expression in metabolic syndrome-related liver injury.","METTL3","promote","HDAC1","Metabolic Syndrome-related Liver Injury","METTL3","STIMULATES","HDAC1","Metabolic Syndrome-related Liver Injury"
"4146","36542845","HDAC1 overexpression promoted by METTL3-IGF2BP2 inhibits FGF21 expression in metabolic syndrome-related liver injury.","IGF2BP2","promote","HDAC1","Metabolic Syndrome-related Liver Injury","IGF2BP2","STIMULATES","HDAC1","Metabolic Syndrome-related Liver Injury"
"4147","36542845","HDAC1 overexpression promoted by METTL3-IGF2BP2 inhibits FGF21 expression in metabolic syndrome-related liver injury.","HDAC1","inhibit","FGF21","Metabolic Syndrome-related Liver Injury","HDAC1","INHIBITS","FGF21","Metabolic Syndrome-related Liver Injury"
"4149","36545239","Intrathecal administration of the fat-mass and obesity-associated protein inhibitor mitigates neuropathic pain in female rats.","fat-mass and obesity-associated protein inhibitor","mitigate","neuropathic pain","Female Rats","fat-mass and obesity-associated protein inhibitor","INHIBITS","Neuralgia","Female Rats"
"4151","36546578","METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells.","METTL3","suppress","proliferation","Endometriosis and Endometrial Stromal Cells","METTL3","INHIBITS","cell population proliferation","UCEC(Uterine Corpus Endometrial Carcinoma)"
"4152","36546578","METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells.","METTL3","suppress","invasion","Endometriosis and Endometrial Stromal Cells","METTL3","INHIBITS","Neoplasm Invasiveness","UCEC(Uterine Corpus Endometrial Carcinoma)"
"4153","36546578","METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells.","METTL3","suppress","migration","Endometriosis and Endometrial Stromal Cells","METTL3","INHIBITS","migration","UCEC(Uterine Corpus Endometrial Carcinoma)"
"4155","36550542","The YTHDF1-TRAF6 pathway regulates the neuroinflammatory response and contributes to morphine tolerance and hyperalgesia in the periaqueductal gray.","YTHDF1-TRAF6 pathway","regulate","neuroinflammatory response","Periaqueductal gray","YTHDF1-TRAF6 pathway","AFFECTS","neuroinflammatory response","Periaqueductal Gray"
"4156","36550542","The YTHDF1-TRAF6 pathway regulates the neuroinflammatory response and contributes to morphine tolerance and hyperalgesia in the periaqueductal gray.","YTHDF1-TRAF6 pathway","contribute","morphine tolerance","Periaqueductal gray","YTHDF1-TRAF6 pathway","AFFECTS","morphine tolerance","Periaqueductal Gray"
"4157","36550542","The YTHDF1-TRAF6 pathway regulates the neuroinflammatory response and contributes to morphine tolerance and hyperalgesia in the periaqueductal gray.","YTHDF1-TRAF6 pathway","contribute","hyperalgesia","Periaqueductal gray","YTHDF1-TRAF6 pathway","AFFECTS","Hyperalgesia","Periaqueductal Gray"
"4159","36551532","GMEB2 Promotes the Growth of Colorectal Cancer by Activating ADRM1 Transcription and NF-kappaB Signalling and Is Positively Regulated by the m6A Reader YTHDF1.","GMEB2","promote","Growth","Colorectal Cancer","GMEB2","STIMULATES","Growth","COAD(Colon Adenocarcinoma)"
"4160","36551532","GMEB2 Promotes the Growth of Colorectal Cancer by Activating ADRM1 Transcription and NF-kappaB Signalling and Is Positively Regulated by the m6A Reader YTHDF1.","GMEB2","activate","ADRM1 Transcription","Colorectal Cancer","GMEB2","STIMULATES","ADRM1 Transcription","COAD(Colon Adenocarcinoma)"
"4161","36551532","GMEB2 Promotes the Growth of Colorectal Cancer by Activating ADRM1 Transcription and NF-kappaB Signalling and Is Positively Regulated by the m6A Reader YTHDF1.","GMEB2","activate","NF-kappaB Signalling","Colorectal Cancer","GMEB2","STIMULATES","NF-kappaB signaling pathway","COAD(Colon Adenocarcinoma)"
"4162","36551532","GMEB2 Promotes the Growth of Colorectal Cancer by Activating ADRM1 Transcription and NF-kappaB Signalling and Is Positively Regulated by the m6A Reader YTHDF1.","YTHDF1","regulate","GMEB2","Colorectal Cancer","YTHDF1","AFFECTS","GMEB2","COAD(Colon Adenocarcinoma)"
"4163","36551532","GMEB2 Promotes the Growth of Colorectal Cancer by Activating ADRM1 Transcription and NF-kappaB Signalling and Is Positively Regulated by the m6A Reader YTHDF1.","ADRM1 Transcription","regulate","Growth","Colorectal Cancer","ADRM1 Transcription","AFFECTS","Growth","COAD(Colon Adenocarcinoma)"
"4164","36551532","GMEB2 Promotes the Growth of Colorectal Cancer by Activating ADRM1 Transcription and NF-kappaB Signalling and Is Positively Regulated by the m6A Reader YTHDF1.","NF-kappaB Signalling","regulate","Growth","Colorectal Cancer","NF-kappaB signaling pathway","AFFECTS","Growth","COAD(Colon Adenocarcinoma)"
"4166","36555401","m6A-Mediated PPARA Translational Suppression Contributes to Corticosterone-Induced Visceral Fat Deposition in Chickens.","m6A","mediate","PPARA","Chickens","m6A","AFFECTS","PPARA","Chickens"
"4167","36555401","m6A-Mediated PPARA Translational Suppression Contributes to Corticosterone-Induced Visceral Fat Deposition in Chickens.","PPARA","contribute","Visceral Fat Deposition","Chickens","PPARA","AFFECTS","Visceral Fat Deposition","Chickens"
"4168","36555401","m6A-Mediated PPARA Translational Suppression Contributes to Corticosterone-Induced Visceral Fat Deposition in Chickens.","Corticosterone","induce","Visceral Fat Deposition","Chickens","corticosterone","CAUSES","Visceral Fat Deposition","Chickens"
"4170","36555463","The N6-Methyladenosine Regulator ALKBH5 Mediated Stromal Cell-Macrophage Interaction via VEGF Signaling to Promote Recurrent Spontaneous Abortion: A Bioinformatic and In Vitro Study.","ALKBH5","mediate","Stromal Cell-Macrophage Interaction","Bioinformatic and In Vitro Study","ALKBH5","AFFECTS","Stromal Cell-Macrophage Interaction","Bioinformatic and In Vitro Study"
"4171","36555463","The N6-Methyladenosine Regulator ALKBH5 Mediated Stromal Cell-Macrophage Interaction via VEGF Signaling to Promote Recurrent Spontaneous Abortion: A Bioinformatic and In Vitro Study.","Stromal Cell-Macrophage Interaction","via","VEGF Signaling","Bioinformatic and In Vitro Study","Stromal Cell-Macrophage Interaction","via","vascular endothelial growth factor signaling pathway","Bioinformatic and In Vitro Study"
"4172","36555463","The N6-Methyladenosine Regulator ALKBH5 Mediated Stromal Cell-Macrophage Interaction via VEGF Signaling to Promote Recurrent Spontaneous Abortion: A Bioinformatic and In Vitro Study.","VEGF Signaling","promote","Recurrent Spontaneous Abortion","Bioinformatic and In Vitro Study","vascular endothelial growth factor signaling pathway","STIMULATES","Recurrent spontaneous abortion","Bioinformatic and In Vitro Study"
"4173","36555463","The N6-Methyladenosine Regulator ALKBH5 Mediated Stromal Cell-Macrophage Interaction via VEGF Signaling to Promote Recurrent Spontaneous Abortion: A Bioinformatic and In Vitro Study.","ALKBH5","regulate","VEGF Signaling","Bioinformatic and In Vitro Study","ALKBH5","AFFECTS","vascular endothelial growth factor signaling pathway","Bioinformatic and In Vitro Study"
"4175","36555481","METTL3 Regulates the Inflammatory Response in CPB2 Toxin-Exposed IPEC-J2 Cells through the TLR2/NF-kappaB Signaling Pathway.","METTL3","regulate","Inflammatory Response","IPEC-J2 Cells","METTL3","AFFECTS","inflammatory response","IPEC-J2 Cells"
"4176","36555481","METTL3 Regulates the Inflammatory Response in CPB2 Toxin-Exposed IPEC-J2 Cells through the TLR2/NF-kappaB Signaling Pathway.","METTL3","regulate","TLR2/NF-kappaB Signaling Pathway","IPEC-J2 Cells","METTL3","AFFECTS","TLR2/NF-kappaB signaling pathway","IPEC-J2 Cells"
"4178","36564065","METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.","METTL3","mediate","N6-Methyladenosine Methylation","Peripheral Blood of Patients with Asthma","METTL3","AFFECTS","m6A","Peripheral Blood of Patients with Asthma"
"4179","36564065","METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.","N6-Methyladenosine Methylation","modify","Foxp3 mRNA","Peripheral Blood of Patients with Asthma","m6A","AFFECTS","FOXP3","Peripheral Blood of Patients with Asthma"
"4180","36564065","METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.","Foxp3 mRNA","affect","Proportion","Peripheral Blood of Patients with Asthma","FOXP3","AFFECTS","proportion","Peripheral Blood of Patients with Asthma"
"4181","36564065","METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.","Proportion","is in","Treg Cells","Peripheral Blood of Patients with Asthma","proportion","LOCATES","T-Lymphocytes, Regulatory","Peripheral Blood of Patients with Asthma"
"4183","36566000","ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation.","ALKBH5","attenuate","Mitochondrial Fission","Liver","ALKBH5","INHIBITS","mitochondrial fission","Liver"
"4184","36566000","ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation.","ALKBH5","reduce","Drp1","Liver","ALKBH5","INHIBITS","DNM1L","Liver"
"4185","36566000","ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation.","Drp1","regulate","Mitochondrial Fission","Liver","DNM1L","AFFECTS","mitochondrial fission","Liver"
"4186","36566000","ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation.","Mitochondrial Fission","ameliorate","Liver Fibrosis","Liver","mitochondrial fission","TREATS","Liver Cirrhosis","Liver"
"4188","36566195","RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer.","RNA N6-methyladenosine modification","downregulate","NR4A1","Cervical Cancer","m6A","INHIBITS","NR4A1","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"4189","36566195","RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer.","NR4A1","facilitate","malignancy","Cervical Cancer","NR4A1","AUGMENTS","cancer","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"4191","36566230","ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma.","ALKBH5","promote","PD-L1","Glioma","ALKBH5","STIMULATES","CD274","Glioma"
"4192","36566230","ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma.","ALKBH5","modify","m6A","Glioma","ALKBH5","AFFECTS","m6A","Glioma"
"4193","36566230","ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma.","m6A","is on","ZDHHC3","Glioma","m6A","LOCATES","ZDHHC3","Glioma"
"4194","36566230","ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma.","ZDHHC3","regulate","PD-L1","Glioma","ZDHHC3","AFFECTS","CD274","Glioma"
"4197","36574062","The m6A reader YTHDC2 promotes SIRT3 expression by reducing the stabilization of KDM5B to improve mitochondrial metabolic reprogramming in diabetic peripheral neuropathy.","YTHDC2","reduce stabilization","KDM5B","Diabetic Peripheral Neuropathy","YTHDC2","reduce stabilization","KDM5B","Diabetic Peripheral Neuropathy"
"4198","36574062","The m6A reader YTHDC2 promotes SIRT3 expression by reducing the stabilization of KDM5B to improve mitochondrial metabolic reprogramming in diabetic peripheral neuropathy.","YTHDC2","promote","SIRT3","Diabetic Peripheral Neuropathy","YTHDC2","STIMULATES","SIRT3","Diabetic Peripheral Neuropathy"
"4199","36574062","The m6A reader YTHDC2 promotes SIRT3 expression by reducing the stabilization of KDM5B to improve mitochondrial metabolic reprogramming in diabetic peripheral neuropathy.","SIRT3","improve","mitochondrial metabolic reprogramming","Diabetic Peripheral Neuropathy","SIRT3","STIMULATES","mitochondrial metabolic reprogramming","Diabetic Peripheral Neuropathy"
"4200","36574062","The m6A reader YTHDC2 promotes SIRT3 expression by reducing the stabilization of KDM5B to improve mitochondrial metabolic reprogramming in diabetic peripheral neuropathy.","KDM5B","regulate","SIRT3","Diabetic Peripheral Neuropathy","KDM5B","AFFECTS","SIRT3","Diabetic Peripheral Neuropathy"
"4202","36575317","Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1/METTL3/MYC axis.","YY1","mediate","self-renewal","Glioblastoma Stem Cells","YY1","AFFECTS","Self-Renewal","Glioblastoma Stem Cells"
"4203","36575317","Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1/METTL3/MYC axis.","YY1","regulate","SENP1/METTL3/MYC axis","Glioblastoma Stem Cells","YY1","AFFECTS","SENP1/METTL3/MYC axis","Glioblastoma Stem Cells"
"4204","36575317","Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1/METTL3/MYC axis.","SENP1/METTL3/MYC axis","regulate","self-renewal","Glioblastoma Stem Cells","SENP1/METTL3/MYC axis","AFFECTS","Self-Renewal","Glioblastoma Stem Cells"
"4206","36576581","LINC01615 maintains cell survival in adaptation to nutrient starvation through the pentose phosphate pathway and modulates chemosensitivity in colorectal cancer.","LINC01615","maintain","Cell Survival","Colorectal Cancer","LINC01615","MAINTAINS","Cell Survival","COAD(Colon Adenocarcinoma)"
"4207","36576581","LINC01615 maintains cell survival in adaptation to nutrient starvation through the pentose phosphate pathway and modulates chemosensitivity in colorectal cancer.","LINC01615","regulate","Pentose Phosphate Pathway","Colorectal Cancer","LINC01615","AFFECTS","pentose-phosphate shunt","COAD(Colon Adenocarcinoma)"
"4208","36576581","LINC01615 maintains cell survival in adaptation to nutrient starvation through the pentose phosphate pathway and modulates chemosensitivity in colorectal cancer.","LINC01615","modulate","Chemosensitivity","Colorectal Cancer","LINC01615","AFFECTS","chemosensitivity","COAD(Colon Adenocarcinoma)"
"4210","36581942","lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2.","ZNRD1-AS1","promote","Malignant lung cell proliferation","Malignant lung cells","POLR1HASP","STIMULATES","Malignant lung cell proliferation","LUAD(Lung Adenocarcinoma)"
"4211","36581942","lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2.","ZNRD1-AS1","promote","Migration","Malignant lung cells","POLR1HASP","STIMULATES","migration","LUAD(Lung Adenocarcinoma)"
"4212","36581942","lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2.","ZNRD1-AS1","promote","Angiogenesis","Malignant lung cells","POLR1HASP","STIMULATES","angiogenesis","LUAD(Lung Adenocarcinoma)"
"4213","36581942","lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2.","ZNRD1-AS1","promote","miR-942/TNS1 axis","Malignant lung cells","POLR1HASP","STIMULATES","miR-942/TNS1 axis","LUAD(Lung Adenocarcinoma)"
"4214","36581942","lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2.","YTHDC2","regulate","ZNRD1-AS1","Malignant lung cells","YTHDC2","AFFECTS","POLR1HASP","LUAD(Lung Adenocarcinoma)"
"4215","36581942","lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2.","miR-942/TNS1 axis","regulate","Malignant lung cell proliferation","Malignant lung cells","miR-942/TNS1 axis","AFFECTS","Malignant lung cell proliferation","LUAD(Lung Adenocarcinoma)"
"4216","36581942","lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2.","miR-942/TNS1 axis","regulate","Migration","Malignant lung cells","miR-942/TNS1 axis","AFFECTS","migration","LUAD(Lung Adenocarcinoma)"
"4217","36581942","lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m6A reader YTHDC2.","miR-942/TNS1 axis","regulate","Angiogenesis","Malignant lung cells","miR-942/TNS1 axis","AFFECTS","angiogenesis","LUAD(Lung Adenocarcinoma)"
"4219","36584783","METTL14 alleviates the development of osteoporosis in ovariectomized mice by upregulating m6A level of SIRT1 mRNA.","METTL14","alleviate","Osteoporosis","Ovariectomized Mice","METTL14","INHIBITS","Osteoporosis","Ovariectomized Mice"
"4220","36584783","METTL14 alleviates the development of osteoporosis in ovariectomized mice by upregulating m6A level of SIRT1 mRNA.","METTL14","upregulate","m6A","Ovariectomized Mice","METTL14","STIMULATES","m6A","Ovariectomized Mice"
"4221","36584783","METTL14 alleviates the development of osteoporosis in ovariectomized mice by upregulating m6A level of SIRT1 mRNA.","m6A","is on","SIRT1 mRNA","Ovariectomized Mice","m6A","LOCATES","SIRT1","Ovariectomized Mice"
"4222","36584783","METTL14 alleviates the development of osteoporosis in ovariectomized mice by upregulating m6A level of SIRT1 mRNA.","SIRT1 mRNA","regulate","Osteoporosis","Ovariectomized Mice","SIRT1","AFFECTS","Osteoporosis","Ovariectomized Mice"
"4224","36585228","[N6-methyladenosine (m6A) binding protein hnRNPA2B1 is highly expressed in a variety of tumors and regulates tumor immune microenvironment].","hnRNPA2B1","bind","m6A","Tumors","HNRNPA2B1","INTERACTS_WITH","m6A","PANCAN(Pan-Cancer)"
"4225","36585228","[N6-methyladenosine (m6A) binding protein hnRNPA2B1 is highly expressed in a variety of tumors and regulates tumor immune microenvironment].","hnRNPA2B1","regulate","tumor immune microenvironment","Tumors","HNRNPA2B1","AFFECTS","Tumor Immune Microenvironment","PANCAN(Pan-Cancer)"
"4227","36586770","WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.","WTAP","mediate","m6A","Hepatocellular Carcinoma","WTAP","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"4228","36586770","WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.","m6A","modify","circCMTM3","Hepatocellular Carcinoma","m6A","AFFECTS","circCMTM3","LIHC(Liver Hepatocellular Carcinoma)"
"4229","36586770","WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.","circCMTM3","inhibit","ferroptosis","Hepatocellular Carcinoma","circCMTM3","INHIBITS","Ferroptosis","LIHC(Liver Hepatocellular Carcinoma)"
"4230","36586770","WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.","circCMTM3","recruit","IGF2BP1","Hepatocellular Carcinoma","circCMTM3","recruit","IGF2BP1","LIHC(Liver Hepatocellular Carcinoma)"
"4231","36586770","WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.","IGF2BP1","increase","PARK7","Hepatocellular Carcinoma","IGF2BP1","AUGMENTS","PARK7","LIHC(Liver Hepatocellular Carcinoma)"
"4232","36586770","WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.","PARK7","regulate","ferroptosis","Hepatocellular Carcinoma","PARK7","AFFECTS","Ferroptosis","LIHC(Liver Hepatocellular Carcinoma)"
"4234","36587923","KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.","KDM1A","upregulate","METTL3","Alzheimer's disease","KDM1A","STIMULATES","METTL3","Alzheimer Disease"
"4235","36587923","KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.","METTL3","enhance","autophagic clearance","Alzheimer's disease","METTL3","AUGMENTS","autophagic clearance","Alzheimer Disease"
"4236","36587923","KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.","METTL3","regulate","m6A","Alzheimer's disease","METTL3","AFFECTS","m6A","Alzheimer Disease"
"4237","36587923","KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.","m6A","is on","STUB1","Alzheimer's disease","m6A","LOCATES","STUB1","Alzheimer Disease"
"4238","36587923","KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.","STUB1","regulate","autophagic clearance","Alzheimer's disease","STUB1","AFFECTS","autophagic clearance","Alzheimer Disease"
"4240","36591524","BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine.","BTG2","suppress","Renal Cell Carcinoma Progression","Renal Cell Carcinoma","BTG2","INHIBITS","Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4241","36591524","BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine.","BTG2","regulate","N6-methyladenosine","Renal Cell Carcinoma","BTG2","AFFECTS","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4242","36591524","BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine.","N6-methyladenosine","suppress","Renal Cell Carcinoma Progression","Renal Cell Carcinoma","m6A","INHIBITS","Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4245","36451259","Bisphenol A exposure induces testicular oxidative damage via FTO/m6A/Nrf2 axis during postnatal development in mice.","Bisphenol A","induce","Testicular Oxidative Damage","Postnatal Development in Mice","bisphenol A","CAUSES","Testicular Oxidative Damage","Postnatal Development in Mice"
"4246","36451259","Bisphenol A exposure induces testicular oxidative damage via FTO/m6A/Nrf2 axis during postnatal development in mice.","Bisphenol A","regulate","FTO/m6A/Nrf2 axis","Postnatal Development in Mice","bisphenol A","AFFECTS","FTO/m6A/Nrf2 axis","Postnatal Development in Mice"
"4247","36451259","Bisphenol A exposure induces testicular oxidative damage via FTO/m6A/Nrf2 axis during postnatal development in mice.","FTO/m6A/Nrf2 axis","induce","Testicular Oxidative Damage","Postnatal Development in Mice","FTO/m6A/Nrf2 axis","CAUSES","Testicular Oxidative Damage","Postnatal Development in Mice"
"4249","36451863","m6A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease.","hnRNPA2B1","drive","Osteolytic Bone Disease","Multiple Myeloma","HNRNPA2B1","STIMULATES","Osteolytic Bone Disease","Multiple Myeloma"
"4251","36457846","IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells.","IGF2BP3","target","N6-methyladenosine","Lung Adenocarcinoma Cells","IGF2BP3","INTERACTS_WITH","m6A","LUAD(Lung Adenocarcinoma)"
"4252","36457846","IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells.","IGF2BP3","suppress","ferroptosis","Lung Adenocarcinoma Cells","IGF2BP3","INHIBITS","Ferroptosis","LUAD(Lung Adenocarcinoma)"
"4254","36458690","Demethylase FTO promotes neuropathic pain development via regulating the m6A methylation levels of CXCR3.","FTO","promote","Neuropathic Pain Development","Neuropathic Pain Development","FTO","STIMULATES","Neuropathic Pain Development","Neuropathic Pain Development"
"4255","36458690","Demethylase FTO promotes neuropathic pain development via regulating the m6A methylation levels of CXCR3.","FTO","regulate","m6A methylation levels","Neuropathic Pain Development","FTO","AFFECTS","m6A methylation levels","Neuropathic Pain Development"
"4256","36458690","Demethylase FTO promotes neuropathic pain development via regulating the m6A methylation levels of CXCR3.","m6A methylation levels","is on","CXCR3","Neuropathic Pain Development","m6A methylation levels","LOCATES","CXCR3","Neuropathic Pain Development"
"4257","36458690","Demethylase FTO promotes neuropathic pain development via regulating the m6A methylation levels of CXCR3.","CXCR3","regulate","Neuropathic Pain Development","Neuropathic Pain Development","CXCR3","AFFECTS","Neuropathic Pain Development","Neuropathic Pain Development"
"4259","36461116","m6A demethylase FTO regulate CTNNB1 to promote adipogenesis of chicken preadipocyte.","FTO","regulate","CTNNB1","Chicken Preadipocyte","FTO","AFFECTS","CTNNB1","Chicken Preadipocyte"
"4260","36461116","m6A demethylase FTO regulate CTNNB1 to promote adipogenesis of chicken preadipocyte.","CTNNB1","promote","adipogenesis","Chicken Preadipocyte","CTNNB1","STIMULATES","Adipogenesis","Chicken Preadipocyte"
"4262","36461592","m(6)A methyltransferase METTL3 relieves cognitive impairment of hyperuricemia mice via inactivating MyD88/NF-kappaB pathway mediated NLRP3-ASC-Caspase1 inflammasome.","METTL3","relieve","Cognitive Impairment","Hyperuricemia Mice","METTL3","relieve","Cognitive Dysfunction","Hyperuricemia Mice"
"4263","36461592","m(6)A methyltransferase METTL3 relieves cognitive impairment of hyperuricemia mice via inactivating MyD88/NF-kappaB pathway mediated NLRP3-ASC-Caspase1 inflammasome.","METTL3","inactivate","MyD88/NF-kappaB pathway","Hyperuricemia Mice","METTL3","inactivate","MyD88/NF-kappaB pathway","Hyperuricemia Mice"
"4264","36461592","m(6)A methyltransferase METTL3 relieves cognitive impairment of hyperuricemia mice via inactivating MyD88/NF-kappaB pathway mediated NLRP3-ASC-Caspase1 inflammasome.","MyD88/NF-kappaB pathway","mediate","NLRP3-ASC-Caspase1 inflammasome","Hyperuricemia Mice","MyD88/NF-kappaB pathway","AFFECTS","NLRP3-ASC-Caspase1 inflammasome","Hyperuricemia Mice"
"4265","36461592","m(6)A methyltransferase METTL3 relieves cognitive impairment of hyperuricemia mice via inactivating MyD88/NF-kappaB pathway mediated NLRP3-ASC-Caspase1 inflammasome.","NLRP3-ASC-Caspase1 inflammasome","regulate","Cognitive Impairment","Hyperuricemia Mice","NLRP3-ASC-Caspase1 inflammasome","AFFECTS","Cognitive Dysfunction","Hyperuricemia Mice"
"4267","36463205","The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells.","BUD13","mediate","m6A methylation","Glioblastoma cells","BUD13","AFFECTS","m6A","GBM(Glioblastoma Multiforme)"
"4268","36463205","The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells.","m6A methylation","mediate","MBNL1-phosphorylation","Glioblastoma cells","m6A","AFFECTS","MBNL1-phosphorylation","GBM(Glioblastoma Multiforme)"
"4269","36463205","The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells.","CDK12","mediate","MBNL1-phosphorylation","Glioblastoma cells","CDK12","AFFECTS","MBNL1-phosphorylation","GBM(Glioblastoma Multiforme)"
"4270","36463205","The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells.","CDK12","regulate","vasculogenic mimicry","Glioblastoma cells","CDK12","AFFECTS","Vasculogenic Mimicry","GBM(Glioblastoma Multiforme)"
"4271","36463205","The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells.","MBNL1-phosphorylation","regulate","vasculogenic mimicry","Glioblastoma cells","MBNL1-phosphorylation","AFFECTS","Vasculogenic Mimicry","GBM(Glioblastoma Multiforme)"
"4273","36463391","m6A 'writer' KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis.","KIAA1429","regulate","Proliferation","Endothelial Cells in Atherosclerosis","VIRMA","AFFECTS","cell population proliferation","Endothelial Cells in Atherosclerosis"
"4274","36463391","m6A 'writer' KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis.","KIAA1429","regulate","Migration","Endothelial Cells in Atherosclerosis","VIRMA","AFFECTS","migration","Endothelial Cells in Atherosclerosis"
"4276","36468944","The long non-coding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3.","MEG3","inhibit","Oral Squamous Cell Carcinoma Progression","Oral Squamous Cell Carcinoma","MEG3","INHIBITS","Oral Squamous Cell Carcinoma Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4277","36468944","The long non-coding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3.","MEG3","regulate","GATA3","Oral Squamous Cell Carcinoma","MEG3","AFFECTS","GATA3","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4278","36468944","The long non-coding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3.","GATA3","inhibit","Oral Squamous Cell Carcinoma Progression","Oral Squamous Cell Carcinoma","GATA3","INHIBITS","Oral Squamous Cell Carcinoma Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4280","36471428","A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma.","YTHDF3","mediate","m6A modification","Hepatocellular Carcinoma","YTHDF3","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"4281","36471428","A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma.","m6A modification","regulate","PFKL","Hepatocellular Carcinoma","m6A","AFFECTS","PFKL","LIHC(Liver Hepatocellular Carcinoma)"
"4282","36471428","A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma.","PFKL","participate in","glycolysis","Hepatocellular Carcinoma","PFKL","participate in","glycolytic process","LIHC(Liver Hepatocellular Carcinoma)"
"4283","36471428","A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma.","glycolysis","regulate","YTHDF3","Hepatocellular Carcinoma","glycolytic process","AFFECTS","YTHDF3","LIHC(Liver Hepatocellular Carcinoma)"
"4285","36473908","Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib.","SLP2","mediate","Lipid Metabolism","Hepatocellular Carcinoma","STOML2","AFFECTS","Lipid Metabolism","LIHC(Liver Hepatocellular Carcinoma)"
"4286","36473908","Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib.","Lipid Metabolism","restrict","Proliferation","Hepatocellular Carcinoma","Lipid Metabolism","INHIBITS","cell population proliferation","LIHC(Liver Hepatocellular Carcinoma)"
"4287","36473908","Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib.","Lipid Metabolism","restrict","Metastasis","Hepatocellular Carcinoma","Lipid Metabolism","INHIBITS","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"4288","36473908","Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib.","Lipid Metabolism","promote sensitivity","Lenvatinib","Hepatocellular Carcinoma","Lipid Metabolism","promote sensitivity","lenvatinib","LIHC(Liver Hepatocellular Carcinoma)"
"4289","36473908","Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib.","Proliferation","contribute","Hepatocellular Carcinoma","Hepatocellular Carcinoma","cell population proliferation","AFFECTS","hepatocellular carcinoma","LIHC(Liver Hepatocellular Carcinoma)"
"4290","36473908","Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib.","Metastasis","contribute","Hepatocellular Carcinoma","Hepatocellular Carcinoma","Neoplasm Metastasis","AFFECTS","hepatocellular carcinoma","LIHC(Liver Hepatocellular Carcinoma)"
"4292","36476503","METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.","METTL3","promote","glycolysis","Cholangiocarcinoma","METTL3","STIMULATES","glycolytic process","CHOL(Cholangiocarcinoma)"
"4293","36476503","METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.","METTL3","promote","cholangiocarcinoma progression","Cholangiocarcinoma","METTL3","STIMULATES","Choriocarcinoma progression","CHOL(Cholangiocarcinoma)"
"4294","36476503","METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.","METTL3","mediate","m6A","Cholangiocarcinoma","METTL3","AFFECTS","m6A","CHOL(Cholangiocarcinoma)"
"4295","36476503","METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.","m6A","is on","AKR1B10","Cholangiocarcinoma","m6A","LOCATES","AKR1B10","CHOL(Cholangiocarcinoma)"
"4296","36476503","METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.","AKR1B10","regulate","glycolysis","Cholangiocarcinoma","AKR1B10","AFFECTS","glycolytic process","CHOL(Cholangiocarcinoma)"
"4297","36476503","METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.","AKR1B10","regulate","cholangiocarcinoma progression","Cholangiocarcinoma","AKR1B10","AFFECTS","Choriocarcinoma progression","CHOL(Cholangiocarcinoma)"
"4299","36478193","Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T-Cell Acute Lymphoblastic Leukemia.","m6A Modification","mediate","IRF8","T-Cell Acute Lymphoblastic Leukemia","m6A","AFFECTS","IRF8","LAML(Acute Myeloid Leukemia)"
"4300","36478193","Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T-Cell Acute Lymphoblastic Leukemia.","IRF8","promote","Progression","T-Cell Acute Lymphoblastic Leukemia","IRF8","STIMULATES","progression","LAML(Acute Myeloid Leukemia)"
"4302","36484103","m6 A Reader YTHDF1-targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy Via Epigenetic and Immune Regulation.","YTHDF1","target","Engineered Small Extracellular Vesicles","Gastric Cancer","YTHDF1","INTERACTS_WITH","Engineered Small Extracellular Vesicles","STAD(Stomach adenocarcinoma)"
"4303","36484103","m6 A Reader YTHDF1-targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy Via Epigenetic and Immune Regulation.","Engineered Small Extracellular Vesicles","used for","Gastric Cancer Therapy","Gastric Cancer","Engineered Small Extracellular Vesicles","USES","Gastric Cancer Therapy","STAD(Stomach adenocarcinoma)"
"4304","36484103","m6 A Reader YTHDF1-targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy Via Epigenetic and Immune Regulation.","Engineered Small Extracellular Vesicles","regulate","Epigenetic Regulation","Gastric Cancer","Engineered Small Extracellular Vesicles","AFFECTS","epigenetic regulation","STAD(Stomach adenocarcinoma)"
"4305","36484103","m6 A Reader YTHDF1-targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy Via Epigenetic and Immune Regulation.","Engineered Small Extracellular Vesicles","regulate","Immune Regulation","Gastric Cancer","Engineered Small Extracellular Vesicles","AFFECTS","Immune Regulation","STAD(Stomach adenocarcinoma)"
"4306","36484103","m6 A Reader YTHDF1-targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy Via Epigenetic and Immune Regulation.","Epigenetic Regulation","regulate","Gastric Cancer Therapy","Gastric Cancer","epigenetic regulation","AFFECTS","Gastric Cancer Therapy","STAD(Stomach adenocarcinoma)"
"4307","36484103","m6 A Reader YTHDF1-targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy Via Epigenetic and Immune Regulation.","Immune Regulation","regulate","Gastric Cancer Therapy","Gastric Cancer","Immune Regulation","AFFECTS","Gastric Cancer Therapy","STAD(Stomach adenocarcinoma)"
"4309","36484368","N6-methyladenosine-induced long non-coding RNA PVT1 regulates the miR-27b-3p/BLM axis to promote prostate cancer progression.","N6-methyladenosine","induce","PVT1","Prostate Cancer","m6A","CAUSES","PVT1","PRAD(Prostate Adenocarcinoma)"
"4310","36484368","N6-methyladenosine-induced long non-coding RNA PVT1 regulates the miR-27b-3p/BLM axis to promote prostate cancer progression.","PVT1","regulate","miR-27b-3p/BLM axis","Prostate Cancer","PVT1","AFFECTS","miR-27b-3p/BLM axis","PRAD(Prostate Adenocarcinoma)"
"4311","36484368","N6-methyladenosine-induced long non-coding RNA PVT1 regulates the miR-27b-3p/BLM axis to promote prostate cancer progression.","miR-27b-3p/BLM axis","promote","Prostate Cancer Progression","Prostate Cancer","miR-27b-3p/BLM axis","STIMULATES","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"4313","36484954","Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.","Fear Stress","promote","Glioma Progression","Fear Stress","Fear Stress","STIMULATES","Glioma Progression","Fear Stress"
"4314","36484954","Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.","Fear Stress","inhibit","Ferroptosis","Fear Stress","Fear Stress","INHIBITS","Ferroptosis","Fear Stress"
"4315","36484954","Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.","Fear Stress","enhance","FSP1","Fear Stress","Fear Stress","AUGMENTS","FSP1","Fear Stress"
"4316","36484954","Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.","FSP1","inhibit","Ferroptosis","Fear Stress","FSP1","INHIBITS","Ferroptosis","Fear Stress"
"4318","36493511","KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner.","KIAA1429","promote","tumorigenesis","Lung Adenocarcinoma","VIRMA","STIMULATES","Carcinogenesis","LUAD(Lung Adenocarcinoma)"
"4319","36493511","KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner.","KIAA1429","promote","gefitinib resistance","Lung Adenocarcinoma","VIRMA","STIMULATES","Gefitinib Resistance","LUAD(Lung Adenocarcinoma)"
"4320","36493511","KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner.","KIAA1429","activate","JNK/MAPK pathway","Lung Adenocarcinoma","VIRMA","STIMULATES","JNK/MAPK pathway","LUAD(Lung Adenocarcinoma)"
"4321","36493511","KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner.","KIAA1429","regulate","m6A","Lung Adenocarcinoma","VIRMA","AFFECTS","m6A","LUAD(Lung Adenocarcinoma)"
"4322","36493511","KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner.","JNK/MAPK pathway","regulate","tumorigenesis","Lung Adenocarcinoma","JNK/MAPK pathway","AFFECTS","Carcinogenesis","LUAD(Lung Adenocarcinoma)"
"4323","36493511","KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner.","JNK/MAPK pathway","regulate","gefitinib resistance","Lung Adenocarcinoma","JNK/MAPK pathway","AFFECTS","Gefitinib Resistance","LUAD(Lung Adenocarcinoma)"
"4325","36512307","YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m6A-mediated YWHAZ stability.","YBX1","regulate","Survival","Chronic Myeloid Leukemia Stem Cells","YBX1","AFFECTS","Survival","Chronic Myeloid Leukemia Stem Cells"
"4326","36512307","YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m6A-mediated YWHAZ stability.","YBX1","modulate","m6A","Chronic Myeloid Leukemia Stem Cells","YBX1","AFFECTS","m6A","Chronic Myeloid Leukemia Stem Cells"
"4327","36512307","YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m6A-mediated YWHAZ stability.","m6A","mediate","YWHAZ","Chronic Myeloid Leukemia Stem Cells","m6A","AFFECTS","YWHAZ","Chronic Myeloid Leukemia Stem Cells"
"4328","36512307","YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m6A-mediated YWHAZ stability.","YWHAZ","regulate","Survival","Chronic Myeloid Leukemia Stem Cells","YWHAZ","AFFECTS","Survival","Chronic Myeloid Leukemia Stem Cells"
"4330","36513634","SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C.","SMOC2","promote","aggressive behavior of fibroblast-like synoviocytes","Rheumatoid Arthritis","SMOC2","STIMULATES","aggressive behavior of fibroblast-like synoviocytes","Arthritis, Rheumatoid"
"4331","36513634","SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C.","SMOC2","regulate","MYO1C","Rheumatoid Arthritis","SMOC2","AFFECTS","MYO1C","Arthritis, Rheumatoid"
"4332","36513634","SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C.","MYO1C","regulate","aggressive behavior of fibroblast-like synoviocytes","Rheumatoid Arthritis","MYO1C","AFFECTS","aggressive behavior of fibroblast-like synoviocytes","Arthritis, Rheumatoid"
"4334","36516773","Chromatin-associated YTHDC1 coordinates heat-induced reprogramming of gene expression.","YTHDC1","associate","Chromatin","Null","YTHDC1","ASSOCIATED_WITH","chromatin","Null"
"4335","36516773","Chromatin-associated YTHDC1 coordinates heat-induced reprogramming of gene expression.","YTHDC1","coordinate","reprogramming of gene expression","Null","YTHDC1","coordinate","reprogramming of gene expression","Null"
"4337","36517319","METTL3 and METTL14-mediated N6-methyladenosine modification promotes cell proliferation and invasion in a model of endometriosis.","METTL3","mediate","N6-methyladenosine modification","Model of endometriosis","METTL3","AFFECTS","m6A","Model of endometriosis"
"4338","36517319","METTL3 and METTL14-mediated N6-methyladenosine modification promotes cell proliferation and invasion in a model of endometriosis.","METTL14","mediate","N6-methyladenosine modification","Model of endometriosis","METTL14","AFFECTS","m6A","Model of endometriosis"
"4339","36517319","METTL3 and METTL14-mediated N6-methyladenosine modification promotes cell proliferation and invasion in a model of endometriosis.","N6-methyladenosine modification","promote","cell proliferation","Model of endometriosis","m6A","STIMULATES","cell population proliferation","Model of endometriosis"
"4340","36517319","METTL3 and METTL14-mediated N6-methyladenosine modification promotes cell proliferation and invasion in a model of endometriosis.","N6-methyladenosine modification","promote","cell invasion","Model of endometriosis","m6A","STIMULATES","cell invasion","Model of endometriosis"
"4342","36518278","METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner.","METTL16","translate","CIDEA","Non-alcoholic fatty liver disease","METTL16","translate","CIDEA","Non-alcoholic Fatty Liver Disease"
"4343","36518278","METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner.","CIDEA","promote","Progression","Non-alcoholic fatty liver disease","CIDEA","STIMULATES","progression","Non-alcoholic Fatty Liver Disease"
"4344","36518278","METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner.","METTL16","regulate","m6A","Non-alcoholic fatty liver disease","METTL16","AFFECTS","m6A","Non-alcoholic Fatty Liver Disease"
"4345","36518278","METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner.","m6A","regulate","Progression","Non-alcoholic fatty liver disease","m6A","AFFECTS","progression","Non-alcoholic Fatty Liver Disease"
"4347","36376862","The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1.","ALKBH5","promote","Progression","Lung Cancer","ALKBH5","STIMULATES","progression","LUAD(Lung Adenocarcinoma)"
"4348","36376862","The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1.","ALKBH5","promote","Angiogenesis","Lung Cancer","ALKBH5","STIMULATES","angiogenesis","LUAD(Lung Adenocarcinoma)"
"4349","36376862","The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1.","ALKBH5","regulate","LncRNA PVT1","Lung Cancer","ALKBH5","AFFECTS","PVT1","LUAD(Lung Adenocarcinoma)"
"4350","36376862","The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1.","LncRNA PVT1","regulate","Progression","Lung Cancer","PVT1","AFFECTS","progression","LUAD(Lung Adenocarcinoma)"
"4351","36376862","The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1.","LncRNA PVT1","regulate","Angiogenesis","Lung Cancer","PVT1","AFFECTS","angiogenesis","LUAD(Lung Adenocarcinoma)"
"4353","36378581","Fat mass and obesity-associated protein alleviates Abeta1-40 induced retinal pigment epithelial cells degeneration via PKA/CREB signaling pathway.","Fat mass and obesity-associated protein","alleviate","Retinal Pigment Epithelial Cells Degeneration","Retinal Pigment Epithelial Cells","FTO","INHIBITS","Retinal Pigment Epithelial Cells Degeneration","Retinal Pigment Epithelial Cells"
"4354","36378581","Fat mass and obesity-associated protein alleviates Abeta1-40 induced retinal pigment epithelial cells degeneration via PKA/CREB signaling pathway.","Fat mass and obesity-associated protein","regulate","PKA/CREB","Retinal Pigment Epithelial Cells","FTO","AFFECTS","PKA/CREB","Retinal Pigment Epithelial Cells"
"4355","36378581","Fat mass and obesity-associated protein alleviates Abeta1-40 induced retinal pigment epithelial cells degeneration via PKA/CREB signaling pathway.","PKA/CREB","regulate","Retinal Pigment Epithelial Cells Degeneration","Retinal Pigment Epithelial Cells","PKA/CREB","AFFECTS","Retinal Pigment Epithelial Cells Degeneration","Retinal Pigment Epithelial Cells"
"4357","36380687","YTHDF3 mediates HNF1alpha regulation of cervical cancer radio-resistance by promoting RAD51D translation in an m6A-dependent manner.","YTHDF3","mediate","HNF1alpha","Cervical Cancer","YTHDF3","AFFECTS","HNF1A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"4358","36380687","YTHDF3 mediates HNF1alpha regulation of cervical cancer radio-resistance by promoting RAD51D translation in an m6A-dependent manner.","YTHDF3","promote","RAD51D","Cervical Cancer","YTHDF3","STIMULATES","RAD51D","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"4359","36380687","YTHDF3 mediates HNF1alpha regulation of cervical cancer radio-resistance by promoting RAD51D translation in an m6A-dependent manner.","RAD51D","regulate","Radio-resistance","Cervical Cancer","RAD51D","AFFECTS","Radioresistance","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"4360","36380687","YTHDF3 mediates HNF1alpha regulation of cervical cancer radio-resistance by promoting RAD51D translation in an m6A-dependent manner.","YTHDF3","depend on","m6A","Cervical Cancer","YTHDF3","INTERACTS_WITH","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"4361","36380687","YTHDF3 mediates HNF1alpha regulation of cervical cancer radio-resistance by promoting RAD51D translation in an m6A-dependent manner.","m6A","regulate","RAD51D","Cervical Cancer","m6A","AFFECTS","RAD51D","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"4363","36382943","Early recruitment of PARP-dependent m8A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation.","PARP","regulate","m8A RNA methylation","Null","PARP1","AFFECTS","m8A","Null"
"4364","36382943","Early recruitment of PARP-dependent m8A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation.","m8A RNA methylation","recruit","DNA lesions","Null","m8A","recruit","dna lesions","Null"
"4365","36382943","Early recruitment of PARP-dependent m8A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation.","DNA demethylation","accompany","DNA lesions","Null","DNA demethylation","COEXISTS_WITH","dna lesions","Null"
"4366","36382943","Early recruitment of PARP-dependent m8A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation.","m8A RNA methylation","regulate","DNA demethylation","Null","m8A","AFFECTS","DNA demethylation","Null"
"4368","36384975","LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.","LncRNA Airn","alleviate","Cardiac Fibrosis","Diabetic Cardiac Fibrosis","AIRN","INHIBITS","Cardiac Fibrosis","Diabetic Cardiac Fibrosis"
"4369","36384975","LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.","LncRNA Airn","regulate","m6A-IMP2-p53 axis","Diabetic Cardiac Fibrosis","AIRN","AFFECTS","m6A-IMP2-p53 axis","Diabetic Cardiac Fibrosis"
"4370","36384975","LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.","m6A-IMP2-p53 axis","inhibit","Cardiac Fibroblasts","Diabetic Cardiac Fibrosis","m6A-IMP2-p53 axis","INHIBITS","Cardiac Fibroblasts","Diabetic Cardiac Fibrosis"
"4371","36384975","LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis.","Cardiac Fibroblasts","contribute to","Cardiac Fibrosis","Diabetic Cardiac Fibrosis","Cardiac Fibroblasts","CAUSES","Cardiac Fibrosis","Diabetic Cardiac Fibrosis"
"4373","36386128","METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma.","METTL3","regulate","m6A","Esophageal Squamous Cell Carcinoma","METTL3","AFFECTS","m6A","ESCA(Esophageal Carcinoma)"
"4374","36386128","METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma.","m6A","regulate","IFIT2","Esophageal Squamous Cell Carcinoma","m6A","AFFECTS","IFIT2","ESCA(Esophageal Carcinoma)"
"4375","36386128","METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma.","IFIT2","regulate","proliferation","Esophageal Squamous Cell Carcinoma","IFIT2","AFFECTS","cell population proliferation","ESCA(Esophageal Carcinoma)"
"4376","36386128","METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma.","IFIT2","regulate","invasion","Esophageal Squamous Cell Carcinoma","IFIT2","AFFECTS","Neoplasm Invasiveness","ESCA(Esophageal Carcinoma)"
"4378","36387210","WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis.","WFDC21P","promote","Proliferation","Triple-negative breast cancer","WFDC21P","STIMULATES","cell population proliferation","BRCA(Breast Invasive Carcinoma)"
"4379","36387210","WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis.","WFDC21P","promote","Migration","Triple-negative breast cancer","WFDC21P","STIMULATES","migration","BRCA(Breast Invasive Carcinoma)"
"4380","36387210","WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis.","WFDC21P","regulate","WFDC21P/miR-628/SMAD3 axis","Triple-negative breast cancer","WFDC21P","AFFECTS","WFDC21P/miR-628/SMAD3 axis","BRCA(Breast Invasive Carcinoma)"
"4381","36387210","WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis.","WFDC21P/miR-628/SMAD3 axis","regulate","Proliferation","Triple-negative breast cancer","WFDC21P/miR-628/SMAD3 axis","AFFECTS","cell population proliferation","BRCA(Breast Invasive Carcinoma)"
"4382","36387210","WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis.","WFDC21P/miR-628/SMAD3 axis","regulate","Migration","Triple-negative breast cancer","WFDC21P/miR-628/SMAD3 axis","AFFECTS","migration","BRCA(Breast Invasive Carcinoma)"
"4384","36397058","N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway.","N6-methyladenosine","mediate","SH3BP5-AS1","Pancreatic Cancer","m6A","AFFECTS","SH3BP5-AS1","PAAD(Pancreatic Adenocarcinoma)"
"4385","36397058","N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway.","SH3BP5-AS1","upregulate","GEM chemoresistance","Pancreatic Cancer","SH3BP5-AS1","STIMULATES","GEM chemoresistance","PAAD(Pancreatic Adenocarcinoma)"
"4386","36397058","N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway.","SH3BP5-AS1","activate","Wnt signaling pathway","Pancreatic Cancer","SH3BP5-AS1","STIMULATES","Wnt signaling pathway","PAAD(Pancreatic Adenocarcinoma)"
"4387","36397058","N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway.","Wnt signaling pathway","promote","GEM chemoresistance","Pancreatic Cancer","Wnt signaling pathway","STIMULATES","GEM chemoresistance","PAAD(Pancreatic Adenocarcinoma)"
"4389","36397699","N6-Methyladenosine modification (m6A) of circRNA-ZNF638 contributes the induced activation of SHF stem cells through miR-361-5p/Wnt5a axis in cashmere goats.","m6A","is on","circRNA-ZNF638","SHF stem cells of cashmere goats","m6A","LOCATES","circRNA-ZNF638","SHF stem cells of cashmere goats"
"4390","36397699","N6-Methyladenosine modification (m6A) of circRNA-ZNF638 contributes the induced activation of SHF stem cells through miR-361-5p/Wnt5a axis in cashmere goats.","circRNA-ZNF638","contribute to","activation","SHF stem cells of cashmere goats","circRNA-ZNF638","CAUSES","activation","SHF stem cells of cashmere goats"
"4391","36397699","N6-Methyladenosine modification (m6A) of circRNA-ZNF638 contributes the induced activation of SHF stem cells through miR-361-5p/Wnt5a axis in cashmere goats.","circRNA-ZNF638","through","miR-361-5p/Wnt5a axis","SHF stem cells of cashmere goats","circRNA-ZNF638","through","miR-361-5p/Wnt5a axis","SHF stem cells of cashmere goats"
"4392","36397699","N6-Methyladenosine modification (m6A) of circRNA-ZNF638 contributes the induced activation of SHF stem cells through miR-361-5p/Wnt5a axis in cashmere goats.","miR-361-5p/Wnt5a axis","regulate","activation","SHF stem cells of cashmere goats","miR-361-5p/Wnt5a axis","AFFECTS","activation","SHF stem cells of cashmere goats"
"4394","36399125","Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration.","Mettl3","mediate","m6A","Heart Regeneration","METTL3","AFFECTS","m6A","Heart Regeneration"
"4395","36399125","Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration.","m6A","modify","Fgf16","Heart Regeneration","m6A","AFFECTS","FGF16","Heart Regeneration"
"4396","36399125","Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration.","Fgf16","restrict","Cardiomyocyte Proliferation","Heart Regeneration","FGF16","restrict","cardiac muscle cell proliferation","Heart Regeneration"
"4398","36399511","METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability.","METTL3","mediate","m6A modification","Null","METTL3","AFFECTS","m6A","Null"
"4399","36399511","METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability.","m6A modification","stabilize","TERRA","Null","m6A","MAINTAINS","TERRA","Null"
"4400","36399511","METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability.","TERRA","maintain","Telomere Stability","Null","TERRA","MAINTAINS","Telomere Stability","Null"
"4402","36401086","METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis.","METTL14","upregulate","TCF1","Osteoporosis","METTL14","STIMULATES","HNF1A","Osteoporosis"
"4403","36401086","METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis.","METTL14","methylate","m6A","Osteoporosis","METTL14","CONVERTS_TO","m6A","Osteoporosis"
"4404","36401086","METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis.","TCF1","stimulate","osteogenic activity","Osteoporosis","HNF1A","STIMULATES","osteogenic activity","Osteoporosis"
"4406","36401285","HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.","HNRNPA2B1","mediate","m6A","Multiple Myeloma","HNRNPA2B1","AFFECTS","m6A","Multiple Myeloma"
"4407","36401285","HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.","m6A","modify","TLR4 mRNA","Multiple Myeloma","m6A","AFFECTS","TLR4","Multiple Myeloma"
"4408","36401285","HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.","TLR4 mRNA","promote","Progression","Multiple Myeloma","TLR4","STIMULATES","progression","Multiple Myeloma"
"4409","36401285","HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.","HNRNPA2B1","promote","Progression","Multiple Myeloma","HNRNPA2B1","STIMULATES","progression","Multiple Myeloma"
"4411","36403721","Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification.","Glutamate","promote","Perineural Invasion","Pancreatic Cancer","L-glutamic acid","STIMULATES","Perineural Invasion","PAAD(Pancreatic Adenocarcinoma)"
"4412","36403721","Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification.","Glutamate","regulate","Tumor Glycolysis","Pancreatic Cancer","L-glutamic acid","AFFECTS","Tumor Glycolysis","PAAD(Pancreatic Adenocarcinoma)"
"4413","36403721","Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification.","Glutamate","regulate","m6A","Pancreatic Cancer","L-glutamic acid","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"4414","36403721","Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification.","m6A","is on","HK2 mRNA","Pancreatic Cancer","m6A","LOCATES","HK2","PAAD(Pancreatic Adenocarcinoma)"
"4415","36403721","Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification.","HK2 mRNA","regulate","Tumor Glycolysis","Pancreatic Cancer","HK2","AFFECTS","Tumor Glycolysis","PAAD(Pancreatic Adenocarcinoma)"
"4417","36403857","N6-methyladenosine (m6A) RNA methylation mediated by methyltransferase complex subunit WTAP regulates amelogenesis.","WTAP","mediate","m6A","Null","WTAP","AFFECTS","m6A","Null"
"4418","36403857","N6-methyladenosine (m6A) RNA methylation mediated by methyltransferase complex subunit WTAP regulates amelogenesis.","m6A","regulate","amelogenesis","Null","m6A","AFFECTS","amelogenesis","Null"
"4419","36403857","N6-methyladenosine (m6A) RNA methylation mediated by methyltransferase complex subunit WTAP regulates amelogenesis.","WTAP","regulate","amelogenesis","Null","WTAP","AFFECTS","amelogenesis","Null"
"4421","36406135","METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis.","METTL16","regulate","m6A methylation","Liver Fibrosis","METTL16","AFFECTS","m6A","Liver Cirrhosis"
"4422","36406135","METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis.","m6A methylation","is on","HLA-DPB1","Liver Fibrosis","m6A","LOCATES","HLA-DPB1","Liver Cirrhosis"
"4423","36406135","METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis.","HLA-DPB1","involve","liver fibrosis","Liver Fibrosis","HLA-DPB1","ASSOCIATED_WITH","Liver Cirrhosis","Liver Cirrhosis"
"4424","36406135","METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis.","m6A methylation","regulate","liver fibrosis","Liver Fibrosis","m6A","AFFECTS","Liver Cirrhosis","Liver Cirrhosis"
"4426","36412513","WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.","WTAP","dysregulate","HMGN3","Early-onset preeclampsia","WTAP","dysregulate","HMGN3","Early-onset preeclampsia"
"4427","36412513","WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.","HMGN3","modify","m6A modification","Early-onset preeclampsia","HMGN3","AFFECTS","m6A","Early-onset preeclampsia"
"4428","36412513","WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.","m6A modification","inhibit","trophoblast invasion","Early-onset preeclampsia","m6A","INHIBITS","Trophoblast Invasion","Early-onset preeclampsia"
"4430","36413861","Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells.","Linc-UROD","stabilize","ENO1","Pancreatic Cancer Cells","Linc-UROD","MAINTAINS","ENO1","PAAD(Pancreatic Adenocarcinoma)"
"4431","36413861","Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells.","Linc-UROD","stabilize","PKM","Pancreatic Cancer Cells","Linc-UROD","MAINTAINS","PKM","PAAD(Pancreatic Adenocarcinoma)"
"4432","36413861","Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells.","ENO1","strengthen","Glycolysis","Pancreatic Cancer Cells","ENO1","strengthen","glycolytic process","PAAD(Pancreatic Adenocarcinoma)"
"4433","36413861","Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells.","ENO1","strengthen","Proliferation and Migration","Pancreatic Cancer Cells","ENO1","strengthen","Proliferation and Migration","PAAD(Pancreatic Adenocarcinoma)"
"4434","36413861","Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells.","PKM","strengthen","Glycolysis","Pancreatic Cancer Cells","PKM","strengthen","glycolytic process","PAAD(Pancreatic Adenocarcinoma)"
"4435","36413861","Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells.","PKM","strengthen","Proliferation and Migration","Pancreatic Cancer Cells","PKM","strengthen","Proliferation and Migration","PAAD(Pancreatic Adenocarcinoma)"
"4437","36416766","FIONA1 is an N6-methyladenosine methyltransferase that plays a vital role in floral transition via affecting the splicing of FLC and the stability of SPL3 and SEP3 in Arabidopsis.","FIONA1","play role in","floral transition","Arabidopsis","FIONA1","play role in","floral transition","Arabidopsis"
"4438","36416766","FIONA1 is an N6-methyladenosine methyltransferase that plays a vital role in floral transition via affecting the splicing of FLC and the stability of SPL3 and SEP3 in Arabidopsis.","FIONA1","affect splicing of","FLC","Arabidopsis","FIONA1","affect splicing of","Fibrolamellar Carcinoma","Arabidopsis"
"4439","36416766","FIONA1 is an N6-methyladenosine methyltransferase that plays a vital role in floral transition via affecting the splicing of FLC and the stability of SPL3 and SEP3 in Arabidopsis.","FIONA1","affect stability of","SPL3","Arabidopsis","FIONA1","affect stability of","SPL3","Arabidopsis"
"4440","36416766","FIONA1 is an N6-methyladenosine methyltransferase that plays a vital role in floral transition via affecting the splicing of FLC and the stability of SPL3 and SEP3 in Arabidopsis.","FIONA1","affect stability of","3-Sep","Arabidopsis","FIONA1","affect stability of","3-Sep","Arabidopsis"
"4441","36416766","FIONA1 is an N6-methyladenosine methyltransferase that plays a vital role in floral transition via affecting the splicing of FLC and the stability of SPL3 and SEP3 in Arabidopsis.","FLC","regulate","floral transition","Arabidopsis","Fibrolamellar Carcinoma","AFFECTS","floral transition","Arabidopsis"
"4442","36416766","FIONA1 is an N6-methyladenosine methyltransferase that plays a vital role in floral transition via affecting the splicing of FLC and the stability of SPL3 and SEP3 in Arabidopsis.","SPL3","regulate","floral transition","Arabidopsis","SPL3","AFFECTS","floral transition","Arabidopsis"
"4443","36416766","FIONA1 is an N6-methyladenosine methyltransferase that plays a vital role in floral transition via affecting the splicing of FLC and the stability of SPL3 and SEP3 in Arabidopsis.","3-Sep","regulate","floral transition","Arabidopsis","3-Sep","AFFECTS","floral transition","Arabidopsis"
"4445","36417851","m6A-modified lincRNA Dubr is required for neuronal development by stabilizing YTHDF1/3 and facilitating mRNA translation.","m6A","modify","lincRNA Dubr","Neuronal Development","m6A","AFFECTS","lincRNA Dubr","Neuronal Development"
"4446","36417851","m6A-modified lincRNA Dubr is required for neuronal development by stabilizing YTHDF1/3 and facilitating mRNA translation.","lincRNA Dubr","stabilize","YTHDF1/3","Neuronal Development","lincRNA Dubr","MAINTAINS","YTHDF1/3","Neuronal Development"
"4447","36417851","m6A-modified lincRNA Dubr is required for neuronal development by stabilizing YTHDF1/3 and facilitating mRNA translation.","lincRNA Dubr","facilitate","mRNA translation","Neuronal Development","lincRNA Dubr","AUGMENTS","translation","Neuronal Development"
"4448","36417851","m6A-modified lincRNA Dubr is required for neuronal development by stabilizing YTHDF1/3 and facilitating mRNA translation.","mRNA translation","regulate","Neuronal Development","Neuronal Development","translation","AFFECTS","Neuronal Development","Neuronal Development"
"4450","36418936","ALKBH5 in mouse testicular Sertoli cells regulates Cdh2 mRNA translation to maintain blood-testis barrier integrity.","ALKBH5","regulate","Cdh2 mRNA","Mouse Testicular Sertoli Cells","ALKBH5","AFFECTS","CDH2","Mouse Testicular Sertoli Cells"
"4451","36418936","ALKBH5 in mouse testicular Sertoli cells regulates Cdh2 mRNA translation to maintain blood-testis barrier integrity.","Cdh2 mRNA","maintain","Blood-Testis Barrier Integrity","Mouse Testicular Sertoli Cells","CDH2","MAINTAINS","Blood-Testis Barrier Integrity","Mouse Testicular Sertoli Cells"
"4453","36419136","UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.","UBR7","inhibit","tumorigenesis","HCC","UBR7","INHIBITS","Carcinogenesis","HYCC1"
"4454","36419136","UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.","UBR7","target","Keap1","HCC","UBR7","INTERACTS_WITH","KEAP1","HYCC1"
"4455","36419136","UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.","UBR7","target","Nrf2","HCC","UBR7","INTERACTS_WITH","NFE2L2","HYCC1"
"4456","36419136","UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.","UBR7","target","Bach1","HCC","UBR7","INTERACTS_WITH","BACH1","HYCC1"
"4457","36419136","UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.","UBR7","target","HK2","HCC","UBR7","INTERACTS_WITH","HK2","HYCC1"
"4458","36419136","UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.","UBR7","target","glycolysis","HCC","UBR7","INTERACTS_WITH","glycolytic process","HYCC1"
"4460","36422864","N6-methyladenosine (m6A) reader Pho92 is recruited co-transcriptionally and couples translation to mRNA decay to promote meiotic fitness in yeast.","Pho92","read","m6A","Yeast","Pho92","read","m6A","Yeasts"
"4461","36422864","N6-methyladenosine (m6A) reader Pho92 is recruited co-transcriptionally and couples translation to mRNA decay to promote meiotic fitness in yeast.","Pho92","regulate","translation","Yeast","Pho92","AFFECTS","translation","Yeasts"
"4462","36422864","N6-methyladenosine (m6A) reader Pho92 is recruited co-transcriptionally and couples translation to mRNA decay to promote meiotic fitness in yeast.","Pho92","regulate","mRNA decay","Yeast","Pho92","AFFECTS","mRNA catabolic process","Yeasts"
"4463","36422864","N6-methyladenosine (m6A) reader Pho92 is recruited co-transcriptionally and couples translation to mRNA decay to promote meiotic fitness in yeast.","translation","promote","meiotic fitness","Yeast","translation","STIMULATES","meiotic fitness","Yeasts"
"4464","36422864","N6-methyladenosine (m6A) reader Pho92 is recruited co-transcriptionally and couples translation to mRNA decay to promote meiotic fitness in yeast.","mRNA decay","promote","meiotic fitness","Yeast","mRNA catabolic process","STIMULATES","meiotic fitness","Yeasts"
"4466","36423520","HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.","HDLBP","stabilize","lncFAL","Hepatocellular Carcinoma","HDLBP","MAINTAINS","PLXNB2","LIHC(Liver Hepatocellular Carcinoma)"
"4467","36423520","HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.","lncFAL","inhibit","ferroptosis vulnerability","Hepatocellular Carcinoma","PLXNB2","INHIBITS","ferroptosis vulnerability","LIHC(Liver Hepatocellular Carcinoma)"
"4468","36423520","HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.","lncFAL","diminish","Trim69","Hepatocellular Carcinoma","PLXNB2","diminish","TRIM69","LIHC(Liver Hepatocellular Carcinoma)"
"4469","36423520","HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.","Trim69","degrade","FSP1 degradation","Hepatocellular Carcinoma","TRIM69","INHIBITS","FSP1 degradation","LIHC(Liver Hepatocellular Carcinoma)"
"4470","36423520","HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.","FSP1 degradation","regulate","ferroptosis vulnerability","Hepatocellular Carcinoma","FSP1 degradation","AFFECTS","ferroptosis vulnerability","LIHC(Liver Hepatocellular Carcinoma)"
"4472","36428672","N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.","METTL3","initiate","N6-Methyladenosine","Lung Adenocarcinoma","METTL3","CAUSES","m6A","LUAD(Lung Adenocarcinoma)"
"4473","36428672","N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.","N6-Methyladenosine","modify","CIRCKRT17","Lung Adenocarcinoma","m6A","AFFECTS","CIRCKRT17","LUAD(Lung Adenocarcinoma)"
"4474","36428672","N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.","CIRCKRT17","promote","Osimertinib Resistance","Lung Adenocarcinoma","CIRCKRT17","STIMULATES","Osimertinib Resistance","LUAD(Lung Adenocarcinoma)"
"4475","36428672","N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.","EIF4A3","enhance","Osimertinib Resistance","Lung Adenocarcinoma","EIF4A3","AUGMENTS","Osimertinib Resistance","LUAD(Lung Adenocarcinoma)"
"4476","36428672","N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.","Osimertinib Resistance","enhance","YAP1 Stability","Lung Adenocarcinoma","Osimertinib Resistance","AUGMENTS","YAP1 Stability","LUAD(Lung Adenocarcinoma)"
"4478","36434904","METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.","METTL16","enhance","GPX4 expression","Breast Cancer","METTL16","AUGMENTS","GPX4","BRCA(Breast Invasive Carcinoma)"
"4479","36434904","METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.","METTL16","enhance","m6A modification","Breast Cancer","METTL16","AUGMENTS","m6A","BRCA(Breast Invasive Carcinoma)"
"4480","36434904","METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.","m6A modification","is on","GPX4","Breast Cancer","m6A","LOCATES","GPX4","BRCA(Breast Invasive Carcinoma)"
"4481","36434904","METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.","GPX4 expression","promote","Breast Cancer Progression","Breast Cancer","GPX4","STIMULATES","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"4482","36434904","METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.","GPX4 expression","inhibit","Ferroptosis","Breast Cancer","GPX4","INHIBITS","Ferroptosis","BRCA(Breast Invasive Carcinoma)"
"4483","36434904","METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.","Ferroptosis","inhibit","Breast Cancer Progression","Breast Cancer","Ferroptosis","INHIBITS","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"4485","36438499","Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer.","Cancer-associated fibroblasts","facilitate","premetastatic niche formation","Breast Cancer","Cancer-Associated Fibroblasts","AUGMENTS","premetastatic niche formation","BRCA(Breast Invasive Carcinoma)"
"4486","36438499","Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer.","Cancer-associated fibroblasts","regulate","lncRNA SNHG5","Breast Cancer","Cancer-Associated Fibroblasts","AFFECTS","SNHG5","BRCA(Breast Invasive Carcinoma)"
"4487","36438499","Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer.","lncRNA SNHG5","mediate","angiogenesis","Breast Cancer","SNHG5","AFFECTS","angiogenesis","BRCA(Breast Invasive Carcinoma)"
"4488","36438499","Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer.","lncRNA SNHG5","mediate","vascular permeability","Breast Cancer","SNHG5","AFFECTS","vascular permeability","BRCA(Breast Invasive Carcinoma)"
"4489","36438499","Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer.","angiogenesis","facilitate","premetastatic niche formation","Breast Cancer","angiogenesis","AUGMENTS","premetastatic niche formation","BRCA(Breast Invasive Carcinoma)"
"4490","36438499","Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer.","vascular permeability","facilitate","premetastatic niche formation","Breast Cancer","vascular permeability","AUGMENTS","premetastatic niche formation","BRCA(Breast Invasive Carcinoma)"
"4492","36439881","ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.","ELK1","mediate","YTHDF1","Prostate Cancer","ELK1","AFFECTS","YTHDF1","PRAD(Prostate Adenocarcinoma)"
"4493","36439881","ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.","YTHDF1","drive","Prostate Cancer Progression","Prostate Cancer","YTHDF1","STIMULATES","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"4494","36439881","ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.","YTHDF1","facilitate translation of","Polo-like kinase 1","Prostate Cancer","YTHDF1","facilitate translation of","PLK1","PRAD(Prostate Adenocarcinoma)"
"4495","36439881","ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.","m6A","dependent on","YTHDF1","Prostate Cancer","m6A","dependent on","YTHDF1","PRAD(Prostate Adenocarcinoma)"
"4496","36439881","ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.","Polo-like kinase 1","contribute to","Prostate Cancer Progression","Prostate Cancer","PLK1","CAUSES","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"4498","36441764","A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells.","N6-methyladenosine site","regulate","lncRNA HOTAIR","Breast Cancer Cells","m6A","AFFECTS","HOTAIR","BRCA(Breast Invasive Carcinoma)"
"4499","36441764","A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells.","lncRNA HOTAIR","have","function","Breast Cancer Cells","HOTAIR","have","function","BRCA(Breast Invasive Carcinoma)"
"4501","36444808","N6-methyladenosine plays a dual role in arsenic carcinogenesis by temporal-specific control of core target AKT1.","N6-methyladenosine","control","AKT1","Arsenic Carcinogenesis","m6A","AFFECTS","AKT1","PANCAN(Pan-Cancer)"
"4503","36445237","m6A methyltransferase METTL3 inhibits endometriosis by regulating alternative splicing of MIR17HG.","METTL3","inhibit","Endometriosis","Endometriosis","METTL3","INHIBITS","Endometriosis","Endometriosis"
"4504","36445237","m6A methyltransferase METTL3 inhibits endometriosis by regulating alternative splicing of MIR17HG.","METTL3","regulate","MIR17HG","Endometriosis","METTL3","AFFECTS","MIR17HG","Endometriosis"
"4506","36448247","RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.","METTL14","promote","procession of non-small cell lung cancer","Non-small cell lung cancer","METTL14","STIMULATES","procession of non-small cell lung cancer","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4507","36448247","RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.","METTL14","target","CSF1R","Non-small cell lung cancer","METTL14","INTERACTS_WITH","CSF1R","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4508","36448247","RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.","CSF1R","regulate","procession of non-small cell lung cancer","Non-small cell lung cancer","CSF1R","AFFECTS","procession of non-small cell lung cancer","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4510","36305219","The blue light receptor CRY1 interacts with FIP37 to promote N6-methyladenosine RNA modification and photomorphogenesis in Arabidopsis.","CRY1","interact","FIP37","Arabidopsis","CRY1","interact","FIP37","Arabidopsis"
"4511","36305219","The blue light receptor CRY1 interacts with FIP37 to promote N6-methyladenosine RNA modification and photomorphogenesis in Arabidopsis.","FIP37","promote","N6-methyladenosine RNA modification","Arabidopsis","FIP37","STIMULATES","m6A","Arabidopsis"
"4512","36305219","The blue light receptor CRY1 interacts with FIP37 to promote N6-methyladenosine RNA modification and photomorphogenesis in Arabidopsis.","FIP37","promote","photomorphogenesis","Arabidopsis","FIP37","STIMULATES","photomorphogenesis","Arabidopsis"
"4514","36305690","PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.","FTO","stabilize","PRKAA1","Gastric Cancer","FTO","MAINTAINS","PRKAA1","STAD(Stomach adenocarcinoma)"
"4515","36305690","PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.","FTO","regulate","m6A","Gastric Cancer","FTO","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"4516","36305690","PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.","YTHDF2","bind","m6A","Gastric Cancer","YTHDF2","INTERACTS_WITH","m6A","STAD(Stomach adenocarcinoma)"
"4517","36305690","PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.","PRKAA1","promote","Cell Proliferation","Gastric Cancer","PRKAA1","STIMULATES","cell population proliferation","STAD(Stomach adenocarcinoma)"
"4518","36305690","PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.","PRKAA1","promote","Glycolysis","Gastric Cancer","PRKAA1","STIMULATES","glycolytic process","STAD(Stomach adenocarcinoma)"
"4519","36305690","PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.","Cell Proliferation","regulate","Node 7","Gastric Cancer","cell population proliferation","AFFECTS","redox balance","STAD(Stomach adenocarcinoma)"
"4520","36305690","PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.","Glycolysis","regulate","Node 7","Gastric Cancer","glycolytic process","AFFECTS","redox balance","STAD(Stomach adenocarcinoma)"
"4522","36306790","The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia.","IGF2BP2","regulate","Glutamine Metabolism","Acute Myeloid Leukemia","IGF2BP2","AFFECTS","glutamine metabolic process","LAML(Acute Myeloid Leukemia)"
"4523","36306790","The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia.","IGF2BP2","is","Therapeutic Target","Acute Myeloid Leukemia","IGF2BP2","is","Therapeutic Target","LAML(Acute Myeloid Leukemia)"
"4525","36307435","The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity.","METTL16","enable","Erythropoiesis","Erythropoiesis","METTL16","enable","Erythropoiesis","Erythropoiesis"
"4526","36307435","The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity.","METTL16","safeguard","Genome Integrity","Erythropoiesis","METTL16","safeguard","Genome Integrity","Erythropoiesis"
"4527","36307435","The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity.","Genome Integrity","enable","Erythropoiesis","Erythropoiesis","Genome Integrity","enable","Erythropoiesis","Erythropoiesis"
"4529","36307991","N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.","FTO","enhance","chemo-resistance","Colorectal Cancer","FTO","AUGMENTS","chemo-resistance","COAD(Colon Adenocarcinoma)"
"4530","36307991","N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.","FTO","regulate","SIVA1","Colorectal Cancer","FTO","AFFECTS","SIVA1","COAD(Colon Adenocarcinoma)"
"4531","36307991","N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.","SIVA1","mediate","apoptosis","Colorectal Cancer","SIVA1","AFFECTS","apoptotic process","COAD(Colon Adenocarcinoma)"
"4532","36307991","N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.","apoptosis","enhance","chemo-resistance","Colorectal Cancer","apoptotic process","AUGMENTS","chemo-resistance","COAD(Colon Adenocarcinoma)"
"4534","36308276","Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma.","IMP1","regulate","YAP/TAZ","Glioblastoma","IGF2BP1","AFFECTS","YAP/TAZ","GBM(Glioblastoma Multiforme)"
"4535","36308276","Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma.","YAP/TAZ","regulate","IMP1","Glioblastoma","YAP/TAZ","AFFECTS","IGF2BP1","GBM(Glioblastoma Multiforme)"
"4536","36308276","Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma.","IMP1","promote","tumorigenesis","Glioblastoma","IGF2BP1","STIMULATES","Carcinogenesis","GBM(Glioblastoma Multiforme)"
"4537","36308276","Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma.","IMP1","promote","malignant progression","Glioblastoma","IGF2BP1","STIMULATES","Malignant Progression","GBM(Glioblastoma Multiforme)"
"4538","36308276","Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma.","YAP/TAZ","promote","tumorigenesis","Glioblastoma","YAP/TAZ","STIMULATES","Carcinogenesis","GBM(Glioblastoma Multiforme)"
"4539","36308276","Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma.","YAP/TAZ","promote","malignant progression","Glioblastoma","YAP/TAZ","STIMULATES","Malignant Progression","GBM(Glioblastoma Multiforme)"
"4541","36313631","IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N6-methyladenosine-dependent binding.","IGF2BP3","promote","Progression","Gallbladder Carcinoma","IGF2BP3","STIMULATES","progression","CHOL(Cholangiocarcinoma)"
"4542","36313631","IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N6-methyladenosine-dependent binding.","IGF2BP3","stabilize","KLK5 mRNA","Gallbladder Carcinoma","IGF2BP3","MAINTAINS","KLK5","CHOL(Cholangiocarcinoma)"
"4543","36313631","IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N6-methyladenosine-dependent binding.","IGF2BP3","bind","N6-methyladenosine","Gallbladder Carcinoma","IGF2BP3","INTERACTS_WITH","m6A","CHOL(Cholangiocarcinoma)"
"4544","36313631","IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N6-methyladenosine-dependent binding.","KLK5 mRNA","regulate","Progression","Gallbladder Carcinoma","KLK5","AFFECTS","progression","CHOL(Cholangiocarcinoma)"
"4547","36319624","Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1.","dummy","induce downregulation of","METTL14","Postmenopausal Osteoporosis","dummy","induce downregulation of","METTL14","Osteoporosis, Postmenopausal"
"4548","36319624","Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1.","METTL14","improve","Postmenopausal Osteoporosis","Postmenopausal Osteoporosis","METTL14","STIMULATES","Osteoporosis, Postmenopausal","Osteoporosis, Postmenopausal"
"4549","36319624","Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1.","IGF2BP1","bind","SMAD1","Postmenopausal Osteoporosis","IGF2BP1","INTERACTS_WITH","SMAD1","Osteoporosis, Postmenopausal"
"4550","36319624","Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1.","SMAD1","regulate","Postmenopausal Osteoporosis","Postmenopausal Osteoporosis","SMAD1","AFFECTS","Osteoporosis, Postmenopausal","Osteoporosis, Postmenopausal"
"4552","36324258","N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.","YTHDF3","regulate","metastasis","Melanoma","YTHDF3","AFFECTS","Neoplasm Metastasis","SKCM(Skin Cutaneous Melanoma)"
"4553","36324258","N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.","YTHDF3","regulate","LOXL3","Melanoma","YTHDF3","AFFECTS","LOXL3","SKCM(Skin Cutaneous Melanoma)"
"4554","36324258","N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.","LOXL3","regulate","metastasis","Melanoma","LOXL3","AFFECTS","Neoplasm Metastasis","SKCM(Skin Cutaneous Melanoma)"
"4555","36324258","N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.","N6-methyladenosine","bind","YTHDF3","Melanoma","m6A","INTERACTS_WITH","YTHDF3","SKCM(Skin Cutaneous Melanoma)"
"4557","36326914","N6-methyladenosine (m6A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1.","KIAA1429","accelerate","Oxaliplatin Chemoresistance","Gastric Cancer","VIRMA","STIMULATES","Oxaliplatin Chemoresistance","STAD(Stomach adenocarcinoma)"
"4558","36326914","N6-methyladenosine (m6A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1.","KIAA1429","target","FOXM1","Gastric Cancer","VIRMA","INTERACTS_WITH","FOXM1","STAD(Stomach adenocarcinoma)"
"4559","36326914","N6-methyladenosine (m6A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1.","FOXM1","regulate","Oxaliplatin Chemoresistance","Gastric Cancer","FOXM1","AFFECTS","Oxaliplatin Chemoresistance","STAD(Stomach adenocarcinoma)"
"4561","36327034","FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.","FTO","inhibit","Oxidative Stress","Cerebral ischemia/reperfusion injury","FTO","INHIBITS","Oxidative Stress","Cerebral ischemia/reperfusion injury"
"4562","36327034","FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.","FTO","demethylate","m6A","Cerebral ischemia/reperfusion injury","FTO","CONVERTS_TO","m6A","Cerebral ischemia/reperfusion injury"
"4563","36327034","FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.","m6A","is on","Nrf2","Cerebral ischemia/reperfusion injury","m6A","LOCATES","NFE2L2","Cerebral ischemia/reperfusion injury"
"4564","36327034","FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.","Nrf2","regulate","Oxidative Stress","Cerebral ischemia/reperfusion injury","NFE2L2","AFFECTS","Oxidative Stress","Cerebral ischemia/reperfusion injury"
"4566","36333113","PARP1 Is Upregulated by Hyperglycemia Via N6-methyladenosine Modification and Promotes Diabetic Retinopathy.","Hyperglycemia","upregulate","PARP1","Diabetic Retinopathy","Hyperglycemia","STIMULATES","PARP1","Diabetic Retinopathy"
"4567","36333113","PARP1 Is Upregulated by Hyperglycemia Via N6-methyladenosine Modification and Promotes Diabetic Retinopathy.","Hyperglycemia","induce","N6-methyladenosine Modification","Diabetic Retinopathy","Hyperglycemia","CAUSES","m6A","Diabetic Retinopathy"
"4568","36333113","PARP1 Is Upregulated by Hyperglycemia Via N6-methyladenosine Modification and Promotes Diabetic Retinopathy.","N6-methyladenosine Modification","upregulate","PARP1","Diabetic Retinopathy","m6A","STIMULATES","PARP1","Diabetic Retinopathy"
"4569","36333113","PARP1 Is Upregulated by Hyperglycemia Via N6-methyladenosine Modification and Promotes Diabetic Retinopathy.","PARP1","promote","Diabetic Retinopathy","Diabetic Retinopathy","PARP1","STIMULATES","Diabetic Retinopathy","Diabetic Retinopathy"
"4571","36333630","NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.","NRP1","contribute","stemness","Breast Cancer","NRP1","AFFECTS","Stemness","BRCA(Breast Invasive Carcinoma)"
"4572","36333630","NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.","NRP1","potentiate","radioresistance","Breast Cancer","NRP1","AUGMENTS","Radioresistance","BRCA(Breast Invasive Carcinoma)"
"4573","36333630","NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.","NRP1","regulate","WTAP","Breast Cancer","NRP1","AFFECTS","WTAP","BRCA(Breast Invasive Carcinoma)"
"4574","36333630","NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.","WTAP","mediate","m6A","Breast Cancer","WTAP","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"4575","36333630","NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.","m6A","is on","Bcl-2 mRNA","Breast Cancer","m6A","LOCATES","BCL2","BRCA(Breast Invasive Carcinoma)"
"4576","36333630","NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.","Bcl-2 mRNA","regulate","stemness","Breast Cancer","BCL2","AFFECTS","Stemness","BRCA(Breast Invasive Carcinoma)"
"4577","36333630","NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.","Bcl-2 mRNA","regulate","radioresistance","Breast Cancer","BCL2","AFFECTS","Radioresistance","BRCA(Breast Invasive Carcinoma)"
"4579","36335087","ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis.","ALKBH5","mediate","m6A","Hepatocellular Carcinoma","ALKBH5","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"4580","36335087","ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis.","m6A","modify","LINC02551","Hepatocellular Carcinoma","m6A","AFFECTS","LINC02551","LIHC(Liver Hepatocellular Carcinoma)"
"4581","36335087","ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis.","LINC02551","enhance stability","DDX24","Hepatocellular Carcinoma","LINC02551","enhance stability","DDX24","LIHC(Liver Hepatocellular Carcinoma)"
"4582","36335087","ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis.","DDX24","promote","growth and metastasis","Hepatocellular Carcinoma","DDX24","STIMULATES","growth and metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"4584","36336035","Long-term cadmium exposure impairs cognitive function by activating lnc-Gm10532/m6A/FIS1 axis-mediated mitochondrial fission and dysfunction.","lnc-Gm10532/m6A/FIS1 axis","impair","cognitive function","Long-term cadmium exposure","lnc-Gm10532/m6A/FIS1 axis","INHIBITS","cognition","Long-term cadmium exposure"
"4585","36336035","Long-term cadmium exposure impairs cognitive function by activating lnc-Gm10532/m6A/FIS1 axis-mediated mitochondrial fission and dysfunction.","lnc-Gm10532/m6A/FIS1 axis","mediate","mitochondrial fission and dysfunction","Long-term cadmium exposure","lnc-Gm10532/m6A/FIS1 axis","AFFECTS","mitochondrial fission and dysfunction","Long-term cadmium exposure"
"4587","36341394","Mettl14-mediated m6A modification enhances the function of Foxp3<sup>+</sup> regulatory T cells and promotes allograft acceptance.","Mettl14","mediate","m6A modification","Regulatory T cells","METTL14","AFFECTS","m6A","T-Lymphocytes, Regulatory"
"4588","36341394","Mettl14-mediated m6A modification enhances the function of Foxp3<sup>+</sup> regulatory T cells and promotes allograft acceptance.","m6A modification","enhance","Foxp3+ regulatory T cells","Regulatory T cells","m6A","AUGMENTS","Foxp3+ regulatory T cells","T-Lymphocytes, Regulatory"
"4589","36341394","Mettl14-mediated m6A modification enhances the function of Foxp3<sup>+</sup> regulatory T cells and promotes allograft acceptance.","Foxp3+ regulatory T cells","promote","allograft acceptance","Regulatory T cells","Foxp3+ regulatory T cells","STIMULATES","allograft acceptance","T-Lymphocytes, Regulatory"
"4591","36344496","LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.","LINC01468","drive","NAFLD-HCC progression","NAFLD-HCC","LNCAROD","STIMULATES","NAFLD-HCC progression","NAFLD-HCC"
"4592","36344496","LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.","LINC01468","link","CUL4A","NAFLD-HCC","LNCAROD","link","CUL4A","NAFLD-HCC"
"4593","36344496","LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.","CUL4A","degrade","SHIP2","NAFLD-HCC","CUL4A","INHIBITS","INPPL1","NAFLD-HCC"
"4594","36344496","LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.","SHIP2","regulate","NAFLD-HCC progression","NAFLD-HCC","INPPL1","AFFECTS","NAFLD-HCC progression","NAFLD-HCC"
"4596","36347844","FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner.","FMR1","promote","Progression","Colorectal Cancer Cells","FMR1","STIMULATES","progression","COAD(Colon Adenocarcinoma)"
"4597","36347844","FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner.","FMR1","stabilize","EGFR mRNA","Colorectal Cancer Cells","FMR1","MAINTAINS","EGFR","COAD(Colon Adenocarcinoma)"
"4598","36347844","FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner.","m6A","regulate","EGFR mRNA","Colorectal Cancer Cells","m6A","AFFECTS","EGFR","COAD(Colon Adenocarcinoma)"
"4599","36347844","FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner.","EGFR mRNA","promote","Progression","Colorectal Cancer Cells","EGFR","STIMULATES","progression","COAD(Colon Adenocarcinoma)"
"4601","36348020","METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b.","METTL3","promote","metastasis","Colorectal Cancer","METTL3","STIMULATES","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"4602","36348020","METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b.","METTL3","promote","pri-microRNA-196b","Colorectal Cancer","METTL3","STIMULATES","pri-microRNA-196b","COAD(Colon Adenocarcinoma)"
"4603","36348020","METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b.","pri-microRNA-196b","promote","metastasis","Colorectal Cancer","pri-microRNA-196b","STIMULATES","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"4605","36351918","METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury.","METTL14","required for","exercise-induced cardiac hypertrophy","Heart","METTL14","CAUSES","exercise-induced cardiac hypertrophy","Heart"
"4606","36351918","METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury.","METTL14","protects","protection","Heart","METTL14","protects","protection","Heart"
"4608","36352154","Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin.","METTL14","mediate","m6A modification","Non-small cell lung cancer cells","METTL14","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4609","36352154","Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin.","m6A modification","is in","non-small cell lung cancer cell","Non-small cell lung cancer cells","m6A","LOCATES","non-small cell lung cancer cell","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4610","36352154","Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin.","non-small cell lung cancer cell","resist","cisplatin","Non-small cell lung cancer cells","non-small cell lung cancer cell","resist","cisplatin","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4611","36352154","Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin.","m6A modification","regulate","cisplatin","Non-small cell lung cancer cells","m6A","AFFECTS","cisplatin","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4613","36352530","Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.","dummy","elevate","FTO","Liver","dummy","STIMULATES","FTO","Liver"
"4614","36352530","Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.","FTO","promote","Liver Steatosis","Liver","FTO","STIMULATES","Fatty Liver","Liver"
"4615","36352530","Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.","FTO","decrease","m6A methylation","Liver","FTO","INHIBITS","m6A","Liver"
"4616","36352530","Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.","FTO","increase stability","SREBF1 mRNAs","Liver","FTO","increase stability","SREBF1","Liver"
"4617","36352530","Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.","FTO","increase stability","ChREBP mRNAs","Liver","FTO","increase stability","MLXIPL","Liver"
"4618","36352530","Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.","SREBF1 mRNAs","regulate","Liver Steatosis","Liver","SREBF1","AFFECTS","Fatty Liver","Liver"
"4619","36352530","Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs.","ChREBP mRNAs","regulate","Liver Steatosis","Liver","MLXIPL","AFFECTS","Fatty Liver","Liver"
"4621","36357715","RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.","dummy","induce deficiency","NSun2","Neurodegeneration","dummy","induce deficiency","NSUN2","Neurodegeneration"
"4622","36357715","RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.","NSun2","promote","Neurodegeneration","Neurodegeneration","NSUN2","STIMULATES","Neurodegeneration","Neurodegeneration"
"4623","36357715","RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.","NSun2","regulate","epitranscriptomic regulation","Neurodegeneration","NSUN2","AFFECTS","epitranscriptomic regulation","Neurodegeneration"
"4624","36357715","RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.","epitranscriptomic regulation","regulate","tau phosphorylation","Neurodegeneration","epitranscriptomic regulation","AFFECTS","tau phosphorylation","Neurodegeneration"
"4625","36357715","RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.","tau phosphorylation","regulate","Neurodegeneration","Neurodegeneration","tau phosphorylation","AFFECTS","Neurodegeneration","Neurodegeneration"
"4627","36358799","IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer.","IGF2BP2","promote","Epithelial","Gastric Cancer","IGF2BP2","STIMULATES","epithelial","STAD(Stomach adenocarcinoma)"
"4628","36358799","IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer.","IGF2BP2","promote","Metastasis","Gastric Cancer","IGF2BP2","STIMULATES","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"4629","36358799","IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer.","IGF2BP2","stabilize","HMGA1 mRNA","Gastric Cancer","IGF2BP2","MAINTAINS","HMGA1","STAD(Stomach adenocarcinoma)"
"4630","36358799","IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer.","HMGA1 mRNA","regulate","Epithelial","Gastric Cancer","HMGA1","AFFECTS","epithelial","STAD(Stomach adenocarcinoma)"
"4631","36358799","IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer.","HMGA1 mRNA","regulate","Metastasis","Gastric Cancer","HMGA1","AFFECTS","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"4633","36368367","YTHDF1 regulates endoplasmic reticulum stress, NF-kappaB, MAPK and PI3K-AKT signaling pathways in inflammatory osteoclastogenesis.","YTHDF1","regulate","endoplasmic reticulum stress","Inflammatory osteoclastogenesis","YTHDF1","AFFECTS","Endoplasmic Reticulum Stress","Inflammatory osteoclastogenesis"
"4634","36368367","YTHDF1 regulates endoplasmic reticulum stress, NF-kappaB, MAPK and PI3K-AKT signaling pathways in inflammatory osteoclastogenesis.","YTHDF1","regulate","NF-kappaB","Inflammatory osteoclastogenesis","YTHDF1","AFFECTS","NF-kappaB signaling pathway","Inflammatory osteoclastogenesis"
"4635","36368367","YTHDF1 regulates endoplasmic reticulum stress, NF-kappaB, MAPK and PI3K-AKT signaling pathways in inflammatory osteoclastogenesis.","YTHDF1","regulate","MAPK","Inflammatory osteoclastogenesis","YTHDF1","AFFECTS","MAPK","Inflammatory osteoclastogenesis"
"4636","36368367","YTHDF1 regulates endoplasmic reticulum stress, NF-kappaB, MAPK and PI3K-AKT signaling pathways in inflammatory osteoclastogenesis.","YTHDF1","regulate","PI3K-AKT signaling","Inflammatory osteoclastogenesis","YTHDF1","AFFECTS","PI3K/AKT signaling pathway","Inflammatory osteoclastogenesis"
"4638","36368640","Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis.","Matr3","reshape","m6A modification complex","Atherosclerosis","MATR3","reshape","m6A","Atherosclerosis"
"4639","36368640","Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis.","m6A modification complex","alleviate","macrophage inflammation","Atherosclerosis","m6A","INHIBITS","macrophage inflammation","Atherosclerosis"
"4640","36368640","Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis.","macrophage inflammation","cause","atherosclerosis","Atherosclerosis","macrophage inflammation","CAUSES","Atherosclerosis","Atherosclerosis"
"4642","36369887","METTL3-mediated long non-coding RNA MIR99AHG methylation targets miR-4660 to promote bone marrow mesenchymal stem cell osteogenic differentiation.","METTL3","mediate","long non-coding RNA MIR99AHG","Bone Marrow Mesenchymal Stem Cells","METTL3","AFFECTS","MIR99AHG","Bone Marrow Mesenchymal Stem Cells"
"4643","36369887","METTL3-mediated long non-coding RNA MIR99AHG methylation targets miR-4660 to promote bone marrow mesenchymal stem cell osteogenic differentiation.","long non-coding RNA MIR99AHG","target","miR-4660","Bone Marrow Mesenchymal Stem Cells","MIR99AHG","INTERACTS_WITH","MIR4660","Bone Marrow Mesenchymal Stem Cells"
"4644","36369887","METTL3-mediated long non-coding RNA MIR99AHG methylation targets miR-4660 to promote bone marrow mesenchymal stem cell osteogenic differentiation.","miR-4660","promote","osteogenic differentiation","Bone Marrow Mesenchymal Stem Cells","MIR4660","STIMULATES","Osteogenic Differentiation","Bone Marrow Mesenchymal Stem Cells"
"4646","36370665","N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells.","N6-methyladenosine","modify","circular RNA QSOX1","Colorectal Cancer","m6A","AFFECTS","circular RNA QSOX1","COAD(Colon Adenocarcinoma)"
"4647","36370665","N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells.","circular RNA QSOX1","promote","resistance","Colorectal Cancer","circular RNA QSOX1","STIMULATES","resistance","COAD(Colon Adenocarcinoma)"
"4648","36370665","N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells.","circular RNA QSOX1","induce","intratumoral regulatory T cells","Colorectal Cancer","circular RNA QSOX1","CAUSES","intratumoral regulatory T cells","COAD(Colon Adenocarcinoma)"
"4649","36370665","N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells.","intratumoral regulatory T cells","promote","resistance","Colorectal Cancer","intratumoral regulatory T cells","STIMULATES","resistance","COAD(Colon Adenocarcinoma)"
"4651","36370857","METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation.","METTL3","boost","glycolysis","Cardiac Fibroblasts","METTL3","boost","glycolytic process","Cardiac Fibroblasts"
"4652","36370857","METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation.","METTL3","boost","Cardiac Fibroblast Proliferation","Cardiac Fibroblasts","METTL3","boost","Cardiac Fibroblast Proliferation","Cardiac Fibroblasts"
"4653","36370857","METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation.","METTL3","methylate","AR","Cardiac Fibroblasts","METTL3","CONVERTS_TO","AR","Cardiac Fibroblasts"
"4654","36370857","METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation.","AR","regulate","glycolysis","Cardiac Fibroblasts","AR","AFFECTS","glycolytic process","Cardiac Fibroblasts"
"4655","36370857","METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation.","AR","regulate","Cardiac Fibroblast Proliferation","Cardiac Fibroblasts","AR","AFFECTS","Cardiac Fibroblast Proliferation","Cardiac Fibroblasts"
"4657","36249006","m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma.","IGF2BP1","promote","malignant phenotypes","Lung Adenocarcinoma","IGF2BP1","STIMULATES","malignant phenotypes","LUAD(Lung Adenocarcinoma)"
"4658","36249006","m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma.","IGF2BP1","bind","m6A","Lung Adenocarcinoma","IGF2BP1","INTERACTS_WITH","m6A","LUAD(Lung Adenocarcinoma)"
"4659","36249006","m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma.","m6A","regulate","malignant phenotypes","Lung Adenocarcinoma","m6A","AFFECTS","malignant phenotypes","LUAD(Lung Adenocarcinoma)"
"4661","36250924","RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression.","IGF2BP3","promote","metastasis","Triple-negative breast cancer","IGF2BP3","STIMULATES","Neoplasm Metastasis","BRCA(Breast Invasive Carcinoma)"
"4662","36250924","RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression.","IGF2BP3","repress","SLIT2","Triple-negative breast cancer","IGF2BP3","INHIBITS","SLIT2","BRCA(Breast Invasive Carcinoma)"
"4663","36250924","RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression.","SLIT2","regulate","metastasis","Triple-negative breast cancer","SLIT2","AFFECTS","Neoplasm Metastasis","BRCA(Breast Invasive Carcinoma)"
"4665","36257380","METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance.","METTL3","mediate","N6-methyladenosine modification","Tumor development and chemo-resistance","METTL3","AFFECTS","m6A","Tumor development and chemo-resistance"
"4666","36257380","METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance.","N6-methyladenosine modification","promote","IFFO1 downregulation","Tumor development and chemo-resistance","m6A","STIMULATES","IFFO1 downregulation","Tumor development and chemo-resistance"
"4667","36257380","METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance.","HDAC5/YY1","promote","IFFO1 downregulation","Tumor development and chemo-resistance","HDAC5/YY1","STIMULATES","IFFO1 downregulation","Tumor development and chemo-resistance"
"4668","36257380","METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance.","IFFO1 downregulation","regulate","Tumor development and chemo-resistance","Tumor development and chemo-resistance","IFFO1 downregulation","AFFECTS","Tumor development and chemo-resistance","Tumor development and chemo-resistance"
"4670","36257938","LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis.","LCAT1","stabilize","IGF2BP2-CDC6 axis","Null","LCAT1","MAINTAINS","IGF2BP2-CDC6 axis","Null"
"4672","36260529","N6-methyladenosine modification in trophoblasts promotes circSETD2 expression, inhibits miR-181a-5p, and elevates MCL1 transcription to reduce apoptosis of trophoblasts.","N6-methyladenosine modification","promote","circSETD2","Trophoblasts","m6A","STIMULATES","circSETD2","Trophoblasts"
"4673","36260529","N6-methyladenosine modification in trophoblasts promotes circSETD2 expression, inhibits miR-181a-5p, and elevates MCL1 transcription to reduce apoptosis of trophoblasts.","N6-methyladenosine modification","inhibit","miR-181a-5p","Trophoblasts","m6A","INHIBITS","miR-181a-5p","Trophoblasts"
"4674","36260529","N6-methyladenosine modification in trophoblasts promotes circSETD2 expression, inhibits miR-181a-5p, and elevates MCL1 transcription to reduce apoptosis of trophoblasts.","N6-methyladenosine modification","elevate","MCL1 transcription","Trophoblasts","m6A","STIMULATES","MCL1 transcription","Trophoblasts"
"4675","36260529","N6-methyladenosine modification in trophoblasts promotes circSETD2 expression, inhibits miR-181a-5p, and elevates MCL1 transcription to reduce apoptosis of trophoblasts.","N6-methyladenosine modification","reduce","apoptosis","Trophoblasts","m6A","INHIBITS","apoptotic process","Trophoblasts"
"4677","36263168","N6-methyladenosine of Socs1 modulates macrophage inflammatory response in different stiffness environments.","N6-methyladenosine","is on","Socs1","Null","m6A","LOCATES","SOCS1","Null"
"4678","36263168","N6-methyladenosine of Socs1 modulates macrophage inflammatory response in different stiffness environments.","Socs1","modulate","macrophage inflammatory response","Null","SOCS1","AFFECTS","macrophage inflammation","Null"
"4679","36263168","N6-methyladenosine of Socs1 modulates macrophage inflammatory response in different stiffness environments.","different stiffness environments","in","Socs1","Null","different stiffness environments","in","SOCS1","Null"
"4681","36263177","FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.","FTO","mediate","Autophagy","Clear Cell Renal Cell Carcinoma","FTO","AFFECTS","autophagy","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4682","36263177","FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.","Autophagy","promote","Progression","Clear Cell Renal Cell Carcinoma","autophagy","STIMULATES","progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4683","36263177","FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.","Autophagy","regulate","SIK2 mRNA","Clear Cell Renal Cell Carcinoma","autophagy","AFFECTS","SIK2","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4684","36263177","FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.","SIK2 mRNA","regulate","Progression","Clear Cell Renal Cell Carcinoma","SIK2","AFFECTS","progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4686","36264173","Extracellular vesicle-mediated transfer of lncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma.","Extracellular vesicle","transfer","lncRNA IGFL2-AS1","Renal Cell Carcinoma","extracellular vesicle","transfer","IGFL2-AS1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4687","36264173","Extracellular vesicle-mediated transfer of lncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma.","lncRNA IGFL2-AS1","confer","Sunitinib resistance","Renal Cell Carcinoma","IGFL2-AS1","PRODUCES","Sunitinib Resistance","KIRC(Kidney Renal Clear Cell Carcinoma)"
"4689","36264762","METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification.","METTL14","promote","migration and invasion","Choroidal Melanoma","METTL14","STIMULATES","migration and invasion","Choroidal melanoma"
"4690","36264762","METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification.","METTL14","target","RUNX2 mRNA","Choroidal Melanoma","METTL14","INTERACTS_WITH","RUNX2","Choroidal melanoma"
"4691","36264762","METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification.","METTL14","modify","m6A","Choroidal Melanoma","METTL14","AFFECTS","m6A","Choroidal melanoma"
"4692","36264762","METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification.","m6A","is on","RUNX2 mRNA","Choroidal Melanoma","m6A","LOCATES","RUNX2","Choroidal melanoma"
"4693","36264762","METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification.","RUNX2 mRNA","regulate","migration and invasion","Choroidal Melanoma","RUNX2","AFFECTS","migration and invasion","Choroidal melanoma"
"4695","36265285","RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.","Mettl3","mediate","RNA-m6A modification","Atherosclerosis","METTL3","AFFECTS","m6A","Atherosclerosis"
"4696","36265285","RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.","RNA-m6A modification","is on","HDGF","Atherosclerosis","m6A","LOCATES","HDGF","Atherosclerosis"
"4697","36265285","RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.","HDGF","aggravate","progression of atherosclerosis","Atherosclerosis","HDGF","COMPLICATES","progression of atherosclerosis","Atherosclerosis"
"4698","36265285","RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.","HDGF","regulate","macrophages polarization","Atherosclerosis","HDGF","AFFECTS","macrophages polarization","Atherosclerosis"
"4699","36265285","RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.","macrophages polarization","via","energy metabolism reprogramming","Atherosclerosis","macrophages polarization","via","energy metabolism reprogramming","Atherosclerosis"
"4700","36265285","RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.","energy metabolism reprogramming","regulate","progression of atherosclerosis","Atherosclerosis","energy metabolism reprogramming","AFFECTS","progression of atherosclerosis","Atherosclerosis"
"4702","36276112","METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification.","METTL3-IGF2BP3-axis","mediate","Proliferation","Pancreatic Cancer","METTL3-IGF2BP3-axis","AFFECTS","cell population proliferation","PAAD(Pancreatic Adenocarcinoma)"
"4703","36276112","METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification.","METTL3-IGF2BP3-axis","mediate","Migration","Pancreatic Cancer","METTL3-IGF2BP3-axis","AFFECTS","migration","PAAD(Pancreatic Adenocarcinoma)"
"4704","36276112","METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification.","METTL3-IGF2BP3-axis","regulate","Spermine Synthase","Pancreatic Cancer","METTL3-IGF2BP3-axis","AFFECTS","SMS","PAAD(Pancreatic Adenocarcinoma)"
"4705","36276112","METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification.","Spermine Synthase","regulate","Proliferation","Pancreatic Cancer","SMS","AFFECTS","cell population proliferation","PAAD(Pancreatic Adenocarcinoma)"
"4706","36276112","METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification.","Spermine Synthase","regulate","Migration","Pancreatic Cancer","SMS","AFFECTS","migration","PAAD(Pancreatic Adenocarcinoma)"
"4708","36281789","IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.","IGF2BP2","regulate","m6A","Head and Neck Squamous Cell Carcinoma","IGF2BP2","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4710","36282350","METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction.","METTL3","modify","lncRNA-SNHG8","Myocardial Infarction","METTL3","AFFECTS","SNHG8","Myocardial Infarction"
"4711","36282350","METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction.","lncRNA-SNHG8","bind","PTBP1","Myocardial Infarction","SNHG8","INTERACTS_WITH","PTBP1","Myocardial Infarction"
"4712","36282350","METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction.","PTBP1","regulate","ALAS2 expression","Myocardial Infarction","PTBP1","AFFECTS","ALAS2","Myocardial Infarction"
"4713","36282350","METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction.","ALAS2 expression","increase","oxidative stress","Myocardial Infarction","ALAS2","AUGMENTS","Oxidative Stress","Myocardial Infarction"
"4714","36282350","METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction.","oxidative stress","promote.","myocardial infarction","Myocardial Infarction","Oxidative Stress","promote.","Myocardial Infarction","Myocardial Infarction"
"4716","36284068","LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA.","LOC101929709","promote","Gastric Cancer Progression","Gastric Cancer","LOC101929709","STIMULATES","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"4717","36284068","LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA.","LOC101929709","aid","LIN28B","Gastric Cancer","LOC101929709","aid","LIN28B","STAD(Stomach adenocarcinoma)"
"4718","36284068","LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA.","LIN28B","stabilize","c-MYC mRNA","Gastric Cancer","LIN28B","MAINTAINS","MYC","STAD(Stomach adenocarcinoma)"
"4719","36284068","LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA.","c-MYC mRNA","regulate","Gastric Cancer Progression","Gastric Cancer","MYC","AFFECTS","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"4721","36284300","LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation.","FENDRR","with","m6A RNA methylation","Pulmonary Artery Endothelial Cell","FENDRR","with","m6A","Pulmonary Artery Endothelial Cell"
"4722","36284300","LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation.","FENDRR","regulate","pyroptosis","Pulmonary Artery Endothelial Cell","FENDRR","AFFECTS","pyroptosis","Pulmonary Artery Endothelial Cell"
"4723","36284300","LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation.","FENDRR","mediate","DRP1 DNA methylation","Pulmonary Artery Endothelial Cell","FENDRR","AFFECTS","DRP1 DNA methylation","Pulmonary Artery Endothelial Cell"
"4724","36284300","LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation.","DRP1 DNA methylation","regulate","pyroptosis","Pulmonary Artery Endothelial Cell","DRP1 DNA methylation","AFFECTS","pyroptosis","Pulmonary Artery Endothelial Cell"
"4726","36284441","Mettl14 mutation restrains liver regeneration by attenuating mitogens derived from non-parenchymal liver cells.","Mettl14","restrain","Liver Regeneration","Liver","METTL14","INHIBITS","liver regeneration","Liver"
"4727","36284441","Mettl14 mutation restrains liver regeneration by attenuating mitogens derived from non-parenchymal liver cells.","Mettl14","attenuate","Mitogens","Liver","METTL14","INHIBITS","mitogen","Liver"
"4728","36284441","Mettl14 mutation restrains liver regeneration by attenuating mitogens derived from non-parenchymal liver cells.","Non-parenchymal liver cells","derive","Mitogens","Liver","Non-parenchymal liver cells","derive","mitogen","Liver"
"4729","36284441","Mettl14 mutation restrains liver regeneration by attenuating mitogens derived from non-parenchymal liver cells.","Mitogens","regulate","Liver Regeneration","Liver","mitogen","AFFECTS","liver regeneration","Liver"
"4731","36288387","The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer.","METTL14","regulate","USP38","Bladder Cancer","METTL14","AFFECTS","USP38","BLCA(Bladder Urothelial Carcinoma)"
"4732","36288387","The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer.","USP38","regulate","METTL14","Bladder Cancer","USP38","AFFECTS","METTL14","BLCA(Bladder Urothelial Carcinoma)"
"4733","36288387","The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer.","METTL14","regulate","Cell Migration-6","Bladder Cancer","METTL14","AFFECTS","Cell Migration-6","BLCA(Bladder Urothelial Carcinoma)"
"4734","36288387","The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer.","USP38","regulate","Cell Migration-6","Bladder Cancer","USP38","AFFECTS","Cell Migration-6","BLCA(Bladder Urothelial Carcinoma)"
"4736","36288717","m6A modification confers thermal vulnerability to HPV E7 oncotranscripts via reverse regulation of its reader protein IGF2BP1 upon heat stress.","dummy","modify","m6A modification","Heat Stress","dummy","AFFECTS","m6A","heat stress"
"4737","36288717","m6A modification confers thermal vulnerability to HPV E7 oncotranscripts via reverse regulation of its reader protein IGF2BP1 upon heat stress.","m6A modification","confer","thermal vulnerability","Heat Stress","m6A","PRODUCES","thermal vulnerability","heat stress"
"4738","36288717","m6A modification confers thermal vulnerability to HPV E7 oncotranscripts via reverse regulation of its reader protein IGF2BP1 upon heat stress.","m6A modification","reverse regulate","IGF2BP1","Heat Stress","m6A","reverse regulate","IGF2BP1","heat stress"
"4739","36288717","m6A modification confers thermal vulnerability to HPV E7 oncotranscripts via reverse regulation of its reader protein IGF2BP1 upon heat stress.","heat stress","regulate","IGF2BP1","Heat Stress","heat stress","AFFECTS","IGF2BP1","heat stress"
"4740","36288717","m6A modification confers thermal vulnerability to HPV E7 oncotranscripts via reverse regulation of its reader protein IGF2BP1 upon heat stress.","IGF2BP1","regulate","thermal vulnerability","Heat Stress","IGF2BP1","AFFECTS","thermal vulnerability","heat stress"
"4742","36288719","METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma.","METTL3","regulate","m6A","SHH-medulloblastoma","METTL3","AFFECTS","m6A","SHH-medulloblastoma"
"4743","36288719","METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma.","m6A","is on","PTCH1","SHH-medulloblastoma","m6A","LOCATES","PTCH1","SHH-medulloblastoma"
"4744","36288719","METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma.","m6A","is on","GLI2","SHH-medulloblastoma","m6A","LOCATES","GLI2","SHH-medulloblastoma"
"4745","36288719","METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma.","PTCH1","is in","Sonic hedgehog signaling","SHH-medulloblastoma","PTCH1","LOCATES","Sonic hedgehog signaling pathway","SHH-medulloblastoma"
"4746","36288719","METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma.","GLI2","is in","Sonic hedgehog signaling","SHH-medulloblastoma","GLI2","LOCATES","Sonic hedgehog signaling pathway","SHH-medulloblastoma"
"4747","36288719","METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma.","Sonic hedgehog signaling","promote","Node 6","SHH-medulloblastoma","Sonic hedgehog signaling pathway","STIMULATES","Tumor Progression","SHH-medulloblastoma"
"4749","36291811","m6A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA.","KIAA1429","regulate","Cisplatin Sensitivity","Gastric Cancer Cells","VIRMA","AFFECTS","Cisplatin Sensitivity","STAD(Stomach adenocarcinoma)"
"4750","36291811","m6A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA.","KIAA1429","stabilize","FOXM1 mRNA","Gastric Cancer Cells","VIRMA","MAINTAINS","FOXM1","STAD(Stomach adenocarcinoma)"
"4751","36291811","m6A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA.","FOXM1 mRNA","regulate","Cisplatin Sensitivity","Gastric Cancer Cells","FOXM1","AFFECTS","Cisplatin Sensitivity","STAD(Stomach adenocarcinoma)"
"4753","36293529","Reduction of Methyltransferase-like 3-Mediated RNA N6-Methyladenosine Exacerbates the Development of Psoriasis Vulgaris in Imiquimod-Induced Psoriasis-like Mouse Model.","dummy","reduce","RNA N6-Methyladenosine","Imiquimod-Induced Psoriasis-like Mouse Model","dummy","INHIBITS","m6A","Imiquimod-Induced Psoriasis-like Mouse Model"
"4754","36293529","Reduction of Methyltransferase-like 3-Mediated RNA N6-Methyladenosine Exacerbates the Development of Psoriasis Vulgaris in Imiquimod-Induced Psoriasis-like Mouse Model.","Methyltransferase-like 3","mediate","RNA N6-Methyladenosine","Imiquimod-Induced Psoriasis-like Mouse Model","METTL3","AFFECTS","m6A","Imiquimod-Induced Psoriasis-like Mouse Model"
"4755","36293529","Reduction of Methyltransferase-like 3-Mediated RNA N6-Methyladenosine Exacerbates the Development of Psoriasis Vulgaris in Imiquimod-Induced Psoriasis-like Mouse Model.","RNA N6-Methyladenosine","exacerbate","Psoriasis Vulgaris","Imiquimod-Induced Psoriasis-like Mouse Model","m6A","COMPLICATES","psoriasis vulgaris","Imiquimod-Induced Psoriasis-like Mouse Model"
"4756","36293529","Reduction of Methyltransferase-like 3-Mediated RNA N6-Methyladenosine Exacerbates the Development of Psoriasis Vulgaris in Imiquimod-Induced Psoriasis-like Mouse Model.","Imiquimod","induce","Psoriasis Vulgaris","Imiquimod-Induced Psoriasis-like Mouse Model","imiquimod","CAUSES","psoriasis vulgaris","Imiquimod-Induced Psoriasis-like Mouse Model"
"4758","36302453","Downregulation of the m6A reader protein YTHDC1 leads to islet beta-cell failure and diabetes.","dummy","induce downregulation of","YTHDC1","Islet Beta-Cell","dummy","induce downregulation of","YTHDC1","Islet Beta-Cell"
"4759","36302453","Downregulation of the m6A reader protein YTHDC1 leads to islet beta-cell failure and diabetes.","YTHDC1","lead to","Islet Beta-Cell Failure","Islet Beta-Cell","YTHDC1","CAUSES","Islet Beta-Cell Failure","Islet Beta-Cell"
"4760","36302453","Downregulation of the m6A reader protein YTHDC1 leads to islet beta-cell failure and diabetes.","Islet Beta-Cell Failure","lead to","Diabetes","Islet Beta-Cell","Islet Beta-Cell Failure","CAUSES","Diabetes Mellitus","Islet Beta-Cell"
"4762","36303109","Acetaminophen changes the RNA m6A levels and m6A-related proteins expression in IL-1beta-treated chondrocyte cells.","Acetaminophen","change","RNA m6A levels","IL-1beta-treated chondrocyte cells","paracetamol","change","m6A levels","IL-1beta-treated chondrocyte cells"
"4763","36303109","Acetaminophen changes the RNA m6A levels and m6A-related proteins expression in IL-1beta-treated chondrocyte cells.","Acetaminophen","change","m6A-related proteins","IL-1beta-treated chondrocyte cells","paracetamol","change","m6A-related proteins","IL-1beta-treated chondrocyte cells"
"4764","36303109","Acetaminophen changes the RNA m6A levels and m6A-related proteins expression in IL-1beta-treated chondrocyte cells.","Acetaminophen","change","expression","IL-1beta-treated chondrocyte cells","paracetamol","change","expression","IL-1beta-treated chondrocyte cells"
"4766","36170767","The m6A methyltransferase METTL3 promotes trophoblast cell invasion by regulating MYLK expression.","METTL3","promote","Trophoblast cell invasion","Trophoblast cells","METTL3","STIMULATES","Trophoblast cell invasion","Trophoblast cells"
"4767","36170767","The m6A methyltransferase METTL3 promotes trophoblast cell invasion by regulating MYLK expression.","METTL3","regulate","MYLK","Trophoblast cells","METTL3","AFFECTS","MYLK","Trophoblast cells"
"4768","36170767","The m6A methyltransferase METTL3 promotes trophoblast cell invasion by regulating MYLK expression.","MYLK","regulate","Trophoblast cell invasion","Trophoblast cells","MYLK","AFFECTS","Trophoblast cell invasion","Trophoblast cells"
"4770","36171455","N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability.","YTHDF3","bind","N6-methyladenosine","Osteosarcoma","YTHDF3","INTERACTS_WITH","m6A","SARC(Sarcoma)"
"4771","36171455","N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability.","YTHDF3","stabilize","PGK1","Osteosarcoma","YTHDF3","MAINTAINS","PGK1","SARC(Sarcoma)"
"4772","36171455","N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability.","YTHDF3","contribute","aerobic glycolysis","Osteosarcoma","YTHDF3","AFFECTS","aerobic glycolysis","SARC(Sarcoma)"
"4773","36171455","N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability.","PGK1","regulate","aerobic glycolysis","Osteosarcoma","PGK1","AFFECTS","aerobic glycolysis","SARC(Sarcoma)"
"4775","36171622","Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.","NEAT1","mediate","RPRD1B stability","Gastric Cancer","NEAT1","AFFECTS","RPRD1B stability","STAD(Stomach adenocarcinoma)"
"4776","36171622","Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.","RPRD1B stability","facilitate","fatty acid metabolism","Gastric Cancer","RPRD1B stability","AUGMENTS","fatty acid metabolic process","STAD(Stomach adenocarcinoma)"
"4777","36171622","Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.","RPRD1B stability","facilitate","lymph node metastasis","Gastric Cancer","RPRD1B stability","AUGMENTS","lymph node metastatic carcinoma","STAD(Stomach adenocarcinoma)"
"4778","36171622","Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.","RPRD1B stability","regulate","c-Jun/c-Fos/SREBP1 axis","Gastric Cancer","RPRD1B stability","AFFECTS","c-Jun/c-Fos/SREBP1 axis","STAD(Stomach adenocarcinoma)"
"4779","36171622","Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.","c-Jun/c-Fos/SREBP1 axis","regulate","fatty acid metabolism","Gastric Cancer","c-Jun/c-Fos/SREBP1 axis","AFFECTS","fatty acid metabolic process","STAD(Stomach adenocarcinoma)"
"4780","36171622","Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.","c-Jun/c-Fos/SREBP1 axis","regulate","lymph node metastasis","Gastric Cancer","c-Jun/c-Fos/SREBP1 axis","AFFECTS","lymph node metastatic carcinoma","STAD(Stomach adenocarcinoma)"
"4782","36172147","FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.","FTO","promote","inflammation","Liver","FTO","STIMULATES","inflammatory response","Liver"
"4783","36172147","FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.","FTO","suppress","m6A","Liver","FTO","INHIBITS","m6A","Liver"
"4784","36172147","FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.","m6A","is on","IL-17RA","Liver","m6A","LOCATES","IL17RA","Liver"
"4785","36172147","FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.","IL-17RA","regulate","inflammation","Liver","IL17RA","AFFECTS","inflammatory response","Liver"
"4787","36173464","WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.","WTAP","mediate","FOXP3 mRNA","Colon Adenocarcinoma","WTAP","AFFECTS","FOXP3","COAD(Colon Adenocarcinoma)"
"4788","36173464","WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.","FOXP3 mRNA","promote","SMARCE1 expression","Colon Adenocarcinoma","FOXP3","STIMULATES","SMARCE1 expression","COAD(Colon Adenocarcinoma)"
"4789","36173464","WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.","SMARCE1 expression","augment","Glycolysis","Colon Adenocarcinoma","SMARCE1 expression","AUGMENTS","glycolytic process","COAD(Colon Adenocarcinoma)"
"4790","36173464","WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.","FOXP3 mRNA","regulate","Glycolysis","Colon Adenocarcinoma","FOXP3","AFFECTS","glycolytic process","COAD(Colon Adenocarcinoma)"
"4792","36174712","N6-methyladenosine modification on Hmbox1 is related to telomere dysfunction in DEHP-induced male reproductive injury.","N6-methyladenosine modification","is on","Hmbox1","DEHP-induced male reproductive injury","m6A","LOCATES","HMBOX1","DEHP-induced male reproductive injury"
"4793","36174712","N6-methyladenosine modification on Hmbox1 is related to telomere dysfunction in DEHP-induced male reproductive injury.","N6-methyladenosine modification","relate","telomere dysfunction","DEHP-induced male reproductive injury","m6A","relate","telomere dysfunction","DEHP-induced male reproductive injury"
"4795","36174881","m6A transferase METTL3 regulates endothelial-mesenchymal transition in diabetic retinopathy via lncRNA SNHG7/KHSRP/MKL1 axis.","METTL3","regulate","Endothelial-Mesenchymal Transition","Diabetic Retinopathy","METTL3","AFFECTS","Endothelial-Mesenchymal Transition","Diabetic Retinopathy"
"4796","36174881","m6A transferase METTL3 regulates endothelial-mesenchymal transition in diabetic retinopathy via lncRNA SNHG7/KHSRP/MKL1 axis.","METTL3","regulate","lncRNA SNHG7/KHSRP/MKL1 axis","Diabetic Retinopathy","METTL3","AFFECTS","SNHG7/KHSRP/MKL1 axis","Diabetic Retinopathy"
"4797","36174881","m6A transferase METTL3 regulates endothelial-mesenchymal transition in diabetic retinopathy via lncRNA SNHG7/KHSRP/MKL1 axis.","lncRNA SNHG7/KHSRP/MKL1 axis","regulate","Endothelial-Mesenchymal Transition","Diabetic Retinopathy","SNHG7/KHSRP/MKL1 axis","AFFECTS","Endothelial-Mesenchymal Transition","Diabetic Retinopathy"
"4799","36175708","WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m6A-dependent manner.","WTAP","promote","Oesophageal Squamous Cell Carcinoma Development","Oesophageal Squamous Cell Carcinoma","WTAP","STIMULATES","Oesophageal Squamous Cell Carcinoma Development","ESCA(Esophageal Carcinoma)"
"4800","36175708","WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m6A-dependent manner.","WTAP","decrease","CPSF4","Oesophageal Squamous Cell Carcinoma","WTAP","INHIBITS","CPSF4","ESCA(Esophageal Carcinoma)"
"4801","36175708","WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m6A-dependent manner.","WTAP","regulate","m6A","Oesophageal Squamous Cell Carcinoma","WTAP","AFFECTS","m6A","ESCA(Esophageal Carcinoma)"
"4802","36175708","WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m6A-dependent manner.","m6A","regulate","CPSF4","Oesophageal Squamous Cell Carcinoma","m6A","AFFECTS","CPSF4","ESCA(Esophageal Carcinoma)"
"4804","36175801","Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.","Serum-derived extracellular vesicles","promote","growth","Non-small cell lung cancer","Serum-derived extracellular vesicles","STIMULATES","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4805","36175801","Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.","Serum-derived extracellular vesicles","promote","metastasis","Non-small cell lung cancer","Serum-derived extracellular vesicles","STIMULATES","Neoplasm Metastasis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4806","36175801","Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.","Serum-derived extracellular vesicles","deliver","HNRNPC","Non-small cell lung cancer","Serum-derived extracellular vesicles","deliver","HNRNPC","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4807","36175801","Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.","HNRNPC","regulate","DLGAP5","Non-small cell lung cancer","HNRNPC","AFFECTS","DLGAP5","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4808","36175801","Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.","DLGAP5","regulate","growth","Non-small cell lung cancer","DLGAP5","AFFECTS","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4809","36175801","Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.","DLGAP5","regulate","metastasis","Non-small cell lung cancer","DLGAP5","AFFECTS","Neoplasm Metastasis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4811","36182806","RNA binding protein IGF2BP1 meditates oxidative stress-induced granulosa cell dysfunction by regulating MDM2 mRNA stability in an m6A-dependent manner.","IGF2BP1","mediate","Granulosa Cell Dysfunction","Granulosa Cells","IGF2BP1","AFFECTS","Granulosa Cell Dysfunction","Granulosa Cells"
"4812","36182806","RNA binding protein IGF2BP1 meditates oxidative stress-induced granulosa cell dysfunction by regulating MDM2 mRNA stability in an m6A-dependent manner.","IGF2BP1","regulate","MDM2 mRNA","Granulosa Cells","IGF2BP1","AFFECTS","MDM2","Granulosa Cells"
"4813","36182806","RNA binding protein IGF2BP1 meditates oxidative stress-induced granulosa cell dysfunction by regulating MDM2 mRNA stability in an m6A-dependent manner.","IGF2BP1","depend on","m6A","Granulosa Cells","IGF2BP1","INTERACTS_WITH","m6A","Granulosa Cells"
"4814","36182806","RNA binding protein IGF2BP1 meditates oxidative stress-induced granulosa cell dysfunction by regulating MDM2 mRNA stability in an m6A-dependent manner.","MDM2 mRNA","regulate","Granulosa Cell Dysfunction","Granulosa Cells","MDM2","AFFECTS","Granulosa Cell Dysfunction","Granulosa Cells"
"4816","36183833","m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-beta-induced epithelial-mesenchymal transition of lung cancer cells.","m6A RNA methylation","regulate","transcription factors","Lung Cancer Cells","m6A","AFFECTS","Transcription Factors","LUSC(Lung Squamous Cell Carcinoma)"
"4817","36183833","m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-beta-induced epithelial-mesenchymal transition of lung cancer cells.","transcription factors","include","JUN","Lung Cancer Cells","Transcription Factors","include","JUN_family","LUSC(Lung Squamous Cell Carcinoma)"
"4818","36183833","m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-beta-induced epithelial-mesenchymal transition of lung cancer cells.","transcription factors","include","JUNB","Lung Cancer Cells","Transcription Factors","include","JUNB","LUSC(Lung Squamous Cell Carcinoma)"
"4819","36183833","m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-beta-induced epithelial-mesenchymal transition of lung cancer cells.","JUN","regulate","epithelial-mesenchymal transition","Lung Cancer Cells","JUN_family","AFFECTS","epithelial to mesenchymal transition","LUSC(Lung Squamous Cell Carcinoma)"
"4820","36183833","m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-beta-induced epithelial-mesenchymal transition of lung cancer cells.","JUNB","regulate","epithelial-mesenchymal transition","Lung Cancer Cells","JUNB","AFFECTS","epithelial to mesenchymal transition","LUSC(Lung Squamous Cell Carcinoma)"
"4822","36195598","Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA.","YTHDF3","promote","Autophagy induction","Null","YTHDF3","STIMULATES","Autophagy induction","Null"
"4823","36195598","Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA.","YTHDF3","bind","m6A","Null","YTHDF3","INTERACTS_WITH","m6A","Null"
"4824","36195598","Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA.","YTHDF3","upregulate translation","FOXO3 mRNA","Null","YTHDF3","upregulate translation","FOXO3","Null"
"4825","36195598","Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA.","FOXO3 mRNA","regulate","Autophagy induction","Null","FOXO3","AFFECTS","Autophagy induction","Null"
"4827","36195720","LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer.","LncNAP1L6","activate","MMP pathway","Prostate Cancer","NAP1L6P","STIMULATES","MMP pathway","PRAD(Prostate Adenocarcinoma)"
"4828","36195720","LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer.","LncNAP1L6","stabilize","m6A","Prostate Cancer","NAP1L6P","MAINTAINS","m6A","PRAD(Prostate Adenocarcinoma)"
"4829","36195720","LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer.","m6A","modify","NAP1L2","Prostate Cancer","m6A","AFFECTS","NAP1L2","PRAD(Prostate Adenocarcinoma)"
"4830","36195720","LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer.","NAP1L2","promote","malignant progression","Prostate Cancer","NAP1L2","STIMULATES","Malignant Progression","PRAD(Prostate Adenocarcinoma)"
"4832","36199110","N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer.","N6-methyladenosine-related single-nucleotide polymorphism","identify","RNFT2","Bladder Cancer","m6A-related single-nucleotide polymorphism","DIAGNOSES","RNFT2","BLCA(Bladder Urothelial Carcinoma)"
"4833","36199110","N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer.","RNFT2","is in","Bladder Cancer","Bladder Cancer","RNFT2","LOCATES","Urinary Bladder Neoplasms","BLCA(Bladder Urothelial Carcinoma)"
"4835","36202872","METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer.","METTL3","regulate","LINC00662","Triple Negative Breast Cancer","METTL3","AFFECTS","LINC00662","BRCA(Breast Invasive Carcinoma)"
"4836","36202872","METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer.","LINC00662","regulate","miR-186-5p","Triple Negative Breast Cancer","LINC00662","AFFECTS","miR-186-5p","BRCA(Breast Invasive Carcinoma)"
"4837","36202872","METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer.","miR-186-5p","regulate","METTL3","Triple Negative Breast Cancer","miR-186-5p","AFFECTS","METTL3","BRCA(Breast Invasive Carcinoma)"
"4838","36202872","METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer.","feedback loop","regulate","docetaxel resistance","Triple Negative Breast Cancer","feedback loop","AFFECTS","docetaxel resistance","BRCA(Breast Invasive Carcinoma)"
"4840","36212476","LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer.","LncRNA MALAT1","regulate","METTL3","Pancreatic Cancer","MALAT1","AFFECTS","METTL3","PAAD(Pancreatic Adenocarcinoma)"
"4841","36212476","LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer.","METTL3","mediate","PD-L1 expression","Pancreatic Cancer","METTL3","AFFECTS","PD-L1 Expression","PAAD(Pancreatic Adenocarcinoma)"
"4842","36212476","LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer.","PD-L1 expression","regulate","immune infiltrates","Pancreatic Cancer","PD-L1 Expression","AFFECTS","immune infiltration","PAAD(Pancreatic Adenocarcinoma)"
"4844","36216883","YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation.","YTHDF2","mediate","FGF14-AS2 decay","Breast Cancer","YTHDF2","AFFECTS","FGF14-AS2 decay","BRCA(Breast Invasive Carcinoma)"
"4845","36216883","YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation.","FGF14-AS2 decay","promote","osteolytic metastasis","Breast Cancer","FGF14-AS2 decay","STIMULATES","osteolytic metastasis","BRCA(Breast Invasive Carcinoma)"
"4846","36216883","YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation.","FGF14-AS2 decay","enhance","RUNX2 mRNA","Breast Cancer","FGF14-AS2 decay","AUGMENTS","RUNX2","BRCA(Breast Invasive Carcinoma)"
"4847","36216883","YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation.","RUNX2 mRNA","translate","translation","Breast Cancer","RUNX2","translate","translation","BRCA(Breast Invasive Carcinoma)"
"4848","36216883","YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation.","translation","promote","osteolytic metastasis","Breast Cancer","translation","STIMULATES","osteolytic metastasis","BRCA(Breast Invasive Carcinoma)"
"4850","36217548","Oncofetal protein IGF2BP1 regulates IQGAP3 expression to maintain stem cell potential in cancer.","IGF2BP1","regulate","IQGAP3","Cancer","IGF2BP1","AFFECTS","IQGAP3","PANCAN(Pan-Cancer)"
"4851","36217548","Oncofetal protein IGF2BP1 regulates IQGAP3 expression to maintain stem cell potential in cancer.","IQGAP3","maintain","Stem Cell Potential","Cancer","IQGAP3","MAINTAINS","stem cell Phenotype","PANCAN(Pan-Cancer)"
"4853","36222159","circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13/N6-methyladenosine (m6A) to promote growth and invasion of hepatocellular carcinoma cells.","circRERE","regulate","miR-1299","Hepatocellular Carcinoma Cells","circRERE","AFFECTS","MIR1299","LIHC(Liver Hepatocellular Carcinoma)"
"4854","36222159","circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13/N6-methyladenosine (m6A) to promote growth and invasion of hepatocellular carcinoma cells.","ZC3H13","bind","m6A","Hepatocellular Carcinoma Cells","ZC3H13","INTERACTS_WITH","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"4855","36222159","circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13/N6-methyladenosine (m6A) to promote growth and invasion of hepatocellular carcinoma cells.","m6A","regulate","GBX2","Hepatocellular Carcinoma Cells","m6A","AFFECTS","GBX2","LIHC(Liver Hepatocellular Carcinoma)"
"4856","36222159","circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13/N6-methyladenosine (m6A) to promote growth and invasion of hepatocellular carcinoma cells.","GBX2","promote","growth and invasion","Hepatocellular Carcinoma Cells","GBX2","STIMULATES","growth and invasion","LIHC(Liver Hepatocellular Carcinoma)"
"4858","36227651","m6 A demethylase Fto regulates the TNF-alpha-induced inflammatory response in cementoblasts.","Fto","regulate","Inflammatory Response","Cementoblasts","FTO","AFFECTS","inflammatory response","Cementoblasts"
"4859","36227651","m6 A demethylase Fto regulates the TNF-alpha-induced inflammatory response in cementoblasts.","TNF-alpha","induce","Inflammatory Response","Cementoblasts","TNF","CAUSES","inflammatory response","Cementoblasts"
"4861","36228542","MiR-654-3p, reduced by the excessive ALKBH5, Alleviated the Inflammation in OA by targeting TNFRSF9, the trigger of the NF-kappaB pathway.","ALKBH5","reduce","dummy","OA","ALKBH5","INHIBITS","dummy","oleanolic acid"
"4862","36228542","MiR-654-3p, reduced by the excessive ALKBH5, Alleviated the Inflammation in OA by targeting TNFRSF9, the trigger of the NF-kappaB pathway.","MiR-654-3p","alleviate","Inflammation","OA","MiR-654-3p","INHIBITS","inflammatory response","oleanolic acid"
"4863","36228542","MiR-654-3p, reduced by the excessive ALKBH5, Alleviated the Inflammation in OA by targeting TNFRSF9, the trigger of the NF-kappaB pathway.","MiR-654-3p","target","TNFRSF9","OA","MiR-654-3p","INTERACTS_WITH","TNFRSF9","oleanolic acid"
"4864","36228542","MiR-654-3p, reduced by the excessive ALKBH5, Alleviated the Inflammation in OA by targeting TNFRSF9, the trigger of the NF-kappaB pathway.","TNFRSF9","trigger","NF-kappaB pathway","OA","TNFRSF9","CAUSES","NF-kappaB signaling pathway","oleanolic acid"
"4865","36228542","MiR-654-3p, reduced by the excessive ALKBH5, Alleviated the Inflammation in OA by targeting TNFRSF9, the trigger of the NF-kappaB pathway.","NF-kappaB pathway","regulate","Inflammation","OA","NF-kappaB signaling pathway","AFFECTS","inflammatory response","oleanolic acid"
"4867","36239013","Protein kinase C beta relieves autism-like behavior in EN2 knockout mice via upregulation of the FTO/PGC-1alpha/UCP1 axis.","Protein kinase C beta","relieve","autism-like behavior","EN2 knockout mice","PRKCB","relieve","autism-like behavior","EN2 knockout mice"
"4868","36239013","Protein kinase C beta relieves autism-like behavior in EN2 knockout mice via upregulation of the FTO/PGC-1alpha/UCP1 axis.","Protein kinase C beta","upregulate","FTO/PGC-1alpha/UCP1 axis","EN2 knockout mice","PRKCB","STIMULATES","FTO/PGC-1alpha/UCP1 axis","EN2 knockout mice"
"4869","36239013","Protein kinase C beta relieves autism-like behavior in EN2 knockout mice via upregulation of the FTO/PGC-1alpha/UCP1 axis.","FTO/PGC-1alpha/UCP1 axis","regulate","autism-like behavior","EN2 knockout mice","FTO/PGC-1alpha/UCP1 axis","AFFECTS","autism-like behavior","EN2 knockout mice"
"4871","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","HIF-1alpha","overexpress in","Extracellular Vesicles","Pancreatic Beta Cells","HIF1A","overexpress in","extracellular vesicle","Insulin-Secreting Cells"
"4872","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","Extracellular Vesicles","ameliorate","Apoptosis","Pancreatic Beta Cells","extracellular vesicle","TREATS","apoptotic process","Insulin-Secreting Cells"
"4873","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","Extracellular Vesicles","ameliorate","Senescence","Pancreatic Beta Cells","extracellular vesicle","TREATS","cellular senescence","Insulin-Secreting Cells"
"4874","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","Hypoxia","induce","Apoptosis","Pancreatic Beta Cells","Hypoxia","CAUSES","apoptotic process","Insulin-Secreting Cells"
"4875","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","Hypoxia","induce","Senescence","Pancreatic Beta Cells","Hypoxia","CAUSES","cellular senescence","Insulin-Secreting Cells"
"4876","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","Extracellular Vesicles","activate","YTHDF1","Pancreatic Beta Cells","extracellular vesicle","STIMULATES","YTHDF1","Insulin-Secreting Cells"
"4877","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","YTHDF1","mediate","Autophagy","Pancreatic Beta Cells","YTHDF1","AFFECTS","autophagy","Insulin-Secreting Cells"
"4878","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","Autophagy","ameliorate","Apoptosis","Pancreatic Beta Cells","autophagy","TREATS","apoptotic process","Insulin-Secreting Cells"
"4879","36244321","Mesenchymal stem cells-derived HIF-1alpha-overexpressed extracellular vesicles ameliorate hypoxia-induced pancreatic beta cell apoptosis and senescence through activating YTHDF1-mediated protective autophagy.","Autophagy","ameliorate","Senescence","Pancreatic Beta Cells","autophagy","TREATS","cellular senescence","Insulin-Secreting Cells"
"4881","36100071","METTL3 upregulates COPS5 expression in osteosarcoma in an m6A-related manner to promote osteosarcoma progression.","METTL3","upregulate","COPS5","Osteosarcoma","METTL3","STIMULATES","COPS5","SARC(Sarcoma)"
"4882","36100071","METTL3 upregulates COPS5 expression in osteosarcoma in an m6A-related manner to promote osteosarcoma progression.","METTL3","regulate","m6A","Osteosarcoma","METTL3","AFFECTS","m6A","SARC(Sarcoma)"
"4883","36100071","METTL3 upregulates COPS5 expression in osteosarcoma in an m6A-related manner to promote osteosarcoma progression.","m6A","regulate","COPS5","Osteosarcoma","m6A","AFFECTS","COPS5","SARC(Sarcoma)"
"4884","36100071","METTL3 upregulates COPS5 expression in osteosarcoma in an m6A-related manner to promote osteosarcoma progression.","COPS5","promote","Osteosarcoma Progression","Osteosarcoma","COPS5","STIMULATES","Osteosarcoma Progression","SARC(Sarcoma)"
"4886","36102650","N6-Methyladenine Modification of Hepatitis Delta Virus Regulates Its Virion Assembly by Recruiting YTHDF1.","N6-Methyladenine Modification","modify","Hepatitis Delta Virus","Hepatitis Delta Virus","m6A","AFFECTS","Hepatitis Delta Virus","Hepatitis Delta Virus"
"4887","36102650","N6-Methyladenine Modification of Hepatitis Delta Virus Regulates Its Virion Assembly by Recruiting YTHDF1.","N6-Methyladenine Modification","recruit","YTHDF1","Hepatitis Delta Virus","m6A","recruit","YTHDF1","Hepatitis Delta Virus"
"4888","36102650","N6-Methyladenine Modification of Hepatitis Delta Virus Regulates Its Virion Assembly by Recruiting YTHDF1.","YTHDF1","regulate","Virion Assembly","Hepatitis Delta Virus","YTHDF1","AFFECTS","virion assembly","Hepatitis Delta Virus"
"4890","36103831","Histone H1 regulates non-coding RNA turnover on chromatin in a m6A-dependent manner.","Histone H1","regulate","non-coding RNA turnover","Null","Histone_H1","AFFECTS","non-coding RNA turnover","Null"
"4891","36103831","Histone H1 regulates non-coding RNA turnover on chromatin in a m6A-dependent manner.","non-coding RNA turnover","is on","chromatin","Null","non-coding RNA turnover","LOCATES","chromatin","Null"
"4892","36103831","Histone H1 regulates non-coding RNA turnover on chromatin in a m6A-dependent manner.","m6A","regulate","non-coding RNA turnover","Null","m6A","AFFECTS","non-coding RNA turnover","Null"
"4894","36111643","Inhibition of METTL5 improves preimplantation development of mouse somatic cell nuclear transfer embryos.","dummy","inhibit","METTL5","Mouse somatic cell nuclear transfer embryos","dummy","INHIBITS","METTL5","Mouse somatic cell nuclear transfer embryos"
"4895","36111643","Inhibition of METTL5 improves preimplantation development of mouse somatic cell nuclear transfer embryos.","METTL5","improve","preimplantation development","Mouse somatic cell nuclear transfer embryos","METTL5","STIMULATES","preimplantation development","Mouse somatic cell nuclear transfer embryos"
"4897","36113565","Adenosine N6-methylation upregulates the expression of human CYP2B6 by altering the chromatin status.","Adenosine N6-methylation","upregulate","CYP2B6","Human Cells","m6A","STIMULATES","CYP2B6","Human Cells"
"4898","36113565","Adenosine N6-methylation upregulates the expression of human CYP2B6 by altering the chromatin status.","Adenosine N6-methylation","alter","chromatin status","Human Cells","m6A","AFFECTS","chromatin status","Human Cells"
"4899","36113565","Adenosine N6-methylation upregulates the expression of human CYP2B6 by altering the chromatin status.","chromatin status","regulate","CYP2B6","Human Cells","chromatin status","AFFECTS","CYP2B6","Human Cells"
"4901","36113831","IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","IGF2BP2","promote","Progression","Ovarian Endometriosis","IGF2BP2","STIMULATES","progression","endometriosis of ovary"
"4902","36113831","IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","IGF2BP2","regulate","m6A","Ovarian Endometriosis","IGF2BP2","AFFECTS","m6A","endometriosis of ovary"
"4903","36113831","IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","IGF2BP2","regulate","MEIS2","Ovarian Endometriosis","IGF2BP2","AFFECTS","MEIS2","endometriosis of ovary"
"4904","36113831","IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","IGF2BP2","regulate","GATA6","Ovarian Endometriosis","IGF2BP2","AFFECTS","GATA6","endometriosis of ovary"
"4905","36113831","IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","m6A","modify","MEIS2","Ovarian Endometriosis","m6A","AFFECTS","MEIS2","endometriosis of ovary"
"4906","36113831","IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","m6A","modify","GATA6","Ovarian Endometriosis","m6A","AFFECTS","GATA6","endometriosis of ovary"
"4908","36114749","METTL3 mediated m6 A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small cell lung cancer.","METTL3","mediate","m6A mRNA","Non-Small Cell Lung Cancer","METTL3","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4909","36114749","METTL3 mediated m6 A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small cell lung cancer.","m6A mRNA","contribute to resistance of","carbon-ion radiotherapy","Non-Small Cell Lung Cancer","m6A","contribute to resistance of","carbon-ion radiotherapy","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4911","36114757","m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability.","m6A modification","mediate","lncRNA TP53TG1","Gastric Cancer","m6A","AFFECTS","TP53TG1","STAD(Stomach adenocarcinoma)"
"4912","36114757","m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability.","lncRNA TP53TG1","inhibit","Cancer Progression","Gastric Cancer","TP53TG1","INHIBITS","Cancer Progression","STAD(Stomach adenocarcinoma)"
"4913","36114757","m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability.","lncRNA TP53TG1","regulate","CIP2A stability","Gastric Cancer","TP53TG1","AFFECTS","CIP2A stability","STAD(Stomach adenocarcinoma)"
"4914","36114757","m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability.","CIP2A stability","inhibit","Cancer Progression","Gastric Cancer","CIP2A stability","INHIBITS","Cancer Progression","STAD(Stomach adenocarcinoma)"
"4916","36114893","METTL3 dual regulation of the stability of LINC00662 and VEGFA RNAs promotes colorectal cancer angiogenesis.","METTL3","regulate","LINC00662","Colorectal Cancer","METTL3","AFFECTS","LINC00662","COAD(Colon Adenocarcinoma)"
"4917","36114893","METTL3 dual regulation of the stability of LINC00662 and VEGFA RNAs promotes colorectal cancer angiogenesis.","METTL3","regulate","VEGFA RNAs","Colorectal Cancer","METTL3","AFFECTS","VEGFA","COAD(Colon Adenocarcinoma)"
"4918","36114893","METTL3 dual regulation of the stability of LINC00662 and VEGFA RNAs promotes colorectal cancer angiogenesis.","LINC00662","promote","Angiogenesis","Colorectal Cancer","LINC00662","STIMULATES","angiogenesis","COAD(Colon Adenocarcinoma)"
"4919","36114893","METTL3 dual regulation of the stability of LINC00662 and VEGFA RNAs promotes colorectal cancer angiogenesis.","VEGFA RNAs","promote","Angiogenesis","Colorectal Cancer","VEGFA","STIMULATES","angiogenesis","COAD(Colon Adenocarcinoma)"
"4921","36118827","MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.","MicroRNA-1306-5p","regulate","METTL14","Acute Myeloid Leukemia","MicroRNA-1306-5p","AFFECTS","METTL14","LAML(Acute Myeloid Leukemia)"
"4922","36118827","MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.","METTL14","guide","m6A Methylation","Acute Myeloid Leukemia","METTL14","guide","m6A","LAML(Acute Myeloid Leukemia)"
"4923","36118827","MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.","m6A Methylation","repress","Acute Myeloid Leukemia","Acute Myeloid Leukemia","m6A","INHIBITS","Leukemia, Myeloid, Acute","LAML(Acute Myeloid Leukemia)"
"4924","36118827","MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.","MicroRNA-1306-5p","repress","Acute Myeloid Leukemia","Acute Myeloid Leukemia","MicroRNA-1306-5p","INHIBITS","Leukemia, Myeloid, Acute","LAML(Acute Myeloid Leukemia)"
"4926","36123390","YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma.","YAP","undergo","5-methylcytosine modification","Lung Adenocarcinoma","YAP1","undergo","5-methylcytosine modification","LUAD(Lung Adenocarcinoma)"
"4927","36123390","YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma.","5-methylcytosine modification","increase","mRNA stability","Lung Adenocarcinoma","5-methylcytosine modification","AUGMENTS","mrna stability","LUAD(Lung Adenocarcinoma)"
"4928","36123390","YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma.","mRNA stability","promote transcription of","exosome secretion-related genes","Lung Adenocarcinoma","mrna stability","promote transcription of","exosome secretion-related genes","LUAD(Lung Adenocarcinoma)"
"4929","36123390","YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma.","YAP","increase","mRNA stability","Lung Adenocarcinoma","YAP1","AUGMENTS","mrna stability","LUAD(Lung Adenocarcinoma)"
"4931","36127319","N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis.","N6-methyladenosine modification","modify","circ_0003215","Colorectal Cancer","m6A","AFFECTS","circ_0003215","COAD(Colon Adenocarcinoma)"
"4932","36127319","N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis.","circ_0003215","suppress","pentose phosphate pathway","Colorectal Cancer","circ_0003215","INHIBITS","pentose-phosphate shunt","COAD(Colon Adenocarcinoma)"
"4933","36127319","N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis.","circ_0003215","suppress","malignancy","Colorectal Cancer","circ_0003215","INHIBITS","cancer","COAD(Colon Adenocarcinoma)"
"4934","36127319","N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis.","circ_0003215","regulate","miR-663b/DLG4/G6PD axis","Colorectal Cancer","circ_0003215","AFFECTS","miR-663b/DLG4/G6PD axis","COAD(Colon Adenocarcinoma)"
"4935","36127319","N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis.","miR-663b/DLG4/G6PD axis","regulate","pentose phosphate pathway","Colorectal Cancer","miR-663b/DLG4/G6PD axis","AFFECTS","pentose-phosphate shunt","COAD(Colon Adenocarcinoma)"
"4936","36127319","N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis.","miR-663b/DLG4/G6PD axis","regulate","malignancy","Colorectal Cancer","miR-663b/DLG4/G6PD axis","AFFECTS","cancer","COAD(Colon Adenocarcinoma)"
"4938","36127411","m6A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis.","m6A","modify","circFOXK2","Oral Squamous Cell Carcinoma","m6A","AFFECTS","circFOXK2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4939","36127411","m6A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis.","circFOXK2","target","GLUT1","Oral Squamous Cell Carcinoma","circFOXK2","INTERACTS_WITH","SLC2A1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4940","36127411","m6A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis.","GLUT1","accelerate","Aerobic Glycolysis","Oral Squamous Cell Carcinoma","SLC2A1","STIMULATES","aerobic glycolysis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4941","36127411","m6A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis.","Aerobic Glycolysis","promote","Oral Squamous Cell Carcinoma","Oral Squamous Cell Carcinoma","aerobic glycolysis","STIMULATES","oral squamous cell carcinoma","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4943","36138131","METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma.","MRE11","mediate","DNA end resection","Pancreatic Ductal Adenocarcinoma","MRE11","AFFECTS","DNA end resection","PAAD(Pancreatic Adenocarcinoma)"
"4944","36138131","METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma.","METTL16","antagonize","DNA end resection","Pancreatic Ductal Adenocarcinoma","METTL16","antagonize","DNA end resection","PAAD(Pancreatic Adenocarcinoma)"
"4945","36138131","METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma.","METTL16","confer","synthetic lethality","Pancreatic Ductal Adenocarcinoma","METTL16","PRODUCES","synthetic lethality","PAAD(Pancreatic Adenocarcinoma)"
"4946","36138131","METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma.","METTL16","confer","PARP inhibition","Pancreatic Ductal Adenocarcinoma","METTL16","PRODUCES","PARP inhibition","PAAD(Pancreatic Adenocarcinoma)"
"4947","36138131","METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma.","PARP inhibition","induce","synthetic lethality","Pancreatic Ductal Adenocarcinoma","PARP inhibition","CAUSES","synthetic lethality","PAAD(Pancreatic Adenocarcinoma)"
"4949","36147665","RBM15 condensates modulate m6A modification of STYK1 to promote tumorigenesis.","RBM15 condensates","modulate","m6A modification","Null","RBM15 condensates","AFFECTS","m6A","Null"
"4950","36147665","RBM15 condensates modulate m6A modification of STYK1 to promote tumorigenesis.","m6A modification","is on","STYK1","Null","m6A","LOCATES","STYK1","Null"
"4951","36147665","RBM15 condensates modulate m6A modification of STYK1 to promote tumorigenesis.","m6A modification","promote","tumorigenesis","Null","m6A","STIMULATES","Carcinogenesis","Null"
"4952","36147665","RBM15 condensates modulate m6A modification of STYK1 to promote tumorigenesis.","STYK1","regulate","tumorigenesis","Null","STYK1","AFFECTS","Carcinogenesis","Null"
"4954","36149370","Reduced N6-methyladenosine mediated by METTL3 acetylation promotes MTF1 expression and hepatocellular carcinoma cell growth.","METTL3","reduce","N6-methyladenosine","Hepatocellular Carcinoma Cells","METTL3","INHIBITS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"4955","36149370","Reduced N6-methyladenosine mediated by METTL3 acetylation promotes MTF1 expression and hepatocellular carcinoma cell growth.","acetylation","mediate","METTL3","Hepatocellular Carcinoma Cells","Acetylation","AFFECTS","METTL3","LIHC(Liver Hepatocellular Carcinoma)"
"4956","36149370","Reduced N6-methyladenosine mediated by METTL3 acetylation promotes MTF1 expression and hepatocellular carcinoma cell growth.","N6-methyladenosine","promote","MTF1 expression","Hepatocellular Carcinoma Cells","m6A","STIMULATES","MTF1 expression","LIHC(Liver Hepatocellular Carcinoma)"
"4957","36149370","Reduced N6-methyladenosine mediated by METTL3 acetylation promotes MTF1 expression and hepatocellular carcinoma cell growth.","MTF1 expression","promote","cell growth","Hepatocellular Carcinoma Cells","MTF1 expression","STIMULATES","cell growth","LIHC(Liver Hepatocellular Carcinoma)"
"4959","36154586","WTAP mediated the N6-methyladenosine modification of PDK4 to regulate the malignant behaviors of colorectal cancer cells in vitro and in vivo.","WTAP","mediate","N6-methyladenosine modification","Colorectal Cancer Cells","WTAP","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"4960","36154586","WTAP mediated the N6-methyladenosine modification of PDK4 to regulate the malignant behaviors of colorectal cancer cells in vitro and in vivo.","N6-methyladenosine modification","is on","PDK4","Colorectal Cancer Cells","m6A","LOCATES","PDK4","COAD(Colon Adenocarcinoma)"
"4961","36154586","WTAP mediated the N6-methyladenosine modification of PDK4 to regulate the malignant behaviors of colorectal cancer cells in vitro and in vivo.","PDK4","regulate","malignant behaviors","Colorectal Cancer Cells","PDK4","AFFECTS","Malignant Behaviors","COAD(Colon Adenocarcinoma)"
"4963","36163017","Long-term exercise training down-regulates m6A RNA demethylase FTO expression in the hippocampus and hypothalamus: an effective intervention for epigenetic modification.","Long-term exercise training","down-regulate","m6A RNA demethylase FTO","Hippocampus and Hypothalamus","Long-term exercise training","INHIBITS","FTO","Hippocampus and Hypothalamus"
"4964","36163017","Long-term exercise training down-regulates m6A RNA demethylase FTO expression in the hippocampus and hypothalamus: an effective intervention for epigenetic modification.","Long-term exercise training","intervene","Epigenetic modification","Hippocampus and Hypothalamus","Long-term exercise training","intervene","Epigenetic modification","Hippocampus and Hypothalamus"
"4966","36167542","METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma.","METTL3","suppress","anlotinib sensitivity","Oral Squamous Cell Carcinoma","METTL3","INHIBITS","anlotinib sensitivity","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4967","36167542","METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma.","METTL3","regulate","m6A","Oral Squamous Cell Carcinoma","METTL3","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4968","36167542","METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma.","m6A","is on","FGFR3","Oral Squamous Cell Carcinoma","m6A","LOCATES","FGFR3","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4969","36167542","METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma.","FGFR3","regulate","anlotinib sensitivity","Oral Squamous Cell Carcinoma","FGFR3","AFFECTS","anlotinib sensitivity","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4971","36168624","m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism.","m6A","induce","lncDBET","Bladder Cancer","m6A","CAUSES","lncDBET","BLCA(Bladder Urothelial Carcinoma)"
"4972","36168624","m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism.","lncDBET","promote","Malignant Progression","Bladder Cancer","lncDBET","STIMULATES","Malignant Progression","BLCA(Bladder Urothelial Carcinoma)"
"4973","36168624","m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism.","lncDBET","regulate","FABP5","Bladder Cancer","lncDBET","AFFECTS","FABP5","BLCA(Bladder Urothelial Carcinoma)"
"4974","36168624","m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism.","FABP5","mediate","Lipid Metabolism","Bladder Cancer","FABP5","AFFECTS","Lipid Metabolism","BLCA(Bladder Urothelial Carcinoma)"
"4975","36168624","m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism.","Lipid Metabolism","regulate","Malignant Progression","Bladder Cancer","Lipid Metabolism","AFFECTS","Malignant Progression","BLCA(Bladder Urothelial Carcinoma)"
"4977","36168628","The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.","N6-methyladenosine","mediate","lncRNA WEE2-AS1","Glioblastoma","m6A","AFFECTS","lncRNA WEE2-AS1","GBM(Glioblastoma Multiforme)"
"4978","36168628","The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.","lncRNA WEE2-AS1","promote","Glioblastoma Progression","Glioblastoma","lncRNA WEE2-AS1","STIMULATES","Glioblastoma Progression","GBM(Glioblastoma Multiforme)"
"4979","36168628","The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.","lncRNA WEE2-AS1","stabilize","RPN2","Glioblastoma","lncRNA WEE2-AS1","MAINTAINS","RPN2","GBM(Glioblastoma Multiforme)"
"4980","36168628","The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.","RPN2","promote","Glioblastoma Progression","Glioblastoma","RPN2","STIMULATES","Glioblastoma Progression","GBM(Glioblastoma Multiforme)"
"4982","36016928","The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses.","LSm1-7","exert opposite effects on","Hepatitis B virus biosynthesis","Hepatitis B virus biosynthesis and interferon responses","lsm1-7","exert opposite effects on","Hepatitis B virus biosynthesis","Hepatitis B virus biosynthesis and interferon responses"
"4983","36016928","The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses.","LSm1-7","exert opposite effects on","interferon responses","Hepatitis B virus biosynthesis and interferon responses","lsm1-7","exert opposite effects on","interferon responses","Hepatitis B virus biosynthesis and interferon responses"
"4984","36016928","The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses.","LSm2-8","exert opposite effects on","Hepatitis B virus biosynthesis","Hepatitis B virus biosynthesis and interferon responses","lsm2-8","exert opposite effects on","Hepatitis B virus biosynthesis","Hepatitis B virus biosynthesis and interferon responses"
"4985","36016928","The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses.","LSm2-8","exert opposite effects on","interferon responses","Hepatitis B virus biosynthesis and interferon responses","lsm2-8","exert opposite effects on","interferon responses","Hepatitis B virus biosynthesis and interferon responses"
"4987","36027936","N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.","N6-methyladenosine","upregulate","LINC00520","Breast Cancer","m6A","STIMULATES","LINC00520","BRCA(Breast Invasive Carcinoma)"
"4988","36027936","N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.","LINC00520","accelerate","Breast Cancer Progression","Breast Cancer","LINC00520","STIMULATES","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"4989","36027936","N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.","LINC00520","regulate","miR-577/POSTN axis","Breast Cancer","LINC00520","AFFECTS","miR-577/POSTN axis","BRCA(Breast Invasive Carcinoma)"
"4990","36027936","N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.","LINC00520","regulate","ILK/AKT/mTOR signaling pathway","Breast Cancer","LINC00520","AFFECTS","ILK/AKT/mTOR signaling pathway","BRCA(Breast Invasive Carcinoma)"
"4991","36027936","N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.","miR-577/POSTN axis","regulate","ILK/AKT/mTOR signaling pathway","Breast Cancer","miR-577/POSTN axis","AFFECTS","ILK/AKT/mTOR signaling pathway","BRCA(Breast Invasive Carcinoma)"
"4993","36030434","Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-beta and enhances chemoradiotherapy resistance.","Wilms tumor 1 associated protein","promote","epithelial mesenchymal transition","Gastric Cancer Cells","Wilms tumor 1 associated protein","STIMULATES","epithelial to mesenchymal transition","STAD(Stomach adenocarcinoma)"
"4994","36030434","Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-beta and enhances chemoradiotherapy resistance.","Wilms tumor 1 associated protein","accelerate","TGF-beta","Gastric Cancer Cells","Wilms tumor 1 associated protein","STIMULATES","TGFB","STAD(Stomach adenocarcinoma)"
"4995","36030434","Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-beta and enhances chemoradiotherapy resistance.","Wilms tumor 1 associated protein","enhance","chemoradiotherapy resistance","Gastric Cancer Cells","Wilms tumor 1 associated protein","AUGMENTS","Chemo-radiotherapy resistance","STAD(Stomach adenocarcinoma)"
"4996","36030434","Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-beta and enhances chemoradiotherapy resistance.","TGF-beta","regulate","epithelial mesenchymal transition","Gastric Cancer Cells","TGFB","AFFECTS","epithelial to mesenchymal transition","STAD(Stomach adenocarcinoma)"
"4997","36030434","Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-beta and enhances chemoradiotherapy resistance.","epithelial mesenchymal transition","regulate","chemoradiotherapy resistance","Gastric Cancer Cells","epithelial to mesenchymal transition","AFFECTS","Chemo-radiotherapy resistance","STAD(Stomach adenocarcinoma)"
"4999","36030651","IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma.","IGF2BP3-NRF2 axis","regulate","ferroptosis","Hepatocellular Carcinoma","IGF2BP3-NRF2 axis","AFFECTS","Ferroptosis","LIHC(Liver Hepatocellular Carcinoma)"
"5001","36035179","SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma.","SETD2","regulate","Gene Transcription Patterns","Lung Adenocarcinoma","SETD2","AFFECTS","Gene Transcription Patterns","LUAD(Lung Adenocarcinoma)"
"5002","36035179","SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma.","SETD2","associate","Radiosensitivity","Lung Adenocarcinoma","SETD2","ASSOCIATED_WITH","Radiation Tolerance","LUAD(Lung Adenocarcinoma)"
"5004","36040683","Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.","METTL3","mediate","m6A modifications","Gastrointestinal Stromal Tumors (GISTs)","METTL3","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"5005","36040683","Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.","m6A modifications","facilitate","mir-25-3p maturation","Gastrointestinal Stromal Tumors (GISTs)","m6A","AUGMENTS","mir-25-3p maturation","STAD(Stomach adenocarcinoma)"
"5006","36040683","Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.","mir-25-3p maturation","promote","GISTs progression","Gastrointestinal Stromal Tumors (GISTs)","mir-25-3p maturation","STIMULATES","GISTs progression","STAD(Stomach adenocarcinoma)"
"5007","36040683","Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.","METTL3","facilitate","GISTs progression","Gastrointestinal Stromal Tumors (GISTs)","METTL3","AUGMENTS","GISTs progression","STAD(Stomach adenocarcinoma)"
"5009","36044854","RBM45 is an m6A-binding protein that affects neuronal differentiation and the splicing of a subset of mRNAs.","RBM45","bind","m6A","Neurons","RBM45","INTERACTS_WITH","m6A","Neurons"
"5010","36044854","RBM45 is an m6A-binding protein that affects neuronal differentiation and the splicing of a subset of mRNAs.","RBM45","affect","Neuronal Differentiation","Neurons","RBM45","AFFECTS","Neuronal Differentiation","Neurons"
"5011","36044854","RBM45 is an m6A-binding protein that affects neuronal differentiation and the splicing of a subset of mRNAs.","RBM45","splice","mRNAs","Neurons","RBM45","splice","messenger RNA","Neurons"
"5013","36058192","The m6A demethylase FTO promotes renal epithelial-mesenchymal transition by reducing the m6A modification of lncRNA GAS5.","FTO","promote","epithelial-mesenchymal transition","Renal epithelial cells","FTO","STIMULATES","epithelial to mesenchymal transition","Renal epithelial cells"
"5014","36058192","The m6A demethylase FTO promotes renal epithelial-mesenchymal transition by reducing the m6A modification of lncRNA GAS5.","FTO","reduce","m6A","Renal epithelial cells","FTO","INHIBITS","m6A","Renal epithelial cells"
"5015","36058192","The m6A demethylase FTO promotes renal epithelial-mesenchymal transition by reducing the m6A modification of lncRNA GAS5.","m6A","is on","lncRNA GAS5","Renal epithelial cells","m6A","LOCATES","GAS5","Renal epithelial cells"
"5016","36058192","The m6A demethylase FTO promotes renal epithelial-mesenchymal transition by reducing the m6A modification of lncRNA GAS5.","lncRNA GAS5","regulate","epithelial-mesenchymal transition","Renal epithelial cells","GAS5","AFFECTS","epithelial to mesenchymal transition","Renal epithelial cells"
"5018","36058761","Quercetin ameliorated insulin resistance via regulating METTL3-mediated N6-methyladenosine modification of PRKD2 mRNA in skeletal muscle and C2C12 myocyte cell line.","Quercetin","ameliorate","Insulin Resistance","Skeletal Muscle and C2C12 Myocyte Cell Line","quercetin","TREATS","Insulin Resistance","Skeletal Muscle and C2C12 Myocyte Cell Line"
"5019","36058761","Quercetin ameliorated insulin resistance via regulating METTL3-mediated N6-methyladenosine modification of PRKD2 mRNA in skeletal muscle and C2C12 myocyte cell line.","Quercetin","regulate","METTL3","Skeletal Muscle and C2C12 Myocyte Cell Line","quercetin","AFFECTS","METTL3","Skeletal Muscle and C2C12 Myocyte Cell Line"
"5020","36058761","Quercetin ameliorated insulin resistance via regulating METTL3-mediated N6-methyladenosine modification of PRKD2 mRNA in skeletal muscle and C2C12 myocyte cell line.","METTL3","regulate","N6-methyladenosine","Skeletal Muscle and C2C12 Myocyte Cell Line","METTL3","AFFECTS","m6A","Skeletal Muscle and C2C12 Myocyte Cell Line"
"5021","36058761","Quercetin ameliorated insulin resistance via regulating METTL3-mediated N6-methyladenosine modification of PRKD2 mRNA in skeletal muscle and C2C12 myocyte cell line.","N6-methyladenosine","is on","PRKD2 mRNA","Skeletal Muscle and C2C12 Myocyte Cell Line","m6A","LOCATES","PRKD2","Skeletal Muscle and C2C12 Myocyte Cell Line"
"5022","36058761","Quercetin ameliorated insulin resistance via regulating METTL3-mediated N6-methyladenosine modification of PRKD2 mRNA in skeletal muscle and C2C12 myocyte cell line.","PRKD2 mRNA","regulate","Insulin Resistance","Skeletal Muscle and C2C12 Myocyte Cell Line","PRKD2","AFFECTS","Insulin Resistance","Skeletal Muscle and C2C12 Myocyte Cell Line"
"5024","36058919","Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients.","METTL3","increase","expression","Pancreatic Cancer Tissues","METTL3","AUGMENTS","expression","PAAD(Pancreatic Adenocarcinoma)"
"5025","36058919","Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients.","expression","associate","survival","Pancreatic Cancer Tissues","expression","ASSOCIATED_WITH","Survival","PAAD(Pancreatic Adenocarcinoma)"
"5027","36064747","CPEB2 m6A methylation regulates blood-tumor barrier permeability by regulating splicing factor SRSF5 stability.","CPEB2","regulate","m6A methylation","Blood-Tumor Barrier","CPEB2","AFFECTS","m6A","Blood Tumor"
"5028","36064747","CPEB2 m6A methylation regulates blood-tumor barrier permeability by regulating splicing factor SRSF5 stability.","m6A methylation","regulate","blood-tumor barrier permeability","Blood-Tumor Barrier","m6A","AFFECTS","blood-tumor barrier permeability","Blood Tumor"
"5029","36064747","CPEB2 m6A methylation regulates blood-tumor barrier permeability by regulating splicing factor SRSF5 stability.","m6A methylation","regulate","SRSF5 stability","Blood-Tumor Barrier","m6A","AFFECTS","SRSF5 stability","Blood Tumor"
"5030","36064747","CPEB2 m6A methylation regulates blood-tumor barrier permeability by regulating splicing factor SRSF5 stability.","SRSF5 stability","regulate","blood-tumor barrier permeability","Blood-Tumor Barrier","SRSF5 stability","AFFECTS","blood-tumor barrier permeability","Blood Tumor"
"5032","36068012","METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.","METTL3","regulate","miR-30b-5p","Slow transit constipation","METTL3","AFFECTS","miR-30b-5p","Slow transit constipation"
"5033","36068012","METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.","METTL3","regulate","DGCR8","Slow transit constipation","METTL3","AFFECTS","DGCR8","Slow transit constipation"
"5034","36068012","METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.","miR-30b-5p","regulate","PIK3R2","Slow transit constipation","miR-30b-5p","AFFECTS","PIK3R2","Slow transit constipation"
"5035","36068012","METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.","PIK3R2","regulate","Akt","Slow transit constipation","PIK3R2","AFFECTS","AKT","Slow transit constipation"
"5036","36068012","METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.","Akt","regulate","mTOR signaling cascade","Slow transit constipation","AKT","AFFECTS","mTOR signaling pathway","Slow transit constipation"
"5037","36068012","METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.","DGCR8","regulate","miR-30b-5p","Slow transit constipation","DGCR8","AFFECTS","miR-30b-5p","Slow transit constipation"
"5039","36069931","ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer.","ALKBH5","demethylate","m6A","Breast Cancer","ALKBH5","CONVERTS_TO","m6A","BRCA(Breast Invasive Carcinoma)"
"5040","36069931","ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer.","m6A","is on","GLUT4 mRNA","Breast Cancer","m6A","LOCATES","SLC2A4","BRCA(Breast Invasive Carcinoma)"
"5041","36069931","ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer.","GLUT4 mRNA","promote","glycolysis","Breast Cancer","SLC2A4","STIMULATES","glycolytic process","BRCA(Breast Invasive Carcinoma)"
"5042","36069931","ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer.","glycolysis","resist","HER2-targeted therapy","Breast Cancer","glycolytic process","resist","HER2-targeted therapy","BRCA(Breast Invasive Carcinoma)"
"5044","36070054","ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.","ALKBH5","inhibit","Cancer Progression","Thyroid Cancer","ALKBH5","INHIBITS","Cancer Progression","THCA(Thyroid Carcinoma)"
"5045","36070054","ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.","ALKBH5","promote","Ferroptosis","Thyroid Cancer","ALKBH5","STIMULATES","Ferroptosis","THCA(Thyroid Carcinoma)"
"5046","36070054","ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.","ALKBH5","regulate","TIAM1-Nrf2/HO-1 axis","Thyroid Cancer","ALKBH5","AFFECTS","TIAM1-Nrf2/HO-1 axis","THCA(Thyroid Carcinoma)"
"5047","36070054","ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.","TIAM1-Nrf2/HO-1 axis","promote","Ferroptosis","Thyroid Cancer","TIAM1-Nrf2/HO-1 axis","STIMULATES","Ferroptosis","THCA(Thyroid Carcinoma)"
"5049","36074102","TFAP4 activates IGF2BP1 and promotes progression of non-small cell lung cancer by stabilizing TK1 expression through m6A modification.","TFAP4","activate","IGF2BP1","Non-small cell lung cancer","TFAP4","STIMULATES","IGF2BP1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5050","36074102","TFAP4 activates IGF2BP1 and promotes progression of non-small cell lung cancer by stabilizing TK1 expression through m6A modification.","TFAP4","promote","Progression","Non-small cell lung cancer","TFAP4","STIMULATES","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5051","36074102","TFAP4 activates IGF2BP1 and promotes progression of non-small cell lung cancer by stabilizing TK1 expression through m6A modification.","TFAP4","stabilize","TK1","Non-small cell lung cancer","TFAP4","MAINTAINS","TK1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5052","36074102","TFAP4 activates IGF2BP1 and promotes progression of non-small cell lung cancer by stabilizing TK1 expression through m6A modification.","TK1","is on","m6A","Non-small cell lung cancer","TK1","LOCATES","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5053","36074102","TFAP4 activates IGF2BP1 and promotes progression of non-small cell lung cancer by stabilizing TK1 expression through m6A modification.","m6A","regulate","Progression","Non-small cell lung cancer","m6A","AFFECTS","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5055","36074324","METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.","METTL3","regulate","m6A","Choriocarcinoma","METTL3","AFFECTS","m6A","Choriocarcinoma"
"5056","36074324","METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.","m6A","promote","miR-21-5p maturation","Choriocarcinoma","m6A","STIMULATES","miR-21-5p maturation","Choriocarcinoma"
"5057","36074324","METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.","miR-21-5p maturation","accelerate","Choriocarcinoma progression","Choriocarcinoma","miR-21-5p maturation","STIMULATES","Choriocarcinoma progression","Choriocarcinoma"
"5058","36074324","METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.","HIF1AN","inactivate","HIF1A/VEGF pathway","Choriocarcinoma","HIF1AN","inactivate","HIF1A/VEGF pathway","Choriocarcinoma"
"5059","36074324","METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.","HIF1A/VEGF pathway","regulate","Choriocarcinoma progression","Choriocarcinoma","HIF1A/VEGF pathway","AFFECTS","Choriocarcinoma progression","Choriocarcinoma"
"5061","36075458","E6E7 regulates the HK2 expression in cervical cancer via GSK3beta/FTO signal.","E6E7","regulate","HK2","Cervical Cancer","E6E7","AFFECTS","HK2","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5062","36075458","E6E7 regulates the HK2 expression in cervical cancer via GSK3beta/FTO signal.","E6E7","regulate","GSK3beta/FTO signal","Cervical Cancer","E6E7","AFFECTS","GSK3beta/FTO signal","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5063","36075458","E6E7 regulates the HK2 expression in cervical cancer via GSK3beta/FTO signal.","GSK3beta/FTO signal","regulate","HK2","Cervical Cancer","GSK3beta/FTO signal","AFFECTS","HK2","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5065","36077054","RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.","ADAR1","regulate","METTL3","Breast Cancer","ADAR","AFFECTS","METTL3","BRCA(Breast Invasive Carcinoma)"
"5066","36077054","RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.","METTL3","promote","Breast Cancer Progression","Breast Cancer","METTL3","STIMULATES","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"5067","36077054","RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.","METTL3/ARHGAP5/YTHDF1 Axis","regulate","Breast Cancer Progression","Breast Cancer","METTL3/ARHGAP5/YTHDF1 Axis","AFFECTS","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"5069","36084732","FTO/RUNX2 signaling axis promotes cementoblast differentiation under normal and inflammatory condition.","FTO/RUNX2 signaling axis","promote","differentiation","Normal and inflammatory condition","FTO/RUNX2 signaling axis","STIMULATES","cell differentiation","Normal and inflammatory condition"
"5071","36086906","1m6A-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma.","m6A","modify","HOTAIRM1","Glioma","m6A","AFFECTS","HOTAIRM1","Glioma"
"5072","36086906","1m6A-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma.","HOTAIRM1","promote","Vasculogenic Mimicry Formation","Glioma","HOTAIRM1","STIMULATES","Vasculogenic Mimicry Formation","Glioma"
"5074","36087219","METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.","METTL3","promote","m6A","Hepatocellular Carcinoma","METTL3","STIMULATES","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"5075","36087219","METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.","m6A","is on","RBM14","Hepatocellular Carcinoma","m6A","LOCATES","RBM14","LIHC(Liver Hepatocellular Carcinoma)"
"5076","36087219","METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.","YTHDF1","bind","m6A","Hepatocellular Carcinoma","YTHDF1","INTERACTS_WITH","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"5077","36087219","METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.","RBM14","lead to","progression","Hepatocellular Carcinoma","RBM14","CAUSES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"5079","36094741","Nuclear m6 A reader YTHDC1 suppresses proximal alternative polyadenylation sites by interfering with the 3' processing machinery.","YTHDC1","bind","m6A","Nucleus","YTHDC1","INTERACTS_WITH","m6A","nucleus"
"5080","36094741","Nuclear m6 A reader YTHDC1 suppresses proximal alternative polyadenylation sites by interfering with the 3' processing machinery.","YTHDC1","suppress","proximal alternative polyadenylation sites","Nucleus","YTHDC1","INHIBITS","proximal alternative polyadenylation sites","nucleus"
"5081","36094741","Nuclear m6 A reader YTHDC1 suppresses proximal alternative polyadenylation sites by interfering with the 3' processing machinery.","YTHDC1","interfere","3' processing machinery","Nucleus","YTHDC1","interfere","3' processing machinery","nucleus"
"5082","36094741","Nuclear m6 A reader YTHDC1 suppresses proximal alternative polyadenylation sites by interfering with the 3' processing machinery.","3' processing machinery","regulate","proximal alternative polyadenylation sites","Nucleus","3' processing machinery","AFFECTS","proximal alternative polyadenylation sites","nucleus"
"5084","35941702","N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer.","N6-methyladenosine","mediate","CELF2","Pancreatic Cancer","m6A","AFFECTS","CELF2","PAAD(Pancreatic Adenocarcinoma)"
"5085","35941702","N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer.","CELF2","regulate","CD44 alternative splicing","Pancreatic Cancer","CELF2","AFFECTS","CD44 alternative splicing","PAAD(Pancreatic Adenocarcinoma)"
"5086","35941702","N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer.","CD44 alternative splicing","affect","ERAD pathway","Pancreatic Cancer","CD44 alternative splicing","AFFECTS","ERAD pathway","PAAD(Pancreatic Adenocarcinoma)"
"5087","35941702","N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer.","ERAD pathway","affect","tumorigenesis","Pancreatic Cancer","ERAD pathway","AFFECTS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"5088","35941702","N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer.","CELF2","regulate","tumorigenesis","Pancreatic Cancer","CELF2","AFFECTS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"5090","35945194","Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma.","dummy","down-regulate","m6A reader FTO","Lung Adenocarcinoma","dummy","INHIBITS","FTO","LUAD(Lung Adenocarcinoma)"
"5091","35945194","Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma.","m6A reader FTO","destabilize","PHF1","Lung Adenocarcinoma","FTO","DISRUPTS","PHF1","LUAD(Lung Adenocarcinoma)"
"5092","35945194","Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma.","PHF1","trigger","stemness capacity","Lung Adenocarcinoma","PHF1","CAUSES","stemness capacity","LUAD(Lung Adenocarcinoma)"
"5093","35945194","Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma.","stemness capacity","enhance","tumor progression","Lung Adenocarcinoma","stemness capacity","AUGMENTS","Tumor Progression","LUAD(Lung Adenocarcinoma)"
"5095","35947961","Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming.","Mettl14","drive","senescence-associated secretory phenotype","Somatic cells","METTL14","STIMULATES","Senescence-Associated Secretory Phenotype","Somatic cells"
"5096","35947961","Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming.","senescence-associated secretory phenotype","facilitate","somatic cell reprogramming","Somatic cells","Senescence-Associated Secretory Phenotype","AUGMENTS","Somatic Cell Reprogramming","Somatic cells"
"5098","35949109","m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA.","m6A modification","mediate","BATF2","Tongue Squamous Cell Carcinoma","m6A","AFFECTS","BATF2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5099","35949109","m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA.","BATF2","suppress","Metastasis","Tongue Squamous Cell Carcinoma","BATF2","INHIBITS","Neoplasm Metastasis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5100","35949109","m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA.","BATF2","suppress","Angiogenesis","Tongue Squamous Cell Carcinoma","BATF2","INHIBITS","angiogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5101","35949109","m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA.","BATF2","inhibit","VEGFA","Tongue Squamous Cell Carcinoma","BATF2","INHIBITS","VEGFA","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5102","35949109","m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA.","VEGFA","regulate","Metastasis","Tongue Squamous Cell Carcinoma","VEGFA","AFFECTS","Neoplasm Metastasis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5103","35949109","m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA.","VEGFA","regulate","Angiogenesis","Tongue Squamous Cell Carcinoma","VEGFA","AFFECTS","angiogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5105","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","Cromolyn Chitosan Nanoparticles","reverse","DNA Methylation","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","Cromolyn Chitosan Nanoparticles","reverse","DNA methylation","BRCA(Breast Invasive Carcinoma)"
"5106","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","Cromolyn Chitosan Nanoparticles","mitigate","DNMT1","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","Cromolyn Chitosan Nanoparticles","INHIBITS","DNMT1","BRCA(Breast Invasive Carcinoma)"
"5107","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","Cromolyn Chitosan Nanoparticles","mitigate","METTL3","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","Cromolyn Chitosan Nanoparticles","INHIBITS","METTL3","BRCA(Breast Invasive Carcinoma)"
"5108","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","DNA Methylation","is on","RASSF1A","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","DNA methylation","LOCATES","RASSF1","BRCA(Breast Invasive Carcinoma)"
"5109","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","DNA Methylation","is on","p16 genes","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","DNA methylation","LOCATES","Genes, p16","BRCA(Breast Invasive Carcinoma)"
"5110","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","RASSF1A","regulate","DNMT1","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","RASSF1","AFFECTS","DNMT1","BRCA(Breast Invasive Carcinoma)"
"5111","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","RASSF1A","regulate","METTL3","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","RASSF1","AFFECTS","METTL3","BRCA(Breast Invasive Carcinoma)"
"5112","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","p16 genes","regulate","DNMT1","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","Genes, p16","AFFECTS","DNMT1","BRCA(Breast Invasive Carcinoma)"
"5113","35961540","Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.","p16 genes","regulate","METTL3","Breast Cancer Cell Line and Tumor Xenograft Model in Mice","Genes, p16","AFFECTS","METTL3","BRCA(Breast Invasive Carcinoma)"
"5115","35961973","FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway.","FTO","upregulate","PDK1","Clear Cell Renal Cell Carcinoma","FTO","STIMULATES","PDPK1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5116","35961973","FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway.","FTO","promote","Clear Cell Renal Cell Carcinoma Progression","Clear Cell Renal Cell Carcinoma","FTO","STIMULATES","Clear Cell Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5117","35961973","FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway.","FTO","regulate","m6A","Clear Cell Renal Cell Carcinoma","FTO","AFFECTS","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5118","35961973","FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway.","m6A","regulate","PDK1","Clear Cell Renal Cell Carcinoma","m6A","AFFECTS","PDPK1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5120","35965785","The m6A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m6A modification of catenin beta 1.","WTAP","play a key role in","Development of Diffuse Large B-cell Lymphoma","Diffuse Large B-cell Lymphoma","WTAP","play a key role in","Development of Diffuse Large B-cell Lymphoma","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"5121","35965785","The m6A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m6A modification of catenin beta 1.","WTAP","regulate","m6A","Diffuse Large B-cell Lymphoma","WTAP","AFFECTS","m6A","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"5122","35965785","The m6A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m6A modification of catenin beta 1.","m6A","is on","catenin beta 1","Diffuse Large B-cell Lymphoma","m6A","LOCATES","CTNNB1","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"5123","35965785","The m6A methyltransferase WTAP plays a key role in the development of diffuse large B-cell lymphoma via regulating the m6A modification of catenin beta 1.","catenin beta 1","regulate","Development of Diffuse Large B-cell Lymphoma","Diffuse Large B-cell Lymphoma","CTNNB1","AFFECTS","Development of Diffuse Large B-cell Lymphoma","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"5125","35966596","RNA N6 -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer.","YTHDC1","essential for","Metastasis","Triple Negative Breast Cancer","YTHDC1","PREDISPOSES","Neoplasm Metastasis","BRCA(Breast Invasive Carcinoma)"
"5126","35966596","RNA N6 -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer.","TGF-beta","mediate","Metastasis","Triple Negative Breast Cancer","TGFB","AFFECTS","Neoplasm Metastasis","BRCA(Breast Invasive Carcinoma)"
"5128","35971034","m6A mRNA methylation regulates the ERK/NF-kappaB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer.","m6A","regulate","ERK/NF-kappaB/AKT signaling pathway","Endometrial Cancer","m6A","AFFECTS","ERK/NF-kappaB/AKT signaling pathway","Dientamoebiasis"
"5129","35971034","m6A mRNA methylation regulates the ERK/NF-kappaB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer.","m6A","regulate","PAPPA/IGFBP4 axis","Endometrial Cancer","m6A","AFFECTS","PAPPA/IGFBP4 axis","Dientamoebiasis"
"5130","35971034","m6A mRNA methylation regulates the ERK/NF-kappaB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer.","PAPPA/IGFBP4 axis","regulate","ERK/NF-kappaB/AKT signaling pathway","Endometrial Cancer","PAPPA/IGFBP4 axis","AFFECTS","ERK/NF-kappaB/AKT signaling pathway","Dientamoebiasis"
"5131","35971034","m6A mRNA methylation regulates the ERK/NF-kappaB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer.","ERK/NF-kappaB/AKT signaling pathway","promote","proliferation","Endometrial Cancer","ERK/NF-kappaB/AKT signaling pathway","STIMULATES","cell population proliferation","Dientamoebiasis"
"5132","35971034","m6A mRNA methylation regulates the ERK/NF-kappaB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer.","ERK/NF-kappaB/AKT signaling pathway","promote","tumor formation","Endometrial Cancer","ERK/NF-kappaB/AKT signaling pathway","STIMULATES","tumor formation","Dientamoebiasis"
"5134","35972892","METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m6A/c-Myc-dependent aerobic glycolysis.","METTL3","induce","DLGAP1-AS2","Non-small cell lung cancer","METTL3","CAUSES","DLGAP1-AS2","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5135","35972892","METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m6A/c-Myc-dependent aerobic glycolysis.","DLGAP1-AS2","regulate","m6A","Non-small cell lung cancer","DLGAP1-AS2","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5136","35972892","METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m6A/c-Myc-dependent aerobic glycolysis.","c-Myc","bind","m6A","Non-small cell lung cancer","MYC","INTERACTS_WITH","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5137","35972892","METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m6A/c-Myc-dependent aerobic glycolysis.","m6A","promote","tumorigenesis","Non-small cell lung cancer","m6A","STIMULATES","Carcinogenesis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5139","35974388","YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.","YY1/HDAC2 complex","downregulate","YTHDC1","ccRCC","YY1/HDAC2 complex","INHIBITS","YTHDC1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5140","35974388","YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.","YTHDC1","control","sensitivity","ccRCC","YTHDC1","AFFECTS","hypersensitivity reaction disease","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5141","35974388","YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.","YTHDC1","target","ANXA1-MAPK pathway","ccRCC","YTHDC1","INTERACTS_WITH","ANXA1-MAPK pathway","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5142","35974388","YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.","ANXA1-MAPK pathway","regulate","sensitivity","ccRCC","ANXA1-MAPK pathway","AFFECTS","hypersensitivity reaction disease","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5144","35977935","m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer.","m6A","mediate","RNA methylation","Gastric Cancer","m6A","AFFECTS","RNA methylation","STAD(Stomach adenocarcinoma)"
"5145","35977935","m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer.","RNA methylation","mediate","NDUFA4","Gastric Cancer","RNA methylation","AFFECTS","NDUFA4","STAD(Stomach adenocarcinoma)"
"5146","35977935","m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer.","NDUFA4","promote","Cell Proliferation","Gastric Cancer","NDUFA4","STIMULATES","cell population proliferation","STAD(Stomach adenocarcinoma)"
"5147","35977935","m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer.","NDUFA4","promote","Metabolism","Gastric Cancer","NDUFA4","STIMULATES","metabolic process","STAD(Stomach adenocarcinoma)"
"5149","35978821","ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators.","ELAVL1","promote","Prostate Cancer Progression","Prostate Cancer","ELAVL1","STIMULATES","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"5150","35978821","ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators.","ELAVL1","interact","m6A regulators","Prostate Cancer","ELAVL1","interact","m6A Regulators","PRAD(Prostate Adenocarcinoma)"
"5152","35979628","N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.","ALKBH5","suppress","Colorectal Cancer Progression","Colorectal Cancer","ALKBH5","INHIBITS","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"5153","35979628","N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.","ALKBH5","decrease","methylation","Colorectal Cancer","ALKBH5","INHIBITS","methylation","COAD(Colon Adenocarcinoma)"
"5154","35979628","N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.","methylation","is on","PHF20 mRNA","Colorectal Cancer","methylation","LOCATES","PHF20","COAD(Colon Adenocarcinoma)"
"5155","35979628","N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.","PHF20 mRNA","regulate","Colorectal Cancer Progression","Colorectal Cancer","PHF20","AFFECTS","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"5157","35981698","Mettl3 regulates hypertrophic differentiation of chondrocytes through modulating Dmp1 mRNA via Ythdf1-mediated m6A modification.","Mettl3","regulate","Hypertrophic Differentiation","Chondrocytes","METTL3","AFFECTS","Hypertrophic Differentiation","Chondrocytes"
"5158","35981698","Mettl3 regulates hypertrophic differentiation of chondrocytes through modulating Dmp1 mRNA via Ythdf1-mediated m6A modification.","Mettl3","modulate","Dmp1 mRNA","Chondrocytes","METTL3","AFFECTS","DMP1","Chondrocytes"
"5159","35981698","Mettl3 regulates hypertrophic differentiation of chondrocytes through modulating Dmp1 mRNA via Ythdf1-mediated m6A modification.","Ythdf1","mediate","m6A","Chondrocytes","YTHDF1","AFFECTS","m6A","Chondrocytes"
"5160","35981698","Mettl3 regulates hypertrophic differentiation of chondrocytes through modulating Dmp1 mRNA via Ythdf1-mediated m6A modification.","m6A","modify","Dmp1 mRNA","Chondrocytes","m6A","AFFECTS","DMP1","Chondrocytes"
"5162","35982895","ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression.","ALKBH5/MAP3K8 axis","regulate","PD-L1+ macrophage infiltration","Hepatocellular Carcinoma","ALKBH5/MAP3K8 axis","AFFECTS","PD-L1+ macrophage infiltration","LIHC(Liver Hepatocellular Carcinoma)"
"5163","35982895","ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression.","PD-L1+ macrophage infiltration","promote","hepatocellular carcinoma progression","Hepatocellular Carcinoma","PD-L1+ macrophage infiltration","STIMULATES","hepatocellular carcinoma progression","LIHC(Liver Hepatocellular Carcinoma)"
"5165","35982900","The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma.","m6A","induce","lncRNA CASC8","Esophageal Squamous Cell Carcinoma","m6A","CAUSES","CASC8","ESCA(Esophageal Carcinoma)"
"5166","35982900","The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma.","lncRNA CASC8","upregulate","hnRNPL","Esophageal Squamous Cell Carcinoma","CASC8","STIMULATES","HNRNPL","ESCA(Esophageal Carcinoma)"
"5167","35982900","The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma.","hnRNPL","promote","Proliferation","Esophageal Squamous Cell Carcinoma","HNRNPL","STIMULATES","cell population proliferation","ESCA(Esophageal Carcinoma)"
"5168","35982900","The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma.","hnRNPL","promote","Chemoresistance","Esophageal Squamous Cell Carcinoma","HNRNPL","STIMULATES","Chemoresistance","ESCA(Esophageal Carcinoma)"
"5169","35982900","The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma.","lncRNA CASC8","promote","Proliferation","Esophageal Squamous Cell Carcinoma","CASC8","STIMULATES","cell population proliferation","ESCA(Esophageal Carcinoma)"
"5170","35982900","The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma.","lncRNA CASC8","promote","Chemoresistance","Esophageal Squamous Cell Carcinoma","CASC8","STIMULATES","Chemoresistance","ESCA(Esophageal Carcinoma)"
"5172","35985439","METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.","METTL3","promote","growth","Pancreatic Cancer","METTL3","STIMULATES","Growth","PAAD(Pancreatic Adenocarcinoma)"
"5173","35985439","METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.","METTL3","promote","metastasis","Pancreatic Cancer","METTL3","STIMULATES","Neoplasm Metastasis","PAAD(Pancreatic Adenocarcinoma)"
"5174","35985439","METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.","METTL3","regulate","m6A","Pancreatic Cancer","METTL3","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"5175","35985439","METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.","METTL3","regulate","E2F5","Pancreatic Cancer","METTL3","AFFECTS","E2F5","PAAD(Pancreatic Adenocarcinoma)"
"5176","35985439","METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.","m6A","modify","E2F5","Pancreatic Cancer","m6A","AFFECTS","E2F5","PAAD(Pancreatic Adenocarcinoma)"
"5177","35985439","METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.","E2F5","regulate","growth","Pancreatic Cancer","E2F5","AFFECTS","Growth","PAAD(Pancreatic Adenocarcinoma)"
"5178","35985439","METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.","E2F5","regulate","metastasis","Pancreatic Cancer","E2F5","AFFECTS","Neoplasm Metastasis","PAAD(Pancreatic Adenocarcinoma)"
"5180","35985997","METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner.","METTL3","promote","Prostatic Hyperplasia","Prostatic Hyperplasia","METTL3","STIMULATES","Prostatic Hyperplasia","Prostatic Hyperplasia"
"5181","35985997","METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner.","METTL3","regulate","PTEN","Prostatic Hyperplasia","METTL3","AFFECTS","PTEN","Prostatic Hyperplasia"
"5182","35985997","METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Prostatic Hyperplasia","YTHDF2","INTERACTS_WITH","m6A","Prostatic Hyperplasia"
"5183","35985997","METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner.","PTEN","regulate","Prostatic Hyperplasia","Prostatic Hyperplasia","PTEN","AFFECTS","Prostatic Hyperplasia","Prostatic Hyperplasia"
"5185","35986274","Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/beta-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA.","Hypoxia","induce","lncRNA STEAP3-AS1","Colorectal Cancer","Hypoxia","CAUSES","STEAP3-AS1","COAD(Colon Adenocarcinoma)"
"5186","35986274","Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/beta-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA.","lncRNA STEAP3-AS1","activate","Wnt/beta-catenin signaling","Colorectal Cancer","STEAP3-AS1","STIMULATES","WNT/beta-catenin pathway","COAD(Colon Adenocarcinoma)"
"5187","35986274","Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/beta-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA.","Wnt/beta-catenin signaling","promote","Colorectal Cancer Progression","Colorectal Cancer","WNT/beta-catenin pathway","STIMULATES","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"5188","35986274","Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/beta-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA.","lncRNA STEAP3-AS1","prevent","m6A","Colorectal Cancer","STEAP3-AS1","PREVENTS","m6A","COAD(Colon Adenocarcinoma)"
"5189","35986274","Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/beta-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA.","m6A","degrade","STEAP3 mRNA","Colorectal Cancer","m6A","INHIBITS","STEAP3","COAD(Colon Adenocarcinoma)"
"5190","35986274","Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/beta-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA.","STEAP3 mRNA","regulate","Wnt/beta-catenin signaling","Colorectal Cancer","STEAP3","AFFECTS","WNT/beta-catenin pathway","COAD(Colon Adenocarcinoma)"
"5192","35987159","Melatonin enhances spermatogonia activity through promoting KIAA1429-mediated m6A deposition to activate the PI3K/AKT signaling.","Melatonin","enhance","spermatogonia activity","Spermatogonia","melatonin","AUGMENTS","spermatogonia activity","Spermatogonia"
"5193","35987159","Melatonin enhances spermatogonia activity through promoting KIAA1429-mediated m6A deposition to activate the PI3K/AKT signaling.","Melatonin","promote","KIAA1429","Spermatogonia","melatonin","STIMULATES","VIRMA","Spermatogonia"
"5194","35987159","Melatonin enhances spermatogonia activity through promoting KIAA1429-mediated m6A deposition to activate the PI3K/AKT signaling.","KIAA1429","mediate","m6A","Spermatogonia","VIRMA","AFFECTS","m6A","Spermatogonia"
"5195","35987159","Melatonin enhances spermatogonia activity through promoting KIAA1429-mediated m6A deposition to activate the PI3K/AKT signaling.","m6A","activate","PI3K/AKT signaling","Spermatogonia","m6A","STIMULATES","PI3K/AKT signaling pathway","Spermatogonia"
"5196","35987159","Melatonin enhances spermatogonia activity through promoting KIAA1429-mediated m6A deposition to activate the PI3K/AKT signaling.","PI3K/AKT signaling","regulate","spermatogonia activity","Spermatogonia","PI3K/AKT signaling pathway","AFFECTS","spermatogonia activity","Spermatogonia"
"5198","35987795","METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.","METTL3","potentiate","Progression","Cervical Cancer","METTL3","AUGMENTS","progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5199","35987795","METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.","METTL3","suppress","ER stress","Cervical Cancer","METTL3","INHIBITS","Endoplasmic Reticulum Stress","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5200","35987795","METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.","METTL3","regulate","m6A","Cervical Cancer","METTL3","AFFECTS","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5201","35987795","METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.","m6A","is on","TXNDC5 mRNA","Cervical Cancer","m6A","LOCATES","TXNDC5","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5202","35987795","METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.","TXNDC5 mRNA","regulate","ER stress","Cervical Cancer","TXNDC5","AFFECTS","Endoplasmic Reticulum Stress","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5204","35992092","Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism.","HOTAIRM1","ameliorate","Glioblastoma","Glioblastoma","HOTAIRM1","TREATS","Glioblastoma","GBM(Glioblastoma Multiforme)"
"5205","35992092","Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism.","HOTAIRM1","disrupt","Mitochondrial Oxidative Phosphorylation","Glioblastoma","HOTAIRM1","DISRUPTS","Mitochondrial Oxidative Phosphorylation","GBM(Glioblastoma Multiforme)"
"5206","35992092","Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism.","HOTAIRM1","disrupt","Serine Metabolism","Glioblastoma","HOTAIRM1","DISRUPTS","Serine Metabolism","GBM(Glioblastoma Multiforme)"
"5207","35992092","Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism.","Mitochondrial Oxidative Phosphorylation","regulate","Glioblastoma","Glioblastoma","Mitochondrial Oxidative Phosphorylation","AFFECTS","Glioblastoma","GBM(Glioblastoma Multiforme)"
"5208","35992092","Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism.","Serine Metabolism","regulate","Glioblastoma","Glioblastoma","Serine Metabolism","AFFECTS","Glioblastoma","GBM(Glioblastoma Multiforme)"
"5210","35996844","METTL3 enhances PNN mRNA stability through m6A modification to augment tumorigenesis of colon adenocarcinoma.","METTL3","enhance","PNN mRNA","Colon Adenocarcinoma","METTL3","AUGMENTS","PNN","COAD(Colon Adenocarcinoma)"
"5211","35996844","METTL3 enhances PNN mRNA stability through m6A modification to augment tumorigenesis of colon adenocarcinoma.","METTL3","cause","m6A modification","Colon Adenocarcinoma","METTL3","CAUSES","m6A","COAD(Colon Adenocarcinoma)"
"5212","35996844","METTL3 enhances PNN mRNA stability through m6A modification to augment tumorigenesis of colon adenocarcinoma.","m6A modification","augment","tumorigenesis","Colon Adenocarcinoma","m6A","AUGMENTS","Carcinogenesis","COAD(Colon Adenocarcinoma)"
"5213","35996844","METTL3 enhances PNN mRNA stability through m6A modification to augment tumorigenesis of colon adenocarcinoma.","PNN mRNA","regulate","tumorigenesis","Colon Adenocarcinoma","PNN","AFFECTS","Carcinogenesis","COAD(Colon Adenocarcinoma)"
"5215","36004481","Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m6A modification decrease dependent manner.","Oxymatrine","suppress","Oral Squamous Cell Carcinoma Progression","Oral Squamous Cell Carcinoma","oxymatrine","INHIBITS","Oral Squamous Cell Carcinoma Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5216","36004481","Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m6A modification decrease dependent manner.","Oxymatrine","suppress","CXC Chemokine Receptor 4","Oral Squamous Cell Carcinoma","oxymatrine","INHIBITS","CXCR4","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5217","36004481","Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m6A modification decrease dependent manner.","Oxymatrine","decrease","m6A","Oral Squamous Cell Carcinoma","oxymatrine","INHIBITS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5218","36004481","Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m6A modification decrease dependent manner.","m6A","regulate","CXC Chemokine Receptor 4","Oral Squamous Cell Carcinoma","m6A","AFFECTS","CXCR4","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5220","36008805","METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.","METTL3","promote","cell proliferation","NSCLC cells","METTL3","STIMULATES","cell population proliferation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5221","36008805","METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.","METTL3","promote","colony formation","NSCLC cells","METTL3","STIMULATES","Colony Formation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5222","36008805","METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.","METTL3","regulate","m6A","NSCLC cells","METTL3","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5223","36008805","METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.","YTHDF1","bind","m6A","NSCLC cells","YTHDF1","INTERACTS_WITH","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5224","36008805","METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.","m6A","promote","cell proliferation","NSCLC cells","m6A","STIMULATES","cell population proliferation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5225","36008805","METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.","m6A","promote","colony formation","NSCLC cells","m6A","STIMULATES","Colony Formation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5227","36009021","YTHDF3 Is Involved in the Diapause Process of Bivoltine Bombyx mori Strains by Regulating the Expression of Cyp307a1 and Cyp18a1 Genes in the Ecdysone Synthesis Pathway.","YTHDF3","involve","Diapause Process","Bivoltine Bombyx mori Strains","YTHDF3","ASSOCIATED_WITH","Diapause Process","Bivoltine Bombyx mori Strains"
"5228","36009021","YTHDF3 Is Involved in the Diapause Process of Bivoltine Bombyx mori Strains by Regulating the Expression of Cyp307a1 and Cyp18a1 Genes in the Ecdysone Synthesis Pathway.","YTHDF3","regulate","Cyp307a1","Bivoltine Bombyx mori Strains","YTHDF3","AFFECTS","Cyp307a1","Bivoltine Bombyx mori Strains"
"5229","36009021","YTHDF3 Is Involved in the Diapause Process of Bivoltine Bombyx mori Strains by Regulating the Expression of Cyp307a1 and Cyp18a1 Genes in the Ecdysone Synthesis Pathway.","YTHDF3","regulate","Cyp18a1","Bivoltine Bombyx mori Strains","YTHDF3","AFFECTS","Cyp18a1","Bivoltine Bombyx mori Strains"
"5230","36009021","YTHDF3 Is Involved in the Diapause Process of Bivoltine Bombyx mori Strains by Regulating the Expression of Cyp307a1 and Cyp18a1 Genes in the Ecdysone Synthesis Pathway.","Cyp307a1","regulate","Ecdysone Synthesis Pathway","Bivoltine Bombyx mori Strains","Cyp307a1","AFFECTS","Ecdysone Synthesis Pathway","Bivoltine Bombyx mori Strains"
"5231","36009021","YTHDF3 Is Involved in the Diapause Process of Bivoltine Bombyx mori Strains by Regulating the Expression of Cyp307a1 and Cyp18a1 Genes in the Ecdysone Synthesis Pathway.","Cyp18a1","regulate","Ecdysone Synthesis Pathway","Bivoltine Bombyx mori Strains","Cyp18a1","AFFECTS","Ecdysone Synthesis Pathway","Bivoltine Bombyx mori Strains"
"5233","35852867","RP11-552D4.1: a novel m6a-related LncRNA associated with immune status in glioblastoma.","m6A","related","RP11-552D4.1","Glioblastoma","m6A","related","LINC01736","GBM(Glioblastoma Multiforme)"
"5234","35852867","RP11-552D4.1: a novel m6a-related LncRNA associated with immune status in glioblastoma.","RP11-552D4.1","associated","Immune Status","Glioblastoma","LINC01736","associated","Immune Status","GBM(Glioblastoma Multiforme)"
"5236","35853000","Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA.","Alternative splicing","of","METTL3","Null","Alternative Splicing","of","METTL3","Null"
"5237","35853000","Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA.","METTL3","independent","m6A modifications in mRNA","Null","METTL3","independent","m6A","Null"
"5239","35857761","Enzymes flying under the radar: Cryptic METTL3 can persist in knockout cells.","Enzymes","persist in","METTL3","Knockout cells","Enzymes","persist in","METTL3","Knockout cells"
"5241","35864150","The N6-methyladenosine writer WTAP contributes to the induction of immune tolerance post kidney transplantation by targeting regulatory T cells.","WTAP","contribute to","Immune Tolerance","Post Kidney Transplantation","WTAP","CAUSES","Immune Tolerance","Post Kidney Transplantation"
"5242","35864150","The N6-methyladenosine writer WTAP contributes to the induction of immune tolerance post kidney transplantation by targeting regulatory T cells.","WTAP","target","Regulatory T cells","Post Kidney Transplantation","WTAP","INTERACTS_WITH","T-Lymphocytes, Regulatory","Post Kidney Transplantation"
"5243","35864150","The N6-methyladenosine writer WTAP contributes to the induction of immune tolerance post kidney transplantation by targeting regulatory T cells.","Regulatory T cells","regulate","Immune Tolerance","Post Kidney Transplantation","T-Lymphocytes, Regulatory","AFFECTS","Immune Tolerance","Post Kidney Transplantation"
"5245","35867754","RNA m1A methylation regulates glycolysis of cancer cells through modulating ATP5D.","RNA m1A methylation","regulate","glycolysis","Cancer Cells","cyclosporin A metabolite M1A","AFFECTS","glycolytic process","PANCAN(Pan-Cancer)"
"5246","35867754","RNA m1A methylation regulates glycolysis of cancer cells through modulating ATP5D.","RNA m1A methylation","modulate","ATP5D","Cancer Cells","cyclosporin A metabolite M1A","AFFECTS","ATP5F1D","PANCAN(Pan-Cancer)"
"5247","35867754","RNA m1A methylation regulates glycolysis of cancer cells through modulating ATP5D.","ATP5D","regulate","glycolysis","Cancer Cells","ATP5F1D","AFFECTS","glycolytic process","PANCAN(Pan-Cancer)"
"5249","35869392","PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA.","PLAA","suppress","metastasis","Ovarian Cancer","PLAA","INHIBITS","Neoplasm Metastasis","OV(Ovarian Serous Cystadenocarcinoma)"
"5250","35869392","PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA.","PLAA","regulate","METTL3","Ovarian Cancer","PLAA","AFFECTS","METTL3","OV(Ovarian Serous Cystadenocarcinoma)"
"5251","35869392","PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA.","METTL3","mediate","m6A","Ovarian Cancer","METTL3","AFFECTS","m6A","OV(Ovarian Serous Cystadenocarcinoma)"
"5252","35869392","PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA.","m6A","modify","TRPC3 mRNA","Ovarian Cancer","m6A","AFFECTS","TRPC3","OV(Ovarian Serous Cystadenocarcinoma)"
"5253","35869392","PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA.","TRPC3 mRNA","regulate","metastasis","Ovarian Cancer","TRPC3","AFFECTS","Neoplasm Metastasis","OV(Ovarian Serous Cystadenocarcinoma)"
"5255","35869629","Mmu-LncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p /HtrA3 signaling axis.","METTL3","induce","Mmu-LncRNA 121686","AKI","METTL3","CAUSES","Mmu-LncRNA 121686","aki"
"5256","35869629","Mmu-LncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p /HtrA3 signaling axis.","METTL3","induce","hsa-lncRNA 520657","AKI","METTL3","CAUSES","hsa-lncRNA 520657","aki"
"5257","35869629","Mmu-LncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p /HtrA3 signaling axis.","Mmu-LncRNA 121686","target","miR-328-5p","AKI","Mmu-LncRNA 121686","INTERACTS_WITH","miR-328-5p","aki"
"5258","35869629","Mmu-LncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p /HtrA3 signaling axis.","Mmu-LncRNA 121686","target","HtrA3 signaling axis","AKI","Mmu-LncRNA 121686","INTERACTS_WITH","HtrA3 signaling axis","aki"
"5259","35869629","Mmu-LncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p /HtrA3 signaling axis.","hsa-lncRNA 520657","target","miR-328-5p","AKI","hsa-lncRNA 520657","INTERACTS_WITH","miR-328-5p","aki"
"5260","35869629","Mmu-LncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p /HtrA3 signaling axis.","hsa-lncRNA 520657","target","HtrA3 signaling axis","AKI","hsa-lncRNA 520657","INTERACTS_WITH","HtrA3 signaling axis","aki"
"5261","35869629","Mmu-LncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p /HtrA3 signaling axis.","miR-328-5p","regulate","progression","AKI","miR-328-5p","AFFECTS","progression","aki"
"5262","35869629","Mmu-LncRNA 121686/hsa-lncRNA 520657 induced by METTL3 drive the progression of AKI by targeting miR-328-5p /HtrA3 signaling axis.","HtrA3 signaling axis","regulate","progression","AKI","HtrA3 signaling axis","AFFECTS","progression","aki"
"5264","35871232","N6-Methyladenosine-modified lncRNA LINREP promotes Glioblastoma progression by recruiting the PTBP1/HuR complex.","N6-Methyladenosine-modified lncRNA LINREP","promote","Glioblastoma progression","Glioblastoma","m6A-modified lncRNA LINREP","STIMULATES","Glioblastoma Progression","GBM(Glioblastoma Multiforme)"
"5265","35871232","N6-Methyladenosine-modified lncRNA LINREP promotes Glioblastoma progression by recruiting the PTBP1/HuR complex.","N6-Methyladenosine-modified lncRNA LINREP","recruit","PTBP1/HuR complex","Glioblastoma","m6A-modified lncRNA LINREP","recruit","PTBP1/HuR complex","GBM(Glioblastoma Multiforme)"
"5266","35871232","N6-Methyladenosine-modified lncRNA LINREP promotes Glioblastoma progression by recruiting the PTBP1/HuR complex.","PTBP1/HuR complex","promote","Glioblastoma progression","Glioblastoma","PTBP1/HuR complex","STIMULATES","Glioblastoma Progression","GBM(Glioblastoma Multiforme)"
"5268","35878734","N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells.","FTO","regulate","inflammatory cytokine secretion","Retinal Pigment Epithelium Cells","FTO","AFFECTS","inflammatory cytokine secretion","Retinal Pigment Epithelium Cells"
"5269","35878734","N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells.","FTO","regulate","tight junctions","Retinal Pigment Epithelium Cells","FTO","AFFECTS","tight junction","Retinal Pigment Epithelium Cells"
"5271","35880837","WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma.","WWP2 overexpression","inhibit","antitumor effects","Hepatocellular Carcinoma","WWP2 overexpression","INHIBITS","antitumor effects","LIHC(Liver Hepatocellular Carcinoma)"
"5272","35880837","WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma.","doxorubicin","induce","antitumor effects","Hepatocellular Carcinoma","doxorubicin","CAUSES","antitumor effects","LIHC(Liver Hepatocellular Carcinoma)"
"5274","35902569","m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression.","METTL3","induce","lncRNA SNHG17","Lung Adenocarcinoma","METTL3","CAUSES","SNHG17","LUAD(Lung Adenocarcinoma)"
"5275","35902569","m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression.","lncRNA SNHG17","promote","Gefitinib Resistance","Lung Adenocarcinoma","SNHG17","STIMULATES","Gefitinib Resistance","LUAD(Lung Adenocarcinoma)"
"5276","35902569","m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression.","lncRNA SNHG17","repress","LATS2","Lung Adenocarcinoma","SNHG17","INHIBITS","LATS2","LUAD(Lung Adenocarcinoma)"
"5277","35902569","m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression.","LATS2","regulate","Gefitinib Resistance","Lung Adenocarcinoma","LATS2","AFFECTS","Gefitinib Resistance","LUAD(Lung Adenocarcinoma)"
"5279","35904284","FTO promoted adipocyte differentiation by regulating ADRB1 gene through m6A modification in Hycole rabbits.","FTO","promote","Adipocyte Differentiation","Hycole Rabbits","FTO","STIMULATES","fat cell differentiation","Hycole Rabbits"
"5280","35904284","FTO promoted adipocyte differentiation by regulating ADRB1 gene through m6A modification in Hycole rabbits.","FTO","regulate","ADRB1 gene","Hycole Rabbits","FTO","AFFECTS","ADRB1","Hycole Rabbits"
"5281","35904284","FTO promoted adipocyte differentiation by regulating ADRB1 gene through m6A modification in Hycole rabbits.","FTO","modify","m6A","Hycole Rabbits","FTO","AFFECTS","m6A","Hycole Rabbits"
"5282","35904284","FTO promoted adipocyte differentiation by regulating ADRB1 gene through m6A modification in Hycole rabbits.","ADRB1 gene","regulate","Adipocyte Differentiation","Hycole Rabbits","ADRB1","AFFECTS","fat cell differentiation","Hycole Rabbits"
"5283","35904284","FTO promoted adipocyte differentiation by regulating ADRB1 gene through m6A modification in Hycole rabbits.","m6A","modify","ADRB1 gene","Hycole Rabbits","m6A","AFFECTS","ADRB1","Hycole Rabbits"
"5285","35908253","IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.","IGF2BP2","promote","Pancreatic Carcinoma Progression","Pancreatic Carcinoma","IGF2BP2","STIMULATES","Pancreatic Carcinoma Progression","PAAD(Pancreatic Adenocarcinoma)"
"5286","35908253","IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.","IGF2BP2","enhance","Stability","Pancreatic Carcinoma","IGF2BP2","AUGMENTS","stability","PAAD(Pancreatic Adenocarcinoma)"
"5287","35908253","IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.","Stability","of","B3GNT6 mRNA","Pancreatic Carcinoma","stability","of","B3GNT6","PAAD(Pancreatic Adenocarcinoma)"
"5288","35908253","IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.","IGF2BP2","regulate","m6A methylation","Pancreatic Carcinoma","IGF2BP2","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"5289","35908253","IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.","m6A methylation","enhance","Stability","Pancreatic Carcinoma","m6A","AUGMENTS","stability","PAAD(Pancreatic Adenocarcinoma)"
"5291","35916787","Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.","METTL3","promote","Progression","Nasopharyngeal Carcinoma","METTL3","STIMULATES","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5292","35916787","Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.","METTL3","mediate","M6A","Nasopharyngeal Carcinoma","METTL3","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5293","35916787","Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.","M6A","modify","EZH2","Nasopharyngeal Carcinoma","m6A","AFFECTS","EZH2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5294","35916787","Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.","EZH2","regulate","Progression","Nasopharyngeal Carcinoma","EZH2","AFFECTS","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5296","35923112","The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis.","Mettl3","attenuate","cell activation","Hepatic Stellate Cells","METTL3","INHIBITS","cell activation","Hepatic Stellate Cells"
"5297","35923112","The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis.","Mettl3","attenuate","liver fibrosis","Hepatic Stellate Cells","METTL3","INHIBITS","Liver Cirrhosis","Hepatic Stellate Cells"
"5299","35926466","METTL14-dependent m6A modification controls iNKT cell development and function.","METTL14","dependent","m6A modification","iNKT cells","METTL14","dependent","m6A","iNKT cells"
"5300","35926466","METTL14-dependent m6A modification controls iNKT cell development and function.","m6A modification","control","iNKT cell development","iNKT cells","m6A","AFFECTS","iNKT cell development","iNKT cells"
"5301","35926466","METTL14-dependent m6A modification controls iNKT cell development and function.","m6A modification","control","iNKT cell function","iNKT cells","m6A","AFFECTS","iNKT cell function","iNKT cells"
"5303","35927451","METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis.","METTL3","enhance","non-m6A translation","Null","METTL3","AUGMENTS","non-m6A translation","Null"
"5304","35927451","METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis.","non-m6A translation","enhance","epigenetic factors","Null","non-m6A translation","AUGMENTS","epigenetic factor","Null"
"5305","35927451","METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis.","METTL3","promote","tumourigenesis","Null","METTL3","STIMULATES","tumourigenesis","Null"
"5307","35930768","Cap-independent translation of GPLD1 enhances markers of brain health in long-lived mutant and drug-treated mice.","Cap-independent translation","translate","GPLD1","Long-lived mutant and drug-treated mice","cap-independent translation","translate","GPLD1","Long-lived mutant and drug-treated mice"
"5308","35930768","Cap-independent translation of GPLD1 enhances markers of brain health in long-lived mutant and drug-treated mice.","GPLD1","enhance","markers of brain health","Long-lived mutant and drug-treated mice","GPLD1","AUGMENTS","markers of brain health","Long-lived mutant and drug-treated mice"
"5310","35931692","Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a.","Mettl3","mediate","mRNA m6A modification","Postnatal Liver","METTL3","AFFECTS","m6A","Postnatal Liver"
"5311","35931692","Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a.","mRNA m6A modification","control","Liver Development","Postnatal Liver","m6A","AFFECTS","liver development","Postnatal Liver"
"5312","35931692","Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a.","mRNA m6A modification","modulate","Hnf4a","Postnatal Liver","m6A","AFFECTS","HNF4A","Postnatal Liver"
"5313","35931692","Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a.","Hnf4a","control","Liver Development","Postnatal Liver","HNF4A","AFFECTS","liver development","Postnatal Liver"
"5315","35933406","Intermittent hypoxia-induced METTL3 downregulation facilitates MGLL-mediated lipolysis of adipocytes in OSAS.","METTL3","downregulate","MGLL","OSAS","METTL3","INHIBITS","MGLL","Sleep Apnea, Obstructive"
"5316","35933406","Intermittent hypoxia-induced METTL3 downregulation facilitates MGLL-mediated lipolysis of adipocytes in OSAS.","MGLL","mediate","lipolysis","OSAS","MGLL","AFFECTS","Lipolysis","Sleep Apnea, Obstructive"
"5317","35933406","Intermittent hypoxia-induced METTL3 downregulation facilitates MGLL-mediated lipolysis of adipocytes in OSAS.","lipolysis","is in","adipocytes","OSAS","Lipolysis","LOCATES","Adipocytes","Sleep Apnea, Obstructive"
"5319","35934316","The S. cerevisiae m6A-reader Pho92 promotes timely meiotic recombination by controlling key methylated transcripts.","Pho92","promote","meiotic recombination","S. cerevisiae","Pho92","STIMULATES","meiotic recombination","Saccharomyces cerevisiae"
"5320","35934316","The S. cerevisiae m6A-reader Pho92 promotes timely meiotic recombination by controlling key methylated transcripts.","Pho92","control","key methylated transcripts","S. cerevisiae","Pho92","AFFECTS","key methylated transcripts","Saccharomyces cerevisiae"
"5321","35934316","The S. cerevisiae m6A-reader Pho92 promotes timely meiotic recombination by controlling key methylated transcripts.","Pho92","bind","m6A","S. cerevisiae","Pho92","INTERACTS_WITH","m6A","Saccharomyces cerevisiae"
"5322","35934316","The S. cerevisiae m6A-reader Pho92 promotes timely meiotic recombination by controlling key methylated transcripts.","key methylated transcripts","regulate","meiotic recombination","S. cerevisiae","key methylated transcripts","AFFECTS","meiotic recombination","Saccharomyces cerevisiae"
"5324","35936005","METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner.","METTL3","inhibit","inflammation","Retinal Pigment Epithelium Cells","METTL3","INHIBITS","inflammatory response","Retinal Pigment Epithelium Cells"
"5325","35936005","METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner.","METTL3","regulate","NR2F1","Retinal Pigment Epithelium Cells","METTL3","AFFECTS","NR2F1","Retinal Pigment Epithelium Cells"
"5326","35936005","METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner.","METTL3","regulate","m6A","Retinal Pigment Epithelium Cells","METTL3","AFFECTS","m6A","Retinal Pigment Epithelium Cells"
"5327","35936005","METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner.","m6A","regulate","NR2F1","Retinal Pigment Epithelium Cells","m6A","AFFECTS","NR2F1","Retinal Pigment Epithelium Cells"
"5329","35939687","RNA m6A demethylase ALKBH5 regulates the development of gammadelta T cells.","ALKBH5","demethylate","m6A","gammadelta T cells","ALKBH5","CONVERTS_TO","m6A","gammadelta T cells"
"5330","35939687","RNA m6A demethylase ALKBH5 regulates the development of gammadelta T cells.","ALKBH5","regulate","development of gammadelta T cells","gammadelta T cells","ALKBH5","AFFECTS","development of gammadelta T cells","gammadelta T cells"
"5332","35764614","m6A demethylase ALKBH5 is required for antibacterial innate defense by intrinsic motivation of neutrophil migration.","ALKBH5","required for","antibacterial innate defense","Neutrophils","ALKBH5","CAUSES","antibacterial innate defense","Segmented Neutrophils to Neutrophils Ratio Measurement"
"5333","35764614","m6A demethylase ALKBH5 is required for antibacterial innate defense by intrinsic motivation of neutrophil migration.","ALKBH5","motivate","neutrophil migration","Neutrophils","ALKBH5","motivate","NM","Segmented Neutrophils to Neutrophils Ratio Measurement"
"5334","35764614","m6A demethylase ALKBH5 is required for antibacterial innate defense by intrinsic motivation of neutrophil migration.","neutrophil migration","contribute to","antibacterial innate defense","Neutrophils","NM","CAUSES","antibacterial innate defense","Segmented Neutrophils to Neutrophils Ratio Measurement"
"5336","35773310","N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma.","N(6)-methyladenosine methylation","regulate","Polo-like kinase 1","Pancreatic Adenocarcinoma","m6A","AFFECTS","PLK1","PAAD(Pancreatic Adenocarcinoma)"
"5337","35773310","N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma.","Polo-like kinase 1","regulate","Cell Cycle Homeostasis","Pancreatic Adenocarcinoma","PLK1","AFFECTS","Cell Cycle Homeostasis","PAAD(Pancreatic Adenocarcinoma)"
"5338","35773310","N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma.","Polo-like kinase 1","target","Radiotherapy","Pancreatic Adenocarcinoma","PLK1","INTERACTS_WITH","Radiotherapy","PAAD(Pancreatic Adenocarcinoma)"
"5340","35774226","METTL3-Mediated m6A RNA Methylation of ZBTB4 Interferes With Trophoblast Invasion and Maybe Involved in RSA.","METTL3","mediate","m6A RNA Methylation","Trophoblast","METTL3","AFFECTS","m6A","Trophoblasts"
"5341","35774226","METTL3-Mediated m6A RNA Methylation of ZBTB4 Interferes With Trophoblast Invasion and Maybe Involved in RSA.","m6A RNA Methylation","is on","ZBTB4","Trophoblast","m6A","LOCATES","ZBTB4","Trophoblasts"
"5342","35774226","METTL3-Mediated m6A RNA Methylation of ZBTB4 Interferes With Trophoblast Invasion and Maybe Involved in RSA.","ZBTB4","interfere","Trophoblast Invasion","Trophoblast","ZBTB4","interfere","Trophoblast Invasion","Trophoblasts"
"5344","35779442","The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis.","YTHDF3","mediate","PRDX3 translation","Liver","YTHDF3","AFFECTS","PRDX3 translation","Liver"
"5345","35779442","The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis.","YTHDF3","bind","m6A","Liver","YTHDF3","INTERACTS_WITH","m6A","Liver"
"5346","35779442","The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis.","PRDX3 translation","alleviate","Liver Fibrosis","Liver","PRDX3 translation","INHIBITS","Liver Cirrhosis","Liver"
"5347","35779442","The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis.","m6A","regulate","PRDX3 translation","Liver","m6A","AFFECTS","PRDX3 translation","Liver"
"5349","35780619","The methyltransferase METTL3-mediated fatty acid metabolism revealed the mechanism of cinnamaldehyde on alleviating steatosis.","METTL3","mediate","fatty acid metabolism","Steatosis","METTL3","AFFECTS","fatty acid metabolic process","Fatty Liver"
"5350","35780619","The methyltransferase METTL3-mediated fatty acid metabolism revealed the mechanism of cinnamaldehyde on alleviating steatosis.","cinnamaldehyde","alleviate","steatosis","Steatosis","cinnamaldehyde","INHIBITS","Fatty Liver","Fatty Liver"
"5351","35780619","The methyltransferase METTL3-mediated fatty acid metabolism revealed the mechanism of cinnamaldehyde on alleviating steatosis.","fatty acid metabolism","mediate","steatosis","Steatosis","fatty acid metabolic process","AFFECTS","Fatty Liver","Fatty Liver"
"5353","35794111","Substrates of the m6A demethylase FTO: FTO-LINE1 RNA axis regulates chromatin state in mESCs.","FTO","demethylate","Substrates","mESCs","FTO","CONVERTS_TO","substrate","Mouse Embryonic Stem Cells"
"5354","35794111","Substrates of the m6A demethylase FTO: FTO-LINE1 RNA axis regulates chromatin state in mESCs.","FTO-LINE1 RNA axis","regulate","Chromatin State","mESCs","FTO-LINE1 RNA axis","AFFECTS","Chromatin State","Mouse Embryonic Stem Cells"
"5356","35794583","The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.","METTL3","promote","tumorigenesis","Human Renal Cell Carcinoma","METTL3","STIMULATES","Carcinogenesis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5357","35794583","The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.","METTL3","mediate","m6A modification","Human Renal Cell Carcinoma","METTL3","AFFECTS","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5358","35794583","The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.","m6A modification","is on","HHLA2 mRNA","Human Renal Cell Carcinoma","m6A","LOCATES","HHLA2","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5359","35794583","The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.","HHLA2 mRNA","regulate","tumorigenesis","Human Renal Cell Carcinoma","HHLA2","AFFECTS","Carcinogenesis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5361","35798250","SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.","SHMT2","promote","tumorigenesis","Renal Cell Carcinoma","SHMT2","STIMULATES","Carcinogenesis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5362","35798250","SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.","SHMT2","regulate","m6A","Renal Cell Carcinoma","SHMT2","AFFECTS","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5363","35798250","SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.","m6A","is on","PPAT","Renal Cell Carcinoma","m6A","LOCATES","PPAT","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5364","35798250","SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.","PPAT","regulate","tumorigenesis","Renal Cell Carcinoma","PPAT","AFFECTS","Carcinogenesis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5366","35798874","TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.","TTC22","promote","m6A","Colon Cancer","TTC22","STIMULATES","m6A","COAD(Colon Adenocarcinoma)"
"5367","35798874","TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.","m6A","mediate","WTAP expression","Colon Cancer","m6A","AFFECTS","WTAP expression","COAD(Colon Adenocarcinoma)"
"5368","35798874","TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.","TTC22","bind","RPL4","Colon Cancer","TTC22","INTERACTS_WITH","RPL4","COAD(Colon Adenocarcinoma)"
"5369","35798874","TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.","WTAP expression","promote","metastasis","Colon Cancer","WTAP expression","STIMULATES","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"5371","35799597","ALKBH5 inhibits TNF-alpha-induced apoptosis of HUVECs through Bcl-2 pathway.","ALKBH5","inhibit","apoptosis","HUVECs","ALKBH5","INHIBITS","apoptotic process","Human Umbilical Vein Endothelial Cells"
"5372","35799597","ALKBH5 inhibits TNF-alpha-induced apoptosis of HUVECs through Bcl-2 pathway.","ALKBH5","regulate","Bcl-2 pathway","HUVECs","ALKBH5","AFFECTS","Bcl-2 pathway","Human Umbilical Vein Endothelial Cells"
"5373","35799597","ALKBH5 inhibits TNF-alpha-induced apoptosis of HUVECs through Bcl-2 pathway.","TNF-alpha","induce","apoptosis","HUVECs","TNF","CAUSES","apoptotic process","Human Umbilical Vein Endothelial Cells"
"5374","35799597","ALKBH5 inhibits TNF-alpha-induced apoptosis of HUVECs through Bcl-2 pathway.","Bcl-2 pathway","inhibit","apoptosis","HUVECs","Bcl-2 pathway","INHIBITS","apoptotic process","Human Umbilical Vein Endothelial Cells"
"5376","35804542","FTO Regulates Apoptosis in CPB2-Treated IPEC-J2 Cells by Targeting Caspase 3 Apoptotic Protein.","FTO","regulate","Apoptosis","CPB2-Treated IPEC-J2 Cells","FTO","AFFECTS","apoptotic process","CPB2-Treated IPEC-J2 Cells"
"5377","35804542","FTO Regulates Apoptosis in CPB2-Treated IPEC-J2 Cells by Targeting Caspase 3 Apoptotic Protein.","FTO","target","Caspase 3 Apoptotic Protein","CPB2-Treated IPEC-J2 Cells","FTO","INTERACTS_WITH","Caspase 3 Apoptotic Protein","CPB2-Treated IPEC-J2 Cells"
"5378","35804542","FTO Regulates Apoptosis in CPB2-Treated IPEC-J2 Cells by Targeting Caspase 3 Apoptotic Protein.","Caspase 3 Apoptotic Protein","regulate","Apoptosis","CPB2-Treated IPEC-J2 Cells","Caspase 3 Apoptotic Protein","AFFECTS","apoptotic process","CPB2-Treated IPEC-J2 Cells"
"5380","35810559","METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.","METTL14","mediate","MN1 mRNA","Osteosarcoma","METTL14","AFFECTS","MN1","SARC(Sarcoma)"
"5381","35810559","METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.","MN1 mRNA","promote","tumorigenicity","Osteosarcoma","MN1","STIMULATES","Tumorigenicity","SARC(Sarcoma)"
"5382","35810559","METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.","MN1 mRNA","promote","all-trans-retinoic acid resistance","Osteosarcoma","MN1","STIMULATES","all-trans-retinoic acid resistance","SARC(Sarcoma)"
"5384","35813476","Integrative Analyses of m6A Regulators Identify that METTL3 is Associated with HPV Status and Immunosuppressive Microenvironment in HPV-related Cancers.","m6A Regulators","identify","METTL3","HPV-related Cancers","m6A Regulators","DIAGNOSES","METTL3","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5385","35813476","Integrative Analyses of m6A Regulators Identify that METTL3 is Associated with HPV Status and Immunosuppressive Microenvironment in HPV-related Cancers.","METTL3","associate","HPV Status","HPV-related Cancers","METTL3","ASSOCIATED_WITH","HPV Status","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5386","35813476","Integrative Analyses of m6A Regulators Identify that METTL3 is Associated with HPV Status and Immunosuppressive Microenvironment in HPV-related Cancers.","METTL3","associate","Immunosuppressive Microenvironment","HPV-related Cancers","METTL3","ASSOCIATED_WITH","Immunosuppressive Microenvironment","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5388","35816995","Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization.","Isoliquiritigenin","inhibit","Cancer Progression","Non-small cell lung cancer","isoliquiritigenin","INHIBITS","Cancer Progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5389","35816995","Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization.","Isoliquiritigenin","regulate","m6A","Non-small cell lung cancer","isoliquiritigenin","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5390","35816995","Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization.","IGF2BP3","bind","m6A","Non-small cell lung cancer","IGF2BP3","INTERACTS_WITH","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5391","35816995","Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization.","m6A","stabilize","TWIST1 mRNA","Non-small cell lung cancer","m6A","MAINTAINS","TWIST1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5393","35832094","N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming.","N6-methyladenosine","mediate","LDHA","Colorectal Cancer Cells","m6A","AFFECTS","LDHA","COAD(Colon Adenocarcinoma)"
"5394","35832094","N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming.","LDHA","potentiate","Chemoresistance","Colorectal Cancer Cells","LDHA","AUGMENTS","Chemoresistance","COAD(Colon Adenocarcinoma)"
"5395","35832094","N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming.","LDHA","induce","Metabolic Reprogramming","Colorectal Cancer Cells","LDHA","CAUSES","Metabolic Reprogramming","COAD(Colon Adenocarcinoma)"
"5396","35832094","N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming.","Metabolic Reprogramming","regulate","Chemoresistance","Colorectal Cancer Cells","Metabolic Reprogramming","AFFECTS","Chemoresistance","COAD(Colon Adenocarcinoma)"
"5398","35836108","METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.","METTL3","mediate","Cardiac Hypertrophy","Heart","METTL3","AFFECTS","Cardiac Hypertrophy","Heart"
"5399","35836108","METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.","METTL3","accelerate","pri-miR-221/222","Heart","METTL3","STIMULATES","pri-miR-221/222","Heart"
"5400","35836108","METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.","METTL3","regulate","m6A","Heart","METTL3","AFFECTS","m6A","Heart"
"5401","35836108","METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.","pri-miR-221/222","regulate","Cardiac Hypertrophy","Heart","pri-miR-221/222","AFFECTS","Cardiac Hypertrophy","Heart"
"5403","35836137","Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-kappaB axis.","Propofol","enhance","cisplatin-sensitivity","Non-small cell lung cancer cells","propofol","AUGMENTS","cisplatin-sensitivity","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5404","35836137","Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-kappaB axis.","Propofol","regulate","N6-methyladenosine","Non-small cell lung cancer cells","propofol","AFFECTS","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5405","35836137","Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-kappaB axis.","N6-methyladenosine","regulate","miR-486-5p/RAP1-NF-kappaB axis","Non-small cell lung cancer cells","m6A","AFFECTS","miR-486-5p/RAP1-NF-kappaB axis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5406","35836137","Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-kappaB axis.","miR-486-5p/RAP1-NF-kappaB axis","regulate","cisplatin-sensitivity","Non-small cell lung cancer cells","miR-486-5p/RAP1-NF-kappaB axis","AFFECTS","cisplatin-sensitivity","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5408","35839979","FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis.","FTO","regulate","N(6)-Methyladenosine (m6A)","Endometriosis","FTO","AFFECTS","m6A","Endometriosis"
"5409","35839979","FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis.","N(6)-Methyladenosine (m6A)","regulate","Progression","Endometriosis","m6A","AFFECTS","progression","Endometriosis"
"5410","35839979","FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis.","N(6)-Methyladenosine (m6A)","regulate","ATG5/PKM2 Axis","Endometriosis","m6A","AFFECTS","ATG5/PKM2 Axis","Endometriosis"
"5411","35839979","FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis.","ATG5/PKM2 Axis","regulate","Progression","Endometriosis","ATG5/PKM2 Axis","AFFECTS","progression","Endometriosis"
"5413","35840562","N6-methyladenosine (m6A) methyltransferase METTL3 regulates sepsis-induced myocardial injury through IGF2BP1/HDAC4 dependent manner.","METTL3","regulate","Sepsis-induced myocardial injury","Sepsis-induced myocardial injury","METTL3","AFFECTS","Sepsis-induced myocardial injury","Sepsis-induced myocardial injury"
"5414","35840562","N6-methyladenosine (m6A) methyltransferase METTL3 regulates sepsis-induced myocardial injury through IGF2BP1/HDAC4 dependent manner.","METTL3","regulate","m6A","Sepsis-induced myocardial injury","METTL3","AFFECTS","m6A","Sepsis-induced myocardial injury"
"5415","35840562","N6-methyladenosine (m6A) methyltransferase METTL3 regulates sepsis-induced myocardial injury through IGF2BP1/HDAC4 dependent manner.","IGF2BP1","bind","m6A","Sepsis-induced myocardial injury","IGF2BP1","INTERACTS_WITH","m6A","Sepsis-induced myocardial injury"
"5416","35840562","N6-methyladenosine (m6A) methyltransferase METTL3 regulates sepsis-induced myocardial injury through IGF2BP1/HDAC4 dependent manner.","m6A","regulate","Sepsis-induced myocardial injury","Sepsis-induced myocardial injury","m6A","AFFECTS","Sepsis-induced myocardial injury","Sepsis-induced myocardial injury"
"5418","35840930","Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.","circPOLR2A","promote","progression","Clear Cell Renal Cell Carcinoma","circPOLR2A","STIMULATES","progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5419","35840930","Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.","circPOLR2A","facilitate","UBE3C","Clear Cell Renal Cell Carcinoma","circPOLR2A","AUGMENTS","UBE3C","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5420","35840930","Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.","UBE3C","induce","ubiquitination","Clear Cell Renal Cell Carcinoma","UBE3C","CAUSES","Ubiquitination","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5421","35840930","Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.","ubiquitination","is on","PEBP1","Clear Cell Renal Cell Carcinoma","Ubiquitination","LOCATES","PEBP1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5422","35840930","Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.","ubiquitination","activate","ERK signaling pathway","Clear Cell Renal Cell Carcinoma","Ubiquitination","STIMULATES","ERK signaling pathway","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5423","35840930","Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.","ERK signaling pathway","regulate","progression","Clear Cell Renal Cell Carcinoma","ERK signaling pathway","AFFECTS","progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5425","35842714","Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.","human umbilical cord mesenchymal stem cells","derive","Extracellular vesicles","Osteoarthritis of the knee in mice model","human umbilical cord mesenchymal stem cells","derive","extracellular vesicle","Osteoarthritis of the knee in mice model"
"5426","35842714","Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.","Extracellular vesicles","alleviate","Osteoarthritis of the knee","Osteoarthritis of the knee in mice model","extracellular vesicle","INHIBITS","Osteoarthritis, Knee","Osteoarthritis of the knee in mice model"
"5427","35842714","Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.","Extracellular vesicles","interact","METTL3","Osteoarthritis of the knee in mice model","extracellular vesicle","interact","METTL3","Osteoarthritis of the knee in mice model"
"5428","35842714","Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.","METTL3","reduce","m6A","Osteoarthritis of the knee in mice model","METTL3","INHIBITS","m6A","Osteoarthritis of the knee in mice model"
"5429","35842714","Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.","m6A","is on.","NLRP3","Osteoarthritis of the knee in mice model","m6A","is on.","NLRP3","Osteoarthritis of the knee in mice model"
"5430","35842714","Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.","NLRP3","regulate.","Osteoarthritis of the knee","Osteoarthritis of the knee in mice model","NLRP3","regulate.","Osteoarthritis, Knee","Osteoarthritis of the knee in mice model"
"5432","35681299","METTL3 Regulated the Meat Quality of Rex Rabbits by Controlling PCK2 Expression via a YTHDF2-N6-Methyladenosine Axis.","METTL3","control","PCK2 Expression","Rex Rabbits","METTL3","AFFECTS","PCK2 Expression","Rex Rabbits"
"5433","35681299","METTL3 Regulated the Meat Quality of Rex Rabbits by Controlling PCK2 Expression via a YTHDF2-N6-Methyladenosine Axis.","METTL3","control","YTHDF2-N6-Methyladenosine Axis","Rex Rabbits","METTL3","AFFECTS","YTHDF2-N6-Methyladenosine Axis","Rex Rabbits"
"5434","35681299","METTL3 Regulated the Meat Quality of Rex Rabbits by Controlling PCK2 Expression via a YTHDF2-N6-Methyladenosine Axis.","PCK2 Expression","control","Meat Quality","Rex Rabbits","PCK2 Expression","AFFECTS","Meat Quality","Rex Rabbits"
"5435","35681299","METTL3 Regulated the Meat Quality of Rex Rabbits by Controlling PCK2 Expression via a YTHDF2-N6-Methyladenosine Axis.","YTHDF2-N6-Methyladenosine Axis","regulate","PCK2 Expression","Rex Rabbits","YTHDF2-N6-Methyladenosine Axis","AFFECTS","PCK2 Expression","Rex Rabbits"
"5437","35687301","MSC Promotes the Secretion of Exosomal miR-34a-5p and Improve Intestinal Barrier Function Through METTL3-Mediated Pre-miR-34A m6A Modification.","MSC","promote","Exosomal miR-34a-5p","MSC","MSC","STIMULATES","Exosomal miR-34a-5p","MSC"
"5438","35687301","MSC Promotes the Secretion of Exosomal miR-34a-5p and Improve Intestinal Barrier Function Through METTL3-Mediated Pre-miR-34A m6A Modification.","MSC","improve","Intestinal Barrier Function","MSC","MSC","STIMULATES","Intestinal Barrier Function","MSC"
"5439","35687301","MSC Promotes the Secretion of Exosomal miR-34a-5p and Improve Intestinal Barrier Function Through METTL3-Mediated Pre-miR-34A m6A Modification.","METTL3","mediate","Pre-miR-34A","MSC","METTL3","AFFECTS","Pre-miR-34A","MSC"
"5440","35687301","MSC Promotes the Secretion of Exosomal miR-34a-5p and Improve Intestinal Barrier Function Through METTL3-Mediated Pre-miR-34A m6A Modification.","Pre-miR-34A","modify","m6A","MSC","Pre-miR-34A","AFFECTS","m6A","MSC"
"5441","35687301","MSC Promotes the Secretion of Exosomal miR-34a-5p and Improve Intestinal Barrier Function Through METTL3-Mediated Pre-miR-34A m6A Modification.","m6A","regulate","Exosomal miR-34a-5p","MSC","m6A","AFFECTS","Exosomal miR-34a-5p","MSC"
"5442","35687301","MSC Promotes the Secretion of Exosomal miR-34a-5p and Improve Intestinal Barrier Function Through METTL3-Mediated Pre-miR-34A m6A Modification.","m6A","regulate","Intestinal Barrier Function","MSC","m6A","AFFECTS","Intestinal Barrier Function","MSC"
"5444","35689537","RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m6 A-IGF2BP2-dependent manner.","ALKBH5","regulate","Ferroptosis","Hypopharyngeal Squamous Cell Carcinoma","ALKBH5","AFFECTS","Ferroptosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5445","35689537","RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m6 A-IGF2BP2-dependent manner.","ALKBH5","activate","NFE2L2/NRF2","Hypopharyngeal Squamous Cell Carcinoma","ALKBH5","STIMULATES","NFE2L2/NRF2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5446","35689537","RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m6 A-IGF2BP2-dependent manner.","ALKBH5","regulate","m6A","Hypopharyngeal Squamous Cell Carcinoma","ALKBH5","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5447","35689537","RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m6 A-IGF2BP2-dependent manner.","IGF2BP2","bind","m6A","Hypopharyngeal Squamous Cell Carcinoma","IGF2BP2","INTERACTS_WITH","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5448","35689537","RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m6 A-IGF2BP2-dependent manner.","m6A","regulate","Ferroptosis","Hypopharyngeal Squamous Cell Carcinoma","m6A","AFFECTS","Ferroptosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5450","35696608","YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.","YTHDF2","promote","Intrahepatic Cholangiocarcinoma Progression","Intrahepatic Cholangiocarcinoma","YTHDF2","STIMULATES","Intrahepatic Cholangiocarcinoma Progression","CHOL(Cholangiocarcinoma)"
"5451","35696608","YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.","YTHDF2","degrade","CDKN1B mRNA","Intrahepatic Cholangiocarcinoma","YTHDF2","INHIBITS","CDKN1B","CHOL(Cholangiocarcinoma)"
"5452","35696608","YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.","YTHDF2","desensitise","Cisplatin Treatment","Intrahepatic Cholangiocarcinoma","YTHDF2","desensitise","Cisplatin Treatment","CHOL(Cholangiocarcinoma)"
"5453","35696608","YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.","CDKN1B mRNA","regulate","Intrahepatic Cholangiocarcinoma Progression","Intrahepatic Cholangiocarcinoma","CDKN1B","AFFECTS","Intrahepatic Cholangiocarcinoma Progression","CHOL(Cholangiocarcinoma)"
"5455","35698136","Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival.","Mettl14","mediate","m6A modification","Retinal Photoreceptor","METTL14","AFFECTS","m6A","Retinal Photoreceptor"
"5456","35698136","Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival.","m6A modification","is essential for","visual function","Retinal Photoreceptor","m6A","PREDISPOSES","visual function","Retinal Photoreceptor"
"5457","35698136","Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival.","m6A modification","is essential for","retinal photoreceptor survival","Retinal Photoreceptor","m6A","PREDISPOSES","retinal photoreceptor survival","Retinal Photoreceptor"
"5459","35700773","METTL3 inhibits anti-tumor immunity by targeting m6A-BHLHE41-CXCL1/CXCR2 axis to promote colorectal cancer.","METTL3","inhibit","anti-tumor immunity","Colorectal Cancer","METTL3","INHIBITS","anti-tumor immunity","COAD(Colon Adenocarcinoma)"
"5460","35700773","METTL3 inhibits anti-tumor immunity by targeting m6A-BHLHE41-CXCL1/CXCR2 axis to promote colorectal cancer.","METTL3","target","m6A-BHLHE41-CXCL1/CXCR2 axis","Colorectal Cancer","METTL3","INTERACTS_WITH","m6A-BHLHE41-CXCL1/CXCR2 axis","COAD(Colon Adenocarcinoma)"
"5461","35700773","METTL3 inhibits anti-tumor immunity by targeting m6A-BHLHE41-CXCL1/CXCR2 axis to promote colorectal cancer.","m6A-BHLHE41-CXCL1/CXCR2 axis","promote","colorectal cancer","Colorectal Cancer","m6A-BHLHE41-CXCL1/CXCR2 axis","STIMULATES","colorectal cancer","COAD(Colon Adenocarcinoma)"
"5463","35711823","LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.","LncRNA AC098934","promote","Proliferation","Lung Adenocarcinoma Cells","AC098934","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"5464","35711823","LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.","LncRNA AC098934","promote","Invasion","Lung Adenocarcinoma Cells","AC098934","STIMULATES","Neoplasm Invasiveness","LUAD(Lung Adenocarcinoma)"
"5465","35711823","LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.","LncRNA AC098934","combine","METTL3","Lung Adenocarcinoma Cells","AC098934","combine","METTL3","LUAD(Lung Adenocarcinoma)"
"5466","35711823","LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.","LncRNA AC098934","combine","m6A","Lung Adenocarcinoma Cells","AC098934","combine","m6A","LUAD(Lung Adenocarcinoma)"
"5467","35711823","LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.","METTL3","regulate","Proliferation","Lung Adenocarcinoma Cells","METTL3","AFFECTS","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"5468","35711823","LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.","METTL3","regulate","Invasion","Lung Adenocarcinoma Cells","METTL3","AFFECTS","Neoplasm Invasiveness","LUAD(Lung Adenocarcinoma)"
"5469","35711823","LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.","m6A","regulate","Proliferation","Lung Adenocarcinoma Cells","m6A","AFFECTS","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"5470","35711823","LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.","m6A","regulate","Invasion","Lung Adenocarcinoma Cells","m6A","AFFECTS","Neoplasm Invasiveness","LUAD(Lung Adenocarcinoma)"
"5472","35714699","CircFAT1 regulates retinal pigment epithelial cell pyroptosis and autophagy via mediating m6A reader protein YTHDF2 expression in diabetic retinopathy.","CircFAT1","mediate","YTHDF2","Diabetic Retinopathy","CircFAT1","AFFECTS","YTHDF2","Diabetic Retinopathy"
"5473","35714699","CircFAT1 regulates retinal pigment epithelial cell pyroptosis and autophagy via mediating m6A reader protein YTHDF2 expression in diabetic retinopathy.","YTHDF2","bind","m6A","Diabetic Retinopathy","YTHDF2","INTERACTS_WITH","m6A","Diabetic Retinopathy"
"5474","35714699","CircFAT1 regulates retinal pigment epithelial cell pyroptosis and autophagy via mediating m6A reader protein YTHDF2 expression in diabetic retinopathy.","YTHDF2","regulate","Retinal Pigment Epithelial Cell Pyroptosis","Diabetic Retinopathy","YTHDF2","AFFECTS","Retinal Pigment Epithelial Cell Pyroptosis","Diabetic Retinopathy"
"5475","35714699","CircFAT1 regulates retinal pigment epithelial cell pyroptosis and autophagy via mediating m6A reader protein YTHDF2 expression in diabetic retinopathy.","YTHDF2","regulate","Autophagy","Diabetic Retinopathy","YTHDF2","AFFECTS","autophagy","Diabetic Retinopathy"
"5477","35717715","m6A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-kappaB pathway and ROS production.","METTL3","participate","sympathetic neural remodeling","Post-MI","METTL3","participate","sympathetic neural remodeling","Post-MI"
"5478","35717715","m6A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-kappaB pathway and ROS production.","METTL3","regulate","TRAF6/NF-kappaB pathway","Post-MI","METTL3","AFFECTS","TRAF6/NF-kappaB pathway","Post-MI"
"5479","35717715","m6A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-kappaB pathway and ROS production.","METTL3","regulate","ROS production","Post-MI","METTL3","AFFECTS","ROS production","Post-MI"
"5480","35717715","m6A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-kappaB pathway and ROS production.","TRAF6/NF-kappaB pathway","regulate","sympathetic neural remodeling","Post-MI","TRAF6/NF-kappaB pathway","AFFECTS","sympathetic neural remodeling","Post-MI"
"5481","35717715","m6A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6/NF-kappaB pathway and ROS production.","ROS production","regulate","sympathetic neural remodeling","Post-MI","ROS production","AFFECTS","sympathetic neural remodeling","Post-MI"
"5483","35718042","Methyltransferase-like 3 leads to lung injury by up-regulation of interleukin 24 through N6-methyladenosine-dependent mRNA stability and translation efficiency in mice exposed to fine particulate matter 2.5.","Methyltransferase-like 3","lead to","lung injury","Mice exposed to fine particulate matter 2.5","METTL3","CAUSES","Lung Injury","Mice exposed to fine particulate matter 2.5"
"5484","35718042","Methyltransferase-like 3 leads to lung injury by up-regulation of interleukin 24 through N6-methyladenosine-dependent mRNA stability and translation efficiency in mice exposed to fine particulate matter 2.5.","Methyltransferase-like 3","up-regulate","interleukin 24","Mice exposed to fine particulate matter 2.5","METTL3","STIMULATES","IL24","Mice exposed to fine particulate matter 2.5"
"5485","35718042","Methyltransferase-like 3 leads to lung injury by up-regulation of interleukin 24 through N6-methyladenosine-dependent mRNA stability and translation efficiency in mice exposed to fine particulate matter 2.5.","Methyltransferase-like 3","regulate","N6-methyladenosine","Mice exposed to fine particulate matter 2.5","METTL3","AFFECTS","m6A","Mice exposed to fine particulate matter 2.5"
"5486","35718042","Methyltransferase-like 3 leads to lung injury by up-regulation of interleukin 24 through N6-methyladenosine-dependent mRNA stability and translation efficiency in mice exposed to fine particulate matter 2.5.","N6-methyladenosine","regulate","mRNA stability and translation efficiency","Mice exposed to fine particulate matter 2.5","m6A","AFFECTS","mRNA stability and translation efficiency","Mice exposed to fine particulate matter 2.5"
"5487","35718042","Methyltransferase-like 3 leads to lung injury by up-regulation of interleukin 24 through N6-methyladenosine-dependent mRNA stability and translation efficiency in mice exposed to fine particulate matter 2.5.","mRNA stability and translation efficiency","regulate","lung injury","Mice exposed to fine particulate matter 2.5","mRNA stability and translation efficiency","AFFECTS","Lung Injury","Mice exposed to fine particulate matter 2.5"
"5489","35724807","Hypoxia induced ALKBH5 prevents spontaneous abortion by mediating m6A-demethylation of SMAD1/5 mRNAs.","Hypoxia","induce","ALKBH5","Hypoxia","Hypoxia","CAUSES","ALKBH5","Hypoxia"
"5490","35724807","Hypoxia induced ALKBH5 prevents spontaneous abortion by mediating m6A-demethylation of SMAD1/5 mRNAs.","ALKBH5","prevent","spontaneous abortion","Hypoxia","ALKBH5","PREVENTS","Abortion, Spontaneous","Hypoxia"
"5491","35724807","Hypoxia induced ALKBH5 prevents spontaneous abortion by mediating m6A-demethylation of SMAD1/5 mRNAs.","ALKBH5","demethylate","m6A","Hypoxia","ALKBH5","CONVERTS_TO","m6A","Hypoxia"
"5492","35724807","Hypoxia induced ALKBH5 prevents spontaneous abortion by mediating m6A-demethylation of SMAD1/5 mRNAs.","m6A","is on","SMAD1/5 mRNAs","Hypoxia","m6A","LOCATES","SMAD1/5","Hypoxia"
"5493","35724807","Hypoxia induced ALKBH5 prevents spontaneous abortion by mediating m6A-demethylation of SMAD1/5 mRNAs.","SMAD1/5 mRNAs","regulate","spontaneous abortion","Hypoxia","SMAD1/5","AFFECTS","Abortion, Spontaneous","Hypoxia"
"5495","35730068","Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.","KIAA1429","promote","tumorigenesis","Lung Adenocarcinoma","VIRMA","STIMULATES","Carcinogenesis","LUAD(Lung Adenocarcinoma)"
"5496","35730068","Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.","KIAA1429","regulate","BTG2","Lung Adenocarcinoma","VIRMA","AFFECTS","BTG2","LUAD(Lung Adenocarcinoma)"
"5497","35730068","Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.","KIAA1429","regulate","m6A","Lung Adenocarcinoma","VIRMA","AFFECTS","m6A","LUAD(Lung Adenocarcinoma)"
"5498","35730068","Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.","YTHDF2","bind","m6A","Lung Adenocarcinoma","YTHDF2","INTERACTS_WITH","m6A","LUAD(Lung Adenocarcinoma)"
"5499","35730068","Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.","m6A","regulate","BTG2","Lung Adenocarcinoma","m6A","AFFECTS","BTG2","LUAD(Lung Adenocarcinoma)"
"5501","35733354","N6 -methyladenosine-modified circRNA RERE modulates osteoarthritis by regulating beta-catenin ubiquitination and degradation.","N6 -methyladenosine-modified circRNA RERE","modulate","Osteoarthritis","Osteoarthritis","m6A-modified circRNA RERE","AFFECTS","Osteoarthritis","Osteoarthritis"
"5502","35733354","N6 -methyladenosine-modified circRNA RERE modulates osteoarthritis by regulating beta-catenin ubiquitination and degradation.","N6 -methyladenosine-modified circRNA RERE","regulate","beta-catenin","Osteoarthritis","m6A-modified circRNA RERE","AFFECTS","CTNNB1","Osteoarthritis"
"5503","35733354","N6 -methyladenosine-modified circRNA RERE modulates osteoarthritis by regulating beta-catenin ubiquitination and degradation.","beta-catenin","undergo","Ubiquitination and Degradation","Osteoarthritis","CTNNB1","undergo","Ubiquitination and Degradation","Osteoarthritis"
"5504","35733354","N6 -methyladenosine-modified circRNA RERE modulates osteoarthritis by regulating beta-catenin ubiquitination and degradation.","Ubiquitination and Degradation","modulate","Osteoarthritis","Osteoarthritis","Ubiquitination and Degradation","AFFECTS","Osteoarthritis","Osteoarthritis"
"5506","35749893","Fine particulate matter induces METTL3-mediated m6A modification of BIRC5 mRNA in bladder cancer.","Fine Particulate Matter","induce","METTL3","Bladder Cancer","Fine Particulate Matter","CAUSES","METTL3","BLCA(Bladder Urothelial Carcinoma)"
"5507","35749893","Fine particulate matter induces METTL3-mediated m6A modification of BIRC5 mRNA in bladder cancer.","METTL3","mediate","m6A","Bladder Cancer","METTL3","AFFECTS","m6A","BLCA(Bladder Urothelial Carcinoma)"
"5508","35749893","Fine particulate matter induces METTL3-mediated m6A modification of BIRC5 mRNA in bladder cancer.","m6A","modify","BIRC5 mRNA","Bladder Cancer","m6A","AFFECTS","BIRC5","BLCA(Bladder Urothelial Carcinoma)"
"5510","35752056","METTL3 plays a crucial function in multiple biological processes.","METTL3","play function in","multiple biological processes","Null","METTL3","play function in","multiple biological processes","Null"
"5512","35758042","Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.","Ibuprofen","promote","p75 neurotrophin receptor expression","Human Gastric Cancer Cells","ibuprofen","STIMULATES","p75 neurotrophin receptor expression","STAD(Stomach adenocarcinoma)"
"5513","35758042","Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.","Ibuprofen","modify","promoter methylation","Human Gastric Cancer Cells","ibuprofen","AFFECTS","promoter methylation","STAD(Stomach adenocarcinoma)"
"5514","35758042","Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.","Ibuprofen","modify","N6-methyladenosine-RNA-methylation","Human Gastric Cancer Cells","ibuprofen","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"5515","35758042","Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.","promoter methylation","regulate","p75 neurotrophin receptor expression","Human Gastric Cancer Cells","promoter methylation","AFFECTS","p75 neurotrophin receptor expression","STAD(Stomach adenocarcinoma)"
"5516","35758042","Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.","N6-methyladenosine-RNA-methylation","regulate","p75 neurotrophin receptor expression","Human Gastric Cancer Cells","m6A","AFFECTS","p75 neurotrophin receptor expression","STAD(Stomach adenocarcinoma)"
"5518","35758158","N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer.","N(6)-methyladenosine","mediate","miR-380-3p maturation","Pancreatic Cancer","m6A","AFFECTS","miR-380-3p maturation","PAAD(Pancreatic Adenocarcinoma)"
"5519","35758158","N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer.","miR-380-3p maturation","induce","upregulation","Pancreatic Cancer","miR-380-3p maturation","CAUSES","Up-Regulation","PAAD(Pancreatic Adenocarcinoma)"
"5520","35758158","N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer.","upregulation","promote","cancer aggressiveness","Pancreatic Cancer","Up-Regulation","STIMULATES","cancer aggressiveness","PAAD(Pancreatic Adenocarcinoma)"
"5522","35758287","Methyltransferase-like 3 silenced inhibited the ferroptosis development via regulating the glutathione peroxidase 4 levels in the intracerebral hemorrhage progression.","Methyltransferase-like 3","inhibit","Ferroptosis","Intracerebral Hemorrhage Progression","METTL3","INHIBITS","Ferroptosis","Intracerebral Hemorrhage Progression"
"5523","35758287","Methyltransferase-like 3 silenced inhibited the ferroptosis development via regulating the glutathione peroxidase 4 levels in the intracerebral hemorrhage progression.","Methyltransferase-like 3","regulate","Glutathione Peroxidase 4","Intracerebral Hemorrhage Progression","METTL3","AFFECTS","GPX4","Intracerebral Hemorrhage Progression"
"5524","35758287","Methyltransferase-like 3 silenced inhibited the ferroptosis development via regulating the glutathione peroxidase 4 levels in the intracerebral hemorrhage progression.","Glutathione Peroxidase 4","regulate","Ferroptosis","Intracerebral Hemorrhage Progression","GPX4","AFFECTS","Ferroptosis","Intracerebral Hemorrhage Progression"
"5526","35759451","METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion.","METTL3","mediate","m6A modification","Nasopharyngeal Carcinoma Cells","METTL3","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5527","35759451","METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion.","m6A modification","promote","pri-miRNA-19a","Nasopharyngeal Carcinoma Cells","m6A","STIMULATES","pri-miRNA-19a","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5528","35759451","METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion.","pri-miRNA-19a","undergo","processing and maturation","Nasopharyngeal Carcinoma Cells","pri-miRNA-19a","undergo","processing and maturation","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5529","35759451","METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion.","pri-miRNA-19a","facilitate","cell proliferation","Nasopharyngeal Carcinoma Cells","pri-miRNA-19a","AUGMENTS","cell population proliferation","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5530","35759451","METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion.","pri-miRNA-19a","facilitate","invasion","Nasopharyngeal Carcinoma Cells","pri-miRNA-19a","AUGMENTS","Neoplasm Invasiveness","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5531","35759451","METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion.","cell proliferation","facilitate","invasion","Nasopharyngeal Carcinoma Cells","cell population proliferation","AUGMENTS","Neoplasm Invasiveness","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5533","35761379","Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.","MEG3","induce","microRNA-493-5p","Acute Myeloid Leukemia cells","MEG3","CAUSES","microRNA-493-5p","LAML(Acute Myeloid Leukemia)"
"5534","35761379","Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.","microRNA-493-5p","reduce","arabinocytosine chemoresistance","Acute Myeloid Leukemia cells","microRNA-493-5p","INHIBITS","arabinocytosine chemoresistance","LAML(Acute Myeloid Leukemia)"
"5535","35761379","Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.","microRNA-493-5p","downregulate","METTL3/MYC axis","Acute Myeloid Leukemia cells","microRNA-493-5p","INHIBITS","METTL3/MYC axis","LAML(Acute Myeloid Leukemia)"
"5536","35761379","Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.","METTL3/MYC axis","include","METTL3","Acute Myeloid Leukemia cells","METTL3/MYC axis","include","METTL3","LAML(Acute Myeloid Leukemia)"
"5537","35761379","Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.","METTL3/MYC axis","include","MYC","Acute Myeloid Leukemia cells","METTL3/MYC axis","include","MYC","LAML(Acute Myeloid Leukemia)"
"5539","35763110","N6-methyladenosine (m6A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression.","IGF2BP2","stabilize","HK2","Oral Squamous Cell Carcinoma","IGF2BP2","MAINTAINS","HK2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5540","35763110","N6-methyladenosine (m6A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression.","HK2","accelerate","Warburg effect","Oral Squamous Cell Carcinoma","HK2","STIMULATES","Warburg effect","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5541","35763110","N6-methyladenosine (m6A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression.","Warburg effect","accelerate","Oral Squamous Cell Carcinoma Progression","Oral Squamous Cell Carcinoma","Warburg effect","STIMULATES","Oral Squamous Cell Carcinoma Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5543","35581183","METTL3-mediated m6A RNA methylation regulates dorsal lingual epithelium homeostasis.","METTL3","mediate","m6A RNA methylation","Dorsal Lingual Epithelium","METTL3","AFFECTS","m6A","Dorsal Lingual Epithelium"
"5544","35581183","METTL3-mediated m6A RNA methylation regulates dorsal lingual epithelium homeostasis.","m6A RNA methylation","regulate","homeostasis","Dorsal Lingual Epithelium","m6A","AFFECTS","Homeostasis","Dorsal Lingual Epithelium"
"5546","35582627","YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-kappaB signalling pathways via inhibiting EPHB3 and TNFAIP3.","YTHDF2","promote","Temozolomide Resistance","Glioblastoma","YTHDF2","STIMULATES","Temozolomide Resistance","GBM(Glioblastoma Multiforme)"
"5547","35582627","YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-kappaB signalling pathways via inhibiting EPHB3 and TNFAIP3.","YTHDF2","activate","Akt","Glioblastoma","YTHDF2","STIMULATES","AKT","GBM(Glioblastoma Multiforme)"
"5548","35582627","YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-kappaB signalling pathways via inhibiting EPHB3 and TNFAIP3.","YTHDF2","activate","NF-kappaB signalling pathways","Glioblastoma","YTHDF2","STIMULATES","NF-kappaB signaling pathway","GBM(Glioblastoma Multiforme)"
"5549","35582627","YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-kappaB signalling pathways via inhibiting EPHB3 and TNFAIP3.","YTHDF2","inhibit","EPHB3","Glioblastoma","YTHDF2","INHIBITS","EPHB3","GBM(Glioblastoma Multiforme)"
"5550","35582627","YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-kappaB signalling pathways via inhibiting EPHB3 and TNFAIP3.","YTHDF2","inhibit","TNFAIP3","Glioblastoma","YTHDF2","INHIBITS","TNFAIP3","GBM(Glioblastoma Multiforme)"
"5551","35582627","YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-kappaB signalling pathways via inhibiting EPHB3 and TNFAIP3.","Akt","regulate","Temozolomide Resistance","Glioblastoma","AKT","AFFECTS","Temozolomide Resistance","GBM(Glioblastoma Multiforme)"
"5552","35582627","YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF-kappaB signalling pathways via inhibiting EPHB3 and TNFAIP3.","NF-kappaB signalling pathways","regulate","Temozolomide Resistance","Glioblastoma","NF-kappaB signaling pathway","AFFECTS","Temozolomide Resistance","GBM(Glioblastoma Multiforme)"
"5554","35583059","[Lipopolysaccharide induces inflammation and up-regulates the expression of methyltransferase-like 3 (METTL3) and METTL14 in human and mouse intestinal epithelial cells].","Lipopolysaccharide","induce","inflammation","Human and mouse intestinal epithelial cells","lipopolysaccharide","CAUSES","inflammatory response","Human and mouse intestinal epithelial cells"
"5555","35583059","[Lipopolysaccharide induces inflammation and up-regulates the expression of methyltransferase-like 3 (METTL3) and METTL14 in human and mouse intestinal epithelial cells].","Lipopolysaccharide","up-regulate","METTL3","Human and mouse intestinal epithelial cells","lipopolysaccharide","STIMULATES","METTL3","Human and mouse intestinal epithelial cells"
"5556","35583059","[Lipopolysaccharide induces inflammation and up-regulates the expression of methyltransferase-like 3 (METTL3) and METTL14 in human and mouse intestinal epithelial cells].","Lipopolysaccharide","up-regulate","METTL14","Human and mouse intestinal epithelial cells","lipopolysaccharide","STIMULATES","METTL14","Human and mouse intestinal epithelial cells"
"5558","35592497","Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","YTHDF1","facilitate","Progression","Hepatocellular Carcinoma","YTHDF1","AUGMENTS","progression","LIHC(Liver Hepatocellular Carcinoma)"
"5559","35592497","Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","YTHDF1","promote","FZD5 mRNA","Hepatocellular Carcinoma","YTHDF1","STIMULATES","FZD5","LIHC(Liver Hepatocellular Carcinoma)"
"5560","35592497","Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","FZD5 mRNA","undergo","Translation","Hepatocellular Carcinoma","FZD5","undergo","translation","LIHC(Liver Hepatocellular Carcinoma)"
"5561","35592497","Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","YTHDF1","bind","m6A","Hepatocellular Carcinoma","YTHDF1","INTERACTS_WITH","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"5562","35592497","Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","m6A","regulate","FZD5 mRNA","Hepatocellular Carcinoma","m6A","AFFECTS","FZD5","LIHC(Liver Hepatocellular Carcinoma)"
"5564","35592502","Retraction Notice to: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","FTO","suppress","Tumorigenesis","Pancreatic Cancer","FTO","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"5565","35592502","Retraction Notice to: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","FTO","demethylate","PJA2","Pancreatic Cancer","FTO","CONVERTS_TO","PJA2","PAAD(Pancreatic Adenocarcinoma)"
"5566","35592502","Retraction Notice to: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","FTO","inhibit","Wnt signaling","Pancreatic Cancer","FTO","INHIBITS","Wnt signaling pathway","PAAD(Pancreatic Adenocarcinoma)"
"5567","35592502","Retraction Notice to: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","PJA2","regulate","Wnt signaling","Pancreatic Cancer","PJA2","AFFECTS","Wnt signaling pathway","PAAD(Pancreatic Adenocarcinoma)"
"5569","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","m6A","methylate","EphA2","Colorectal Cancer","m6A","CONVERTS_TO","EPHA2","COAD(Colon Adenocarcinoma)"
"5570","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","m6A","methylate","VEGFA","Colorectal Cancer","m6A","CONVERTS_TO","VEGFA","COAD(Colon Adenocarcinoma)"
"5571","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","IGF2BP2/3","regulate","EphA2","Colorectal Cancer","IGF2BP2/3","AFFECTS","EPHA2","COAD(Colon Adenocarcinoma)"
"5572","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","IGF2BP2/3","regulate","VEGFA","Colorectal Cancer","IGF2BP2/3","AFFECTS","VEGFA","COAD(Colon Adenocarcinoma)"
"5573","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","EphA2","promote","Vasculogenic Mimicry","Colorectal Cancer","EPHA2","STIMULATES","Vasculogenic Mimicry","COAD(Colon Adenocarcinoma)"
"5574","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","VEGFA","promote","Vasculogenic Mimicry","Colorectal Cancer","VEGFA","STIMULATES","Vasculogenic Mimicry","COAD(Colon Adenocarcinoma)"
"5575","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","PI3K/AKT signaling","regulate","Vasculogenic Mimicry","Colorectal Cancer","PI3K/AKT signaling pathway","AFFECTS","Vasculogenic Mimicry","COAD(Colon Adenocarcinoma)"
"5576","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","ERK1/2 signaling","regulate","Vasculogenic Mimicry","Colorectal Cancer","ERK1/2 signaling pathway","AFFECTS","Vasculogenic Mimicry","COAD(Colon Adenocarcinoma)"
"5577","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","IGF2BP2/3","regulate","PI3K/AKT signaling","Colorectal Cancer","IGF2BP2/3","AFFECTS","PI3K/AKT signaling pathway","COAD(Colon Adenocarcinoma)"
"5578","35595748","m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.","IGF2BP2/3","regulate","ERK1/2 signaling","Colorectal Cancer","IGF2BP2/3","AFFECTS","ERK1/2 signaling pathway","COAD(Colon Adenocarcinoma)"
"5580","35596159","METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner.","METTL16","promote","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","METTL16","STIMULATES","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"5581","35596159","METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner.","METTL16","downregulate","RAB11B-AS1","Hepatocellular Carcinoma","METTL16","INHIBITS","RAB11B-AS1","LIHC(Liver Hepatocellular Carcinoma)"
"5582","35596159","METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner.","METTL16","regulate","m6A","Hepatocellular Carcinoma","METTL16","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"5583","35596159","METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner.","RAB11B-AS1","regulate","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","RAB11B-AS1","AFFECTS","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"5585","35596790","RPL38 knockdown inhibits the inflammation and apoptosis in chondrocytes through regulating METTL3-mediated SOCS2 m6A modification in osteoarthritis.","RPL38","inhibit","Inflammation","Osteoarthritis","RPL38","INHIBITS","inflammatory response","Osteoarthritis"
"5586","35596790","RPL38 knockdown inhibits the inflammation and apoptosis in chondrocytes through regulating METTL3-mediated SOCS2 m6A modification in osteoarthritis.","RPL38","inhibit","Apoptosis","Osteoarthritis","RPL38","INHIBITS","apoptotic process","Osteoarthritis"
"5587","35596790","RPL38 knockdown inhibits the inflammation and apoptosis in chondrocytes through regulating METTL3-mediated SOCS2 m6A modification in osteoarthritis.","RPL38","regulate","METTL3","Osteoarthritis","RPL38","AFFECTS","METTL3","Osteoarthritis"
"5588","35596790","RPL38 knockdown inhibits the inflammation and apoptosis in chondrocytes through regulating METTL3-mediated SOCS2 m6A modification in osteoarthritis.","METTL3","mediate","m6A","Osteoarthritis","METTL3","AFFECTS","m6A","Osteoarthritis"
"5589","35596790","RPL38 knockdown inhibits the inflammation and apoptosis in chondrocytes through regulating METTL3-mediated SOCS2 m6A modification in osteoarthritis.","m6A","is on","SOCS2","Osteoarthritis","m6A","LOCATES","SOCS2","Osteoarthritis"
"5590","35596790","RPL38 knockdown inhibits the inflammation and apoptosis in chondrocytes through regulating METTL3-mediated SOCS2 m6A modification in osteoarthritis.","SOCS2","regulate","Inflammation","Osteoarthritis","SOCS2","AFFECTS","inflammatory response","Osteoarthritis"
"5591","35596790","RPL38 knockdown inhibits the inflammation and apoptosis in chondrocytes through regulating METTL3-mediated SOCS2 m6A modification in osteoarthritis.","SOCS2","regulate","Apoptosis","Osteoarthritis","SOCS2","AFFECTS","apoptotic process","Osteoarthritis"
"5593","35597169","Upregulation of METTL14 contributes to trophoblast dysfunction by elevating FOXO3a expression in an m6A-dependent manner.","dummy","upregulate","METTL14","Trophoblast","dummy","STIMULATES","METTL14","Trophoblasts"
"5594","35597169","Upregulation of METTL14 contributes to trophoblast dysfunction by elevating FOXO3a expression in an m6A-dependent manner.","METTL14","contribute to","trophoblast dysfunction","Trophoblast","METTL14","CAUSES","trophoblast dysfunction","Trophoblasts"
"5595","35597169","Upregulation of METTL14 contributes to trophoblast dysfunction by elevating FOXO3a expression in an m6A-dependent manner.","METTL14","elevate","FOXO3a","Trophoblast","METTL14","STIMULATES","FOXO3","Trophoblasts"
"5596","35597169","Upregulation of METTL14 contributes to trophoblast dysfunction by elevating FOXO3a expression in an m6A-dependent manner.","METTL14","regulate","m6A","Trophoblast","METTL14","AFFECTS","m6A","Trophoblasts"
"5597","35597169","Upregulation of METTL14 contributes to trophoblast dysfunction by elevating FOXO3a expression in an m6A-dependent manner.","m6A","regulate","FOXO3a","Trophoblast","m6A","AFFECTS","FOXO3","Trophoblasts"
"5599","35598196","Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-kappaB/IL-6 signaling pathway.","Mettl14","mediate","inflammatory response","Atherosclerosis","METTL14","AFFECTS","inflammatory response","Atherosclerosis"
"5600","35598196","Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-kappaB/IL-6 signaling pathway.","Mettl14","regulate","NF-kappaB/IL-6 signaling pathway","Atherosclerosis","METTL14","AFFECTS","NF-kappaB/IL-6 signaling pathway","Atherosclerosis"
"5601","35598196","Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-kappaB/IL-6 signaling pathway.","NF-kappaB/IL-6 signaling pathway","mediate","inflammatory response","Atherosclerosis","NF-kappaB/IL-6 signaling pathway","AFFECTS","inflammatory response","Atherosclerosis"
"5603","35613576","UPF1 adds an m6A feather to its (de)cap.","UPF1","add","m6A","Null","UPF1","add","m6A","Null"
"5605","35613594","UPF1 promotes rapid degradation of m6A-containing RNAs.","UPF1","promote degradation","m6A-containing RNAs","Null","UPF1","promote degradation","m6A","Null"
"5607","35614315","Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation.","Nsun4","mediate","translational reprogramming","BMSC","NSUN4","AFFECTS","translational reprogramming","BMSC"
"5608","35614315","Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation.","Mettl3","mediate","translational reprogramming","BMSC","METTL3","AFFECTS","translational reprogramming","BMSC"
"5609","35614315","Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation.","translational reprogramming","reprogram","Sox9","BMSC","translational reprogramming","CONVERTS_TO","SOX9","BMSC"
"5610","35614315","Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation.","Sox9","promote","chondrogenic differentiation","BMSC","SOX9","STIMULATES","chondrogenic differentiation","BMSC"
"5612","35637959","METTL3 promotes cell cycle progression via m6A/YTHDF1-dependent regulation of CDC25B translation.","METTL3","promote","cell cycle progression","Null","METTL3","STIMULATES","cell cycle progression","Null"
"5613","35637959","METTL3 promotes cell cycle progression via m6A/YTHDF1-dependent regulation of CDC25B translation.","METTL3","regulate","m6A","Null","METTL3","AFFECTS","m6A","Null"
"5614","35637959","METTL3 promotes cell cycle progression via m6A/YTHDF1-dependent regulation of CDC25B translation.","YTHDF1","bind","m6A","Null","YTHDF1","INTERACTS_WITH","m6A","Null"
"5615","35637959","METTL3 promotes cell cycle progression via m6A/YTHDF1-dependent regulation of CDC25B translation.","m6A","regulate","cell cycle progression","Null","m6A","AFFECTS","cell cycle progression","Null"
"5617","35638109","DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer.","DARS-AS1","recruit","METTL3","Cervical Cancer","DARS1-AS1","recruit","METTL3","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5618","35638109","DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer.","DARS-AS1","recruit","METTL14","Cervical Cancer","DARS1-AS1","recruit","METTL14","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5619","35638109","DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer.","METTL3","bind","DARS mRNA","Cervical Cancer","METTL3","INTERACTS_WITH","DARS1","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5620","35638109","DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer.","METTL14","bind","DARS mRNA","Cervical Cancer","METTL14","INTERACTS_WITH","DARS1","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5621","35638109","DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer.","METTL3","enhance","m6A modification","Cervical Cancer","METTL3","AUGMENTS","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5622","35638109","DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer.","METTL14","enhance","m6A modification","Cervical Cancer","METTL14","AUGMENTS","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5623","35638109","DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer.","m6A modification","for","cytoprotective autophagy","Cervical Cancer","m6A","for","cytoprotective autophagy","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5624","35638109","DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer.","DARS mRNA","undergo","m6A modification","Cervical Cancer","DARS1","undergo","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5626","35639481","Specific recognition between YTHDF3 and m6 A-modified RNA: An all-atom molecular dynamics simulation study.","YTHDF3","recognize","m6A-modified RNA","Null","YTHDF3","DIAGNOSES","m6A","Null"
"5628","35639638","Mettl3 downregulation in germinal vesicle oocytes inhibits mRNA decay and the 1st polar body extrusion during maturation.","Mettl3","inhibit","mRNA decay","Germinal Vesicle Oocytes","METTL3","INHIBITS","mRNA catabolic process","Germinal Vesicle Oocytes"
"5629","35639638","Mettl3 downregulation in germinal vesicle oocytes inhibits mRNA decay and the 1st polar body extrusion during maturation.","Mettl3","inhibit","1st polar body extrusion","Germinal Vesicle Oocytes","METTL3","INHIBITS","1st polar body extrusion","Germinal Vesicle Oocytes"
"5630","35639638","Mettl3 downregulation in germinal vesicle oocytes inhibits mRNA decay and the 1st polar body extrusion during maturation.","maturation","during","mRNA decay","Germinal Vesicle Oocytes","maturation","during","mRNA catabolic process","Germinal Vesicle Oocytes"
"5631","35639638","Mettl3 downregulation in germinal vesicle oocytes inhibits mRNA decay and the 1st polar body extrusion during maturation.","maturation","during","1st polar body extrusion","Germinal Vesicle Oocytes","maturation","during","1st polar body extrusion","Germinal Vesicle Oocytes"
"5633","35649302","RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation.","YTHDF1","facilitate","inflammation","Null","YTHDF1","AUGMENTS","inflammatory response","Null"
"5634","35649302","RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation.","YTHDF1","enhance","NLRP3","Null","YTHDF1","AUGMENTS","NLRP3","Null"
"5635","35649302","RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation.","NLRP3","facilitate","inflammation","Null","NLRP3","AUGMENTS","inflammatory response","Null"
"5637","35650605","circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.","circPDE5A","regulate","Metastasis","Prostate Cancer","circPDE5A","AFFECTS","Neoplasm Metastasis","PRAD(Prostate Adenocarcinoma)"
"5638","35650605","circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.","circPDE5A","control","WTAP","Prostate Cancer","circPDE5A","AFFECTS","WTAP","PRAD(Prostate Adenocarcinoma)"
"5639","35650605","circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.","WTAP","induce","N6-methyladenisine methylation","Prostate Cancer","WTAP","CAUSES","m6A","PRAD(Prostate Adenocarcinoma)"
"5640","35650605","circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.","N6-methyladenisine methylation","is on","EIF3C mRNA","Prostate Cancer","m6A","LOCATES","EIF3C","PRAD(Prostate Adenocarcinoma)"
"5641","35650605","circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.","EIF3C mRNA","regulate","Metastasis","Prostate Cancer","EIF3C","AFFECTS","Neoplasm Metastasis","PRAD(Prostate Adenocarcinoma)"
"5643","35660571","Enterovirus 71 VP1 promotes 5-HT release by upregulating the expression of ERICH3 and methyltransferase ZC3H13.","VP1","promote","5-HT","Enterovirus 71","VP1","STIMULATES","serotonin","Enterovirus 71"
"5644","35660571","Enterovirus 71 VP1 promotes 5-HT release by upregulating the expression of ERICH3 and methyltransferase ZC3H13.","VP1","upregulate","ERICH3","Enterovirus 71","VP1","STIMULATES","ERICH3","Enterovirus 71"
"5645","35660571","Enterovirus 71 VP1 promotes 5-HT release by upregulating the expression of ERICH3 and methyltransferase ZC3H13.","VP1","upregulate","ZC3H13","Enterovirus 71","VP1","STIMULATES","ZC3H13","Enterovirus 71"
"5646","35660571","Enterovirus 71 VP1 promotes 5-HT release by upregulating the expression of ERICH3 and methyltransferase ZC3H13.","ERICH3","regulate","5-HT","Enterovirus 71","ERICH3","AFFECTS","serotonin","Enterovirus 71"
"5647","35660571","Enterovirus 71 VP1 promotes 5-HT release by upregulating the expression of ERICH3 and methyltransferase ZC3H13.","ZC3H13","regulate","5-HT","Enterovirus 71","ZC3H13","AFFECTS","serotonin","Enterovirus 71"
"5649","35678231","ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.","ZNF677","suppress","Renal Cell Carcinoma Progression","Renal Cell Carcinoma","ZNF677","INHIBITS","Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5650","35678231","ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.","ZNF677","regulate","m6A","Renal Cell Carcinoma","ZNF677","AFFECTS","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5651","35678231","ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.","ZNF677","repress","CDKN3","Renal Cell Carcinoma","ZNF677","INHIBITS","CDKN3","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5652","35678231","ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.","CDKN3","regulate","Renal Cell Carcinoma Progression","Renal Cell Carcinoma","CDKN3","AFFECTS","Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5654","35502895","METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis.","METTL3","promote","Homologous Recombination Repair","Breast Cancer","METTL3","STIMULATES","recombinational repair","BRCA(Breast Invasive Carcinoma)"
"5655","35502895","METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis.","METTL3","regulate","EGF/RAD51 axis","Breast Cancer","METTL3","AFFECTS","EGF/RAD51 axis","BRCA(Breast Invasive Carcinoma)"
"5656","35502895","METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis.","EGF/RAD51 axis","modulate","Chemotherapeutic Response","Breast Cancer","EGF/RAD51 axis","AFFECTS","Chemotherapeutic Response","BRCA(Breast Invasive Carcinoma)"
"5657","35502895","METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis.","Homologous Recombination Repair","modulate","Chemotherapeutic Response","Breast Cancer","recombinational repair","AFFECTS","Chemotherapeutic Response","BRCA(Breast Invasive Carcinoma)"
"5659","35503144","p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.","p53","modulate","m6A modulation","Hepatocellular Carcinoma","TP53","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"5660","35503144","p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.","m6A modulation","sensitize","Hepatocellular Carcinoma","Hepatocellular Carcinoma","m6A","STIMULATES","hepatocellular carcinoma","LIHC(Liver Hepatocellular Carcinoma)"
"5661","35503144","p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.","m6A modulation","induce","Apoptosis","Hepatocellular Carcinoma","m6A","CAUSES","apoptotic process","LIHC(Liver Hepatocellular Carcinoma)"
"5662","35503144","p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.","Apoptosis","is on","Apatinib","Hepatocellular Carcinoma","apoptotic process","LOCATES","apatinib","LIHC(Liver Hepatocellular Carcinoma)"
"5663","35503144","p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.","Apatinib","sensitize","Hepatocellular Carcinoma","Hepatocellular Carcinoma","apatinib","STIMULATES","hepatocellular carcinoma","LIHC(Liver Hepatocellular Carcinoma)"
"5665","35504087","N6-methyladenosine RNA demethylase ALKBH5 is testis-specifically downregulated in hybrid male sterile dzo and is a target gene of bta-miR-200a.","ALKBH5","target","bta-miR-200a","Hybrid male sterile dzo","ALKBH5","INTERACTS_WITH","bta-miR-200a","Hybrid male sterile dzo"
"5667","35507004","Anti-HIV drug elvitegravir suppresses cancer metastasis via increased proteasomal degradation of m6A methyltransferase METTL3.","elvitegravir","suppress","cancer metastasis","Cancer Metastasis","elvitegravir","INHIBITS","Neoplasm Metastasis","Neoplasm Metastasis"
"5668","35507004","Anti-HIV drug elvitegravir suppresses cancer metastasis via increased proteasomal degradation of m6A methyltransferase METTL3.","elvitegravir","increase","proteasomal degradation","Cancer Metastasis","elvitegravir","AUGMENTS","Proteasomal Degradation","Neoplasm Metastasis"
"5669","35507004","Anti-HIV drug elvitegravir suppresses cancer metastasis via increased proteasomal degradation of m6A methyltransferase METTL3.","proteasomal degradation","degrade","METTL3","Cancer Metastasis","Proteasomal Degradation","INHIBITS","METTL3","Neoplasm Metastasis"
"5670","35507004","Anti-HIV drug elvitegravir suppresses cancer metastasis via increased proteasomal degradation of m6A methyltransferase METTL3.","METTL3","regulate","cancer metastasis","Cancer Metastasis","METTL3","AFFECTS","Neoplasm Metastasis","Neoplasm Metastasis"
"5672","35508474","YTHDF1 alleviates sepsis by upregulating WWP1 to induce NLRP3 ubiquitination and inhibit caspase-1-dependent pyroptosis.","YTHDF1","upregulate","WWP1","Sepsis","YTHDF1","STIMULATES","WWP1","Sepsis"
"5673","35508474","YTHDF1 alleviates sepsis by upregulating WWP1 to induce NLRP3 ubiquitination and inhibit caspase-1-dependent pyroptosis.","WWP1","induce ubiquitination","NLRP3","Sepsis","WWP1","induce ubiquitination","NLRP3","Sepsis"
"5674","35508474","YTHDF1 alleviates sepsis by upregulating WWP1 to induce NLRP3 ubiquitination and inhibit caspase-1-dependent pyroptosis.","NLRP3","inhibit","caspase-1","Sepsis","NLRP3","INHIBITS","CASP1","Sepsis"
"5675","35508474","YTHDF1 alleviates sepsis by upregulating WWP1 to induce NLRP3 ubiquitination and inhibit caspase-1-dependent pyroptosis.","caspase-1","induce","pyroptosis","Sepsis","CASP1","CAUSES","pyroptosis","Sepsis"
"5677","35509101","SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.","SRSF9","promote","Colorectal Cancer Progression","Colorectal Cancer","SRSF9","STIMULATES","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"5678","35509101","SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.","SRSF9","stabilize","DSN1 mRNA","Colorectal Cancer","SRSF9","MAINTAINS","DSN1","COAD(Colon Adenocarcinoma)"
"5679","35509101","SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.","m6A","related to","DSN1 mRNA","Colorectal Cancer","m6A","related to","DSN1","COAD(Colon Adenocarcinoma)"
"5680","35509101","SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.","DSN1 mRNA","regulate","Colorectal Cancer Progression","Colorectal Cancer","DSN1","AFFECTS","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"5682","35511947","FTO mediates LINE1 m6A demethylation and chromatin regulation in mESCs and mouse development.","FTO","mediate","LINE1 m6A","mESCs and mouse development","FTO","AFFECTS","LINE1 m6A","mESCs and mouse development"
"5683","35511947","FTO mediates LINE1 m6A demethylation and chromatin regulation in mESCs and mouse development.","LINE1 m6A","regulate","Chromatin regulation","mESCs and mouse development","LINE1 m6A","AFFECTS","Chromatin regulation","mESCs and mouse development"
"5685","35524319","M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.","m6A","upregulate","circMDK","Hepatocellular Carcinoma","m6A","STIMULATES","circMDK","LIHC(Liver Hepatocellular Carcinoma)"
"5686","35524319","M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.","circMDK","promote","tumorigenesis","Hepatocellular Carcinoma","circMDK","STIMULATES","Carcinogenesis","LIHC(Liver Hepatocellular Carcinoma)"
"5688","35524932","FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells.","FTO","demethylate","ERBB2","Esophageal Squamous Cell Carcinoma Cells","FTO","CONVERTS_TO","ERBB2","ESCA(Esophageal Carcinoma)"
"5689","35524932","FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells.","ERBB2","promote","Tumor Progression","Esophageal Squamous Cell Carcinoma Cells","ERBB2","STIMULATES","Tumor Progression","ESCA(Esophageal Carcinoma)"
"5691","35526051","PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.","PA2G4","promote","Metastasis","Hepatocellular Carcinoma","PA2G4","STIMULATES","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"5692","35526051","PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.","PA2G4","stabilize","FYN mRNA","Hepatocellular Carcinoma","PA2G4","MAINTAINS","FYN","LIHC(Liver Hepatocellular Carcinoma)"
"5693","35526051","PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.","PA2G4","depend on","YTHDF2","Hepatocellular Carcinoma","PA2G4","INTERACTS_WITH","YTHDF2","LIHC(Liver Hepatocellular Carcinoma)"
"5694","35526051","PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.","FYN mRNA","regulate","Metastasis","Hepatocellular Carcinoma","FYN","AFFECTS","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"5696","35530959","Downregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m6A modification of Trio mRNA.","ALKBH5","contribute","Myocardial Ischemia/Reperfusion Injury","Myocardial Ischemia/Reperfusion Injury","ALKBH5","AFFECTS","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia/Reperfusion Injury"
"5697","35530959","Downregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m6A modification of Trio mRNA.","ALKBH5","increase","m6A","Myocardial Ischemia/Reperfusion Injury","ALKBH5","AUGMENTS","m6A","Myocardial Ischemia/Reperfusion Injury"
"5698","35530959","Downregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m6A modification of Trio mRNA.","m6A","modify","Trio mRNA","Myocardial Ischemia/Reperfusion Injury","m6A","AFFECTS","Trio","Myocardial Ischemia/Reperfusion Injury"
"5699","35530959","Downregulated ALKBH5 contributes to myocardial ischemia/reperfusion injury by increasing m6A modification of Trio mRNA.","Trio mRNA","contribute","Myocardial Ischemia/Reperfusion Injury","Myocardial Ischemia/Reperfusion Injury","Trio","AFFECTS","Myocardial Ischemia Reperfusion Injury","Myocardial Ischemia/Reperfusion Injury"
"5701","35538475","N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","N6-methyladenosine","modify","TRAF1","Renal Cell Carcinoma","m6A","AFFECTS","TRAF1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5702","35538475","N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","TRAF1","promote","Sunitinib Resistance","Renal Cell Carcinoma","TRAF1","STIMULATES","Sunitinib Resistance","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5703","35538475","N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","TRAF1","regulate","Apoptosis","Renal Cell Carcinoma","TRAF1","AFFECTS","apoptotic process","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5704","35538475","N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","TRAF1","regulate","Angiogenesis","Renal Cell Carcinoma","TRAF1","AFFECTS","angiogenesis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5705","35538475","N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","METTL14","depend","TRAF1","Renal Cell Carcinoma","METTL14","depend","TRAF1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5706","35538475","N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","Apoptosis","regulate","Sunitinib Resistance","Renal Cell Carcinoma","apoptotic process","AFFECTS","Sunitinib Resistance","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5707","35538475","N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","Angiogenesis","regulate","Sunitinib Resistance","Renal Cell Carcinoma","angiogenesis","AFFECTS","Sunitinib Resistance","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5709","35541914","RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis.","RNA methylation","mediate","LINC01559","Colorectal Cancer","RNA methylation","AFFECTS","LINC01559","COAD(Colon Adenocarcinoma)"
"5710","35541914","RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis.","LINC01559","suppress","Colorectal Cancer Progression","Colorectal Cancer","LINC01559","INHIBITS","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"5711","35541914","RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis.","LINC01559","regulate","miR-106b-5p/PTEN axis","Colorectal Cancer","LINC01559","AFFECTS","miR-106b-5p/PTEN axis","COAD(Colon Adenocarcinoma)"
"5712","35541914","RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis.","miR-106b-5p/PTEN axis","regulate","Colorectal Cancer Progression","Colorectal Cancer","miR-106b-5p/PTEN axis","AFFECTS","Colorectal Cancer Progression","COAD(Colon Adenocarcinoma)"
"5714","35545048","SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.","SRSF3","regulate","lncRNA ANRIL","Pancreatic Cancer","SRSF3","AFFECTS","CDKN2B-AS1","PAAD(Pancreatic Adenocarcinoma)"
"5715","35545048","SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.","lncRNA ANRIL","promote","resistance","Pancreatic Cancer","CDKN2B-AS1","STIMULATES","resistance","PAAD(Pancreatic Adenocarcinoma)"
"5716","35545048","SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.","splicing","regulate","lncRNA ANRIL","Pancreatic Cancer","splicing","AFFECTS","CDKN2B-AS1","PAAD(Pancreatic Adenocarcinoma)"
"5718","35546050","N6-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner.","KIAA1429","elevate","Aerobic Glycolysis","Colorectal Cancer","VIRMA","STIMULATES","aerobic glycolysis","COAD(Colon Adenocarcinoma)"
"5719","35546050","N6-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner.","KIAA1429","regulate","HK2","Colorectal Cancer","VIRMA","AFFECTS","HK2","COAD(Colon Adenocarcinoma)"
"5720","35546050","N6-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner.","HK2","regulate","Aerobic Glycolysis","Colorectal Cancer","HK2","AFFECTS","aerobic glycolysis","COAD(Colon Adenocarcinoma)"
"5722","35552718","ALKBH5 regulates somatic cell reprogramming in a phase specific manner.","ALKBH5","regulate","Somatic Cell Reprogramming","Somatic Cell Reprogramming","ALKBH5","AFFECTS","Somatic Cell Reprogramming","Somatic Cell Reprogramming"
"5724","35562334","N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.","N6-methyladenosine","regulate","FGFR4","HER2-positive breast cancer","m6A","AFFECTS","FGFR4","BRCA(Breast Invasive Carcinoma)"
"5725","35562334","N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.","FGFR4","attenuate","ferroptotic cell death","HER2-positive breast cancer","FGFR4","INHIBITS","ferroptotic cell death","BRCA(Breast Invasive Carcinoma)"
"5727","35567945","METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.","METTL3","promote","Metastasis","Colorectal Cancer","METTL3","STIMULATES","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"5728","35567945","METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.","METTL3","stabilize","PLAU mRNA","Colorectal Cancer","METTL3","MAINTAINS","PLAU","COAD(Colon Adenocarcinoma)"
"5729","35567945","METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.","METTL3","regulate","m6A","Colorectal Cancer","METTL3","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"5730","35567945","METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.","m6A","regulate","PLAU mRNA","Colorectal Cancer","m6A","AFFECTS","PLAU","COAD(Colon Adenocarcinoma)"
"5732","35568876","m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer.","FTO","promote","Tumor Progression","Esophageal Cancer","FTO","STIMULATES","Tumor Progression","ESCA(Esophageal Carcinoma)"
"5733","35568876","m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer.","FTO","regulate","Regulation","Esophageal Cancer","FTO","AFFECTS","regulation","ESCA(Esophageal Carcinoma)"
"5734","35568876","m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer.","Regulation","regulate","Lipid Metabolism","Esophageal Cancer","regulation","AFFECTS","Lipid Metabolism","ESCA(Esophageal Carcinoma)"
"5735","35568876","m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer.","Lipid Metabolism","promote","Tumor Progression","Esophageal Cancer","Lipid Metabolism","STIMULATES","Tumor Progression","ESCA(Esophageal Carcinoma)"
"5737","35572575","m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs.","m6A","bind","Igf2bp1","Microglia","m6A","INTERACTS_WITH","IGF2BP1","Microglia"
"5738","35572575","m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs.","Igf2bp1","regulate","Inflammatory Responses","Microglia","IGF2BP1","AFFECTS","inflammatory response","Microglia"
"5739","35572575","m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs.","Igf2bp1","stabilize","Gbp11","Microglia","IGF2BP1","MAINTAINS","Gbp11","Microglia"
"5740","35572575","m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs.","Igf2bp1","stabilize","Cp mRNAs","Microglia","IGF2BP1","MAINTAINS","CP","Microglia"
"5741","35572575","m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs.","Gbp11","regulate","Inflammatory Responses","Microglia","Gbp11","AFFECTS","inflammatory response","Microglia"
"5742","35572575","m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs.","Cp mRNAs","regulate","Inflammatory Responses","Microglia","CP","AFFECTS","inflammatory response","Microglia"
"5744","35573410","MEF2C Expression Is Regulated by the Post-transcriptional Activation of the METTL3-m6A-YTHDF1 Axis in Myoblast Differentiation.","METTL3","regulate","MEF2C","Myoblast Differentiation","METTL3","AFFECTS","MEF2C","myoblast differentiation"
"5745","35573410","MEF2C Expression Is Regulated by the Post-transcriptional Activation of the METTL3-m6A-YTHDF1 Axis in Myoblast Differentiation.","METTL3","activate","MEF2C","Myoblast Differentiation","METTL3","STIMULATES","MEF2C","myoblast differentiation"
"5746","35573410","MEF2C Expression Is Regulated by the Post-transcriptional Activation of the METTL3-m6A-YTHDF1 Axis in Myoblast Differentiation.","METTL3","regulate","m6A","Myoblast Differentiation","METTL3","AFFECTS","m6A","myoblast differentiation"
"5747","35573410","MEF2C Expression Is Regulated by the Post-transcriptional Activation of the METTL3-m6A-YTHDF1 Axis in Myoblast Differentiation.","m6A","regulate","YTHDF1","Myoblast Differentiation","m6A","AFFECTS","YTHDF1","myoblast differentiation"
"5749","35579750","Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.","Bioactive peptide","inhibit","cell proliferation","Acute Myeloid Leukemia","Bioactive peptide","INHIBITS","cell population proliferation","LAML(Acute Myeloid Leukemia)"
"5750","35579750","Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.","Bioactive peptide","downregulate","ALKBH5","Acute Myeloid Leukemia","Bioactive peptide","INHIBITS","ALKBH5","LAML(Acute Myeloid Leukemia)"
"5751","35579750","Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.","ALKBH5","demethylate","m6A","Acute Myeloid Leukemia","ALKBH5","CONVERTS_TO","m6A","LAML(Acute Myeloid Leukemia)"
"5752","35579750","Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.","m6A","is on","EIF4EBP1 mRNA","Acute Myeloid Leukemia","m6A","LOCATES","EIF4EBP1","LAML(Acute Myeloid Leukemia)"
"5753","35579750","Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.","m6A","is on","MLST8 mRNA","Acute Myeloid Leukemia","m6A","LOCATES","MLST8","LAML(Acute Myeloid Leukemia)"
"5754","35579750","Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.","EIF4EBP1 mRNA","regulate","cell proliferation","Acute Myeloid Leukemia","EIF4EBP1","AFFECTS","cell population proliferation","LAML(Acute Myeloid Leukemia)"
"5755","35579750","Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.","MLST8 mRNA","regulate","cell proliferation","Acute Myeloid Leukemia","MLST8","AFFECTS","cell population proliferation","LAML(Acute Myeloid Leukemia)"
"5757","35580525","SIAH1 promotes senescence and apoptosis of nucleus pulposus cells to exacerbate disc degeneration through ubiquitinating XIAP.","SIAH1","promote","Senescence","Nucleus Pulposus Cells","SIAH1","STIMULATES","cellular senescence","Nucleus Pulposus Cells"
"5758","35580525","SIAH1 promotes senescence and apoptosis of nucleus pulposus cells to exacerbate disc degeneration through ubiquitinating XIAP.","SIAH1","promote","Apoptosis","Nucleus Pulposus Cells","SIAH1","STIMULATES","apoptotic process","Nucleus Pulposus Cells"
"5759","35580525","SIAH1 promotes senescence and apoptosis of nucleus pulposus cells to exacerbate disc degeneration through ubiquitinating XIAP.","Senescence","exacerbate","Disc Degeneration","Nucleus Pulposus Cells","cellular senescence","COMPLICATES","Intervertebral Disc Degeneration","Nucleus Pulposus Cells"
"5760","35580525","SIAH1 promotes senescence and apoptosis of nucleus pulposus cells to exacerbate disc degeneration through ubiquitinating XIAP.","Apoptosis","exacerbate","Disc Degeneration","Nucleus Pulposus Cells","apoptotic process","COMPLICATES","Intervertebral Disc Degeneration","Nucleus Pulposus Cells"
"5761","35580525","SIAH1 promotes senescence and apoptosis of nucleus pulposus cells to exacerbate disc degeneration through ubiquitinating XIAP.","SIAH1","ubiquitinate","XIAP","Nucleus Pulposus Cells","SIAH1","ubiquitinate","XIAP","Nucleus Pulposus Cells"
"5762","35580525","SIAH1 promotes senescence and apoptosis of nucleus pulposus cells to exacerbate disc degeneration through ubiquitinating XIAP.","XIAP","regulate","Disc Degeneration","Nucleus Pulposus Cells","XIAP","AFFECTS","Intervertebral Disc Degeneration","Nucleus Pulposus Cells"
"5764","35404184","m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.","FTO","promote","Growth","Pancreatic Cancer Cells","FTO","STIMULATES","Growth","PAAD(Pancreatic Adenocarcinoma)"
"5765","35404184","m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.","FTO","promote","Migration","Pancreatic Cancer Cells","FTO","STIMULATES","migration","PAAD(Pancreatic Adenocarcinoma)"
"5766","35404184","m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.","FTO","promote","Invasion","Pancreatic Cancer Cells","FTO","STIMULATES","Neoplasm Invasiveness","PAAD(Pancreatic Adenocarcinoma)"
"5767","35404184","m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.","FTO","inhibit","TFPI-2","Pancreatic Cancer Cells","FTO","INHIBITS","TFPI2","PAAD(Pancreatic Adenocarcinoma)"
"5768","35404184","m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.","TFPI-2","inhibit","Growth","Pancreatic Cancer Cells","TFPI2","INHIBITS","Growth","PAAD(Pancreatic Adenocarcinoma)"
"5769","35404184","m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.","TFPI-2","inhibit","Migration","Pancreatic Cancer Cells","TFPI2","INHIBITS","migration","PAAD(Pancreatic Adenocarcinoma)"
"5770","35404184","m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.","TFPI-2","inhibit","Invasion","Pancreatic Cancer Cells","TFPI2","INHIBITS","Neoplasm Invasiveness","PAAD(Pancreatic Adenocarcinoma)"
"5772","35405116","METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis.","METTL3","stabilize","SNHG7","Prostate Cancer","METTL3","MAINTAINS","SNHG7","PRAD(Prostate Adenocarcinoma)"
"5773","35405116","METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis.","SNHG7","accelerate","glycolysis","Prostate Cancer","SNHG7","STIMULATES","glycolytic process","PRAD(Prostate Adenocarcinoma)"
"5774","35405116","METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis.","SNHG7","regulate","SRSF1/c-Myc axis","Prostate Cancer","SNHG7","AFFECTS","SRSF1/c-Myc axis","PRAD(Prostate Adenocarcinoma)"
"5775","35405116","METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis.","SRSF1/c-Myc axis","regulate","glycolysis","Prostate Cancer","SRSF1/c-Myc axis","AFFECTS","glycolytic process","PRAD(Prostate Adenocarcinoma)"
"5777","35406777","5-Azacytidine Inhibits the Activation of Senescence Program and Promotes Cytotoxic Autophagy during Trdmt1-Mediated Oxidative Stress Response in Insulinoma beta-TC-6 Cells.","5-Azacytidine","inhibit","Activation","Insulinoma beta-TC-6 Cells","5-azacytidine","INHIBITS","activation","Insulinoma beta-TC-6 Cells"
"5778","35406777","5-Azacytidine Inhibits the Activation of Senescence Program and Promotes Cytotoxic Autophagy during Trdmt1-Mediated Oxidative Stress Response in Insulinoma beta-TC-6 Cells.","5-Azacytidine","promote","Cytotoxic Autophagy","Insulinoma beta-TC-6 Cells","5-azacytidine","STIMULATES","Cytotoxic Autophagy","Insulinoma beta-TC-6 Cells"
"5779","35406777","5-Azacytidine Inhibits the Activation of Senescence Program and Promotes Cytotoxic Autophagy during Trdmt1-Mediated Oxidative Stress Response in Insulinoma beta-TC-6 Cells.","Trdmt1","mediate","Oxidative Stress Response","Insulinoma beta-TC-6 Cells","TRDMT1","AFFECTS","Oxidative Stress Response","Insulinoma beta-TC-6 Cells"
"5780","35406777","5-Azacytidine Inhibits the Activation of Senescence Program and Promotes Cytotoxic Autophagy during Trdmt1-Mediated Oxidative Stress Response in Insulinoma beta-TC-6 Cells.","Activation","is on","Senescence Program","Insulinoma beta-TC-6 Cells","activation","LOCATES","Senescence Program","Insulinoma beta-TC-6 Cells"
"5781","35406777","5-Azacytidine Inhibits the Activation of Senescence Program and Promotes Cytotoxic Autophagy during Trdmt1-Mediated Oxidative Stress Response in Insulinoma beta-TC-6 Cells.","Oxidative Stress Response","induce","Activation","Insulinoma beta-TC-6 Cells","Oxidative Stress Response","CAUSES","activation","Insulinoma beta-TC-6 Cells"
"5783","35413135","METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.","METTL3","promote","Prostate Cancer Progression","Prostate Cancer","METTL3","STIMULATES","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"5784","35413135","METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.","METTL3","regulate","miR-182 maturation","Prostate Cancer","METTL3","AFFECTS","miR-182 maturation","PRAD(Prostate Adenocarcinoma)"
"5785","35413135","METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.","METTL3","regulate","m6A","Prostate Cancer","METTL3","AFFECTS","m6A","PRAD(Prostate Adenocarcinoma)"
"5786","35413135","METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.","m6A","regulate","miR-182 maturation","Prostate Cancer","m6A","AFFECTS","miR-182 maturation","PRAD(Prostate Adenocarcinoma)"
"5788","35414790","ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype.","ALKBH5","promote","Tumorigenicity","Multiple Myeloma","ALKBH5","STIMULATES","Tumorigenicity","Multiple Myeloma"
"5789","35414790","ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype.","ALKBH5","demethylate","m6A","Multiple Myeloma","ALKBH5","CONVERTS_TO","m6A","Multiple Myeloma"
"5790","35414790","ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype.","m6A","is on","SAV1 mRNA","Multiple Myeloma","m6A","LOCATES","SAV1","Multiple Myeloma"
"5791","35414790","ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype.","SAV1 mRNA","induce","Myeloma Stem Cell Phenotype","Multiple Myeloma","SAV1","CAUSES","Myeloma Stem Cell Phenotype","Multiple Myeloma"
"5792","35414790","ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype.","Myeloma Stem Cell Phenotype","promote","Tumorigenicity","Multiple Myeloma","Myeloma Stem Cell Phenotype","STIMULATES","Tumorigenicity","Multiple Myeloma"
"5794","35417191","Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.","dummy","inhibit","METTL3","Renal injury and inflammation","dummy","INHIBITS","METTL3","Renal injury and inflammation"
"5795","35417191","Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.","METTL3","attenuate","Renal injury","Renal injury and inflammation","METTL3","INHIBITS","Renal injury","Renal injury and inflammation"
"5796","35417191","Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.","METTL3","attenuate","Inflammation","Renal injury and inflammation","METTL3","INHIBITS","inflammatory response","Renal injury and inflammation"
"5797","35417191","Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.","METTL3","alleviate","TAB3 m6A modifications","Renal injury and inflammation","METTL3","INHIBITS","TAB3 m6A modifications","Renal injury and inflammation"
"5798","35417191","Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.","IGF2BP2","bind","TAB3 m6A modifications","Renal injury and inflammation","IGF2BP2","INTERACTS_WITH","TAB3 m6A modifications","Renal injury and inflammation"
"5799","35417191","Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.","TAB3 m6A modifications","regulate","Renal injury","Renal injury and inflammation","TAB3 m6A modifications","AFFECTS","Renal injury","Renal injury and inflammation"
"5800","35417191","Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.","TAB3 m6A modifications","regulate","Inflammation","Renal injury and inflammation","TAB3 m6A modifications","AFFECTS","inflammatory response","Renal injury and inflammation"
"5802","35418191","SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer.","SMAD3","involve","miR-5581-3p","Bladder Cancer","SMAD3","ASSOCIATED_WITH","miR-5581-3p","BLCA(Bladder Urothelial Carcinoma)"
"5803","35418191","SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer.","FTO","involve","miR-5581-3p","Bladder Cancer","FTO","ASSOCIATED_WITH","miR-5581-3p","BLCA(Bladder Urothelial Carcinoma)"
"5804","35418191","SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer.","miR-5581-3p","inhibit","Cell Migration","Bladder Cancer","miR-5581-3p","INHIBITS","cell migration","BLCA(Bladder Urothelial Carcinoma)"
"5805","35418191","SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer.","miR-5581-3p","inhibit","Cell Proliferation","Bladder Cancer","miR-5581-3p","INHIBITS","cell population proliferation","BLCA(Bladder Urothelial Carcinoma)"
"5807","35422475","RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner.","FTO","promote","Pancreatic Cancer Progression","Pancreatic Cancer","FTO","STIMULATES","Pancreatic Cancer Progression","PAAD(Pancreatic Adenocarcinoma)"
"5808","35422475","RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner.","FTO","induce","PDGFC","Pancreatic Cancer","FTO","CAUSES","PDGFC","PAAD(Pancreatic Adenocarcinoma)"
"5809","35422475","RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner.","FTO","regulate","m6A","Pancreatic Cancer","FTO","AFFECTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"5810","35422475","RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Pancreatic Cancer","YTHDF2","INTERACTS_WITH","m6A","PAAD(Pancreatic Adenocarcinoma)"
"5811","35422475","RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner.","m6A","facilitate","Pancreatic Cancer Progression","Pancreatic Cancer","m6A","AUGMENTS","Pancreatic Cancer Progression","PAAD(Pancreatic Adenocarcinoma)"
"5813","35433957","Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.","dummy","increase","m6A","Pancreatic Cancer","dummy","AUGMENTS","m6A","PAAD(Pancreatic Adenocarcinoma)"
"5814","35433957","Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.","m6A","modify","lncRNA DBH-AS1","Pancreatic Cancer","m6A","AFFECTS","DBH-AS1","PAAD(Pancreatic Adenocarcinoma)"
"5815","35433957","Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.","lncRNA DBH-AS1","suppress","Pancreatic Cancer Growth","Pancreatic Cancer","DBH-AS1","INHIBITS","Pancreatic Cancer Growth","PAAD(Pancreatic Adenocarcinoma)"
"5816","35433957","Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.","lncRNA DBH-AS1","suppress","Gemcitabine Resistance","Pancreatic Cancer","DBH-AS1","INHIBITS","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"5817","35433957","Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.","lncRNA DBH-AS1","regulate","miR-3163/USP44 axis","Pancreatic Cancer","DBH-AS1","AFFECTS","miR-3163/USP44 axis","PAAD(Pancreatic Adenocarcinoma)"
"5818","35433957","Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.","miR-3163/USP44 axis","regulate","Pancreatic Cancer Growth","Pancreatic Cancer","miR-3163/USP44 axis","AFFECTS","Pancreatic Cancer Growth","PAAD(Pancreatic Adenocarcinoma)"
"5819","35433957","Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis.","miR-3163/USP44 axis","regulate","Gemcitabine Resistance","Pancreatic Cancer","miR-3163/USP44 axis","AFFECTS","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"5821","35434840","METTL3 Promotes the Progression of Lung Cancer via Activating PI3K/AKT/mTOR Pathway.","METTL3","promote","Progression of Lung Cancer","Lung Cancer","METTL3","STIMULATES","Progression of Lung Cancer","LUAD(Lung Adenocarcinoma)"
"5822","35434840","METTL3 Promotes the Progression of Lung Cancer via Activating PI3K/AKT/mTOR Pathway.","METTL3","activate","PI3K/AKT/mTOR Pathway","Lung Cancer","METTL3","STIMULATES","PI3K/AKT/mTOR pathway","LUAD(Lung Adenocarcinoma)"
"5823","35434840","METTL3 Promotes the Progression of Lung Cancer via Activating PI3K/AKT/mTOR Pathway.","PI3K/AKT/mTOR Pathway","promote","Progression of Lung Cancer","Lung Cancer","PI3K/AKT/mTOR pathway","STIMULATES","Progression of Lung Cancer","LUAD(Lung Adenocarcinoma)"
"5825","35436474","Exenatide ameliorates hydrogen peroxide-induced pancreatic beta-cell apoptosis through regulation of METTL3-mediated m6A methylation.","Exenatide","ameliorate","Apoptosis","Pancreatic Beta-Cell","exendin-4","TREATS","apoptotic process","Insulin-Secreting Cells"
"5826","35436474","Exenatide ameliorates hydrogen peroxide-induced pancreatic beta-cell apoptosis through regulation of METTL3-mediated m6A methylation.","Exenatide","regulate","METTL3","Pancreatic Beta-Cell","exendin-4","AFFECTS","METTL3","Insulin-Secreting Cells"
"5827","35436474","Exenatide ameliorates hydrogen peroxide-induced pancreatic beta-cell apoptosis through regulation of METTL3-mediated m6A methylation.","METTL3","mediate","m6A methylation","Pancreatic Beta-Cell","METTL3","AFFECTS","m6A","Insulin-Secreting Cells"
"5828","35436474","Exenatide ameliorates hydrogen peroxide-induced pancreatic beta-cell apoptosis through regulation of METTL3-mediated m6A methylation.","m6A methylation","regulate","Apoptosis","Pancreatic Beta-Cell","m6A","AFFECTS","apoptotic process","Insulin-Secreting Cells"
"5830","35438468","Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.","Lipopolysaccharide","facilitate","Immune Escape","Hepatocellular Carcinoma Cells","lipopolysaccharide","AUGMENTS","Immune Escape","LIHC(Liver Hepatocellular Carcinoma)"
"5831","35438468","Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.","Lipopolysaccharide","modify","m6A","Hepatocellular Carcinoma Cells","lipopolysaccharide","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"5832","35438468","Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.","m6A","is on","lncRNA MIR155HG","Hepatocellular Carcinoma Cells","m6A","LOCATES","MIR155HG","LIHC(Liver Hepatocellular Carcinoma)"
"5833","35438468","Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.","lncRNA MIR155HG","upregulate","PD-L1","Hepatocellular Carcinoma Cells","MIR155HG","STIMULATES","CD274","LIHC(Liver Hepatocellular Carcinoma)"
"5834","35438468","Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.","PD-L1","is","Expression","Hepatocellular Carcinoma Cells","CD274","is","expression","LIHC(Liver Hepatocellular Carcinoma)"
"5837","35443090","Resina Draconis extract exerts anti-HCC effects through METTL3-m6A-Survivin axis.","Resina Draconis extract","exert","anti-HCC effects","HCC","Resina Draconis extract","exert","anti-HCC effects","HYCC1"
"5838","35443090","Resina Draconis extract exerts anti-HCC effects through METTL3-m6A-Survivin axis.","Resina Draconis extract","regulate","METTL3-m6A-Survivin axis","HCC","Resina Draconis extract","AFFECTS","METTL3-m6A-Survivin axis","HYCC1"
"5839","35443090","Resina Draconis extract exerts anti-HCC effects through METTL3-m6A-Survivin axis.","METTL3-m6A-Survivin axis","regulate","anti-HCC effects","HCC","METTL3-m6A-Survivin axis","AFFECTS","anti-HCC effects","HYCC1"
"5841","35446451","The ""m6A writer"" METTL3 and the ""m6A reader"" IGF2BP2 regulate cutaneous T-cell lymphomas (CTCL) progression via CDKN2A.","METTL3","regulate","CDKN2A","Cutaneous T-cell Lymphomas (CTCL)","METTL3","AFFECTS","CDKN2A","Cutaneous T-cell Lymphomas (CTCL)"
"5842","35446451","The ""m6A writer"" METTL3 and the ""m6A reader"" IGF2BP2 regulate cutaneous T-cell lymphomas (CTCL) progression via CDKN2A.","IGF2BP2","regulate","CDKN2A","Cutaneous T-cell Lymphomas (CTCL)","IGF2BP2","AFFECTS","CDKN2A","Cutaneous T-cell Lymphomas (CTCL)"
"5843","35446451","The ""m6A writer"" METTL3 and the ""m6A reader"" IGF2BP2 regulate cutaneous T-cell lymphomas (CTCL) progression via CDKN2A.","CDKN2A","regulate","CTCL progression","Cutaneous T-cell Lymphomas (CTCL)","CDKN2A","AFFECTS","CTCL progression","Cutaneous T-cell Lymphomas (CTCL)"
"5844","35446451","The ""m6A writer"" METTL3 and the ""m6A reader"" IGF2BP2 regulate cutaneous T-cell lymphomas (CTCL) progression via CDKN2A.","METTL3","regulate","CTCL progression","Cutaneous T-cell Lymphomas (CTCL)","METTL3","AFFECTS","CTCL progression","Cutaneous T-cell Lymphomas (CTCL)"
"5845","35446451","The ""m6A writer"" METTL3 and the ""m6A reader"" IGF2BP2 regulate cutaneous T-cell lymphomas (CTCL) progression via CDKN2A.","IGF2BP2","regulate","CTCL progression","Cutaneous T-cell Lymphomas (CTCL)","IGF2BP2","AFFECTS","CTCL progression","Cutaneous T-cell Lymphomas (CTCL)"
"5847","35451955","A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells.","genes","regulate","accumulation of CD138+ plasma cells","CD138+ plasma cells","Genes","AFFECTS","accumulation of CD138+ plasma cells","CD138+ plasma cells"
"5849","35461899","METTL3 mediates osteoblast apoptosis by regulating endoplasmic reticulum stress during LPS-induced inflammation.","METTL3","mediate","osteoblast apoptosis","LPS-induced inflammation","METTL3","AFFECTS","osteoblast apoptosis","LPS-induced inflammation"
"5850","35461899","METTL3 mediates osteoblast apoptosis by regulating endoplasmic reticulum stress during LPS-induced inflammation.","METTL3","regulate","endoplasmic reticulum stress","LPS-induced inflammation","METTL3","AFFECTS","Endoplasmic Reticulum Stress","LPS-induced inflammation"
"5851","35461899","METTL3 mediates osteoblast apoptosis by regulating endoplasmic reticulum stress during LPS-induced inflammation.","endoplasmic reticulum stress","induce","osteoblast apoptosis","LPS-induced inflammation","Endoplasmic Reticulum Stress","CAUSES","osteoblast apoptosis","LPS-induced inflammation"
"5853","35467477","Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.","circVMP1","facilitate","progression","Non-small cell lung cancer","circVMP1","AUGMENTS","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5854","35467477","Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.","circVMP1","facilitate","cisplatin resistance","Non-small cell lung cancer","circVMP1","AUGMENTS","Cisplatin Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5855","35467477","Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.","circVMP1","target","miR-524-5p-METTL3/SOX2 axis","Non-small cell lung cancer","circVMP1","INTERACTS_WITH","miR-524-5p-METTL3/SOX2 axis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5856","35467477","Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.","exosome","transmit","circVMP1","Non-small cell lung cancer","extracellular exosome","transmit","circVMP1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5857","35467477","Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.","miR-524-5p-METTL3/SOX2 axis","regulate","progression","Non-small cell lung cancer","miR-524-5p-METTL3/SOX2 axis","AFFECTS","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5858","35467477","Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.","miR-524-5p-METTL3/SOX2 axis","regulate","cisplatin resistance","Non-small cell lung cancer","miR-524-5p-METTL3/SOX2 axis","AFFECTS","Cisplatin Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5860","35474040","Molecular mechanism of m6A methylation of circDLC1 mediated by RNA methyltransferase METTL3 in the malignant proliferation of glioma cells.","m6A","is on","circDLC1","Glioma Cells","m6A","LOCATES","circDLC1","Glioma"
"5861","35474040","Molecular mechanism of m6A methylation of circDLC1 mediated by RNA methyltransferase METTL3 in the malignant proliferation of glioma cells.","METTL3","mediate","m6A","Glioma Cells","METTL3","AFFECTS","m6A","Glioma"
"5862","35474040","Molecular mechanism of m6A methylation of circDLC1 mediated by RNA methyltransferase METTL3 in the malignant proliferation of glioma cells.","m6A","promote","Malignant Proliferation","Glioma Cells","m6A","STIMULATES","Malignant Proliferation","Glioma"
"5863","35474040","Molecular mechanism of m6A methylation of circDLC1 mediated by RNA methyltransferase METTL3 in the malignant proliferation of glioma cells.","METTL3","promote","Malignant Proliferation","Glioma Cells","METTL3","STIMULATES","Malignant Proliferation","Glioma"
"5865","35480861","Yes-associated protein contributes to magnesium alloy-derivedinflammation in endothelial cells.","Yes-associated protein","contribute","Inflammation","Endothelial Cells","Yes-Associated Protein","AFFECTS","inflammatory response","Endothelial Cells"
"5866","35480861","Yes-associated protein contributes to magnesium alloy-derivedinflammation in endothelial cells.","Magnesium Alloy","derive","Inflammation","Endothelial Cells","Magnesium Alloy","derive","inflammatory response","Endothelial Cells"
"5868","35489084","YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.","YTHDF2","suppress","EMT","Cervical Cancer Cells","YTHDF2","INHIBITS","epithelial to mesenchymal transition","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5869","35489084","YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.","YTHDF2","enhance","Cisplatin Chemosensitivity","Cervical Cancer Cells","YTHDF2","AUGMENTS","Cisplatin Chemosensitivity","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5870","35489084","YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.","YTHDF2","regulate","AXIN1","Cervical Cancer Cells","YTHDF2","AFFECTS","AXIN1","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5871","35489084","YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.","AXIN1","regulate","EMT","Cervical Cancer Cells","AXIN1","AFFECTS","epithelial to mesenchymal transition","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5872","35489084","YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.","AXIN1","regulate","Cisplatin Chemosensitivity","Cervical Cancer Cells","AXIN1","AFFECTS","Cisplatin Chemosensitivity","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5874","35489385","N6-methyladenosine (m6A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner.","IGF2BP1","bind","m6A","Gastric Cancer","IGF2BP1","INTERACTS_WITH","m6A","STAD(Stomach adenocarcinoma)"
"5875","35489385","N6-methyladenosine (m6A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner.","IGF2BP1","accelerate","Gastric Cancer Aerobic Glycolysis","Gastric Cancer","IGF2BP1","STIMULATES","Gastric Cancer Aerobic Glycolysis","STAD(Stomach adenocarcinoma)"
"5876","35489385","N6-methyladenosine (m6A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner.","c-Myc","regulate","Gastric Cancer Aerobic Glycolysis","Gastric Cancer","MYC","AFFECTS","Gastric Cancer Aerobic Glycolysis","STAD(Stomach adenocarcinoma)"
"5877","35489385","N6-methyladenosine (m6A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner.","m6A","regulate","c-Myc","Gastric Cancer","m6A","AFFECTS","MYC","STAD(Stomach adenocarcinoma)"
"5879","35490460","ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.","ALKBH5","regulate","STAT3 activity","Osteosarcoma","ALKBH5","AFFECTS","STAT3 activity","SARC(Sarcoma)"
"5880","35490460","ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.","ALKBH5","regulate","proliferation","Osteosarcoma","ALKBH5","AFFECTS","cell population proliferation","SARC(Sarcoma)"
"5881","35490460","ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.","YTHDF2","bind","proliferation","Osteosarcoma","YTHDF2","INTERACTS_WITH","cell population proliferation","SARC(Sarcoma)"
"5882","35490460","ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.","proliferation","regulate","STAT3 activity","Osteosarcoma","cell population proliferation","AFFECTS","STAT3 activity","SARC(Sarcoma)"
"5884","35499052","Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.","lncRNA-CBSLR","modulate","ferroptosis","Gastric Cancer","CBSLR","AFFECTS","Ferroptosis","STAD(Stomach adenocarcinoma)"
"5885","35499052","Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.","lncRNA-CBSLR","regulate","m6A","Gastric Cancer","CBSLR","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"5886","35499052","Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.","YTHDF2","bind","m6A","Gastric Cancer","YTHDF2","INTERACTS_WITH","m6A","STAD(Stomach adenocarcinoma)"
"5887","35499052","Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.","m6A","modulate","ferroptosis","Gastric Cancer","m6A","AFFECTS","Ferroptosis","STAD(Stomach adenocarcinoma)"
"5889","35501316","N6-methyladenosine (m6A) methyltransferase METTL3-mediated LINC00680 accelerates osteoarthritis through m6A/SIRT1 manner.","METTL3","mediate","LINC00680","Osteoarthritis","METTL3","AFFECTS","LINC00680","Osteoarthritis"
"5890","35501316","N6-methyladenosine (m6A) methyltransferase METTL3-mediated LINC00680 accelerates osteoarthritis through m6A/SIRT1 manner.","METTL3","regulate","m6A","Osteoarthritis","METTL3","AFFECTS","m6A","Osteoarthritis"
"5891","35501316","N6-methyladenosine (m6A) methyltransferase METTL3-mediated LINC00680 accelerates osteoarthritis through m6A/SIRT1 manner.","SIRT1","bind","m6A","Osteoarthritis","SIRT1","INTERACTS_WITH","m6A","Osteoarthritis"
"5892","35501316","N6-methyladenosine (m6A) methyltransferase METTL3-mediated LINC00680 accelerates osteoarthritis through m6A/SIRT1 manner.","m6A","regulate","LINC00680","Osteoarthritis","m6A","AFFECTS","LINC00680","Osteoarthritis"
"5894","35501461","Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-beta signaling.","dummy","induce insufficient","ablation","Hepatocellular Carcinoma","dummy","induce insufficient","ablation","LIHC(Liver Hepatocellular Carcinoma)"
"5895","35501461","Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-beta signaling.","ablation","induce","E3-ligase Nedd4","Hepatocellular Carcinoma","ablation","CAUSES","E3-ligase Nedd4","LIHC(Liver Hepatocellular Carcinoma)"
"5896","35501461","Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-beta signaling.","E3-ligase Nedd4","promote","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","E3-ligase Nedd4","STIMULATES","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"5897","35501461","Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-beta signaling.","E3-ligase Nedd4","tune","TGF-beta signaling","Hepatocellular Carcinoma","E3-ligase Nedd4","tune","TGF-beta signaling pathway","LIHC(Liver Hepatocellular Carcinoma)"
"5898","35501461","Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-beta signaling.","TGF-beta signaling","regulate","Hepatocellular Carcinoma Progression","Hepatocellular Carcinoma","TGF-beta signaling pathway","AFFECTS","Hepatocellular Carcinoma Progression","LIHC(Liver Hepatocellular Carcinoma)"
"5900","35502827","N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1.","IGF2BP2","promote","Gastric Cancer Progression","Gastric Cancer","IGF2BP2","STIMULATES","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"5901","35502827","N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1.","IGF2BP2","target","SIRT1","Gastric Cancer","IGF2BP2","INTERACTS_WITH","SIRT1","STAD(Stomach adenocarcinoma)"
"5902","35502827","N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1.","SIRT1","regulate","Gastric Cancer Progression","Gastric Cancer","SIRT1","AFFECTS","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"5904","35319018","YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis.","YTHDF1","regulate","PKM2","Breast Cancer","YTHDF1","AFFECTS","PKM","BRCA(Breast Invasive Carcinoma)"
"5905","35319018","YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis.","PKM2","affect","glycolysis","Breast Cancer","PKM","AFFECTS","glycolytic process","BRCA(Breast Invasive Carcinoma)"
"5906","35319018","YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis.","glycolysis","promote","cancer growth","Breast Cancer","glycolytic process","STIMULATES","cancer growth","BRCA(Breast Invasive Carcinoma)"
"5907","35319018","YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis.","glycolysis","promote","metastasis","Breast Cancer","glycolytic process","STIMULATES","Neoplasm Metastasis","BRCA(Breast Invasive Carcinoma)"
"5909","35320754","Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells.","Lactylation","drive","METTL3","Tumor-infiltrating myeloid cells","Lactylation","STIMULATES","METTL3","Tumor-infiltrating myeloid cells"
"5910","35320754","Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells.","METTL3","mediate","RNA m6A modification","Tumor-infiltrating myeloid cells","METTL3","AFFECTS","m6A","Tumor-infiltrating myeloid cells"
"5911","35320754","Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells.","RNA m6A modification","promote","Immunosuppression","Tumor-infiltrating myeloid cells","m6A","STIMULATES","Immunosuppression Therapy","Tumor-infiltrating myeloid cells"
"5912","35320754","Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells.","Immunosuppression","affect","Tumor-infiltrating myeloid cells","Tumor-infiltrating myeloid cells","Immunosuppression Therapy","AFFECTS","Tumor-infiltrating myeloid cells","Tumor-infiltrating myeloid cells"
"5914","35333330","Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes.","ALKBH5","form complex","RNA","ALKBH5-RNA complexes","ALKBH5","form complex","ribonucleic acid","ALKBH5-RNA complexes"
"5915","35333330","Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes.","ALKBH5","demethylate","N6-methyladenosine","ALKBH5-RNA complexes","ALKBH5","CONVERTS_TO","m6A","ALKBH5-RNA complexes"
"5917","35333576","m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-kappaB-mediated antiapoptotic pathway.","m6A","maintain","Homeostasis","Colonic Epithelial Cell","m6A","MAINTAINS","Homeostasis","Colonic Epithelial Cell"
"5918","35333576","m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-kappaB-mediated antiapoptotic pathway.","m6A","regulate","NF-kappaB","Colonic Epithelial Cell","m6A","AFFECTS","NF-kappaB signaling pathway","Colonic Epithelial Cell"
"5919","35333576","m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-kappaB-mediated antiapoptotic pathway.","NF-kappaB","mediate","Antiapoptotic Pathway","Colonic Epithelial Cell","NF-kappaB signaling pathway","AFFECTS","Antiapoptotic Pathway","Colonic Epithelial Cell"
"5920","35333576","m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-kappaB-mediated antiapoptotic pathway.","Antiapoptotic Pathway","maintain","Homeostasis","Colonic Epithelial Cell","Antiapoptotic Pathway","MAINTAINS","Homeostasis","Colonic Epithelial Cell"
"5922","35339477","CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy.","CircRNA CDR1as","promote","Cardiomyocyte Apoptosis","Diabetic Cardiomyopathy","CircRNA CDR1as","STIMULATES","Cardiomyocyte Apoptosis","Diabetic Cardiomyopathies"
"5923","35339477","CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy.","CircRNA CDR1as","activate","Hippo Signaling Pathway","Diabetic Cardiomyopathy","CircRNA CDR1as","STIMULATES","Hippo Signaling Pathway","Diabetic Cardiomyopathies"
"5924","35339477","CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy.","Hippo Signaling Pathway","regulate","Cardiomyocyte Apoptosis","Diabetic Cardiomyopathy","Hippo Signaling Pathway","AFFECTS","Cardiomyocyte Apoptosis","Diabetic Cardiomyopathies"
"5926","35340126","m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.","m6A","is on","DNMT3B","Intervertebral Disc","m6A","LOCATES","DNMT3B","Intervertebral Disc"
"5927","35340126","m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.","ALKBH5","regulate","m6A","Intervertebral Disc","ALKBH5","AFFECTS","m6A","Intervertebral Disc"
"5928","35340126","m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.","DNMT3B","promote","Intervertebral Disc Degeneration","Intervertebral Disc","DNMT3B","STIMULATES","Intervertebral Disc Degeneration","Intervertebral Disc"
"5929","35340126","m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.","DNMT3B","cause deficiency","E4F1","Intervertebral Disc","DNMT3B","cause deficiency","E4F1","Intervertebral Disc"
"5930","35340126","m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.","E4F1","regulate","Intervertebral Disc Degeneration","Intervertebral Disc","E4F1","AFFECTS","Intervertebral Disc Degeneration","Intervertebral Disc"
"5932","35346372","MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification.","MIR210HG","promote","Breast Cancer Progression","Breast Cancer","MIR210HG","STIMULATES","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"5933","35346372","MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification.","MIR210HG","regulate","IGF2BP1","Breast Cancer","MIR210HG","AFFECTS","IGF2BP1","BRCA(Breast Invasive Carcinoma)"
"5934","35346372","MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification.","IGF2BP1","mediate","m6A modification","Breast Cancer","IGF2BP1","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"5935","35346372","MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification.","m6A modification","promote","Breast Cancer Progression","Breast Cancer","m6A","STIMULATES","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"5937","35351467","METTL3 promotes proliferation and myogenic differentiation through m6A RNA methylation/YTHDF1/2 signaling axis in myoblasts.","METTL3","promote","Proliferation","Myoblasts","METTL3","STIMULATES","cell population proliferation","Myoblasts"
"5938","35351467","METTL3 promotes proliferation and myogenic differentiation through m6A RNA methylation/YTHDF1/2 signaling axis in myoblasts.","METTL3","promote","Myogenic Differentiation","Myoblasts","METTL3","STIMULATES","Myogenic Differentiation","Myoblasts"
"5939","35351467","METTL3 promotes proliferation and myogenic differentiation through m6A RNA methylation/YTHDF1/2 signaling axis in myoblasts.","METTL3","regulate","m6A RNA methylation/YTHDF1/2 signaling axis","Myoblasts","METTL3","AFFECTS","m6A/YTHDF1/2 signaling axis","Myoblasts"
"5940","35351467","METTL3 promotes proliferation and myogenic differentiation through m6A RNA methylation/YTHDF1/2 signaling axis in myoblasts.","m6A RNA methylation/YTHDF1/2 signaling axis","regulate","Proliferation","Myoblasts","m6A/YTHDF1/2 signaling axis","AFFECTS","cell population proliferation","Myoblasts"
"5941","35351467","METTL3 promotes proliferation and myogenic differentiation through m6A RNA methylation/YTHDF1/2 signaling axis in myoblasts.","m6A RNA methylation/YTHDF1/2 signaling axis","regulate","Myogenic Differentiation","Myoblasts","m6A/YTHDF1/2 signaling axis","AFFECTS","Myogenic Differentiation","Myoblasts"
"5943","35354439","METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy.","METTL3","enhance stability","NSD2 mRNA","Diabetic Nephropathy in mice","METTL3","enhance stability","NSD2","Diabetic Nephropathy in mice"
"5944","35354439","METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy.","NSD2 mRNA","reduce","renal impairment","Diabetic Nephropathy in mice","NSD2","INHIBITS","renal impairment","Diabetic Nephropathy in mice"
"5945","35354439","METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy.","NSD2 mRNA","reduce","interstitial fibrosis","Diabetic Nephropathy in mice","NSD2","INHIBITS","interstitial fibrosis","Diabetic Nephropathy in mice"
"5947","35354789","METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.","METTL14","inhibit","THBS1","Prostate Tumorigenesis","METTL14","INHIBITS","THBS1","PRAD(Prostate Adenocarcinoma)"
"5948","35354789","METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.","METTL14","regulate","m6A","Prostate Tumorigenesis","METTL14","AFFECTS","m6A","PRAD(Prostate Adenocarcinoma)"
"5949","35354789","METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.","YTHDF2","bind","m6A","Prostate Tumorigenesis","YTHDF2","INTERACTS_WITH","m6A","PRAD(Prostate Adenocarcinoma)"
"5950","35354789","METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.","m6A","inhibit","THBS1","Prostate Tumorigenesis","m6A","INHIBITS","THBS1","PRAD(Prostate Adenocarcinoma)"
"5952","35356854","N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis.","WTAP","stabilize","FOXD2-AS1","Osteosarcoma","WTAP","MAINTAINS","FOXD2-AS1","SARC(Sarcoma)"
"5953","35356854","N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis.","FOXD2-AS1","promote","Osteosarcoma Progression","Osteosarcoma","FOXD2-AS1","STIMULATES","Osteosarcoma Progression","SARC(Sarcoma)"
"5954","35356854","N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis.","FOXD2-AS1","regulate","m6A","Osteosarcoma","FOXD2-AS1","AFFECTS","m6A","SARC(Sarcoma)"
"5955","35356854","N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis.","m6A","is in","FOXM1 axis","Osteosarcoma","m6A","LOCATES","FOXM1 axis","SARC(Sarcoma)"
"5956","35356854","N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis.","FOXM1 axis","regulate","Osteosarcoma Progression","Osteosarcoma","FOXM1 axis","AFFECTS","Osteosarcoma Progression","SARC(Sarcoma)"
"5958","35356881","[METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m6A Myc expression].","METTL14","promote","Proliferation","Cervical Cancer Cells","METTL14","STIMULATES","cell population proliferation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5959","35356881","[METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m6A Myc expression].","METTL14","promote","Migration","Cervical Cancer Cells","METTL14","STIMULATES","migration","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5960","35356881","[METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m6A Myc expression].","METTL14","up-regulate","m6A","Cervical Cancer Cells","METTL14","STIMULATES","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5961","35356881","[METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m6A Myc expression].","m6A","is on","Myc","Cervical Cancer Cells","m6A","LOCATES","MYC","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5962","35356881","[METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m6A Myc expression].","Myc","regulate","Proliferation","Cervical Cancer Cells","MYC","AFFECTS","cell population proliferation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5963","35356881","[METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m6A Myc expression].","Myc","regulate","Migration","Cervical Cancer Cells","MYC","AFFECTS","migration","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"5965","35357550","LncRNA NEAT1 sponges miR-214 to promoted tumor growth in hepatocellular carcinoma.","NEAT1","sponge","miR-214","Hepatocellular Carcinoma","NEAT1","sponge","MIR214","LIHC(Liver Hepatocellular Carcinoma)"
"5966","35357550","LncRNA NEAT1 sponges miR-214 to promoted tumor growth in hepatocellular carcinoma.","NEAT1","promote","Tumor Growth","Hepatocellular Carcinoma","NEAT1","STIMULATES","Tumor Growth","LIHC(Liver Hepatocellular Carcinoma)"
"5967","35357550","LncRNA NEAT1 sponges miR-214 to promoted tumor growth in hepatocellular carcinoma.","miR-214","regulate","Tumor Growth","Hepatocellular Carcinoma","MIR214","AFFECTS","Tumor Growth","LIHC(Liver Hepatocellular Carcinoma)"
"5969","35359726","Vitamin D3 Suppresses Human Cytomegalovirus-Induced Vascular Endothelial Apoptosis via Rectification of Paradoxical m6A Modification of Mitochondrial Calcium Uniporter mRNA, Which Is Regulated by METTL3 and YTHDF3.","Vitamin D3","suppress","Apoptosis","Human Cytomegalovirus-Induced Vascular Endothelial Cells","calciol","INHIBITS","apoptotic process","Human Cytomegalovirus-Induced Vascular Endothelial Cells"
"5970","35359726","Vitamin D3 Suppresses Human Cytomegalovirus-Induced Vascular Endothelial Apoptosis via Rectification of Paradoxical m6A Modification of Mitochondrial Calcium Uniporter mRNA, Which Is Regulated by METTL3 and YTHDF3.","Vitamin D3","rectify","m6A","Human Cytomegalovirus-Induced Vascular Endothelial Cells","calciol","rectify","m6A","Human Cytomegalovirus-Induced Vascular Endothelial Cells"
"5971","35359726","Vitamin D3 Suppresses Human Cytomegalovirus-Induced Vascular Endothelial Apoptosis via Rectification of Paradoxical m6A Modification of Mitochondrial Calcium Uniporter mRNA, Which Is Regulated by METTL3 and YTHDF3.","m6A","modify","Mitochondrial Calcium Uniporter mRNA","Human Cytomegalovirus-Induced Vascular Endothelial Cells","m6A","AFFECTS","Mitochondrial Calcium Uniporter mRNA","Human Cytomegalovirus-Induced Vascular Endothelial Cells"
"5972","35359726","Vitamin D3 Suppresses Human Cytomegalovirus-Induced Vascular Endothelial Apoptosis via Rectification of Paradoxical m6A Modification of Mitochondrial Calcium Uniporter mRNA, Which Is Regulated by METTL3 and YTHDF3.","METTL3","regulate","m6A","Human Cytomegalovirus-Induced Vascular Endothelial Cells","METTL3","AFFECTS","m6A","Human Cytomegalovirus-Induced Vascular Endothelial Cells"
"5973","35359726","Vitamin D3 Suppresses Human Cytomegalovirus-Induced Vascular Endothelial Apoptosis via Rectification of Paradoxical m6A Modification of Mitochondrial Calcium Uniporter mRNA, Which Is Regulated by METTL3 and YTHDF3.","YTHDF3","regulate","m6A","Human Cytomegalovirus-Induced Vascular Endothelial Cells","YTHDF3","AFFECTS","m6A","Human Cytomegalovirus-Induced Vascular Endothelial Cells"
"5974","35359726","Vitamin D3 Suppresses Human Cytomegalovirus-Induced Vascular Endothelial Apoptosis via Rectification of Paradoxical m6A Modification of Mitochondrial Calcium Uniporter mRNA, Which Is Regulated by METTL3 and YTHDF3.","Mitochondrial Calcium Uniporter mRNA","regulate","Apoptosis","Human Cytomegalovirus-Induced Vascular Endothelial Cells","Mitochondrial Calcium Uniporter mRNA","AFFECTS","apoptotic process","Human Cytomegalovirus-Induced Vascular Endothelial Cells"
"5976","35361747","Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.","Aurora kinase A","switch","YTHDC1","Nucleus","AURKA","switch","YTHDC1","nucleus"
"5977","35361747","Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.","YTHDC1","bind","m6A","Nucleus","YTHDC1","INTERACTS_WITH","m6A","nucleus"
"5978","35361747","Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.","YTHDC1","enhance","oncogenic RNA splicing","Nucleus","YTHDC1","AUGMENTS","oncogenic RNA splicing","nucleus"
"5979","35361747","Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.","oncogenic RNA splicing","is on","RBM4","Nucleus","oncogenic RNA splicing","LOCATES","RBM4","nucleus"
"5981","35364458","HNRNPA2B1 inhibited SFRP2 and activated Wnt-beta/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.","HNRNPA2B1","inhibit","SFRP2","Lung Adenocarcinoma","HNRNPA2B1","INHIBITS","SFRP2","LUAD(Lung Adenocarcinoma)"
"5982","35364458","HNRNPA2B1 inhibited SFRP2 and activated Wnt-beta/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.","HNRNPA2B1","activate","Wnt-beta/catenin","Lung Adenocarcinoma","HNRNPA2B1","STIMULATES","WNT/beta-catenin pathway","LUAD(Lung Adenocarcinoma)"
"5983","35364458","HNRNPA2B1 inhibited SFRP2 and activated Wnt-beta/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.","HNRNPA2B1","regulate","m6A","Lung Adenocarcinoma","HNRNPA2B1","AFFECTS","m6A","LUAD(Lung Adenocarcinoma)"
"5984","35364458","HNRNPA2B1 inhibited SFRP2 and activated Wnt-beta/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.","m6A","mediate","miR-106b-5p","Lung Adenocarcinoma","m6A","AFFECTS","miR-106b-5p","LUAD(Lung Adenocarcinoma)"
"5985","35364458","HNRNPA2B1 inhibited SFRP2 and activated Wnt-beta/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.","miR-106b-5p","regulate","stemness","Lung Adenocarcinoma","miR-106b-5p","AFFECTS","Stemness","LUAD(Lung Adenocarcinoma)"
"5987","35365563","Mettl14-Mediated m6A Modification Is Essential for Germinal Center B Cell Response.","Mettl14","mediate","m6A Modification","Germinal Center B Cell","METTL14","AFFECTS","m6A","germinal center b cell"
"5988","35365563","Mettl14-Mediated m6A Modification Is Essential for Germinal Center B Cell Response.","m6A Modification","is essential for","B Cell Response","Germinal Center B Cell","m6A","PREDISPOSES","B Cell Response","germinal center b cell"
"5990","35368867","Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer.","Dietary Phytochemicals","target","Nrf2","Cancer","Phytochemicals","INTERACTS_WITH","NFE2L2","PANCAN(Pan-Cancer)"
"5991","35368867","Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer.","Nrf2","enhance","Radiosensitivity","Cancer","NFE2L2","AUGMENTS","Radiation Tolerance","PANCAN(Pan-Cancer)"
"5993","35378463","Novel electrochemical immunosensor for O6-methylguanine-DNA methyltransferase gene methylation based on graphene oxide-magnetic nanoparticles-beta-cyclodextrin nanocomposite.","electrochemical immunosensor","for","O6-methylguanine-DNA methyltransferase gene methylation","Null","electrochemical immunosensor","for","O6-methylguanine-DNA methyltransferase gene methylation","Null"
"5994","35378463","Novel electrochemical immunosensor for O6-methylguanine-DNA methyltransferase gene methylation based on graphene oxide-magnetic nanoparticles-beta-cyclodextrin nanocomposite.","graphene oxide-magnetic nanoparticles-beta-cyclodextrin nanocomposite","based on","electrochemical immunosensor","Null","graphene oxide-magnetic nanoparticles-beta-cyclodextrin nanocomposite","based on","electrochemical immunosensor","Null"
"5996","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","Dummy","activate","RBM15","Clear Cell Renal Cell Carcinoma","dummy","STIMULATES","RBM15","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5997","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","RBM15","promote","Growth","Clear Cell Renal Cell Carcinoma","RBM15","STIMULATES","Growth","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5998","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","RBM15","promote","Metastasis","Clear Cell Renal Cell Carcinoma","RBM15","STIMULATES","Neoplasm Metastasis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"5999","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","RBM15","promote","Macrophage Infiltration","Clear Cell Renal Cell Carcinoma","RBM15","STIMULATES","Macrophage Infiltration","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6000","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","RBM15","regulate","m6A","Clear Cell Renal Cell Carcinoma","RBM15","AFFECTS","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6001","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","m6A","is on","CXCL11","Clear Cell Renal Cell Carcinoma","m6A","LOCATES","CXCL11","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6002","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","CXCL11","regulate","Growth","Clear Cell Renal Cell Carcinoma","CXCL11","AFFECTS","Growth","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6003","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","CXCL11","regulate","Metastasis","Clear Cell Renal Cell Carcinoma","CXCL11","AFFECTS","Neoplasm Metastasis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6004","35381326","Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.","CXCL11","regulate","Macrophage Infiltration","Clear Cell Renal Cell Carcinoma","CXCL11","AFFECTS","Macrophage Infiltration","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6006","35383152","The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2.","MIAT","regulate","CPT-1a","Cardiac Hypertrophy","MIAT","AFFECTS","CPT1A","Cardiac Hypertrophy"
"6007","35383152","The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2.","CPT-1a","mediate","Cardiac Hypertrophy","Cardiac Hypertrophy","CPT1A","AFFECTS","Cardiac Hypertrophy","Cardiac Hypertrophy"
"6008","35383152","The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2.","Ythdf2","bind","m6A","Cardiac Hypertrophy","YTHDF2","INTERACTS_WITH","m6A","Cardiac Hypertrophy"
"6010","35395767","The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKepsilon/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.","ALKBH5","promote","Tumor Progression","Head and Neck Squamous Cell Carcinoma","ALKBH5","STIMULATES","Tumor Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6011","35395767","The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKepsilon/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.","ALKBH5","inhibit","RIG-I","Head and Neck Squamous Cell Carcinoma","ALKBH5","INHIBITS","DDX58","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6012","35395767","The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKepsilon/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.","ALKBH5","inhibit","Interferon alpha","Head and Neck Squamous Cell Carcinoma","ALKBH5","INHIBITS","Interferon-alpha","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6013","35395767","The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKepsilon/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.","ALKBH5","regulate","IKKepsilon/TBK1/IRF3 pathway","Head and Neck Squamous Cell Carcinoma","ALKBH5","AFFECTS","IKKepsilon/TBK1/IRF3 pathway","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6014","35395767","The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKepsilon/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.","IKKepsilon/TBK1/IRF3 pathway","regulate","RIG-I","Head and Neck Squamous Cell Carcinoma","IKKepsilon/TBK1/IRF3 pathway","AFFECTS","DDX58","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6015","35395767","The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKepsilon/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.","IKKepsilon/TBK1/IRF3 pathway","regulate","Interferon alpha","Head and Neck Squamous Cell Carcinoma","IKKepsilon/TBK1/IRF3 pathway","AFFECTS","Interferon-alpha","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6017","35396379","METTL3 stabilizes HDAC5 mRNA in an m6A-dependent manner to facilitate malignant proliferation of osteosarcoma cells.","METTL3","stabilize","HDAC5 mRNA","Osteosarcoma Cells","METTL3","MAINTAINS","HDAC5","SARC(Sarcoma)"
"6018","35396379","METTL3 stabilizes HDAC5 mRNA in an m6A-dependent manner to facilitate malignant proliferation of osteosarcoma cells.","METTL3","regulate","m6A","Osteosarcoma Cells","METTL3","AFFECTS","m6A","SARC(Sarcoma)"
"6019","35396379","METTL3 stabilizes HDAC5 mRNA in an m6A-dependent manner to facilitate malignant proliferation of osteosarcoma cells.","HDAC5 mRNA","facilitate","Malignant Proliferation","Osteosarcoma Cells","HDAC5","AUGMENTS","Malignant Proliferation","SARC(Sarcoma)"
"6021","35397614","N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability.","FTO","suppress","Prostate Cancer Progression","Prostate Cancer","FTO","INHIBITS","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"6022","35397614","N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability.","FTO","maintain","CLIC4 mRNA","Prostate Cancer","FTO","MAINTAINS","CLIC4","PRAD(Prostate Adenocarcinoma)"
"6023","35397614","N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability.","CLIC4 mRNA","regulate","Prostate Cancer Progression","Prostate Cancer","CLIC4","AFFECTS","Prostate Cancer Progression","PRAD(Prostate Adenocarcinoma)"
"6025","35398093","Solution structure ensemble of human obesity-associated protein FTO reveals druggable surface pockets at the interface between the N- and C-terminal domain.","FTO","reveal","surface pockets","Human obesity-associated protein FTO","FTO","reveal","surface pockets","Human obesity-associated protein FTO"
"6026","35398093","Solution structure ensemble of human obesity-associated protein FTO reveals druggable surface pockets at the interface between the N- and C-terminal domain.","surface pockets","is at","the interface between the N- and C-terminal domain","Human obesity-associated protein FTO","surface pockets","is at","the interface between the N- and C-terminal domain","Human obesity-associated protein FTO"
"6028","35402071","m6A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1.","m6A","repress","SIAH1","Null","m6A","INHIBITS","SIAH1","Null"
"6029","35402071","m6A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1.","SIAH1","facilitate","Alternative Splicing","Null","SIAH1","AUGMENTS","Alternative Splicing","Null"
"6030","35402071","m6A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1.","Alternative Splicing","is of","Androgen Receptor Variant 7","Null","Alternative Splicing","is of","Androgen Receptor Variant 7","Null"
"6031","35402071","m6A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1.","SIAH1","regulate","CPSF1","Null","SIAH1","AFFECTS","CPSF1","Null"
"6032","35402071","m6A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1.","CPSF1","regulate","Alternative Splicing","Null","CPSF1","AFFECTS","Alternative Splicing","Null"
"6034","37223505","N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.","N6-methyladenosine","modify","LINC00901","Pancreatic Cancer","m6A","AFFECTS","LINC00901","PAAD(Pancreatic Adenocarcinoma)"
"6035","37223505","N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.","LINC00901","promote","Pancreatic Cancer Progression","Pancreatic Cancer","LINC00901","STIMULATES","Pancreatic Cancer Progression","PAAD(Pancreatic Adenocarcinoma)"
"6036","37223505","N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.","LINC00901","regulate","IGF2BP2/MYC axis","Pancreatic Cancer","LINC00901","AFFECTS","IGF2BP2/MYC axis","PAAD(Pancreatic Adenocarcinoma)"
"6037","37223505","N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.","IGF2BP2/MYC axis","promote","Pancreatic Cancer Progression","Pancreatic Cancer","IGF2BP2/MYC axis","STIMULATES","Pancreatic Cancer Progression","PAAD(Pancreatic Adenocarcinoma)"
"6039","35246004","Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3 -mediated NLR family pyrin domain containing 3 expression.","Emodin","relieve","Inflammation","1321N1 cells","emodin","relieve","inflammatory response","1321N1 cells"
"6040","35246004","Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3 -mediated NLR family pyrin domain containing 3 expression.","Emodin","relieve","Pyroptosis","1321N1 cells","emodin","relieve","pyroptosis","1321N1 cells"
"6041","35246004","Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3 -mediated NLR family pyrin domain containing 3 expression.","Emodin","regulate","METTL3","1321N1 cells","emodin","AFFECTS","METTL3","1321N1 cells"
"6042","35246004","Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3 -mediated NLR family pyrin domain containing 3 expression.","METTL3","mediate","NLRP3","1321N1 cells","METTL3","AFFECTS","NLRP3","1321N1 cells"
"6043","35246004","Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3 -mediated NLR family pyrin domain containing 3 expression.","NLRP3","regulate","Inflammation","1321N1 cells","NLRP3","AFFECTS","inflammatory response","1321N1 cells"
"6044","35246004","Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3 -mediated NLR family pyrin domain containing 3 expression.","NLRP3","regulate","Pyroptosis","1321N1 cells","NLRP3","AFFECTS","pyroptosis","1321N1 cells"
"6046","35249103","METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.","METTL14","mediate","N6-methyladenosine modification","Clear-cell Renal Cell Carcinoma","METTL14","AFFECTS","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6047","35249103","METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.","N6-methyladenosine modification","is on","Pten mRNA","Clear-cell Renal Cell Carcinoma","m6A","LOCATES","PTEN","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6048","35249103","METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.","Pten mRNA","inhibit","Tumor Progression","Clear-cell Renal Cell Carcinoma","PTEN","INHIBITS","Tumor Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6050","35255992","Chronic corticosterone disrupts the circadian rhythm of CRH expression and m6A RNA methylation in the chicken hypothalamus.","Chronic corticosterone","disrupt","circadian rhythm","Chicken hypothalamus","Chronic corticosterone","DISRUPTS","circadian rhythm","Chicken hypothalamus"
"6051","35255992","Chronic corticosterone disrupts the circadian rhythm of CRH expression and m6A RNA methylation in the chicken hypothalamus.","circadian rhythm","regulate","CRH expression","Chicken hypothalamus","circadian rhythm","AFFECTS","CRH expression","Chicken hypothalamus"
"6052","35255992","Chronic corticosterone disrupts the circadian rhythm of CRH expression and m6A RNA methylation in the chicken hypothalamus.","circadian rhythm","regulate","m6A RNA methylation","Chicken hypothalamus","circadian rhythm","AFFECTS","m6A","Chicken hypothalamus"
"6054","35256595","Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.","N6AMT1","reduce","6mA DNA modification","Breast Tumor","N6AMT1","INHIBITS","6mA DNA modification","BRCA(Breast Invasive Carcinoma)"
"6055","35256595","Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.","6mA DNA modification","promote","Tumor Progression","Breast Tumor","6mA DNA modification","STIMULATES","Tumor Progression","BRCA(Breast Invasive Carcinoma)"
"6056","35256595","Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.","6mA DNA modification","induce","transcriptional repression","Breast Tumor","6mA DNA modification","CAUSES","transcriptional repression","BRCA(Breast Invasive Carcinoma)"
"6057","35256595","Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.","transcriptional repression","repress","cell cycle inhibitors","Breast Tumor","transcriptional repression","INHIBITS","cell cycle inhibitors","BRCA(Breast Invasive Carcinoma)"
"6058","35256595","Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.","cell cycle inhibitors","regulate","Tumor Progression","Breast Tumor","cell cycle inhibitors","AFFECTS","Tumor Progression","BRCA(Breast Invasive Carcinoma)"
"6060","35256950","A novel inhibitor of N 6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities.","Inhibitor","inhibit","FTO","Null","inhibitor","INHIBITS","FTO","Null"
"6061","35256950","A novel inhibitor of N 6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities.","Inhibitor","induce","mRNA methylation","Null","inhibitor","CAUSES","mRNA methylation","Null"
"6062","35256950","A novel inhibitor of N 6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities.","Inhibitor","show","anti-cancer activities","Null","inhibitor","show","anti-cancer activities","Null"
"6064","35261206","m6 A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels.","m6A","regulate","PBX1-GCH1 axis","Gastric Cancer","m6A","AFFECTS","PBX1-GCH1 axis","STAD(Stomach adenocarcinoma)"
"6065","35261206","m6 A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels.","PBX1-GCH1 axis","elevate","Tetrahydrobiopterin","Gastric Cancer","PBX1-GCH1 axis","STIMULATES","5,6,7,8-tetrahydrobiopterin","STAD(Stomach adenocarcinoma)"
"6066","35261206","m6 A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels.","Tetrahydrobiopterin","promote","Gastric Cancer Proliferation","Gastric Cancer","5,6,7,8-tetrahydrobiopterin","STIMULATES","Gastric Cancer Proliferation","STAD(Stomach adenocarcinoma)"
"6067","35261206","m6 A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels.","Tetrahydrobiopterin","promote","Metastasis","Gastric Cancer","5,6,7,8-tetrahydrobiopterin","STIMULATES","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"6068","35261206","m6 A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels.","PBX1-GCH1 axis","promote","Gastric Cancer Proliferation","Gastric Cancer","PBX1-GCH1 axis","STIMULATES","Gastric Cancer Proliferation","STAD(Stomach adenocarcinoma)"
"6069","35261206","m6 A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels.","PBX1-GCH1 axis","promote","Metastasis","Gastric Cancer","PBX1-GCH1 axis","STIMULATES","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"6071","35264707","LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma.","MAPKAPK5_AS1","facilitate","cell proliferation","Hepatitis B virus-related Hepatocellular Carcinoma","MAPKAPK5_AS1","AUGMENTS","cell population proliferation","LIHC(Liver Hepatocellular Carcinoma)"
"6073","35266112","rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N6-methyladenosine-dependent E2F3/E2F6 mRNA stability.","E2F","promote","Self-renewal","Liver Tumor-Initiating Cells","E2F","STIMULATES","Self-Renewal","LIHC(Liver Hepatocellular Carcinoma)"
"6074","35266112","rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N6-methyladenosine-dependent E2F3/E2F6 mRNA stability.","E2F","promote","Metastasis","Liver Tumor-Initiating Cells","E2F","STIMULATES","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"6075","35266112","rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N6-methyladenosine-dependent E2F3/E2F6 mRNA stability.","E2F","regulate","N6-methyladenosine","Liver Tumor-Initiating Cells","E2F","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"6076","35266112","rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N6-methyladenosine-dependent E2F3/E2F6 mRNA stability.","N6-methyladenosine","regulate","E2F3/E2F6 mRNA stability","Liver Tumor-Initiating Cells","m6A","AFFECTS","E2F3/E2F6 mRNA stability","LIHC(Liver Hepatocellular Carcinoma)"
"6077","35266112","rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N6-methyladenosine-dependent E2F3/E2F6 mRNA stability.","E2F3/E2F6 mRNA stability","regulate","Self-renewal","Liver Tumor-Initiating Cells","E2F3/E2F6 mRNA stability","AFFECTS","Self-Renewal","LIHC(Liver Hepatocellular Carcinoma)"
"6078","35266112","rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N6-methyladenosine-dependent E2F3/E2F6 mRNA stability.","E2F3/E2F6 mRNA stability","regulate","Metastasis","Liver Tumor-Initiating Cells","E2F3/E2F6 mRNA stability","AFFECTS","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"6080","35273176","Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis.","Fusobacterium nucleatum","reduce","METTL3","Colorectal Cancer","Fusobacterium nucleatum","INHIBITS","METTL3","COAD(Colon Adenocarcinoma)"
"6081","35273176","Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis.","METTL3","mediate","m6A","Colorectal Cancer","METTL3","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"6082","35273176","Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis.","Fusobacterium nucleatum","contribute","metastasis","Colorectal Cancer","Fusobacterium nucleatum","AFFECTS","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"6083","35273176","Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis.","m6A","regulate","metastasis","Colorectal Cancer","m6A","AFFECTS","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"6085","35278676","PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.","PRMT5","regulate","RNA m6A","Breast Cancer","PRMT5","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"6086","35278676","PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.","RNA m6A","regulate","doxorubicin sensitivity","Breast Cancer","m6A","AFFECTS","doxorubicin sensitivity","BRCA(Breast Invasive Carcinoma)"
"6087","35278676","PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.","PRMT5","regulate","doxorubicin sensitivity","Breast Cancer","PRMT5","AFFECTS","doxorubicin sensitivity","BRCA(Breast Invasive Carcinoma)"
"6089","35279083","ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1.","ALKBH5","promote","Activation","Lung Fibroblast","ALKBH5","STIMULATES","activation","Lung Fibroblast"
"6090","35279083","ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1.","ALKBH5","regulate","miR-320a-3p","Lung Fibroblast","ALKBH5","AFFECTS","miR-320a-3p","Lung Fibroblast"
"6091","35279083","ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1.","miR-320a-3p","target","FOXM1","Lung Fibroblast","miR-320a-3p","INTERACTS_WITH","FOXM1","Lung Fibroblast"
"6092","35279083","ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1.","FOXM1","regulate","Activation","Lung Fibroblast","FOXM1","AFFECTS","activation","Lung Fibroblast"
"6094","35279688","YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance.","YTHDF1","promote","Breast Cancer Cell Growth","Breast Cancer Cells","YTHDF1","STIMULATES","Breast Cancer Cell Growth","BRCA(Breast Invasive Carcinoma)"
"6095","35279688","YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance.","YTHDF1","promote","DNA Damage Repair","Breast Cancer Cells","YTHDF1","STIMULATES","DNA Damage Repair","BRCA(Breast Invasive Carcinoma)"
"6096","35279688","YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance.","YTHDF1","promote","Chemoresistance","Breast Cancer Cells","YTHDF1","STIMULATES","Chemoresistance","BRCA(Breast Invasive Carcinoma)"
"6098","35282088","YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner.","YTHDF3","facilitate","Cancer Progression","Triple-negative Breast Cancer","YTHDF3","AUGMENTS","Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"6099","35282088","YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner.","YTHDF3","stabilize","ZEB1 mRNA","Triple-negative Breast Cancer","YTHDF3","MAINTAINS","ZEB1","BRCA(Breast Invasive Carcinoma)"
"6100","35282088","YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner.","m6A","is on","ZEB1 mRNA","Triple-negative Breast Cancer","m6A","LOCATES","ZEB1","BRCA(Breast Invasive Carcinoma)"
"6101","35282088","YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner.","ZEB1 mRNA","regulate","Cancer Progression","Triple-negative Breast Cancer","ZEB1","AFFECTS","Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"6103","35284536","Methyltransferase-like 3 upregulation is involved in the chemoresistance of non-small cell lung cancer.","Methyltransferase-like 3","involve","chemoresistance","Non-small cell lung cancer","METTL3","ASSOCIATED_WITH","chemoresistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"6105","35287752","METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.","METTL3","modulate","m6A","Head and Neck Squamous Cell Carcinoma","METTL3","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6106","35287752","METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.","m6A","is on","CDC25B","Head and Neck Squamous Cell Carcinoma","m6A","LOCATES","CDC25B","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6107","35287752","METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.","METTL3","promote","Malignant Progression","Head and Neck Squamous Cell Carcinoma","METTL3","STIMULATES","Malignant Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6108","35287752","METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.","CDC25B","regulate","Malignant Progression","Head and Neck Squamous Cell Carcinoma","CDC25B","AFFECTS","Malignant Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6110","35289035","FTO Regulates Arecoline-exposed Oral Cancer Immune Response through PD-L1.","FTO","regulate","PD-L1","Oral Cancer","FTO","AFFECTS","CD274","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6111","35289035","FTO Regulates Arecoline-exposed Oral Cancer Immune Response through PD-L1.","PD-L1","regulate","Immune Response","Oral Cancer","CD274","AFFECTS","immune response","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6112","35289035","FTO Regulates Arecoline-exposed Oral Cancer Immune Response through PD-L1.","Arecoline","expose","FTO","Oral Cancer","arecoline","expose","FTO","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6114","35304463","WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration.","WTAP","mediate","m6A","Intervertebral disc","WTAP","AFFECTS","m6A","Intervertebral Disc"
"6115","35304463","WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration.","m6A","modify","lncRNA NORAD","Intervertebral disc","m6A","AFFECTS","NORAD","Intervertebral Disc"
"6116","35304463","WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration.","lncRNA NORAD","promote","intervertebral disc degeneration","Intervertebral disc","NORAD","STIMULATES","Intervertebral Disc Degeneration","Intervertebral Disc"
"6118","35305312","The XRN1-regulated RNA helicase activity of YTHDC2 ensures mouse fertility independently of m6A recognition.","XRN1","regulate","RNA helicase activity of YTHDC2","Mouse Fertility","XRN1","AFFECTS","RNA helicase activity of YTHDC2","Mouse Fertility"
"6120","35305647","The N6-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p/PGF signalling pathway.","N6-methyladenosine modification of circALG1","promote","metastasis","Colorectal Cancer","m6A modification of circALG1","STIMULATES","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"6121","35305647","The N6-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p/PGF signalling pathway.","N6-methyladenosine modification of circALG1","mediate","miR-342-5p/PGF signalling pathway","Colorectal Cancer","m6A modification of circALG1","AFFECTS","miR-342-5p/PGF signalling pathway","COAD(Colon Adenocarcinoma)"
"6122","35305647","The N6-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p/PGF signalling pathway.","miR-342-5p/PGF signalling pathway","promote","metastasis","Colorectal Cancer","miR-342-5p/PGF signalling pathway","STIMULATES","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"6124","35305660","METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma.","METTL14","mediate","N6-methyladenosine modification","Clear Cell Renal Cell Carcinoma","METTL14","AFFECTS","m6A","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6125","35305660","METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma.","N6-methyladenosine modification","is on","ITGB4 mRNA","Clear Cell Renal Cell Carcinoma","m6A","LOCATES","ITGB4","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6126","35305660","METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma.","ITGB4 mRNA","inhibit","metastasis","Clear Cell Renal Cell Carcinoma","ITGB4","INHIBITS","Neoplasm Metastasis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6127","35305660","METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma.","N6-methyladenosine modification","inhibit","metastasis","Clear Cell Renal Cell Carcinoma","m6A","INHIBITS","Neoplasm Metastasis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6129","35306138","IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway.","IGF2BP2","promote","Gastric Cancer Progression","Gastric Cancer","IGF2BP2","STIMULATES","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"6130","35306138","IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway.","IGF2BP2","regulate","IGF1R-RhoA-ROCK signaling pathway","Gastric Cancer","IGF2BP2","AFFECTS","IGF1R-RhoA-ROCK signaling pathway","STAD(Stomach adenocarcinoma)"
"6131","35306138","IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway.","IGF1R-RhoA-ROCK signaling pathway","promote","Gastric Cancer Progression","Gastric Cancer","IGF1R-RhoA-ROCK signaling pathway","STIMULATES","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"6133","35311620","Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kruppel-like factor 3 (KLF3) promotes osteosarcoma progression.","FTO","mediate","N6-methyladenosine","Osteosarcoma","FTO","AFFECTS","m6A","SARC(Sarcoma)"
"6134","35311620","Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kruppel-like factor 3 (KLF3) promotes osteosarcoma progression.","N6-methyladenosine","modify","KLF3","Osteosarcoma","m6A","AFFECTS","KLF3","SARC(Sarcoma)"
"6135","35311620","Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kruppel-like factor 3 (KLF3) promotes osteosarcoma progression.","KLF3","promote","Osteosarcoma Progression","Osteosarcoma","KLF3","STIMULATES","Osteosarcoma Progression","SARC(Sarcoma)"
"6136","35311620","Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kruppel-like factor 3 (KLF3) promotes osteosarcoma progression.","N6-methyladenosine","regulate","Osteosarcoma Progression","Osteosarcoma","m6A","AFFECTS","Osteosarcoma Progression","SARC(Sarcoma)"
"6138","35317283","SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner.","SPI1","downregulate","FTO","GBM","SPI1","INHIBITS","FTO","GBM(Glioblastoma Multiforme)"
"6139","35317283","SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner.","FTO","promote","GBM progression","GBM","FTO","STIMULATES","GBM progression","GBM(Glioblastoma Multiforme)"
"6140","35317283","SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner.","FTO","regulate","pri-miR-10a","GBM","FTO","AFFECTS","pri-miR-10a","GBM(Glioblastoma Multiforme)"
"6141","35317283","SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner.","pri-miR-10a","undergo","processing","GBM","pri-miR-10a","undergo","processing","GBM(Glioblastoma Multiforme)"
"6142","35317283","SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner.","m6A","regulate","processing","GBM","m6A","AFFECTS","processing","GBM(Glioblastoma Multiforme)"
"6143","35317283","SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner.","processing","regulate","GBM progression","GBM","processing","AFFECTS","GBM progression","GBM(Glioblastoma Multiforme)"
"6145","35318034","ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner.","ALKBH5","ameliorate","Liver Fibrosis","Liver","ALKBH5","TREATS","Liver Cirrhosis","Liver"
"6146","35318034","ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner.","ALKBH5","suppress","HSCs activation","Liver","ALKBH5","INHIBITS","HSCs activation","Liver"
"6147","35318034","ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner.","ALKBH5","trigger","PTCH1 activation","Liver","ALKBH5","CAUSES","PTCH1 activation","Liver"
"6148","35318034","ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner.","ALKBH5","regulate","m6A","Liver","ALKBH5","AFFECTS","m6A","Liver"
"6149","35318034","ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner.","PTCH1 activation","regulate","Liver Fibrosis","Liver","PTCH1 activation","AFFECTS","Liver Cirrhosis","Liver"
"6150","35318034","ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner.","PTCH1 activation","suppress","HSCs activation","Liver","PTCH1 activation","INHIBITS","HSCs activation","Liver"
"6152","35154166","Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor Activity.","SIAH2","decrease","PD-L1","Cholangiocarcinoma","SIAH2","INHIBITS","CD274","CHOL(Cholangiocarcinoma)"
"6153","35154166","Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor Activity.","PD-L1","enhance","T-Cell-Mediated Antitumor Activity","Cholangiocarcinoma","CD274","AUGMENTS","T-Cell-Mediated Antitumor Activity","CHOL(Cholangiocarcinoma)"
"6155","35154467","The m6A RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in acute myeloid leukemia.","METTL3/METTL14","promote","leukemogenesis","Acute Myeloid Leukemia","METTL3/METTL14","STIMULATES","Leukemogenesis","LAML(Acute Myeloid Leukemia)"
"6156","35154467","The m6A RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in acute myeloid leukemia.","METTL3/METTL14","regulate","mdm2/p53 pathway","Acute Myeloid Leukemia","METTL3/METTL14","AFFECTS","MDM2-p53 pathway","LAML(Acute Myeloid Leukemia)"
"6157","35154467","The m6A RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in acute myeloid leukemia.","mdm2/p53 pathway","regulate","leukemogenesis","Acute Myeloid Leukemia","MDM2-p53 pathway","AFFECTS","Leukemogenesis","LAML(Acute Myeloid Leukemia)"
"6159","35156522","Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).","YTHDF1","regulate","Proliferation","Osteosarcoma","YTHDF1","AFFECTS","cell population proliferation","SARC(Sarcoma)"
"6160","35156522","Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).","YTHDF1","regulate","Migration","Osteosarcoma","YTHDF1","AFFECTS","migration","SARC(Sarcoma)"
"6161","35156522","Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).","YTHDF1","regulate","Invasion","Osteosarcoma","YTHDF1","AFFECTS","Neoplasm Invasiveness","SARC(Sarcoma)"
"6162","35156522","Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).","YTHDF1","regulate","m6A","Osteosarcoma","YTHDF1","AFFECTS","m6A","SARC(Sarcoma)"
"6163","35156522","Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).","m6A","is on","CNOT7","Osteosarcoma","m6A","LOCATES","CNOT7","SARC(Sarcoma)"
"6164","35156522","Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).","CNOT7","regulate","Proliferation","Osteosarcoma","CNOT7","AFFECTS","cell population proliferation","SARC(Sarcoma)"
"6165","35156522","Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).","CNOT7","regulate","Migration","Osteosarcoma","CNOT7","AFFECTS","migration","SARC(Sarcoma)"
"6166","35156522","Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).","CNOT7","regulate","Invasion","Osteosarcoma","CNOT7","AFFECTS","Neoplasm Invasiveness","SARC(Sarcoma)"
"6168","35165263","Dynamic FMR1 granule phase switch instructed by m6A modification contributes to maternal RNA decay.","m6A modification","instruct","FMR1 granule phase switch","Null","m6A","instruct","FMR1 granule phase switch","Null"
"6169","35165263","Dynamic FMR1 granule phase switch instructed by m6A modification contributes to maternal RNA decay.","FMR1 granule phase switch","contribute","decay","Null","FMR1 granule phase switch","AFFECTS","decay","Null"
"6170","35165263","Dynamic FMR1 granule phase switch instructed by m6A modification contributes to maternal RNA decay.","decay","is on","maternal RNA","Null","decay","LOCATES","maternal RNA","Null"
"6171","35165263","Dynamic FMR1 granule phase switch instructed by m6A modification contributes to maternal RNA decay.","m6A modification","regulate","decay","Null","m6A","AFFECTS","decay","Null"
"6173","35172162","TBK1-METTL3 axis facilitates antiviral immunity.","TBK1-METTL3 axis","facilitate","antiviral immunity","Null","TBK1-METTL3 axis","AUGMENTS","antiviral immunity","Null"
"6175","35173309","LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.","LINC01021","maintain","tumorigenicity","Colorectal Cancer","PURPL","MAINTAINS","Tumorigenicity","COAD(Colon Adenocarcinoma)"
"6176","35173309","LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.","LINC01021","enhance","IMP2","Colorectal Cancer","PURPL","AUGMENTS","IMMP2L","COAD(Colon Adenocarcinoma)"
"6177","35173309","LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.","IMP2","bind","N6-methyladenosine","Colorectal Cancer","IMMP2L","INTERACTS_WITH","m6A","COAD(Colon Adenocarcinoma)"
"6178","35173309","LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.","IMP2","stabilize","MSX1","Colorectal Cancer","IMMP2L","MAINTAINS","MSX1","COAD(Colon Adenocarcinoma)"
"6179","35173309","LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.","IMP2","stabilize","JARID2","Colorectal Cancer","IMMP2L","MAINTAINS","JARID2","COAD(Colon Adenocarcinoma)"
"6180","35173309","LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.","MSX1","regulate","tumorigenicity","Colorectal Cancer","MSX1","AFFECTS","Tumorigenicity","COAD(Colon Adenocarcinoma)"
"6181","35173309","LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.","JARID2","regulate","tumorigenicity","Colorectal Cancer","JARID2","AFFECTS","Tumorigenicity","COAD(Colon Adenocarcinoma)"
"6183","35174450","The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer.","hub ten gene-based risk score system","use","RNA m6A methylation regulator features","Breast Cancer","hub ten gene-based risk score system","USES","m6A","BRCA(Breast Invasive Carcinoma)"
"6184","35174450","The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer.","RNA m6A methylation regulator features","is in","tumor immune microenvironment","Breast Cancer","m6A","LOCATES","Tumor Immune Microenvironment","BRCA(Breast Invasive Carcinoma)"
"6186","35176453","METTL3 regulates LPS-induced inflammatory response via the NOD1 signaling pathway.","METTL3","regulate","LPS-induced inflammatory response","Null","METTL3","AFFECTS","LPS-induced inflammatory response","Null"
"6187","35176453","METTL3 regulates LPS-induced inflammatory response via the NOD1 signaling pathway.","METTL3","regulate","NOD1 signaling pathway","Null","METTL3","AFFECTS","nucleotide-binding oligomerization domain containing 1 signaling pathway","Null"
"6188","35176453","METTL3 regulates LPS-induced inflammatory response via the NOD1 signaling pathway.","NOD1 signaling pathway","regulate","LPS-induced inflammatory response","Null","nucleotide-binding oligomerization domain containing 1 signaling pathway","AFFECTS","LPS-induced inflammatory response","Null"
"6189","35176453","METTL3 regulates LPS-induced inflammatory response via the NOD1 signaling pathway.","NOD1","part of","NOD1 signaling pathway","Null","NOD1","PART_OF","nucleotide-binding oligomerization domain containing 1 signaling pathway","Null"
"6191","35176940","m6A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury.","FTO","regulate","Apoptosis","Ischemia-reperfusion injury","FTO","AFFECTS","apoptotic process","Reperfusion Injury"
"6192","35176940","m6A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury.","FTO","regulate","Inflammation","Ischemia-reperfusion injury","FTO","AFFECTS","inflammatory response","Reperfusion Injury"
"6193","35176940","m6A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury.","FTO","regulate","YAP1","Ischemia-reperfusion injury","FTO","AFFECTS","YAP1","Reperfusion Injury"
"6194","35176940","m6A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury.","YAP1","regulate","Apoptosis","Ischemia-reperfusion injury","YAP1","AFFECTS","apoptotic process","Reperfusion Injury"
"6195","35176940","m6A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury.","YAP1","regulate","Inflammation","Ischemia-reperfusion injury","YAP1","AFFECTS","inflammatory response","Reperfusion Injury"
"6197","35177478","The m6A reader YTHDC2 is essential for escape from KSHV SOX-induced RNA decay.","YTHDC2","read","m6A","KSHV SOX-induced RNA decay","YTHDC2","read","m6A","KSHV SOX-induced RNA decay"
"6198","35177478","The m6A reader YTHDC2 is essential for escape from KSHV SOX-induced RNA decay.","YTHDC2","essential for","escape","KSHV SOX-induced RNA decay","YTHDC2","PREDISPOSES","escape","KSHV SOX-induced RNA decay"
"6200","35178087","LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.","UCA1","promote","Progression","AML","UCA1","STIMULATES","progression","LAML(Acute Myeloid Leukemia)"
"6201","35178087","LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.","UCA1","upregulate","CXCR4","AML","UCA1","STIMULATES","CXCR4","LAML(Acute Myeloid Leukemia)"
"6202","35178087","LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.","UCA1","upregulate","CYP1B1","AML","UCA1","STIMULATES","CYP1B1","LAML(Acute Myeloid Leukemia)"
"6203","35178087","LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.","UCA1","affect","METTL14","AML","UCA1","AFFECTS","METTL14","LAML(Acute Myeloid Leukemia)"
"6204","35178087","LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.","METTL14","regulate","CXCR4","AML","METTL14","AFFECTS","CXCR4","LAML(Acute Myeloid Leukemia)"
"6205","35178087","LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.","METTL14","regulate","CYP1B1","AML","METTL14","AFFECTS","CYP1B1","LAML(Acute Myeloid Leukemia)"
"6207","35179655","METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.","METTL3","promote","Oxaliplatin Resistance","Gastric Cancer CD133+ Stem Cells","METTL3","STIMULATES","Oxaliplatin Resistance","STAD(Stomach adenocarcinoma)"
"6208","35179655","METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.","METTL3","promote","PARP1 mRNA","Gastric Cancer CD133+ Stem Cells","METTL3","STIMULATES","PARP1","STAD(Stomach adenocarcinoma)"
"6209","35179655","METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.","PARP1 mRNA","promote","Stability","Gastric Cancer CD133+ Stem Cells","PARP1","STIMULATES","stability","STAD(Stomach adenocarcinoma)"
"6210","35179655","METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.","Stability","promote","Oxaliplatin Resistance","Gastric Cancer CD133+ Stem Cells","stability","STIMULATES","Oxaliplatin Resistance","STAD(Stomach adenocarcinoma)"
"6212","35182329","ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.","ALKBH5","promote","Progression","Infantile Hemangioma","ALKBH5","STIMULATES","progression","Hemangioma, Capillary"
"6213","35182329","ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.","ALKBH5","regulate","NEAT1/miR-378b/FOSL1 axis","Infantile Hemangioma","ALKBH5","AFFECTS","NEAT1/miR-378b/FOSL1 axis","Hemangioma, Capillary"
"6214","35182329","ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.","NEAT1/miR-378b/FOSL1 axis","regulate","Progression","Infantile Hemangioma","NEAT1/miR-378b/FOSL1 axis","AFFECTS","progression","Hemangioma, Capillary"
"6216","35186724","YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFbeta1-SMAD2/3 Pathway.","YTHDF2","negatively regulate","FAM83D-TGFbeta1-SMAD2/3 Pathway","Lung Adenocarcinoma","YTHDF2","INHIBITS","FAM83D-TGFbeta1-SMAD2/3 Pathway","LUAD(Lung Adenocarcinoma)"
"6217","35186724","YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFbeta1-SMAD2/3 Pathway.","FAM83D-TGFbeta1-SMAD2/3 Pathway","regulate","Migration","Lung Adenocarcinoma","FAM83D-TGFbeta1-SMAD2/3 Pathway","AFFECTS","migration","LUAD(Lung Adenocarcinoma)"
"6218","35186724","YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFbeta1-SMAD2/3 Pathway.","FAM83D-TGFbeta1-SMAD2/3 Pathway","regulate","Invasion","Lung Adenocarcinoma","FAM83D-TGFbeta1-SMAD2/3 Pathway","AFFECTS","Neoplasm Invasiveness","LUAD(Lung Adenocarcinoma)"
"6219","35186724","YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFbeta1-SMAD2/3 Pathway.","YTHDF2","inhibit","Migration","Lung Adenocarcinoma","YTHDF2","INHIBITS","migration","LUAD(Lung Adenocarcinoma)"
"6220","35186724","YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFbeta1-SMAD2/3 Pathway.","YTHDF2","inhibit","Invasion","Lung Adenocarcinoma","YTHDF2","INHIBITS","Neoplasm Invasiveness","LUAD(Lung Adenocarcinoma)"
"6222","35192037","METTL3-mediated LINC00657 promotes osteogenic differentiation of mesenchymal stem cells via miR-144-3p/BMPR1B axis.","METTL3","mediate","LINC00657","Mesenchymal Stem Cells","METTL3","AFFECTS","NORAD","Mesenchymal Stem Cells"
"6223","35192037","METTL3-mediated LINC00657 promotes osteogenic differentiation of mesenchymal stem cells via miR-144-3p/BMPR1B axis.","LINC00657","promote","osteogenic differentiation","Mesenchymal Stem Cells","NORAD","STIMULATES","Osteogenic Differentiation","Mesenchymal Stem Cells"
"6224","35192037","METTL3-mediated LINC00657 promotes osteogenic differentiation of mesenchymal stem cells via miR-144-3p/BMPR1B axis.","LINC00657","regulate","miR-144-3p","Mesenchymal Stem Cells","NORAD","AFFECTS","miR-144-3p","Mesenchymal Stem Cells"
"6225","35192037","METTL3-mediated LINC00657 promotes osteogenic differentiation of mesenchymal stem cells via miR-144-3p/BMPR1B axis.","miR-144-3p","is in","BMPR1B","Mesenchymal Stem Cells","miR-144-3p","LOCATES","BMPR1B","Mesenchymal Stem Cells"
"6226","35192037","METTL3-mediated LINC00657 promotes osteogenic differentiation of mesenchymal stem cells via miR-144-3p/BMPR1B axis.","BMPR1B","regulate","osteogenic differentiation","Mesenchymal Stem Cells","BMPR1B","AFFECTS","Osteogenic Differentiation","Mesenchymal Stem Cells"
"6228","35193930","Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells.","dummy","induce loss of","YTHDF1","Gastric Tumors","dummy","INHIBITS","YTHDF1","STAD(Stomach adenocarcinoma)"
"6229","35193930","Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells.","YTHDF1","restore","sensitivity","Gastric Tumors","YTHDF1","restore","hypersensitivity reaction disease","STAD(Stomach adenocarcinoma)"
"6230","35193930","Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells.","YTHDF1","recruit","mature dendritic cells","Gastric Tumors","YTHDF1","recruit","mature dendritic cells","STAD(Stomach adenocarcinoma)"
"6231","35193930","Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells.","mature dendritic cells","restore","sensitivity","Gastric Tumors","mature dendritic cells","restore","hypersensitivity reaction disease","STAD(Stomach adenocarcinoma)"
"6233","35197058","METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer.","METTL3/IGF2BP3 axis","inhibit","Tumor Immune Surveillance","Breast Cancer","METTL3/IGF2BP3 axis","INHIBITS","Tumor Immune Surveillance","BRCA(Breast Invasive Carcinoma)"
"6234","35197058","METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer.","METTL3/IGF2BP3 axis","upregulate","N6-methyladenosine","Breast Cancer","METTL3/IGF2BP3 axis","STIMULATES","m6A","BRCA(Breast Invasive Carcinoma)"
"6235","35197058","METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer.","N6-methyladenosine","modify","PD-L1 mRNA","Breast Cancer","m6A","AFFECTS","PD-L1","BRCA(Breast Invasive Carcinoma)"
"6236","35197058","METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer.","PD-L1 mRNA","inhibit","Tumor Immune Surveillance","Breast Cancer","PD-L1","INHIBITS","Tumor Immune Surveillance","BRCA(Breast Invasive Carcinoma)"
"6238","35197112","YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.","YTHDF1","promote","Breast Cancer Progression","Breast Cancer","YTHDF1","STIMULATES","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"6239","35197112","YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.","YTHDF1","facilitate","FOXM1","Breast Cancer","YTHDF1","AUGMENTS","FOXM1","BRCA(Breast Invasive Carcinoma)"
"6240","35197112","YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.","YTHDF1","bind","m6A","Breast Cancer","YTHDF1","INTERACTS_WITH","m6A","BRCA(Breast Invasive Carcinoma)"
"6241","35197112","YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.","FOXM1","regulate","Breast Cancer Progression","Breast Cancer","FOXM1","AFFECTS","Breast Cancer Progression","BRCA(Breast Invasive Carcinoma)"
"6243","35198364","MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.","MiR-451a","promote","Cell Growth","Osteosarcoma","MIR451A","STIMULATES","cell growth","SARC(Sarcoma)"
"6244","35198364","MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.","MiR-451a","promote","Migration","Osteosarcoma","MIR451A","STIMULATES","migration","SARC(Sarcoma)"
"6245","35198364","MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.","MiR-451a","promote","EMT","Osteosarcoma","MIR451A","STIMULATES","epithelial to mesenchymal transition","SARC(Sarcoma)"
"6246","35198364","MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.","MiR-451a","regulate","YTHDC1","Osteosarcoma","MIR451A","AFFECTS","YTHDC1","SARC(Sarcoma)"
"6247","35198364","MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.","YTHDC1","mediate","m6A methylation","Osteosarcoma","YTHDC1","AFFECTS","m6A","SARC(Sarcoma)"
"6248","35198364","MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.","m6A methylation","activate","AKT/mTOR signaling pathway","Osteosarcoma","m6A","STIMULATES","AKT/mTOR pathway","SARC(Sarcoma)"
"6250","35201342","Chronic Hexavalent Chromium Exposure Up-regulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-like Property and Tumorigenesis.","dummy","up-regulate","METTL3","Chronic Hexavalent Chromium Exposure","dummy","STIMULATES","METTL3","Chronic Hexavalent Chromium Exposure"
"6251","35201342","Chronic Hexavalent Chromium Exposure Up-regulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-like Property and Tumorigenesis.","METTL3","promote","Cell Transformation","Chronic Hexavalent Chromium Exposure","METTL3","STIMULATES","Cell Transformation","Chronic Hexavalent Chromium Exposure"
"6252","35201342","Chronic Hexavalent Chromium Exposure Up-regulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-like Property and Tumorigenesis.","METTL3","promote","Cancer Stem Cell-like Property","Chronic Hexavalent Chromium Exposure","METTL3","STIMULATES","Cancer Stem Cell-like Property","Chronic Hexavalent Chromium Exposure"
"6253","35201342","Chronic Hexavalent Chromium Exposure Up-regulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-like Property and Tumorigenesis.","METTL3","promote","Tumorigenesis","Chronic Hexavalent Chromium Exposure","METTL3","STIMULATES","Carcinogenesis","Chronic Hexavalent Chromium Exposure"
"6255","35210391","METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing.","METTL3","suppress","Neuropathic Pain","Neuropathic Pain","METTL3","INHIBITS","Neuralgia","Neuralgia"
"6256","35210391","METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing.","METTL3","modulate","N6-methyladenosine","Neuropathic Pain","METTL3","AFFECTS","m6A","Neuralgia"
"6257","35210391","METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing.","N6-methyladenosine","is on","primary miR-150","Neuropathic Pain","m6A","LOCATES","primary miR-150","Neuralgia"
"6258","35210391","METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing.","primary miR-150","regulate","Neuropathic Pain","Neuropathic Pain","primary miR-150","AFFECTS","Neuralgia","Neuralgia"
"6260","35217651","m6A methyltransferase KIAA1429 acts as an oncogenic factor in colorectal cancer by regulating SIRT1 in an m6A-dependent manner.","KIAA1429","act as","oncogenic factor","Colorectal Cancer","VIRMA","act as","oncogenic factor","COAD(Colon Adenocarcinoma)"
"6261","35217651","m6A methyltransferase KIAA1429 acts as an oncogenic factor in colorectal cancer by regulating SIRT1 in an m6A-dependent manner.","KIAA1429","regulate","SIRT1","Colorectal Cancer","VIRMA","AFFECTS","SIRT1","COAD(Colon Adenocarcinoma)"
"6262","35217651","m6A methyltransferase KIAA1429 acts as an oncogenic factor in colorectal cancer by regulating SIRT1 in an m6A-dependent manner.","KIAA1429","regulate","m6A","Colorectal Cancer","VIRMA","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"6263","35217651","m6A methyltransferase KIAA1429 acts as an oncogenic factor in colorectal cancer by regulating SIRT1 in an m6A-dependent manner.","m6A","regulate","SIRT1","Colorectal Cancer","m6A","AFFECTS","SIRT1","COAD(Colon Adenocarcinoma)"
"6265","35217832","The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.","IGF2BP3","promote","Acute Myeloid Leukemia Progression","Acute Myeloid Leukemia","IGF2BP3","STIMULATES","Acute Myeloid Leukemia Progression","LAML(Acute Myeloid Leukemia)"
"6266","35217832","The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.","IGF2BP3","enhance","RCC2","Acute Myeloid Leukemia","IGF2BP3","AUGMENTS","RCC2","LAML(Acute Myeloid Leukemia)"
"6267","35217832","The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.","RCC2","have","Stability","Acute Myeloid Leukemia","RCC2","have","stability","LAML(Acute Myeloid Leukemia)"
"6268","35217832","The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.","Stability","promote","Acute Myeloid Leukemia Progression","Acute Myeloid Leukemia","stability","STIMULATES","Acute Myeloid Leukemia Progression","LAML(Acute Myeloid Leukemia)"
"6270","35226250","AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance.","AS3MT","facilitate","NLRP3 inflammasome activation","Arsenic-induced hepatic insulin resistance","AS3MT","AUGMENTS","NLRP3 inflammasome complex assembly","Arsenic-induced hepatic insulin resistance"
"6271","35226250","AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance.","AS3MT","induce","m6A modification","Arsenic-induced hepatic insulin resistance","AS3MT","CAUSES","m6A","Arsenic-induced hepatic insulin resistance"
"6272","35226250","AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance.","m6A modification","regulate","NLRP3 inflammasome activation","Arsenic-induced hepatic insulin resistance","m6A","AFFECTS","NLRP3 inflammasome complex assembly","Arsenic-induced hepatic insulin resistance"
"6274","35233461","LINC00665 regulates hepatocellular carcinoma by modulating mRNA via the m6A enzyme.","LINC00665","regulate","Hepatocellular Carcinoma","Hepatocellular Carcinoma","LINC00665","AFFECTS","hepatocellular carcinoma","LIHC(Liver Hepatocellular Carcinoma)"
"6275","35233461","LINC00665 regulates hepatocellular carcinoma by modulating mRNA via the m6A enzyme.","LINC00665","modulate","mRNA","Hepatocellular Carcinoma","LINC00665","AFFECTS","messenger RNA","LIHC(Liver Hepatocellular Carcinoma)"
"6276","35233461","LINC00665 regulates hepatocellular carcinoma by modulating mRNA via the m6A enzyme.","mRNA","is on","m6A enzyme","Hepatocellular Carcinoma","messenger RNA","LOCATES","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"6277","35233461","LINC00665 regulates hepatocellular carcinoma by modulating mRNA via the m6A enzyme.","m6A enzyme","regulate","Hepatocellular Carcinoma","Hepatocellular Carcinoma","m6A","AFFECTS","hepatocellular carcinoma","LIHC(Liver Hepatocellular Carcinoma)"
"6279","35070958","Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.","Metformin","stimulate","Let-7 Maturation","Null","metformin","STIMULATES","Let-7 Maturation","Null"
"6280","35070958","Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.","Let-7 Maturation","improve","Response","Null","Let-7 Maturation","STIMULATES","response","Null"
"6281","35070958","Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.","m6A","regulate","Response","Null","m6A","AFFECTS","response","Null"
"6282","35070958","Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.","Metformin","regulate","m6A","Null","metformin","AFFECTS","m6A","Null"
"6284","35073459","LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.","LINC00942","promote","chemoresistance","Gastric Cancer","LINC00942","STIMULATES","chemoresistance","STAD(Stomach adenocarcinoma)"
"6285","35073459","LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.","LINC00942","suppress","MSI2","Gastric Cancer","LINC00942","INHIBITS","MSI2","STAD(Stomach adenocarcinoma)"
"6286","35073459","LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.","MSI2","enhance","c-Myc mRNA","Gastric Cancer","MSI2","AUGMENTS","MYC","STAD(Stomach adenocarcinoma)"
"6287","35073459","LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.","c-Myc mRNA","regulate","chemoresistance","Gastric Cancer","MYC","AFFECTS","chemoresistance","STAD(Stomach adenocarcinoma)"
"6289","35078505","The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.","m6A RNA modification","stimulate","ENO1","Lung Adenocarcinoma","m6A","STIMULATES","ENO1","LUAD(Lung Adenocarcinoma)"
"6290","35078505","The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.","m6A RNA modification","stimulate","glycolysis","Lung Adenocarcinoma","m6A","STIMULATES","glycolytic process","LUAD(Lung Adenocarcinoma)"
"6291","35078505","The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.","m6A RNA modification","stimulate","tumorigenesis","Lung Adenocarcinoma","m6A","STIMULATES","Carcinogenesis","LUAD(Lung Adenocarcinoma)"
"6292","35078505","The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.","ENO1","stimulate","glycolysis","Lung Adenocarcinoma","ENO1","STIMULATES","glycolytic process","LUAD(Lung Adenocarcinoma)"
"6293","35078505","The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.","glycolysis","stimulate","tumorigenesis","Lung Adenocarcinoma","glycolytic process","STIMULATES","Carcinogenesis","LUAD(Lung Adenocarcinoma)"
"6295","35090515","FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.","FTO","suppress","glycolysis","Papillary Thyroid Cancer","FTO","INHIBITS","glycolytic process","THCA(Thyroid Carcinoma)"
"6296","35090515","FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.","FTO","suppress","growth","Papillary Thyroid Cancer","FTO","INHIBITS","Growth","THCA(Thyroid Carcinoma)"
"6297","35090515","FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.","FTO","decrease stability of","APOE mRNA","Papillary Thyroid Cancer","FTO","decrease stability of","APOE","THCA(Thyroid Carcinoma)"
"6298","35090515","FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.","FTO","erase","N6-methyladenosine","Papillary Thyroid Cancer","FTO","erase","m6A","THCA(Thyroid Carcinoma)"
"6299","35090515","FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.","APOE mRNA","regulate","glycolysis","Papillary Thyroid Cancer","APOE","AFFECTS","glycolytic process","THCA(Thyroid Carcinoma)"
"6300","35090515","FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.","APOE mRNA","regulate","growth","Papillary Thyroid Cancer","APOE","AFFECTS","Growth","THCA(Thyroid Carcinoma)"
"6302","35094011","METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner.","METTL3","promote","Intrahepatic Cholangiocarcinoma Progression","Intrahepatic Cholangiocarcinoma","METTL3","STIMULATES","Intrahepatic Cholangiocarcinoma Progression","CHOL(Cholangiocarcinoma)"
"6303","35094011","METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner.","METTL3","regulate","IFIT2","Intrahepatic Cholangiocarcinoma","METTL3","AFFECTS","IFIT2","CHOL(Cholangiocarcinoma)"
"6304","35094011","METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner.","METTL3","regulate","m6A","Intrahepatic Cholangiocarcinoma","METTL3","AFFECTS","m6A","CHOL(Cholangiocarcinoma)"
"6305","35094011","METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Intrahepatic Cholangiocarcinoma","YTHDF2","INTERACTS_WITH","m6A","CHOL(Cholangiocarcinoma)"
"6306","35094011","METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner.","IFIT2","regulate","Intrahepatic Cholangiocarcinoma Progression","Intrahepatic Cholangiocarcinoma","IFIT2","AFFECTS","Intrahepatic Cholangiocarcinoma Progression","CHOL(Cholangiocarcinoma)"
"6308","35096816","METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification.","METTL3","Contribute","Osteosarcoma Progression","Osteosarcoma","METTL3","AFFECTS","Osteosarcoma Progression","SARC(Sarcoma)"
"6309","35096816","METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification.","METTL3","increase stability of","DANCR mRNA","Osteosarcoma","METTL3","increase stability of","DANCR","SARC(Sarcoma)"
"6310","35096816","METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification.","METTL3","cause","m6A Modification","Osteosarcoma","METTL3","CAUSES","m6A","SARC(Sarcoma)"
"6311","35096816","METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification.","m6A Modification","modify","DANCR mRNA","Osteosarcoma","m6A","AFFECTS","DANCR","SARC(Sarcoma)"
"6313","35101069","YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity.","YTHDC1","regulate","post-integration steps","HIV-1 replication","YTHDC1","AFFECTS","post-integration steps","HIV-1 replication"
"6314","35101069","YTHDC1 regulates distinct post-integration steps of HIV-1 replication and is important for viral infectivity.","YTHDC1","is important for","viral infectivity","HIV-1 replication","YTHDC1","is important for","viral infectivity","HIV-1 replication"
"6316","35101091","FIONA1 is an RNA N6-methyladenosine methyltransferase affecting Arabidopsis photomorphogenesis and flowering.","FIONA1","affect","photomorphogenesis","Arabidopsis","FIONA1","AFFECTS","photomorphogenesis","Arabidopsis"
"6317","35101091","FIONA1 is an RNA N6-methyladenosine methyltransferase affecting Arabidopsis photomorphogenesis and flowering.","FIONA1","affect","flowering","Arabidopsis","FIONA1","AFFECTS","vegetative to reproductive phase transition of meristem","Arabidopsis"
"6319","35110680","The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation.","YTHDF3","potentiate","tumorigenicity","Ocular Melanoma","YTHDF3","AUGMENTS","Tumorigenicity","UVM(Uveal Melanoma)"
"6320","35110680","The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation.","YTHDF3","facilitate","CTNNB1","Ocular Melanoma","YTHDF3","AUGMENTS","CTNNB1","UVM(Uveal Melanoma)"
"6321","35110680","The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation.","CTNNB1","regulate","tumorigenicity","Ocular Melanoma","CTNNB1","AFFECTS","Tumorigenicity","UVM(Uveal Melanoma)"
"6323","35112553","YTHDF3 modulates hematopoietic stem cells by recognizing RNA m6A modification on Ccnd1.","YTHDF3","modulate","Hematopoietic Stem Cells","Hematopoietic Stem Cells","YTHDF3","AFFECTS","Hematopoietic Stem Cells","Hematopoietic Stem Cells"
"6324","35112553","YTHDF3 modulates hematopoietic stem cells by recognizing RNA m6A modification on Ccnd1.","YTHDF3","recognize","RNA m6A modification","Hematopoietic Stem Cells","YTHDF3","DIAGNOSES","m6A","Hematopoietic Stem Cells"
"6325","35112553","YTHDF3 modulates hematopoietic stem cells by recognizing RNA m6A modification on Ccnd1.","RNA m6A modification","is on","Ccnd1","Hematopoietic Stem Cells","m6A","LOCATES","CCND1","Hematopoietic Stem Cells"
"6326","35112553","YTHDF3 modulates hematopoietic stem cells by recognizing RNA m6A modification on Ccnd1.","Ccnd1","regulate","Hematopoietic Stem Cells","Hematopoietic Stem Cells","CCND1","AFFECTS","Hematopoietic Stem Cells","Hematopoietic Stem Cells"
"6328","35114989","Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.","ALKBH5","suppress","Invasion","Gastric Cancer","ALKBH5","INHIBITS","Neoplasm Invasiveness","STAD(Stomach adenocarcinoma)"
"6329","35114989","Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.","ALKBH5","demethylate","m6A","Gastric Cancer","ALKBH5","CONVERTS_TO","m6A","STAD(Stomach adenocarcinoma)"
"6330","35114989","Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.","m6A","is on","PKMYT1","Gastric Cancer","m6A","LOCATES","PKMYT1","STAD(Stomach adenocarcinoma)"
"6331","35114989","Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.","PKMYT1","regulate","Invasion","Gastric Cancer","PKMYT1","AFFECTS","Neoplasm Invasiveness","STAD(Stomach adenocarcinoma)"
"6333","35117988","m6A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation.","METTL3","promote","Progression","Primary Acral Melanoma","METTL3","STIMULATES","progression","SKCM(Skin Cutaneous Melanoma)"
"6334","35117988","m6A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation.","METTL3","mediate","TXNDC5","Primary Acral Melanoma","METTL3","AFFECTS","TXNDC5","SKCM(Skin Cutaneous Melanoma)"
"6335","35117988","m6A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation.","TXNDC5","regulate","Progression","Primary Acral Melanoma","TXNDC5","AFFECTS","progression","SKCM(Skin Cutaneous Melanoma)"
"6337","35120571","N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-kappaB/A20 axis.","dummy","modify","circGARS","Systemic Lupus Erythematosus (SLE)","dummy","AFFECTS","circGARS","Systemic Lupus Erythematosus (SLE)"
"6338","35120571","N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-kappaB/A20 axis.","circGARS","act","NF-kappaB/A20 axis","Systemic Lupus Erythematosus (SLE)","circGARS","act","NF-kappaB/A20 axis","Systemic Lupus Erythematosus (SLE)"
"6339","35120571","N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-kappaB/A20 axis.","NF-kappaB/A20 axis","promote","SLE progression","Systemic Lupus Erythematosus (SLE)","NF-kappaB/A20 axis","STIMULATES","SLE progression","Systemic Lupus Erythematosus (SLE)"
"6340","35120571","N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-kappaB/A20 axis.","circGARS","promote","SLE progression","Systemic Lupus Erythematosus (SLE)","circGARS","STIMULATES","SLE progression","Systemic Lupus Erythematosus (SLE)"
"6342","35121825","M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression.","FTO","downregulate","DACT1 mRNA","Osteosarcoma","FTO","INHIBITS","DACT1","SARC(Sarcoma)"
"6343","35121825","M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression.","DACT1 mRNA","promote","Wnt signaling","Osteosarcoma","DACT1","STIMULATES","Wnt signaling pathway","SARC(Sarcoma)"
"6344","35121825","M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression.","Wnt signaling","facilitate","Osteosarcoma Progression","Osteosarcoma","Wnt signaling pathway","AUGMENTS","Osteosarcoma Progression","SARC(Sarcoma)"
"6346","35127873","ALKBH5 Regulates SPHK1-Dependent Endothelial Cell Angiogenesis Following Ischemic Stress.","ALKBH5","regulate","SPHK1","Ischemic Stress","ALKBH5","AFFECTS","SPHK1","Ischemic Stress"
"6347","35127873","ALKBH5 Regulates SPHK1-Dependent Endothelial Cell Angiogenesis Following Ischemic Stress.","SPHK1","regulate","Endothelial Cell","Ischemic Stress","SPHK1","AFFECTS","Endothelial Cells","Ischemic Stress"
"6348","35127873","ALKBH5 Regulates SPHK1-Dependent Endothelial Cell Angiogenesis Following Ischemic Stress.","Endothelial Cell","induce","Angiogenesis","Ischemic Stress","Endothelial Cells","CAUSES","angiogenesis","Ischemic Stress"
"6349","35127873","ALKBH5 Regulates SPHK1-Dependent Endothelial Cell Angiogenesis Following Ischemic Stress.","SPHK1","regulate","Angiogenesis","Ischemic Stress","SPHK1","AFFECTS","angiogenesis","Ischemic Stress"
"6351","35132536","circCELF1 Inhibits Myocardial Fibrosis by Regulating the Expression of DKK2 Through FTO/m6A and miR-636.","circCELF1","inhibit","Myocardial Fibrosis","Myocardial Fibrosis","circCELF1","INHIBITS","Myocardial fibrosis","Myocardial fibrosis"
"6352","35132536","circCELF1 Inhibits Myocardial Fibrosis by Regulating the Expression of DKK2 Through FTO/m6A and miR-636.","circCELF1","regulate","DKK2","Myocardial Fibrosis","circCELF1","AFFECTS","DKK2","Myocardial fibrosis"
"6353","35132536","circCELF1 Inhibits Myocardial Fibrosis by Regulating the Expression of DKK2 Through FTO/m6A and miR-636.","circCELF1","regulate","FTO","Myocardial Fibrosis","circCELF1","AFFECTS","FTO","Myocardial fibrosis"
"6354","35132536","circCELF1 Inhibits Myocardial Fibrosis by Regulating the Expression of DKK2 Through FTO/m6A and miR-636.","miR-636","bind","m6A","Myocardial Fibrosis","MIR636","INTERACTS_WITH","m6A","Myocardial fibrosis"
"6355","35132536","circCELF1 Inhibits Myocardial Fibrosis by Regulating the Expression of DKK2 Through FTO/m6A and miR-636.","FTO","regulate","DKK2","Myocardial Fibrosis","FTO","AFFECTS","DKK2","Myocardial fibrosis"
"6356","35132536","circCELF1 Inhibits Myocardial Fibrosis by Regulating the Expression of DKK2 Through FTO/m6A and miR-636.","miR-636","regulate","DKK2","Myocardial Fibrosis","MIR636","AFFECTS","DKK2","Myocardial fibrosis"
"6358","35135551","DHA alleviates diet-induced skeletal muscle fiber remodeling via FTO/m6A/DDIT4/PGC1alpha signaling.","DHA","alleviate","skeletal muscle fiber remodeling","Skeletal muscle fiber","dihydroartemisinin","INHIBITS","skeletal muscle fiber remodeling","Muscle Fibers, Skeletal"
"6359","35135551","DHA alleviates diet-induced skeletal muscle fiber remodeling via FTO/m6A/DDIT4/PGC1alpha signaling.","DHA","regulate","FTO/m6A/DDIT4/PGC1alpha signaling","Skeletal muscle fiber","dihydroartemisinin","AFFECTS","FTO/m6A/DDIT4/PGC1alpha signaling pathway","Muscle Fibers, Skeletal"
"6360","35135551","DHA alleviates diet-induced skeletal muscle fiber remodeling via FTO/m6A/DDIT4/PGC1alpha signaling.","FTO/m6A/DDIT4/PGC1alpha signaling","regulate","skeletal muscle fiber remodeling","Skeletal muscle fiber","FTO/m6A/DDIT4/PGC1alpha signaling pathway","AFFECTS","skeletal muscle fiber remodeling","Muscle Fibers, Skeletal"
"6362","35136045","MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.","MYC","activate","IGF2BP3","Nasopharyngeal Carcinoma","MYC","STIMULATES","IGF2BP3","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6363","35136045","MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.","IGF2BP3","promote","Cell Proliferation","Nasopharyngeal Carcinoma","IGF2BP3","STIMULATES","cell population proliferation","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6364","35136045","MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.","IGF2BP3","promote","Metastasis","Nasopharyngeal Carcinoma","IGF2BP3","STIMULATES","Neoplasm Metastasis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6366","35136989","LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.","LINC02253","mediate","N6-methyladenosine","Gastric Cancer","LINC02253","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"6367","35136989","LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.","N6-methyladenosine","modify","KRT18 mRNA","Gastric Cancer","m6A","AFFECTS","KRT18","STAD(Stomach adenocarcinoma)"
"6368","35136989","LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.","KRT18 mRNA","is on","KRT18","Gastric Cancer","KRT18","LOCATES","KRT18","STAD(Stomach adenocarcinoma)"
"6369","35136989","LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.","KRT18","activate","MAPK","Gastric Cancer","KRT18","STIMULATES","MAPK","STAD(Stomach adenocarcinoma)"
"6370","35136989","LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.","MAPK","activate","ERK pathway","Gastric Cancer","MAPK","STIMULATES","ERK pathway","STAD(Stomach adenocarcinoma)"
"6372","35138268","Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency.","Pathogenic variants","in","YTHDC2","Human","Pathogenic variants","in","YTHDC2","Humans"
"6373","35138268","Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency.","Pathogenic variants","associate","primary ovarian insufficiency","Human","Pathogenic variants","ASSOCIATED_WITH","Primary Ovarian Insufficiency","Humans"
"6375","35139773","Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.","METTL14","mediate","N6-methyladenosine modification","RPE","METTL14","AFFECTS","m6A","RPE"
"6376","35139773","Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.","N6-methyladenosine modification","modulate","RPE activity","RPE","m6A","AFFECTS","RPE activity","RPE"
"6377","35139773","Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.","N6-methyladenosine modification","regulate","MAP2","RPE","m6A","AFFECTS","MAP2","RPE"
"6378","35139773","Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.","MAP2","regulate","RPE activity","RPE","MAP2","AFFECTS","RPE activity","RPE"
"6380","35143475","Dynamic assembly of the mRNA m6A methyltransferase complex is regulated by METTL3 phase separation.","METTL3","regulate","mRNA m6A methyltransferase complex","Null","METTL3","AFFECTS","mRNA m6A methyltransferase complex","Null"
"6381","35143475","Dynamic assembly of the mRNA m6A methyltransferase complex is regulated by METTL3 phase separation.","METTL3","regulate","phase separation","Null","METTL3","AFFECTS","Phase Separation","Null"
"6383","35144642","Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma.","Methyltransferase like 7B","is","therapeutic target","Lung Adenocarcinoma","METTL7B","is","Therapeutic Target","LUAD(Lung Adenocarcinoma)"
"6384","35144642","Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma.","therapeutic target","reverse","EGFR-TKIs resistance","Lung Adenocarcinoma","Therapeutic Target","reverse","EGFR-TKIs resistance","LUAD(Lung Adenocarcinoma)"
"6386","35145225","METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis.","METTL16","facilitate","translation","Null","METTL16","AUGMENTS","translation","Null"
"6387","35145225","METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis.","METTL16","facilitate","tumorigenesis","Null","METTL16","AUGMENTS","Carcinogenesis","Null"
"6388","35145225","METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis.","METTL16","independent of","m6A","Null","METTL16","independent of","m6A","Null"
"6390","35145273","FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma.","FTO","promote","Bortezomib resistance","Multiple Myeloma","FTO","STIMULATES","Bortezomib resistance","Multiple Myeloma"
"6391","35145273","FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma.","FTO","regulate","m6A","Multiple Myeloma","FTO","AFFECTS","m6A","Multiple Myeloma"
"6392","35145273","FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma.","m6A","destabilize","SOD2 expression","Multiple Myeloma","m6A","DISRUPTS","SOD2 expression","Multiple Myeloma"
"6393","35145273","FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma.","SOD2 expression","regulate","Bortezomib resistance","Multiple Myeloma","SOD2 expression","AFFECTS","Bortezomib resistance","Multiple Myeloma"
"6395","35145841","m6A-dependent upregulation of TRAF6 by METTL3 is associated with metastatic osteosarcoma.","m6A","upregulate","TRAF6","Metastatic Osteosarcoma","m6A","STIMULATES","TRAF6","Metastatic Osteosarcoma"
"6396","35145841","m6A-dependent upregulation of TRAF6 by METTL3 is associated with metastatic osteosarcoma.","METTL3","regulate","m6A","Metastatic Osteosarcoma","METTL3","AFFECTS","m6A","Metastatic Osteosarcoma"
"6398","34976433","SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer.","KIAA1429","regulate","SMC1A","Breast Cancer","VIRMA","AFFECTS","SMC1A","BRCA(Breast Invasive Carcinoma)"
"6399","34976433","SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer.","SMC1A","promote","EMT progress","Breast Cancer","SMC1A","STIMULATES","EMT progress","BRCA(Breast Invasive Carcinoma)"
"6401","34980191","The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1.","METTL3","affect","Autophagy","Nasopharyngeal Carcinoma","METTL3","AFFECTS","autophagy","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6402","34980191","The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1.","METTL3","affect","Progression","Nasopharyngeal Carcinoma","METTL3","AFFECTS","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6403","34980191","The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1.","METTL3","regulate","Stability","Nasopharyngeal Carcinoma","METTL3","AFFECTS","stability","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6404","34980191","The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1.","Stability","of","lncRNA ZFAS1","Nasopharyngeal Carcinoma","stability","of","ZFAS1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6405","34980191","The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1.","lncRNA ZFAS1","regulate","Autophagy","Nasopharyngeal Carcinoma","ZFAS1","AFFECTS","autophagy","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6406","34980191","The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1.","lncRNA ZFAS1","regulate","Progression","Nasopharyngeal Carcinoma","ZFAS1","AFFECTS","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6408","34980207","RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.","IGF2BP2","promote","Lymphatic Metastasis","Head and Neck Squamous Carcinoma Cells","IGF2BP2","STIMULATES","Lymphatic Metastasis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6409","34980207","RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.","IGF2BP2","promote","Epithelial-Mesenchymal Transition","Head and Neck Squamous Carcinoma Cells","IGF2BP2","STIMULATES","epithelial to mesenchymal transition","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6410","34980207","RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.","IGF2BP2","stabilize","Slug mRNA","Head and Neck Squamous Carcinoma Cells","IGF2BP2","MAINTAINS","SNAI2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6411","34980207","RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.","Slug mRNA","promote","Lymphatic Metastasis","Head and Neck Squamous Carcinoma Cells","SNAI2","STIMULATES","Lymphatic Metastasis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6412","34980207","RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.","Slug mRNA","promote","Epithelial-Mesenchymal Transition","Head and Neck Squamous Carcinoma Cells","SNAI2","STIMULATES","epithelial to mesenchymal transition","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6413","34980207","RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.","dummy","depend on","m6A","Head and Neck Squamous Carcinoma Cells","dummy","INTERACTS_WITH","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6414","34980207","RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.","m6A","bind","IGF2BP2","Head and Neck Squamous Carcinoma Cells","m6A","INTERACTS_WITH","IGF2BP2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6416","34995801","ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m6A-dependent manner.","ATXN2","mediate translation of","TNFR1","Esophageal Squamous Cell Carcinoma","ATXN2","mediate translation of","TNFRSF1A","ESCA(Esophageal Carcinoma)"
"6417","34995801","ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m6A-dependent manner.","TNFR1","promote","Esophageal Squamous Cell Carcinoma","Esophageal Squamous Cell Carcinoma","TNFRSF1A","STIMULATES","Esophageal Squamous Cell Carcinoma","ESCA(Esophageal Carcinoma)"
"6418","34995801","ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m6A-dependent manner.","TNFR1","regulate","m6A","Esophageal Squamous Cell Carcinoma","TNFRSF1A","AFFECTS","m6A","ESCA(Esophageal Carcinoma)"
"6419","34995801","ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m6A-dependent manner.","m6A","regulate","Esophageal Squamous Cell Carcinoma","Esophageal Squamous Cell Carcinoma","m6A","AFFECTS","Esophageal Squamous Cell Carcinoma","ESCA(Esophageal Carcinoma)"
"6421","34996459","Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis.","Hypoxia","mediate","YTHDF2","Lung Squamous Cell Carcinoma","Hypoxia","AFFECTS","YTHDF2","LUSC(Lung Squamous Cell Carcinoma)"
"6422","34996459","Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis.","YTHDF2","promote","Lung Squamous Cell Carcinoma Progression","Lung Squamous Cell Carcinoma","YTHDF2","STIMULATES","Lung Squamous Cell Carcinoma Progression","LUSC(Lung Squamous Cell Carcinoma)"
"6423","34996459","Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis.","YTHDF2","activate","mTOR/AKT axis","Lung Squamous Cell Carcinoma","YTHDF2","STIMULATES","mTOR/AKT axis","LUSC(Lung Squamous Cell Carcinoma)"
"6424","34996459","Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis.","mTOR/AKT axis","promote","Lung Squamous Cell Carcinoma Progression","Lung Squamous Cell Carcinoma","mTOR/AKT axis","STIMULATES","Lung Squamous Cell Carcinoma Progression","LUSC(Lung Squamous Cell Carcinoma)"
"6426","34996469","METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification.","METTL3","promote","Tumor Growth","Lung Adenocarcinoma","METTL3","STIMULATES","Tumor Growth","LUAD(Lung Adenocarcinoma)"
"6427","34996469","METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification.","METTL3","inhibit","Ferroptosis","Lung Adenocarcinoma","METTL3","INHIBITS","Ferroptosis","LUAD(Lung Adenocarcinoma)"
"6428","34996469","METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification.","METTL3","stabilize","m6A","Lung Adenocarcinoma","METTL3","MAINTAINS","m6A","LUAD(Lung Adenocarcinoma)"
"6429","34996469","METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification.","m6A","is on","SLC7A11","Lung Adenocarcinoma","m6A","LOCATES","SLC7A11","LUAD(Lung Adenocarcinoma)"
"6430","34996469","METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification.","SLC7A11","regulate","Tumor Growth","Lung Adenocarcinoma","SLC7A11","AFFECTS","Tumor Growth","LUAD(Lung Adenocarcinoma)"
"6431","34996469","METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification.","SLC7A11","regulate","Ferroptosis","Lung Adenocarcinoma","SLC7A11","AFFECTS","Ferroptosis","LUAD(Lung Adenocarcinoma)"
"6433","34998823","m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.","dummy","demethylate","m6A","Null","dummy","CONVERTS_TO","m6A","Null"
"6434","34998823","m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.","m6A","is on","APOBEC3B mRNA","Null","m6A","LOCATES","APOBEC3B","Null"
"6435","34998823","m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.","arsenic","induce","mutagenesis","Null","arsenic atom","CAUSES","Mutagenesis","Null"
"6436","34998823","m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.","APOBEC3B mRNA","regulate","mutagenesis","Null","APOBEC3B","AFFECTS","Mutagenesis","Null"
"6438","34999731","WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis.","WTAP","mediate","m6A","Nasopharyngeal Carcinoma","WTAP","AFFECTS","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6439","34999731","WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis.","m6A","modify","lncRNA DIAPH1-AS1","Nasopharyngeal Carcinoma","m6A","AFFECTS","DIAPH1-AS1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6440","34999731","WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis.","lncRNA DIAPH1-AS1","enhance","lncRNA DIAPH1-AS1","Nasopharyngeal Carcinoma","DIAPH1-AS1","AUGMENTS","DIAPH1-AS1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6441","34999731","WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis.","lncRNA DIAPH1-AS1","facilitate","Carcinoma Growth","Nasopharyngeal Carcinoma","DIAPH1-AS1","AUGMENTS","Carcinoma Growth","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6442","34999731","WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis.","lncRNA DIAPH1-AS1","facilitate","Metastasis","Nasopharyngeal Carcinoma","DIAPH1-AS1","AUGMENTS","Neoplasm Metastasis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6444","35002506","HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression.","HPV E6/E7","promote","Aerobic Glycolysis","Cervical Cancer","HPV E6/E7","STIMULATES","aerobic glycolysis","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"6445","35002506","HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression.","HPV E6/E7","regulate","IGF2BP2","Cervical Cancer","HPV E6/E7","AFFECTS","IGF2BP2","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"6446","35002506","HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression.","IGF2BP2","stabilize","m6A","Cervical Cancer","IGF2BP2","MAINTAINS","m6A","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"6447","35002506","HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression.","m6A","modify","MYC","Cervical Cancer","m6A","AFFECTS","MYC","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"6448","35002506","HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression.","MYC","regulate","Aerobic Glycolysis","Cervical Cancer","MYC","AFFECTS","aerobic glycolysis","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"6450","35007522","Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A.","Isovitexin","target","PTEN","Acute liver injury","isovitexin","INTERACTS_WITH","PTEN","Acute liver injury"
"6451","35007522","Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A.","Isovitexin","target","PI3K","Acute liver injury","isovitexin","INTERACTS_WITH","PI3K","Acute liver injury"
"6452","35007522","Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A.","Isovitexin","target","BiP","Acute liver injury","isovitexin","INTERACTS_WITH","HSPA5","Acute liver injury"
"6453","35007522","Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A.","Isovitexin","modify","m6A","Acute liver injury","isovitexin","AFFECTS","m6A","Acute liver injury"
"6454","35007522","Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A.","m6A","regulate","PTEN","Acute liver injury","m6A","AFFECTS","PTEN","Acute liver injury"
"6455","35007522","Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A.","m6A","regulate","PI3K","Acute liver injury","m6A","AFFECTS","PI3K","Acute liver injury"
"6456","35007522","Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A.","m6A","regulate","BiP","Acute liver injury","m6A","AFFECTS","HSPA5","Acute liver injury"
"6459","35012593","METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.","METTL3","promote","Colorectal Carcinoma Progression","Colorectal Carcinoma","METTL3","STIMULATES","Colorectal Carcinoma Progression","COAD(Colon Adenocarcinoma)"
"6460","35012593","METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.","METTL3","regulate","m6A-CRB3-Hippo axis","Colorectal Carcinoma","METTL3","AFFECTS","m6A-CRB3-Hippo axis","COAD(Colon Adenocarcinoma)"
"6461","35012593","METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.","m6A-CRB3-Hippo axis","regulate","Colorectal Carcinoma Progression","Colorectal Carcinoma","m6A-CRB3-Hippo axis","AFFECTS","Colorectal Carcinoma Progression","COAD(Colon Adenocarcinoma)"
"6463","35013106","METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.","METTL14","suppress","pyroptosis","Diabetic Cardiomyopathy","METTL14","INHIBITS","pyroptosis","Diabetic Cardiomyopathies"
"6464","35013106","METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.","METTL14","downregulate","TINCR lncRNA","Diabetic Cardiomyopathy","METTL14","INHIBITS","TINCR lncRNA","Diabetic Cardiomyopathies"
"6465","35013106","METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.","TINCR lncRNA","regulate","diabetic cardiomyopathy","Diabetic Cardiomyopathy","TINCR lncRNA","AFFECTS","Diabetic Cardiomyopathies","Diabetic Cardiomyopathies"
"6467","35013140","METTL14 promotes apoptosis of spinal cord neurons by inducing EEF1A2 m6A methylation in spinal cord injury.","METTL14","promote","apoptosis","Spinal Cord Injury","METTL14","STIMULATES","apoptotic process","Spinal Cord Injuries"
"6468","35013140","METTL14 promotes apoptosis of spinal cord neurons by inducing EEF1A2 m6A methylation in spinal cord injury.","METTL14","induce","m6A","Spinal Cord Injury","METTL14","CAUSES","m6A","Spinal Cord Injuries"
"6469","35013140","METTL14 promotes apoptosis of spinal cord neurons by inducing EEF1A2 m6A methylation in spinal cord injury.","m6A","is on","EEF1A2","Spinal Cord Injury","m6A","LOCATES","EEF1A2","Spinal Cord Injuries"
"6470","35013140","METTL14 promotes apoptosis of spinal cord neurons by inducing EEF1A2 m6A methylation in spinal cord injury.","EEF1A2","regulate","apoptosis","Spinal Cord Injury","EEF1A2","AFFECTS","apoptotic process","Spinal Cord Injuries"
"6472","35014676","N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer.","N6-methyladenosine","upregulate","miR-181d-5p","Colorectal Cancer","m6A","STIMULATES","miR-181d-5p","COAD(Colon Adenocarcinoma)"
"6473","35014676","N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer.","miR-181d-5p","is in","exosomes","Colorectal Cancer","miR-181d-5p","LOCATES","Exosomes","COAD(Colon Adenocarcinoma)"
"6474","35014676","N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer.","exosomes","derived from","cancer-associated fibroblasts","Colorectal Cancer","Exosomes","derived from","Cancer-Associated Fibroblasts","COAD(Colon Adenocarcinoma)"
"6475","35014676","N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer.","miR-181d-5p","inhibit","5-FU sensitivity","Colorectal Cancer","miR-181d-5p","INHIBITS","5-FU sensitivity","COAD(Colon Adenocarcinoma)"
"6476","35014676","N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer.","miR-181d-5p","target.","NCALD","Colorectal Cancer","miR-181d-5p","target.","NCALD","COAD(Colon Adenocarcinoma)"
"6477","35014676","N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer.","NCALD","regulate","5-FU sensitivity","Colorectal Cancer","NCALD","AFFECTS","5-FU sensitivity","COAD(Colon Adenocarcinoma)"
"6479","35018683","Alkbh1-mediated DNA N6-methyladenine modification regulates bone marrow mesenchymal stem cell fate during skeletal aging.","Alkbh1","mediate","DNA N6-methyladenine modification","Bone Marrow Mesenchymal Stem Cell","ALKBH1","AFFECTS","DNA N6 -methyladenine","Bone Marrow Mesenchymal Stem Cell"
"6480","35018683","Alkbh1-mediated DNA N6-methyladenine modification regulates bone marrow mesenchymal stem cell fate during skeletal aging.","DNA N6-methyladenine modification","regulate","Stem Cell Fate","Bone Marrow Mesenchymal Stem Cell","DNA N6 -methyladenine","AFFECTS","stem cell fate","Bone Marrow Mesenchymal Stem Cell"
"6481","35018683","Alkbh1-mediated DNA N6-methyladenine modification regulates bone marrow mesenchymal stem cell fate during skeletal aging.","Stem Cell Fate","affect","Skeletal Aging","Bone Marrow Mesenchymal Stem Cell","stem cell fate","AFFECTS","Skeletal Aging","Bone Marrow Mesenchymal Stem Cell"
"6483","35022519","LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m6A modification of miR-375 by METTL14 through DNA methylation.","LncRNA UCA1","promote","SOX12","Breast Cancer","UCA1","STIMULATES","SOX12","BRCA(Breast Invasive Carcinoma)"
"6484","35022519","LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m6A modification of miR-375 by METTL14 through DNA methylation.","LncRNA UCA1","regulate","m6A","Breast Cancer","UCA1","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"6485","35022519","LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m6A modification of miR-375 by METTL14 through DNA methylation.","m6A","modify","miR-375","Breast Cancer","m6A","AFFECTS","MIR375","BRCA(Breast Invasive Carcinoma)"
"6486","35022519","LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m6A modification of miR-375 by METTL14 through DNA methylation.","miR-375","regulate","METTL14","Breast Cancer","MIR375","AFFECTS","METTL14","BRCA(Breast Invasive Carcinoma)"
"6487","35022519","LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m6A modification of miR-375 by METTL14 through DNA methylation.","METTL14","regulate","DNA methylation","Breast Cancer","METTL14","AFFECTS","DNA methylation","BRCA(Breast Invasive Carcinoma)"
"6489","35033535","The METTL5-TRMT112 N6-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation.","METTL5-TRMT112 N6-methyladenosine methyltransferase complex","regulate","mRNA translation","Null","METTL5-TRMT112 N6-methyladenosine methyltransferase complex","AFFECTS","translation","Null"
"6490","35033535","The METTL5-TRMT112 N6-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation.","METTL5-TRMT112 N6-methyladenosine methyltransferase complex","methylate","18S rRNA","Null","METTL5-TRMT112 N6-methyladenosine methyltransferase complex","CONVERTS_TO","RNA, Ribosomal, 18S","Null"
"6491","35033535","The METTL5-TRMT112 N6-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation.","18S rRNA","undergo","methylation","Null","RNA, Ribosomal, 18S","undergo","methylation","Null"
"6492","35033535","The METTL5-TRMT112 N6-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation.","methylation","regulate","mRNA translation","Null","methylation","AFFECTS","translation","Null"
"6494","35041860","Arsenic trioxide activates yes-associated protein by lysophosphatidic acid metabolism to selectively induce apoptosis of vascular smooth muscle cells.","Arsenic Trioxide","activate","Yes-Associated Protein","Vascular Smooth Muscle Cells","diarsenic trioxide","STIMULATES","Yes-Associated Protein","Vascular Smooth Muscle Cells"
"6495","35041860","Arsenic trioxide activates yes-associated protein by lysophosphatidic acid metabolism to selectively induce apoptosis of vascular smooth muscle cells.","Arsenic Trioxide","regulate","Lysophosphatidic Acid Metabolism","Vascular Smooth Muscle Cells","diarsenic trioxide","AFFECTS","Lysophosphatidic Acid Metabolism","Vascular Smooth Muscle Cells"
"6496","35041860","Arsenic trioxide activates yes-associated protein by lysophosphatidic acid metabolism to selectively induce apoptosis of vascular smooth muscle cells.","Lysophosphatidic Acid Metabolism","activate","Yes-Associated Protein","Vascular Smooth Muscle Cells","Lysophosphatidic Acid Metabolism","STIMULATES","Yes-Associated Protein","Vascular Smooth Muscle Cells"
"6497","35041860","Arsenic trioxide activates yes-associated protein by lysophosphatidic acid metabolism to selectively induce apoptosis of vascular smooth muscle cells.","Yes-Associated Protein","induce","Apoptosis","Vascular Smooth Muscle Cells","Yes-Associated Protein","CAUSES","apoptotic process","Vascular Smooth Muscle Cells"
"6499","35042525","CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3.","CircMET","promote","Tumor Proliferation","Tumor","CircMET","STIMULATES","Tumor Proliferation","PANCAN(Pan-Cancer)"
"6500","35042525","CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3.","CircMET","enhance decay of","CDKN2A mRNA","Tumor","CircMET","enhance decay of","CDKN2A","PANCAN(Pan-Cancer)"
"6501","35042525","CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3.","CircMET","upregulate","SMAD3","Tumor","CircMET","STIMULATES","SMAD3","PANCAN(Pan-Cancer)"
"6502","35042525","CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3.","CDKN2A mRNA","regulate","Tumor Proliferation","Tumor","CDKN2A","AFFECTS","Tumor Proliferation","PANCAN(Pan-Cancer)"
"6503","35042525","CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3.","SMAD3","regulate","Tumor Proliferation","Tumor","SMAD3","AFFECTS","Tumor Proliferation","PANCAN(Pan-Cancer)"
"6505","35054897","Glucocorticoid Regulates the Synthesis of Porcine Muscle Protein through m6A Modified Amino Acid Transporter SLC7A7.","Glucocorticoid","regulate","Synthesis of Porcine Muscle Protein","Porcine Muscle","glucocorticoid","AFFECTS","Synthesis of Porcine Muscle Protein","Porcine Muscle"
"6506","35054897","Glucocorticoid Regulates the Synthesis of Porcine Muscle Protein through m6A Modified Amino Acid Transporter SLC7A7.","Glucocorticoid","regulate","m6A","Porcine Muscle","glucocorticoid","AFFECTS","m6A","Porcine Muscle"
"6507","35054897","Glucocorticoid Regulates the Synthesis of Porcine Muscle Protein through m6A Modified Amino Acid Transporter SLC7A7.","m6A","is on","SLC7A7","Porcine Muscle","m6A","LOCATES","SLC7A7","Porcine Muscle"
"6508","35054897","Glucocorticoid Regulates the Synthesis of Porcine Muscle Protein through m6A Modified Amino Acid Transporter SLC7A7.","SLC7A7","regulate","Synthesis of Porcine Muscle Protein","Porcine Muscle","SLC7A7","AFFECTS","Synthesis of Porcine Muscle Protein","Porcine Muscle"
"6510","35058317","YTHDC2 control of gametogenesis requires helicase activity but not m6A binding.","YTHDC2","control","helicase activity","Gametogenesis","YTHDC2","AFFECTS","helicase activity","Gametogenesis"
"6511","35058317","YTHDC2 control of gametogenesis requires helicase activity but not m6A binding.","YTHDC2","not bind","m6A","Gametogenesis","YTHDC2","not bind","m6A","Gametogenesis"
"6513","35059772","Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis.","Dihydroartemisinin","block","FTO/NR4A3 axis","Vascular Smooth Muscle Cells","dihydroartemisinin","INHIBITS","FTO/NR4A3 axis","Vascular Smooth Muscle Cells"
"6514","35059772","Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis.","AngII","induce","Proliferation","Vascular Smooth Muscle Cells","AGT","CAUSES","cell population proliferation","Vascular Smooth Muscle Cells"
"6515","35059772","Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis.","AngII","induce","Inflammatory Response","Vascular Smooth Muscle Cells","AGT","CAUSES","inflammatory response","Vascular Smooth Muscle Cells"
"6516","35059772","Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis.","FTO/NR4A3 axis","regulate","Proliferation","Vascular Smooth Muscle Cells","FTO/NR4A3 axis","AFFECTS","cell population proliferation","Vascular Smooth Muscle Cells"
"6517","35059772","Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis.","FTO/NR4A3 axis","regulate","Inflammatory Response","Vascular Smooth Muscle Cells","FTO/NR4A3 axis","AFFECTS","inflammatory response","Vascular Smooth Muscle Cells"
"6519","35064107","N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics.","FTO","promote","Growth","Gastric Cancer","FTO","STIMULATES","Growth","STAD(Stomach adenocarcinoma)"
"6520","35064107","N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics.","FTO","promote","Metastasis","Gastric Cancer","FTO","STIMULATES","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"6521","35064107","N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics.","FTO","demethylate","m6A","Gastric Cancer","FTO","CONVERTS_TO","m6A","STAD(Stomach adenocarcinoma)"
"6522","35064107","N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics.","m6A","is on","Caveolin-1","Gastric Cancer","m6A","LOCATES","CAV1","STAD(Stomach adenocarcinoma)"
"6523","35064107","N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics.","Caveolin-1","regulate","Mitochondrial Dynamics","Gastric Cancer","CAV1","AFFECTS","Mitochondrial Dynamics","STAD(Stomach adenocarcinoma)"
"6525","35064112","RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner.","NKAP","protect","Ferroptosis","Glioblastoma cells","NKAP","PREVENTS","Ferroptosis","GBM(Glioblastoma Multiforme)"
"6526","35064112","RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner.","NKAP","promote","SLC7A11 mRNA","Glioblastoma cells","NKAP","STIMULATES","SLC7A11","GBM(Glioblastoma Multiforme)"
"6527","35064112","RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner.","m6A","dependent","NKAP","Glioblastoma cells","m6A","dependent","NKAP","GBM(Glioblastoma Multiforme)"
"6528","35064112","RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner.","SLC7A11 mRNA","regulate","Ferroptosis","Glioblastoma cells","SLC7A11","AFFECTS","Ferroptosis","GBM(Glioblastoma Multiforme)"
"6530","35069732","beta-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N6 Methyladenosine Modification.","PTEN mRNA","degrade","dummy","Lung Cancer Cells","PTEN","INHIBITS","dummy","LUSC(Lung Squamous Cell Carcinoma)"
"6531","35069732","beta-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N6 Methyladenosine Modification.","beta-Elemene","restrain","PTEN mRNA","Lung Cancer Cells","beta-elemene","INHIBITS","PTEN","LUSC(Lung Squamous Cell Carcinoma)"
"6532","35069732","beta-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N6 Methyladenosine Modification.","PTEN mRNA","restrain","Growth","Lung Cancer Cells","PTEN","INHIBITS","Growth","LUSC(Lung Squamous Cell Carcinoma)"
"6533","35069732","beta-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N6 Methyladenosine Modification.","METTL3","mediate","N6 Methyladenosine Modification","Lung Cancer Cells","METTL3","AFFECTS","m6A","LUSC(Lung Squamous Cell Carcinoma)"
"6534","35069732","beta-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N6 Methyladenosine Modification.","N6 Methyladenosine Modification","modify","PTEN mRNA","Lung Cancer Cells","m6A","AFFECTS","PTEN","LUSC(Lung Squamous Cell Carcinoma)"
"6535","35069732","beta-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N6 Methyladenosine Modification.","N6 Methyladenosine Modification","regulate","Growth","Lung Cancer Cells","m6A","AFFECTS","Growth","LUSC(Lung Squamous Cell Carcinoma)"
"6537","34678169","Differential m6A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function.","m6A RNA landscapes","regulate","Hematopoiesis","Hematopoiesis","m6A","AFFECTS","Hematopoiesis","Hematopoiesis"
"6538","34678169","Differential m6A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function.","IGF2BP2","preserve","Hematopoietic Stem Cell Function","Hematopoiesis","IGF2BP2","preserve","Hematopoietic Stem Cell Function","Hematopoiesis"
"6539","34678169","Differential m6A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function.","m6A RNA landscapes","regulate","IGF2BP2","Hematopoiesis","m6A","AFFECTS","IGF2BP2","Hematopoiesis"
"6541","34706873","METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression.","METTL3","mediate","m6A","Osteoarthritis","METTL3","AFFECTS","m6A","Osteoarthritis"
"6542","34706873","METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression.","m6A","modify","ATG7","Osteoarthritis","m6A","AFFECTS","ATG7","Osteoarthritis"
"6543","34706873","METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression.","ATG7","regulate","autophagy-GATA4 axis","Osteoarthritis","ATG7","AFFECTS","autophagy-GATA4 axis","Osteoarthritis"
"6544","34706873","METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression.","autophagy-GATA4 axis","promote","cellular senescence","Osteoarthritis","autophagy-GATA4 axis","STIMULATES","cellular senescence","Osteoarthritis"
"6545","34706873","METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression.","autophagy-GATA4 axis","promote","osteoarthritis progression","Osteoarthritis","autophagy-GATA4 axis","STIMULATES","Osteoarthritis Progression","Osteoarthritis"
"6546","34706873","METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression.","cellular senescence","promote","osteoarthritis progression","Osteoarthritis","cellular senescence","STIMULATES","Osteoarthritis Progression","Osteoarthritis"
"6548","34717005","The RNA N6 -methyladenosine modulator HNRNPA2B1 is involved in the development of non-small cell lung cancer.","HNRNPA2B1","involved in","Development of non-small cell lung cancer","Non-small cell lung cancer","HNRNPA2B1","involved in","Development of non-small cell lung cancer","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"6550","34735003","N6-Methyladenosine Modification of CDH1 mRNA Promotes PM2.5-Induced Pulmonary Fibrosis via Mediating Epithelial Mesenchymal Transition.","N6-Methyladenosine Modification","modify","CDH1 mRNA","Pulmonary Fibrosis","m6A","AFFECTS","CDH1","Pulmonary Fibrosis"
"6551","34735003","N6-Methyladenosine Modification of CDH1 mRNA Promotes PM2.5-Induced Pulmonary Fibrosis via Mediating Epithelial Mesenchymal Transition.","CDH1 mRNA","promote","Pulmonary Fibrosis","Pulmonary Fibrosis","CDH1","STIMULATES","Pulmonary Fibrosis","Pulmonary Fibrosis"
"6552","34735003","N6-Methyladenosine Modification of CDH1 mRNA Promotes PM2.5-Induced Pulmonary Fibrosis via Mediating Epithelial Mesenchymal Transition.","PM2.5","induce","Pulmonary Fibrosis","Pulmonary Fibrosis","PM2.5","CAUSES","Pulmonary Fibrosis","Pulmonary Fibrosis"
"6553","34735003","N6-Methyladenosine Modification of CDH1 mRNA Promotes PM2.5-Induced Pulmonary Fibrosis via Mediating Epithelial Mesenchymal Transition.","CDH1 mRNA","mediate","Epithelial Mesenchymal Transition","Pulmonary Fibrosis","CDH1","AFFECTS","epithelial to mesenchymal transition","Pulmonary Fibrosis"
"6554","34735003","N6-Methyladenosine Modification of CDH1 mRNA Promotes PM2.5-Induced Pulmonary Fibrosis via Mediating Epithelial Mesenchymal Transition.","Epithelial Mesenchymal Transition","promote","Pulmonary Fibrosis","Pulmonary Fibrosis","epithelial to mesenchymal transition","STIMULATES","Pulmonary Fibrosis","Pulmonary Fibrosis"
"6556","34747116","Dual regulatory actions of LncBMP4 on BMP4 promote chicken primordial germ cell formation.","LncBMP4","regulate","BMP4","Chicken Primordial Germ Cells","LncBMP4","AFFECTS","BMP4","Chicken Primordial Germ Cells"
"6557","34747116","Dual regulatory actions of LncBMP4 on BMP4 promote chicken primordial germ cell formation.","LncBMP4","regulate","BMP4","Chicken Primordial Germ Cells","LncBMP4","AFFECTS","BMP4","Chicken Primordial Germ Cells"
"6558","34747116","Dual regulatory actions of LncBMP4 on BMP4 promote chicken primordial germ cell formation.","BMP4","promote","Primordial Germ Cell Formation","Chicken Primordial Germ Cells","BMP4","STIMULATES","Primordial Germ Cell Formation","Chicken Primordial Germ Cells"
"6560","34759347","RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways.","ALKBH5","promote","Tumorigenesis","Multiple Myeloma","ALKBH5","STIMULATES","Carcinogenesis","Multiple Myeloma"
"6561","34759347","RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways.","ALKBH5","regulate","TRAF1","Multiple Myeloma","ALKBH5","AFFECTS","TRAF1","Multiple Myeloma"
"6562","34759347","RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways.","TRAF1","mediate","activation","Multiple Myeloma","TRAF1","AFFECTS","activation","Multiple Myeloma"
"6563","34759347","RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways.","activation","is on","NF-kappaB","Multiple Myeloma","activation","LOCATES","NF-kappaB signaling pathway","Multiple Myeloma"
"6564","34759347","RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways.","activation","is on","MAPK signaling pathways","Multiple Myeloma","activation","LOCATES","MAPK signaling pathways","Multiple Myeloma"
"6565","34759347","RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways.","NF-kappaB","regulate","Tumorigenesis","Multiple Myeloma","NF-kappaB signaling pathway","AFFECTS","Carcinogenesis","Multiple Myeloma"
"6566","34759347","RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways.","MAPK signaling pathways","regulate","Tumorigenesis","Multiple Myeloma","MAPK signaling pathways","AFFECTS","Carcinogenesis","Multiple Myeloma"
"6568","34763315","Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway.","Baicalin","suppress","Progression","Type 2 diabetes-induced liver tumor","baicalin","INHIBITS","progression","Type 2 diabetes-induced liver tumor"
"6569","34763315","Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway.","Baicalin","regulate","METTL3/m6A/HKDC1 axis","Type 2 diabetes-induced liver tumor","baicalin","AFFECTS","METTL3/m6A/HKDC1 axis","Type 2 diabetes-induced liver tumor"
"6570","34763315","Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway.","Baicalin","regulate","p-JAK2/STAT1/clevaged Capase3 pathway","Type 2 diabetes-induced liver tumor","baicalin","AFFECTS","p-JAK2/STAT1/clevaged Capase3 pathway","Type 2 diabetes-induced liver tumor"
"6571","34763315","Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway.","METTL3/m6A/HKDC1 axis","regulate","Progression","Type 2 diabetes-induced liver tumor","METTL3/m6A/HKDC1 axis","AFFECTS","progression","Type 2 diabetes-induced liver tumor"
"6572","34763315","Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway.","p-JAK2/STAT1/clevaged Capase3 pathway","regulate","Progression","Type 2 diabetes-induced liver tumor","p-JAK2/STAT1/clevaged Capase3 pathway","AFFECTS","progression","Type 2 diabetes-induced liver tumor"
"6574","34779644","FTO demethylates YAP mRNA promoting oral squamous cell carcinoma tumorigenesis.","FTO","demethylate","YAP mRNA","Oral Squamous Cell Carcinoma","FTO","CONVERTS_TO","YAP1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6575","34779644","FTO demethylates YAP mRNA promoting oral squamous cell carcinoma tumorigenesis.","YAP mRNA","promote","tumorigenesis","Oral Squamous Cell Carcinoma","YAP1","STIMULATES","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6577","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","FTO","regulate","Proliferation","Prostate Cancer","FTO","AFFECTS","cell population proliferation","PRAD(Prostate Adenocarcinoma)"
"6578","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","FTO","regulate","Migration","Prostate Cancer","FTO","AFFECTS","migration","PRAD(Prostate Adenocarcinoma)"
"6579","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","FTO","regulate","Invasion","Prostate Cancer","FTO","AFFECTS","Neoplasm Invasiveness","PRAD(Prostate Adenocarcinoma)"
"6580","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","FTO","regulate","Tumor Growth","Prostate Cancer","FTO","AFFECTS","Tumor Growth","PRAD(Prostate Adenocarcinoma)"
"6581","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","FTO","modulate","MC4R","Prostate Cancer","FTO","AFFECTS","MC4R","PRAD(Prostate Adenocarcinoma)"
"6582","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","MC4R","regulate","Proliferation","Prostate Cancer","MC4R","AFFECTS","cell population proliferation","PRAD(Prostate Adenocarcinoma)"
"6583","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","MC4R","regulate","Migration","Prostate Cancer","MC4R","AFFECTS","migration","PRAD(Prostate Adenocarcinoma)"
"6584","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","MC4R","regulate","Invasion","Prostate Cancer","MC4R","AFFECTS","Neoplasm Invasiveness","PRAD(Prostate Adenocarcinoma)"
"6585","34787056","Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R).","MC4R","regulate","Tumor Growth","Prostate Cancer","MC4R","AFFECTS","Tumor Growth","PRAD(Prostate Adenocarcinoma)"
"6587","34799724","METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression.","METTL3","mediate","N6-methyladenosine modification","Gallbladder Cancer","METTL3","AFFECTS","m6A","CHOL(Cholangiocarcinoma)"
"6588","34799724","METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression.","N6-methyladenosine modification","modify","DUSP5 mRNA","Gallbladder Cancer","m6A","AFFECTS","DUSP5","CHOL(Cholangiocarcinoma)"
"6589","34799724","METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression.","DUSP5 mRNA","promote","Cancer Progression","Gallbladder Cancer","DUSP5","STIMULATES","Cancer Progression","CHOL(Cholangiocarcinoma)"
"6591","34813676","METTL14 suppresses growth and metastasis of renal cell carcinoma by decreasing long non-coding RNA NEAT1.","METTL14","decrease","long non-coding RNA NEAT1","Renal Cell Carcinoma","METTL14","INHIBITS","NEAT1","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6592","34813676","METTL14 suppresses growth and metastasis of renal cell carcinoma by decreasing long non-coding RNA NEAT1.","long non-coding RNA NEAT1","promote","growth and metastasis","Renal Cell Carcinoma","NEAT1","STIMULATES","growth and metastasis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6593","34813676","METTL14 suppresses growth and metastasis of renal cell carcinoma by decreasing long non-coding RNA NEAT1.","METTL14","suppress","growth and metastasis","Renal Cell Carcinoma","METTL14","INHIBITS","growth and metastasis","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6595","34818872","m6A reader Ythdf3 protects hematopoietic stem cell integrity under stress by promoting the translation of Foxm1 and Asxl1 transcripts.","Ythdf3","protect","Hematopoietic Stem Cell Integrity","Hematopoietic Stem Cells","YTHDF3","PREVENTS","Hematopoietic Stem Cell Integrity","Hematopoietic Stem Cells"
"6596","34818872","m6A reader Ythdf3 protects hematopoietic stem cell integrity under stress by promoting the translation of Foxm1 and Asxl1 transcripts.","Ythdf3","promote","Translation","Hematopoietic Stem Cells","YTHDF3","STIMULATES","translation","Hematopoietic Stem Cells"
"6597","34818872","m6A reader Ythdf3 protects hematopoietic stem cell integrity under stress by promoting the translation of Foxm1 and Asxl1 transcripts.","Translation","is on","Foxm1","Hematopoietic Stem Cells","translation","LOCATES","FOXM1","Hematopoietic Stem Cells"
"6598","34818872","m6A reader Ythdf3 protects hematopoietic stem cell integrity under stress by promoting the translation of Foxm1 and Asxl1 transcripts.","Translation","is on","Asxl1","Hematopoietic Stem Cells","translation","LOCATES","ASXL1","Hematopoietic Stem Cells"
"6599","34818872","m6A reader Ythdf3 protects hematopoietic stem cell integrity under stress by promoting the translation of Foxm1 and Asxl1 transcripts.","Foxm1","regulate","Hematopoietic Stem Cell Integrity","Hematopoietic Stem Cells","FOXM1","AFFECTS","Hematopoietic Stem Cell Integrity","Hematopoietic Stem Cells"
"6600","34818872","m6A reader Ythdf3 protects hematopoietic stem cell integrity under stress by promoting the translation of Foxm1 and Asxl1 transcripts.","Asxl1","regulate","Hematopoietic Stem Cell Integrity","Hematopoietic Stem Cells","ASXL1","AFFECTS","Hematopoietic Stem Cell Integrity","Hematopoietic Stem Cells"
"6602","34825733","Mettl3 promotes oxLDL-mediated inflammation through activating STAT1 signaling.","Mettl3","promote","oxLDL-mediated inflammation","Null","METTL3","STIMULATES","oxLDL-mediated inflammation","Null"
"6603","34825733","Mettl3 promotes oxLDL-mediated inflammation through activating STAT1 signaling.","Mettl3","activate","STAT1 signaling","Null","METTL3","STIMULATES","STAT1 signaling pathway","Null"
"6604","34825733","Mettl3 promotes oxLDL-mediated inflammation through activating STAT1 signaling.","STAT1 signaling","promote","oxLDL-mediated inflammation","Null","STAT1 signaling pathway","STIMULATES","oxLDL-mediated inflammation","Null"
"6606","34843901","The m6A mRNA demethylase FTO regulates GnRH secretion in Mn-induced precocious puberty.","FTO","regulate","GnRH secretion","Mn-induced precocious puberty","FTO","AFFECTS","GnRH secretion","Mn-induced precocious puberty"
"6607","34843901","The m6A mRNA demethylase FTO regulates GnRH secretion in Mn-induced precocious puberty.","FTO","demethylate","m6A","Mn-induced precocious puberty","FTO","CONVERTS_TO","m6A","Mn-induced precocious puberty"
"6608","34843901","The m6A mRNA demethylase FTO regulates GnRH secretion in Mn-induced precocious puberty.","m6A","regulate","GnRH secretion","Mn-induced precocious puberty","m6A","AFFECTS","GnRH secretion","Mn-induced precocious puberty"
"6610","34850551","ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.","ALKBH5","mediate","m6A","LSCC","ALKBH5","AFFECTS","m6A","LUSC(Lung Squamous Cell Carcinoma)"
"6611","34850551","ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.","m6A","modify","lncRNA KCNQ1OT1","LSCC","m6A","AFFECTS","KCNQ1OT1","LUSC(Lung Squamous Cell Carcinoma)"
"6612","34850551","ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.","lncRNA KCNQ1OT1","trigger","development of LSCC","LSCC","KCNQ1OT1","CAUSES","development of LSCC","LUSC(Lung Squamous Cell Carcinoma)"
"6613","34850551","ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.","lncRNA KCNQ1OT1","upregulate","HOXA9","LSCC","KCNQ1OT1","STIMULATES","HOXA9","LUSC(Lung Squamous Cell Carcinoma)"
"6614","34850551","ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.","HOXA9","regulate","development of LSCC","LSCC","HOXA9","AFFECTS","development of LSCC","LUSC(Lung Squamous Cell Carcinoma)"
"6616","34882623","Research progress on the relationship between m6A methylation of YTHDF1 gene in the striatum and stereotyped behavior.","m6A methylation","is on","YTHDF1 gene","Striatum","m6A","LOCATES","YTHDF1","striatum"
"6617","34882623","Research progress on the relationship between m6A methylation of YTHDF1 gene in the striatum and stereotyped behavior.","YTHDF1 gene","relate to","stereotyped behavior","Striatum","YTHDF1","relate to","Stereotyped Behavior","striatum"
"6619","34882999","M6A methylation-mediated elevation of SM22alpha inhibits the proliferation and migration of vascular smooth muscle cells and ameliorates intimal hyperplasia in type 2 diabetes mellitus.","m6A methylation","elevate","SM22alpha","Type 2 Diabetes Mellitus","m6A","STIMULATES","TAGLN","Diabetes Mellitus, Type 2"
"6620","34882999","M6A methylation-mediated elevation of SM22alpha inhibits the proliferation and migration of vascular smooth muscle cells and ameliorates intimal hyperplasia in type 2 diabetes mellitus.","SM22alpha","inhibit","proliferation","Type 2 Diabetes Mellitus","TAGLN","INHIBITS","cell population proliferation","Diabetes Mellitus, Type 2"
"6621","34882999","M6A methylation-mediated elevation of SM22alpha inhibits the proliferation and migration of vascular smooth muscle cells and ameliorates intimal hyperplasia in type 2 diabetes mellitus.","SM22alpha","inhibit","migration","Type 2 Diabetes Mellitus","TAGLN","INHIBITS","migration","Diabetes Mellitus, Type 2"
"6622","34882999","M6A methylation-mediated elevation of SM22alpha inhibits the proliferation and migration of vascular smooth muscle cells and ameliorates intimal hyperplasia in type 2 diabetes mellitus.","SM22alpha","ameliorate","intimal hyperplasia","Type 2 Diabetes Mellitus","TAGLN","TREATS","Intimal hyperplasia","Diabetes Mellitus, Type 2"
"6624","34896211","IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer.","IGF2BP2","activate","ERBB2 signaling","Radioiodine-refractory Papillary Thyroid Cancer","IGF2BP2","STIMULATES","erbb2 signaling pathway","THCA(Thyroid Carcinoma)"
"6625","34896211","IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer.","ERBB2 signaling","contribute","Resistance","Radioiodine-refractory Papillary Thyroid Cancer","erbb2 signaling pathway","AFFECTS","resistance","THCA(Thyroid Carcinoma)"
"6626","34896211","IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer.","Resistance","to","Tyrosine kinase inhibitor","Radioiodine-refractory Papillary Thyroid Cancer","resistance","to","tyrosine kinase inhibitor","THCA(Thyroid Carcinoma)"
"6627","34896211","IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer.","Tyrosine kinase inhibitor","in","Differentiation therapy","Radioiodine-refractory Papillary Thyroid Cancer","tyrosine kinase inhibitor","in","Differentiation therapy","THCA(Thyroid Carcinoma)"
"6628","34896211","IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer.","Differentiation therapy","regulate","Resistance","Radioiodine-refractory Papillary Thyroid Cancer","Differentiation therapy","AFFECTS","resistance","THCA(Thyroid Carcinoma)"
"6630","34911015","The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation.","YTHDC2","promote","Gastric Cancer Progression","Gastric Cancer","YTHDC2","STIMULATES","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"6631","34911015","The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation.","YTHDC2","enhance","Translation","Gastric Cancer","YTHDC2","AUGMENTS","translation","STAD(Stomach adenocarcinoma)"
"6632","34911015","The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation.","Translation","promote","Gastric Cancer Progression","Gastric Cancer","translation","STIMULATES","Gastric Cancer Progression","STAD(Stomach adenocarcinoma)"
"6634","34915192","FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner.","FTO","promote","Multiple Myeloma Progression","Multiple Myeloma","FTO","STIMULATES","Multiple Myeloma Progression","Multiple Myeloma"
"6635","34915192","FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner.","FTO","activate","HSF1","Multiple Myeloma","FTO","STIMULATES","HSF1","Multiple Myeloma"
"6636","34915192","FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Multiple Myeloma","YTHDF2","INTERACTS_WITH","m6A","Multiple Myeloma"
"6637","34915192","FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner.","HSF1","promote","Multiple Myeloma Progression","Multiple Myeloma","HSF1","STIMULATES","Multiple Myeloma Progression","Multiple Myeloma"
"6639","34921949","N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through Hedgehog pathway.","AcSDKP","mitigate","Liver Fibrosis","Liver","goralatide","INHIBITS","Liver Cirrhosis","Liver"
"6640","34921949","N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through Hedgehog pathway.","AcSDKP","regulate","WTAP","Liver","goralatide","AFFECTS","WTAP","Liver"
"6641","34921949","N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through Hedgehog pathway.","WTAP","regulate","m6A","Liver","WTAP","AFFECTS","m6A","Liver"
"6642","34921949","N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through Hedgehog pathway.","m6A","regulate","Ptch1","Liver","m6A","AFFECTS","PTCH1","Liver"
"6643","34921949","N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through Hedgehog pathway.","Ptch1","regulate","Hedgehog pathway","Liver","PTCH1","AFFECTS","Hedgehog Pathway","Liver"
"6644","34921949","N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through Hedgehog pathway.","Hedgehog pathway","regulate","Liver Fibrosis","Liver","Hedgehog Pathway","AFFECTS","Liver Cirrhosis","Liver"
"6646","34921979","MiR-155 regulates m6A level and cell progression by targeting FTO in clear cell renal cell carcinoma.","MiR-155","regulate","m6A level","Clear Cell Renal Cell Carcinoma","MIR155","AFFECTS","m6A level","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6647","34921979","MiR-155 regulates m6A level and cell progression by targeting FTO in clear cell renal cell carcinoma.","MiR-155","target","FTO","Clear Cell Renal Cell Carcinoma","MIR155","INTERACTS_WITH","FTO","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6648","34921979","MiR-155 regulates m6A level and cell progression by targeting FTO in clear cell renal cell carcinoma.","FTO","regulate","m6A level","Clear Cell Renal Cell Carcinoma","FTO","AFFECTS","m6A level","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6649","34921979","MiR-155 regulates m6A level and cell progression by targeting FTO in clear cell renal cell carcinoma.","m6A level","regulate","Cell Progression","Clear Cell Renal Cell Carcinoma","m6A level","AFFECTS","Cell Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"6651","34930676","N6-methyladenosine-modified long non-coding RNA AGAP2-AS1 promotes psoriasis pathogenesis via miR-424-5p/AKT3 axis.","AGAP2-AS1","promote","psoriasis pathogenesis","Psoriasis","AGAP2-AS1","STIMULATES","psoriasis pathogenesis","Psoriasis"
"6652","34930676","N6-methyladenosine-modified long non-coding RNA AGAP2-AS1 promotes psoriasis pathogenesis via miR-424-5p/AKT3 axis.","AGAP2-AS1","regulate","miR-424-5p/AKT3 axis","Psoriasis","AGAP2-AS1","AFFECTS","miR-424-5p/AKT3 axis","Psoriasis"
"6653","34930676","N6-methyladenosine-modified long non-coding RNA AGAP2-AS1 promotes psoriasis pathogenesis via miR-424-5p/AKT3 axis.","miR-424-5p/AKT3 axis","regulate","psoriasis pathogenesis","Psoriasis","miR-424-5p/AKT3 axis","AFFECTS","psoriasis pathogenesis","Psoriasis"
"6655","34939643","Regulation of AR mRNA translation in response to acute AR pathway inhibition.","AR mRNA","undergo","translation","Null","AR","undergo","translation","Null"
"6656","34939643","Regulation of AR mRNA translation in response to acute AR pathway inhibition.","AR pathway","inhibit","translation","Null","AR pathway","INHIBITS","translation","Null"
"6658","34951345","Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.","UBA6-AS1","inhibit","malignancy","Ovarian Cancer Cells","UBA6-DT","INHIBITS","cancer","OV(Ovarian Serous Cystadenocarcinoma)"
"6659","34951345","Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.","UBA6-AS1","suppress decay of","UBA6 mRNA","Ovarian Cancer Cells","UBA6-DT","suppress decay of","UBA6","OV(Ovarian Serous Cystadenocarcinoma)"
"6660","34951345","Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.","UBA6 mRNA","regulate","malignancy","Ovarian Cancer Cells","UBA6","AFFECTS","cancer","OV(Ovarian Serous Cystadenocarcinoma)"
"6662","34952201","PHLDB2 mediates cetuximab resistance via interacting with EGFR in latent metastasis of colorectal cancer.","PHLDB2","mediate","Cetuximab Resistance","Colorectal Cancer","PHLDB2","AFFECTS","Cetuximab Resistance","COAD(Colon Adenocarcinoma)"
"6663","34952201","PHLDB2 mediates cetuximab resistance via interacting with EGFR in latent metastasis of colorectal cancer.","PHLDB2","interact","EGFR","Colorectal Cancer","PHLDB2","interact","EGFR","COAD(Colon Adenocarcinoma)"
"6664","34952201","PHLDB2 mediates cetuximab resistance via interacting with EGFR in latent metastasis of colorectal cancer.","EGFR","mediate","Cetuximab Resistance","Colorectal Cancer","EGFR","AFFECTS","Cetuximab Resistance","COAD(Colon Adenocarcinoma)"
"6666","34964205","Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.","METTL3","mediate","MALAT1/E2F1/AGR2 axis","Breast Cancer","METTL3","AFFECTS","MALAT1/E2F1/AGR2 axis","BRCA(Breast Invasive Carcinoma)"
"6667","34964205","Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.","MALAT1/E2F1/AGR2 axis","affect","Adriamycin Resistance","Breast Cancer","MALAT1/E2F1/AGR2 axis","AFFECTS","Adriamycin resistance","BRCA(Breast Invasive Carcinoma)"
"6669","34968454","N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer.","YTHDF1","promote","ARHGEF2 translation","Colorectal Cancer","YTHDF1","STIMULATES","ARHGEF2 translation","COAD(Colon Adenocarcinoma)"
"6670","34968454","N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer.","YTHDF1","bind","N6-methyladenosine","Colorectal Cancer","YTHDF1","INTERACTS_WITH","m6A","COAD(Colon Adenocarcinoma)"
"6671","34968454","N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer.","ARHGEF2 translation","promote","RhoA signaling","Colorectal Cancer","ARHGEF2 translation","STIMULATES","RhoA signaling pathway","COAD(Colon Adenocarcinoma)"
"6672","34968454","N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer.","RhoA signaling","promote","Colorectal Cancer","Colorectal Cancer","RhoA signaling pathway","STIMULATES","colorectal cancer","COAD(Colon Adenocarcinoma)"
"6674","34968619","N6-methyladenosine(m6A) demethylase FTO regulates cellular apoptosis following cobalt-induced oxidative stress.","FTO","regulate","cellular apoptosis","Null","FTO","AFFECTS","cellular apoptosis","Null"
"6675","34968619","N6-methyladenosine(m6A) demethylase FTO regulates cellular apoptosis following cobalt-induced oxidative stress.","cobalt","induce","oxidative stress","Null","Cobalt","CAUSES","Oxidative Stress","Null"
"6676","34968619","N6-methyladenosine(m6A) demethylase FTO regulates cellular apoptosis following cobalt-induced oxidative stress.","oxidative stress","condition","FTO","Null","Oxidative Stress","condition","FTO","Null"
"6678","34968770","METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation.","METTL3","ameliorate","Liver Damage","Mouse with hepatitis B virus-associated acute-on-chronic liver failure","METTL3","TREATS","Liver Damage","Mouse with hepatitis B virus-associated acute-on-chronic liver failure"
"6679","34968770","METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation.","METTL3","regulate","miR-146a-5p","Mouse with hepatitis B virus-associated acute-on-chronic liver failure","METTL3","AFFECTS","miR-146a-5p","Mouse with hepatitis B virus-associated acute-on-chronic liver failure"
"6680","34968770","METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation.","miR-146a-5p","undergo","Maturation","Mouse with hepatitis B virus-associated acute-on-chronic liver failure","miR-146a-5p","undergo","maturation","Mouse with hepatitis B virus-associated acute-on-chronic liver failure"
"6681","34968770","METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation.","Maturation","ameliorate","Liver Damage","Mouse with hepatitis B virus-associated acute-on-chronic liver failure","maturation","TREATS","Liver Damage","Mouse with hepatitis B virus-associated acute-on-chronic liver failure"
"6683","34970694","Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c-Myc translation.","METTL5","promote","Pancreatic Cancer Progression","Pancreatic Cancer","METTL5","STIMULATES","Pancreatic Cancer Progression","PAAD(Pancreatic Adenocarcinoma)"
"6684","34970694","Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c-Myc translation.","METTL5","modulate","c-Myc","Pancreatic Cancer","METTL5","AFFECTS","MYC","PAAD(Pancreatic Adenocarcinoma)"
"6685","34970694","Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c-Myc translation.","c-Myc","regulate","Pancreatic Cancer Progression","Pancreatic Cancer","MYC","AFFECTS","Pancreatic Cancer Progression","PAAD(Pancreatic Adenocarcinoma)"
"6687","34974052","Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas-2B cells induced by tobacco carcinogen NNK.","tobacco carcinogen NNK","induce","malignant transformation","Human bronchial epithelial Beas-2B cells","tobacco carcinogen NNK","CAUSES","Malignant Transformation","Human bronchial epithelial Beas-2B cells"
"6688","34974052","Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas-2B cells induced by tobacco carcinogen NNK.","m6A regulatory factor IGF2BP1","involve","malignant transformation","Human bronchial epithelial Beas-2B cells","IGF2BP1","ASSOCIATED_WITH","Malignant Transformation","Human bronchial epithelial Beas-2B cells"
"6690","34974239","BH+/MH+-matching method for discovery of cis-diol-containing modified nucleosides in urine by ribose-targeted solid phase extraction followed by dual-mass spectrometry platform identification.","BH+/MH+-matching method","discover","cis-diol-containing modified nucleosides","Urine","BH+/MH+-matching method","discover","cis-diol-containing modified nucleosides","Urine"
"6691","34974239","BH+/MH+-matching method for discovery of cis-diol-containing modified nucleosides in urine by ribose-targeted solid phase extraction followed by dual-mass spectrometry platform identification.","BH+/MH+-matching method","use","ribose-targeted solid phase extraction","Urine","BH+/MH+-matching method","USES","ribose-targeted solid phase extraction","Urine"
"6692","34974239","BH+/MH+-matching method for discovery of cis-diol-containing modified nucleosides in urine by ribose-targeted solid phase extraction followed by dual-mass spectrometry platform identification.","ribose-targeted solid phase extraction","followed by","dual-mass spectrometry platform","Urine","ribose-targeted solid phase extraction","followed by","dual-mass spectrometry platform","Urine"
"6693","34974239","BH+/MH+-matching method for discovery of cis-diol-containing modified nucleosides in urine by ribose-targeted solid phase extraction followed by dual-mass spectrometry platform identification.","dual-mass spectrometry platform","identify","identification","Urine","dual-mass spectrometry platform","DIAGNOSES","identification","Urine"
"6695","34974791","Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.","circPTK2","promote","proliferation","Colorectal Cancer","circPTK2","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"6696","34974791","Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.","circPTK2","promote","migration","Colorectal Cancer","circPTK2","STIMULATES","migration","COAD(Colon Adenocarcinoma)"
"6697","34974791","Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.","circPTK2","promote","invasion","Colorectal Cancer","circPTK2","STIMULATES","Neoplasm Invasiveness","COAD(Colon Adenocarcinoma)"
"6698","34974791","Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.","circPTK2","promote","chemoresistance","Colorectal Cancer","circPTK2","STIMULATES","chemoresistance","COAD(Colon Adenocarcinoma)"
"6709","33526437","Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells.","Gluten","induce","RNA methylation changes","Epithelial Cells","Glutens","CAUSES","RNA methylation changes","Epithelial Cells"
"6710","33526437","Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells.","RNA methylation changes","regulate","Intestinal Inflammation","Epithelial Cells","RNA methylation changes","AFFECTS","Intestinal Inflammation","Epithelial Cells"
"6711","33526437","Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells.","RNA methylation changes","regulate","allele-specific XPO1 translation","Epithelial Cells","RNA methylation changes","AFFECTS","allele-specific XPO1 translation","Epithelial Cells"
"6712","33526437","Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells.","XPO1","is in","allele-specific XPO1 translation","Epithelial Cells","XPO1","LOCATES","allele-specific XPO1 translation","Epithelial Cells"
"6713","33526437","Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells.","allele-specific XPO1 translation","regulate","Intestinal Inflammation","Epithelial Cells","allele-specific XPO1 translation","AFFECTS","Intestinal Inflammation","Epithelial Cells"
"6726","34479400","Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.","Methyltransferase-like 3","induce","N6-methyladenosine","Oral Squamous Cell Carcinoma","METTL3","CAUSES","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6727","34479400","Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.","N6-methyladenosine","regulate","p38","Oral Squamous Cell Carcinoma","m6A","AFFECTS","p38","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6728","34479400","Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.","p38","promote","Oral Squamous Cell Carcinoma","Oral Squamous Cell Carcinoma","p38","STIMULATES","oral squamous cell carcinoma","HNSC(Head and Neck Squamous Cell Carcinoma)"
"6743","34581943","Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice.","dummy","increase","m6A-RNA methylation","Endotoxemia in mice","dummy","AUGMENTS","m6A","Endotoxemia in mice"
"6744","34581943","Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice.","dummy","suppress","FTO","Endotoxemia in mice","dummy","INHIBITS","FTO","Endotoxemia in mice"
"6745","34581943","Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice.","m6A-RNA methylation","is associated with","myocardial inflammation","Endotoxemia in mice","m6A","is associated with","Myocarditis","Endotoxemia in mice"
"6746","34581943","Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice.","m6A-RNA methylation","is associated with","dysfunction","Endotoxemia in mice","m6A","is associated with","dysfunction","Endotoxemia in mice"
"6747","34581943","Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice.","FTO","is associated with","myocardial inflammation","Endotoxemia in mice","FTO","is associated with","Myocarditis","Endotoxemia in mice"
"6748","34581943","Increased m6A-RNA methylation and FTO suppression is associated with myocardial inflammation and dysfunction during endotoxemia in mice.","FTO","is associated with","dysfunction","Endotoxemia in mice","FTO","is associated with","dysfunction","Endotoxemia in mice"
"6750","34586620","METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.","METTL14","mediate","miR-30c-1-3p","Lung Cancer","METTL14","AFFECTS","miR-30c-1-3p","LUAD(Lung Adenocarcinoma)"
"6751","34586620","METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.","miR-30c-1-3p","repress","Progression","Lung Cancer","miR-30c-1-3p","INHIBITS","progression","LUAD(Lung Adenocarcinoma)"
"6752","34586620","METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.","miR-30c-1-3p","regulate","MARCKSL1","Lung Cancer","miR-30c-1-3p","AFFECTS","MARCKSL1","LUAD(Lung Adenocarcinoma)"
"6753","34586620","METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.","MARCKSL1","regulate","Progression","Lung Cancer","MARCKSL1","AFFECTS","progression","LUAD(Lung Adenocarcinoma)"
"6755","34599880","METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm-Controlled Gene Expression in Mice.","METTL3","regulate","Liver Homeostasis","Mice","METTL3","AFFECTS","Liver Homeostasis","Mice"
"6756","34599880","METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm-Controlled Gene Expression in Mice.","METTL3","regulate","Hepatocyte Ploidy","Mice","METTL3","AFFECTS","Hepatocyte Ploidy","Mice"
"6757","34599880","METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm-Controlled Gene Expression in Mice.","METTL3","regulate","Circadian Rhythm-Controlled Gene Expression","Mice","METTL3","AFFECTS","Circadian Rhythm-Controlled Gene Expression","Mice"
"6759","34608273","lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.","SP1","activate","THAP7-AS1","Null","SP1","STIMULATES","THAP7-AS1","Null"
"6760","34608273","lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.","METTL3","stabilize","m6A modification","Null","METTL3","MAINTAINS","m6A","Null"
"6761","34608273","lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.","THAP7-AS1","improve entry","CUL4B","Null","THAP7-AS1","improve entry","CUL4B","Null"
"6763","34648132","METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis.","Doxorubicin","induce","Ferroptosis","Cardiomyocytes","doxorubicin","CAUSES","Ferroptosis","Myocytes, Cardiac"
"6764","34648132","METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis.","METTL14","promote","Ferroptosis","Cardiomyocytes","METTL14","STIMULATES","Ferroptosis","Myocytes, Cardiac"
"6765","34648132","METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis.","METTL14","regulate","KCNQ1OT1-miR-7-5p-TFRC axis","Cardiomyocytes","METTL14","AFFECTS","KCNQ1OT1-miR-7-5p-TFRC axis","Myocytes, Cardiac"
"6766","34648132","METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis.","KCNQ1OT1-miR-7-5p-TFRC axis","regulate","Ferroptosis","Cardiomyocytes","KCNQ1OT1-miR-7-5p-TFRC axis","AFFECTS","Ferroptosis","Myocytes, Cardiac"
"6768","34657574","m6A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin.","YTHDC1","target","SQSTM1","Diabetic Skin","YTHDC1","INTERACTS_WITH","SQSTM1","Diabetic Skin"
"6769","34657574","m6A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin.","YTHDC1","modulate","Autophagy","Diabetic Skin","YTHDC1","AFFECTS","autophagy","Diabetic Skin"
"6770","34657574","m6A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin.","SQSTM1","regulate","Autophagy","Diabetic Skin","SQSTM1","AFFECTS","autophagy","Diabetic Skin"
"6772","35005123","Mettl5 mediated 18S rRNA N6-methyladenosine (m6A) modification controls stem cell fate determination and neural function.","Mettl5","mediate","18S rRNA N6-methyladenosine (m6A) modification","Stem cells and neural function","METTL5","AFFECTS","18S rRNA m6A modification","Stem cells and neural function"
"6773","35005123","Mettl5 mediated 18S rRNA N6-methyladenosine (m6A) modification controls stem cell fate determination and neural function.","18S rRNA N6-methyladenosine (m6A) modification","control","stem cell fate determination","Stem cells and neural function","18S rRNA m6A modification","AFFECTS","stem cell fate determination","Stem cells and neural function"
"6775","35224163","Melatonin antagonizes ovarian aging via YTHDF2-MAPK-NF-kappaB pathway.","Melatonin","antagonize","YTHDF2-MAPK-NF-kappaB pathway","Ovarian Aging","melatonin","antagonize","YTHDF2-MAPK-NF-kappaB pathway","Ovarian Aging"
"6777","37156816","LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer.","LINC00969","promote","gefitinib resistance","Lung Cancer","MIR570HG","STIMULATES","Gefitinib Resistance","LUAD(Lung Adenocarcinoma)"
"6778","37156816","LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer.","LINC00969","suppress","NLRP3","Lung Cancer","MIR570HG","INHIBITS","NLRP3","LUAD(Lung Adenocarcinoma)"
"6779","37156816","LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer.","NLRP3","inhibit","pyroptosis","Lung Cancer","NLRP3","INHIBITS","pyroptosis","LUAD(Lung Adenocarcinoma)"
"6780","37156816","LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer.","gefitinib resistance","regulate","pyroptosis","Lung Cancer","Gefitinib Resistance","AFFECTS","pyroptosis","LUAD(Lung Adenocarcinoma)"
"6787","NO_PMID","The m6A-Binding Protein YTHDF1 Mediates Immune Evasion.","YTHDF1","mediate","Immune Evasion","Null","YTHDF1","AFFECTS","Immune Evasion","Null"
"1","37735974","NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription","NRF1","mitigate","motor dysfunction","mice with Parkinson's disease","NRF1","INHIBITS","motor dysfunction","Parkinson Disease"
"2","37735974","NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription","NRF1","mitigate","dopamine neuron degeneration","mice with Parkinson's disease","NRF1","INHIBITS","motor dysfunction","Parkinson Disease"
"3","37735974","NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription","NRF1","upregulate","METTL3 transcription","mice with Parkinson's disease","NRF1","STIMULATES","motor dysfunction","Parkinson Disease"
"4","37735974","NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription","METTL3 transcription","promote","GLRX m6A methylation","mice with Parkinson's disease","METTL3","STIMULATES","GLRX m6A methylation","Parkinson Disease"
"5","37735974","NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription","GLRX m6A methylation","mitigate","motor dysfunction","mice with Parkinson's disease","GLRX m6A methylation","INHIBITS","motor dysfunction","Parkinson Disease"
"6","37735974","NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription","GLRX m6A methylation","mitigate","dopamine neuron degeneration","mice with Parkinson's disease","GLRX m6A methylation","INHIBITS","motor dysfunction","Parkinson Disease"
"11","37742191","ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control","ALKBH5","modulate","energy metabolism","hematopoietic stem and progenitor cell","ALKBH5","AFFECTS","Energy Metabolism","hematopoietic stem and progenitor cell"
"21","37742191","ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control","ALKBH5","regulate","m6A","hematopoietic stem and progenitor cell","ALKBH5","AFFECTS","Energy Metabolism","hematopoietic stem and progenitor cell"
"32","37742191","ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control","m6A","mediate","RNA stability control","hematopoietic stem and progenitor cell","m6A","AFFECTS","RNA stability control","hematopoietic stem and progenitor cell"
"41","37742191","ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control","RNA stability control","regulate","energy metabolism","hematopoietic stem and progenitor cell","RNA stability control","AFFECTS","Energy Metabolism","hematopoietic stem and progenitor cell"
"12","37658049","IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner","IGF2BP3","promote","progression","colorectal cancer","IGF2BP3","STIMULATES","progression","COAD(Colon Adenocarcinoma)"
"22","37658049","IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner","IGF2BP3","mediate","cetuximab resistance","colorectal cancer","IGF2BP3","AFFECTS","progression","COAD(Colon Adenocarcinoma)"
"33","37658049","IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner","IGF2BP3","regulate","m6A","colorectal cancer","IGF2BP3","AFFECTS","progression","COAD(Colon Adenocarcinoma)"
"42","37658049","IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner","m6A","stabilize","EGFR","colorectal cancer","m6A","MAINTAINS","EGFR","COAD(Colon Adenocarcinoma)"
"51","37658049","IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner","EGFR","stabilize","progression","colorectal cancer","EGFR","MAINTAINS","progression","COAD(Colon Adenocarcinoma)"
"61","37658049","IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner","EGFR","stabilize","cetuximab resistance","colorectal cancer","EGFR","MAINTAINS","progression","COAD(Colon Adenocarcinoma)"
"13","37803021","YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner","YTHDF2","facilitate","aggresome formation","Null","YTHDF2","STIMULATES","aggresome formation","Null"
"23","37803021","YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner","YTHDF2","bind","m6A","Null","YTHDF2","INTERACTS_WITH","aggresome formation","Null"
"34","37803021","YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner","m6A","regulate","UPF1","Null","m6A","AFFECTS","UPF1","Null"
"43","37803021","YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner","UPF1","facilitate","aggresome formation","Null","UPF1","STIMULATES","aggresome formation","Null"
"14","37663284","RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.","IGF2BP3","promote","progression","acute myeloid leukemia","IGF2BP3","STIMULATES","progression","LAML(Acute Myeloid Leukemia)"
"24","37663284","RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.","IGF2BP3","control stabilization of","EPOR mRNA","acute myeloid leukemia","IGF2BP3","MAINTAINS","progression","LAML(Acute Myeloid Leukemia)"
"35","37663284","RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.","EPOR mRNA","promote","progression","acute myeloid leukemia","EPOR","STIMULATES","progression","LAML(Acute Myeloid Leukemia)"
"15","37812443","YTHDF2 promotes DNA damage repair by positively regulating the histone methyltransferase SETDB1 in spermatogonia.","YTHDF2","promote","DNA damage repair","spermatogonia","YTHDF2","STIMULATES","DNA Damage Repair","Spermatogonia"
"25","37812443","YTHDF2 promotes DNA damage repair by positively regulating the histone methyltransferase SETDB1 in spermatogonia.","YTHDF2","positively regulate","SETDB1","spermatogonia","YTHDF2","STIMULATES","DNA Damage Repair","Spermatogonia"
"36","37812443","YTHDF2 promotes DNA damage repair by positively regulating the histone methyltransferase SETDB1 in spermatogonia.","SETDB1","promote","DNA damage repair","spermatogonia","SETDB1","STIMULATES","DNA Damage Repair","Spermatogonia"
"16","37692484","The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy","KIAA1429","stabilize","RAB27B","chronic myeloid leukemia","VIRMA","MAINTAINS","RAB27B","LAML(Acute Myeloid Leukemia)"
"26","37692484","The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy","KIAA1429","promote","progression","chronic myeloid leukemia","VIRMA","STIMULATES","RAB27B","LAML(Acute Myeloid Leukemia)"
"37","37692484","The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy","KIAA1429","promote resistance to","targeted therapy","chronic myeloid leukemia","VIRMA","PREVENTS","RAB27B","LAML(Acute Myeloid Leukemia)"
"17","37694982","N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.","N6-methyladenosine","induce","METTL1","Null","m6A","CAUSES","METTL1","Null"
"27","37694982","N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.","METTL1","promote","tumor proliferation","Null","METTL1","STIMULATES","Tumor Proliferation","Null"
"38","37694982","N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.","METTL1","regulate","CDK4","Null","METTL1","AFFECTS","Tumor Proliferation","Null"
"44","37694982","N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.","CDK4","promote","tumor proliferation","Null","CDK4","STIMULATES","Tumor Proliferation","Null"
"18","37700438","YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation","YTHDF2","promote","progression","gallbladder cancer","YTHDF2","STIMULATES","progression","CHOL(Cholangiocarcinoma)"
"28","37700438","YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation","YTHDF2","promote","gemcitabine resistance","gallbladder cancer","YTHDF2","STIMULATES","progression","CHOL(Cholangiocarcinoma)"
"39","37700438","YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation","YTHDF2","bind","m6A","gallbladder cancer","YTHDF2","INTERACTS_WITH","progression","CHOL(Cholangiocarcinoma)"
"45","37700438","YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation","m6A","regulate","DAPK3 degradation","gallbladder cancer","m6A","AFFECTS","DAPK3 degradation","CHOL(Cholangiocarcinoma)"
"52","37700438","YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation","DAPK3 degradation","promote","progression","gallbladder cancer","DAPK3 degradation","STIMULATES","progression","CHOL(Cholangiocarcinoma)"
"62","37700438","YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation","DAPK3 degradation","promote","gemcitabine resistance","gallbladder cancer","DAPK3 degradation","STIMULATES","progression","CHOL(Cholangiocarcinoma)"
"19","37710320","METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6","METTL3","exacerbate","insulin resistance","hepatocytes","METTL3","COMPLICATES","Insulin Resistance","Hepatocytes"
"210","37710320","METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6","METTL3","regulate","m6A","hepatocytes","METTL3","AFFECTS","Insulin Resistance","Hepatocytes"
"310","37710320","METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6","m6A","is on","cytochrome P450 2B6","hepatocytes","m6A","LOCATES","CYP2B6","Hepatocytes"
"46","37710320","METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6","cytochrome P450 2B6","exacerbate","insulin resistance","hepatocytes","CYP2B6","COMPLICATES","Insulin Resistance","Hepatocytes"
"110","37721438","VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models.","VIRMA","promote","neuron apoptosis","spinal cord injury animal models","VIRMA","STIMULATES","neuron apoptosis","spinal cord injury animal models"
"211","37721438","VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models.","VIRMA","induce","m6A","spinal cord injury animal models","VIRMA","CAUSES","neuron apoptosis","spinal cord injury animal models"
"311","37721438","VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models.","m6A","is on","STK10","spinal cord injury animal models","m6A","LOCATES","STK10","spinal cord injury animal models"
"47","37721438","VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models.","STK10","promote","neuron apoptosis","spinal cord injury animal models","STK10","STIMULATES","neuron apoptosis","spinal cord injury animal models"
"111","37733108","M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway","M6A","mediate upregulation of","HOXC10","human hepatocellular carcinoma","m6A","STIMULATES","HOXC10","LIHC(Liver Hepatocellular Carcinoma)"
"212","37733108","M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway","HOXC10","promote","development","human hepatocellular carcinoma","HOXC10","STIMULATES","development","LIHC(Liver Hepatocellular Carcinoma)"
"312","37733108","M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway","HOXC10","regulate","PTEN/AKT/mTOR signaling pathway","human hepatocellular carcinoma","HOXC10","AFFECTS","development","LIHC(Liver Hepatocellular Carcinoma)"
"48","37733108","M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway","PTEN/AKT/mTOR signaling pathway","promote","development","human hepatocellular carcinoma","PTEN/AKT/mTOR signaling pathway","STIMULATES","development","LIHC(Liver Hepatocellular Carcinoma)"
"112","37584615","ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes.","ALKBH5","mediate","m6A","rheumatoid fibroblast-like synoviocytes","ALKBH5","AFFECTS","m6A","rheumatoid fibroblast-like synoviocytes"
"213","37584615","ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes.","m6A","regulate","migration","rheumatoid fibroblast-like synoviocytes","m6A","AFFECTS","migration","rheumatoid fibroblast-like synoviocytes"
"313","37584615","ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes.","m6A","regulate","invasion","rheumatoid fibroblast-like synoviocytes","m6A","AFFECTS","migration","rheumatoid fibroblast-like synoviocytes"
"49","37584615","ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes.","m6A","regulate","proliferation","rheumatoid fibroblast-like synoviocytes","m6A","AFFECTS","migration","rheumatoid fibroblast-like synoviocytes"
"113","37588203","RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression.","YTHDF2","facilitate","miR-126","acute myeloid leukemia","YTHDF2","STIMULATES","MIR126","LAML(Acute Myeloid Leukemia)"
"214","37588203","RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression.","miR-126","promote","progression","acute myeloid leukemia","MIR126","STIMULATES","progression","LAML(Acute Myeloid Leukemia)"
"114","37589705","A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression.","METTL3","potentiate","METTL3-WTAP interaction","breast cancer","METTL3","STIMULATES","METTL3-WTAP interaction","BRCA(Breast Invasive Carcinoma)"
"215","37589705","A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression.","METTL3","potentiate","progression","breast cancer","METTL3","STIMULATES","METTL3-WTAP interaction","BRCA(Breast Invasive Carcinoma)"
"115","37591781","Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner.","Gemcitabine","Inhibit","Progression","Pancreatic Cancer","gemcitabine","INHIBITS","progression","PAAD(Pancreatic Adenocarcinoma)"
"216","37591781","Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner.","Gemcitabine","regulate","m6A","Pancreatic Cancer","gemcitabine","AFFECTS","progression","PAAD(Pancreatic Adenocarcinoma)"
"314","37591781","Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner.","m6A","restrain","WTAP/MYC Chain","Pancreatic Cancer","m6A","INHIBITS","WTAP/MYC Chain","PAAD(Pancreatic Adenocarcinoma)"
"410","37591781","Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner.","WTAP/MYC Chain","Inhibit","Progression","Pancreatic Cancer","WTAP/MYC Chain","INHIBITS","progression","PAAD(Pancreatic Adenocarcinoma)"
"118","37594665","METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression","METTL14","drive","growth","non-small cell lung cancer","METTL14","STIMULATES","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"217","37594665","METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression","METTL14","drive","metastasis","non-small cell lung cancer","METTL14","STIMULATES","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"315","37594665","METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression","METTL14","regulate","pri-miR-93-5p","non-small cell lung cancer","METTL14","AFFECTS","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"411","37594665","METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression","METTL14","regulate","TXNIP","non-small cell lung cancer","METTL14","AFFECTS","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"53","37594665","METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression","pri-miR-93-5p","drive","growth","non-small cell lung cancer","pri-miR-93-5p","STIMULATES","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"66","37594665","METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression","pri-miR-93-5p","drive","metastasis","non-small cell lung cancer","pri-miR-93-5p","STIMULATES","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"7","37594665","METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression","TXNIP","drive","growth","non-small cell lung cancer","TXNIP","STIMULATES","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"8","37594665","METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression","TXNIP","drive","metastasis","non-small cell lung cancer","TXNIP","STIMULATES","Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"119","37599611","Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner.","Xanthine derivatives","inhibit","FTO","Null","Xanthine derivatives","INHIBITS","FTO","Null"
"218","37599611","Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner.","Xanthine derivatives","regualte","L-ascorbic acid","Null","Xanthine derivatives","AFFECTS","FTO","Null"
"316","37599611","Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner.","L-ascorbic acid","inhibit","FTO","Null","L-ascorbic acid","INHIBITS","FTO","Null"
"120","37603553","Kar4, the yeast homolog of METTL14, is required for mRNA m6A methylation and meiosis","Kar4","is required for","m6A","Null","KAR 4","CAUSES","m6A","Null"
"219","37603553","Kar4, the yeast homolog of METTL14, is required for mRNA m6A methylation and meiosis","Kar4","is required for","meiosis","Null","KAR 4","CAUSES","m6A","Null"
"121","37604948","miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.","miR-33a-3p","regulate","METTL3","pancreatic cancer","miR-33a-3p","AFFECTS","METTL3","PAAD(Pancreatic Adenocarcinoma)"
"220","37604948","miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.","METTL3","mediate","AREG","pancreatic cancer","METTL3","AFFECTS","AREG","PAAD(Pancreatic Adenocarcinoma)"
"317","37604948","miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.","miR-33a-3p","alter","EMT","pancreatic cancer","miR-33a-3p","AFFECTS","METTL3","PAAD(Pancreatic Adenocarcinoma)"
"412","37604948","miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.","AREG","inhibit","invasion","pancreatic cancer","AREG","INHIBITS","Neoplasm Invasiveness","PAAD(Pancreatic Adenocarcinoma)"
"54","37604948","miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.","AREG","inhibit","metastasis","pancreatic cancer","AREG","INHIBITS","Neoplasm Invasiveness","PAAD(Pancreatic Adenocarcinoma)"
"67","37604948","miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.","EMT","inhibit","invasion","pancreatic cancer","epithelial to mesenchymal transition","INHIBITS","Neoplasm Invasiveness","PAAD(Pancreatic Adenocarcinoma)"
"71","37604948","miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.","EMT","inhibit","metastasis","pancreatic cancer","epithelial to mesenchymal transition","INHIBITS","Neoplasm Invasiveness","PAAD(Pancreatic Adenocarcinoma)"
"122","37611825","eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.","eIF3i","promote","survival","colorectal cancer cell","EIF3I","STIMULATES","Survival","COAD(Colon Adenocarcinoma)"
"221","37611825","eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.","eIF3i","augment","PHGDH","colorectal cancer cell","EIF3I","AUGMENTS","Survival","COAD(Colon Adenocarcinoma)"
"318","37611825","eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.","PHGDH","promote","survival","colorectal cancer cell","PHGDH","STIMULATES","Survival","COAD(Colon Adenocarcinoma)"
"123","37612282","ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.","ALKBH5","promote","apoptosis","hypopharyngeal squamous cell carcinoma","ALKBH5","STIMULATES","apoptotic process","HNSC(Head and Neck Squamous Cell Carcinoma)"
"222","37612282","ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.","ALKBH5","regulate","YTHDF1","hypopharyngeal squamous cell carcinoma","ALKBH5","AFFECTS","apoptotic process","HNSC(Head and Neck Squamous Cell Carcinoma)"
"322","37612282","ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.","ALKBH5","regulate","IGF2BP2","hypopharyngeal squamous cell carcinoma","ALKBH5","AFFECTS","apoptotic process","HNSC(Head and Neck Squamous Cell Carcinoma)"
"413","37612282","ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.","YTHDF1","target","TLR2","hypopharyngeal squamous cell carcinoma","YTHDF1","INTERACTS_WITH","TLR2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"55","37612282","ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.","IGF2BP2","target","TLR2","hypopharyngeal squamous cell carcinoma","IGF2BP2","INTERACTS_WITH","TLR2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"68","37612282","ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.","TLR2","promote","apoptosis","hypopharyngeal squamous cell carcinoma","TLR2","STIMULATES","apoptotic process","HNSC(Head and Neck Squamous Cell Carcinoma)"
"124","32566583","ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.","ALKBH5","promote","proliferation","renal cell carcinoma","ALKBH5","STIMULATES","cell population proliferation","KIRC(Kidney Renal Clear Cell Carcinoma)"
"223","32566583","ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.","ALKBH5","regulate","m6A","renal cell carcinoma","ALKBH5","AFFECTS","cell population proliferation","KIRC(Kidney Renal Clear Cell Carcinoma)"
"323","32566583","ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.","m6A","regulate","AURKB","renal cell carcinoma","m6A","AFFECTS","AURKB","KIRC(Kidney Renal Clear Cell Carcinoma)"
"414","32566583","ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.","AURKB","promote","proliferation","renal cell carcinoma","AURKB","STIMULATES","cell population proliferation","KIRC(Kidney Renal Clear Cell Carcinoma)"
"125","33230473","YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","YTHDF1","facilitate","progression","hepatocellular carcinoma","YTHDF1","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"224","33230473","YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","YTHDF1","bind","m6A","hepatocellular carcinoma","YTHDF1","INTERACTS_WITH","progression","LIHC(Liver Hepatocellular Carcinoma)"
"324","33230473","YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","m6A","promote","FZD5","hepatocellular carcinoma","m6A","STIMULATES","FZD5","LIHC(Liver Hepatocellular Carcinoma)"
"415","33230473","YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.","FZD5","facilitate","progression","hepatocellular carcinoma","FZD5","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"126","30648791","N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1alpha signalling axis.","FTO","suppress","clear cell renal cell carcinoma","clear cell renal cell carcinoma","FTO","INHIBITS","Clear Cell Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"225","30648791","N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1alpha signalling axis.","FTO","regulate","FTO-PGC-1alpha signalling axis","clear cell renal cell carcinoma","FTO","AFFECTS","Clear Cell Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"325","30648791","N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1alpha signalling axis.","FTO-PGC-1alpha signalling axis","suppress","clear cell renal cell carcinoma","clear cell renal cell carcinoma","FTO-PGC-1alpha signalling axis","INHIBITS","Clear Cell Renal Cell Carcinoma Progression","KIRC(Kidney Renal Clear Cell Carcinoma)"
"127","33634966","FTO modifies the m6A level of MALAT and promotes bladder cancer progression.","FTO","modify","m6A","bladder cancer","FTO","AFFECTS","m6A","BLCA(Bladder Urothelial Carcinoma)"
"226","33634966","FTO modifies the m6A level of MALAT and promotes bladder cancer progression.","m6A","is on","MALAT","bladder cancer","m6A","LOCATES","MALAT","BLCA(Bladder Urothelial Carcinoma)"
"326","33634966","FTO modifies the m6A level of MALAT and promotes bladder cancer progression.","FTO","promote","progression","bladder cancer","FTO","STIMULATES","m6A","BLCA(Bladder Urothelial Carcinoma)"
"128","30659266","The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network.","METTL3","promote","progression","bladder cancer","METTL3","STIMULATES","progression","BLCA(Bladder Urothelial Carcinoma)"
"227","30659266","The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network.","METTL3","regulate","AFF4/NF-kappaB/MYC signaling network","bladder cancer","METTL3","AFFECTS","progression","BLCA(Bladder Urothelial Carcinoma)"
"327","30659266","The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network.","AFF4/NF-kappaB/MYC signaling network","promote","progression","bladder cancer","AFF4/NF-kappaB/MYC signaling network","STIMULATES","progression","BLCA(Bladder Urothelial Carcinoma)"
"129","32110044","FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.","FTO","facilitate","cell progression","lung adenocarcinoma","FTO","STIMULATES","Cell Progression","LUAD(Lung Adenocarcinoma)"
"228","32110044","FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.","FTO","regulate","mRNA demethylation","lung adenocarcinoma","FTO","AFFECTS","Cell Progression","LUAD(Lung Adenocarcinoma)"
"328","32110044","FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.","mRNA demethylation","activate","cell migration","lung adenocarcinoma","mRNA demethylation","STIMULATES","cell migration","LUAD(Lung Adenocarcinoma)"
"416","32110044","FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.","cell migration","facilitate","cell progression","lung adenocarcinoma","cell migration","STIMULATES","Cell Progression","LUAD(Lung Adenocarcinoma)"
"130","33980824","RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.","YTHDF2","facilitate","cell proliferation","lung adenocarcinoma","YTHDF2","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"229","33980824","RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.","YTHDF2","facilitate","metastasis","lung adenocarcinoma","YTHDF2","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"329","33980824","RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.","YTHDF2","target","AXIN1/Wnt/beta-catenin signaling","lung adenocarcinoma","YTHDF2","INTERACTS_WITH","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"417","33980824","RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.","AXIN1/Wnt/beta-catenin signaling","facilitate","cell proliferation","lung adenocarcinoma","AXIN1/Wnt/beta-catenin signaling pathway","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"56","33980824","RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.","AXIN1/Wnt/beta-catenin signaling","facilitate","metastasis","lung adenocarcinoma","AXIN1/Wnt/beta-catenin signaling pathway","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"131","32772918","ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.","ALKBH5","suppress","malignancy","hepatocellular carcinoma","ALKBH5","INHIBITS","cancer","LIHC(Liver Hepatocellular Carcinoma)"
"230","32772918","ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.","ALKBH5","regulate","m6A","hepatocellular carcinoma","ALKBH5","AFFECTS","cancer","LIHC(Liver Hepatocellular Carcinoma)"
"330","32772918","ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.","m6A","inhibit","LYPD1","hepatocellular carcinoma","m6A","INHIBITS","LYPD1","LIHC(Liver Hepatocellular Carcinoma)"
"418","32772918","ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.","LYPD1","suppress","malignancy","hepatocellular carcinoma","LYPD1","INHIBITS","cancer","LIHC(Liver Hepatocellular Carcinoma)"
"132","31735169","YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.","dummy","reduct","YTHDF2","hepatocellular carcinoma","dummy","INHIBITS","YTHDF2","LIHC(Liver Hepatocellular Carcinoma)"
"231","31735169","YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.","YTHDF2","fuel","inflammation","hepatocellular carcinoma","YTHDF2","STIMULATES","inflammatory response","LIHC(Liver Hepatocellular Carcinoma)"
"331","31735169","YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.","YTHDF2","fuel","vascular abnormalization","hepatocellular carcinoma","YTHDF2","STIMULATES","inflammatory response","LIHC(Liver Hepatocellular Carcinoma)"
"133","31632576","m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.","FTO","promote","tumorigenesis","hepatocellular carcinoma","FTO","STIMULATES","Carcinogenesis","LIHC(Liver Hepatocellular Carcinoma)"
"232","31632576","m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.","FTO","demethylate","PKM2","hepatocellular carcinoma","FTO","CONVERTS_TO","Carcinogenesis","LIHC(Liver Hepatocellular Carcinoma)"
"332","31632576","m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.","PKM2","promote","tumorigenesis","hepatocellular carcinoma","PKM","STIMULATES","Carcinogenesis","LIHC(Liver Hepatocellular Carcinoma)"
"134","34503454","METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.","METTL14","promote","glomerular endothelial cell injury","diabetic nephropathy","METTL14","STIMULATES","glomerular endothelial cell injury","DIANPH"
"233","34503454","METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.","METTL14","promote","diabetic nephropathy","diabetic nephropathy","METTL14","STIMULATES","glomerular endothelial cell injury","DIANPH"
"333","34503454","METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.","METTL14","regulate","m6A","diabetic nephropathy","METTL14","AFFECTS","glomerular endothelial cell injury","DIANPH"
"419","34503454","METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.","m6A","is on","alpha-klotho","diabetic nephropathy","m6A","LOCATES","KL","DIANPH"
"57","34503454","METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.","alpha-klotho","promote","glomerular endothelial cell injury","diabetic nephropathy","KL","STIMULATES","glomerular endothelial cell injury","DIANPH"
"69","34503454","METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.","alpha-klotho","promote","diabetic nephropathy","diabetic nephropathy","KL","STIMULATES","glomerular endothelial cell injury","DIANPH"
"135","34169564","ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.","ALKBH5","demethylate","m6A","T-cell acute lymphoblastic leukemia cell","ALKBH5","CONVERTS_TO","m6A","T-cell acute lymphoblastic leukemia cell"
"234","34169564","ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.","m6A","is on","USP1","T-cell acute lymphoblastic leukemia cell","m6A","LOCATES","USP1","T-cell acute lymphoblastic leukemia cell"
"334","34169564","ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.","USP1","regulate","glucocorticoid resistance","T-cell acute lymphoblastic leukemia cell","USP1","AFFECTS","Glucocorticoid Receptor Deficiency","T-cell acute lymphoblastic leukemia cell"
"420","34169564","ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.","USP1","regulate","Aurora B","T-cell acute lymphoblastic leukemia cell","USP1","AFFECTS","Glucocorticoid Receptor Deficiency","T-cell acute lymphoblastic leukemia cell"
"58","34169564","ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.","Aurora B","regulate","glucocorticoid resistance","T-cell acute lymphoblastic leukemia cell","Aurora B","AFFECTS","Glucocorticoid Receptor Deficiency","T-cell acute lymphoblastic leukemia cell"
"136","34530048","METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation.","METTL3","induce the resistance of","PLX4032","melanoma","METTL3","PREVENTS","PLX4032","SKCM(Skin Cutaneous Melanoma)"
"235","34530048","METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation.","METTL3","promote","m6A","melanoma","METTL3","STIMULATES","PLX4032","SKCM(Skin Cutaneous Melanoma)"
"335","34530048","METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation.","m6A","regulate","EGRF","melanoma","m6A","AFFECTS","EGRF","SKCM(Skin Cutaneous Melanoma)"
"421","34530048","METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation.","EGRF","induce the resistance of","PLX4032","melanoma","EGRF","PREVENTS","PLX4032","SKCM(Skin Cutaneous Melanoma)"
"137","32633395","METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.","METTL14","regulate","M6A","cardiovascular endothelial cell","METTL14","AFFECTS","m6A","cardiovascular endothelial cell"
"236","32633395","METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.","M6A","regulate","miR-19a","cardiovascular endothelial cell","m6A","AFFECTS","MIR19A","cardiovascular endothelial cell"
"336","32633395","METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.","miR-19a","promote","proliferation","cardiovascular endothelial cell","MIR19A","STIMULATES","cell population proliferation","cardiovascular endothelial cell"
"422","32633395","METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.","miR-19a","promote","invasion","cardiovascular endothelial cell","MIR19A","STIMULATES","cell population proliferation","cardiovascular endothelial cell"
"138","34088349","YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.","YTHDF1","promote","progression","hepatocellular carcinoma","YTHDF1","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"237","34088349","YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.","YTHDF1","activate","PI3K/AKT/mTOR signaling pathway","hepatocellular carcinoma","YTHDF1","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"337","34088349","YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.","YTHDF1","induce","epithelial-mesenchymal transition.","hepatocellular carcinoma","YTHDF1","CAUSES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"423","34088349","YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.","PI3K/AKT/mTOR signaling pathway","promote","progression","hepatocellular carcinoma","PI3K/AKT/mTOR pathway","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"59","34088349","YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.","epithelial-mesenchymal transition.","promote","progression","hepatocellular carcinoma","epithelial-mesenchymal transition.","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"139","31434789","The RNA demethylase FTO is required for maintenance of bone mass and functions to protect osteoblasts from genotoxic damage.","FTO","maintain","bone mass","osteoblasts","FTO","MAINTAINS","bone mass","Osteoblasts"
"238","31434789","The RNA demethylase FTO is required for maintenance of bone mass and functions to protect osteoblasts from genotoxic damage.","FTO","prevent","genotoxic damage","osteoblasts","FTO","PREVENTS","bone mass","Osteoblasts"
"140","33505426","YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.","YTHDF2","inhibit","cell growth","Gastric Cancer","YTHDF2","INHIBITS","cell growth","STAD(Stomach adenocarcinoma)"
"239","33505426","YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.","YTHDF2","regulate","FOXC2 signaling pathway","Gastric Cancer","YTHDF2","AFFECTS","cell growth","STAD(Stomach adenocarcinoma)"
"338","33505426","YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.","FOXC2 signaling pathway","inhibit","cell growth","Gastric Cancer","FOXC2 signaling pathway","INHIBITS","cell growth","STAD(Stomach adenocarcinoma)"
"141","33335426","METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.","METTL14","promote","Apoptosis","Osteosarcoma","METTL14","STIMULATES","apoptotic process","SARC(Sarcoma)"
"240","33335426","METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.","METTL14","slow","Tumor Progression","Osteosarcoma","METTL14","INHIBITS","apoptotic process","SARC(Sarcoma)"
"339","33335426","METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.","METTL14","activate","Caspase 3","Osteosarcoma","METTL14","STIMULATES","apoptotic process","SARC(Sarcoma)"
"424","33335426","METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.","Caspase 3","promote","Apoptosis","Osteosarcoma","CASP3","STIMULATES","apoptotic process","SARC(Sarcoma)"
"510","33335426","METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.","Caspase 3","slow","Tumor Progression","Osteosarcoma","CASP3","INHIBITS","apoptotic process","SARC(Sarcoma)"
"142","34326699","Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.","dummy","downregulate","YTHDC2","Malignant Lung Cells","dummy","INHIBITS","YTHDC2","LUAD(Lung Adenocarcinoma)"
"241","34326699","Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.","YTHDC2","promote","Proliferation","Malignant Lung Cells","YTHDC2","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"340","34326699","Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.","YTHDC2","promote","Migration","Malignant Lung Cells","YTHDC2","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"425","34326699","Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.","YTHDC2","regulate","CYLD/NF-kappaB Pathway","Malignant Lung Cells","YTHDC2","AFFECTS","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"511","34326699","Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.","CYLD/NF-kappaB Pathway","promote","Proliferation","Malignant Lung Cells","CYLD/NF-kappaB Pathway","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"610","34326699","Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.","CYLD/NF-kappaB Pathway","promote","Migration","Malignant Lung Cells","CYLD/NF-kappaB Pathway","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"143","34520821","VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.","VIRMA","contribute","Progression","Non-small cell lung cancer","VIRMA","AFFECTS","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"242","34520821","VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.","VIRMA","modify","N6-methyladenosine","Non-small cell lung cancer","VIRMA","AFFECTS","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"341","34520821","VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.","N6-methyladenosine","is on","DAPK3","Non-small cell lung cancer","m6A","LOCATES","DAPK3","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"426","34520821","VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.","DAPK3","contribute","Progression","Non-small cell lung cancer","DAPK3","AFFECTS","progression","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"144","32954854","METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.","METTL3","contribute","Renal Ischemia-Reperfusion Injury","Renal Ischemia-Reperfusion Injury","METTL3","AFFECTS","Renal Ischemia-Reperfusion Injury","Renal Ischemia-Reperfusion Injury"
"243","32954854","METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.","METTL3","methylate","Foxd1","Renal Ischemia-Reperfusion Injury","METTL3","CONVERTS_TO","Renal Ischemia-Reperfusion Injury","Renal Ischemia-Reperfusion Injury"
"342","32954854","METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.","Foxd1","regulate","Renal Ischemia-Reperfusion Injury","Renal Ischemia-Reperfusion Injury","FOXD1","AFFECTS","Renal Ischemia-Reperfusion Injury","Renal Ischemia-Reperfusion Injury"
"145","32802173","METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.","METTL14","aggravate","Endothelial inflammation","Atherosclerosis","METTL14","COMPLICATES","Endothelial inflammation","Atherosclerosis"
"244","32802173","METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.","METTL14","aggravate","Atherosclerosis","Atherosclerosis","METTL14","COMPLICATES","Endothelial inflammation","Atherosclerosis"
"343","32802173","METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.","METTL14","increase","N6-methyladeosine","Atherosclerosis","METTL14","AUGMENTS","Endothelial inflammation","Atherosclerosis"
"427","32802173","METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.","N6-methyladeosine","is on","FOXO1","Atherosclerosis","m6A","LOCATES","FOXO1","Atherosclerosis"
"512","32802173","METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.","FOXO1","aggravate","Endothelial inflammation","Atherosclerosis","FOXO1","COMPLICATES","Endothelial inflammation","Atherosclerosis"
"611","32802173","METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.","FOXO1","aggravate","Atherosclerosis","Atherosclerosis","FOXO1","COMPLICATES","Endothelial inflammation","Atherosclerosis"
"149","32914682","Enterotoxigenic Escherichia coli infection promotes enteric defensin expression via FOXO6-METTL3-m6A-GPR161 signaling axis.","Enterotoxigenic Escherichia coli infection","promote","enteric defensin expression","Enterotoxigenic Escherichia coli infection","Enterotoxigenic Escherichia coli infection","STIMULATES","enteric defensin expression","Enterotoxigenic Escherichia coli infection"
"245","32914682","Enterotoxigenic Escherichia coli infection promotes enteric defensin expression via FOXO6-METTL3-m6A-GPR161 signaling axis.","Enterotoxigenic Escherichia coli infection","regulate","FOXO6-METTL3-m6A-GPR161 signaling axis","Enterotoxigenic Escherichia coli infection","Enterotoxigenic Escherichia coli infection","AFFECTS","enteric defensin expression","Enterotoxigenic Escherichia coli infection"
"344","32914682","Enterotoxigenic Escherichia coli infection promotes enteric defensin expression via FOXO6-METTL3-m6A-GPR161 signaling axis.","FOXO6-METTL3-m6A-GPR161 signaling axis","promote","enteric defensin expression","Enterotoxigenic Escherichia coli infection","FOXO6-METTL3-m6A-GPR161 signaling axis","STIMULATES","enteric defensin expression","Enterotoxigenic Escherichia coli infection"
"153","32719557","NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.","NADP","enhance","FTO","Null","NADP","AUGMENTS","FTO","Null"
"246","32719557","NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.","FTO","modulate","m6A methylation","Null","FTO","AFFECTS","m6A","Null"
"345","32719557","NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.","FTO","modulate","adipogenesis","Null","FTO","AFFECTS","m6A","Null"
"428","32719557","NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.","NADP","modulate","m6A methylation","Null","NADP","AFFECTS","FTO","Null"
"513","32719557","NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.","NADP","modulate","adipogenesis","Null","NADP","AFFECTS","FTO","Null"
"154","29795461","Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.","Epigallocatechin gallate","target","FTO","Null","epigallocatechin gallate","INTERACTS_WITH","FTO","Null"
"247","29795461","Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.","Epigallocatechin gallate","inhibit","adipogenesis","Null","epigallocatechin gallate","INHIBITS","FTO","Null"
"346","29795461","Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.","Epigallocatechin gallate","regulate","m6A","Null","epigallocatechin gallate","AFFECTS","FTO","Null"
"429","29795461","Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Null","YTHDF2","INTERACTS_WITH","m6A","Null"
"514","29795461","Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.","m6A","inhibit","adipogenesis","Null","m6A","INHIBITS","Adipogenesis","Null"
"155","33783988","AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.","AMD1","upregulate","Stemness","Hepatocellular Carcinoma","AMD1","STIMULATES","Stemness","LIHC(Liver Hepatocellular Carcinoma)"
"248","33783988","AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.","AMD1","regulate","FTO","Hepatocellular Carcinoma","AMD1","AFFECTS","Stemness","LIHC(Liver Hepatocellular Carcinoma)"
"351","33783988","AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.","FTO","mediate","mRNA demethylation","Hepatocellular Carcinoma","FTO","AFFECTS","mRNA demethylation","LIHC(Liver Hepatocellular Carcinoma)"
"430","33783988","AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.","mRNA demethylation","upregulate","Stemness","Hepatocellular Carcinoma","mRNA demethylation","STIMULATES","Stemness","LIHC(Liver Hepatocellular Carcinoma)"
"156","33283713","Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway.","Hsa-let-7b-5p","inhibit","Proliferation","Human Leukemia THP-1 Cells","Hsa-let-7b-5p","INHIBITS","cell population proliferation","Human Leukemia THP-1 Cells"
"249","33283713","Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway.","Hsa-let-7b-5p","regulate","FTO/m6A/MYC Signaling Pathway","Human Leukemia THP-1 Cells","Hsa-let-7b-5p","AFFECTS","cell population proliferation","Human Leukemia THP-1 Cells"
"352","33283713","Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway.","FTO/m6A/MYC Signaling Pathway","inhibit","Proliferation","Human Leukemia THP-1 Cells","FTO/m6A/MYC signaling pathway","INHIBITS","cell population proliferation","Human Leukemia THP-1 Cells"
"157","33614908","Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.","YTHDF1","resensitize","Cisplatin-resistant colon cancer cells","Cisplatin-resistant colon cancer","YTHDF1","SENSITIZES","Cisplatin-resistant colon cancer cells","Cisplatin-resistant colon cancer"
"250","33614908","Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.","YTHDF1","modulate","GLS","Cisplatin-resistant colon cancer","YTHDF1","AFFECTS","Cisplatin-resistant colon cancer cells","Cisplatin-resistant colon cancer"
"353","33614908","Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.","GLS","mediate","glutamine metabolism","Cisplatin-resistant colon cancer","GLS","AFFECTS","glutamine metabolic process","Cisplatin-resistant colon cancer"
"431","33614908","Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.","glutamine metabolism","cause","Cisplatin-resistant colon cancer","Cisplatin-resistant colon cancer","glutamine metabolic process","CAUSES","Cisplatin-resistant colon cancer","Cisplatin-resistant colon cancer"
"158","34094960","METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression.","METTL3","promote","Metastasis","Esophageal Squamous Cell Carcinoma","METTL3","STIMULATES","Neoplasm Metastasis","ESCA(Esophageal Carcinoma)"
"251","34094960","METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression.","METTL3","enhance","GLS2","Esophageal Squamous Cell Carcinoma","METTL3","AUGMENTS","Neoplasm Metastasis","ESCA(Esophageal Carcinoma)"
"354","34094960","METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression.","GLS2","promote","Metastasis","Esophageal Squamous Cell Carcinoma","GLS2","STIMULATES","Neoplasm Metastasis","ESCA(Esophageal Carcinoma)"
"159","33378974","N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability.","WTAP","accelerate","Warburg effect","Gastric Cancer","WTAP","STIMULATES","Warburg effect","STAD(Stomach adenocarcinoma)"
"252","33378974","N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability.","WTAP","regulate","HK2","Gastric Cancer","WTAP","AFFECTS","Warburg effect","STAD(Stomach adenocarcinoma)"
"355","33378974","N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability.","HK2","accelerate","Warburg effect","Gastric Cancer","HK2","STIMULATES","Warburg effect","STAD(Stomach adenocarcinoma)"
"160","32323801","METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.","METTL14","promote","Migration","Breast Cancer","METTL14","STIMULATES","migration","BRCA(Breast Invasive Carcinoma)"
"253","32323801","METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.","METTL14","promote","Invasion","Breast Cancer","METTL14","STIMULATES","migration","BRCA(Breast Invasive Carcinoma)"
"356","32323801","METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.","METTL14","modulate","N6-methyladenosine","Breast Cancer","METTL14","AFFECTS","migration","BRCA(Breast Invasive Carcinoma)"
"432","32323801","METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.","METTL14","modulate","hsa-miR-146a-5p","Breast Cancer","METTL14","AFFECTS","migration","BRCA(Breast Invasive Carcinoma)"
"515","32323801","METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.","N6-methyladenosine","promote","Migration","Breast Cancer","m6A","STIMULATES","migration","BRCA(Breast Invasive Carcinoma)"
"612","32323801","METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.","hsa-miR-146a-5p","promote","Migration","Breast Cancer","hsa-miR-146a-5p","STIMULATES","migration","BRCA(Breast Invasive Carcinoma)"
"72","32323801","METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.","N6-methyladenosine","promote","Invasion","Breast Cancer","m6A","STIMULATES","migration","BRCA(Breast Invasive Carcinoma)"
"81","32323801","METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.","hsa-miR-146a-5p","promote","Invasion","Breast Cancer","hsa-miR-146a-5p","STIMULATES","migration","BRCA(Breast Invasive Carcinoma)"
"161","33794982","HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.","HNRNPA2B1","promote","Progression","Multiple Myeloma","HNRNPA2B1","STIMULATES","progression","Multiple Myeloma"
"256","33794982","HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.","HNRNPA2B1","bind","m6A","Multiple Myeloma","HNRNPA2B1","INTERACTS_WITH","progression","Multiple Myeloma"
"357","33794982","HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.","m6A","stabilize","ILF3","Multiple Myeloma","m6A","MAINTAINS","ILF3","Multiple Myeloma"
"433","33794982","HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.","ILF3","increase","AKT3","Multiple Myeloma","ILF3","AUGMENTS","AKT3","Multiple Myeloma"
"516","33794982","HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.","AKT3 expression","promote","Progression","Multiple Myeloma","AKT3","STIMULATES","progression","Multiple Myeloma"
"162","34044094","ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.","ALKBH5","modify","HMGB1-STING Activation","Radiation Induced Liver Disease","ALKBH5","AFFECTS","HMGB1-STING Activation","Radiation Induced Liver Disease"
"257","34044094","ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.","HMGB1-STING Activation","contribute","Radiation Induced Liver Disease","Radiation Induced Liver Disease","HMGB1-STING Activation","AFFECTS","Radiation Induced Liver Disease","Radiation Induced Liver Disease"
"358","34044094","ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.","HMGB1-STING Activation","regulate","Innate Immune Response","Radiation Induced Liver Disease","HMGB1-STING Activation","AFFECTS","Radiation Induced Liver Disease","Radiation Induced Liver Disease"
"434","34044094","ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.","Innate Immune Response","contribute","Radiation Induced Liver Disease","Radiation Induced Liver Disease","innate immune response","AFFECTS","Radiation Induced Liver Disease","Radiation Induced Liver Disease"
"163","32329830","m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.","METTL3","promote","Progression","Prostate Cancer","METTL3","STIMULATES","progression","PRAD(Prostate Adenocarcinoma)"
"258","32329830","m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.","METTL3","modify","m6A","Prostate Cancer","METTL3","AFFECTS","progression","PRAD(Prostate Adenocarcinoma)"
"359","32329830","m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.","m6A","is on","LEF1","Prostate Cancer","m6A","LOCATES","LEF1","PRAD(Prostate Adenocarcinoma)"
"435","32329830","m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.","LEF1","promote","Progression","Prostate Cancer","LEF1","STIMULATES","progression","PRAD(Prostate Adenocarcinoma)"
"164","32116145","GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.","GR","mediate","FTO transactivation","Hepatocytes","GSR","AFFECTS","FTO transactivation","Hepatocytes"
"259","32116145","GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.","FTO transactivation","induce","Lipid Accumulation","Hepatocytes","FTO transactivation","CAUSES","Lipid Accumulation","Hepatocytes"
"360","32116145","GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.","FTO transactivation","demethylate","m6A","Hepatocytes","FTO transactivation","CONVERTS_TO","Lipid Accumulation","Hepatocytes"
"436","32116145","GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.","m6A","is on","lipogenic mRNAs","Hepatocytes","m6A","LOCATES","lipogenic mRNAs","Hepatocytes"
"517","32116145","GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.","lipogenic mRNAs","regulate","Lipid Accumulation","Hepatocytes","lipogenic mRNAs","AFFECTS","Lipid Accumulation","Hepatocytes"
"165","33748113","METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis.","METTL3","regulate","Ossification","Ossification of the Posterior Longitudinal Ligament","METTL3","AFFECTS","ossification","Ossification of the Posterior Longitudinal Ligament"
"260","33748113","METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis.","METTL3","regulate","lncRNA XIST/miR-302a-3p/USP8 Axis","Ossification of the Posterior Longitudinal Ligament","METTL3","AFFECTS","ossification","Ossification of the Posterior Longitudinal Ligament"
"361","33748113","METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis.","lncRNA XIST/miR-302a-3p/USP8 Axis","regulate","Ossification","Ossification of the Posterior Longitudinal Ligament","XIST/miR-302a-3p/USP8 Axis","AFFECTS","ossification","Ossification of the Posterior Longitudinal Ligament"
"166","30032148","ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.","ALKBH5","inhibit","Motility","Pancreatic Cancer","ALKBH5","INHIBITS","motility","PAAD(Pancreatic Adenocarcinoma)"
"261","30032148","ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.","ALKBH5","decrease","KCNK15-AS1","Pancreatic Cancer","ALKBH5","INHIBITS","motility","PAAD(Pancreatic Adenocarcinoma)"
"362","30032148","ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.","KCNK15-AS1","inhibit","Motility","Pancreatic Cancer","KCNK15-AS1","INHIBITS","motility","PAAD(Pancreatic Adenocarcinoma)"
"167","32766145","Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.","dummy","reduce","METTL3","Triple-Negative Breast Cancer","dummy","INHIBITS","METTL3","BRCA(Breast Invasive Carcinoma)"
"265","32766145","Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.","METTL3","promote","Metastasis","Triple-Negative Breast Cancer","METTL3","STIMULATES","Neoplasm Metastasis","BRCA(Breast Invasive Carcinoma)"
"363","32766145","Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.","METTL3","regulate","m6A","Triple-Negative Breast Cancer","METTL3","AFFECTS","Neoplasm Metastasis","BRCA(Breast Invasive Carcinoma)"
"437","32766145","Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.","m6A","upregulate","COL3A1","Triple-Negative Breast Cancer","m6A","STIMULATES","COL3A1","BRCA(Breast Invasive Carcinoma)"
"518","32766145","Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.","COL3A1","promote","Metastasis","Triple-Negative Breast Cancer","COL3A1","STIMULATES","Neoplasm Metastasis","BRCA(Breast Invasive Carcinoma)"
"168","33380825","METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.","METTL14","inhibit","Metastasis","Hepatocellular Carcinoma","METTL14","INHIBITS","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"266","33380825","METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.","METTL14","regulate","m6A","Hepatocellular Carcinoma","METTL14","AFFECTS","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"364","33380825","METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.","m6A","regulate","EGFR/PI3K/AKT Signaling Pathway","Hepatocellular Carcinoma","m6A","AFFECTS","EGFR/PI3K/AKT Signaling Pathway","LIHC(Liver Hepatocellular Carcinoma)"
"438","33380825","METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.","EGFR/PI3K/AKT Signaling Pathway","inhibit","Metastasis","Hepatocellular Carcinoma","EGFR/PI3K/AKT Signaling Pathway","INHIBITS","Neoplasm Metastasis","LIHC(Liver Hepatocellular Carcinoma)"
"169","34336690","METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.","METTL3","promote the resistance of","Temozolomide","Glioma","METTL3","STIMULATES","temozolomide","Glioma"
"267","34336690","METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.","METTL3","regulate","m6A","Glioma","METTL3","AFFECTS","temozolomide","Glioma"
"365","34336690","METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.","m6A","increase","MGMT","Glioma","m6A","AUGMENTS","MGMT","Glioma"
"439","34336690","METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.","m6A","increase","ANPG","Glioma","m6A","AUGMENTS","MGMT","Glioma"
"519","34336690","METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.","MGMT","promote the resistance of","Resistance to Temozolomide","Glioma","MGMT","STIMULATES","Resistance to Temozolomide","Glioma"
"613","34336690","METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.","ANPG","promote the resistance of","Resistance to Temozolomide","Glioma","MPG","STIMULATES","Resistance to Temozolomide","Glioma"
"170","34438274","ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.","ALKBH5","promote","cadmium-induced transformation","human bronchial epithelial cell","ALKBH5","STIMULATES","cadmium-induced transformation","human bronchial epithelial cell"
"268","34438274","ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.","ALKBH5","regulate","m6A","human bronchial epithelial cell","ALKBH5","AFFECTS","cadmium-induced transformation","human bronchial epithelial cell"
"366","34438274","ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.","m6A","regulate","PTEN","human bronchial epithelial cell","m6A","AFFECTS","PTEN","human bronchial epithelial cell"
"440","34438274","ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.","PTEN","promote","cadmium-induced transformation","human bronchial epithelial cell","PTEN","STIMULATES","cadmium-induced transformation","human bronchial epithelial cell"
"171","32145676","METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.","METTL3","facilitate","Tumorigenesis","Oral Squamous Cell Carcinoma","METTL3","STIMULATES","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"269","32145676","METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.","METTL3","regulate","YTHDF1","Oral Squamous Cell Carcinoma","METTL3","AFFECTS","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"367","32145676","METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.","YTHDF1","bind","m6A","Oral Squamous Cell Carcinoma","YTHDF1","INTERACTS_WITH","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"441","32145676","METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.","m6A","stabilize","c-Myc","Oral Squamous Cell Carcinoma","m6A","MAINTAINS","MYC","HNSC(Head and Neck Squamous Cell Carcinoma)"
"520","32145676","METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.","c-Myc","facilitate","Tumorigenesis","Oral Squamous Cell Carcinoma","MYC","STIMULATES","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"172","33376625","ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.","ALKBH5","inhibit","Proliferation","Bladder Cancer Cells","ALKBH5","INHIBITS","cell population proliferation","BLCA(Bladder Urothelial Carcinoma)"
"270","33376625","ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.","ALKBH5","sensitize","Cisplatin","Bladder Cancer Cells","ALKBH5","STIMULATES","cell population proliferation","BLCA(Bladder Urothelial Carcinoma)"
"368","33376625","ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.","ALKBH5","regulate","m6A-CK2alpha-Mediated Glycolysis","Bladder Cancer Cells","ALKBH5","AFFECTS","cell population proliferation","BLCA(Bladder Urothelial Carcinoma)"
"442","33376625","ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.","m6A-CK2alpha-Mediated Glycolysis","inhibit","Proliferation","Bladder Cancer Cells","m6A-CK2alpha-Mediated Glycolysis","INHIBITS","cell population proliferation","BLCA(Bladder Urothelial Carcinoma)"
"521","33376625","ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.","m6A-CK2alpha-Mediated Glycolysis","sensitize","Cisplatin","Bladder Cancer Cells","m6A-CK2alpha-Mediated Glycolysis","STIMULATES","cell population proliferation","BLCA(Bladder Urothelial Carcinoma)"
"173","31230592","METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.","METTL3","facilitate","Tumor Progression","Colorectal Carcinoma","METTL3","STIMULATES","Tumor Progression","COAD(Colon Adenocarcinoma)"
"271","31230592","METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.","METTL3","regulate","m6A","Colorectal Carcinoma","METTL3","AFFECTS","Tumor Progression","COAD(Colon Adenocarcinoma)"
"369","31230592","METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.","IGF2BP2","bind","m6A","Colorectal Carcinoma","IGF2BP2","INTERACTS_WITH","m6A","COAD(Colon Adenocarcinoma)"
"443","31230592","METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.","m6A","facilitate","Tumor Progression","Colorectal Carcinoma","m6A","STIMULATES","Tumor Progression","COAD(Colon Adenocarcinoma)"
"174","32531187","FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism.","FTO","regulate","Angiogenesis","Ocular","FTO","AFFECTS","angiogenesis","ocular"
"272","32531187","FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism.","FTO","regulate","m6A","Ocular","FTO","AFFECTS","angiogenesis","ocular"
"370","32531187","FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism.","YTHDF2","bind","m6A","Ocular","YTHDF2","INTERACTS_WITH","m6A","ocular"
"444","32531187","FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism.","m6A","regulate","Angiogenesis","Ocular","m6A","AFFECTS","angiogenesis","ocular"
"175","32653519","circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1.","circ_KIAA1429","accelerate","Advancement","Hepatocellular Carcinoma","circ_KIAA1429","STIMULATES","Advancement","LIHC(Liver Hepatocellular Carcinoma)"
"273","32653519","circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1.","circ_KIAA1429","regulate","m6A-YTHDF3-Zeb1","Hepatocellular Carcinoma","circ_KIAA1429","AFFECTS","Advancement","LIHC(Liver Hepatocellular Carcinoma)"
"371","32653519","circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1.","m6A-YTHDF3-Zeb1","accelerate","Advancement","Hepatocellular Carcinoma","m6A-YTHDF3-Zeb1","STIMULATES","Advancement","LIHC(Liver Hepatocellular Carcinoma)"
"176","33933553","METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.","METTL3","regulate","m6A","IDH-wildtype glioma","METTL3","AFFECTS","m6A","GBM(Glioblastoma Multiforme)"
"274","33933553","METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.","HuR","bind","m6A","IDH-wildtype glioma","ELAVL1","INTERACTS_WITH","m6A","GBM(Glioblastoma Multiforme)"
"372","33933553","METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.","m6A","stabilize","MALAT1","IDH-wildtype glioma","m6A","MAINTAINS","MALAT1","GBM(Glioblastoma Multiforme)"
"445","33933553","METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.","METTL3","activate","NF-kappaB","IDH-wildtype glioma","METTL3","STIMULATES","m6A","GBM(Glioblastoma Multiforme)"
"522","33933553","METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.","NF-kappaB","promote","Malignant Progression","IDH-wildtype glioma","NF-kappaB signaling pathway","STIMULATES","Malignant Progression","GBM(Glioblastoma Multiforme)"
"177","34419065","The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.","METTL3","control","epithelial-mesenchymal transition","Breast Cancer","METTL3","AFFECTS","epithelial to mesenchymal transition","BRCA(Breast Invasive Carcinoma)"
"275","34419065","The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.","METTL3","control","migration","Breast Cancer","METTL3","AFFECTS","epithelial to mesenchymal transition","BRCA(Breast Invasive Carcinoma)"
"373","34419065","The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.","METTL3","control","invasion","Breast Cancer","METTL3","AFFECTS","epithelial to mesenchymal transition","BRCA(Breast Invasive Carcinoma)"
"446","34419065","The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.","METTL3","regulate","MALAT1/miR-26b/HMGA2 axis","Breast Cancer","METTL3","AFFECTS","epithelial to mesenchymal transition","BRCA(Breast Invasive Carcinoma)"
"523","34419065","The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.","MALAT1/miR-26b/HMGA2 axis","control","epithelial-mesenchymal transition","Breast Cancer","MALAT1/miR-26b/HMGA2 axis","AFFECTS","epithelial to mesenchymal transition","BRCA(Breast Invasive Carcinoma)"
"614","34419065","The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.","MALAT1/miR-26b/HMGA2 axis","control","migration","Breast Cancer","MALAT1/miR-26b/HMGA2 axis","AFFECTS","epithelial to mesenchymal transition","BRCA(Breast Invasive Carcinoma)"
"73","34419065","The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.","MALAT1/miR-26b/HMGA2 axis","control","invasion","Breast Cancer","MALAT1/miR-26b/HMGA2 axis","AFFECTS","epithelial to mesenchymal transition","BRCA(Breast Invasive Carcinoma)"
"178","30762711","RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2.","METTL3","regulate","Invasiveness","Melanoma","METTL3","AFFECTS","Neoplasm Invasiveness","SKCM(Skin Cutaneous Melanoma)"
"276","30762711","RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2.","METTL3","regulate","Matrix Metallopeptidase 2","Melanoma","METTL3","AFFECTS","Neoplasm Invasiveness","SKCM(Skin Cutaneous Melanoma)"
"374","30762711","RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2.","Matrix Metallopeptidase 2","regulate","Invasiveness","Melanoma","MMP2","AFFECTS","Neoplasm Invasiveness","SKCM(Skin Cutaneous Melanoma)"
"179","37615536","METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner","METTL14","inhibit","malignant progression","oral squamous cell carcinoma","METTL14","INHIBITS","Malignant Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"277","37615536","METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner","METTL14","regulate","m6A","oral squamous cell carcinoma","METTL14","AFFECTS","Malignant Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"375","37615536","METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner","IGF2BP2","bind","m6A","oral squamous cell carcinoma","IGF2BP2","INTERACTS_WITH","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"447","37615536","METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner","m6A","target","RB1CC1","oral squamous cell carcinoma","m6A","INTERACTS_WITH","RB1CC1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"524","37615536","METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner","RB1CC1","inhibit","malignant progression","oral squamous cell carcinoma","RB1CC1","INHIBITS","Malignant Progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"180","31395342","MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.","MiR-4429","prevent","Progression","Gastric Cancer","MIR4429","PREVENTS","progression","STAD(Stomach adenocarcinoma)"
"278","31395342","MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.","MiR-4429","target","METTL3","Gastric Cancer","MIR4429","INTERACTS_WITH","progression","STAD(Stomach adenocarcinoma)"
"376","31395342","MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.","METTL3","inhibit","SEC62","Gastric Cancer","METTL3","INHIBITS","SEC62","STAD(Stomach adenocarcinoma)"
"448","31395342","MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.","m6A","regulate","SEC62","Gastric Cancer","m6A","AFFECTS","SEC62","STAD(Stomach adenocarcinoma)"
"525","31395342","MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.","SEC62","regulate","Progression","Gastric Cancer","SEC62","AFFECTS","progression","STAD(Stomach adenocarcinoma)"
"181","31492150","Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.","dummy","upregulate","METTL3","Colorectal Cancer","dummy","STIMULATES","METTL3","COAD(Colon Adenocarcinoma)"
"279","31492150","Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.","METTL3","promote","Metastasis","Colorectal Cancer","METTL3","STIMULATES","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"377","31492150","Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.","METTL3","regulate","miR-1246/SPRED2/MAPK signaling pathway","Colorectal Cancer","METTL3","AFFECTS","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"449","31492150","Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.","miR-1246/SPRED2/MAPK signaling pathway","promote","Metastasis","Colorectal Cancer","miR-1246/SPRED2/MAPK signaling pathway","STIMULATES","Neoplasm Metastasis","COAD(Colon Adenocarcinoma)"
"182","33431790","Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway.","Metformin","exhibit","antiproliferation activity","Breast Cancer","metformin","MANIFESTS","antiproliferation activity","BRCA(Breast Invasive Carcinoma)"
"280","33431790","Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway.","Metformin","regulate","miR-483-3p/METTL3/m6A/p21 pathway","Breast Cancer","metformin","AFFECTS","antiproliferation activity","BRCA(Breast Invasive Carcinoma)"
"378","33431790","Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway.","miR-483-3p/METTL3/m6A/p21 pathway","exhibit","antiproliferation activity","Breast Cancer","miR-483-3p/METTL3/m6A/p21 pathway","MANIFESTS","antiproliferation activity","BRCA(Breast Invasive Carcinoma)"
"183","29315835","FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation.","FTO","regulate","mRNA demethylation","Cervical Squamous Cell Carcinoma (CSCC)","FTO","AFFECTS","mRNA demethylation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"281","29315835","FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation.","mRNA demethylation","target","beta-catenin","Cervical Squamous Cell Carcinoma (CSCC)","mRNA demethylation","INTERACTS_WITH","CTNNB1","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"379","29315835","FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation.","beta-catenin","regulate","Chemo-radiotherapy resistance","Cervical Squamous Cell Carcinoma (CSCC)","CTNNB1","AFFECTS","Chemo-radiotherapy resistance","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"450","29315835","FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation.","FTO","regulate","Chemo-radiotherapy resistance","Cervical Squamous Cell Carcinoma (CSCC)","FTO","AFFECTS","mRNA demethylation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"184","34301919","RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.","RBM15","mediate","N6-methyladenosine","COVID-19","RBM15","AFFECTS","m6A","COVID-19"
"282","34301919","RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.","N6-methyladenosine","is on","multitarget genes","COVID-19","m6A","LOCATES","multitarget genes","COVID-19"
"380","34301919","RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.","multitarget genes","affect","Severity","COVID-19","multitarget genes","AFFECTS","Severity","COVID-19"
"454","34301919","RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.","RBM15","affect","Severity","COVID-19","RBM15","AFFECTS","m6A","COVID-19"
"185","32509177","N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.","METTL3","promote","Cell Proliferation","Colorectal Cancer","METTL3","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"283","32509177","N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.","METTL3","enhance","MYC","Colorectal Cancer","METTL3","AUGMENTS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"381","32509177","N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.","MYC","promote","Cell Proliferation","Colorectal Cancer","MYC","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"186","32284755","The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.","METTL3","promote","Development","Prostate Carcinoma","METTL3","STIMULATES","development","PRAD(Prostate Adenocarcinoma)"
"284","32284755","The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.","METTL3","promote","progression","Prostate Carcinoma","METTL3","STIMULATES","development","PRAD(Prostate Adenocarcinoma)"
"382","32284755","The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.","METTL3","mediate","MYC","Prostate Carcinoma","METTL3","AFFECTS","development","PRAD(Prostate Adenocarcinoma)"
"459","32284755","The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.","MYC","promote","Development","Prostate Carcinoma","MYC","STIMULATES","development","PRAD(Prostate Adenocarcinoma)"
"526","32284755","The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.","MYC","promote","progression","Prostate Carcinoma","MYC","STIMULATES","development","PRAD(Prostate Adenocarcinoma)"
"187","29842885","m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.","FTO","facilitate","Tumor Progression","Lung Squamous Cell Carcinoma","FTO","STIMULATES","Tumor Progression","LUSC(Lung Squamous Cell Carcinoma)"
"285","29842885","m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.","FTO","regulate","MZF1","Lung Squamous Cell Carcinoma","FTO","AFFECTS","Tumor Progression","LUSC(Lung Squamous Cell Carcinoma)"
"383","29842885","m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.","MZF1","facilitate","Tumor Progression","Lung Squamous Cell Carcinoma","MZF1","STIMULATES","Tumor Progression","LUSC(Lung Squamous Cell Carcinoma)"
"188","25412662","FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.","FTO","demethylate","N6-methyladenosine","Adipogenesis","FTO","CONVERTS_TO","m6A","Adipogenesis"
"286","25412662","FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.","N6-methyladenosine","regulate","mRNA splicing","Adipogenesis","m6A","AFFECTS","Group I intron splicing","Adipogenesis"
"384","25412662","FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.","N6-methyladenosine","is required","Adipogenesis","Adipogenesis","m6A","CAUSES","Group I intron splicing","Adipogenesis"
"189","34169146","m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.","FTO","induce","NELL2","Non-small cell lung cancer","FTO","CAUSES","NELL2","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"289","34169146","m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.","FTO","lead to","Metastasis","Non-small cell lung cancer","FTO","CAUSES","NELL2","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"385","34169146","m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.","FTO","inhibit","m6A","Non-small cell lung cancer","FTO","INHIBITS","NELL2","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"460","34169146","m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.","m6A","is on","E2F1","Non-small cell lung cancer","m6A","LOCATES","E2F1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"527","34169146","m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.","E2F1","regulate","NELL2","Non-small cell lung cancer","E2F1","AFFECTS","NELL2","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"190","34246306","YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.","YTHDF2","degrade","UBXN1","Glioma","YTHDF2","INHIBITS","UBXN1","Glioma"
"294","34246306","YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.","YTHDF2","bind","m6A","Glioma","YTHDF2","INTERACTS_WITH","UBXN1","Glioma"
"386","34246306","YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.","METTL3","mediate","m6A","Glioma","METTL3","AFFECTS","m6A","Glioma"
"461","34246306","YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.","UBXN1","activate","NF-kappaB","Glioma","UBXN1","STIMULATES","NF-kappaB signaling pathway","Glioma"
"532","34246306","YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.","NF-kappaB","promote","Malignant Progression","Glioma","NF-kappaB signaling pathway","STIMULATES","Malignant Progression","Glioma"
"615","34246306","YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.","m6A","regulate","UBXN1","Glioma","m6A","AFFECTS","UBXN1","Glioma"
"191","34093712","METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.","METTL3","mediate","m6A Methylation","Muscle","METTL3","AFFECTS","m6A","Muscles"
"295","34093712","METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.","m6A Methylation","regulate","Muscle Stem Cells","Muscle","m6A","AFFECTS","Muscle Stem Cells","Muscles"
"387","34093712","METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.","m6A Methylation","regulate","Muscle Regeneration","Muscle","m6A","AFFECTS","Muscle Stem Cells","Muscles"
"462","34093712","METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.","METTL3","regulate","Notch Signaling Pathway","Muscle","METTL3","AFFECTS","m6A","Muscles"
"533","34093712","METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.","Notch Signaling Pathway","regulate","Muscle Stem Cells","Muscle","Notch signaling pathway","AFFECTS","Muscle Stem Cells","Muscles"
"616","34093712","METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.","Notch Signaling Pathway","regulate","Muscle Regeneration","Muscle","Notch signaling pathway","AFFECTS","Muscle Stem Cells","Muscles"
"192","34513292","FTO-mediated demethylation of GADD45B promotes myogenesis through the activation of p38 MAPK pathway.","FTO","demethylate","GADD45B","Null","FTO","CONVERTS_TO","GADD45B","Null"
"296","34513292","FTO-mediated demethylation of GADD45B promotes myogenesis through the activation of p38 MAPK pathway.","GADD45B","promote","myogenesis","Null","GADD45B","STIMULATES","skeletal muscle tissue development","Null"
"388","34513292","FTO-mediated demethylation of GADD45B promotes myogenesis through the activation of p38 MAPK pathway.","GADD45B","activate","p38 MAPK pathway","Null","GADD45B","STIMULATES","skeletal muscle tissue development","Null"
"463","34513292","FTO-mediated demethylation of GADD45B promotes myogenesis through the activation of p38 MAPK pathway.","p38 MAPK pathway","promote","myogenesis","Null","p38 MAPK pathway","STIMULATES","skeletal muscle tissue development","Null"
"193","31239708","m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.","METTL3","suppress","Proliferation","Colorectal Cancer","METTL3","INHIBITS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"297","31239708","m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.","METTL3","suppress","Migration","Colorectal Cancer","METTL3","INHIBITS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"389","31239708","m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.","METTL3","regulate","p38/ERK pathways","Colorectal Cancer","METTL3","AFFECTS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"464","31239708","m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.","p38/ERK pathways","suppress","Proliferation","Colorectal Cancer","p38/ERK pathways","INHIBITS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"534","31239708","m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.","p38/ERK pathways","suppress","Migration","Colorectal Cancer","p38/ERK pathways","INHIBITS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"194","32890792","microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation.","microRNA-421-3p","prevent","Inflammatory Response","Cerebral Ischemia/Reperfusion Injury","microRNA-421-3p","PREVENTS","inflammatory response","Cerebral Ischemia/Reperfusion Injury"
"298","32890792","microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation.","microRNA-421-3p","target","YTHDF1","Cerebral Ischemia/Reperfusion Injury","microRNA-421-3p","INTERACTS_WITH","inflammatory response","Cerebral Ischemia/Reperfusion Injury"
"390","32890792","microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation.","YTHDF1","inhibit","p65","Cerebral Ischemia/Reperfusion Injury","YTHDF1","INHIBITS","RELA","Cerebral Ischemia/Reperfusion Injury"
"465","32890792","microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation.","p65","prevent","Inflammatory Response","Cerebral Ischemia/Reperfusion Injury","RELA","PREVENTS","inflammatory response","Cerebral Ischemia/Reperfusion Injury"
"195","32429928","RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.","ALKBH5","prevent","Progression","Pancreatic Cancer","ALKBH5","PREVENTS","progression","PAAD(Pancreatic Adenocarcinoma)"
"299","32429928","RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.","ALKBH5","regulate","m6A","Pancreatic Cancer","ALKBH5","AFFECTS","progression","PAAD(Pancreatic Adenocarcinoma)"
"391","32429928","RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Pancreatic Cancer","YTHDF2","INTERACTS_WITH","m6A","PAAD(Pancreatic Adenocarcinoma)"
"470","32429928","RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.","m6A","activate","PER1","Pancreatic Cancer","m6A","STIMULATES","PER1","PAAD(Pancreatic Adenocarcinoma)"
"535","32429928","RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.","PER1","prevent","Progression","Pancreatic Cancer","PER1","PREVENTS","progression","PAAD(Pancreatic Adenocarcinoma)"
"196","33157234","DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.","dummy","methylate","FTO","Alcohol-induced kidney injury","dummy","CONVERTS_TO","FTO","Alcohol-induced kidney injury"
"2104","33157234","DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.","FTO","promote","Renal Inflammation","Alcohol-induced kidney injury","FTO","STIMULATES","Renal Inflammation","Alcohol-induced kidney injury"
"392","33157234","DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.","FTO","enhance","m6A","Alcohol-induced kidney injury","FTO","AUGMENTS","Renal Inflammation","Alcohol-induced kidney injury"
"471","33157234","DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.","m6A","is on","PPAR-alpha","Alcohol-induced kidney injury","m6A","LOCATES","PPARA","Alcohol-induced kidney injury"
"536","33157234","DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.","PPAR-alpha","promote","Renal Inflammation","Alcohol-induced kidney injury","PPARA","STIMULATES","Renal Inflammation","Alcohol-induced kidney injury"
"197","34490238","KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.","KIAA1429","methylate","m6A","Aortic Dissection","VIRMA","CONVERTS_TO","m6A","Aortic dissection"
"2108","34490238","KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.","ALKBH5","demethylate","m6A","Aortic Dissection","ALKBH5","CONVERTS_TO","m6A","Aortic dissection"
"393","34490238","KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.","m6A","regulate","Pri-miR-143-3p","Aortic Dissection","m6A","AFFECTS","Pri-miR-143-3p","Aortic dissection"
"472","34490238","KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.","Pri-miR-143-3p","influence","Progression","Aortic Dissection","Pri-miR-143-3p","AFFECTS","progression","Aortic dissection"
"537","34490238","KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.","KIAA1429","influence","Progression","Aortic Dissection","VIRMA","AFFECTS","m6A","Aortic dissection"
"617","34490238","KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.","ALKBH5","influence","Progression","Aortic Dissection","ALKBH5","AFFECTS","m6A","Aortic dissection"
"198","33706799","Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.","Mettl14","mediate","m6A","Spinal Cord Injury","METTL14","AFFECTS","m6A","Spinal Cord Injuries"
"2113","33706799","Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.","m6A","modulate","neuron apoptosis","Spinal Cord Injury","m6A","AFFECTS","neuron apoptosis","Spinal Cord Injuries"
"394","33706799","Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.","m6A","regulate","pri-mir-375","Spinal Cord Injury","m6A","AFFECTS","neuron apoptosis","Spinal Cord Injuries"
"473","33706799","Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.","pri-mir-375","transform to","miR-375","Spinal Cord Injury","pri-mir-375","CONVERTS_TO","MIR375","Spinal Cord Injuries"
"538","33706799","Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.","miR-375","modulate","neuron apoptosis","Spinal Cord Injury","MIR375","AFFECTS","neuron apoptosis","Spinal Cord Injuries"
"199","35797982","METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.","METTL14","suppress","Progression","Colorectal Cancer","METTL14","INHIBITS","progression","COAD(Colon Adenocarcinoma)"
"2115","35797982","METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.","METTL14","regulate","N6-Methyladenosine","Colorectal Cancer","METTL14","AFFECTS","progression","COAD(Colon Adenocarcinoma)"
"395","35797982","METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.","N6-Methyladenosine","is on","miR-375","Colorectal Cancer","m6A","LOCATES","MIR375","COAD(Colon Adenocarcinoma)"
"474","35797982","METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.","miR-375","suppress","Progression","Colorectal Cancer","MIR375","INHIBITS","progression","COAD(Colon Adenocarcinoma)"
"1100","34476213","The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.","METTL14","mediate","N6-Methyladenosine","Stomach Adenocarcinoma","METTL14","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"2118","34476213","The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.","N6-Methyladenosine","is on","PTEN","Stomach Adenocarcinoma","m6A","LOCATES","PTEN","STAD(Stomach adenocarcinoma)"
"396","34476213","The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.","PTEN","inhibit","Tumor Growth","Stomach Adenocarcinoma","PTEN","INHIBITS","Tumor Growth","STAD(Stomach adenocarcinoma)"
"475","34476213","The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.","PTEN","inhibit","Metastasis","Stomach Adenocarcinoma","PTEN","INHIBITS","Tumor Growth","STAD(Stomach adenocarcinoma)"
"1101","29384213","FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.","FTO","reduce","Mitochondria","Null","FTO","INHIBITS","mitochondrion","Null"
"2120","29384213","FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.","FTO","promote","Hepatic fat accumulation","Null","FTO","STIMULATES","mitochondrion","Null"
"397","29384213","FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.","FTO","demethylate","RNA","Null","FTO","CONVERTS_TO","mitochondrion","Null"
"476","29384213","FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.","RNA","reduce","Mitochondria","Null","ribonucleic acid","INHIBITS","mitochondrion","Null"
"539","29384213","FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.","RNA","promote","Hepatic fat accumulation","Null","ribonucleic acid","STIMULATES","mitochondrion","Null"
"1102","34105773","The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.","ALKBH5","promote","differentiation","Osteoblast","ALKBH5","STIMULATES","cell differentiation","Osteoblasts"
"2126","34105773","The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.","ALKBH5","modulate the stability of","Runx2","Osteoblast","ALKBH5","DISRUPTS","cell differentiation","Osteoblasts"
"398","34105773","The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.","Runx2","promote","differentiation","Osteoblast","RUNX2","STIMULATES","cell differentiation","Osteoblasts"
"1103","33232910","The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function.","YTHDC2","inhibit","Tumorigenesis","Lung Adenocarcinoma","YTHDC2","INHIBITS","Carcinogenesis","LUAD(Lung Adenocarcinoma)"
"2130","33232910","The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function.","YTHDC2","suppress","SLC7A11","Lung Adenocarcinoma","YTHDC2","INHIBITS","Carcinogenesis","LUAD(Lung Adenocarcinoma)"
"399","33232910","The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function.","SLC7A11","inhibit","Tumorigenesis","Lung Adenocarcinoma","SLC7A11","INHIBITS","Carcinogenesis","LUAD(Lung Adenocarcinoma)"
"1104","34457066","RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.","METTL3","promote","cell proliferation","Colorectal Cancer","METTL3","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"2137","34457066","RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.","METTL3","promote","Invasion","Colorectal Cancer","METTL3","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"3103","34457066","RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.","METTL3","regulate","Snail","Colorectal Cancer","METTL3","AFFECTS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"477","34457066","RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.","Snail","promote","cell proliferation","Colorectal Cancer","SNAI1","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"540","34457066","RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.","Snail","promote","Invasion","Colorectal Cancer","SNAI1","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"1105","30197299","Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development.","METTL16","regulate","Methylation of Structured RNA","mouse embryo","METTL16","AFFECTS","Methylation of Structured RNA","mouse embryo"
"2144","30197299","Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development.","Methylation of Structured RNA","essential for","Development","mouse embryo","Methylation of Structured RNA","CAUSES","development","mouse embryo"
"1106","33961858","m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.","ALKBH5","suppress","proliferation","Hirschsprung's disease","ALKBH5","INHIBITS","cell population proliferation","Hirschsprung Disease"
"2149","33961858","m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.","ALKBH5","suppress","migration","Hirschsprung's disease","ALKBH5","INHIBITS","cell population proliferation","Hirschsprung Disease"
"3106","33961858","m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.","proliferation","is on","enteric neural crest cells","Hirschsprung's disease","cell population proliferation","LOCATES","enteric neural crest cells","Hirschsprung Disease"
"478","33961858","m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.","migration","is on","enteric neural crest cells","Hirschsprung's disease","migration","LOCATES","enteric neural crest cells","Hirschsprung Disease"
"541","33961858","m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.","ALKBH5","regulate","TAGLN","Hirschsprung's disease","ALKBH5","AFFECTS","cell population proliferation","Hirschsprung Disease"
"618","33961858","m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.","TAGLN","suppress","proliferation","Hirschsprung's disease","TAGLN","INHIBITS","cell population proliferation","Hirschsprung Disease"
"74","33961858","m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.","TAGLN","suppress","migration","Hirschsprung's disease","TAGLN","INHIBITS","cell population proliferation","Hirschsprung Disease"
"1107","33791305","The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.","YTHDF1","facilitate","Tumorigenesis","Gastric Cancer","YTHDF1","STIMULATES","Carcinogenesis","STAD(Stomach adenocarcinoma)"
"2152","33791305","The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.","YTHDF1","facilitate","Metastasis","Gastric Cancer","YTHDF1","STIMULATES","Carcinogenesis","STAD(Stomach adenocarcinoma)"
"3111","33791305","The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.","YTHDF1","bind","m6A","Gastric Cancer","YTHDF1","INTERACTS_WITH","Carcinogenesis","STAD(Stomach adenocarcinoma)"
"479","33791305","The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.","m6A","regulate","USP14","Gastric Cancer","m6A","AFFECTS","USP14","STAD(Stomach adenocarcinoma)"
"542","33791305","The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.","USP14","facilitate","Tumorigenesis","Gastric Cancer","USP14","STIMULATES","Carcinogenesis","STAD(Stomach adenocarcinoma)"
"619","33791305","The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.","USP14","facilitate","Metastasis","Gastric Cancer","USP14","STIMULATES","Carcinogenesis","STAD(Stomach adenocarcinoma)"
"1108","31906946","m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.","ALKBH5","inhibit","Tumorigenesis","Pancreatic Cancer","ALKBH5","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"2158","31906946","m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.","ALKBH5","decrease","WIF-1","Pancreatic Cancer","ALKBH5","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"3115","31906946","m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.","ALKBH5","mediate","Wnt signaling","Pancreatic Cancer","ALKBH5","AFFECTS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"480","31906946","m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.","WIF-1","inhibit","Tumorigenesis","Pancreatic Cancer","WIF1","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"543","31906946","m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.","Wnt signaling","inhibit","Tumorigenesis","Pancreatic Cancer","Wnt signaling pathway","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"1109","33759344","METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.","METTL3","attenuate","Proliferative vitreoretinopathy","retinal pigment epithelial cells","METTL3","INHIBITS","Vitreoretinopathy, Proliferative","retinal pigment epithelial cells"
"2163","33759344","METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.","METTL3","attenuate","Epithelial-mesenchymal transition","retinal pigment epithelial cells","METTL3","INHIBITS","Vitreoretinopathy, Proliferative","retinal pigment epithelial cells"
"3119","33759344","METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.","METTL3","use","wnt/beta-catenin pathway","retinal pigment epithelial cells","METTL3","USES","Vitreoretinopathy, Proliferative","retinal pigment epithelial cells"
"481","33759344","METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.","wnt/beta-catenin pathway","attenuate","Proliferative vitreoretinopathy","retinal pigment epithelial cells","WNT/beta-catenin pathway","INHIBITS","Vitreoretinopathy, Proliferative","retinal pigment epithelial cells"
"544","33759344","METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.","wnt/beta-catenin pathway","attenuate","Epithelial-mesenchymal transition","retinal pigment epithelial cells","WNT/beta-catenin pathway","INHIBITS","Vitreoretinopathy, Proliferative","retinal pigment epithelial cells"
"1110","34130310","Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.","Methyltransferase-like 3","contribute","Inflammatory Pain","Null","METTL3","AFFECTS","Inflammatory Pain","Null"
"2171","34130310","Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.","YTHDF2","target","TET1","Null","YTHDF2","INTERACTS_WITH","TET1","Null"
"3125","34130310","Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.","Methyltransferase-like 3","target","TET1","Null","METTL3","INTERACTS_WITH","Inflammatory Pain","Null"
"482","34130310","Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.","TET1","contribute","Inflammatory Pain","Null","TET1","AFFECTS","Inflammatory Pain","Null"
"1111","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","ALKBH5","inhibit","Tumor growth","NSCLC","ALKBH5","INHIBITS","Tumor Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2176","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","ALKBH5","inhibit","Metastasis","NSCLC","ALKBH5","INHIBITS","Tumor Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3128","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","ALKBH5","reduce","YAP","NSCLC","ALKBH5","INHIBITS","Tumor Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"483","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","YTHDFs","mediate","YAP","NSCLC","YTHDFs","AFFECTS","YAP1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"545","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","ALKBH5","inhibit","YAP","NSCLC","ALKBH5","INHIBITS","Tumor Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"620","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","miR-107","mediate","YAP","NSCLC","MIR107","AFFECTS","YAP1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"75","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","LATS2","mediate","YAP","NSCLC","LATS2","AFFECTS","YAP1","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"82","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","YAP","inhibit","Tumor growth","NSCLC","YAP1","INHIBITS","Tumor Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"9","32106857","m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.","YAP","inhibit","Metastasis","NSCLC","YAP1","INHIBITS","Tumor Growth","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"1112","33510938","METTL3-mediated m6A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung.","METTL3","mediate","m6A","cancer of the lung","METTL3","AFFECTS","m6A","LUAD(Lung Adenocarcinoma)"
"2177","33510938","METTL3-mediated m6A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung.","m6A","is on","ZBTB4","cancer of the lung","m6A","LOCATES","ZBTB4","LUAD(Lung Adenocarcinoma)"
"3131","33510938","METTL3-mediated m6A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung.","ZBTB4","involve","EMT","cancer of the lung","ZBTB4","ASSOCIATED_WITH","epithelial to mesenchymal transition","LUAD(Lung Adenocarcinoma)"
"1113","32044716","Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.","dummy","silence","METTL3","Osteosarcoma","dummy","INHIBITS","METTL3","SARC(Sarcoma)"
"2187","32044716","Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.","METTL3","inhibit","Proliferation","Osteosarcoma","METTL3","INHIBITS","cell population proliferation","SARC(Sarcoma)"
"3136","32044716","Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.","METTL3","inhibit","Invasion","Osteosarcoma","METTL3","INHIBITS","cell population proliferation","SARC(Sarcoma)"
"484","32044716","Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.","METTL3","regulate","ATAD2","Osteosarcoma","METTL3","AFFECTS","cell population proliferation","SARC(Sarcoma)"
"546","32044716","Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.","ATAD2","inhibit","Proliferation","Osteosarcoma","ATAD2","INHIBITS","cell population proliferation","SARC(Sarcoma)"
"621","32044716","Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.","ATAD2","inhibit","Invasion","Osteosarcoma","ATAD2","INHIBITS","cell population proliferation","SARC(Sarcoma)"
"1114","33968659","The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.","METTL3","regulate","Autophagy","Seminoma","METTL3","AFFECTS","autophagy","Seminoma"
"2192","33968659","The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.","METTL3","regulate","sensitivity","Seminoma","METTL3","AFFECTS","autophagy","Seminoma"
"3142","33968659","The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.","METTL3","target","ATG5","Seminoma","METTL3","INTERACTS_WITH","autophagy","Seminoma"
"485","33968659","The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.","ATG5","regulate","Autophagy","Seminoma","ATG5","AFFECTS","autophagy","Seminoma"
"547","33968659","The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.","ATG5","regulate","sensitivity","Seminoma","ATG5","AFFECTS","autophagy","Seminoma"
"1115","31454538","N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.","METTL3","promote","Progression","Breast Cancer","METTL3","STIMULATES","progression","BRCA(Breast Invasive Carcinoma)"
"2193","31454538","N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.","METTL3","target","Bcl-2","Breast Cancer","METTL3","INTERACTS_WITH","progression","BRCA(Breast Invasive Carcinoma)"
"3147","31454538","N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.","Bcl-2","promote","Progression","Breast Cancer","BCL2","STIMULATES","progression","BRCA(Breast Invasive Carcinoma)"
"1116","31226160","EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis.","METTL14","reprogram","EBV epitranscriptome","Null","METTL14","CONVERTS_TO","EBV epitranscriptome","Null"
"2194","31226160","EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis.","EBV epitranscriptome","critical for","Tumorigenesis","Null","EBV epitranscriptome","CAUSES","Carcinogenesis","Null"
"1117","28344040","m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.","ALKBH5","maintain","Tumorigenicity","Glioblastoma Stem-like Cells","ALKBH5","MAINTAINS","Tumorigenicity","Glioblastoma Stem-like Cells"
"2195","28344040","m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.","ALKBH5","sustain","FOXM1","Glioblastoma Stem-like Cells","ALKBH5","MAINTAINS","Tumorigenicity","Glioblastoma Stem-like Cells"
"3152","28344040","m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.","ALKBH5","sustain","Cell Proliferation","Glioblastoma Stem-like Cells","ALKBH5","MAINTAINS","Tumorigenicity","Glioblastoma Stem-like Cells"
"486","28344040","m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.","FOXM1","maintain","Tumorigenicity","Glioblastoma Stem-like Cells","FOXM1","MAINTAINS","Tumorigenicity","Glioblastoma Stem-like Cells"
"548","28344040","m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.","Cell Proliferation","maintain","Tumorigenicity","Glioblastoma Stem-like Cells","cell population proliferation","MAINTAINS","Tumorigenicity","Glioblastoma Stem-like Cells"
"1118","33866220","Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.","dummy","Exposure to","constant light","Mouse Hippocampus","dummy","ADMINISTERED_TO","constant light","Mouse Hippocampus"
"2196","33866220","Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.","constant light","impair","Cognition","Mouse Hippocampus","constant light","INHIBITS","cognition","Mouse Hippocampus"
"3155","33866220","Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.","constant light","regulate the inhibition of","FTO","Mouse Hippocampus","constant light","INHIBITS","cognition","Mouse Hippocampus"
"487","33866220","Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.","constant light","regulate","m6A","Mouse Hippocampus","constant light","AFFECTS","cognition","Mouse Hippocampus"
"549","33866220","Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.","m6A","repress","TrkappaB","Mouse Hippocampus","m6A","INHIBITS","TrkappaB","Mouse Hippocampus"
"622","33866220","Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.","FTO","impair","Cognition","Mouse Hippocampus","FTO","INHIBITS","cognition","Mouse Hippocampus"
"76","33866220","Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.","TrkappaB","impair","Cognition","Mouse Hippocampus","TrkappaB","INHIBITS","cognition","Mouse Hippocampus"
"1119","31806999","RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway.","METTL3","promote","Growth","Prostate Cancer","METTL3","STIMULATES","Growth","PRAD(Prostate Adenocarcinoma)"
"2197","31806999","RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway.","METTL3","regulate","Hedgehog Pathway","Prostate Cancer","METTL3","AFFECTS","Growth","PRAD(Prostate Adenocarcinoma)"
"3159","31806999","RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway.","Hedgehog Pathway","promote","Growth","Prostate Cancer","Hedgehog Pathway","STIMULATES","Growth","PRAD(Prostate Adenocarcinoma)"
"1120","32148516","Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.","Hypoxia","promote","VSMC Differentiation","Adipose-Derived Stem Cell (ADSC)","Hypoxia","STIMULATES","vascular smooth muscle cell differentiation","Adipose-Derived Stem Cell (ADSC)"
"2200","32148516","Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.","Hypoxia","regulate","Mettl3","Adipose-Derived Stem Cell (ADSC)","Hypoxia","AFFECTS","vascular smooth muscle cell differentiation","Adipose-Derived Stem Cell (ADSC)"
"3164","32148516","Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.","Hypoxia","regulate","Paracrine Factors","Adipose-Derived Stem Cell (ADSC)","Hypoxia","AFFECTS","vascular smooth muscle cell differentiation","Adipose-Derived Stem Cell (ADSC)"
"488","32148516","Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.","Mettl3","promote","VSMC Differentiation","Adipose-Derived Stem Cell (ADSC)","METTL3","STIMULATES","vascular smooth muscle cell differentiation","Adipose-Derived Stem Cell (ADSC)"
"550","32148516","Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.","Paracrine Factors","promote","VSMC Differentiation","Adipose-Derived Stem Cell (ADSC)","Paracrine Factors","STIMULATES","vascular smooth muscle cell differentiation","Adipose-Derived Stem Cell (ADSC)"
"1121","33456585","ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.","ALKBH5","regulate","Cardiomyocyte Proliferation","Null","ALKBH5","AFFECTS","cardiac muscle cell proliferation","Null"
"2205","33456585","ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.","ALKBH5","regulate","heart regeneration","Null","ALKBH5","AFFECTS","cardiac muscle cell proliferation","Null"
"3168","33456585","ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.","ALKBH5","demethylate","YTHDF1","Null","ALKBH5","CONVERTS_TO","cardiac muscle cell proliferation","Null"
"489","33456585","ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.","YTHDF1","regulate","Cardiomyocyte Proliferation","Null","YTHDF1","AFFECTS","cardiac muscle cell proliferation","Null"
"551","33456585","ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.","YTHDF1","regulate","heart regeneration","Null","YTHDF1","AFFECTS","cardiac muscle cell proliferation","Null"
"1122","32175271","METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.","METTL3","promote","Progression","Gastric Cancer","METTL3","STIMULATES","progression","STAD(Stomach adenocarcinoma)"
"2210","32175271","METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.","METTL3","target","MYC Pathway","Gastric Cancer","METTL3","INTERACTS_WITH","progression","STAD(Stomach adenocarcinoma)"
"3174","32175271","METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.","MYC Pathway","promote","Progression","Gastric Cancer","MYC Pathway","STIMULATES","progression","STAD(Stomach adenocarcinoma)"
"1123","31643040","The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.","METTL3","regulate","Osteogenic Differentiation","osteogenic differentiation","METTL3","AFFECTS","Osteogenic Differentiation","osteogenic differentiation"
"2211","31643040","The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.","METTL3","regulate","NF-kappaB signaling","osteogenic differentiation","METTL3","AFFECTS","Osteogenic Differentiation","osteogenic differentiation"
"3178","31643040","The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.","ALKBH5","regulate","Osteogenic Differentiation","osteogenic differentiation","ALKBH5","AFFECTS","Osteogenic Differentiation","osteogenic differentiation"
"490","31643040","The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.","ALKBH5","regulate","NF-kappaB signaling","osteogenic differentiation","ALKBH5","AFFECTS","Osteogenic Differentiation","osteogenic differentiation"
"552","31643040","The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.","NF-kappaB signaling","regulate","Osteogenic Differentiation","osteogenic differentiation","NF-kappaB signaling pathway","AFFECTS","Osteogenic Differentiation","osteogenic differentiation"
"1124","33090698","m6A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway.","METTL3","promote","Progression","Retinoblastoma","METTL3","STIMULATES","progression","Retinoblastoma"
"2212","33090698","m6A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway.","METTL3","promote","PI3K/AKT/mTOR pathway","Retinoblastoma","METTL3","STIMULATES","progression","Retinoblastoma"
"3185","33090698","m6A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway.","PI3K/AKT/mTOR pathway","promote","Progression","Retinoblastoma","PI3K/AKT/mTOR pathway","STIMULATES","progression","Retinoblastoma"
"1125","34484859","m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","FTO","suppress","Tumorigenesis","Pancreatic Cancer","FTO","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"2213","34484859","m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","FTO","demethylate","PJA2","Pancreatic Cancer","FTO","CONVERTS_TO","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"3192","34484859","m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","FTO","inhibit","Wnt signaling","Pancreatic Cancer","FTO","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"491","34484859","m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","PJA2","suppress","Tumorigenesis","Pancreatic Cancer","PJA2","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"553","34484859","m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.","Wnt signaling","suppress","Tumorigenesis","Pancreatic Cancer","Wnt signaling pathway","INHIBITS","Carcinogenesis","PAAD(Pancreatic Adenocarcinoma)"
"1126","31914601","METTL3 regulates inflammatory pain by modulating m6A-dependent pri-miR-365-3p processing.","METTL3","regulate","Inflammatory Pain","Null","METTL3","AFFECTS","Inflammatory Pain","Null"
"2214","31914601","METTL3 regulates inflammatory pain by modulating m6A-dependent pri-miR-365-3p processing.","METTL3","regulate","m6A","Null","METTL3","AFFECTS","Inflammatory Pain","Null"
"3196","31914601","METTL3 regulates inflammatory pain by modulating m6A-dependent pri-miR-365-3p processing.","m6A","modulate","pri-miR-365-3p processing","Null","m6A","AFFECTS","pri-miR-365-3p processing","Null"
"492","31914601","METTL3 regulates inflammatory pain by modulating m6A-dependent pri-miR-365-3p processing.","pri-miR-365-3p processing","regulate","Inflammatory Pain","Null","pri-miR-365-3p processing","AFFECTS","Inflammatory Pain","Null"
"1127","29535189","Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.","Zc3h13/Flacc","is required for","adenosine methylation","Null","Zc3h13/Flacc","CAUSES","adenosine methylation","Null"
"2215","29535189","Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.","Zc3h13/Flacc","bridge","Rbm15/Spenito","Null","Zc3h13/Flacc","ASSOCIATED_WITH","adenosine methylation","Null"
"3200","29535189","Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.","Rbm15/Spenito","bind to","Wtap/Fl(2)d","Null","Rbm15/Spenito","INTERACTS_WITH","Wtap/Fl(2)d","Null"
"493","29535189","Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.","Wtap/Fl(2)d","regulate","adenosine methylation","Null","Wtap/Fl(2)d","AFFECTS","adenosine methylation","Null"
"1128","34496349","RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.","FTO","promote","Osteoporosis","Osteoporosis","FTO","STIMULATES","Osteoporosis","Osteoporosis"
"2216","34496349","RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.","FTO","demethylate","Runx2 mRNA","Osteoporosis","FTO","CONVERTS_TO","Osteoporosis","Osteoporosis"
"3203","34496349","RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.","FTO","inhibit","Osteogenic differentiation","Osteoporosis","FTO","INHIBITS","Osteoporosis","Osteoporosis"
"494","34496349","RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.","Runx2 mRNA","regulate","Osteoporosis","Osteoporosis","RUNX2","AFFECTS","Osteoporosis","Osteoporosis"
"554","34496349","RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.","Osteogenic differentiation","regulate","Osteoporosis","Osteoporosis","Osteogenic Differentiation","AFFECTS","Osteoporosis","Osteoporosis"
"1129","32126149","METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.","METTL3/YTHDF2 m6A axis","promote","Tumorigenesis","Bladder Cancer","METTL3/YTHDF2 m6A axis","STIMULATES","Carcinogenesis","BLCA(Bladder Urothelial Carcinoma)"
"2219","32126149","METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.","METTL3/YTHDF2 m6A axis","degrade","SETD7","Bladder Cancer","METTL3/YTHDF2 m6A axis","INHIBITS","Carcinogenesis","BLCA(Bladder Urothelial Carcinoma)"
"3207","32126149","METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.","METTL3/YTHDF2 m6A axis","degrade","KLF4","Bladder Cancer","METTL3/YTHDF2 m6A axis","INHIBITS","Carcinogenesis","BLCA(Bladder Urothelial Carcinoma)"
"495","32126149","METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.","SETD7","inhibit","Tumorigenesis","Bladder Cancer","SETD7","INHIBITS","Carcinogenesis","BLCA(Bladder Urothelial Carcinoma)"
"555","32126149","METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.","KLF4","inhibit","Tumorigenesis","Bladder Cancer","KLF4","INHIBITS","Carcinogenesis","BLCA(Bladder Urothelial Carcinoma)"
"1130","29186125","Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.","METTL3","maintain","Myeloid Leukaemia","Myeloid Leukaemia","METTL3","MAINTAINS","Leukemia, Myeloid","LAML(Acute Myeloid Leukemia)"
"2220","29186125","Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.","METTL3","regulate","m6A","Myeloid Leukaemia","METTL3","AFFECTS","Leukemia, Myeloid","LAML(Acute Myeloid Leukemia)"
"3211","29186125","Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.","m6A","regulate","translation","Myeloid Leukaemia","m6A","AFFECTS","translation","LAML(Acute Myeloid Leukemia)"
"496","29186125","Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.","m6A","maintain","Myeloid Leukaemia","Myeloid Leukaemia","m6A","MAINTAINS","translation","LAML(Acute Myeloid Leukemia)"
"1131","32111213","METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.","METTL14","suppress","Proliferation","Colorectal Cancer","METTL14","INHIBITS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"2221","32111213","METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.","METTL14","suppress","Metastasis","Colorectal Cancer","METTL14","INHIBITS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"3216","32111213","METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.","METTL14","down-regulate","XIST","Colorectal Cancer","METTL14","INHIBITS","cell population proliferation","COAD(Colon Adenocarcinoma)"
"497","32111213","METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.","XIST","promote","Proliferation","Colorectal Cancer","XIST","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"556","32111213","METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.","XIST","promote","Metastasis","Colorectal Cancer","XIST","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"1132","31619268","Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.","GAS5","inhibit","Progression","Colorectal Cancer","GAS5","INHIBITS","progression","COAD(Colon Adenocarcinoma)"
"2222","31619268","Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.","GAS5","Phosphorylate","YAP","Colorectal Cancer","GAS5","CONVERTS_TO","progression","COAD(Colon Adenocarcinoma)"
"3220","31619268","Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.","GAS5","degrade","YAP","Colorectal Cancer","GAS5","INHIBITS","progression","COAD(Colon Adenocarcinoma)"
"498","31619268","Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.","YAP","inhibit","Progression","Colorectal Cancer","YAP1","INHIBITS","progression","COAD(Colon Adenocarcinoma)"
"557","31619268","Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.","YTHDF3","negatively regulate","GAS5","Colorectal Cancer","YTHDF3","INHIBITS","GAS5","COAD(Colon Adenocarcinoma)"
"1133","31318098","The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.","METTL14","promote","Renal Ischemic Reperfusion Injury","Renal Ischemic Reperfusion Injury","METTL14","STIMULATES","Renal Ischemic Reperfusion Injury","Renal Ischemic Reperfusion Injury"
"2223","31318098","The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.","METTL14","suppress","YAP1","Renal Ischemic Reperfusion Injury","METTL14","INHIBITS","Renal Ischemic Reperfusion Injury","Renal Ischemic Reperfusion Injury"
"3225","31318098","The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.","YAP1","inhibit","Renal Ischemic Reperfusion Injury","Renal Ischemic Reperfusion Injury","YAP1","INHIBITS","Renal Ischemic Reperfusion Injury","Renal Ischemic Reperfusion Injury"
"1134","33411363","METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.","METTL3/YTHDF2 m6A axis","accelerate","Colorectal Carcinogenesis","Colorectal Carcinogenesis","METTL3/YTHDF2 m6A axis","STIMULATES","Colorectal Carcinogenesis","COAD(Colon Adenocarcinoma)"
"2224","33411363","METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.","METTL3/YTHDF2 m6A axis","suppress","YPEL5","Colorectal Carcinogenesis","METTL3/YTHDF2 m6A axis","INHIBITS","Colorectal Carcinogenesis","COAD(Colon Adenocarcinoma)"
"3230","33411363","METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.","YPEL5","accelerate","Colorectal Carcinogenesis","Colorectal Carcinogenesis","YPEL5","STIMULATES","Colorectal Carcinogenesis","COAD(Colon Adenocarcinoma)"
"1135","33280517","Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.","MicroRNA-376c","inhibit","Properties","Non-Small Cell Lung Cancer","MIR376C","INHIBITS","Properties","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2225","33280517","Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.","MicroRNA-376c","is in","Extracellular Vesicles","Non-Small Cell Lung Cancer","MIR376C","LOCATES","Properties","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3233","33280517","Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.","MicroRNA-376c","target","YTHDF1","Non-Small Cell Lung Cancer","MIR376C","INTERACTS_WITH","Properties","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"499","33280517","Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.","YTHDF1","regulate","Properties","Non-Small Cell Lung Cancer","YTHDF1","AFFECTS","Properties","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"1136","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","dummy","inhibit","METTL3","Endometriosis","dummy","INHIBITS","METTL3","Endometriosis"
"2230","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","dummy","inhibit","m6A","Endometriosis","dummy","INHIBITS","METTL3","Endometriosis"
"3236","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","dummy","inhibit","miR126","Endometriosis","dummy","INHIBITS","METTL3","Endometriosis"
"4104","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","METTL3","promote","migration","Endometriosis","METTL3","STIMULATES","migration","Endometriosis"
"558","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","METTL3","promote","invasion of endometrial stromal cells","Endometriosis","METTL3","STIMULATES","migration","Endometriosis"
"623","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","m6A","promote","migration","Endometriosis","m6A","STIMULATES","migration","Endometriosis"
"77","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","m6A","promote","invasion of endometrial stromal cells","Endometriosis","m6A","STIMULATES","migration","Endometriosis"
"83","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","miR126","promote","migration","Endometriosis","MIR126","STIMULATES","migration","Endometriosis"
"91","34382070","Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.","miR126","promote","invasion of endometrial stromal cells","Endometriosis","MIR126","STIMULATES","migration","Endometriosis"
"1137","33926120","Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons.","Small-Molecule Inhibitors","process of","FTO","Dopamine Neurons","Small-Molecule Inhibitors","PROCESS_OF","FTO","Dopaminergic Neurons"
"2236","33926120","Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons.","Small-Molecule Inhibitors","support","Survival","Dopamine Neurons","Small-Molecule Inhibitors","STIMULATES","FTO","Dopaminergic Neurons"
"1138","34112124","A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.","HBx","promote","ALKBH5","Hepatocellular Carcinogenesis","Q157B2","STIMULATES","ALKBH5","LIHC(Liver Hepatocellular Carcinoma)"
"2237","34112124","A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.","ALKBH5","promote","HBx","Hepatocellular Carcinogenesis","ALKBH5","STIMULATES","Q157B2","LIHC(Liver Hepatocellular Carcinoma)"
"3239","34112124","A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.","HBx","promote","Hepatocellular Carcinogenesis","Hepatocellular Carcinogenesis","Q157B2","STIMULATES","ALKBH5","LIHC(Liver Hepatocellular Carcinoma)"
"4108","34112124","A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.","ALKBH5","promote","Hepatocellular Carcinogenesis","Hepatocellular Carcinogenesis","ALKBH5","STIMULATES","Q157B2","LIHC(Liver Hepatocellular Carcinoma)"
"1139","32554504","Early-life m6A RNA demethylation by fat mass and obesity-associated protein (FTO) influences resilience or vulnerability to heat stress later in life.","FTO","demethylate","m6A","Heat Stress","FTO","CONVERTS_TO","m6A","heat stress"
"2238","32554504","Early-life m6A RNA demethylation by fat mass and obesity-associated protein (FTO) influences resilience or vulnerability to heat stress later in life.","m6A","influences","resilience","Heat Stress","m6A","AFFECTS","resilience","heat stress"
"3244","32554504","Early-life m6A RNA demethylation by fat mass and obesity-associated protein (FTO) influences resilience or vulnerability to heat stress later in life.","m6A","influences","vulnerability","Heat Stress","m6A","AFFECTS","resilience","heat stress"
"1140","33364952","Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.","Genistein","ameliorate","Renal Fibrosis","Renal Fibrosis","genistein","TREATS","Renal fibrosis","Renal fibrosis"
"2239","33364952","Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.","Genistein","regulate","ALKBH5","Renal Fibrosis","genistein","AFFECTS","Renal fibrosis","Renal fibrosis"
"3249","33364952","Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.","ALKBH5","regulate","Snail","Renal Fibrosis","ALKBH5","AFFECTS","SNAI1","Renal fibrosis"
"4111","33364952","Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.","Snail","ameliorate","Renal Fibrosis","Renal Fibrosis","SNAI1","TREATS","Renal fibrosis","Renal fibrosis"
"1141","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","HIF-1alpha","induce","YTHDF1","Hepatocellular Carcinoma","HIF1A","CAUSES","YTHDF1","LIHC(Liver Hepatocellular Carcinoma)"
"2240","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","Hypoxia","induce","autophagy","Hepatocellular Carcinoma","Hypoxia","CAUSES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"3253","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","YTHDF1","drive","autophagy","Hepatocellular Carcinoma","YTHDF1","STIMULATES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"4117","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","YTHDF1","drive","malignancy","Hepatocellular Carcinoma","YTHDF1","STIMULATES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"559","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","YTHDF1","promote","ATG2A","Hepatocellular Carcinoma","YTHDF1","STIMULATES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"624","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","YTHDF1","promote","ATG14","Hepatocellular Carcinoma","YTHDF1","STIMULATES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"78","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","ATG2A","promote","autophagy","Hepatocellular Carcinoma","ATG2A","STIMULATES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"84","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","ATG14","promote","autophagy","Hepatocellular Carcinoma","ATG14","STIMULATES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"92","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","ATG2A","promote","malignancy","Hepatocellular Carcinoma","ATG2A","STIMULATES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"10","33619246","HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.","ATG14","promote","malignancy","Hepatocellular Carcinoma","ATG14","STIMULATES","autophagy","LIHC(Liver Hepatocellular Carcinoma)"
"1142","34279591","Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.","dummy","induce knockdown of","METTL3","mouse Schwann cells","dummy","INHIBITS","METTL3","mouse Schwann cells"
"2241","34279591","Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.","METTL3","inhibit","Apoptosis","mouse Schwann cells","METTL3","INHIBITS","apoptotic process","mouse Schwann cells"
"3257","34279591","Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.","Enterovirus 71","induce","Apoptosis","mouse Schwann cells","Enterovirus 71","CAUSES","apoptotic process","mouse Schwann cells"
"4122","34279591","Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.","METTL3","regulate","Autophagy","mouse Schwann cells","METTL3","AFFECTS","apoptotic process","mouse Schwann cells"
"560","34279591","Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.","Autophagy","regulate","Apoptosis","mouse Schwann cells","autophagy","AFFECTS","apoptotic process","mouse Schwann cells"
"1143","32621798","METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.","METTL3","promote","Tumorigenesis","Oral Squamous Cell Carcinoma","METTL3","STIMULATES","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2242","32621798","METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.","METTL3","promote","Metastasis","Oral Squamous Cell Carcinoma","METTL3","STIMULATES","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3262","32621798","METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.","METTL3","methylate","BMI1","Oral Squamous Cell Carcinoma","METTL3","CONVERTS_TO","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4129","32621798","METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.","BMI1","promote","Tumorigenesis","Oral Squamous Cell Carcinoma","BMI1","STIMULATES","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"561","32621798","METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.","BMI1","promote","Metastasis","Oral Squamous Cell Carcinoma","BMI1","STIMULATES","Carcinogenesis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"1144","30922314","RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.","FTO","promote","Progression","Breast Tumor","FTO","STIMULATES","progression","BRCA(Breast Invasive Carcinoma)"
"2243","30922314","RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.","FTO","inhibit","BNIP3","Breast Tumor","FTO","INHIBITS","progression","BRCA(Breast Invasive Carcinoma)"
"3264","30922314","RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.","BNIP3","inhibit","Progression","Breast Tumor","BNIP3","INHIBITS","progression","BRCA(Breast Invasive Carcinoma)"
"1145","31281518","The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA.","ALKBH5","control","Trophoblast Invasion","Maternal-Fetal Interface","ALKBH5","AFFECTS","Trophoblast Invasion","Maternal-Fetal Interface"
"2244","31281518","The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA.","ALKBH5","regulate the stability of","CYR61","Maternal-Fetal Interface","ALKBH5","AFFECTS","Trophoblast Invasion","Maternal-Fetal Interface"
"3269","31281518","The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA.","CYR61","control","Trophoblast Invasion","Maternal-Fetal Interface","CCN1","AFFECTS","Trophoblast Invasion","Maternal-Fetal Interface"
"1146","32365051","Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.","METTL3","attenuate","pyroptosis","High-glucose induced RPE cell","METTL3","INHIBITS","pyroptosis","High-glucose induced RPE cell"
"2245","32365051","Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.","METTL3","regulate","DGCR8","High-glucose induced RPE cell","METTL3","AFFECTS","pyroptosis","High-glucose induced RPE cell"
"3279","32365051","Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.","DGCR8","regulate","miR-25-3p/PTEN/Akt signaling cascade","High-glucose induced RPE cell","DGCR8","AFFECTS","miR-25-3p/PTEN/Akt signaling cascade","High-glucose induced RPE cell"
"4132","32365051","Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.","miR-25-3p/PTEN/Akt signaling cascade","regulate","pyroptosis","High-glucose induced RPE cell","miR-25-3p/PTEN/Akt signaling cascade","AFFECTS","pyroptosis","High-glucose induced RPE cell"
"1147","33894271","METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.","METTL3","involve","Progression","Osteoarthritis","METTL3","ASSOCIATED_WITH","progression","Osteoarthritis"
"2246","33894271","METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.","METTL3","affect","ECM","Osteoarthritis","METTL3","AFFECTS","progression","Osteoarthritis"
"3285","33894271","METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.","METTL3","regulate","inflammatory response","Osteoarthritis","METTL3","AFFECTS","progression","Osteoarthritis"
"4138","33894271","METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.","Progression","regulate","ECM","Osteoarthritis","progression","AFFECTS","extracellular matrix","Osteoarthritis"
"562","33894271","METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.","Progression","regulate","inflammatory response","Osteoarthritis","progression","AFFECTS","extracellular matrix","Osteoarthritis"
"1148","31996915","The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.","YTHDF1","promote","Progression","Ovarian Cancer","YTHDF1","STIMULATES","progression","OV(Ovarian Serous Cystadenocarcinoma)"
"2250","31996915","The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.","YTHDF1","augment","EIF3C","Ovarian Cancer","YTHDF1","AUGMENTS","progression","OV(Ovarian Serous Cystadenocarcinoma)"
"3288","31996915","The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.","EIF3C","promote","Progression","Ovarian Cancer","EIF3C","STIMULATES","progression","OV(Ovarian Serous Cystadenocarcinoma)"
"1149","34312368","C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.","C5aR1-positive neutrophils","promote","glycolysis","Breast Cancer","C5aR1-positive neutrophils","STIMULATES","glycolytic process","BRCA(Breast Invasive Carcinoma)"
"2251","34312368","C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.","C5aR1-positive neutrophils","regulate","WTAP","Breast Cancer","C5aR1-positive neutrophils","AFFECTS","glycolytic process","BRCA(Breast Invasive Carcinoma)"
"3292","34312368","C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.","WTAP","methylate","m6A","Breast Cancer","WTAP","CONVERTS_TO","m6A","BRCA(Breast Invasive Carcinoma)"
"4144","34312368","C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.","m6A","is on","ENO1","Breast Cancer","m6A","LOCATES","ENO1","BRCA(Breast Invasive Carcinoma)"
"563","34312368","C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.","ENO1","regulate","glycolysis","Breast Cancer","ENO1","AFFECTS","glycolytic process","BRCA(Breast Invasive Carcinoma)"
"1150","34075693","METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.","METTL16","promote","Cell Proliferation","Gastric Cancer","METTL16","STIMULATES","cell population proliferation","STAD(Stomach adenocarcinoma)"
"2252","34075693","METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.","METTL16","up-regulate","Cyclin D1","Gastric Cancer","METTL16","STIMULATES","cell population proliferation","STAD(Stomach adenocarcinoma)"
"3296","34075693","METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.","Cyclin D1","promote","Cell Proliferation","Gastric Cancer","CCND1","STIMULATES","cell population proliferation","STAD(Stomach adenocarcinoma)"
"1151","32373970","METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.","METTL3","promote","Progression","Nasopharyngeal Carcinoma","METTL3","STIMULATES","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2253","32373970","METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.","METTL3","mediate","M6A","Nasopharyngeal Carcinoma","METTL3","AFFECTS","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3301","32373970","METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.","M6A","is on","EZH2","Nasopharyngeal Carcinoma","m6A","LOCATES","EZH2","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4148","32373970","METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.","EZH2","promote","Progression","Nasopharyngeal Carcinoma","EZH2","STIMULATES","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"1152","32373962","Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.","Simvastatin","benefit","Progression","Lung Cancer","simvastatin","AUGMENTS","progression","LUAD(Lung Adenocarcinoma)"
"2254","32373962","Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.","Simvastatin","induce","METTL3","Lung Cancer","simvastatin","CAUSES","progression","LUAD(Lung Adenocarcinoma)"
"3307","32373962","Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.","m6A","is on","EZH2","Lung Cancer","m6A","LOCATES","EZH2","LUAD(Lung Adenocarcinoma)"
"4150","32373962","Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.","METTL3","induce","m6A","Lung Cancer","METTL3","CAUSES","m6A","LUAD(Lung Adenocarcinoma)"
"564","32373962","Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.","EZH2","benefit","Progression","Lung Cancer","EZH2","AUGMENTS","progression","LUAD(Lung Adenocarcinoma)"
"1153","31405565","METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.","METTL3","inhibit","hepatic insulin sensitivity","Hepatic","METTL3","INHIBITS","hepatic insulin sensitivity","hepatic"
"2255","31405565","METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.","METTL3","regulate","N6-methyladenosine","Hepatic","METTL3","AFFECTS","hepatic insulin sensitivity","hepatic"
"3312","31405565","METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.","N6-methyladenosine","is on","Fasn","Hepatic","m6A","LOCATES","FASN","hepatic"
"4154","31405565","METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.","METTL3","promote","Fatty acid metabolism","Hepatic","METTL3","STIMULATES","hepatic insulin sensitivity","hepatic"
"565","31405565","METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.","Fasn","inhibit","hepatic insulin sensitivity","Hepatic","FASN","INHIBITS","hepatic insulin sensitivity","hepatic"
"625","31405565","METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.","Fatty acid metabolism","inhibit","hepatic insulin sensitivity","Hepatic","fatty acid metabolic process","INHIBITS","hepatic insulin sensitivity","hepatic"
"1154","31974865","DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.","DDX3","modulate","cisplatin resistance","OSCC","DDX3X","AFFECTS","Cisplatin Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2256","31974865","DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.","DDX3","regulate","ALKBH5","OSCC","DDX3X","AFFECTS","Cisplatin Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3317","31974865","DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.","ALKBH5","demethylate","m6A","OSCC","ALKBH5","CONVERTS_TO","m6A","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4158","31974865","DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.","m6A","is on","FOXM1","OSCC","m6A","LOCATES","FOXM1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"566","31974865","DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.","m6A","is on","NANOG","OSCC","m6A","LOCATES","FOXM1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"626","31974865","DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.","NANOG","modulate","cisplatin resistance","OSCC","NANOG","AFFECTS","Cisplatin Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"79","31974865","DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.","FOXM1","modulate","cisplatin resistance","OSCC","FOXM1","AFFECTS","Cisplatin Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"1155","33010548","Increased m6A modification of RNA methylation related to the inhibition of demethylase FTO contributes to MEHP-induced Leydig cell injury .","m6A","inhibit","FTO","Leydig cell","m6A","INHIBITS","FTO","Leydig Cells"
"2257","33010548","Increased m6A modification of RNA methylation related to the inhibition of demethylase FTO contributes to MEHP-induced Leydig cell injury .","FTO","contribute to","injury","Leydig cell","FTO","AFFECTS","Wounds and Injuries","Leydig Cells"
"3321","33010548","Increased m6A modification of RNA methylation related to the inhibition of demethylase FTO contributes to MEHP-induced Leydig cell injury .","MEHP","induce","injury","Leydig cell","mono(2-ethylhexyl) phthalate","CAUSES","Wounds and Injuries","Leydig Cells"
"1156","34297301","ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.","ALKBH5","promote","Proliferation","Glioma Cells","ALKBH5","STIMULATES","cell population proliferation","Glioma"
"2258","34297301","ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.","ALKBH5","stabilize","G6PD","Glioma Cells","ALKBH5","MAINTAINS","cell population proliferation","Glioma"
"3327","34297301","ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.","G6PD","promote","Proliferation","Glioma Cells","G6PD","STIMULATES","cell population proliferation","Glioma"
"1157","32670741","N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons.","FTO","contribute","Neuropathic Pain","Primary Sensory Neurons","FTO","AFFECTS","Neuralgia","Primary Sensory Neurons"
"2259","32670741","N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons.","FTO","stabilize","G9a Expression","Primary Sensory Neurons","FTO","MAINTAINS","Neuralgia","Primary Sensory Neurons"
"3333","32670741","N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons.","G9a Expression","contribute","Neuropathic Pain","Primary Sensory Neurons","EHMT2","AFFECTS","Neuralgia","Primary Sensory Neurons"
"1158","33314339","The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.","METTL14","inhibit","Proliferation","Gastric Cancer","METTL14","INHIBITS","cell population proliferation","STAD(Stomach adenocarcinoma)"
"2260","33314339","The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.","METTL14","inhibit","Migration","Gastric Cancer","METTL14","INHIBITS","cell population proliferation","STAD(Stomach adenocarcinoma)"
"3340","33314339","The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.","METTL14","inhibit","Invasion","Gastric Cancer","METTL14","INHIBITS","cell population proliferation","STAD(Stomach adenocarcinoma)"
"4165","33314339","The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.","METTL14","regulate","PI3K/AKT/mTOR signaling pathway","Gastric Cancer","METTL14","AFFECTS","cell population proliferation","STAD(Stomach adenocarcinoma)"
"567","33314339","The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.","PI3K/AKT/mTOR signaling pathway","inhibit","Proliferation","Gastric Cancer","PI3K/AKT/mTOR pathway","INHIBITS","cell population proliferation","STAD(Stomach adenocarcinoma)"
"627","33314339","The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.","PI3K/AKT/mTOR signaling pathway","inhibit","Migration","Gastric Cancer","PI3K/AKT/mTOR pathway","INHIBITS","cell population proliferation","STAD(Stomach adenocarcinoma)"
"713","33314339","The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.","PI3K/AKT/mTOR signaling pathway","inhibit","Invasion","Gastric Cancer","PI3K/AKT/mTOR pathway","INHIBITS","cell population proliferation","STAD(Stomach adenocarcinoma)"
"1159","33305825","HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.","HBXIP","drive","Metabolic Reprogramming","Hepatocellular Carcinoma cells","LAMTOR5","STIMULATES","Metabolic Reprogramming","LIHC(Liver Hepatocellular Carcinoma)"
"2261","33305825","HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.","HBXIP","regulate","METTL3","Hepatocellular Carcinoma cells","LAMTOR5","AFFECTS","Metabolic Reprogramming","LIHC(Liver Hepatocellular Carcinoma)"
"3347","33305825","HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.","METTL3","mediate","m6A","Hepatocellular Carcinoma cells","METTL3","AFFECTS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"4169","33305825","HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.","m6A","is on","HIF-1alpha","Hepatocellular Carcinoma cells","m6A","LOCATES","HIF1A","LIHC(Liver Hepatocellular Carcinoma)"
"568","33305825","HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.","HIF-1alpha","drive","Metabolic Reprogramming","Hepatocellular Carcinoma cells","HIF1A","STIMULATES","Metabolic Reprogramming","LIHC(Liver Hepatocellular Carcinoma)"
"1160","33103587","FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.","FTO","promote","Metastasis","Endometrial Cancer","FTO","STIMULATES","Neoplasm Metastasis","Dientamoebiasis"
"2265","33103587","FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.","FTO","demethylate","m6A","Endometrial Cancer","FTO","CONVERTS_TO","Neoplasm Metastasis","Dientamoebiasis"
"3354","33103587","FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.","m6A","is in","HOXB13","Endometrial Cancer","m6A","LOCATES","HOXB13","Dientamoebiasis"
"4174","33103587","FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.","FTO","activate","WNT signaling pathway","Endometrial Cancer","FTO","STIMULATES","Neoplasm Metastasis","Dientamoebiasis"
"569","33103587","FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.","HOXB13","regulate","Metastasis","Endometrial Cancer","HOXB13","AFFECTS","Neoplasm Metastasis","Dientamoebiasis"
"628","33103587","FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.","WNT signaling pathway","regulate","Metastasis","Endometrial Cancer","Wnt signaling pathway","AFFECTS","Neoplasm Metastasis","Dientamoebiasis"
"1161","32913456","ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer.","ALKBH5","regulate","IGF1R","Endometrial Cancer","ALKBH5","AFFECTS","IGF1R","Dientamoebiasis"
"2271","32913456","ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer.","IGF1R","promote","Proliferation","Endometrial Cancer","IGF1R","STIMULATES","cell population proliferation","Dientamoebiasis"
"3359","32913456","ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer.","IGF1R","promote","Tumorigenicity","Endometrial Cancer","IGF1R","STIMULATES","cell population proliferation","Dientamoebiasis"
"1162","33637103","RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.","RBM15","facilitate","Progression","Laryngeal Squamous Cell Carcinoma","RBM15","STIMULATES","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2279","33637103","RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.","RBM15","regulate","IGF2BP3","Laryngeal Squamous Cell Carcinoma","RBM15","AFFECTS","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3364","33637103","RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.","IGF2BP3","regulate","TMBIM6","Laryngeal Squamous Cell Carcinoma","IGF2BP3","AFFECTS","TMBIM6","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4177","33637103","RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.","TMBIM6","facilitate","Progression","Laryngeal Squamous Cell Carcinoma","TMBIM6","STIMULATES","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"1163","34467630","Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.","dummy","induce degradation of","WTAP","Null","dummy","CONVERTS_TO","WTAP","Null"
"2282","34467630","Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.","WTAP","block","antiviral responses","Null","WTAP","INHIBITS","defense response to virus","Null"
"3371","34467630","Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.","WTAP","reduce the m6A levels of","IRF3","Null","WTAP","INHIBITS","defense response to virus","Null"
"4182","34467630","Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.","WTAP","reduce the m6A levels of","IFNAR1","Null","WTAP","INHIBITS","defense response to virus","Null"
"570","34467630","Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.","IRF3","block","antiviral responses","Null","IRF3","INHIBITS","defense response to virus","Null"
"629","34467630","Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.","IFNAR1","block","antiviral responses","Null","IFNAR1","INHIBITS","defense response to virus","Null"
"1164","34093789","YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A.","YTHDF2","inhibit","Tumorigenicity","Endometrial Cancer","YTHDF2","INHIBITS","Tumorigenicity","Dientamoebiasis"
"2287","34093789","YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A.","YTHDF2","downregulate","IRS1","Endometrial Cancer","YTHDF2","INHIBITS","Tumorigenicity","Dientamoebiasis"
"3375","34093789","YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A.","m6A","methylate","IRS1","Endometrial Cancer","m6A","CONVERTS_TO","IRS1","Dientamoebiasis"
"4187","34093789","YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A.","IRS1","promote","Tumorigenicity","Endometrial Cancer","IRS1","STIMULATES","Tumorigenicity","Dientamoebiasis"
"1165","34277426","N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.","FTO","promote","Metastasis","Gastric Cancer","FTO","STIMULATES","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"2289","34277426","N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.","FTO","down-regulate","m6A","Gastric Cancer","FTO","INHIBITS","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"3381","34277426","N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.","m6A","is on","ITGB1","Gastric Cancer","m6A","LOCATES","ITGB1","STAD(Stomach adenocarcinoma)"
"4190","34277426","N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.","ITGB1","promote","Metastasis","Gastric Cancer","ITGB1","STIMULATES","Neoplasm Metastasis","STAD(Stomach adenocarcinoma)"
"1166","31982139","The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.","METTL3","regulate","JUNB","Lung Cancer Cells","METTL3","AFFECTS","JUNB","LUSC(Lung Squamous Cell Carcinoma)"
"2293","31982139","The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.","METTL3","contribute","Epithelial-Mesenchymal Transition","Lung Cancer Cells","METTL3","AFFECTS","JUNB","LUSC(Lung Squamous Cell Carcinoma)"
"3385","31982139","The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.","Transforming Growth Factor-beta","induce","Epithelial-Mesenchymal Transition","Lung Cancer Cells","TGFB","CAUSES","epithelial to mesenchymal transition","LUSC(Lung Squamous Cell Carcinoma)"
"4195","31982139","The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.","JUNB","regulate","Epithelial-Mesenchymal Transition","Lung Cancer Cells","JUNB","AFFECTS","epithelial to mesenchymal transition","LUSC(Lung Squamous Cell Carcinoma)"
"1167","34560125","METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.","METTL3","mediate","M6A","Colistin-induced nephrotoxicity","METTL3","AFFECTS","m6A","Colistin-induced nephrotoxicity"
"2299","34560125","METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.","M6A","is involved in","nephrotoxicity","Colistin-induced nephrotoxicity","m6A","PROCESS_OF","nephrotoxicity","Colistin-induced nephrotoxicity"
"3388","34560125","METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.","colistin","induce","nephrotoxicity","Colistin-induced nephrotoxicity","colistin","CAUSES","nephrotoxicity","Colistin-induced nephrotoxicity"
"4196","34560125","METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.","M6A","regulate","Keap1/Nrf2 signaling pathway","Colistin-induced nephrotoxicity","m6A","AFFECTS","nephrotoxicity","Colistin-induced nephrotoxicity"
"571","34560125","METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.","Keap1/Nrf2 signaling pathway","mediate","apoptosis","Colistin-induced nephrotoxicity","Keap1/Nrf2 signaling pathway","AFFECTS","apoptotic process","Colistin-induced nephrotoxicity"
"630","34560125","METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.","apoptosis","is involved in","colistin-induced nephrotoxicity","Colistin-induced nephrotoxicity","apoptotic process","PROCESS_OF","colistin-induced nephrotoxicity","Colistin-induced nephrotoxicity"
"1168","33758320","METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.","METTL3","mediate","m6A","Gastric Cancer","METTL3","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"2304","33758320","METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.","m6A","is on","SPHK2","Gastric Cancer","m6A","LOCATES","SPHK2","STAD(Stomach adenocarcinoma)"
"3396","33758320","METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.","SPHK2","promote","Progression","Gastric Cancer","SPHK2","STIMULATES","progression","STAD(Stomach adenocarcinoma)"
"4201","33758320","METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.","SPHK2","target","KLF2","Gastric Cancer","SPHK2","INTERACTS_WITH","progression","STAD(Stomach adenocarcinoma)"
"572","33758320","METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.","KLF2","promote","Progression","Gastric Cancer","KLF2","STIMULATES","progression","STAD(Stomach adenocarcinoma)"
"1169","33330653","Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.","FTO","promote","Aortic Dissecting Aneurysms","Vascular Smooth Muscle","FTO","STIMULATES","Aortic Dissecting Aneurysms","Muscle, Smooth, Vascular"
"2309","33330653","Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.","FTO","regulate","m6A","Vascular Smooth Muscle","FTO","AFFECTS","Aortic Dissecting Aneurysms","Muscle, Smooth, Vascular"
"3402","33330653","Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.","m6A","is on","Klf5","Vascular Smooth Muscle","m6A","LOCATES","KLF5","Muscle, Smooth, Vascular"
"4205","33330653","Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.","Klf5","promote","Aortic Dissecting Aneurysms","Vascular Smooth Muscle","KLF5","STIMULATES","Aortic Dissecting Aneurysms","Muscle, Smooth, Vascular"
"1170","31253399","The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.","METTL3","promote","Progression","Osteosarcoma","METTL3","STIMULATES","progression","SARC(Sarcoma)"
"2314","31253399","The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.","METTL3","regulate","m6A","Osteosarcoma","METTL3","AFFECTS","progression","SARC(Sarcoma)"
"3408","31253399","The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.","m6A","is on","LEF1","Osteosarcoma","m6A","LOCATES","LEF1","SARC(Sarcoma)"
"4209","31253399","The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.","m6A","regulate","Progression","Osteosarcoma","m6A","AFFECTS","LEF1","SARC(Sarcoma)"
"1171","32913527","ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1.","ALKBH5","promote","Progression","Colon Cancer","ALKBH5","STIMULATES","progression","COAD(Colon Adenocarcinoma)"
"2320","32913527","ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1.","ALKBH5","decrease methylation of","NEAT1","Colon Cancer","ALKBH5","INHIBITS","progression","COAD(Colon Adenocarcinoma)"
"3414","32913527","ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1.","NEAT1","promote","Osteosarcoma Progression","Colon Cancer","NEAT1","STIMULATES","Osteosarcoma Progression","COAD(Colon Adenocarcinoma)"
"1172","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","Hepatic Microenvironment","promote","Proliferation","Lung Adenocarcinoma cell","Hepatic Microenvironment","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"2324","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","Hepatic Microenvironment","promote","Metastasis","Lung Adenocarcinoma cell","Hepatic Microenvironment","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"3419","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","Hepatic Microenvironment","promote","Epithelial-Mesenchymal Transition","Lung Adenocarcinoma cell","Hepatic Microenvironment","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"4218","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","Hepatic Microenvironment","regulate","METTL3","Lung Adenocarcinoma cell","Hepatic Microenvironment","AFFECTS","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"573","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","METTL3","mediate","N6-methyladenosine","Lung Adenocarcinoma cell","METTL3","AFFECTS","m6A","LUAD(Lung Adenocarcinoma)"
"631","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","N6-methyladenosine","is on","YAP1","Lung Adenocarcinoma cell","m6A","LOCATES","YAP1","LUAD(Lung Adenocarcinoma)"
"714","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","YAP1","promote","Proliferation","Lung Adenocarcinoma cell","YAP1","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"85","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","YAP1","promote","Metastasis","Lung Adenocarcinoma cell","YAP1","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"93","33495421","The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.","YAP1","promote","Epithelial-Mesenchymal Transition","Lung Adenocarcinoma cell","YAP1","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"1173","30506811","Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.","dummy","induce loss of","m6A","Porcine Adipocytes","dummy","INHIBITS","m6A","Porcine Adipocytes"
"2326","30506811","Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.","m6A","is on","FAM134B","Porcine Adipocytes","m6A","LOCATES","RETREG1","Porcine Adipocytes"
"3424","30506811","Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.","FAM134B","promote","Adipogenesis","Porcine Adipocytes","RETREG1","STIMULATES","Adipogenesis","Porcine Adipocytes"
"4223","30506811","Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.","FAM134B","regulate","m6a","Porcine Adipocytes","RETREG1","AFFECTS","Adipogenesis","Porcine Adipocytes"
"574","30506811","Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.","YTHDF2","bind","m6a","Porcine Adipocytes","YTHDF2","INTERACTS_WITH","GPM6A","Porcine Adipocytes"
"632","30506811","Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.","m6a","promote","Adipogenesis","Porcine Adipocytes","GPM6A","STIMULATES","Adipogenesis","Porcine Adipocytes"
"1174","32814762","WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner.","WTAP","promote","tumorigenesis","Osteosarcoma","WTAP","STIMULATES","Carcinogenesis","SARC(Sarcoma)"
"2329","32814762","WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner.","WTAP","regulate","m6A","Osteosarcoma","WTAP","AFFECTS","Carcinogenesis","SARC(Sarcoma)"
"3429","32814762","WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner.","m6A","repress","HMBOX1","Osteosarcoma","m6A","INHIBITS","HMBOX1","SARC(Sarcoma)"
"4226","32814762","WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner.","HMBOX1","promote","tumorigenesis","Osteosarcoma","HMBOX1","STIMULATES","Carcinogenesis","SARC(Sarcoma)"
"1175","33431791","ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.","ALKBH5","suppress","Tumor Progression","Osteosarcoma","ALKBH5","INHIBITS","Tumor Progression","SARC(Sarcoma)"
"2334","33431791","ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.","ALKBH5","regulate","m6A","Osteosarcoma","ALKBH5","AFFECTS","Tumor Progression","SARC(Sarcoma)"
"3433","33431791","ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.","m6A","silence","pre-miR-181b-1/YAP signaling axis","Osteosarcoma","m6A","INHIBITS","pre-miR-181b-1/YAP signaling axis","SARC(Sarcoma)"
"4233","33431791","ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.","pre-miR-181b-1/YAP signaling axis","suppress","Tumor Progression","Osteosarcoma","pre-miR-181b-1/YAP signaling axis","INHIBITS","Tumor Progression","SARC(Sarcoma)"
"1176","34359836","YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.","YTHDF1","promote","Cyclin B1 Translation","Lung Adenocarcinoma with KRAS/TP53 Co-Mutation","YTHDF1","STIMULATES","Cyclin B1 Translation","LUAD(Lung Adenocarcinoma)"
"2340","34359836","YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.","YTHDF1","contribute","Poor prognosis","Lung Adenocarcinoma with KRAS/TP53 Co-Mutation","YTHDF1","AFFECTS","Cyclin B1 Translation","LUAD(Lung Adenocarcinoma)"
"3438","34359836","YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.","YTHDF1","bind","m6A","Lung Adenocarcinoma with KRAS/TP53 Co-Mutation","YTHDF1","INTERACTS_WITH","Cyclin B1 Translation","LUAD(Lung Adenocarcinoma)"
"4239","34359836","YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.","m6A","promote","Cyclin B1 Translation","Lung Adenocarcinoma with KRAS/TP53 Co-Mutation","m6A","STIMULATES","Cyclin B1 Translation","LUAD(Lung Adenocarcinoma)"
"1177","31986407","Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.","Total Panax notoginseng saponin","inhibit","Proliferation","Vascular smooth muscle cell","Total Panax notoginseng saponin","INHIBITS","cell population proliferation","vascular smooth muscle cell"
"2348","31986407","Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.","Total Panax notoginseng saponin","inhibit","Migration","Vascular smooth muscle cell","Total Panax notoginseng saponin","INHIBITS","cell population proliferation","vascular smooth muscle cell"
"3440","31986407","Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.","Total Panax notoginseng saponin","inhibit","Intimal hyperplasia","Vascular smooth muscle cell","Total Panax notoginseng saponin","INHIBITS","cell population proliferation","vascular smooth muscle cell"
"4243","31986407","Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.","m6A","regulate","WTAP/p16 signals","Vascular smooth muscle cell","m6A","AFFECTS","WTAP/p16 signals","vascular smooth muscle cell"
"575","31986407","Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.","Total Panax notoginseng saponin","regulate","m6A","Vascular smooth muscle cell","Total Panax notoginseng saponin","AFFECTS","cell population proliferation","vascular smooth muscle cell"
"633","31986407","Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.","WTAP/p16 signals","inhibit","Proliferation","Vascular smooth muscle cell","WTAP/p16 signals","INHIBITS","cell population proliferation","vascular smooth muscle cell"
"715","31986407","Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.","WTAP/p16 signals","inhibit","Migration","Vascular smooth muscle cell","WTAP/p16 signals","INHIBITS","cell population proliferation","vascular smooth muscle cell"
"86","31986407","Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.","WTAP/p16 signals","inhibit","Intimal hyperplasia","Vascular smooth muscle cell","WTAP/p16 signals","INHIBITS","cell population proliferation","vascular smooth muscle cell"
"1178","32366907","YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.","YTHDF2","promote","stem cell Phenotype","Liver Cancer","YTHDF2","STIMULATES","stem cell Phenotype","LIHC(Liver Hepatocellular Carcinoma)"
"2355","32366907","YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.","YTHDF2","promote","Cancer Metastasis","Liver Cancer","YTHDF2","STIMULATES","stem cell Phenotype","LIHC(Liver Hepatocellular Carcinoma)"
"3443","32366907","YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.","m6A","regulate","OCT4 Expression","Liver Cancer","m6A","AFFECTS","OCT4 Expression","LIHC(Liver Hepatocellular Carcinoma)"
"4244","32366907","YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.","YTHDF2","bind","m6A RNA methylation","Liver Cancer","YTHDF2","INTERACTS_WITH","stem cell Phenotype","LIHC(Liver Hepatocellular Carcinoma)"
"576","32366907","YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.","OCT4 Expression","promote","stem cell Phenotype","Liver Cancer","OCT4 Expression","STIMULATES","stem cell Phenotype","LIHC(Liver Hepatocellular Carcinoma)"
"634","32366907","YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.","OCT4 Expression","promote","Cancer Metastasis","Liver Cancer","OCT4 Expression","STIMULATES","stem cell Phenotype","LIHC(Liver Hepatocellular Carcinoma)"
"1179","29033321","Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline.","3' 5' RNA Helicase YTHDC2","regulate","m6A Transcripts","Mammalian Germline","3' 5' RNA Helicase YTHDC2","AFFECTS","m6A","Mammalian Germline"
"2360","29033321","Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline.","m6A Transcripts","is essential for","Meiotic Program","Mammalian Germline","m6A","CAUSES","Meiotic Program","Mammalian Germline"
"1180","32266107","METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.","METTL3","enhance","Cell Adhesion","Prostatic Carcinoma","METTL3","AUGMENTS","cell adhesion","PRAD(Prostate Adenocarcinoma)"
"2365","32266107","METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.","METTL3","modify","m6A","Prostatic Carcinoma","METTL3","AFFECTS","cell adhesion","PRAD(Prostate Adenocarcinoma)"
"3448","32266107","METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.","HuR","bind","m6A","Prostatic Carcinoma","ELAVL1","INTERACTS_WITH","m6A","PRAD(Prostate Adenocarcinoma)"
"4248","32266107","METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.","m6A","stabilize","integrin _1 mRNA","Prostatic Carcinoma","m6A","MAINTAINS","integrin _1","PRAD(Prostate Adenocarcinoma)"
"577","32266107","METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.","integrin _1 mRNA","enhance","Cell Adhesion","Prostatic Carcinoma","integrin _1","AUGMENTS","cell adhesion","PRAD(Prostate Adenocarcinoma)"
"1181","30339471","MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.","MTCH2","promote","adipogenesis","intramuscular preadipocyte","MTCH2","STIMULATES","Adipogenesis","intramuscular preadipocyte"
"2369","30339471","MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.","MTCH2","regulate","m6A","intramuscular preadipocyte","MTCH2","AFFECTS","Adipogenesis","intramuscular preadipocyte"
"3453","30339471","MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.","YTHDF1","bind","m6A","intramuscular preadipocyte","YTHDF1","INTERACTS_WITH","m6A","intramuscular preadipocyte"
"4250","30339471","MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.","m6A","promote","adipogenesis","intramuscular preadipocyte","m6A","STIMULATES","Adipogenesis","intramuscular preadipocyte"
"1182","33651996","FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.","FTO","regulate","myoblast proliferation","Null","FTO","AFFECTS","myoblast proliferation","Null"
"2375","33651996","FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.","FTO","regulate","m6A","Null","FTO","AFFECTS","myoblast proliferation","Null"
"3457","33651996","FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.","m6A","control","CCND1 expression","Null","m6A","AFFECTS","CCND1","Null"
"4253","33651996","FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","Null","YTHDF2","INTERACTS_WITH","m6A","Null"
"578","33651996","FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.","CCND1 expression","regulate","myoblast proliferation","Null","CCND1","AFFECTS","myoblast proliferation","Null"
"1183","30305247","FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.","FTO","regulate","Adipogenesis","Adipogenesis/Adipocytes","FTO","AFFECTS","Adipogenesis","Adipogenesis"
"2379","30305247","FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.","FTO","regulate","m6A","Adipogenesis/Adipocytes","FTO","AFFECTS","Adipogenesis","Adipogenesis"
"3462","30305247","FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.","m6A","control","Cell cycle progression","Adipogenesis/Adipocytes","m6A","AFFECTS","cell cycle progression","Adipogenesis"
"4258","30305247","FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.","YTHDF2","bind","m6A","Adipogenesis/Adipocytes","YTHDF2","INTERACTS_WITH","m6A","Adipogenesis"
"579","30305247","FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.","cell cycle progression","regulate","Adipogenesis","Adipogenesis/Adipocytes","cell cycle progression","AFFECTS","Adipogenesis","Adipogenesis"
"1184","30865855","METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.","METTL3","inhibit","differentiation","BMSC adipogenic","METTL3","INHIBITS","cell differentiation","BMSC adipogenic"
"2385","30865855","METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.","METTL3","regulate","m6A","BMSC adipogenic","METTL3","AFFECTS","cell differentiation","BMSC adipogenic"
"3466","30865855","METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.","m6A","target","JAK1/STAT5/C/EBPbeta pathway","BMSC adipogenic","m6A","INTERACTS_WITH","JAK1/STAT5/C/EBPbeta pathway","BMSC adipogenic"
"4261","30865855","METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.","YTHDF2","bind","m6A","BMSC adipogenic","YTHDF2","INTERACTS_WITH","m6A","BMSC adipogenic"
"580","30865855","METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.","JAK1/STAT5/C/EBPbeta pathway","inhibit","differentiation","BMSC adipogenic","JAK1/STAT5/C/EBPbeta pathway","INHIBITS","cell differentiation","BMSC adipogenic"
"1185","33484966","METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration.","METTL3","restrain","Progression","Papillary Thyroid Cancer","METTL3","INHIBITS","progression","THCA(Thyroid Carcinoma)"
"2392","33484966","METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration.","METTL3","regulate","m6A/c-Rel/IL-8","Papillary Thyroid Cancer","METTL3","AFFECTS","progression","THCA(Thyroid Carcinoma)"
"3470","33484966","METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration.","m6A/c-Rel/IL-8","mediate","Neutrophils Infiltration","Papillary Thyroid Cancer","m6A/c-Rel/IL-8","AFFECTS","Neutrophils Infiltration","THCA(Thyroid Carcinoma)"
"4266","33484966","METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration.","m6A/c-Rel/IL-8","restrain","Progression","Papillary Thyroid Cancer","m6A/c-Rel/IL-8","INHIBITS","Neutrophils Infiltration","THCA(Thyroid Carcinoma)"
"1186","31959747","YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway.","YTHDF2","promote","spermagonial adhesion","Null","YTHDF2","STIMULATES","spermagonial adhesion","Null"
"2398","31959747","YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway.","YTHDF2","regulate","m6A/mRNA pathway","Null","YTHDF2","AFFECTS","spermagonial adhesion","Null"
"3473","31959747","YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway.","m6A/mRNA pathway","modulate","MMPs decay","Null","m6A/mRNA pathway","AFFECTS","MMPs decay","Null"
"4272","31959747","YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway.","MMPs decay","promote","spermagonial adhesion","Null","MMPs decay","STIMULATES","spermagonial adhesion","Null"
"1187","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","m6A mRNA methylation","promote","YAP translation","NSCLC","m6A","STIMULATES","YAP translation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2406","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","m6A mRNA methylation","increase","YAP activity","NSCLC","m6A","AUGMENTS","YAP translation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3478","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","m6A mRNA methylation","regulate","MALAT1-miR-1914-3p-YAP axis","NSCLC","m6A","AFFECTS","YAP translation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4275","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","METTL3","initiate","m6A mRNA methylation","NSCLC","METTL3","CAUSES","m6A","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"581","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","MALAT1-miR-1914-3p-YAP axis","induce","Drug resistance","NSCLC","MALAT1-miR-1914-3p-YAP axis","CAUSES","Drug Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"635","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","MALAT1-miR-1914-3p-YAP axis","induce","Metastasis","NSCLC","MALAT1-miR-1914-3p-YAP axis","CAUSES","Drug Resistance","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"716","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","Drug resistance","induce","YAP translation","NSCLC","Drug Resistance","CAUSES","YAP translation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"87","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","Metastasis","induce","YAP translation","NSCLC","Neoplasm Metastasis","CAUSES","YAP translation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"94","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","Drug resistance","induce","YAP activity","NSCLC","Drug Resistance","CAUSES","YAP translation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"101","31818312","m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.","Metastasis","induce","YAP activity","NSCLC","Neoplasm Metastasis","CAUSES","YAP translation","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"1188","34097350","MeCP2 promotes colorectal cancer metastasis by regulating m6A methylation via METTL14.","MeCP2","promote","Metastasis","Colorectal Cancer","MeCP2","STIMULATES","Metastasis","Colorectal Cancer"
"2413","34097350","MeCP2 promotes colorectal cancer metastasis by regulating m6A methylation via METTL14.","MeCP2","regulate","METTL14","Colorectal Cancer","MeCP2","AFFECTS","Metastasis","Colorectal Cancer"
"3485","34097350","MeCP2 promotes colorectal cancer metastasis by regulating m6A methylation via METTL14.","METTL14","regulate","m6A methylation","Colorectal Cancer","METTL14","AFFECTS","m6A methylation","Colorectal Cancer"
"4279","34097350","MeCP2 promotes colorectal cancer metastasis by regulating m6A methylation via METTL14.","m6A methylation","promote","Metastasis","Colorectal Cancer","m6A methylation","STIMULATES","Metastasis","Colorectal Cancer"
"1189","32576970","LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.","LNC942","promote","METTL14","Breast Cancer cell","LNC942","STIMULATES","METTL14","BRCA(Breast Invasive Carcinoma)"
"2419","32576970","LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.","METTL14","mediate","m6A methylation","Breast Cancer cell","METTL14","AFFECTS","m6A","BRCA(Breast Invasive Carcinoma)"
"3490","32576970","LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.","m6A methylation","promote","Proliferation","Breast Cancer cell","m6A","STIMULATES","cell population proliferation","BRCA(Breast Invasive Carcinoma)"
"4284","32576970","LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.","m6A methylation","promote","Progression","Breast Cancer cell","m6A","STIMULATES","cell population proliferation","BRCA(Breast Invasive Carcinoma)"
"1190","33708859","MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.","MiR-4729","regulate","TIE1 mRNA m6A modification","Hemorrhoids","MIR4729","AFFECTS","TIE1 mRNA m6A modification","Hemorrhoids"
"2422","33708859","MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.","MiR-4729","regulate","Angiogenesis","Hemorrhoids","MIR4729","AFFECTS","TIE1 mRNA m6A modification","Hemorrhoids"
"3491","33708859","MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.","MiR-4729","target","METTL14","Hemorrhoids","MIR4729","INTERACTS_WITH","TIE1 mRNA m6A modification","Hemorrhoids"
"4291","33708859","MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.","METTL14","regulate","TIE1 mRNA m6A modification","Hemorrhoids","METTL14","AFFECTS","TIE1 mRNA m6A modification","Hemorrhoids"
"582","33708859","MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.","METTL14","regulate","Angiogenesis","Hemorrhoids","METTL14","AFFECTS","TIE1 mRNA m6A modification","Hemorrhoids"
"1191","33928080","Novel circGFRalpha1 Promotes Self-Renewal of Female Germline Stem Cells Mediated by m6A Writer METTL14.","circGFRalpha1","promote","Self-Renewal","Female Germline Stem Cells","circGFRalpha1","STIMULATES","Self-Renewal","Oogonial Stem Cells"
"2433","33928080","Novel circGFRalpha1 Promotes Self-Renewal of Female Germline Stem Cells Mediated by m6A Writer METTL14.","circGFRalpha1","regulate","METTL14","Female Germline Stem Cells","circGFRalpha1","AFFECTS","Self-Renewal","Oogonial Stem Cells"
"3492","33928080","Novel circGFRalpha1 Promotes Self-Renewal of Female Germline Stem Cells Mediated by m6A Writer METTL14.","METTL14","mediate","Self-Renewal","Female Germline Stem Cells","METTL14","AFFECTS","Self-Renewal","Oogonial Stem Cells"
"1192","33849617","CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.","CLK1/SRSF5 pathway","induce","aberrant exon skipping","Pancreatic Cancer","CLK1/SRSF5 pathway","CAUSES","aberrant exon skipping","PAAD(Pancreatic Adenocarcinoma)"
"2443","33849617","CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.","aberrant exon skipping","is on","Cyclin L2","Pancreatic Cancer","aberrant exon skipping","LOCATES","CCNL2","PAAD(Pancreatic Adenocarcinoma)"
"3493","33849617","CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.","aberrant exon skipping","is on","METTL14","Pancreatic Cancer","aberrant exon skipping","LOCATES","CCNL2","PAAD(Pancreatic Adenocarcinoma)"
"4298","33849617","CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.","CLK1/SRSF5 pathway","promote","Growth","Pancreatic Cancer","CLK1/SRSF5 pathway","STIMULATES","aberrant exon skipping","PAAD(Pancreatic Adenocarcinoma)"
"583","33849617","CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.","CLK1/SRSF5 pathway","promote","Metastasis","Pancreatic Cancer","CLK1/SRSF5 pathway","STIMULATES","aberrant exon skipping","PAAD(Pancreatic Adenocarcinoma)"
"1193","31434544","ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.","ZFP217","regulate","adipogenesis","Null","ZFP217","AFFECTS","Adipogenesis","Null"
"2448","31434544","ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.","ZFP217","regulate","METTL3","Null","ZFP217","AFFECTS","Adipogenesis","Null"
"3494","31434544","ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.","METTL3","regulate","m6A","Null","METTL3","AFFECTS","m6A","Null"
"4301","31434544","ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.","m6A","regulate","mitotic clonal expansion","Null","m6A","AFFECTS","mitotic clonal expansion","Null"
"584","31434544","ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.","mitotic clonal expansion","regulate","adipogenesis","Null","mitotic clonal expansion","AFFECTS","Adipogenesis","Null"
"1194","33355622","miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.","miR-338-5p","inhibit","Cell Growth","Lung Cancer","miR-338-5p","INHIBITS","cell growth","LUAD(Lung Adenocarcinoma)"
"2455","33355622","miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.","miR-338-5p","inhibit","Migration","Lung Cancer","miR-338-5p","INHIBITS","cell growth","LUAD(Lung Adenocarcinoma)"
"3495","33355622","miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.","miR-338-5p","inhibit","METTL3/m6A/c-Myc pathway","Lung Cancer","miR-338-5p","INHIBITS","cell growth","LUAD(Lung Adenocarcinoma)"
"4308","33355622","miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.","METTL3/m6A/c-Myc pathway","regulate","Cell Growth","Lung Cancer","METTL3/m6A/c-Myc pathway","AFFECTS","cell growth","LUAD(Lung Adenocarcinoma)"
"585","33355622","miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.","METTL3/m6A/c-Myc pathway","regulate","Migration","Lung Cancer","METTL3/m6A/c-Myc pathway","AFFECTS","cell growth","LUAD(Lung Adenocarcinoma)"
"1195","33098220","METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.","METTL3","promote","Degeneration","endplate chondrocytes","METTL3","STIMULATES","degeneration","endplate chondrocytes"
"2458","33098220","METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.","METTL3","drive","m6A","endplate chondrocytes","METTL3","STIMULATES","degeneration","endplate chondrocytes"
"3502","33098220","METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.","m6A","is on","miR-126-5p","endplate chondrocytes","m6A","LOCATES","miR-126-5p","endplate chondrocytes"
"4312","33098220","METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.","IL-1beta","induce","Degeneration","endplate chondrocytes","IL1B","CAUSES","degeneration","endplate chondrocytes"
"586","33098220","METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.","m6A","promote","Degeneration","endplate chondrocytes","m6A","STIMULATES","miR-126-5p","endplate chondrocytes"
"1196","34553450","Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.","METTL3","attenuate","Cardiomyocyte apoptosis","Myocardial ischemia-reperfusion (I/R) injury","METTL3","INHIBITS","Cardiomyocyte Apoptosis","Myocardial ischemia-reperfusion (I/R) injury"
"2462","34553450","Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.","METTL3","regulate","miR-25-3p","Myocardial ischemia-reperfusion (I/R) injury","METTL3","AFFECTS","Cardiomyocyte Apoptosis","Myocardial ischemia-reperfusion (I/R) injury"
"3506","34553450","Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.","METTL3","regulate","miR-873-5p","Myocardial ischemia-reperfusion (I/R) injury","METTL3","AFFECTS","Cardiomyocyte Apoptosis","Myocardial ischemia-reperfusion (I/R) injury"
"4317","34553450","Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.","miR-25-3p","attenuate","Cardiomyocyte apoptosis","Myocardial ischemia-reperfusion (I/R) injury","miR-25-3p","INHIBITS","Cardiomyocyte Apoptosis","Myocardial ischemia-reperfusion (I/R) injury"
"587","34553450","Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.","miR-873-5p","attenuate","Cardiomyocyte apoptosis","Myocardial ischemia-reperfusion (I/R) injury","miR-873-5p","INHIBITS","Cardiomyocyte Apoptosis","Myocardial ischemia-reperfusion (I/R) injury"
"1197","33035345","METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.","METTL3","counteract","Premature aging","Premature aging","METTL3","PREVENTS","Aging, Premature","Aging, Premature"
"2466","33035345","METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.","METTL3","regulate","m6A","Premature aging","METTL3","AFFECTS","Aging, Premature","Aging, Premature"
"3511","33035345","METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.","m6A","stable","MIS12","Premature aging","m6A","MAINTAINS","MIS12","Aging, Premature"
"4324","33035345","METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.","MIS12","regulate","Premature aging","Premature aging","MIS12","AFFECTS","Aging, Premature","Aging, Premature"
"1198","29502358","METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.","METTL3","regulate","alternative splicing of MyD88","Human dental pulp cells","METTL3","AFFECTS","alternative splicing of MyD88","Human dental pulp cells"
"2474","29502358","METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.","lipopolysaccharide","induce","inflammatory response","Human dental pulp cells","lipopolysaccharide","CAUSES","inflammatory response","Human dental pulp cells"
"3515","29502358","METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.","METTL3","regulate","inflammatory response","Human dental pulp cells","METTL3","AFFECTS","alternative splicing of MyD88","Human dental pulp cells"
"4329","29502358","METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.","inflammatory response","regulate","alternative splicing of MyD88","Human dental pulp cells","inflammatory response","AFFECTS","alternative splicing of MyD88","Human dental pulp cells"
"1199","31637575","TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.","TNF-alpha","suppress","Sweat gland differentiation","MSCs","TNF","INHIBITS","Sweat gland differentiation","MSC"
"2477","31637575","TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.","TNF-alpha","reduce","FTO","MSCs","TNF","INHIBITS","Sweat gland differentiation","MSC"
"3520","31637575","TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.","FTO","mediate","m6A-demethylation","MSCs","FTO","AFFECTS","m6A demethylation","MSC"
"4333","31637575","TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.","m6A-demethylation","is on","Nanog mRNA","MSCs","m6A demethylation","LOCATES","Nanog","MSC"
"588","31637575","TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.","m6A-demethylation","regulate","Sweat gland differentiation","MSCs","m6A demethylation","AFFECTS","Nanog","MSC"
"1200","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","Total Flavones of Abelmoschus manihot","target","METTL3","High Glucose Conditions","Total Flavones of Abelmoschus manihot","INTERACTS_WITH","METTL3","High Glucose Conditions"
"2482","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","METTL3","regulate","m6a","High Glucose Conditions","METTL3","AFFECTS","GPM6A","High Glucose Conditions"
"3525","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","m6a","mediate","NLRP3-Inflammasome Activation","High Glucose Conditions","GPM6A","AFFECTS","NLRP3 inflammasome complex assembly","High Glucose Conditions"
"4336","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","m6a","mediate","PTEN/PI3K/Akt Signaling","High Glucose Conditions","GPM6A","AFFECTS","NLRP3 inflammasome complex assembly","High Glucose Conditions"
"589","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","Total Flavones of Abelmoschus manihot","ameliorate","Podocyte Pyroptosis","High Glucose Conditions","Total Flavones of Abelmoschus manihot","TREATS","METTL3","High Glucose Conditions"
"636","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","Total Flavones of Abelmoschus manihot","ameliorate","Injury","High Glucose Conditions","Total Flavones of Abelmoschus manihot","TREATS","METTL3","High Glucose Conditions"
"717","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","NLRP3-Inflammasome Activation","ameliorate","Podocyte Pyroptosis","High Glucose Conditions","NLRP3 inflammasome complex assembly","TREATS","Podocyte Pyroptosis","High Glucose Conditions"
"88","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","PTEN/PI3K/Akt Signaling","ameliorate","Podocyte Pyroptosis","High Glucose Conditions","PTEN/PI3K/Akt Signaling","TREATS","Podocyte Pyroptosis","High Glucose Conditions"
"95","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","NLRP3-Inflammasome Activation","ameliorate","Injury","High Glucose Conditions","NLRP3 inflammasome complex assembly","TREATS","Podocyte Pyroptosis","High Glucose Conditions"
"102","34335245","Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.","PTEN/PI3K/Akt Signaling","ameliorate","Injury","High Glucose Conditions","PTEN/PI3K/Akt Signaling","TREATS","Podocyte Pyroptosis","High Glucose Conditions"
"1201","33911218","Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.","circZbtb20","maintain","ILC3 homeostasis","Null","circZbtb20","MAINTAINS","ILC3 homeostasis","Null"
"2485","33911218","Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.","circZbtb20","maintain","ILC3 function","Null","circZbtb20","MAINTAINS","ILC3 homeostasis","Null"
"3529","33911218","Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.","circZbtb20","regulate","Alkbh5","Null","circZbtb20","AFFECTS","ILC3 homeostasis","Null"
"4341","33911218","Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.","Alkbh5","regulate","m6A demethylation","Null","ALKBH5","AFFECTS","m6A demethylation","Null"
"590","33911218","Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.","m6A demethylation","is on","Nr4a1","Null","m6A demethylation","LOCATES","NR4A1","Null"
"637","33911218","Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.","Nr4a1","maintain","ILC3 homeostasis","Null","NR4A1","MAINTAINS","ILC3 homeostasis","Null"
"720","33911218","Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.","Nr4a1","maintain","ILC3 function","Null","NR4A1","MAINTAINS","ILC3 homeostasis","Null"
"1202","33061938","The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.","METTL3","implicate","DLBCL","DLBCL Development","METTL3","AFFECTS","Lymphoma, Large B-Cell, Diffuse","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"2491","33061938","The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.","METTL3","regulate","m6A","DLBCL Development","METTL3","AFFECTS","Lymphoma, Large B-Cell, Diffuse","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"3532","33061938","The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.","m6A","is on","PEDF","DLBCL Development","m6A","LOCATES","SERPINF1","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"4346","33061938","The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.","PEDF","regulate","DLBCL","DLBCL Development","SERPINF1","AFFECTS","Lymphoma, Large B-Cell, Diffuse","DLBC(Lymphoid Neoplasm Diffuse Large B-cell Lymphoma)"
"1203","34375639","The m6A methyltransferase METTL3 modifies PGC-1alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.","METTL3","modify","PGC-1alpha mRNA","monocytes","METTL3","AFFECTS","PGC-1alpha","Monocytes"
"2496","34375639","The m6A methyltransferase METTL3 modifies PGC-1alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.","PGC-1alpha","promote","mitochondrial dysfunction","monocytes","PPARGC1A","STIMULATES","Abnormality of mitochondrial metabolism","Monocytes"
"3537","34375639","The m6A methyltransferase METTL3 modifies PGC-1alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.","PGC-1alpha","promote","inflammation","monocytes","PPARGC1A","STIMULATES","Abnormality of mitochondrial metabolism","Monocytes"
"4352","34375639","The m6A methyltransferase METTL3 modifies PGC-1alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.","oxLDL","induce","inflammation","monocytes","oxidized low density lipoprotein","CAUSES","inflammatory response","Monocytes"
"1204","33788967","Role of epigenetic m6A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling.","mettl3","regulate","Vascular Development","Vascular Development","METTL3","AFFECTS","Vascular Development","Vascular Development"
"2502","33788967","Role of epigenetic m6A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling.","mettl3","regulate","PHLPP2/mTOR-AKT signaling","Vascular Development","METTL3","AFFECTS","Vascular Development","Vascular Development"
"3538","33788967","Role of epigenetic m6A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling.","PHLPP2/mTOR-AKT signaling","regulate","Vascular Development","Vascular Development","PHLPP2/mTOR-AKT signaling pathway","AFFECTS","Vascular Development","Vascular Development"
"1205","33420414","METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.","METTL3","promote","Adriamycin resistance","MCF-7 breast cancer cells","METTL3","STIMULATES","Adriamycin resistance","BRCA(Breast Invasive Carcinoma)"
"2507","33420414","METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.","METTL3","regulate","m6a","MCF-7 breast cancer cells","METTL3","AFFECTS","Adriamycin resistance","BRCA(Breast Invasive Carcinoma)"
"3545","33420414","METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.","m6a","accelerate","Pri-microRNA-221-3p maturation","MCF-7 breast cancer cells","GPM6A","STIMULATES","Pri-microRNA-221-3p maturation","BRCA(Breast Invasive Carcinoma)"
"4356","33420414","METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.","Pri-microRNA-221-3p maturation","promote","Adriamycin resistance","MCF-7 breast cancer cells","Pri-microRNA-221-3p maturation","STIMULATES","Adriamycin resistance","BRCA(Breast Invasive Carcinoma)"
"1206","31228940","METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.","METTL3","promote","Tumor Proliferation","Bladder Cancer","METTL3","STIMULATES","Tumor Proliferation","BLCA(Bladder Urothelial Carcinoma)"
"2510","31228940","METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.","METTL3","regulate","m6a","Bladder Cancer","METTL3","AFFECTS","Tumor Proliferation","BLCA(Bladder Urothelial Carcinoma)"
"3549","31228940","METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.","m6a","accelerate","pri-miR221/222 Maturation","Bladder Cancer","GPM6A","STIMULATES","pri-miR221/222 Maturation","BLCA(Bladder Urothelial Carcinoma)"
"4362","31228940","METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.","pri-miR221/222 Maturation","promote","Tumor Proliferation","Bladder Cancer","pri-miR221/222 Maturation","STIMULATES","Tumor Proliferation","BLCA(Bladder Urothelial Carcinoma)"
"1207","34476262","METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.","METTL3","intensify","Progress","Oral Squamous Cell Carcinoma","METTL3","STIMULATES","Prognosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2514","34476262","METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.","METTL3","modulate","m6A","Oral Squamous Cell Carcinoma","METTL3","AFFECTS","Prognosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3555","34476262","METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.","m6A","is on","PRMT5","Oral Squamous Cell Carcinoma","m6A","LOCATES","PRMT5","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4367","34476262","METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.","m6A","is on","PD-L1","Oral Squamous Cell Carcinoma","m6A","LOCATES","PRMT5","HNSC(Head and Neck Squamous Cell Carcinoma)"
"591","34476262","METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.","PRMT5","intensify","Progress","Oral Squamous Cell Carcinoma","PRMT5","STIMULATES","Prognosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"638","34476262","METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.","PD-L1","intensify","Progress","Oral Squamous Cell Carcinoma","CD274","STIMULATES","Prognosis","HNSC(Head and Neck Squamous Cell Carcinoma)"
"1208","33414476","METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.","METTL14","regulate","PI3K/Akt signaling pathway","diabetic kidney disease","METTL14","AFFECTS","PI3K/AKT signaling pathway","Diabetic Nephropathies"
"2520","33414476","METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.","METTL14","regulate","PTEN","diabetic kidney disease","METTL14","AFFECTS","PI3K/AKT signaling pathway","Diabetic Nephropathies"
"3563","33414476","METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.","PTEN","regulate","epithelial-mesenchymal transition","diabetic kidney disease","PTEN","AFFECTS","epithelial to mesenchymal transition","Diabetic Nephropathies"
"4372","33414476","METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.","HDAC5","mediate","epithelial-mesenchymal transition","diabetic kidney disease","HDAC5","AFFECTS","epithelial to mesenchymal transition","Diabetic Nephropathies"
"592","33414476","METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.","epithelial-mesenchymal transition","regulate","PI3K/Akt signaling pathway","diabetic kidney disease","epithelial to mesenchymal transition","AFFECTS","PI3K/AKT signaling pathway","Diabetic Nephropathies"
"639","33414476","METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.","epithelial-mesenchymal transition","occur in","renal tubular cells","diabetic kidney disease","epithelial to mesenchymal transition","OCCURS_IN","PI3K/AKT signaling pathway","Diabetic Nephropathies"
"1209","32939058","METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.","METTL3","mediate","miR-126-5p","Ovarian Cancer","METTL3","AFFECTS","miR-126-5p","OV(Ovarian Serous Cystadenocarcinoma)"
"2524","32939058","METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.","miR-126-5p","promote","progression","Ovarian Cancer","miR-126-5p","STIMULATES","progression","OV(Ovarian Serous Cystadenocarcinoma)"
"3571","32939058","METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.","miR-126-5p","regulate","PTEN","Ovarian Cancer","miR-126-5p","AFFECTS","progression","OV(Ovarian Serous Cystadenocarcinoma)"
"4377","32939058","METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.","PTEN","mediate","PI3K/Akt/mTOR pathway","Ovarian Cancer","PTEN","AFFECTS","PI3K/AKT/mTOR pathway","OV(Ovarian Serous Cystadenocarcinoma)"
"593","32939058","METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.","PI3K/Akt/mTOR pathway","promote","Progression","Ovarian Cancer","PI3K/AKT/mTOR pathway","STIMULATES","progression","OV(Ovarian Serous Cystadenocarcinoma)"
"1210","33816306","YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.","YTHDF1","aggravate","Progression","Cervical Cancer","YTHDF1","COMPLICATES","progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2530","33816306","YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.","YTHDF1","regulate","m6A","Cervical Cancer","YTHDF1","AFFECTS","progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"3575","33816306","YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.","m6A","mediate Up-Regulation of","RANBP2","Cervical Cancer","m6A","STIMULATES","RANBP2","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"4383","33816306","YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.","RANBP2","aggravate","Progression","Cervical Cancer","RANBP2","COMPLICATES","progression","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"1211","31020615","RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex.","RBM15","modulate","BAF155","Developing Cortex","RBM15","AFFECTS","SMARCC1","Developing Cortex"
"2537","31020615","RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex.","RBM15","regulate","RNA Methylation","Developing Cortex","RBM15","AFFECTS","SMARCC1","Developing Cortex"
"3583","31020615","RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex.","RNA Methylation","modulate","BAF155","Developing Cortex","RNA methylation","AFFECTS","SMARCC1","Developing Cortex"
"1212","27590511","Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.","Hypoxia-inducible factors","regulate","pluripotency factor expression","Breast Cancer cells","HIF","AFFECTS","pluripotency factor expression","BRCA(Breast Invasive Carcinoma)"
"2543","27590511","Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.","Hypoxia-inducible factors","regulate","ZNF217","Breast Cancer cells","HIF","AFFECTS","pluripotency factor expression","BRCA(Breast Invasive Carcinoma)"
"3587","27590511","Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.","Hypoxia-inducible factors","regulate","ALKBH5","Breast Cancer cells","HIF","AFFECTS","pluripotency factor expression","BRCA(Breast Invasive Carcinoma)"
"4388","27590511","Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.","ZNF217","modulate","RNA methylation","Breast Cancer cells","ZNF217","AFFECTS","RNA methylation","BRCA(Breast Invasive Carcinoma)"
"594","27590511","Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.","ALKBH5","modulate","RNA methylation","Breast Cancer cells","ALKBH5","AFFECTS","RNA methylation","BRCA(Breast Invasive Carcinoma)"
"640","27590511","Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.","RNA methylation","regulate","pluripotency factor expression","Breast Cancer cells","RNA methylation","AFFECTS","pluripotency factor expression","BRCA(Breast Invasive Carcinoma)"
"1213","30843071","The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression.","YTHDF1","regulate","Axon Guidance","Null","YTHDF1","AFFECTS","axon guidance","Null"
"2550","30843071","The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression.","YTHDF1","control","Robo3.1 expression","Null","YTHDF1","AFFECTS","axon guidance","Null"
"3589","30843071","The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression.","Robo3.1 expression","regulate","Axon Guidance","Null","Robo3.1 expression","AFFECTS","axon guidance","Null"
"1218","29171881","RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.","methyltransferase-like 3","promote","Progression","Liver Cancer","METTL3","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"2553","29171881","RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.","methyltransferase-like 3","regulate","YTHDF2","Liver Cancer","METTL3","AFFECTS","progression","LIHC(Liver Hepatocellular Carcinoma)"
"3592","29171881","RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.","YTHDF2","silence","SOCS2","Liver Cancer","YTHDF2","INHIBITS","SOCS2","LIHC(Liver Hepatocellular Carcinoma)"
"4393","29171881","RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.","SOCS2","regulate","Progression","Liver Cancer","SOCS2","AFFECTS","progression","LIHC(Liver Hepatocellular Carcinoma)"
"1219","32705223","m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.","METTL3","maintain","Tumorigenicity","Colon Cancer","METTL3","MAINTAINS","Tumorigenicity","COAD(Colon Adenocarcinoma)"
"2557","32705223","m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.","METTL3","suppress","SOCS2","Colon Cancer","METTL3","INHIBITS","Tumorigenicity","COAD(Colon Adenocarcinoma)"
"3595","32705223","m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.","SOCS2","Promote","Cell Proliferation","Colon Cancer","SOCS2","STIMULATES","cell population proliferation","COAD(Colon Adenocarcinoma)"
"4397","32705223","m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.","Cell Proliferation","maintain","Tumorigenicity","Colon Cancer","cell population proliferation","MAINTAINS","Tumorigenicity","COAD(Colon Adenocarcinoma)"
"1220","31369074","Acute Deletion of METTL14 in beta-cells of adult mice results in glucose intolerance.","dummy","induce acute deletion of","METTL14","Beta-cells of adult mice","dummy","INHIBITS","METTL14","Beta-cells of adult mice"
"2562","31369074","Acute Deletion of METTL14 in beta-cells of adult mice results in glucose intolerance.","METTL14","results in","Glucose intolerance","Beta-cells of adult mice","METTL14","CAUSES","Glucose Intolerance","Beta-cells of adult mice"
"1221","31751468","Dynamic effects of Fto in regulating the proliferation and differentiation of adult neural stem cells of mice.","FTO","regulate","Proliferation","Adult neural stem cells of mice","FTO","AFFECTS","cell population proliferation","Adult neural stem cells of mice"
"2566","31751468","Dynamic effects of Fto in regulating the proliferation and differentiation of adult neural stem cells of mice.","FTO","regulate","Differentiation","Adult neural stem cells of mice","FTO","AFFECTS","cell population proliferation","Adult neural stem cells of mice"
"1222","31827395","The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells.","FTO","facilitate","Proliferation","Human Cervical Cancer cells","FTO","STIMULATES","cell population proliferation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"2572","31827395","The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells.","FTO","facilitate","Migration","Human Cervical Cancer cells","FTO","STIMULATES","cell population proliferation","CESC(Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma)"
"1223","32805088","The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer.","FTO/miR-181b-3p/ARL5B signaling pathway","regulate","Cell migration","Breast Cancer","FTO/miR-181b-3p/ARL5B signaling pathway","AFFECTS","cell migration","BRCA(Breast Invasive Carcinoma)"
"2578","32805088","The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer.","FTO/miR-181b-3p/ARL5B signaling pathway","regulate","invasion","Breast Cancer","FTO/miR-181b-3p/ARL5B signaling pathway","AFFECTS","cell migration","BRCA(Breast Invasive Carcinoma)"
"1224","29279410","ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.","ALKBH5","regulate","m6A demethylation","Male germ cells","ALKBH5","AFFECTS","m6A demethylation","Male germ cells"
"2582","29279410","ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.","m6A demethylation","control","Splicing of long 3'-UTR mRNAs","Male germ cells","m6A demethylation","AFFECTS","Splicing of long 3'-UTR","Male germ cells"
"3599","29279410","ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.","m6A demethylation","control","Stability of long 3'-UTR mRNAs","Male germ cells","m6A demethylation","AFFECTS","Splicing of long 3'-UTR","Male germ cells"
"1225","33375621","The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells.","ALKBH5","promote","Radioresistance","Glioma Stem Cells","ALKBH5","STIMULATES","Radioresistance","Glioma Stem Cells"
"2586","33375621","The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells.","ALKBH5","promote","Invasion Capability","Glioma Stem Cells","ALKBH5","STIMULATES","Radioresistance","Glioma Stem Cells"
"1226","34048572","Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.","dummy","induce post-translational modification of","ALKBH5","Null","dummy","AFFECTS","ALKBH5","Null"
"2589","34048572","Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.","ALKBH5","regulate","DNA damage response","Null","ALKBH5","AFFECTS","cellular response to DNA damage stimulus","Null"
"3604","34048572","Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.","ROS","induce","DNA damage response","Null","Q9SJQ6","CAUSES","cellular response to DNA damage stimulus","Null"
"1227","34134995","m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity.","ALKBH5","control","pathogenicity","CD4+ T cell","ALKBH5","AFFECTS","pathogenicity","CD4+ T cell"
"2594","34134995","m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity.","ALKBH5","promote","Autoimmunity","CD4+ T cell","ALKBH5","STIMULATES","pathogenicity","CD4+ T cell"
"1228","34301762","M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.","ALKBH5","regulate","PD-L1","Intrahepatic Cholangiocarcinoma","ALKBH5","AFFECTS","CD274","CHOL(Cholangiocarcinoma)"
"2598","34301762","M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.","ALKBH5","regulate","Tumor Immunoenvironment","Intrahepatic Cholangiocarcinoma","ALKBH5","AFFECTS","CD274","CHOL(Cholangiocarcinoma)"
"1229","34513291","ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment.","ALKBH5","mediate","m6A mRNA methylation","Human embryonic stem cell","ALKBH5","AFFECTS","m6A","Human Embryonic Stem Cells"
"2604","34513291","ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment.","m6A mRNA methylation","govern","Cardiac commitment","Human embryonic stem cell","m6A","AFFECTS","Cardiac commitment","Human Embryonic Stem Cells"
"1230","31131257","YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma.","YTHDF1","regulate","Tumorigenicity","Human Colorectal Carcinoma","YTHDF1","AFFECTS","Tumorigenicity","COAD(Colon Adenocarcinoma)"
"2608","31131257","YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma.","YTHDF1","regulate","Cancer Stem Cell-Like Activity","Human Colorectal Carcinoma","YTHDF1","AFFECTS","Tumorigenicity","COAD(Colon Adenocarcinoma)"
"1231","33011193","m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.","YTHDF1","bind","m6a","cisplatin-resistant ovarian cancer cells","YTHDF1","INTERACTS_WITH","GPM6A","cisplatin-resistant ovarian cancer cells"
"2613","33011193","m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.","m6a","mediate","upregulation","cisplatin-resistant ovarian cancer cells","GPM6A","AFFECTS","Up-Regulation","cisplatin-resistant ovarian cancer cells"
"3609","33011193","m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.","upregulation","is on","TRIM29","cisplatin-resistant ovarian cancer cells","Up-Regulation","LOCATES","TRIM29","cisplatin-resistant ovarian cancer cells"
"4401","33011193","m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.","TRIM29","facilitate","Stem cell-like phenotype","cisplatin-resistant ovarian cancer cells","TRIM29","STIMULATES","stem cell Phenotype","cisplatin-resistant ovarian cancer cells"
"1232","33605073","N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay.","YTHDF1","suppress","replication","EBV","YTHDF1","INHIBITS","replication","Herpesvirus 4, Human"
"2617","33605073","N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay.","YTHDF1","promote","RNA decay","EBV","YTHDF1","STIMULATES","replication","Herpesvirus 4, Human"
"1233","28867294","The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence.","YTHDF2","regulate","Maternal Transcriptome","Null","YTHDF2","AFFECTS","Maternal Transcriptome","Null"
"2620","28867294","The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence.","YTHDF2","regulate","Oocyte Competence","Null","YTHDF2","AFFECTS","Maternal Transcriptome","Null"
"1234","28938096","Gamete On for m6A: YTHDF2 Exerts Essential Functions in Female Fertility.","YTHDF2","exert","Essential Functions","Female Fertility","YTHDF2","AFFECTS","Essential Functions","female fertility"
"1235","30150673","Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration.","dummy","induce loss of","YTHDF2","Hematopoietic stem cell","dummy","INHIBITS","YTHDF2","Hematopoietic Stem Cells"
"2625","30150673","Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration.","YTHDF2","bind","m6A","Hematopoietic stem cell","YTHDF2","INTERACTS_WITH","m6A","Hematopoietic Stem Cells"
"3613","30150673","Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration.","m6A","facilitate","Regeneration","Hematopoietic stem cell","m6A","STIMULATES","regeneration","Hematopoietic Stem Cells"
"1236","33156926","The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.","YTHDF2","suppress","Proinflammatory pathways","Hematopoietic stem cell function","YTHDF2","INHIBITS","Proinflammatory pathways","Hematopoietic stem cell function"
"2628","33156926","The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.","YTHDF2","sustain","Hematopoietic stem cell function","Hematopoietic stem cell function","YTHDF2","MAINTAINS","Proinflammatory pathways","Hematopoietic stem cell function"
"1237","34160549","The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.","YTHDF2","control","antitumor","NK cell","YTHDF2","AFFECTS","antitumor","Killer Cells, Natural"
"2634","34160549","The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.","YTHDF2","control","antiviral Immunity","NK cell","YTHDF2","AFFECTS","antitumor","Killer Cells, Natural"
"1238","34200988","PBRM1 Cooperates with YTHDF2 to Control HIF-1alpha Protein Translation.","PBRM1","cooperate","YTHDF2","Null","PBRM1","INTERACTS_WITH","YTHDF2","Null"
"2641","34200988","PBRM1 Cooperates with YTHDF2 to Control HIF-1alpha Protein Translation.","PBRM1","control","HIF-1alpha Protein Translation","Null","PBRM1","AFFECTS","YTHDF2","Null"
"3616","34200988","PBRM1 Cooperates with YTHDF2 to Control HIF-1alpha Protein Translation.","YTHDF2","control","HIF-1alpha Protein Translation","Null","YTHDF2","AFFECTS","HIF-1alpha Protein Translation","Null"
"1239","29799838","Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development.","YTHDC1","regulate","Alternative polyadenylation","mouse oocyte development.","YTHDC1","AFFECTS","alternative polyadenylation","mouse oocyte development."
"2646","29799838","Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development.","YTHDC1","regulate","Splicing","mouse oocyte development.","YTHDC1","AFFECTS","alternative polyadenylation","mouse oocyte development."
"1240","34273466","HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.","HNRNPA2B1","regulate","Tamoxifen-sensitivity","Breast Cancer cells","HNRNPA2B1","AFFECTS","Tamoxifen-sensitivity","BRCA(Breast Invasive Carcinoma)"
"2650","34273466","HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.","HNRNPA2B1","regulate","Fulvestrant-sensitivity","Breast Cancer cells","HNRNPA2B1","AFFECTS","Tamoxifen-sensitivity","BRCA(Breast Invasive Carcinoma)"
"3622","34273466","HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.","HNRNPA2B1","regulate","endocrine resistance","Breast Cancer cells","HNRNPA2B1","AFFECTS","Tamoxifen-sensitivity","BRCA(Breast Invasive Carcinoma)"
"1241","30514900","A novel m6A reader Prrc2a controls oligodendroglial specification and myelination.","Prrc2a","control","oligodendroglial specification","Null","PRRC2A","AFFECTS","oligodendroglial specification","Null"
"2656","30514900","A novel m6A reader Prrc2a controls oligodendroglial specification and myelination.","Prrc2a","control","myelination","Null","PRRC2A","AFFECTS","oligodendroglial specification","Null"
"1242","33087165","Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.","dummy","induce activation of","KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis","Prostate Cancer","dummy","STIMULATES","KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis","PRAD(Prostate Adenocarcinoma)"
"2661","33087165","Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.","KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis","facilitate","Progression","Prostate Cancer","KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis","STIMULATES","progression","PRAD(Prostate Adenocarcinoma)"
"1243","30781903","N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.","METTL3","regulate","Actively Transcribed Genes","Glioma Stem-Like Cells","METTL3","AFFECTS","Actively Transcribed Genes","Glioma Stem-Like Cells"
"2665","30781903","N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.","METTL3","regulate","Sustenance of the Oncogenic Signaling","Glioma Stem-Like Cells","METTL3","AFFECTS","Actively Transcribed Genes","Glioma Stem-Like Cells"
"1244","33461172","Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.","dummy","induce dysregulation of","USP18/FTO/PYCR1 signaling","Bladder Cancer","dummy","DISRUPTS","USP18/FTO/PYCR1 signaling pathway","BLCA(Bladder Urothelial Carcinoma)"
"2671","33461172","Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.","USP18/FTO/PYCR1 signaling","promote","Development","Bladder Cancer","USP18/FTO/PYCR1 signaling pathway","STIMULATES","development","BLCA(Bladder Urothelial Carcinoma)"
"3626","33461172","Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.","USP18/FTO/PYCR1 signaling","promote","progression","Bladder Cancer","USP18/FTO/PYCR1 signaling pathway","STIMULATES","development","BLCA(Bladder Urothelial Carcinoma)"
"1245","31606241","The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.","METTL3","promote","Proliferation","Pancreatic Cancer","METTL3","STIMULATES","cell population proliferation","PAAD(Pancreatic Adenocarcinoma)"
"2676","31606241","The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.","METTL3","promote","Invasion","Pancreatic Cancer","METTL3","STIMULATES","cell population proliferation","PAAD(Pancreatic Adenocarcinoma)"
"1246","31916488","METTL3-mediated m6A is required for murine oocyte maturation and maternal-to-zygotic transition.","METTL3","mediate","m6A","Murine oocyte","METTL3","AFFECTS","m6A","Murine oocyte"
"2681","31916488","METTL3-mediated m6A is required for murine oocyte maturation and maternal-to-zygotic transition.","m6A","required for","maturation","Murine oocyte","m6A","CAUSES","maturation","Murine oocyte"
"3631","31916488","METTL3-mediated m6A is required for murine oocyte maturation and maternal-to-zygotic transition.","m6A","required for","maternal-to-zygotic transition","Murine oocyte","m6A","CAUSES","maturation","Murine oocyte"
"1250","32668092","Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.","Upregulated METTL3","enhance motility of","Cancer Cells","Nasopharyngeal Carcinoma","Upregulated METTL3","STIMULATES","Cancer Cells","HNSC(Head and Neck Squamous Cell Carcinoma)"
"1251","33681207","Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.","dummy","induce deficiency of","Mettl3","Bladder Cancer","dummy","INHIBITS","METTL3","BLCA(Bladder Urothelial Carcinoma)"
"2686","33681207","Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.","Mettl3","inhibit","Progression","Bladder Cancer","METTL3","INHIBITS","progression","BLCA(Bladder Urothelial Carcinoma)"
"3633","33681207","Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.","Mettl3","inhibit","Angiogenesis","Bladder Cancer","METTL3","INHIBITS","progression","BLCA(Bladder Urothelial Carcinoma)"
"1252","33842490","Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.","dummy","induce deficiency of","Mettl3","Bladder Cancer","dummy","INHIBITS","METTL3","BLCA(Bladder Urothelial Carcinoma)"
"2692","33842490","Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.","Mettl3","inhibit","Progression","Bladder Cancer","METTL3","INHIBITS","progression","BLCA(Bladder Urothelial Carcinoma)"
"3638","33842490","Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.","Mettl3","inhibit","Angiogenesis","Bladder Cancer","METTL3","INHIBITS","progression","BLCA(Bladder Urothelial Carcinoma)"
"1253","31239444","m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade.","FTO","regulate","Tumorigenicity","Melanoma","FTO","AFFECTS","Tumorigenicity","SKCM(Skin Cutaneous Melanoma)"
"2698","31239444","m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade.","FTO","regulate","Response  to anti-PD-1 blockade","Melanoma","FTO","AFFECTS","Tumorigenicity","SKCM(Skin Cutaneous Melanoma)"
"1254","31677788","ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia.","ALKBH5-m6A-FOXM1 signaling axis","promote","Proliferation","lung adenocarcinoma cells under intermittent hypoxia","ALKBH5-m6A-FOXM1 signaling axis","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"2701","31677788","ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia.","ALKBH5-m6A-FOXM1 signaling axis","promote","Invasion","lung adenocarcinoma cells under intermittent hypoxia","ALKBH5-m6A-FOXM1 signaling axis","STIMULATES","cell population proliferation","LUAD(Lung Adenocarcinoma)"
"1255","33150686","Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.","METTL3","attenuate","Cardiac Fibrosis","Myocardial Infarction","METTL3","INHIBITS","Cardiac Fibrosis","Myocardial Infarction"
"2705","33150686","Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.","myocardial infarction","induce","Cardiac Fibrosis","Myocardial Infarction","Myocardial Infarction","CAUSES","Cardiac Fibrosis","Myocardial Infarction"
"3643","33150686","Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.","METTL3","inhibite","Cardiac Fibroblasts","Myocardial Infarction","METTL3","INHIBITS","Cardiac Fibrosis","Myocardial Infarction"
"4405","33150686","Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.","Cardiac Fibroblasts","regulate","Cardiac Fibrosis","Myocardial Infarction","Cardiac Fibroblasts","AFFECTS","Cardiac Fibrosis","Myocardial Infarction"
"1256","29423080","Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.","miR-493-3p","mediate downregulation of","YTHDF2","Prostate Cancer","miR-493-3p","INHIBITS","YTHDF2","PRAD(Prostate Adenocarcinoma)"
"2711","29423080","Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.","YTHDF2","bind","N6-methyladenosine","Prostate Cancer","YTHDF2","INTERACTS_WITH","m6A","PRAD(Prostate Adenocarcinoma)"
"3646","29423080","Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.","YTHDF2","suppress","Prostate Cancer","Prostate Cancer","YTHDF2","INHIBITS","m6A","PRAD(Prostate Adenocarcinoma)"
"4410","29423080","Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.","YTHDF2","elevate","N6-methyladenosine","Prostate Cancer","YTHDF2","STIMULATES","m6A","PRAD(Prostate Adenocarcinoma)"
"595","29423080","Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.","N6-methyladenosine","suppress","Prostate Cancer","Prostate Cancer","m6A","INHIBITS","Prostatic Neoplasms","PRAD(Prostate Adenocarcinoma)"
"1257","34199793","Loss of WTAP Impairs Early Parthenogenetic Embryo Development.","dummy","induce loos of","WTAP","Early Parthenogenetic Embryo","dummy","INHIBITS","WTAP","Early Parthenogenetic Embryo"
"2715","34199793","Loss of WTAP Impairs Early Parthenogenetic Embryo Development.","WTAP","impair","Development","Early Parthenogenetic Embryo","WTAP","INHIBITS","development","Early Parthenogenetic Embryo"
"1258","33393595","Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.","Omeprazole","improve","Chemosensitivity","Gastric Cancer cells","omeprazole","STIMULATES","chemosensitivity","STAD(Stomach adenocarcinoma)"
"2719","33393595","Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.","Omeprazole","regulate","FTO","Gastric Cancer cells","omeprazole","AFFECTS","chemosensitivity","STAD(Stomach adenocarcinoma)"
"3650","33393595","Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.","FTO","activate","mTORC1","Gastric Cancer cells","FTO","STIMULATES","mTORC1","STAD(Stomach adenocarcinoma)"
"4416","33393595","Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.","FTO","upregulate","DDIT3","Gastric Cancer cells","FTO","STIMULATES","mTORC1","STAD(Stomach adenocarcinoma)"
"596","33393595","Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.","mTORC1","improve","chemosensitivity","Gastric Cancer cells","mTORC1","STIMULATES","chemosensitivity","STAD(Stomach adenocarcinoma)"
"641","33393595","Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.","DDIT3","improve","chemosensitivity","Gastric Cancer cells","DDIT3","STIMULATES","chemosensitivity","STAD(Stomach adenocarcinoma)"
"1259","32948220","YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.","miR-145","repress","YTHDF2","Ovarian Cancer cells","MIR145","INHIBITS","YTHDF2","OV(Ovarian Serous Cystadenocarcinoma)"
"2724","32948220","YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.","YTHDF2","regulate","Proliferation","Ovarian Cancer cells","YTHDF2","AFFECTS","cell population proliferation","OV(Ovarian Serous Cystadenocarcinoma)"
"3654","32948220","YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.","YTHDF2","regulate","Apoptosis","Ovarian Cancer cells","YTHDF2","AFFECTS","cell population proliferation","OV(Ovarian Serous Cystadenocarcinoma)"
"4420","32948220","YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.","YTHDF2","regulate","Migration","Ovarian Cancer cells","YTHDF2","AFFECTS","cell population proliferation","OV(Ovarian Serous Cystadenocarcinoma)"
"1260","33563765","Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.","FTO","confer","Gefitinib Resistance","Recipient Cells","FTO","PRODUCES","Gefitinib Resistance","Recipient Cells"
"2730","33563765","Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.","FTO","regulate","m6A","Recipient Cells","FTO","AFFECTS","Gefitinib Resistance","Recipient Cells"
"3660","33563765","Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.","m6A","regulate","ABCC10","Recipient Cells","m6A","AFFECTS","ABCC10","Recipient Cells"
"4425","33563765","Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.","ABCC10","confer","Gefitinib Resistance","Recipient Cells","ABCC10","PRODUCES","Gefitinib Resistance","Recipient Cells"
"1261","34544413","LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer.","EP300-SMYD2 complex","regulate","LINC01605","Colorectal Cancer","EP300-SMYD2 complex","AFFECTS","LINC01605","COAD(Colon Adenocarcinoma)"
"2738","34544413","LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer.","LINC01605","bind","METTL3","Colorectal Cancer","LINC01605","INTERACTS_WITH","METTL3","COAD(Colon Adenocarcinoma)"
"3663","34544413","LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer.","LINC01605","bind","SPTBN2","Colorectal Cancer","LINC01605","INTERACTS_WITH","METTL3","COAD(Colon Adenocarcinoma)"
"1262","33048840","HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.","HBXIP","promote","Gastric Cancer","Gastric Cancer","LAMTOR5","STIMULATES","Stomach Neoplasms","STAD(Stomach adenocarcinoma)"
"2744","33048840","HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.","HBXIP","regulate","METTL3","Gastric Cancer","LAMTOR5","AFFECTS","Stomach Neoplasms","STAD(Stomach adenocarcinoma)"
"3668","33048840","HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.","METTL3","mediate","MYC mRNA m6A modification","Gastric Cancer","METTL3","AFFECTS","MYC mRNA m6A modification","STAD(Stomach adenocarcinoma)"
"4429","33048840","HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.","MYC mRNA m6A modification","promote","Gastric Cancer","Gastric Cancer","MYC mRNA m6A modification","STIMULATES","Stomach Neoplasms","STAD(Stomach adenocarcinoma)"
"1263","29237556","Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein.","Ubiquitination","regulate","Proteasomal Degradation","Null","Ubiquitination","AFFECTS","Proteasomal Degradation","Null"
"2747","29237556","Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein.","Ubiquitination","regulate","Nuclear Translocation","Null","Ubiquitination","AFFECTS","Proteasomal Degradation","Null"
"3671","29237556","Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein.","Proteasomal Degradation","regulate","FTO Protein","Null","Proteasomal Degradation","AFFECTS","FTO","Null"
"4436","29237556","Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein.","Nuclear Translocation","regulate","Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein","Null","Nuclear Translocation","AFFECTS","Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein","Null"
"1264","33966037","WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.","WNT/beta-catenin","suppress","FTO","Tumor cell glycolysis and tumorigenesis","WNT/beta-catenin pathway","INHIBITS","FTO","Tumor cell glycolysis and tumorigenesis"
"2752","33966037","WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.","FTO","increase","m6A","Tumor cell glycolysis and tumorigenesis","FTO","AUGMENTS","m6A","Tumor cell glycolysis and tumorigenesis"
"3675","33966037","WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.","m6A","is on","c-Myc mRNA","Tumor cell glycolysis and tumorigenesis","m6A","LOCATES","MYC","Tumor cell glycolysis and tumorigenesis"
"4444","33966037","WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.","c-Myc mRNA","promote","glycolysis","Tumor cell glycolysis and tumorigenesis","MYC","STIMULATES","glycolytic process","Tumor cell glycolysis and tumorigenesis"
"597","33966037","WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.","c-Myc mRNA","promote","tumorigenesis","Tumor cell glycolysis and tumorigenesis","MYC","STIMULATES","glycolytic process","Tumor cell glycolysis and tumorigenesis"
"1265","31438961","WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.","WTAP","facilitate","Progression","Hepatocellular Carcinoma","WTAP","STIMULATES","progression","LIHC(Liver Hepatocellular Carcinoma)"
"2756","31438961","WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.","WTAP","regulate","m6A","Hepatocellular Carcinoma","WTAP","AFFECTS","progression","LIHC(Liver Hepatocellular Carcinoma)"
"3683","31438961","WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.","HuR","bind","m6A","Hepatocellular Carcinoma","ELAVL1","INTERACTS_WITH","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"4449","31438961","WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.","HuR","silence","ETS1","Hepatocellular Carcinoma","ELAVL1","INHIBITS","m6A","LIHC(Liver Hepatocellular Carcinoma)"
"598","31438961","WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.","ETS1","inhibit","Progression","Hepatocellular Carcinoma","ETS1","INHIBITS","progression","LIHC(Liver Hepatocellular Carcinoma)"
"1266","33819187","WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.","WTAP","promote","Myocardial Ischemia/Reperfusion Injury","myocardial ischemia/reperfusion injury","WTAP","STIMULATES","Myocardial Ischemia Reperfusion Injury","myocardial ischemia/reperfusion injury"
"2761","33819187","WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.","WTAP","regulate","m6A","myocardial ischemia/reperfusion injury","WTAP","AFFECTS","Myocardial Ischemia Reperfusion Injury","myocardial ischemia/reperfusion injury"
"3686","33819187","WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.","m6A","is on","ATF4 mRNA","myocardial ischemia/reperfusion injury","m6A","LOCATES","ATF4","myocardial ischemia/reperfusion injury"
"4452","33819187","WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.","ATF4 mRNA","increase","Endoplasmic Reticulum Stress","myocardial ischemia/reperfusion injury","ATF4","AUGMENTS","Endoplasmic Reticulum Stress","myocardial ischemia/reperfusion injury"
"599","33819187","WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.","Endoplasmic Reticulum Stress","promote","Myocardial Ischemia/Reperfusion Injury","myocardial ischemia/reperfusion injury","Endoplasmic Reticulum Stress","STIMULATES","Myocardial Ischemia Reperfusion Injury","myocardial ischemia/reperfusion injury"
"1267","32266933","m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.","METTL3","regulate","m6A","Osteosarcoma","METTL3","AFFECTS","m6A","SARC(Sarcoma)"
"2767","32266933","m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.","ELAVL1","regulate","m6A","Osteosarcoma","ELAVL1","AFFECTS","m6A","SARC(Sarcoma)"
"3689","32266933","m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.","m6A","upregulate","DRG1","Osteosarcoma","m6A","STIMULATES","DRG1","SARC(Sarcoma)"
"4459","32266933","m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.","DRG1","promote","Growth","Osteosarcoma","DRG1","STIMULATES","Growth","SARC(Sarcoma)"
"5104","32266933","m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.","DRG1","promote","Migration","Osteosarcoma","DRG1","STIMULATES","Growth","SARC(Sarcoma)"
"644","32266933","m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.","DRG1","promote","Colony Formation","Osteosarcoma","DRG1","STIMULATES","Growth","SARC(Sarcoma)"
"1268","33947842","N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.","FTO","impair","Hepatic Ischemia-Reperfusion Injury","Hepatic Ischemia-Reperfusion Injury","FTO","INHIBITS","Hepatic Ischemia-Reperfusion Injury","Hepatic Ischemia-Reperfusion Injury"
"2773","33947842","N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.","FTO","inhibit","Drp1","Hepatic Ischemia-Reperfusion Injury","FTO","INHIBITS","Hepatic Ischemia-Reperfusion Injury","Hepatic Ischemia-Reperfusion Injury"
"3695","33947842","N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.","Drp1","mediate","Mitochondrial Fragmentation","Hepatic Ischemia-Reperfusion Injury","DNM1L","AFFECTS","mitochondrial fragmentation","Hepatic Ischemia-Reperfusion Injury"
"4465","33947842","N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.","Mitochondrial Fragmentation","impair","Hepatic Ischemia-Reperfusion Injury","Hepatic Ischemia-Reperfusion Injury","mitochondrial fragmentation","INHIBITS","Hepatic Ischemia-Reperfusion Injury","Hepatic Ischemia-Reperfusion Injury"
"1269","34076991","The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.","METTL3","promote","Stemness","Breast Cancer","METTL3","STIMULATES","Stemness","BRCA(Breast Invasive Carcinoma)"
"2778","34076991","The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.","METTL3","promote","Malignant Progression","Breast Cancer","METTL3","STIMULATES","Stemness","BRCA(Breast Invasive Carcinoma)"
"3699","34076991","The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.","METTL3","mediate","m6A","Breast Cancer","METTL3","AFFECTS","Stemness","BRCA(Breast Invasive Carcinoma)"
"4471","34076991","The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.","m6A","is on","SOX2","Breast Cancer","m6A","LOCATES","SOX2","BRCA(Breast Invasive Carcinoma)"
"5114","34076991","The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.","SOX2","promote","Stemness","Breast Cancer","SOX2","STIMULATES","Stemness","BRCA(Breast Invasive Carcinoma)"
"648","34076991","The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.","SOX2","promote","Malignant Progression","Breast Cancer","SOX2","STIMULATES","Stemness","BRCA(Breast Invasive Carcinoma)"
"1270","34164910","METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.","METTL3","promote","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis","METTL3","STIMULATES","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis"
"2784","34164910","METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.","N6-methyladenosine","promote","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis","m6A","STIMULATES","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis"
"3705","34164910","METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.","miR-21-5p","activate","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis","miR-21-5p","STIMULATES","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis"
"4477","34164910","METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.","METTL3","promote","SPRY1/ERK/NF-kappaB pathway activation","Obstructive Renal Fibrosis","METTL3","STIMULATES","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis"
"5119","34164910","METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.","N6-methyladenosine","promote","SPRY1/ERK/NF-kappaB pathway activation","Obstructive Renal Fibrosis","m6A","STIMULATES","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis"
"649","34164910","METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.","miR-21-5p","activate","SPRY1/ERK/NF-kappaB pathway activation","Obstructive Renal Fibrosis","miR-21-5p","STIMULATES","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis"
"721","34164910","METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.","SPRY1/ERK/NF-kappaB pathway","regulate","inflammation","Obstructive Renal Fibrosis","SPRY1/ERK/NF-kappaB pathway","AFFECTS","inflammatory response","Obstructive Renal Fibrosis"
"89","34164910","METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.","inflammation","promote","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis","inflammatory response","STIMULATES","Obstructive Renal Fibrosis","Obstructive Renal Fibrosis"
"1271","31365297","The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA.","METTL3","facilitate","M1 macrophage polarization","Null","METTL3","STIMULATES","M1 macrophage polarization","Null"
"2786","31365297","The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA.","METTL3","methylate","STAT1","Null","METTL3","CONVERTS_TO","M1 macrophage polarization","Null"
"3712","31365297","The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA.","STAT1","facilitate","M1 macrophage polarization","Null","STAT1","STIMULATES","M1 macrophage polarization","Null"
"1272","34450538","Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.","SNHG4","remit","lipopolysaccharide-engendered inflammatory lung damage","Lung","SNHG4","INHIBITS","lipopolysaccharide-engendered inflammatory lung damage","Lung"
"2789","34450538","Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.","SNHG4","inhibit","METTL3","Lung","SNHG4","INHIBITS","lipopolysaccharide-engendered inflammatory lung damage","Lung"
"3720","34450538","Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.","METTL3","mediate","m6A","Lung","METTL3","AFFECTS","m6A","Lung"
"4484","34450538","Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.","m6A","is on","STAT2","Lung","m6A","LOCATES","STAT2","Lung"
"5124","34450538","Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.","STAT2","remit","lipopolysaccharide-engendered inflammatory lung damage","Lung","STAT2","INHIBITS","lipopolysaccharide-engendered inflammatory lung damage","Lung"
"1273","34076564","Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.","FTO","mediate","STAT3","Breast Cancer","FTO","AFFECTS","STAT3","BRCA(Breast Invasive Carcinoma)"
"2792","34076564","Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.","STAT3","derive resistance  to","doxorubicin","Breast Cancer","STAT3","INHIBITS","doxorubicin","BRCA(Breast Invasive Carcinoma)"
"1274","34562008","METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.","METTL3","upregulate","miR-222-3p","Thyroid Carcinoma","METTL3","STIMULATES","miR-222-3p","THCA(Thyroid Carcinoma)"
"2798","34562008","METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.","miR-222-3p","inhibit","STK4","Thyroid Carcinoma","miR-222-3p","INHIBITS","STK4","THCA(Thyroid Carcinoma)"
"3722","34562008","METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.","miR-222-3p","promote","Malignant Behaviors","Thyroid Carcinoma","miR-222-3p","STIMULATES","STK4","THCA(Thyroid Carcinoma)"
"1275","32158230","Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1.","METTL3","promote","Progression","Thyroid Carcinoma","METTL3","STIMULATES","progression","THCA(Thyroid Carcinoma)"
"2807","32158230","Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1.","METTL3","regulate","m6A","Thyroid Carcinoma","METTL3","AFFECTS","progression","THCA(Thyroid Carcinoma)"
"3724","32158230","Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1.","m6A","is on","TCF1","Thyroid Carcinoma","m6A","LOCATES","HNF1A","THCA(Thyroid Carcinoma)"
"4491","32158230","Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1.","TCF1","promote","Progression","Thyroid Carcinoma","HNF1A","STIMULATES","progression","THCA(Thyroid Carcinoma)"
"1276","32857912","METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma.","METTL3","modify","m6A","Seminoma","METTL3","AFFECTS","m6A","Seminoma"
"2813","32857912","METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma.","m6A","is on","TFAP2C","Seminoma","m6A","LOCATES","TFAP2C","Seminoma"
"3729","32857912","METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma.","TFAP2C","potentiate resistance to","cisplatin","Seminoma","TFAP2C","PREVENTS","cisplatin","Seminoma"
"4497","32857912","METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma.","METTL3","potentiate resistance to","cisplatin","Seminoma","METTL3","PREVENTS","m6A","Seminoma"
"1277","33555197","Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.","Tumor-Associated Macrophages","promote","Oxaliplatin Resistance","Colorectal Cancer","Tumor-Associated Macrophages","STIMULATES","Oxaliplatin Resistance","COAD(Colon Adenocarcinoma)"
"2818","33555197","Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.","Tumor-Associated Macrophages","regulate","METTL3","Colorectal Cancer","Tumor-Associated Macrophages","AFFECTS","Oxaliplatin Resistance","COAD(Colon Adenocarcinoma)"
"3733","33555197","Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.","METTL3","mediate","m6A","Colorectal Cancer","METTL3","AFFECTS","m6A","COAD(Colon Adenocarcinoma)"
"4500","33555197","Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.","m6A","is on","TRAF5","Colorectal Cancer","m6A","LOCATES","TRAF5","COAD(Colon Adenocarcinoma)"
"5127","33555197","Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.","TRAF5","promote","Oxaliplatin Resistance","Colorectal Cancer","TRAF5","STIMULATES","Oxaliplatin Resistance","COAD(Colon Adenocarcinoma)"
"650","33555197","Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.","Tumor-Associated Macrophages","regulate","Necroptosis","Colorectal Cancer","Tumor-Associated Macrophages","AFFECTS","Oxaliplatin Resistance","COAD(Colon Adenocarcinoma)"
"722","33555197","Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.","Necroptosis","promote","Oxaliplatin Resistance","Colorectal Cancer","necroptotic process","STIMULATES","Oxaliplatin Resistance","COAD(Colon Adenocarcinoma)"
"1278","33121495","YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.","YTHDF2","mediate the mRNA degradation of","tumor suppressors","Prostate Cancer","YTHDF2","AFFECTS","regulation of cell cycle","PRAD(Prostate Adenocarcinoma)"
"2822","33121495","YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.","tumor suppressors","induce","AKT phosphorylation","Prostate Cancer","regulation of cell cycle","CAUSES","AKT phosphorylation","PRAD(Prostate Adenocarcinoma)"
"3738","33121495","YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.","YTHDF2","regulate","N6-methyladenosine","Prostate Cancer","YTHDF2","AFFECTS","regulation of cell cycle","PRAD(Prostate Adenocarcinoma)"
"4502","33121495","YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.","N6-methyladenosine","regulate","AKT phosphorylation","Prostate Cancer","m6A","AFFECTS","AKT phosphorylation","PRAD(Prostate Adenocarcinoma)"
"1279","30905413","The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.","FTO","promote growth of","Lung Cancer Cells","Lung Cancer","FTO","STIMULATES","Lung Cancer Cells","LUAD(Lung Adenocarcinoma)"
"2828","30905413","The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.","FTO","regulate","m6A","Lung Cancer","FTO","AFFECTS","Lung Cancer Cells","LUAD(Lung Adenocarcinoma)"
"3743","30905413","The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.","m6A","is on","USP7","Lung Cancer","m6A","LOCATES","USP7","LUAD(Lung Adenocarcinoma)"
"4505","30905413","The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.","USP7","promote","Lung Cancer Cells","Lung Cancer","USP7","STIMULATES","Lung Cancer Cells","LUAD(Lung Adenocarcinoma)"
"1280","34047466","Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.","dummy","induce loss of","ALKBH5","Null","dummy","INHIBITS","ALKBH5","Null"
"2831","34047466","Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.","ALKBH5","promote","angiogenesis","Null","ALKBH5","STIMULATES","angiogenesis","Null"
"3748","34047466","Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.","ALKBH5","stabilize","WNT5A","Null","ALKBH5","MAINTAINS","angiogenesis","Null"
"4509","34047466","Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.","WNT5A","promote","angiogenesis","Null","WNT5A","STIMULATES","angiogenesis","Null"
"1281","34362795","N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.","N6-methyladenosine","upregulate","WTAPP1","Pancreatic Cancer","m6A","STIMULATES","WTAPP1","PAAD(Pancreatic Adenocarcinoma)"
"2838","34362795","N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.","WTAPP1","promote","WTAP","Pancreatic Cancer","WTAPP1","STIMULATES","WTAP","PAAD(Pancreatic Adenocarcinoma)"
"3753","34362795","N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.","WTAPP1","promote","Wnt","Pancreatic Cancer","WTAPP1","STIMULATES","WTAP","PAAD(Pancreatic Adenocarcinoma)"
"4513","34362795","N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.","WTAP","facilitate","Progression","Pancreatic Cancer","WTAP","STIMULATES","progression","PAAD(Pancreatic Adenocarcinoma)"
"5133","34362795","N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.","Wnt","facilitate","Progression","Pancreatic Cancer","Wnt","STIMULATES","progression","PAAD(Pancreatic Adenocarcinoma)"
"1282","33317545","Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1.","Musashi-1","upregulate","YTHDF1","Glioblastoma","MSI1","STIMULATES","YTHDF1","GBM(Glioblastoma Multiforme)"
"2846","33317545","Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1.","YTHDF1","promote","Cancer stem cell properties","Glioblastoma","YTHDF1","STIMULATES","Cancer stem cell properties","GBM(Glioblastoma Multiforme)"
"3757","33317545","Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1.","Musashi-1","promote","Cancer stem cell properties","Glioblastoma","MSI1","STIMULATES","YTHDF1","GBM(Glioblastoma Multiforme)"
"1283","30401835","m6A facilitates hippocampus-dependent learning and memory through YTHDF1.","m6A","facilitate","hippocampus","Null","m6A","STIMULATES","Hippocampus","Null"
"2850","30401835","m6A facilitates hippocampus-dependent learning and memory through YTHDF1.","m6A","regulate","YTHDF1","Null","m6A","AFFECTS","Hippocampus","Null"
"3763","30401835","m6A facilitates hippocampus-dependent learning and memory through YTHDF1.","YTHDF1","facilitate","hippocampus","Null","YTHDF1","STIMULATES","Hippocampus","Null"
"1284","30787270","m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.","m6A methylation","control","Pluripotency","porcine induced Pluripotent Stem Cells","m6A","AFFECTS","Pluripotency","porcine induced Pluripotent Stem Cells"
"2852","30787270","m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.","m6A methylation","regulate","YTHDF1","porcine induced Pluripotent Stem Cells","m6A","AFFECTS","Pluripotency","porcine induced Pluripotent Stem Cells"
"3770","30787270","m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.","m6A methylation","regulate","YTHDF2","porcine induced Pluripotent Stem Cells","m6A","AFFECTS","Pluripotency","porcine induced Pluripotent Stem Cells"
"4521","30787270","m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.","YTHDF1","target","SOCS3/JAK2/STAT3 pathway","porcine induced Pluripotent Stem Cells","YTHDF1","INTERACTS_WITH","SOCS3/JAK2/STAT3 pathway","porcine induced Pluripotent Stem Cells"
"5138","30787270","m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.","YTHDF2","target","SOCS3/JAK2/STAT3 pathway","porcine induced Pluripotent Stem Cells","YTHDF2","INTERACTS_WITH","SOCS3/JAK2/STAT3 pathway","porcine induced Pluripotent Stem Cells"
"651","30787270","m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.","SOCS3/JAK2/STAT3 pathway","control","Pluripotency","porcine induced Pluripotent Stem Cells","SOCS3/JAK2/STAT3 pathway","AFFECTS","Pluripotency","porcine induced Pluripotent Stem Cells"
"1285","33726814","Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.","Histone lactylation","drive","Oncogenesis","Ocular Melanoma","Histone lactylation","STIMULATES","Carcinogenesis","UVM(Uveal Melanoma)"
"2856","33726814","Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.","Histone lactylation","facilitate","YTHDF2","Ocular Melanoma","Histone lactylation","STIMULATES","Carcinogenesis","UVM(Uveal Melanoma)"
"3773","33726814","Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.","YTHDF2","drive","Oncogenesis","Ocular Melanoma","YTHDF2","STIMULATES","Carcinogenesis","UVM(Uveal Melanoma)"
"1286","33829656","KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.","KDM5B","promote self-renewal of","hepatocellular carcinoma cells","Hepatocellular Carcinoma","KDM5B","STIMULATES","hepatocellular carcinoma cells","LIHC(Liver Hepatocellular Carcinoma)"
"2862","33829656","KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.","KDM5B","regulate","microRNA-448","Hepatocellular Carcinoma","KDM5B","AFFECTS","hepatocellular carcinoma cells","LIHC(Liver Hepatocellular Carcinoma)"
"3777","33829656","KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.","microRNA-448","mediate","YTHDF3/ITGA6 axis","Hepatocellular Carcinoma","MIR448","AFFECTS","YTHDF3/ITGA6 axis","LIHC(Liver Hepatocellular Carcinoma)"
"4524","33829656","KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.","YTHDF3/ITGA6 axis","promote","hepatocellular carcinoma cells","Hepatocellular Carcinoma","YTHDF3/ITGA6 axis","STIMULATES","hepatocellular carcinoma cells","LIHC(Liver Hepatocellular Carcinoma)"
"1287","33577677","SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.","dummy","induce SUMOylation of","YTHDF2","Cancer Progression","dummy","STIMULATES","YTHDF2","PANCAN(Pan-Cancer)"
"2864","33577677","SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.","YTHDF2","promote","mRNA degradation","Cancer Progression","YTHDF2","STIMULATES","mRNA catabolic process","PANCAN(Pan-Cancer)"
"3782","33577677","SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.","YTHDF2","promote","Cancer Progression","Cancer Progression","YTHDF2","STIMULATES","mRNA catabolic process","PANCAN(Pan-Cancer)"
"4528","33577677","SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.","YTHDF2","bind","m6A-modified mRNAs","Cancer Progression","YTHDF2","INTERACTS_WITH","mRNA catabolic process","PANCAN(Pan-Cancer)"
"5143","33577677","SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.","m6A-modified mRNAs","promote","mRNA degradation","Cancer Progression","m6A","STIMULATES","mRNA catabolic process","PANCAN(Pan-Cancer)"
"652","33577677","SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.","m6A-modified mRNAs","promote","Cancer Progression","Cancer Progression","m6A","STIMULATES","mRNA catabolic process","PANCAN(Pan-Cancer)"
"1288","32615088","METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.","METTL3","promote","Homologous Recombination","DBS","METTL3","STIMULATES","homologous recombination","MCF2L"
"2867","32615088","METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.","N6-Methyladenosine","promote","Homologous Recombination","DBS","m6A","STIMULATES","homologous recombination","MCF2L"
"3788","32615088","METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.","Homologous Recombination","mediate","Repair","DBS","homologous recombination","AFFECTS","repair","MCF2L"
"4533","32615088","METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.","METTL3","modulate","DNA-RNA Hybrid Accumulation","DBS","METTL3","AFFECTS","homologous recombination","MCF2L"
"5148","32615088","METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.","N6-Methyladenosine","modulate","DNA-RNA Hybrid Accumulation","DBS","m6A","AFFECTS","homologous recombination","MCF2L"
"653","32615088","METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.","DNA-RNA Hybrid Accumulation","regulate","Repair","DBS","DNA-RNA Hybrid Accumulation","AFFECTS","repair","MCF2L"
"1289","29249359","R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.","R-2HG","target","FTO/m6A/MYC/CEBPA Signaling","Null","R-2HG","INTERACTS_WITH","FTO/m6A/MYC/CEBPA signaling pathway","Null"
"2872","29249359","R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.","FTO/m6A/MYC/CEBPA Signaling","exhibit","Anti-tumor Activity","Null","FTO/m6A/MYC/CEBPA signaling pathway","MANIFESTS","Anti-tumor Activity","Null"
"3794","29249359","R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.","R-2HG","exhibit","Anti-tumor Activity","Null","R-2HG","MANIFESTS","FTO/m6A/MYC/CEBPA signaling pathway","Null"
"1290","33434505","R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis.","R-2-hydroxyglutarate","attenuate","aerobic glycolysis","Leukemia","R-2HG","INHIBITS","aerobic glycolysis","LAML(Acute Myeloid Leukemia)"
"2878","33434505","R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis.","R-2-hydroxyglutarate","target","FTO/m6A/PFKP/LDHB axis","Leukemia","R-2HG","INTERACTS_WITH","aerobic glycolysis","LAML(Acute Myeloid Leukemia)"
"3798","33434505","R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis.","FTO/m6A/PFKP/LDHB axis","attenuate","aerobic glycolysis","Leukemia","FTO/m6A/PFKP/LDHB axis","INHIBITS","aerobic glycolysis","LAML(Acute Myeloid Leukemia)"
"1291","32850334","m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis.","YTHDC2","promote","Radiotherapy Resistance","Nasopharyngeal Carcinoma","YTHDC2","STIMULATES","Radiotherapy Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"2881","32850334","m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis.","YTHDC2","activate","IGF1R/AKT/S6 Signaling Axis","Nasopharyngeal Carcinoma","YTHDC2","STIMULATES","Radiotherapy Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3803","32850334","m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis.","IGF1R/AKT/S6 Signaling Axis","promote","Radiotherapy Resistance","Nasopharyngeal Carcinoma","IGF1R/AKT/S6 Signaling Axis","STIMULATES","Radiotherapy Resistance","HNSC(Head and Neck Squamous Cell Carcinoma)"
"1292","31186141","METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.","METTL3","promote","experimental osteoarthritis development","Experimental Osteoarthritis","METTL3","STIMULATES","experimental osteoarthritis development","Experimental Osteoarthritis"
"2885","31186141","METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.","METTL3","regulate","Inflammatory Response","Experimental Osteoarthritis","METTL3","AFFECTS","experimental osteoarthritis development","Experimental Osteoarthritis"
"3806","31186141","METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.","METTL3","regulate","Apoptosis","Experimental Osteoarthritis","METTL3","AFFECTS","experimental osteoarthritis development","Experimental Osteoarthritis"
"4540","31186141","METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.","Apoptosis","is on","Chondrocyte","Experimental Osteoarthritis","apoptotic process","LOCATES","Chondrocytes","Experimental Osteoarthritis"
"5151","31186141","METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.","Inflammatory Response","promote","experimental osteoarthritis development","Experimental Osteoarthritis","inflammatory response","STIMULATES","experimental osteoarthritis development","Experimental Osteoarthritis"
"654","31186141","METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.","Apoptosis","promote","experimental osteoarthritis development","Experimental Osteoarthritis","apoptotic process","STIMULATES","Chondrocytes","Experimental Osteoarthritis"
"1293","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","METTL3","modulate","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury","METTL3","AFFECTS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"2889","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","m6A","modulate","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury","m6A","AFFECTS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"3811","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","miRNA-873-5p","modulate","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury","miRNA-873-5p","AFFECTS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"4545","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","Keap1/Nrf2 Pathway","attenuate","Oxidative Stress","Colistin-Induced Kidney Injury","Keap1/Nrf2 Pathway","INHIBITS","Oxidative Stress","Colistin-Induced Kidney Injury"
"5156","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","Keap1/Nrf2 Pathway","attenuate","Apoptosis","Colistin-Induced Kidney Injury","Keap1/Nrf2 Pathway","INHIBITS","Oxidative Stress","Colistin-Induced Kidney Injury"
"655","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","METTL3","attenuate","Oxidative Stress","Colistin-Induced Kidney Injury","METTL3","INHIBITS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"723","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","m6A","attenuate","Oxidative Stress","Colistin-Induced Kidney Injury","m6A","INHIBITS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"811","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","miRNA-873-5p","attenuate","Oxidative Stress","Colistin-Induced Kidney Injury","miRNA-873-5p","INHIBITS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"96","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","METTL3","attenuate","Apoptosis","Colistin-Induced Kidney Injury","METTL3","INHIBITS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"104","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","m6A","attenuate","Apoptosis","Colistin-Induced Kidney Injury","m6A","INHIBITS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"11100","31156435","METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.","miRNA-873-5p","attenuate","Apoptosis","Colistin-Induced Kidney Injury","miRNA-873-5p","INHIBITS","Keap1/Nrf2 Pathway","Colistin-Induced Kidney Injury"
"1294","33879631","Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.","hsa_circ_0072309","promote","Tumorigenesis","Non-small cell lung carcinoma","hsa_circ_0072309","STIMULATES","Carcinogenesis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"2897","33879631","Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.","hsa_circ_0072309","promote","Invasion","Non-small cell lung carcinoma","hsa_circ_0072309","STIMULATES","Carcinogenesis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"3816","33879631","Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.","hsa_circ_0072309","regulate","miR-607/FTO axis","Non-small cell lung carcinoma","hsa_circ_0072309","AFFECTS","Carcinogenesis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"4546","33879631","Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.","miR-607/FTO axis","promote","Tumorigenesis","Non-small cell lung carcinoma","miR-607/FTO axis","STIMULATES","Carcinogenesis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"5161","33879631","Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.","miR-607/FTO axis","promote","Invasion","Non-small cell lung carcinoma","miR-607/FTO axis","STIMULATES","Carcinogenesis","LUAD (Lung Adenocarcinoma) or LUSC(Lung Squamous Cell Carcinoma)"
"1295","28333151","FTO is required for myogenesis by positively regulating mTOR-PGC-1alpha pathway-mediated mitochondria biogenesis.","FTO","is required for","myogenesis","Null","FTO","CAUSES","skeletal muscle tissue development","Null"
"2901","28333151","FTO is required for myogenesis by positively regulating mTOR-PGC-1alpha pathway-mediated mitochondria biogenesis.","FTO","upregulate","mTOR-PGC-1alpha pathway","Null","FTO","STIMULATES","skeletal muscle tissue development","Null"
"3821","28333151","FTO is required for myogenesis by positively regulating mTOR-PGC-1alpha pathway-mediated mitochondria biogenesis.","mTOR-PGC-1alpha pathway","mediate","mitochondria biogenesis","Null","mTOR-PGC-1alpha pathway","AFFECTS","mitochondria biogenesis","Null"
"4551","28333151","FTO is required for myogenesis by positively regulating mTOR-PGC-1alpha pathway-mediated mitochondria biogenesis.","mitochondria biogenesis","is required for","myogenesis","Null","mitochondria biogenesis","CAUSES","skeletal muscle tissue development","Null"
"1296","29290617","METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.","METTL14","modify","m6A","Hematopoietic Stem/Progenitor","METTL14","AFFECTS","m6A","Hematopoietic Stem/Progenitor"
"2906","29290617","METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.","m6A","inhibit","Differentiation","Hematopoietic Stem/Progenitor","m6A","INHIBITS","cell differentiation","Hematopoietic Stem/Progenitor"
"3822","29290617","METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.","m6A","promote","Leukemogenesis","Hematopoietic Stem/Progenitor","m6A","STIMULATES","cell differentiation","Hematopoietic Stem/Progenitor"
"4556","29290617","METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.","METTL14","inhibit","Differentiation","Hematopoietic Stem/Progenitor","METTL14","INHIBITS","m6A","Hematopoietic Stem/Progenitor"
"5164","29290617","METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.","METTL14","promote","Leukemogenesis","Hematopoietic Stem/Progenitor","METTL14","STIMULATES","m6A","Hematopoietic Stem/Progenitor"
"1297","34266473","YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decay.","YTHDF2","alleviate","Cardiac Hypertrophy","Cardiac Hypertrophy","YTHDF2","INHIBITS","Cardiac Hypertrophy","Cardiac Hypertrophy"
"2912","34266473","YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decay.","YTHDF2","regulate","Myh7","Cardiac Hypertrophy","YTHDF2","AFFECTS","Cardiac Hypertrophy","Cardiac Hypertrophy"
"3827","34266473","YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decay.","Myh7","alleviate","Cardiac Hypertrophy","Cardiac Hypertrophy","MYH7","INHIBITS","Cardiac Hypertrophy","Cardiac Hypertrophy"
"1298","32329191","RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-kappaB pathway.","ALKBH5","promote","Ovarian Carcinogenesis","simulated tumour microenvironment","ALKBH5","STIMULATES","Ovarian Carcinogenesis","simulated tumour microenvironment"
"2919","32329191","RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-kappaB pathway.","ALKBH5","stimulate","NF-kappaB Pathway","simulated tumour microenvironment","ALKBH5","STIMULATES","Ovarian Carcinogenesis","simulated tumour microenvironment"
"3831","32329191","RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-kappaB pathway.","NF-kappaB Pathway","promote","Ovarian Carcinogenesis","simulated tumour microenvironment","NF-kappaB signaling pathway","STIMULATES","Ovarian Carcinogenesis","simulated tumour microenvironment"
"1299","34513313","METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.","METTL3","mediate","m6A","Esophageal Cancer","METTL3","AFFECTS","m6A","ESCA(Esophageal Carcinoma)"
"2925","34513313","METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.","m6A","regulate","Notch signaling pathway","Esophageal Cancer","m6A","AFFECTS","Notch signaling pathway","ESCA(Esophageal Carcinoma)"
"3835","34513313","METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.","Notch signaling pathway","promote","initiation","Esophageal Cancer","Notch signaling pathway","STIMULATES","initiation","ESCA(Esophageal Carcinoma)"
"4560","34513313","METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.","Notch signaling pathway","promote","progression","Esophageal Cancer","Notch signaling pathway","STIMULATES","initiation","ESCA(Esophageal Carcinoma)"
"5171","34513313","METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.","m6A","promote","initiation","Esophageal Cancer","m6A","STIMULATES","Notch signaling pathway","ESCA(Esophageal Carcinoma)"
"656","34513313","METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.","m6A","promote","progression","Esophageal Cancer","m6A","STIMULATES","Notch signaling pathway","ESCA(Esophageal Carcinoma)"
"1300","32176425","High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.","WTAP","lead to","prognosis","Gastric Cancer","WTAP","CAUSES","Prognosis","STAD(Stomach adenocarcinoma)"
"2930","32176425","High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.","WTAP","influence","T lymphocyte infiltration","Gastric Cancer","WTAP","AFFECTS","Prognosis","STAD(Stomach adenocarcinoma)"
"3840","32176425","High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.","T lymphocyte infiltration","lead to","prognosis","Gastric Cancer","T lymphocyte infiltration","CAUSES","Prognosis","STAD(Stomach adenocarcinoma)"
"1301","28809392","Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation.","Mettl3","mediate","m6A","Null","METTL3","AFFECTS","m6A","Null"
"2933","28809392","Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation.","m6A","regulate","spermatogonial differentiation","Null","m6A","AFFECTS","spermatogonial differentiation","Null"
"3848","28809392","Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation.","m6A","regulate","meiosis initiation","Null","m6A","AFFECTS","spermatogonial differentiation","Null"
"1302","28920958","The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.","METTL3","control","Myeloid differentiation","normal hematopoietic and leukemia cell","METTL3","AFFECTS","Myeloid differentiation","Normal hematopoietic cell"
"1303","29345285","The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.","METTL3","promote","chemo-resistance","Pancreatic Cancer Cells","METTL3","STIMULATES","chemo-resistance","PAAD(Pancreatic Adenocarcinoma)"
"2939","29345285","The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.","METTL3","promote","radioresistance","Pancreatic Cancer Cells","METTL3","STIMULATES","chemo-resistance","PAAD(Pancreatic Adenocarcinoma)"
"1304","30429466","Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis.","Mettl3","mediate","m6A RNA methylation","Osteoporosis","METTL3","AFFECTS","m6A","Osteoporosis"
"2944","30429466","Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis.","m6A RNA methylation","regulate","bone marrow mesenchymal stem cells","Osteoporosis","m6A","AFFECTS","bone marrow mesenchymal stem cells","Osteoporosis"
"3853","30429466","Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis.","m6A RNA methylation","regulate","Osteoporosis","Osteoporosis","m6A","AFFECTS","bone marrow mesenchymal stem cells","Osteoporosis"
"1305","31607270","METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.","METTL3","mediate","N6-methyladenosine","Gastric Cancer","METTL3","AFFECTS","m6A","STAD(Stomach adenocarcinoma)"
"2947","31607270","METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.","N6-methyladenosine modification","is critical for","epithelial-mesenchymal transition","Gastric Cancer","m6A","CAUSES","epithelial to mesenchymal transition","STAD(Stomach adenocarcinoma)"
"3858","31607270","METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.","N6-methyladenosine modification","is critical for","metastasis","Gastric Cancer","m6A","CAUSES","epithelial to mesenchymal transition","STAD(Stomach adenocarcinoma)"
"1306","33961823","METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.","METTL3","regulate","m6A","SARS-CoV-2 infection","METTL3","AFFECTS","m6A","COVID-19"
"2952","33961823","METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.","METTL3","regulate","host cell innate immune responses","SARS-CoV-2 infection","METTL3","AFFECTS","m6A","COVID-19"
"1307","34335955","Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.","dummy","induce silencing of","METTL3","Prostate Cancer","dummy","INHIBITS","METTL3","PRAD(Prostate Adenocarcinoma)"
"2957","34335955","Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.","METTL3","hinder","Invasion","Prostate Cancer","METTL3","INHIBITS","Neoplasm Invasiveness","PRAD(Prostate Adenocarcinoma)"
"3864","34335955","Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.","METTL3","hinder","Metastasis","Prostate Cancer","METTL3","INHIBITS","Neoplasm Invasiveness","PRAD(Prostate Adenocarcinoma)"
"1308","34428587","Loss of m6A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury.","dummy","induce loss of","METTL3","Myocardial Injury","dummy","INHIBITS","METTL3","Myocardial Injury"
"2958","34428587","Loss of m6A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury.","METTL3","promote","Regeneration","Myocardial Injury","METTL3","STIMULATES","regeneration","Myocardial Injury"
"3866","34428587","Loss of m6A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury.","METTL3","promote","repair","Myocardial Injury","METTL3","STIMULATES","regeneration","Myocardial Injury"
"1309","34452996","METTL14 facilitates global genome repair and suppresses skin tumorigenesis.","METTL14","facilitate","Global Genome Repair","Skin Tumorigenesis","METTL14","STIMULATES","Global Genome Repair","SKCM(Skin Cutaneous Melanoma)"
"2964","34452996","METTL14 facilitates global genome repair and suppresses skin tumorigenesis.","METTL14","suppress","Skin Tumorigenesis","Skin Tumorigenesis","METTL14","INHIBITS","Global Genome Repair","SKCM(Skin Cutaneous Melanoma)"
"1310","32217665","The rRNA m6A methyltransferase METTL5 is involved in pluripotency and developmental programs.","METTL5","involve","pluripotency","Null","METTL5","ASSOCIATED_WITH","Pluripotency","Null"
"2967","32217665","The rRNA m6A methyltransferase METTL5 is involved in pluripotency and developmental programs.","METTL5","involve","developmental programs","Null","METTL5","ASSOCIATED_WITH","Pluripotency","Null"
"1311","33357433","Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.","METTL5","promote","Translation Initiation","Breast Cancer","METTL5","STIMULATES","translational initiation","BRCA(Breast Invasive Carcinoma)"
"2977","33357433","Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.","METTL5","promote","Cell Growth","Breast Cancer","METTL5","STIMULATES","translational initiation","BRCA(Breast Invasive Carcinoma)"
"1312","37606168","METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.","METTL3","promote","growth","Melanoma Cells","METTL3","STIMULATES","Growth","SKCM(Skin Cutaneous Melanoma)"
"2982","37606168","METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.","METTL3","promote","invasion","Melanoma Cells","METTL3","STIMULATES","Growth","SKCM(Skin Cutaneous Melanoma)"
"3870","37606168","METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.","METTL3","regulate","lncRNA SNHG3/miR-330-5p Axis","Melanoma Cells","METTL3","AFFECTS","Growth","SKCM(Skin Cutaneous Melanoma)"
"4565","37606168","METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.","lncRNA SNHG3/miR-330-5p Axis","promote","growth","Melanoma Cells","SNHG3/miR-330-5p Axis","STIMULATES","Growth","SKCM(Skin Cutaneous Melanoma)"
"5179","37606168","METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.","lncRNA SNHG3/miR-330-5p Axis","promote","invasion","Melanoma Cells","SNHG3/miR-330-5p Axis","STIMULATES","Growth","SKCM(Skin Cutaneous Melanoma)"
"1313","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","M6A","mediate the upregulation of","lncRNA BLACAT3","bladder cancer","m6A","STIMULATES","BLACAT3","BLCA(Bladder Urothelial Carcinoma)"
"2984","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","lncRNA BLACAT3","promote","angiogenesis","bladder cancer","BLACAT3","STIMULATES","angiogenesis","BLCA(Bladder Urothelial Carcinoma)"
"3874","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","lncRNA BLACAT3","promote","hematogenous metastasis","bladder cancer","BLACAT3","STIMULATES","angiogenesis","BLCA(Bladder Urothelial Carcinoma)"
"4570","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","lncRNA BLACAT3","regulate the nuclear shuttling of","YBX3","bladder cancer","BLACAT3","AFFECTS","angiogenesis","BLCA(Bladder Urothelial Carcinoma)"
"5184","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","lncRNA BLACAT3","enhance","NCF2 transcription","bladder cancer","BLACAT3","AUGMENTS","angiogenesis","BLCA(Bladder Urothelial Carcinoma)"
"657","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","YBX3","promote","angiogenesis","bladder cancer","YBX3","STIMULATES","angiogenesis","BLCA(Bladder Urothelial Carcinoma)"
"724","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","YBX3","promote","hematogenous metastasis","bladder cancer","YBX3","STIMULATES","angiogenesis","BLCA(Bladder Urothelial Carcinoma)"
"814","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","NCF2 transcription","promote","angiogenesis","bladder cancer","NCF2 transcription","STIMULATES","angiogenesis","BLCA(Bladder Urothelial Carcinoma)"
"97","37612524","M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.","NCF2 transcription","promote","hematogenous metastasis","bladder cancer","NCF2 transcription","STIMULATES","angiogenesis","BLCA(Bladder Urothelial Carcinoma)"
"1314","37605223","m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.","FTO","impair","gemcitabine resistance","pancreatic cancer","FTO","INHIBITS","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"2989","37605223","m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.","FTO","regulate","PTEN/PI3K/AKT pathway","pancreatic cancer","FTO","AFFECTS","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"3877","37605223","m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.","PTEN/PI3K/AKT pathway","influence","NEDD4","pancreatic cancer","PTEN/PI3K/AKT pathway","AFFECTS","NEDD4","PAAD(Pancreatic Adenocarcinoma)"
"4578","37605223","m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.","NEDD4","impair","gemcitabine resistance","pancreatic cancer","NEDD4","INHIBITS","Gemcitabine Resistance","PAAD(Pancreatic Adenocarcinoma)"
"1315","30870073","METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.","METTL3","regulate","m6A","hypoxia/reoxygenation-treated cardiomyocytes","METTL3","AFFECTS","m6A","hypoxia/reoxygenation-treated cardiomyocytes"
"2992","30870073","METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.","ALKBH5","regulate","m6A","hypoxia/reoxygenation-treated cardiomyocytes","ALKBH5","AFFECTS","m6A","hypoxia/reoxygenation-treated cardiomyocytes"
"3882","30870073","METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.","m6A","is on","TFEB mRNA","hypoxia/reoxygenation-treated cardiomyocytes","m6A","LOCATES","TFEB","hypoxia/reoxygenation-treated cardiomyocytes"
"4583","30870073","METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.","TFEB mRNA","dictate","hypoxia/reoxygenation-treated cardiomyocytes","hypoxia/reoxygenation-treated cardiomyocytes","SLC3A2 subunit","AFFECTS","hypoxia/reoxygenation-treated cardiomyocytes","hypoxia/reoxygenation-treated cardiomyocytes"
"1316","33165191","The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-kappaB pathway.","METTL3","promote","inflammation","LPS-induced microglia","METTL3","STIMULATES","inflammatory response","LPS-induced microglia"
"2996","33165191","The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-kappaB pathway.","METTL3","regulate","TRAF6/NF-kappaB pathway","LPS-induced microglia","METTL3","AFFECTS","inflammatory response","LPS-induced microglia"
"3887","33165191","The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-kappaB pathway.","TRAF6/NF-kappaB pathway","promote","inflammation","LPS-induced microglia","TRAF6/NF-kappaB pathway","STIMULATES","inflammatory response","LPS-induced microglia"
"1317","34254281","N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.","FTO","induce","Dysfunctions","Ovarian Granulosa Cells","FTO","CAUSES","dysfunction","Ovarian Granulosa Cells"
"21000","34254281","N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.","FTO","up-regulate","Flotillin 2","Ovarian Granulosa Cells","FTO","STIMULATES","dysfunction","Ovarian Granulosa Cells"
"3891","34254281","N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.","Flotillin 2","induce","Dysfunctions","Ovarian Granulosa Cells","FLOT2","CAUSES","dysfunction","Ovarian Granulosa Cells"
"1318","34462564","The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.","FTO","promote","Osteogenesis","mesenchymal stem cells","FTO","STIMULATES","ossification","Mesenchymal Stem Cells"
"21001","34462564","The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.","FTO","downregulate","PPARG","mesenchymal stem cells","FTO","INHIBITS","ossification","Mesenchymal Stem Cells"
"3894","34462564","The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.","PPARG","inhibit","Osteogenesis","mesenchymal stem cells","PPARG","INHIBITS","ossification","Mesenchymal Stem Cells"
"1319","33785413","Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma.","dummy","target","SLC3A2 subunit of system XC-","Lung Adenocarcinoma","dummy","INTERACTS_WITH","SLC3A2 subunit","LUAD(Lung Adenocarcinoma)"
"21002","33785413","Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma.","SLC3A2 subunit of system XC-","is essential for","YTHDC2","Lung Adenocarcinoma","SLC3A2 subunit","CAUSES","YTHDC2","LUAD(Lung Adenocarcinoma)"
"3897","33785413","Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma.","YTHDC2","induce","Ferroptosis","Lung Adenocarcinoma","YTHDC2","CAUSES","Ferroptosis","LUAD(Lung Adenocarcinoma)"
"1320","25452335","Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.","Meclofenamic acid","inhibit","FTO","Null","meclofenamic acid","INHIBITS","FTO","Null"
"21003","25452335","Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.","Meclofenamic acid","do not inhibit","ALKBH5","Null","meclofenamic acid","INHIBITS","FTO","Null"
"1321","33544495","RNA secondary structure dependence in METTL3-METTL14 mRNA methylation is modulated by the N-terminal domain of METTL3.","N-terminal domain of METTL3","modulate","RNA secondary structure dependence in METTL3-METTL14 mRNA methylation","Null",NA,"AFFECTS",NA,NA
"1322","32656611","Dexmedetomidine Suppressed the Biological Behavior of HK-2 Cells Treated with LPS by Down-Regulating ALKBH5.","Dexmedetomidine","downregulate","ALKBH5","HK-2 Cells","dexmedetomidine","INHIBITS","Biological Behavior","HK-2 Cells treated with LPS"
"21004","32656611","Dexmedetomidine Suppressed the Biological Behavior of HK-2 Cells Treated with LPS by Down-Regulating ALKBH5.","Dexmedetomidine","suppress","Biological Behavior of HK-2 Cells Treated with LPS","HK-2 Cells","dexmedetomidine","INHIBITS","Biological Behavior","HK-2 Cells treated with LPS"
"3904","32656611","Dexmedetomidine Suppressed the Biological Behavior of HK-2 Cells Treated with LPS by Down-Regulating ALKBH5.","ALKBH5","suppress","Biological Behavior of HK-2 Cells Treated with LPS","HK-2 Cells","ALKBH5","INHIBITS","Biological Behavior","HK-2 Cells treated with LPS"
"1323","34530171","Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.","Mettl3","inhibit","Apoptosis","chondrocytes in Inflammation","METTL3","INHIBITS","apoptotic process","chondrocytes in Inflammation"
"21005","34530171","Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.","Mettl3","inhibit","Autophagy","chondrocytes in Inflammation","METTL3","INHIBITS","apoptotic process","chondrocytes in Inflammation"
"3909","34530171","Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.","Mettl3","mediate","m6A","chondrocytes in Inflammation","METTL3","AFFECTS","apoptotic process","chondrocytes in Inflammation"
"4586","34530171","Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.","Ythdf1","bind","m6A","chondrocytes in Inflammation","YTHDF1","INTERACTS_WITH","m6A","chondrocytes in Inflammation"
"5191","34530171","Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.","m6A","mediate","Bcl2 stability","chondrocytes in Inflammation","m6A","AFFECTS","Bcl2 stability","chondrocytes in Inflammation"
"658","34530171","Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.","Bcl2 stability","inhibit","Apoptosis","chondrocytes in Inflammation","Bcl2 stability","INHIBITS","apoptotic process","chondrocytes in Inflammation"
"725","34530171","Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.","Bcl2 stability","inhibit","Autophagy","chondrocytes in Inflammation","Bcl2 stability","INHIBITS","apoptotic process","chondrocytes in Inflammation"
"1324","34286671","miR-302a-3p suppresses melanoma cell progression via targeting METTL3.","miR-302a-3p","suppress","Progression","Melanoma Cell","miR-302a-3p","INHIBITS","progression","SKCM(Skin Cutaneous Melanoma)"
"21006","34286671","miR-302a-3p suppresses melanoma cell progression via targeting METTL3.","miR-302a-3p","target","METTL3","Melanoma Cell","miR-302a-3p","INTERACTS_WITH","progression","SKCM(Skin Cutaneous Melanoma)"
"3914","34286671","miR-302a-3p suppresses melanoma cell progression via targeting METTL3.","METTL3","suppress","Progression","Melanoma Cell","METTL3","INHIBITS","progression","SKCM(Skin Cutaneous Melanoma)"
"1325","32512975","The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.","METTL3","aggravate","Progression","Nasopharyngeal Carcinoma","METTL3","COMPLICATES","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"21007","32512975","The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.","METTL3","regulate","m6A","Nasopharyngeal Carcinoma","METTL3","AFFECTS","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"3920","32512975","The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.","m6A","modify","Snail mRNA","Nasopharyngeal Carcinoma","m6A","AFFECTS","SNAI1","HNSC(Head and Neck Squamous Cell Carcinoma)"
"4590","32512975","The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.","Snail mRNA","induce","EMT","Nasopharyngeal Carcinoma","SNAI1","CAUSES","epithelial to mesenchymal transition","HNSC(Head and Neck Squamous Cell Carcinoma)"
"5197","32512975","The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.","EMT","aggravate","Progression","Nasopharyngeal Carcinoma","epithelial to mesenchymal transition","COMPLICATES","progression","HNSC(Head and Neck Squamous Cell Carcinoma)"
"1326","34491359","METTL3-mediated RNA m6A hypermethylation promotes tumorigenesis and GH secretion of pituitary somatotroph adenomas.","METTL3","mediate","m6A hypermethylation","Pituitary somatotroph adenomas","METTL3","AFFECTS","m6A hypermethylation","Pituitary Somatotroph Adenomas"
"21008","34491359","METTL3-mediated RNA m6A hypermethylation promotes tumorigenesis and GH secretion of pituitary somatotroph adenomas.","m6A hypermethylation","promote","Tumorigenesis","Pituitary somatotroph adenomas","m6A hypermethylation","STIMULATES","Carcinogenesis","Pituitary Somatotroph Adenomas"
"3923","34491359","METTL3-mediated RNA m6A hypermethylation promotes tumorigenesis and GH secretion of pituitary somatotroph adenomas.","m6A hypermethylation","promote","GH secretion","Pituitary somatotroph adenomas","m6A hypermethylation","STIMULATES","Carcinogenesis","Pituitary Somatotroph Adenomas"
